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Prerequisite Skills
and Knowledge:
Participants should have a medical/science
background. Participants may be
researchers, clinicians, laboratorians, veteri-
narians, and other health professionals.
Organized by 
the Centers for Disease Control and Prevention (CDC), 
the Council of State and Territorial Epidemiologists (CSTE), 
the CDC Foundation (CDCF),
the Association for Public Health Laboratories (APHL),
and the World Health Organization (WHO)
The American Society for Microbiology (ASM)
International Conference on
Emerging Infectious Diseases 2002
Program and Abstracts Book
March 24 – 27, 2002
Hyatt Regency
Atlanta, Georgia, USA
I C E I D  2 0 0 2  P R O G R A M  a n d  A B S T R A C T Spage ii
Centers for Disease Control and Prevention (CDC)
Council of State and Territorial Epidemiologists (CSTE)
CDC Foundation (CDCF)
Association of Public Health Laboratories (APHL)
World Health Organization (WHO)
American Society for Microbiology (ASM)
Alliance for the Prudent Use of Antibiotics
American Academy of Pediatrics
American Medical Association
American Public Health Association
American Sexually Transmitted Diseases Association
American Society for Clincal Pathology
American Veterinary Medical Association
Association of State and Territorial Health Officials
College of American Pathologists
Emory University School of Medicine, Division of Infectious Diseases
Fogarty International Center
Food and Drug Administration
ILSA N.A. Technical Committee on Food Microbiology
International Society for Infectious Diseases
International Union of Microbiological Societies
National Association of County and City Health Officials
National Foundation for Infectious Diseases
National Institute of Allergy and Infectious Diseases
Pan American Health Organization
The Robert Wood Johnson Foundation
Rollins School of Public Health at Emory University
U.S. Agency for International Development
U.S. Department of Defense, Global Emerging Infections System
The World Bank
ICEID PARTNERS 2002






Steering Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Scientific Program Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Plenary Sessions at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Invited Panels at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Slide Sessions at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
General Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Satellite Partnership Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Scientific Program
Sunday, March 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Monday, March 25. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Tuesday, March 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Wednesday, March 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Abstracts in Session Order . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Author and Presenter Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
Exhibit Floor Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Inside Back Cover
Hotel Floor Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Back Cover
Table of Contents
I C E I D  2 0 0 2  P R O G R A Mpage 2
Charles Schable, Chair
National Center for Infectious Diseases





National Center for Infectious Diseases









National Center for Infectious Diseases 





National Center for Infectious Diseases





National Center for Infectious Diseases













National Center for Infectious Diseases





National Center for Infectious Diseases





National Center of Infectious Diseases





National Center for Infectious Diseases









National Center for Infectious Diseases









Media Relations Committee 
National Center for Infectious Diseases





National Center for Infectious Diseases





National Center for Infectious Diseases





































































Pan American Health Organization
Washington, DC
Nancy Cox




















U.S. Department of Defense
Silver Springs, MD
Irene Glowinski
National Institutes of Health
Bethesda, MD
Patricia Griffin




























U.S. Department of Defense
Washington, DC
Ali Khan




















Tufts University School of Medicine
Boston, MA 
Art Liang








Centers for Disease Control and
Prevention
Atlanta, GA
continued on next page
PROGRAM COMMITTEE
I C E I D  2 0 0 2  P R O G R A Mpage 4
Susan Maloney
















Food and Drug Administration
Rockville, MD
Steve Monroe




















Infectious Diseases Society of America
Eden Prairie, MN
Christopher Paddock
































American Society for Microbiology
Washington, DC
Charles Schable












Association of Public Health Laboratories
Portland, OR
Harrison Spencer
Association of Schools of Public Health
Washington, DC
Richard Steketee































5:00 p.m. – 7:00 p.m.
14 ICEID 2002 Keynote Session
Patty Stonesifer, Tommy
Thompson, John H. Marburger
Centennial Ballroom
Monday, March 25









17 The Impact of Infectious
Agents on Farming and
Human Health
Peter J. Walker





10:00 a.m. – 11:30 a.m.








65 Trypanosomiasis as a
Reemerging Infection
Anne Moore




Aedes aegypti Control, Mexico
Experiences
Jorge F. Méndez Galváán
Centennial Ballroom III/IV
Wednesday, March 27
8:30 a.m. – 10:00 a.m.
85 Global Drug Resistance: The
Case of Streptococcus 
pneumoniae
Keith Klugman
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Monday, March 25
1:00 p.m. – 2:30 p.m.
39 Zoonotic Diseases
William D. Hueston, Peter











Andrea Ellis, Christine Moe,
Carol Tucker Foreman
Centennial Ballroom III
42 Public Health Policy/Law
Leslie Kux, Richard Hoffman,
Wilfredo Lopez, David Fidler
Centennial Ballroom IV
43 Disease Eradication
Walter Dowdle, Ernesto Ruiz-




1:00 p.m. – 2:30 p.m.
69 Pathogen Discovery
David A. Relman, Carol A.
Glaser, Donald Hunt, Albert
Osterhaus
Centennial Ballroom I
70 Emerging Issues in Healthcare
Settings
Barry Farr, Leonard Mermel,
Julie Gerberding, Trish Perl
Centennial Ballroom II
71 Anthrax 2001: Lessons That
Stunned Us
Steve Wiersma, Marcelle
Layton, James L. Hadler,
Michele L. Pearson
Centennial Ballroom III
72 Preventing Infectious Disease
through Behavior Change 
Emily Zielinski-Gutierrez,
Carmen L. Perez-Guerra, 
Philip S. Makutsa, Rafael Mazin 
Centennial Ballroom IV 








10:30 a.m. – 12:00 noon
89 Emerging Vaccines for
Emerging Diseases
Rajiv Bahn, Gustavo Sierra,
Margaret Ann Liu, Arthur
Friedlander
Centennial Ballroom I
90 Anatomy of Emerging
Infectious Diseases
David Bolton, Dagmar Heim,
Robert Will, Ermias Belay
Centennial Ballroom II
91 Antimicrobial Resistance




92 Infectious Diseases in Aging
Populations




93 Foreign Policy and Infectious
Diseases











10:30 a.m. – 11:30 a.m.
33 Foodborne Illness and
Antibiotic Resistance
S. J. O’Brien, A. Khalakdina, J.
M. Counts, I. S. Fisher
Centennial Ballroom I
34 Vectorborne Diseases I
H. El Sakka, A. E. Platonov, J.
D. Callahan, C. Blackmore
Regency Ballroom V
35 Molecular Diagnostics and
Epidemiology I
P. J. Hoover, C. J. Palmer, A.






3:00 p.m. – 4:30 p.m.
44 Emerging Zoonoses I
Z. Duprey, T. L. Cromeans, Y.
T. Van Duynhoven, Sr., J. G.




D. R. Mayo, K. Musser, D. A.




S. Pitlik, T. St. Louis, P.
Toivanen, H. H. Chang, M.
Starr, Y. Goguet 
Centennial Ballroom III
47 Foodborne and Waterborne
Illness I
M. Widdowson, F. X. Hanon, S.
A. Seys, O. Alvseike, L. Indar,
G. K. Adak
Centennial Ballroom IV
48 Antimicrobial Resistance I
J. Bartkus, S. A. Wang, P. J.
Guerin, I. A. Gillespie, J.
McClellan, J. M. Besser
Centennial Ballroom I
Tuesday, March 26
2:45 p.m. – 4:15 p.m.
74 Emerging Zoonoses II
S. R. Telford, III, D. R.
O’Leary, M. T. Jay, J. H.
McQuiston, M. J. Leslie, M. A.
Guerra
Centennial Ballroom I
75 Foodborne and Waterborne
Illness II
E. Swanson, Q. Phan, C. R.
Braden, M. H. Kennedy, J. A.
Crump, J. Scheftel
Centennial Ballroom II
76 Antimicrobial Resistance II
D. R. Croft, K. Gay, K. Molbak,
J. K. Varma, S. Rossiter, M. C.
Evans
Centennial Ballroom III
77 Vectorborne Diseases II
P. Sen, J. Costa, F. Dantoine, A.
Ammon, P. Effler, G. Comach
Centennial Ballroom IV
78 Prevention and Control
Strategies
C. Dentinger, B. Bolstorff, L.
M. Hammond, Y. T. van
Duynhoven, T. E. Bertrand, G.
A. Mumma
Regency Ballroom V
4:30 p.m. – 6:00 p.m.
79 Molecular Diagnostics and
Epidemiology II
B. Slater, M. Youssef, C.
Fitzgerald, S. B. Hunter, E. J.
Threlfall, S. K. Shukla
Centennial Ballroom I
80 Surveillance and Information
Systems
J. Lee, P. F. Smith, M. G.




F. G. UytdeHaag, D. E.
Salman, M. Kacica, C. Viboud,
L. C. Canas, M. Stoto
Regency Ballroom V
82 Global Health and GIS
M. Yazdanpanah, M. L. Stone,
P. Backenson, J. H. McQuiston,
WHO Global Salm-Surv South






Americans with Disabilities Act Compliance
The Hyatt Regency Atlanta is in compliance with the
Americans with Disabilities Act to the extent of the law. If
special accommodations would enhance your enjoyment of
the conference, please visit the Headquarters Office on the
Ballroom Level. We will make all reasonable accommoda-
tions to ensure your comfort at the meeting.
Audiotapes
Audiotapes of most invited oral sessions will be available
for purchase in the Ballroom Level Lobby of the Hyatt.
Please consult your Program Addendum for a complete 
list of sessions available for sale.
Business Center
Executive Express/Business Center is located in the
Main Lobby of the Hyatt Regency Atlanta. Hours are
posted.
Continuing Education Instructions for 
Physicians, Nurses, Health Educators,
Laboratorians, and Others
All conference participants are eligible for Continuing
Education credit. Award is contingent upon completion 
of an evaluation for every session for which you are
requesting Continuing Education and completion of the
Overall Conference Evaluation. 
Continuing Education credits provided:
Continuing Nursing Education (CNE)
Continuing Medical Education (CME) for physicians 
and nonphysicians
Continuing Education Units (CEU) available for 
other professions
Certified Health Education Specialist (CHES) 
for health educators
Continuing Medical Education (CME) 
This activity has been planned and implemented in accor-
dance with the Essential Areas and policies of the
Accreditation Council for Continuing Education (ACCME)
through the joint sponsorship of Centers for Disease
Control and Prevention (CDC) and the Association for
Public Health Laboratories (APHL) and the Council for
State and Territorial Epidemiologists (CSTE). CDC is
accredited by the ACCME to provide continuing medical
education for physicians and takes responsibility for the
content, quality, and scientific integrity of this CME activity.
CDC designates this educational activity for a maximum 
of 20 hours in category 1 credit towards the AMA
Physician’s Recognition Award. Each physician should
claim only those hours of credit that he/she actually spent
in the educational activity.
Continuing Nursing Education (CNE)
This activity for 24 contact hours is provided by CDC,
which is accredited as a provider of continuing education
in nursing by the American Nurses Credentialing Center’s
Commission on Accreditation.
Continuing Education Units (CEU)
CDC awards 2.0 Continuing Education Units (CEUs).
CDC is an authorized CEU Sponsor of the International
Association for Continuing Education and Training.
Certified Health Education Specialist (CHES)
CDC has been designated as a provider of continuing edu-
cation contact hours in health education by the National
Commission for Health Education Credentialing, Inc. This
conference is a designated event and has been approved
for 20 Category 1 Continuing Education Contact Hours
(CECH) for Certified Health Education Specialist.
Attendance Record and Certificate
Attendees will have two methods for recording ICEID 
session attendance and generating their CE Attendance
Record.
• You may generate your CE Attendance Record on-site
by visiting the Cyber Café in the Hanover Room.
• You may generate your CE Attendance Record on-line
until June 1, 2002, by visiting www.cdc.gov/iceid .
Exhibits
Exhibits will be held in the Grand Hall East (Exhibit
Level) of the Hyatt Regency on Sunday, March 24 through
Tuesday, March 26. Don’t miss the Opening Reception
with food, drink, and camaraderie on Sunday, March 24,
following the Opening Session. Additional Exhibit Hall
hours are from 12:00 noon to 5:00 p.m. on Sunday, March
24, 10:00 a.m. to 6:00 p.m. on Monday, March 25, and 
8:30 a.m. to 1:00 p.m. on Tuesday, March 26.
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GENERAL INFORMATION
Headquarters Office
The ICEID Headquarters Office, located on the Ballroom
Level, will be open and staffed during registration hours.
Feel free to come to us with questions or concerns.
Cyber Café
The CDC is providing internet access for your convenience
during registration hours in the Hanover Room.
Presentations Available Online
You will be able to hear the audio and see the slides of
selected plenary, invited panel, and slide sessions on the
Web (www.cdc.gov/iceid) beginning April 1, 2002. You may
receive continuing education credits by watching presenta-
tions on line at www.cdc.gov/iceid.
Press Room
Press representatives are welcome at the ICEID. Please
check in at the Press Room, located in the Fairlie Room.
Program Addendum
In addition to this program, registrants receive a Program
Addendum, which incorporates all Late-Breaker Abstracts,
additions to the Program, and changes made after this
Program went to press.
Registration
To maintain the quality and size of the conference to
ensure meaningful scientific exchange, registration at the
ICEID is limited to 2,500 attendees. On-site registration is
only available if fewer than 2,500 individuals preregister.
Registration will be open during the following times to
answer your questions and provide information on the
meeting and Atlanta:
Sunday, March 24 . . . . . . . . . 12:00 noon – 5:30 p.m.
Monday, March 25 . . . . . . . . 8:00 a.m. – 6:00 p.m.
Tuesday, March 26 . . . . . . . . 8:00 a.m. – 6:00 p.m.
Wednesday, March 27 . . . . . . 8:00 a.m. – 12:00 noon
Speaker Ready Room
Speakers may preview materials in the Speaker Ready
Room, located in the Greenbriar Room. The room is open
during registration hours Sunday, Monday, and Tuesday.
Speakers should come by the Speaker Ready Room at their
earliest convenience to ensure presentations are in order.  
Professional audiovisual consultants will be available for
assistance. Both Mac and PC platforms will be available.
Presenters will have the opportunity to review, update, or
make changes on computers in the Speaker Ready Room.
Presenters using PowerPoint must visit the Speaker Ready
Room at least 30 minutes prior to their session in order to
upload their presentation.
Slide trays and caramates will be available for those pre-
senters not using PowerPoint. Also provided will be blank
labels to write name, and session number to identify your
slide carousel. Speakers using slides should take their
labeled slide carousel to the projectionist stationed in the
session room.
Verification of Attendance
Conference attendees requiring a letter verifying their
attendance should visit the Headquarters Office during
























8:00 a.m. – 4:30 p.m.
Southern Cone and Amazon Network Surveillance





8:00 a.m. – 4:30 p.m.
Southern Cone and Amazon Network Surveillance




9:00 a.m. – 12:00 noon
Pandemic Planning Discussion 
Contact: Ann Moen
Room: Baker
12:00 noon – 4:00 p.m.
Asia Pacific Economic Cooperation
Infectious Disease Strategy Discussion
Contact: Melinda Moore
Room: Auburn





5:30 p.m. – 7:30 p.m.
DTRA Reception
Opportunities for U.S. Scientists with Defense




6:00 p.m. – 9:00 p.m.
WHO Global Salm-Surv Meeting (open) 
Contact: Beth Imhoff
Room: Chicago AB
7:00 p.m. – 9:00 p.m.
IOM Report on Microbial Threats to Health
Contact: Mark Smolinsky
Room: Regency Ballroom V
Tuesday, March 26










Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East




Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East




Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 36-37.
Session 4
Poster Session
Emerging Nosocomial Infections 
Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East




Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East




Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 42-47.
Session 7
Poster Session
Evolutionary Potential of Viruses
Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East




Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 48-57.
Session 9
Poster Session
GIS and Remote Sensing
Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East




Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 58-59.
Session 11
Poster Session
Infectious Causes of Chronic Diseases 
Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 60-61.
Session 12
Poster Session
Prevention and Control Programs
Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 61-63.









Surveillance and Information Systems Technology
Sunday, March 24, 12:00 noon – 5:00 p.m.; Authors
present 3:30 p.m. – 5:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 63-68.
Session 14
ICEID 2002 Keynote Session
Sunday, March 24, 5:00 p.m. – 7:00 p.m. 
Centennial Ballroom
PATTY STONESIFER, Co-chair and President, Bill and
Melinda Gates Foundation, Seattle, WA
TOMMY THOMPSON, Secretary, U.S. Department of Health
and Human Services, Washington, DC
JOHN H. MARBURGER, Director, White House Office of




Monday, March 25, 7:30 a.m. – 8:15 a.m.
Regency Ballroom VI/VII
Emerging Vectorborne Infections
DUANE GUBLER, CDC, Fort Collins, Co
BARRY BEATY, Colorado State University, Fort Collins, CO
Laboratory Capacity
RAY ARTHUR, World Health Organization, Geneva, Switzerland
Session 16
Plenary Session I
Monday, March 25, 8:30 a.m. – 10:00 a.m.
Centennial Ballroom I/II
Moderators:
CLAIRE BROOME, CDC, Atlanta, GA
RICHARD GUERRANT, University of Virginia Hospital,
Charlottesville, VA
Bioterrorism Preparedness: Lessons, Challenges,
and Opportunities
JAMES HUGHES, CDC, Atlanta, GA
Emerging and Reemerging STDs




Monday, March 25, 8:30 a.m. – 10:00 a.m.
Centennial Ballroom III/IV
Moderators:
BRIAN MAHY, CDC, Atlanta, GA
MORRIS POTTER, Food and Drug Administration, Atlanta, GA
The Impact of Infectious Agents on Farming and
Human Health
PETER J. WALKER, CSIRO Livestock Industries, Indooroopilly,
Australia
The Interface of Animal and Human Health





Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 69-77.
Session 21
Poster Session
Syndromes and Diagnosis I
Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 81-83.




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 84-86.
Session 26
Poster Session
Emerging Aspects of HIV and STDs
Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Molecular Epidemiology I 
Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




New or Rapid Diagnostics I
Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East





Monday, March 25, 10:00 a.m. – 6:00 p.m.; Authors
present 4:30 p.m. – 6:00 p.m.
Grand Hall East




Foodborne Illness and Antibiotic Resistance
Monday, March 25, 10:30 a.m. – 11:30 a.m. 
Centennial Ballroom I
Moderators:
JANET NICHOLSON, CDC, Atlanta, GA
DEBORAH LEVY, CDC, Atlanta, GA
Campylobacter coli – What’s the Big Deal? 
S. J. O’Brien, G. K. Adak, S. M. Long, I. A. Gillespie, J. A. Frost
Public Health Laboratory Service, London, UNITED KINGDOM
Is Drinking Water a Risk Factor for Endemic
Cryptosporidiosis in the Immunocompetent
General Population of the San Francisco Bay Area? 
A. Khalakdina1,2,3, D. J. Vugia2,4, J. Nadle2, J. M. Colford, Jr.1,2
1Division of Public Health Biology and Epidemiology, Centers for
Family & Community Health and Occupational & Environmental
Health, School of Public Health, University of California at Berkeley,
Berkeley, CA, 2California Emerging Infections Program, Oakland, CA,
3Community Health Epidemiology and Disease Control, San
Francisco Department of Public Health, San Francisco, CA, 4Division
of Communicable Disease Control, California Department of Health
Services, Berkeley, CA
Washington Clinical Laboratory Initiative –
Assessment of Laboratory Practice 
J. M. Counts






















Real-Time International Surveillance of
Antimicrobial Resistance by the Enter-net
Surveillance Network
I. S. Fisher1, N. Gill1, B. Reilly2, H. Smith3, J. Threlfall3, on behalf
of the Enter-net participants4
1PHLS Communicable Disease Surveillance Centre, London,
UNITED KINGDOM, 2Scottish Centre for Infection and
Environmental Health, Glasgow, UNITED KINGDOM, 
3PHLS Central Public Health Laboratory, London, UNITED





Monday, March 25, 10:30 a.m. – 11:30 a.m. 
Regency Ballroom V
Moderators:
BARRY BEATY, Colorado State University, Ft. Collins, CO
LYLE PETERSEN, CDC, Ft. Collins, CO
The Emergence of Rift Valley Fever in the Arabian
Peninsula, 2000 
H. El Sakka1, R. Graham1, E. Mohareb1, D. Salma1, S. Lewis1, A.
El Kholy2, M. Ibrahim2, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Field
Epidemiology Training Program, Egyptian Ministry of Health and
Population, Cairo, EGYPT, 3CDC, Atlanta, GA
Microheterogenicity of the Volgograd Clone of
West Nile Virus 
A. E. Platonov1, L. S. Karan1, S. B. Yazyshina1, K. O. Mironov1, E.
M. Krasnova2, V. V. Lazorenko2, N. V. Rusakova2, A. N. Zhukov2, V.
A. Antonov3, I. L. Obukhov4, G. A. Shipulin1
1Central Research Institute of Epidemiology, Moscow, RUSSIAN
FEDERATION, 2State Center for Sanitary and Epidemic Control,
Volgograd, RUSSIAN FEDERATION, 3Anti-Plague Institute,
Volgograd, RUSSIAN FEDERATION, 4State Institute for Control
of Veterinary Products, Moscow, RUSSIAN FEDERATION
Rapid Screening and Identification of West Nile
Virus in Captive and Wild Birds Using Non-
Invasive Environmental Samples and a Portable
TaqMan RT-PCR
J. D. Callahan1, T. S. McNamara2, A. L. Glaser3, M. Turell4, K.
Gaffney1, S. Ellis1, W. M. Nelson1
1Tetracore, Inc, Gaithersburg, MD, 2Wildlife Conservation Society,
New York, NY, 3Cornell University, Ithaca, NY, 4US Army Medical
Research Institute of Infectious Diseases, Fort Detrick, MD
West Nile Virus First Transmission Season in
Florida, 2001 – More than 400 Horse Cases and
170 Chicken Seroconversions but Only Sporadic
Human Disease
C. Blackmore1, L. M. Stark2, R. L. Oliveri3, L. A. Conti3, S. T.
Wiersma3
1Florida Department of Health, Jacksonville, FL, 2Florida




Molecular Diagnostics and Epidemiology I
Monday, March 25, 10:30 a.m. – 11:30 a.m. 
Centennial Ballroom III
Moderators:
JAMIE MAGUIRE, CDC, Atlanta, GA
STEVE MORSE, CDC, Atlanta, GA
A Molecular Approach to the Epidemiology of
Giardia duodenalis in a Peruvian Shantytown 
P. J. Hoover1, C. Reed1, G. D. Sturbaum1, R. H. Gilman2, 
C. R. Sterling1
1University of Arizona, Tucson, AZ, 2Johns Hopkins University,
Baltimore, MD
Increasing Detection of Malaria in U.S. Hospitals
Using the OptiMAL Rapid Diagnostic Test 
C. J. Palmer1, J. A. Bonilla1, D. A. Bruckner2, E. Barnett3, N. S.
Miller4, J. Masci5, M. A. Haseeb6
1University of Florida, Gainesville, FL, 2UCLA Medical Center,
Los Angeles, CA, 3Boston Medical Center, Boston, MA,
4Washington Hospital Center, Washington, DC, 5Elmhurst Hospital
Center, Elmhurst, NY, 6Kings County Hospital, Brooklyn, NY
Incidence and Type Distribution of Astrovirus
Among Spanish Children 
R. M. Dalton1, E. Roman2, N. Negredo1, I. Wilhelmi3, 
A. Sánchez Fauquier1
1Centro Nacional de Microbiología, Madrid, SPAIN, 2Servicio de
Pediatría, Hospital Severo Ochoa, Leganés, Madrid, SPAIN,
3Servicio de Microbiología, Hospital Severo Ochoa, Leganés,
Madrid, SPAIN
Detection and Typing of Enterovirus in
Cerebrospinal Fluid 
B. I. Rosen, B. Slater, M. Dupuis, R. Hull, R. Ferrera, C. Huang




Monday, March 25, 10:30 a.m. – 11:30 a.m.
Centennial Ballroom IV
Moderators:
STEVE OSTROFF, CDC, Atlanta, GA




Monday, March 25, 10:30 a.m. – 11:30 a.m. 
Centennial Ballroom II
Moderators:
D. A. HENDERSON, U.S. Department of Health and 
Human Services
HAROLD MARGOLIS, CDC, Atlanta, GA
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Session 38
Bring-Your-Lunch
First Encounters with New Diseases: The
Clinician’s Perspective
Monday, March 25, 11:30 a.m. – 1:00 p.m.
Regency Ballroom VI/VII
Moderator:
MERLE A. SANDE, University of Utah, Salt Lake City, UT
AIDS in Rural Tennessee: The Search for Meaning
in a Medical Life
ABRAHAM VERGHESE, Texas Tech University Health Sciences




Monday, March 25, 1:00 p.m. – 2:30 p.m. 
Centennial Ballroom I
Conveners/Moderators: 
JAMIE CHILDS, CDC, Atlanta, GA
CHERIE DRENZEK, National Association of Public Health
Veterinarians, Atlanta, GA
Surveillance of Livestock for Zoonotic Diseases and
Veterinary Bio-threat Agents
WILLIAM D. HUESTON, College of Veterinary Medicine,
University of Minnesota, St. Paul, MN 
The Emergence of Infectious Diseases Among
Wildlife and the Origin of Human Zoonoses
PETER DASZAK, Consortium for Conservation Medicine,
Palisades, NY
Shared Animal and Human Influenza Viruses: A
Role in the Next Pandemic? 
KENNEDY F. SHORTRIDGE, University of Hong Kong, Queen
Mary Hospital, HONG KONG
Preventing Human Disease by Controlling
Pathogen Transmission in the Animal Reservoir 




Monday, March 25, 1:00 p.m. – 2:30 p.m. 
Centennial Ballroom II
Conveners/Moderators:
ROBERT PINNER, CDC, Atlanta, GA
DALE MORSE, New York State Department of Health, 
Albany, NY
Syndromic Surveillance in a Managed Care Setting
RICHARD PLATT, Harvard Medical School, Boston, MA
Bioterrorism Surveillance in New York City
FARZAD MOSTASHARI, New York City Department of Health,
New York, NY
CD Electronic Surveillance in the United Kingdom
and European Union
MICHAEL CATCHPOLE, PHLS Communicable Disease
Surveillance Centre, London, UNITED KINGDOM
PULSENET and Beyond




Monday, March 25, 1:00 p.m. – 2:30 p.m.
Centennial Ballroom III
Conveners:
PAUL BERGER, Environmental Protection Agency,
Washington, DC
DEBORAH LEVY, CDC, Atlanta, GA
ART LIANG, CDC, Atlanta, GA
Moderators:
PAUL BERGER, ART LIANG
Public Health and Policy Implications of the
Recent Large Drinking Water Outbreaks in Canada
ANDREA ELLIS, Center for Infectious Diseases Prevention and
Control, Guelph, Ontario, CANADA
The Risk of Food and Water Contamination from
Animal Manure
CHRISTINE MOE, Rollins School of Public Health, Emory
University, Atlanta, GA
Food Safety: Perceived Risk and Public Trust





Monday, March 25, 1:00 p.m. – 2:30 p.m. 
Centennial Ballroom IV
Conveners/Moderators:
RICK GOODMAN, CDC, Atlanta, GA
JOEL GAYDOS, U.S. Department of Defense, Washington, DC
Foodborne Disease
LESLIE KUX, U.S. Food and Drug Administration, Rockville, MD
Bioterrorism
RICHARD HOFFMAN, Colorado Department of Public Health
and Environment, Denver, CO
West Nile Virus Outbreak in New York City
WILFREDO LOPEZ, New York City Department of Health, New
York, NY
Global Health and International Regulations

























Monday, March 25, 1:00 p.m. – 2:30 p.m.
Regency Ballroom V
Conveners:
CAROLYN BLACK, CDC, Atlanta, GA
WALTER DOWDLE, Task Force for Child Survival and
Development, Atlanta, GA
FRANK RICHARDS, CDC, Atlanta, GA
Moderators: 
FRANK RICHARDS, CAROLYN BLACK
Overview
WALTER DOWDLE, Task Force for Child Survival and
Development, Atlanta, GA
Eradication of Dracunculiasis
ERNESTO RUIZ-TIBEN, CDC, Atlanta, GA
Eradication of Lymphatic Filariasis and
Onchocerciasis
ERIC OTTESEN, Rollins School of Public Health, Emory
University, Atlanta, GA
Eradication of Chagas Disease
GABRIEL SCHMUNIS, Pan American Health Organization,
Washington, DC
Eradication of T. solium Cysticercosis




Monday, March 25, 3:00 p.m. – 4:30 p.m.
Regency Ballroom V
Moderators:
FREDERICK A. MURPHY, School of Veterinary Medicine,
University of California, Davis, CA
SHERIF ZAKI, CDC, Atlanta, GA
Emergence of Canine Visceral Leishmaniasis in
Dogs in North America
Z. Duprey1, P. M. Schantz1, F. Steurer1, J. Jackson2, J. Rooney3, E.
Rowton4, M. Gramiccia5, E. Breitschwerdt6
1Division of Parasitic Diseases, NCID, CDC, Atlanta, GA, 2Walter
Reed Army Institute of Research, Silver Spring, MD, 3Virginia
State Department of Health, Richmond, VA, 4Walter Reed Army
Institute of Research, Washington, D.C., DC, 5Institute of Public
Health, Rome, ITALY, 6College of Veterinary Medicine, North
Carolina State University, Raleigh, NC
Detection and Genetic Analysis of Swine Hepatitis
E Virus in Farm Waste 
T. L. Cromeans1,2, A. S. Foust1,2, A. E. Fiore1, M. D. Sobsey2, B. P.
Bell1, H. S. Margolis1, B. H. Robertson1
1CDC, Atlanta, GA, 2University of North Carolina, Chapel Hill, NC
Enhanced Laboratory-based Surveillance of 
Shiga Toxin-Producing Escherichia coli O157, 
the Netherlands
Y. T. Van Duynhoven, Sr.1, C. M. De Jager1, A. E. Heuvelink, Sr.2,
W. K. Van der Zwaluw1, H. M. Maas1, W. Van Pelt, Sr.1, W. J.
Wannet, Sr.1
1National Institute of Public Health and the Environment,
Bilthoven, NETHERLANDS, 2Inspectorate for Health Protection
and Veterinary Public Health, Zutphen, NETHERLANDS
Outbreaks of Multidrug-Resistant Salmonella
Serotype Typhimurium Infections Associated with
Small Animal Veterinary Facilities in Idaho,
Minnesota and Washington, 1999 
J. G. Wright1, K. E. Smith2, L. Tengelsen3, J. Grendon4, D.
Boxrud2, B. Holland1, A. D. Anderson1
1CDC, Atlanta, GA, 2Minnesota Department of Health,
Minneapolis, MN, 3Idaho Department of Health and Welfare,
Boise, ID, 4Washington State Department of Health, Olympia, WA
An Outbreak of Salmonella Javiana Associated with
Amphibian Contact – Mississippi, 2001 
P. Srikantiah1, J. C. Lay1, J. A. Crump1, S. Hand2, J. Campbell2, V.
Janakiraman1, H. Fletemier1, R. Middendorf1, S. Van Duyne1, M.
Currier2, P. S. Mead1, K. Molbak1
1CDC, Atlanta, GA, 2Mississippi State Department of Health,
Jackson, MS
Outbreaks of Salmonellosis at Elementary Schools
Associated with Dissection of Owl Pellets 
F. Anderson1, C. Medus2, F. Leano2, J. Adams2, K. Smith2
1Washington County Department of Public Health and





Monday, March 25, 3:00 p.m. – 4:30 p.m. 
Centennial Ballroom II
Moderators:
RONALD ATLAS, University of Louisville, Louisville, KY
EDWARD EITZEN, U. S. Army Medical Research Institute of
Infectious Diseases, Fort Detrick, MD
Public Health Laboratory Response to an Anthrax
Incident in Connecticut 
D. Barden, T. Brennan, G. Budnick, E. Gaynor, A. Kinney, D. R.
Mayo, M. Ridley, K. Kelley
Connecticut State Health Department, Hartford, CT
Rapid Molecular Identification of B. anthracis in
New York State in Response to Recent
Bioterrorism Incidents 
K. Musser, M. Kelly, S. Davis, C. Egan, N. Dumas, A. Waring, T.
Halse, P. Maupin, K. Hechemy, J. Hibbs, D. Morse, R. Limberger
New York State Department of Health, Albany, NY
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Laboratory Response in the Commonwealth 
of Virginia to the Intentional Release of 
Bacillus anthracis
D. A. Pettit, J. V. Carroll, E. M. Basinger, M. R. Ettinger, S. S.
Walker, T. L. York, J. L. Pearson
Division of Consolidated Laboratory Services, Richmond, VA
Monitoring of Human Exposure to Bacillus
thuringiensis after Aerial Applications for 
Insect Control
D. B. Levin, G. V. de Amorim
University of Victoria, Victoria, BC, CANADA
Threat Letter Menace: The Fiji Experience 
K. Kishore1, E. Buadromo2, S. Singh2
1Fiji School of Medicine, Suva, FIJI, 2Colonial War Memorial
Hospital, Suva, FIJI
Enhanced Emergency Department Surveillance
System Following the World Trade Disaster – New
York City, September 14 to October 10, 2001 
D. Das1, D. Weiss1, S. Balter1, T. Treadwell2, J. McQuiston2, L.
Hutwagner2, A. Karpati2,1, F. Mostashari1, K. Bornschlegel1, B.
Cherry1, S. Mathew2, A. Fine1, M. Layton1





Monday, March 25, 3:00 p.m. – 4:30 p.m. 
Centennial Ballroom III
Moderators:
SIOBHAN O’CONNOR, CDC, Atlanta, GA
CLADD STEVENS, New York Blood Center, New York, NY
Failure to Detect C. pneumoniae in Atherosclerotic
Specimens from Major Arteries of 93 Patients
J. Bishara1, S. Pitlik1, A. Vojdani2, A. Kazakov1, G. Sahar1, M.
Haddad1, S. Rosenberg3, Z. Samra3
1Rabin Medical Center; Beilinson Campus, Petach-Tikva, ISRAEL,
2Immunosciences Lab, Inc., Drew University School of Medicine
and Science, Los Angeles, CA, 3Chlamydia and Mycoplasma
National Center, Department of Microbiology. Rabin Medical
Center, Beilinson Campus, Petach-Tikva, ISRAEL
Prevalence of Hepatitis C and Other Chronic Liver
Disease Etiologies in Primary Care Practices 
T. St. Louis1, V. Navarro1, A. Sofair1, B. Bell2
1Connecticut Emerging Infections Program, New Haven, CT,
2CDC, Atlanta, GA
Intestinal Anaerobic Bacteria in Early 
Rheumatoid Arthritis 
R. Manninen1, S. Vartiainen1, J. Jalava1, R. Luukkainen2, T.
Möttönen3, E. Eerola1, P. Toivanen1
1Department of Medical Microbiology, Turku University, Turku,
FINLAND, 2Satalinna Hospital, Harjavalta, FINLAND, 3Division
of Rheumatology, Department of Medicine, Turku University
Central Hospital, Turku, FINLAND
Postdiarrheal Hemolytic Uremic Syndrome in 
New York State 
B. Tserenpuntsag, H. H. Chang, M. Kacica, P. F. Smith, 
D. L. Morse
New York State Department of Health, Albany, NY
Outbreak of Cryptococcus neoformans var. gattii 
in a Restricted Zone in British Columbia 
M. Starr1, M. Fyfe1, W. Black1, P. Kibsey2, L. MacDougall1, S.
Mak1, M. Pearce3, J. Isaac-Renton1, M. Romney1, L. Stein1, C.
Stephen4, D. Patrick1
1University of British Columbia Centre for Disease Control,
Vancouver, BC, CANADA, 2Victoria General Hospital, Victoria,
BC, CANADA, 3Capital Health Region, Victoria, BC, CANADA,
4Centre for Coastal Health, Nanaimo, BC, CANADA
Tuberculosis Gene Deletion Typing, Not YATM
(“Yet Another Typing Method”) 
Y. Goguet
Stanford University, Stanford, CA
Session 47
Slide Session
Foodborne and Waterborne Illness I
Monday, March 25, 3:00 p.m. – 4:30 p.m. 
Centennial Ballroom IV
Moderators:
ROGER GLASS, CDC, Atlanta, GA
MARGUERITE NEILL, Memorial Hospital of Rhode Island,
Providence, RI
Outbreak of Viral Gastroenteritis and an Ill Baker
Who Should Have Known Better: Novel
Application of Email for Rapid Investigation 
M. Widdowson1, M. A. de Wit2, H. Vennema2, M. Koopmans2
1CDC, Atlanta, GA, 2National Institute of Public Health and the
Environment, Bilthoven, NETHERLANDS
Challenges in the Interpretation of Classical 
and Molecular Epidemiology Results; Two
Calicivirus Outbreaks Due to Oysters: Denmark 
at New Year 2000 
F. X. Hanon1, S. Corbet1, B. Böttiger1, A. C. Schultz2, P. Saadbye2,
A. Perge2, K. Mølbak1
1Statens Serum Institut, Copenhagen, DENMARK, 2National
Food Agency, Søborg, DENMARK
Coordinating Environmental Public Health
Practice with Epidemiology and Laboratory
Analysis: A Waterborne Outbreak of “Norwalk-like
Virus” in the Big Horn Mountains of Wyoming 
S. A. Seys1, H. M. Mainzer2, A. G. Heryford1, A. D. Anderson3,4, S.
S. Monroe4, G. S. Fout5, J. P. Sarisky2, K. J. Musgrave1
1Wyoming Department of Health, Cheyenne, WY, 2National
Center for Environmental Health, CDC, Atlanta, GA,
3Epidemiology Program Office, CDC, Atlanta, GA, 4National
Center for Infectious Diseases, CDC, Atlanta, GA, 5National























Sesame-Seed Paste Caused an International
Outbreak Due to Salmonella Typhimurium 
DT104 – The Investigation in Norway 
O. Alvseike1, P. J. Guerin1,2, T. Stavnes1, P. Aavitsland1
1Norwegian Institute of Public Health, Oslo, NORWAY, 2EPIET
(European Programme for Intervention Epidemiology Training),
Oslo, NORWAY
Changing Epidemiological Patterns of Salmonella
Serotype Enteritidis in Barbados: Implications for
Tourism and Trade 
L. Indar1, P. N. Levett2, R. Knight3, M. Ingram3, E. Commissiong1,
G. Baccus-Taylor1, P. Prabhakar4, J. Hospedales4
1University of the West Indies, St.Augustine, TRINIDAD AND
TOBAGO, 2University of the West Indies, Bridgetown, BARBA-
DOS, 3Ministry of Health, Bridgetown, BARBADOS, 4CAREC,
Port of Spain, TRINIDAD AND TOBAGO
Health Impact of the Salmonella enterica Serotype
Enteritidis Phage Type 4 Epidemic 
G. K. Adak, S. M. Long, S. J. O’Brien, L. R. Ward




Monday, March 25, 3:00 p.m. – 4:30 p.m. 
Centennial Ballroom I
Moderators:
JULIE GERBERDING, CDC, Atlanta, GA
ROBERT WEINSTEIN, Cook County Hospital, Chicago, IL
Antibiotic Susceptibility and the Mechanisms of
Macrolide Resistance in Invasive Group B
Streptococcus, Minnesota, 1998 and 2000
J. Bartkus, C. Morin, S. Vetter, E. Thompson, A. Glennen, 
R. Lynfield
Minnesota Department of Health, Minneapolis, MN
Multi-Drug Resistant Neisseria gonorrhoeae with
Decreased Susceptibility to Cefixime, Hawaii, 2001 
S. A. WANG1, M. V. Lee2, C. J. Iverson1, N. O’Connor3, R. G.
Ohye2, J. A. Hale4, J. S. Knapp1, P. V. Effler2, H. S. Weinstock1
1CDC, Atlanta, GA, 2Hawaii Dept of Health, Honolulu, HI,
3Hawaii Dept of Health State Laboratory, Pearl City, HI, 4Seattle
GISP Laboratory, Seattle, WA
Shigella dysenteriae Serotype 1 in West Africa:
Intervention Strategy for an Outbreak in Sierra
Leone, 1999-2000 
P. J. Guerin1,2,3, C. Brasher4, E. Baron4, D. Mic4, F. Grimont5, M.
Ryan6, P. Aavitsland3, D. Legros1
1Epicentre, Paris, FRANCE, 2EPIET (European Programme for
Intervention Epidemiology Training), Oslo, NORWAY, 3Norwegian
Institute of Public Health, Oslo, NORWAY, 4Médecins Sans
Frontières, Paris, FRANCE, 5Centre National de Référence de
Typage Moléculaire Entérique. Unité Biodiversité des Bactéries
Pathogènes Emergentes. Institut Pasteur, Paris, FRANCE,
6Department of Communicable Disease Surveillance and
Response, World Health Organisation, Geneva, SWITZERLAND
The Acquisition of Ciprofloxacin Resistance 
in Travel-Associated and Home-Acquired
Campylobacter jejuni Infection: A Case-
Case Comparison
I. A. Gillespie1, S. J. O’Brien2, J. A. Frost2
1Public Health Laboratory Service, London, UNITED KING-
DOM, 2Public Health laboratory Service, London, UNITED
KINGDOM
Prevalence and Consequences of Fluoroquinolone-
Resistant Campylobacter Infections: NARMS
1997-2000 
J. McClellan, S. Rossiter, K. Joyce, K. Stamey, A. D. Anderson,
and the NARMS Working Group
CDC, Atlanta, GA
High Prevalence of Antibiotic Resistance in
Enterotoxigenic E. coli (ETEC); Minnesota 
2000 - 2001 
J. M. Besser, K. Smith, C. Taylor, P. Gahr, C. Medus




Tuesday, March 26, 7:30 a.m. – 8:30 a.m.
Regency Ballroom VI/VII
Moderators:
RAY ARTHUR, World Health Organization, Geneva,
SWITZERLAND
JAMES LEDUC, CDC, Atlanta, GA
CDC-PAHO Collaboration: Surveillance of
Emerging/Reemerging Diseases in the Amazon and
the Southern Cone Region
GABRIEL SCHMUNIS, Pan American Health Organization,
Washington, DC
Eradication of Chagas’ Disease
GABRIEL SCHMUNIS, Pan American Health Organization,
Washington, DC
Emerging Infectious Diseases – India
N.K. GANGULY, Indian Council of Medical Research, New
Delhi, INDIA
Protecting the Nation’s Health in an Era of
Globalization: CDC’s Global Infectious Disease
Strategy




Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see pages 
127-136.
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Session 51
Poster Session
Syndromes and Diagnosis II
Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East




Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East




Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East




Detection of Novel Agents
Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East





Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East





Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East





Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East




Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East





Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East





Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East





Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East




New or Rapid Diagnostics II
Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East
























Prions and Public Health
Tuesday, March 26, 8:30 a.m. – 1:00 p.m.; Authors
present 8:30 a.m. – 10:00 a.m.
Grand Hall East
For a complete listing of poster titles and abstracts, see page 164.
Session 64
Plenary Session III
Tuesday, March 26, 10:00 a.m. – 11:30 a.m. 
Centennial Ballroom I/II
Moderators:
BRIAN MAHY, CDC, Atlanta, GA
ROBERT TAUXE, CDC, Atlanta, GA
Foot and Mouth Disease
CHRISTOPHER BOSTOCK, Institute of Animal Health,
Compton, UNITED KINGDOM
Integrated Surveillance and Control of Emerging
Foodborne Diseases—The Successful Danish
Experience
HENRIK C. WEGENER, Danish Zoonosis Institute, DENMARK
Session 65
Plenary Session IV
Tuesday, March 26, 10:00 a.m. – 11:30 a.m. 
Centennial Ballroom III/IV
Moderators:
ENRIQUETA C. BOND, The Burroughs Wellcome Fund,
Research Triangle Park, NC
DUANE GUBLER, CDC, Fort Collins, CO
Trypanosomiasis as a Reemerging Infection
ANNE MOORE, CDC, Atlanta, GA
New Strategies on the Old Ideas: Malaria Control
Without Insecticides and Community Participation
in Aedes aegypti Control, Mexico Experiences




First Encounters with New Diseases: The
Clinician’s Perspective
Tuesday, March 26, 11:30 a.m. – 1:00 p.m.
Regency Ballroom VI/VII
Moderator:
RIMA KHABBAZ, CDC, Atlanta, GA
HAROLD JAFFE, CDC, Atlanta, GA
AIDS
MICHAEL S. GOTTLIEB, Los Angeles, CA
West Nile Virus Infection
DEBORAH ASNIS, Brooklyn, NY
Hantavirus Pulmonary Syndrome




Tuesday, March 26, 1:00 p.m. – 2:30 a.m. 
Centennial Ballroom I
Conveners: 
LARRY ANDERSON, CDC, Atlanta, GA




IAN LIPKIN, Mailman School of Public Health, Columbia
University, New York, NY
Multiple Array Technology To Look for mRNA
Patterns Associated with Disease and Pathogens
DAVID A. RELMAN, Stanford University, Stanford, CA
Clusters of Clinical Syndromes in Patients with
Unexplained Encephalitis
CAROL A. GLASER, California Department of Health Services,
Berkeley, CA 
Proteomics and Pathogen Discovery
DONALD HUNT, University of Virginia, Charlottesville, VA
The New Human Metapneumovirus




Emerging Issues in Healthcare Settings
Tuesday, March 26, 1:00 p.m. – 2:30 p.m. 
Centennial Ballroom II
Conveners/Moderators: 
WILLIAM JARVIS, CDC, Atlanta GA
GEORGIA DASH, Association for Professionals in Infection
Control and Epidemiology, Washington, DC
Controlling Antimicrobial Resistance
BARRY FARR, University of Virginia Hospital, Charlottesville, VA
Prevention of Device-Associated Infections
LEONARD MERMEL, Rhode Island Hospital, Providence, RI 
Patient Safety: Applying Industrial Quality Models
in Healthcare Settings To Improve Outcomes
JULIE GERBERDING, CDC, Atlanta, GA
The Role of Healthcare Systems in Bioterrorism
Preparedness
TRISH PERL, Johns Hopkins Hospital, Baltimore, MD
Session 71
Invited Panel
Anthrax 2001: Lessons That Stunned Us
Tuesday, March 26, 1:00 p.m. – 2:30 p.m. 
Centennial Ballroom III
Conveners:
RIMA KHABBAZ, CDC, Atlanta, GA
BRADLEY PERKINS, CDC, Atlanta, GA
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Moderators:
ANDREA MEYERHOFF, Food and Drug Administration,
Washington, DC
BRADLEY PERKINS
Inhalation Anthrax in Florida
STEVE WIERSMA, Florida Department of Health, 
Tallahassee, FL
Cutaneous Anthrax in New York City
MARCELLE LAYTON, New York City Department of Health,
New York, NY
Inhalation Anthrax of Unknown Source
JAMES L. HADLER, Connecticut Department of Public Health,
Hartford, CT
Anthrax in the U.S. Postal System
MICHELE L. PEARSON, CDC, Atlanta, GA
Session 72
Invited Panel
Preventing Infectious Disease through Behavior
Change
Tuesday, March 26, 1:00 p.m. – 2:30 p.m. 
Centennial Ballroom IV
Conveners:
STEPHEN CORBER, Pan American Health Organization,
Washington, DC
MEREDITH HICKSON, CDC, Atlanta, GA
BOBBIE PERSON, CDC, Atlanta, GA
Moderators:
MITCH COHEN, CDC, Atlanta, GA
MEREDITH HICKSON
The Essential Role of Behavioral and Social
Sciences in the Prevention of Emerging 
Infectious Diseases
EMILY ZIELINSKI-GUTIERREZ, CDC, Fort Collins, CO
Bringing Dengue Prevention Down to Earth:
Evaluation of a Head Start Project in Puerto Rico
CARMEN L. PEREZ-GUERRA, CDC, San Juan, PR
Increasing Water Vessel Use in Kenya
PHILIP S. MAKUTSA, CARE International in Kenya, Homa Bay,
KENYA
Sex Workers as Targets of and Agents for HIV/STI
Prevention




The World and Its Moving Parts: Implications for
Emerging Infectious Diseases
Tuesday, March 26, 1:00 p.m. – 2:30 p.m.
Regency Ballroom V
Conveners:
SUSAN MALONEY, CDC, Atlanta, GA
MICHAEL OSTERHOLM, University of Minnesota Academic
Health Center, Minneapolis, MN
Moderators:
MICHELE BARRY, Yale University School of Medicine, New
Haven, CT
SUSAN MALONEY
The World and Its Moving Parts: An Overview
MARTIN CETRON, CDC, Atlanta, GA
Global Migration and Emerging Infectious
Diseases
DANIELE GRONDIN, International Organization of Migration,
Geneva, SWITZERLAND
The Gobalization of Our Food Supply: Implications
for Emerging Infectious Diseases
MICHAEL OSTERHOLM, University of Minnesota Academic
Health Center, Minneapolis, MN
Emerging Vectorborne Disease: The Case of
Yellow Fever




Tuesday, March 26, 2:45 p.m. – 4:15 p.m. 
Centennial Ballroom I
Moderators:
JANE KOEHLER, University of California, San Francisco, CA
TOM KSIAZEK, CDC, Atlanta, GA
Emerging Rickettsioses of the Thai-Myanmar
Border 
P. Parola1,2,3, R. S. Miller2, P. McDaniel4, P. E. Fournier3, D.
Raoult3, S. R. Telford, III1, C. Wongsrichanalai2
1Harvard School of Public Health, Boston, MA, 2Armed Forces
Institute of Medical Sciences (AFRIMS), Bangkok, THAILAND,
3Unite des Rickettsies, Marseille, FRANCE, 4Kwai River Christian
Hospital, Sangkhlaburi, THAILAND
Clinical Management and Outcomes of Lyme
Disease in Wisconsin 
D. R. O’Leary1, E. Belongia2, K. Orloski1, P. Chyou 2, C. Gale2, M.
Finkel3, E. B. Hayes1
1CDC, Fort Collins, CO, 2Marshfield Medical Research Foundation,
Marshfield, WI, 3Mayo-Midelfort Clinic, Eau Claire, WI
A Neighborhood Outbreak of Q Fever Linked to a
Goat Ranch in California 
M. T. Jay1, J. Douglas2, K. Carter1, J. D. Miller3, J. McQuiston3, G.
Rishwain4, E. Schneider4, H. Thompson3, D. Kelaita2
1California Department of Health Services, Sacramento, CA,
2Calaveras Public Health Department, San Andreas, CA, 3CDC,
Atlanta, GA, 4Stockton Medical Groups, Stockton, CA
Q fever in the United States: Experience of
Infectious Disease Consultants and Comparison to
National Reporting during 2000 
J. H. McQuiston1, L. J. Strausbaugh2, D. B. Jernigan1, L. A.
Liedtke2, J. E. Childs1, H. A. Thompson1






















Emerging Zoonoses: A Novel Epizootic of Skunks
Infected with a Bat Variant of Rabies 
M. J. Leslie1, C. Hanlon2, J. Smith2, R. Rohde3, R. Cheshier1, C.
Rupprecht2
1Arizona Department of Health Services, Phoenix, AZ, 2CDC,
Atlanta, GA, 3Texas Department of Health, Austin, TX
Epidemiology of Raccoon and Skunk Rabies in 
the Eastern United States 
M. A. Guerra, A. T. Curns, W. Ivy, III, C. A. Hanlon, C. E.




Foodborne and Waterborne Illness II
Tuesday, March 26, 2:45 p.m. – 4:15 p.m. 
Centennial Ballroom II
Moderators:
PATRICIA GRIFFIN, CDC, Atlanta, GA
LEE RILEY, University of California–Berkeley, School of
Public Health, Berkeley California
Three Outbreaks of E. coli O157 Infections Due to
Retail Ground Beef in Minnesota, 2000: Detection,
Investigation, and Characteristics 
K. Smith, E. Swanson, E. Wagstrom, F. Leano, D. Boxrud, J.
Adams, J. Besser, R. Danila, H. F. Hull
Minnesota Department of Health, Minneapolis, MN
Epidemiology of Shiga Toxin–Producing
Escherichia coli (STEC)Infections in Connecticut,
February 1, 2000–January 31, 2001 
Q. Phan1, T. McCarthy2, P. Mshar1, C. Welles3, R. Howard3, T.
Rabatsky-Ehr4, J. L. Hadler1
1Connecticut Department of Public Health, Epidemiology Section,
Hartford, CT, 2CDC, Atlanta, GA, 3Connecticut Department of
Public Health, Laboratory Division, Hartford, CT, 4Connecticut
Emerging Infections Program, Yale University, New Haven, CT
Microbiologic Testing to Identify Shiga Toxin-
producing E. coli in HUS Patients: FoodNet 
1997-2001 
C. R. Braden1, J. C. Lay1, E. Boothe2, D. J. Vugia3, N. Dumas4, B.
Shiferaw5, E. Wagstrom6, S. Tong7, S. Burnite8, S. M. Thomas9, S.
Hurd10, and the EIP FoodNet Working Group1
1CDC, Atlanta, GA, 2Tennessee Department of Health, Nashville,
TN, 3California Department of Health Services, Berkeley, CA,
4New York State Department of Health, Albany, NY, 5Oregon
Department of Human Services, Portland, OR, 6Minnesota
Department of Health, Minneapolis, MN, 7Maryland Department
of Health and Mental Hygiene, Baltimore, MD, 8Colorado
Department of Public Health and Environment, Denver, CO,
9Georgia Division of Public Health, Baltimore, MD, 10Connecticut
Emerging Infections Program, Yale University, New Haven, CT
Risk Factors for Sporadic Escherichia coli O157
Infections in the United States: A Case-control
Study in FoodNet Sites, 1999-2000 
M. H. Kennedy1, T. Rabatsky-Ehr2, S. M. Thomas3, S. Lance-
Parker3, J. Mohle-Boetani4, K. Smith5, W. Keene6, P. Sparling7, F. P.
Hardnett1, P. S. Mead1, and the EIP FoodNet Working Group1
1CDC, Atlanta, GA, 2Connecticut Emerging Infections Program,
Yale University, New Haven, CT, 3Georgia Division of Public
Health, Atlanta, GA, 4California Department of Health Services,
San Francisco, CA, 5Minnesota Department of Health,
Minneapolis, MN, 6Oregon Department of Human Services,
Portland, OR, 7USDA, Food Safety and Inspection Service,
Washington, DC
Re-Estimating the Global Burden of Typhoid Fever 
J. A. Crump, S. P. Luby, E. D. Mintz
CDC, Atlanta, GA
Yersinia enterocolitica Surveillance in Minnesota 
J. Scheftel1, J. Bender2, F. Leano1, D. Boxrud1, K. Smith1
1Minnesota Department of Health, Minneapolis, MN, 2University




Tuesday, March 26, 2:45 p.m. – 4:15 p.m. 
Centennial Ballroom III
Moderators:
ANNE SCHUCHAT, CDC, Atlanta, GA
FRED TENOVER, CDC, Atlanta, GA
Randomized Trial of Day Care Staff Education to
Improve Parent Knowledge and Attitudes
Regarding Appropriate Antibiotic Use
D. R. Croft1, E. Belongia2, M. Knobloch2, P. Chyou2, R. Besser3, J.
P. Davis4
1Wisconsin Division of Public Health and CDC, Madison, WI,
2Marshfield Medical Research Foundation, Marshfield, WI, 3CDC,
Atlanta, GA, 4Wisconsin Division of Public Health, Madison, WI
Quinupristin/Dalfopristin-Resistant Enterococcus
faecium Isolated from Human Stools, Retail
Chicken, and Retail Pork: EIP Enterococci Project 
K. Gay, K. Joyce, J. E. Stevenson, F. J. Angulo, T. Barrett, and the
NARMS Working Group
CDC, Atlanta, GA
Antimicrobial Resistance in Salmonella Serotype
Typhimurium, R-Type ACSSuT, is Associated with
Bacteremia: NARMS 1996-2000 
K. Molbak1, J. K. Varma2, S. Rossiter2, J. C. Lay2, K. Joyce2, K.
Stamey2, F. J. Angulo2, and the NARMS Working Group2
1Statens Serum Institut, Copenhagen, DENMARK, 2CDC,
Atlanta, GA
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Antimicrobial Resistance in Salmonella Is
Associated with Increased Hospitalization:
NARMS 1996-2000 
J. K. Varma1, K. Mølbak2, S. Rossiter1, M. A. Hawkins3, T. F.
Jones4, S. H. Mauvais5, T. Rabatsky-Ehr6, S. Stenzel7, D. J. Vugia8,
M. Park9, K. Joyce1, K. Stamey1, H. Chang10, F. J. Angulo1, and the
EIP FoodNet Working Group1
1CDC, Atlanta, GA, 2Staten Serum Institut, Copenhagen, DEN-
MARK, 3University of Maryland School of Medicine, Baltimore,
MD, 4Tennessee Department of Health, Nashville, TN, 5Oregon
Department of Human Services, Portland, OR, 6Connecticut
Emerging Infections Program, Yale University, New Haven, CT,
7Minnesota Department of Health, Minneapolis, MN, 8California
Department of Health Services, Berkeley, CA, 9Georgia Division of
Public Health, Atlanta, GA, 10New York State Department of
Health, Albany, NY
Emerging Fluoroquinolone Resistance among Non-
Typhoidal Salmonella in the United States:
NARMS 1996-2000 
S. Rossiter, J. McClellan, T. Barrett, K. Joyce, A. D. Anderson, and
the NARMS Working Group
CDC, Atlanta, GA
Prevalence of Salmonella spp. and Campylobacter
spp. Following the Discontinued Use of
Antimicrobial Growth Promoters in Broilers 
and Swine in Denmark 
M. C. Evans, H. C. Wegener





Tuesday, March 26, 2:45 p.m. – 4:15 p.m. 
Centennial Ballroom IV
Moderators:
C. J. PETERS, University of Texas Medical Branch, Galveston, TX
BOB SWANEPOEL, National Institute for Virology,
Sandringham, SOUTH AFRICA
A Greenhouse Study to Model Potential Field Use
of Genetically Modified Bacterial Symbionts for
Chagas Disease Control 
P. Sen1,2, E. M. Dotson1, A. Betz1, J. Anderson1, G. Groner1, O.
Kruglov3, R. V. Durvasula3, C. B. Beard1
1CDC, Atlanta, GA, 2Association of Public Health Laboratories,
Washington, DC, 3Yale University School of Medicine, New
Haven, CT
Ecological Niche Modeling and Differentiation of
Populations of Triatoma brasiliensis Neiva, 1911,
the Most Important Chagas Disease Vector in
Northeastern Brazil (Hemiptera, Reduviidae,
Triatominae) 
J. Costa1, A. Townsend Peterson2, C. Ben Beard1
1CDC, Atlanta, GA, 2The University of Kansas, Lawrence, KS
In vivo Sensitivity of Plasmodium falciparum to
Chloroquine and Sulfadoxine/Pyrimethamine
During an Outbreak of Malaria in Burundi, 2001 
F. Dantoine
EPICENTRE, Paris, FRANCE
Risk Factors for Lyme Borreliosis: A German 
Case-Control Study 
J. Fitzner1, A. Ammon1, I. Baumann2, T. Talaska3, A. Schönberg4,
K. Stoebel4, V. Fingerle5, B. Wilske5, L. R. Petersen6
1Robert Koch Institute, Berlin, GERMANY, 2Gesundheitsamt
Oder-Spree, Beeskow, GERMANY, 3Beratergruppe Lyme
Borreliose Oder-Spree, Lindow, GERMANY, 4Federal Institute for
Health Protection of Consumers and Veterinary Medicine, Berlin,
GERMANY, 5Max v. Pettenkofer Institute, Ludwigs-Maximilians-
Universität, Munich, GERMANY, 6CDC, Fort Collins, CO
Dengue Fever Outbreak in Hawaii – 2001 
P. Effler1, L. Pang2, P. Kitsutani3, M. Nakata1, K. Mills2, V.
Vorndam4, K. Street2, J. Elm1, T. Tom1, P. Reiter4, J. Rigau4, J. M.
Hayes4, D. Sasaki1, M. Napier5, G. Clark4, D. Gubler6
1State of Hawaii Department of Health, Honolulu, HI, 2Maui
District Health Office, Wailuku, HI, 3CDC, Atlanta, GA, 4CDC,
San Juan, PR, 5Pacific Disaster Center, Kihei, HI, 6CDC, Fort
Collins, CO
Re-Introduction of Dengue 3 in Aragua, Venezuela:
Clinical, Epidemiological and Laboratory Features
of a New Outbreak 
G. Comach1, M. Jimenez1,2, M. De Quintana1,2, D. Camacho1,2, M.
Salcedo1, A. Chiarello1,2, M. Bracho1, M. Alvarez1, M. Soler1, G.
Sierra1, E. Sanchez1, I. Villalobos3, J. Duarte3, E. Rojas2, F.
Herrera1, L. Urdaneta1, R. Barrios1, N. Zoghbi1, Y. Rubio4, N.
Uzcategui5, R. Cuello De Uzcategui6, E. C. Holmes7, E. A. Gould5,
F. Liprandi8, A. P. Goncalvez8
1LARDIDEV-BIOMED, Universidad de Carabobo, Maracay,
VENEZUELA, 2Corposalud Aragua, Maracay, VENEZUELA,
3Hospital Central de Maracay, Maracay, VENEZUELA, 4IAESP-
MSDS, Maracay, VENEZUELA, 5Centre of Ecology and
Hydrology (CEH), Oxford, UNITED KINGDOM, 6Centro
Microbiologia y Biologia Celular, IVIC, Caracas, VENEZUELA,
7Department of Zoology, University of Oxford, Oxford, UNITED




Prevention and Control Strategies
Tuesday, March 26, 2:45 p.m. – 4:15 p.m.
Regency Ballroom V
Moderators:
LEIGH SAWYER, NIH, Bethesda, MD
LARRY SCHONBERGER, CDC, Atlanta, GA
An Evaluation of an Educational Videotape to
Prevent Botulism Among Alaska Natives 
C. Dentinger1, A. Horn2, L. Chiou3, D. Dahlberg2, T. Hennessy1, J.
Butler1
1CDC, Anchorage, AK, 2Bristol Bay Area Health Corporation,























Active Laboratory Surveillance in Massachusetts 
B. Bolstorff, G. Conidi, J. Daniel, L. Glenn, G. Hamilton, D.
Heisey, T. LaPorte, J. Nsubuga, B. Matyas
Massachusetts Department of Public Health, Jamaica Plain, MA
The Emergence of Serogroup Y Disease and the
Epidemiology of Invasive Meningococcal Disease
in Colorado, 1997 - 2001 
L. M. Hammond, K. A. Gershman
Colorado Department of Public Health and Environment, 
Denver, CO
Transmission of the Main Viral Pathogens Causing
Gastroenteritis, NLV, SLV and Rotavirus 
M. A. de Wit, M. P. Koopmans, Y. T. van Duynhoven
National Institute of Public Health and the Environment,
Bilthoven, NETHERLANDS
Improving Influenza and Pneumococcal
Vaccination Rates for People 65+ in Rhode Island
through Coalition Building Efforts 
T. E. Bertrand
Rhode Island Department of Health, Providence, RI
Evidence of Effectiveness of Egg Quality Assurance
Programs, Mandatory Refrigeration, and Traceback
Investigations To Mitigate Egg-Associated
Salmonella enteritidis Infections in the United States 





Molecular Diagnostics and Epidemiology II
Tuesday, March 26, 4:30 p.m. – 6:00 p.m. 
Centennial Ballroom I
Moderators:
MARY GILCHRIST, Iowa State Health Department, Iowa
City, IA
BALASUBR A. SWAMINATHAN, CDC, Atlanta, GA
Detection of La Crosse Virus in Cerebrospinal
Fluid and Tissues by Reverse Transcription-
Polymerase Chain Reaction 
B. Slater1, K. Bloch2, T. F. Jones3, G. Woodlief4, T. McPherson4, C.
Huang1
1New York State Department of Health, Slingerlands, NY,
2Vanderbilt University Medical Center, Nashville, TN, 3Tennessee
Department of Health, Nashville, TN, 4North Carolina State
Laboratory of Public Health, Raleigh, NC
Real-time Fluorescence PCR Assays for the
Detection and Characterization of Heat-labile and
Heat-stable Enterotoxin Genes from
Enterotoxigenic Escherichia coli
M. Youssef1, N. Strockbine1, N. Lehn2, U. Reischl2
1CDC, Atlanta, GA, 2Institute of Medical Microbiology and
Hygiene, University of Regensburg, Regensburg, GERMANY
Development and Evaluation of PCR-based
Diagnostics for Identification of Salmonella O
Antigens Based on the rfb Locus 
R. Sherwood, C. Fitzgerald, L. Gheesling, P. I. Fields
CDC, Atlanta, GA
PulseNet Experience: Software Changes and
Improvements to Online E. coli National Database 
S. B. Hunter, K. A. Kubota, E. M. Ribot, B. Swaminathan
CDC, Atlanta, GA
Molecular Characterisation of a Multiresistant
Strain of Salmonella enterica Serotype
Typhimurium DT204b Responsible for an
International Outbreak of Salmonellosis 
E. J. Threlfall1, E. A. Lindsay1, A. J. Lawson1, R. A. Walker1, L. R.
Ward1, H. R. Smith1, F. W. Scott1, S. J. O’Brien2, I. S. T. Fisher2, P.
D. Crook2, D. Wilson3, D. J. Brown4, H. Hardardottir5, W. J. B.
Wannet6, H. Tschäpe7
1Central Public Health Laboratory, London, UNITED KING-
DOM, 2PHLS Communicable Diseases Surveillance Centre,
London, UNITED KINGDOM, 3County Durham and Darlington
Health Authority, Durham, UNITED KINGDOM, 4North
Glasgow Univeristy Hospitals NHS Trust, Glasgow, UNITED
KINGDOM, 5Landspitali University Hosptial, Reykjavik, ICE-
LAND, 6National Institute of Public Health and the Environment,
Bilthoven, NETHERLANDS, 7Robert-Koch Institut,
Werningerode/Harz, GERMANY
Determination of Allelic Diversity in the mec
Operon of Methicillin-Resistant Staphylococcus
aureus in Wisconsin 
S. K. Shukla1, M. E. Stemper1, J. M. Conradt1, R. A. Reich2, S. V.
Ramaswamy2, E. A. Graviss2, K. D. Reed1
1Marshfield Medical Research Foundation, Marshfield, WI,
2Baylor College of Medicine, Houston, TX
Session 80
Slide Session
Surveillance and Information Systems
Tuesday, March 26, 4:30 p.m. – 6:00 p.m. 
Centennial Ballroom II
Moderators:
JAMES GIBSON, South Carolina Department of Health,
Columbia, SC
MICHAEL GREGG, Private Consultant in Epidemiology,
Guilford, VT
Analysis of a Health Indicator Surveillance System:
Its Ability To Detect Annual Influenza Activity for
the 1999-2000 and 2000-2001 Seasons Compared
to Traditional Surveillance Systems 
J. Lee, J. Pavlin, Y. Elbert, P. Kelley
Department of Defense Global Emerging Infections System,
Silver Spring, MD
Lessons Learned from Implementing Electronic
Laboratory Reporting, New York State
P. F. Smith, M. Davisson, J. M. Fuhrman, H. Chang, I. J. Gotham,
G. Birkhead, D. L. Morse
New York State Department of Health, Albany, NY
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Outbreak Surveillance: An Important Tool for
Controlling Communicable Diseases 
M. G. Baker, C. N. Thornley
ESR, Wellington, NEW ZEALAND
Lyme Disease Incidence in Wisconsin: A
Comparison of State Reported Rates with Rates
from a Population-Based Cohort 
A. Naleway1, E. Belongia1, J. Kazmierczak2, R. Greenlee1, J. Davis2
1Marshfield Medical Research Foundation, Marshfield, WI,
2Wisconsin Division of Health, Madison, WI
Surveillance for Patients with Acute Febrile Illness
in Egypt 
S. Afifi1, M. A. Azab1, F. G. Youssef1, H. El Sakka1, K. Earhart1, S.
El Oun2, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Ministry
of Health and Population, Cairo, EGYPT, 3Centers for Disease
Control and Prevention, Atlanta, GA
Foodborne Viruses in Europe: Web-Based
Technologies for Investigation of Transnational
Outbreaks of Viral Gastroenteritis
M. Koopmans1, B. A. Lopman2, H. Vennema1, M. Reacher2, J.
Carrique-Mas3, Y. van Duynhoven4, F. Hanon5, D. W. Brown2
1Research Laboratory for Infectious Diseases, National Institute
for Public Health and the Environment (RIVM), Bilthoven,
NETHERLANDS, 2Public Health Laboratory Service, London,
UNITED KINGDOM, 3Swedish Institute for Infectious Disease
Control, Solna, SWEDEN, 42Research Laboratory for Infectious
Diseases, National Institute for Public Health and the
Environment (RIVM), Bilthoven, NETHERLANDS, 5Statens




Tuesday, March 26, 4:30 p.m. – 6:00 p.m.
Regency Ballroom V
Moderators:
JANE SIEGEL, University of Texas Southwestern Medical
Center, Dallas, TX
ROBERT WEBSTER, St. Jude Children’s Research Hospital,
Memphis, TN
PER.C6: A Human Designer Cell Line Providing a
Pandemic Proof Platform for the Manufacturing of
Safe Influenza Vaccines 
M. Pau, C. Ophorst, M. Oerlemans, A. Vooys, J. Pasma, R.
Lonsdale, G. Marzio, C. Tuijn, F. G. UytdeHaag
Crucell Holland BV, Leiden, NETHERLANDS
Acute Respiratory Virus Surveillance in Cairo and
Alexandria, Egypt, July 2000 to June 2001 
D. E. Salman1, S. Lewis1, E. Aoun2, C. Fayez1, H. M. Esmat2, B.
Botros1, A. K. Soliman1, G. D. Chapman1, R. R. Graham1
1U. S. Naval Medical Research Unit No. 3, Cairo, EGYPT,
2Ministry of Health and Population, Cairo, EGYPT
Influenza Surveillance in New York State, 1998-2001
M. Kacica, V. Randle
New York State Department of Health, Albany, NY
Geographical Coherence of Influenza Epidemics in
the US, France and Australia: 1978-98
C. Viboud1, A. Flahault1,2
1INSERM U444, Paris cedex 12, FRANCE, 2Centre-Hospitalier
Saint-Antoine, Paris cedex 12, FRANCE
A DoD Global Influenza Surveillance Program 
L. C. Canas, J. S. Neville, A. R. Krull, M. J. Rodriguez, L. T.
Daum
Brooks Air Force Base, San Antonio, TX
Using CUSUM Techniques To Identify Influenza
Outbreaks
V. Foster1, J. Matheson1, M. Stoto2
1George Washington University School of Public Health & Health
Services, Washington, DC, 2The RAND Corporation, Arlington, VA
Session 82
Slide Session
Global Health and GIS
Tuesday, March 26, 4:30 p.m. – 6:00 p.m. 
Centennial Ballroom IV
Moderators:
HARRISON SPENCER, Association of Schools of Public
Health, Washington, DC
MARY WILSON, Harvard University, Boston, MA
Tuberculosis Status Among Iranian and Afghan
patients Admitted to the National Research
Institute of Tuberculosis and Lung Disease (1998-
2000) 
M. Yazdanpanah, M. R. Masjedi, H. Masjedi, M. Hosseini, A.
Velayati
National Research Institute of Tuberculosis and Lung Disease,
Tehran, IRAN
Modeling Tuberculosis Dissemination in Harris
County, Texas, 1995-1998, with Spatial Analysis and
Geographic Information Systems (GIS) 
M. L. Stone1, E. A. Graviss2, L. Teeter2
1University of Texas-Houston, School of Public Health, Houston,
TX, 2Baylor College of Medicine, Houston, TX
Mapping of West Nile Virus Risk in the Northeast
United States Using Multi-Temporal
Meteorological Satellite Data 
P. Backenson1, D. J. White1, M. Eidson1, P. F. Smith1, L. D.
Kramer1, D. L. Morse1, C. J. Tucker2, M. F. Myers3, S. I. Hay4, S.
E. Randolph4, D. J. Rogers4
1New York State Department of Health, Albany, NY, 2NASA,
Greenbelt, MD, 3International Research Partnership for Infectious























Investigation of Q Fever in Bosnia-Herzegovina,
2000: An Example of International Cooperation 
J. H. McQuiston1, W. L. Nicholson1, R. Velic2, R. V. Gibbons1, L.
Castrodale1, S. H. Wainwright3, T. J. Vannieuwenhoven3, E. W.
Morgan4, L. Arapovic2, A. Delilic2, P. Puvacic5, T. Bajrovic2
1CDC, Atlanta, GA, 2Veterinary Faculty, Sarajevo, BOSNIA AND
HERZEGOVINA, 3USDA-APHIS, Riverdale, MD, 4US Army -
SFOR, Sarajevo, BOSNIA AND HERZEGOVINA, 5Ministry of
Health, Sarajevo, BOSNIA AND HERZEGOVINA
A WHO Global Salm-Surv Retrospective Study
Examining Salmonella Serotypes in South America,
2000: Dominance of Salmonella Serotype Enteritidis
WHO Global Salm-Surv South America Working Group1,WHO
Global Salm-Surv2
1Instituto INEI-ANLIS “Carlos G Malbran”, Buenos Aires,
ARGENTINA, 2World Health Organization, Geneva,
SWITZERLAND
Recurrent Histoplasmosis Outbreaks in Acapulco,
Mexico
Y. A. Roldán, L. E. Soto-Ramírez, G. Rosales, G. R. Pena, J.
Sifuentes-Osornio, L. Taylor, G. M. Ruiz-Palacios





Tuesday, March 26, 4:30 p.m. – 6:00 p.m. 
Centennial Ballroom III
Moderators:
PHILIP BRACHMAN, Emory University, Atlanta, GA





Wednesday, March 27, 7:30 a.m. – 8:15 a.m. 
Regency Ballroom VI/VII
Behind the Scenes at the Emerging Infectious
Disease Journal
PETER DROTMAN, POLY POTTER, BRIAN MAHY, CDC,
Atlanta, GA
Prevention Effectiveness
MARTIN MELTZER, CDC, Atlanta, GA
ANNE HADDIX, Emory University, Atlanta, GA
Session 85
Plenary Session V
Wednesday, March 27, 8:30 a.m. – 10:00 a.m. 
Centennial Ballroom I/II
Moderators:
HAROLD JAFFE, CDC, Atlanta, GA
JOHN McGOWAN, Rollins School of Public Health, Emory
University, Atlanta, GA
Global Drug Resistance: The Case of Streptococcus
pneumoniae
KEITH KLUGMAN, Emory University, Atlanta, GA
Use of Antiretroviral Agents in Developing Countries




Wednesday, March 27, 8:30 a.m. – 10:00 a.m. 
Centennial Ballroom III/IV
Moderators:
NANCY COX, CDC, Atlanta, GA
ALTAF LAL, CDC, Atlanta, GA
Virology of 1918 Flu Pandemic
ANN REID, Armed Forces Institute of Pathology, Rockville, MD
Genetic Susceptibility to Infectious Diseases
JANET MCNICOLL, CDC, Atlanta, GA
Session 89
Invited Panel
Emerging Vaccines for Emerging Diseases
Wednesday, March 27, 10:30 a.m. – 12:00 noon 
Centennial Ballroom I
Conveners/Moderators: 
IRENE GLOWINSKI, NIH, Bethesda, MD
MELINDA WHARTON, CDC, Atlanta, GA
Rotavirus Vaccines in Development
RAJIV BAHN, All India Institute of Medical Sciences, New Delhi,
INDIA
Group B Meningococcal Vaccines
GUSTAVO SIERRA, Finlay Institute, Habana, CUBA
New Technologies and Vaccine Development
MARGARET ANN LIU, Bill and Melinda Gates Foundation,
Seattle, WA
Anthrax Vaccines
ARTHUR FRIEDLANDER, U.S. Army Medical Research
Institute of Infectious Diseases, Fort Detrick, MD
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Session 90
Invited Panel
Anatomy of Emerging Infectious Diseases
Wednesday, March 27, 10:30 a.m. – 12:00 noon 
Centennial Ballroom II
Conveners/Moderators:
LINDA DETWILER, U.S. Department of Agriculture,
Robbinsville, NJ
RIMA KHABBAZ, CDC, Atlanta, GA
The Agent: Prions as Emerging Infectious Particles
DAVID BOLTON, New York State Institute for Basic Research,
Staten Island, NY
The Reservoir: Bovine Spongiform Encephalopathy
(BSE) and What’s Been Done About It
DAGMAR HEIM, Swiss Federal Veterinary Office, Bern,
SWITZERLAND
The Unfolding Variant Creutzfeldt-Jakob Disease
(vCJD) Epidemic
ROBERT WILL, Western General Hospital, Edinburgh, UNIT-
ED KINGDOM
Impact of the BSE/vCJD Outbreak: U.S. Concerns
for TSEs




Wednesday, March 27, 10:30 a.m. – 12:00 noon 
Centennial Ballroom III
Conveners/Moderators:
DAVID BELL, CDC, Atlanta, GA
ABIGAIL SALYERS, American Society for Microbiology,
Washington, DC
Implications of Gene Transfer and Inducible
Resistance for Successful Therapy
ABIGAIL SALYERS, American Society for Microbiology,
Washington, DC
Prospects for New Antimicrobial Drug
Development: Industry Perspective 
GAIL H. CASSELL, Eli Lilly and Company, Indianapolis, IN
Computerized Decision Support for Appropriate
Antimicrobial Drug Prescribing
MATTHEW SAMORE, University of Utah, Salt Lake City, UT
Promoting Appropriate Antimicrobial Drug Use in
Developing Countries




Infectious Diseases in Aging Populations
Wednesday, March 27, 10:30 a.m. – 12:00 noon 
Centennial Ballroom IV
Conveners/Moderators:
JAY BUTLER, CDC, Anchorage, AK
WILLIAM ERSHLER, Institute for Advanced Studies in Aging
and Geriatric Medicine, Washington, DC
Biology of Aging
STEVEN CASTLE, University of California at Los Angeles, Los
Angeles, CA
Biology of Immune Senescence
RICHARD MILLER, University of Michigan, Ann Arbor, MI
Impact of Aging on the Epidemiology of Infections
in Adults
THOMAS YOSHIKAWA, Charles R. Drew University of Medicine
and Science, Los Angeles, CA
HIV in the Older Patient
BRADLEY BENDER, University of Florida, Gainesville, FL
Session 93
Invited Panel
Foreign Policy and Infectious Diseases
Wednesday, March 27, 10:30 a.m. – 12:00 noon 
Regency Ballroom V
Convener/Moderator:
STEPHEN B. BLOUNT, CDC, Atlanta, GA
Global Fund to Fight HIV/AIDS, TB and Malaria
(New Political/Economic Model for Addressing
Priority Infectious Diseases)
BILL STEIGER, U.S. Department of Health and Human
Services, Washington DC
Infectious Diseases and U.S. Foreign Policy from a
State Department Perspective
JACK CHOW, U.S. Department of State, Washington, DC
Infectious Diseases: The World Bank Perspective





















The ICEID Exhibit Hall opens on Sunday, March 24 from 12:00 noon –
5:00 p.m., poster presentations are available for viewing all day, authors will
be standing at their posters from 3:30 – 5:00 p.m. The Opening Reception,
at which substantial hors d’oeuvres and refreshments will be served, will be
held in the Exhibit Hall from 7:00 – 9:00 p.m., Late Breaker poster pre-
sentations will be held at that time. The Exhibit Hall will also open on
Monday, March 25, from 10:00 a.m. to 6:00 p.m. (poster authors available
4:30 – 6:00 p.m.), and Tuesday, March 26, from 8:30 a.m. to 1:00 p.m.
(poster authors available 8:30 – 10:00 a.m.).
Academia Book Exhibits booth 8




Academia Book Exhibits organizes and arranges professional combined
book and journal displays.





Air Sea Atlanta, Inc., is a world-wide supplier of a most comprehensive
range of United Nations–certified packaging for transport of infectious or
diagnostic specimens, with or without dry ice or cool packs, to the pharma-
ceutical and biomedical industries. All items are available for immediate
shipment, with no minimum order quantity.
American Society for Microbiology booth 12




The American Society for Microbiology is the oldest and largest single life
science membership organization in the world, representing over 42,000
microbiologists throughout the world. ASM represents 25 disciplines of
microbiological specialization plus a division for microbiology educators.
ASM is comprised of five boards—Education and Training, Meetings,
Membership, Public and Scientific Affairs, and Publications, plus the
American Academy of Microbiology.  ASM Programs represented at
ICEID include Meetings and Publications.
Applied Maths, Inc. booth 18





Applied Maths develops innovative software solutions for the biosciences.
Areas of specialization are pattern-matching algorithms, clustering and
identification methods, and data-mining tools for massive datasets such as
microarrays and gene chips. Since 1991, Applied Maths has set the trend
for the analysis of fingerprints with the renowned GelCompar package.
Today the company continues to be a pioneer in bioinformatics, with
BioNumerics, GelCompar II, GeneMaths, and GeneBase.
Armed Forces Institute of Pathology—
Public Affairs Office booth 19
6825 16th Street, NW
Bldg 54, Room 1106
Washington, DC 20306-6000
www.afip.org
The AFIP, a tri-service Institute of the U.S. Department of Defense (DoD)
in Washington,DC, presents material highlighting its DoD readiness sup-
port. Included are AFIP efforts to identify emerging infections and disease
patterns, such as bioterrorism agent detection and collaborative research
and surveillance, and sophisticated technology to track environmental toxins
and adverse drug reactions. Programs featured include Persian Gulf War
Illness studies, expanded DNA research and applications, molecular biology
and genetics research programs, and veterinary pathology work.
U.S. Army Healthcare Recruiting booth 31
1568 Hood Avenue
Forest Park, GA 30297-5104
Career and educational opportunities with the Medical Department of the
U..S Army and U.S. Army Reserve.
Association of Public Health Laboratories booth 14





The Association of Public Health Laboratories (APHL) is a professional,
non-profit organization representing national, state, and local public health
laboratories. APHL collaborates with partners in private and public sectors,
advocating and formulating sound public health and environmental health
policies, and providing technical assistance and training.
Blackhawk BioSystems, Inc. booth 9
12945 Alcosta Blvd
San Ramon, CA 94583
800/866-0305
www.blackhawkbiosystems.com
Blackhawk BioSystems is a leading worldwide manufacturer of quality con-
trol products for use in laboratories that perform infectious disease testing.
Products available include the complete line of VIROTROL® independent
quality assurance reagents that are used with commercially available testing
procedures for hepatitis, HIV, sexually transmitted diseases, and other test
procedures.
Centers for Disease Control and Prevention booth 5
1600 Clifton Road, NE
Atlanta, GA 30333
www.cdc.gov
In 1995, the Centers for Disease Control and Prevention (CDC) launched
a national campaign to reduce antimicrobial resistance through the promo-
tion of more judicious antibiotic use. This campaign is comprehensive and
extensive, encompassing public media, professional education, and applied
research and surveillance activities. CDC’s National Campaign for
Appropriate Antibiotic Use has two objectives:
1. Reduce inapppropriate antibiotic use
2. Reduce the spread of resistance to antibiotics
To accomplish these objectives, the campaign has several major areas 
of activity:
• Developing strategies and materials that will lead 
to changes in risk behaviors related to antibiotic use
• Serving as a resource to groups implementing and 
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evaluating campaigns and intervention programs
• Forming partnerships to harness the resources of 
collaborating organizations
• Assessing the impact on antibiotic use, resistance, 
and patient/provider satisfaction.
Centers for Disease Control and Prevention booth 2
Morbidity and Mortality Weekly Report




The office of Scientific and Health Communications (OSHC) mission is
to conduct effective scientific and health communications, develop new
information concepts and systems such as Multimedia MMWR
Epidemic Information Exchange (Epi-X), and provide consultation and
training programs.
Centers for Disease Control and Prevention booth 13
National Center for Infectious Diseases




CDC’s vision for the future is a world in which all available tools are used
to combat today’s diseases and prevent those of tomorrow. Preventing
Emerging Infectious Diseases: A Strategy for the 21st Century describes a
strategy for moving towards the fulfillment of this vision. This strategy
and other informational and educational literature regarding infectious
diseases are available at the exhibit booth.
Cereplex booth 22
1124 Sorrel Ridge Lane
Oakton, VA 22124
www.cereplex.com
Cereplex provides information technologies to hospitals and clinics to help
them automate disease detection and reporting (both routine and for bioter-
rorism detection), address nosocomial infections and antibiotic resistance,
and improve the quality of care they provide.
U.S. Department of Agriculture booth 30
Animal and Plant Health Inspection Service
555 South Howes Street
Fort Collins, CO 80521
www.aphis.usda.gov
The U.S. Department of Agriculture’s (USDA) Animal and Plant Health
Inspection Service (APHIS) provides leadership in ensuring the health and
care of animals and plants. APHIS safeguards resources from exotic inva-
sive pests and diseases, monitors and manages agricultural pests and dis-
eases existing in the United States, resolves and manages trade issues relat-
ed to animal or plant health, and ensures the humane care and treatment
of animals.
U.S. Department of Defense booth 26
Global Emerging Infections System
503 Robert Grant Avenue
Silver Springs, MD 20910-7500
301/319-9072
www.geis.ha.osd.mil
The mission of the DoD-GEIS is to implement the Presidential Directive
on emerging infections through an international, coordinated, joint Service
Program focused on timely recognition and control of emerging and re-
emerging infections. The means include systematic surveillance (especially
laboratory-based), research, response, training, and capacity building. This
mission is executed in two primary settings: the DoD’s unique overseas lab-
oratory network and the service-specific hubs.
ESRI booth 1




ESRI develops computer software that maps health data. ArcView, ESRI’s
most well known geographic information systems (GIS) software is used by
over 5,000 health organizations world wide, in areas such as epidemiology,
in-home service routing, marketing, research and Internet mapping. Visit
ESRI on the web at www.esri.com/industry/health.
EXAKT Technologies, Inc. booth 16
7416 N Broadway Extension
Suite E
Oklahoma City, OK 73116-9066
405/848-5800
www.exaktpak.com
Whether you’re shipping vials, jars, Petri dishes, or even medical devices,
EXAKT offers infectious substance and diagnostic specimen packaging tai-
lored to fit your specific shipping needs. Our packaging approach gives us
the flexibility to provide a customized packaging solution to best match
your unique shipping requirements. Visit our website at www.exaktpak.com
and take our 5Q test, or contact us by e-mail at infopak@exaktusa.com or
call toll-free 800/866-7172.
Focus Technologies booth 28-29
10703 Progress Way
Cypress, CA 90630
At Focus Technologies, formerly MRL, our world revolves around one
thing—infectious disease. Our full-service infectious disease laboratory
offers over 1200 assays. Our diagnostics group sells serological products
worldwide for rare and emerging diseases, as well as type-specific kits for
HSV-1 and HSV-2, HerpeSelect™. Focus is also a leader in antimicrobial
drug resistance surveillance with TSN—the world’s largest antimicrobial
susceptibility database.
Fogarty International Center booth 25




The Fogarty International Center has been a critical component of the
NIH international effort since 1968. The Center’s mission is to reduce glob-
al health disparities by supporting and promoting research and to prepare
the current and future generation of international and U.S. scientists to
meet global health needs.
Gen-Probe booth 23
10210 Genetic Center Drive
San Diego, CA 92121
800/523-5001
www.gen-probe.com
Gen-Probe, the recognized world leader in the development, manufacture,
and commercialization of genetic probe tests for diagnosing human disease,
has been a pioneer in bringing DNA probe assays to the clinical laboratory.
Its advanced amplification technologies continue to lead the industry.
Representatives will be available to discuss the new APTIMA® Combo 2





















MIDI, Inc. is dedicated to developing microbial identifcation products and
services for research and diagnostic purposes. MIDI develops, manufac-
tures, and sells the Sherlock Microbial Identificaton System worldwide.
The Sherlock System identifies bacteria and yeast based on gas chromato-
graphic analysis of their whole cell fatty acid content. Additionally, MIDI
provides a Bioterrorism database with each system capable of identifying
key agents of biological warfare, including Bacillus anthracis.
National Institute of Allergy booth 24
and Infectious Diseases




Institute staff will provide materials and information for health care profes-
sionals and the general public on NIAID biomedical research areas. These
areas include allergic, immunologic, and infectious diseases.
Packard Instrument Company booth 15
800 Research Pkwy
Meriden, CT 06450
Packard Instrument Company is a subsidiary of Packard Bioscience
Company, a leading developer, manufacturer, and marketer of analytical
instruments and related products and services for use in the drug discovery
and molecular biology segments of the life sciences industry and in the
nuclear instrumentation industry. Primary products incude the following:
automated liquid handling and sample preparation systems, microwell plate
readers and plate imaging systems, drug screening and detection reagents,
biochip systems, and bioanalytical scintillation instrumentation.





Established in 1987, PANBIO, Inc. is a globally focused Australian biotech-
nology company which specializes in the development, manufacturing, and
marketing of diagnostic kits for infectious diseases. With the acquisition of
Integrated Diagnostics, Inc. USA (INDX) in 1999 and Stellar Bio Systems,
Inc. in 2001, PANBIO’s product range includes more than 60 diagnostic
assays with a core focus on arbovirus and tick-borne diseases and high qual-
ity mouse serum and mouse serum proteins. It has an FDA-approved facil-
ity in Columbia, MD.
Pfizer, Inc. booth 11
Public Health Foundation booth 33





The Public Health Foundation is a national nonprofit organization, which
works in partnership with the Centers for Disease Control and Prevention,
to provide training and resource materials to public health and clinical pro-
fessionals. Topics include bioterrorism and emergency preparedness,
appropriate antibiotic use, epidemiology, immunizations, influenza, travel
medicine, and infectious diseases. PHF also has a free on-line clearing-
house of distance learning courses at www.TrainingFinder.org.
Purified div Germfree Labs booth 10




Purified microEnvironments a Division of Germfree Laboratories, Inc., has
been manufacturing biological and chemical safety equipment for over 40
years. We specialize in transportable high containment class III gloveboxes
and related NBC filtration systems. New products include rapid contain-
ment systems for the first responder.
Response Biomedical Corporation booth 21
8855 Northbrook Court
Burnaby, BC, Canada  V5J 5J1
604/681-4101
www.responsebio.com
Response Biomedical develops diagnostic tests for use with its FDA cleared
RAMP Reader for use in clinical, STAT-lab, and point-of-care applications,
as well as rapid on-site environmental testing for biological agents. The
RAMP System delivers accurate and reliable results in less than fifteen
minutes, and has the potential to be used with more than 250 medical and
non-medical tests currently performed in laboratories.





Thermo Formo is a leading manufacturer of controlled-environment
equipment for the educational, biomedical, pharmaceutical, clinical, and
industrial research markets. Product lines include cell culture incubators,
ultra-low temperature freezers, biological safety cabinets, orbital shakers,
LN2 cryopreservation equipment, laboratory refrigerators/freezers, blood





Medical books, journals, and multimedia
Wyeth Pharmaceuticals booth 27
150 Radnor Chester Road
St. Davids, PA 19087
ZOSYN is an everyday empiric antibiotic for moderate to severe infections
due to its broad specturm. Its spectrum covers gram-positive, gram-nega-
tive, and anaerobic pathogens, and ZOSYN is not associated with
Clostridium difficile disease, emergence of vancomycin-resistant entero-
coccus, and gram-negative multi-drug resistance.
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Grand Hall East
Board 1. Boston’s Early Warning Surveillance System for
Bioterrorism: September 11 - November 11 
J. E. Gunn1, V. McKenna1, K. H. Brinsfield2, K. S. Dyer2, M. A.
Barry1, Surveillance Task Force1
1Boston Public Health Commission, Boston, MA, 2Boston Emergency
Medical Services, Boston, MA
Objective: Traditional surveillance systems based in the
reporting of specific diseases have limited potential for early detec-
tion of mass casualty events such as bioterrorism or pandemic
influenza. Prior to 9/11, an electronic real time volume based sur-
veillance system was developed to identify a potential bioterrorism
related event in Boston. We report our experience with this sur-
veillance system from 9/11-11/11. Methods: Every 24 hours vol-
ume data from Boston hospitals was sent electronically to a secure
web site. Volume data included urgent care visits and pediatric
(PED) and adult (AED) emergency department visits. Using 2000
data, monthly averages of site specific volume were obtained.
Adjustments for day of the week were done based on site specific
usage patterns. A binomial distribution was used to calculate 99%
confidence intervals (CI). The upper 99% CI was compared with
daily volume in 2000 to detect excess activity. On days exceeding
threshold, rapid on site follow-up was done to identify potential
infectious disease clusters. Results: From 9/11-11/11 daily volume
data was obtained from 9 hospitals which included 11 sites (9 AED,
2 PED, and 1 urgent care center). For all sites a total of 17 days
exceeded threshold with at least 2 sites exceeding threshold on 3
days. Combined volume data identified 4 sites exceeding threshold
on 10/15 (3 AED and 1 PED). This correlated with reports of
anthrax exposures in FL, DC and NYC. Follow-up with sites iden-
tified persons seeking nasal swabs and antibiotics for anthrax as the
cause of increased activity despite the fact that no anthrax cases or
anthrax contaminated environmental specimens had been identi-
fied in Massachusetts. Conclusions: Volume based surveillance is
a feasible method for the early identification of mass morbidity
events. In Boston, information from this system was used in
October to design public health messages for the general public. A
rapid follow-up system is a critical component to understand initial
signals. Additional research is needed to define the sensitivity of
the individual or combined measures being used and the optimal
combination to detect significant activity.
Board 2. The Electronic Surveillance System for the Early
Notification of Community-based Epidemics (ESSENCE): GIS
Modeling in an Early Detection Surveillance System for
Bioterrorist and Natural Disease Threats 
C. S. Polyak, Y. Elbert, J. A. Pavlin, P. W. Kelley
Department of Defense Global Emerging Infections System (DoD-
GEIS), Washington, DC
Introduction: Current infectious disease surveillance sys-
tems are usually not automated, often depend on laboratory con-
firmation and rely on passive information. ESSENCE, the
Electronic Surveillance System for the Early Notification of
Community-based Epidemics, is an early detection system for
bioterrorist and natural disease threats using syndromic surveil-
lance in the greater Washington, DC area. This automated system
provides earlier indication of disease outbreaks in military treat-
ment facilities (MTF) and defines geographically aberrant clinical
patterns at the community level allowing for rapid epidemiologic-
based targeting of limited response assets. Several agents likely to
be used in a bioterrorist attack, such as the causative agents of
anthrax, plague and smallpox, initially present as a non-specific flu-
like syndrome. In order to assess ESSENCE’s ability to geograph-
ically track the community-wide patterns of non-specific flu-like
syndrome in the greater Washington, DC area, we evaluated data
during two influenza outbreaks in 1999 and 2000. Geospatial char-
acteristics of the respiratory syndrome group were used to track
the spread of flu-like illness through the community and to assess
the utility of incorporating GIS into ESSENCE.
Methods: All military personnel, retirees and beneficiaries
located within a 50-mile radius of the National Capital Area (NCA)
were included in the study population. Population densities were
mapped for those eligible for care at MTFs by residence zip code
using ArcView®, a GIS program. The study period incorporates
January 1999 to November 2001, including two influenza outbreak
periods, defined as October through April of each year (1999/2000;
2000/1). Outpatient clinical information, collected from each clin-
ic and matched to existing demographic databases, was categorized
by ICD9 diagnosis into seven separate syndrome groups.
Results & Discussion: A total of 26 MTF’s with 106 pri-
mary care or emergency clinics serve a population of 400,000 with-
in the NCA. There were a total of 485, 965 respiratory syndrome
cases in the study period with a significantly higher number of
cases (p<0.001) during the influenza outbreak periods. Respiratory
syndrome data was examined by day, week, month and season and
combined with NCA population data which was classified by zip
code, community and city. Rates of respiratory illness were calcu-
lated for the combinations and mapped using ArcView®. The
average rate of respiratory illness per zip code parcel was greater in
the 2000/1 flu season (214/1000 population) than in the 1999/2000
season (154/1000 population). Preliminary analyses determined
that clustering based on merged zip code parcels, which depended
on population density, have the greatest accuracy. Automatic
geospatial analyses, including GIS maps, are a valuable analysis
tool and will be incorporated into ESSENCE.
Board 3. A Mathematical Model of the Potential Spread of
Smallpox via Air Travel 
R. Freeman1, J. H. Ellis1, G. E. Glass2
1Johns Hopkins University, Baltimore, MD, 2Bloomberg School of
Public Health, Johns Hopkins University, Baltimore, MD
Of potential pathogens likely to be used as biological
weapons, smallpox (variola) may pose one of the greatest risks.
Many experts now believe that there are supplies of smallpox out-
side the confines of the CDC and the Russian State Research
Center of Virology and Biotechnology. Although the probability of
an intentional release of smallpox is small, if it were to occur, the
results would potentially be disastrous.
If a release of the virus were to occur in a US city, smallpox
would likely spread both within the city and the US via the trans-
portation network. Over one million travelers board planes every
day within the continental US magnifying the potential threat of
disease spread. Thus, quarantine of an urban area where smallpox
was detected may be a key aspect of disease control strategies.
However, the cessation of air travel on September 11 significantly
impacted the airline industry and the nation’s economy. Stopping
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air travel within the US for an extended period to contain the
spread of smallpox would have extraordinary consequences.
Mathematical models of the potential spread of smallpox may pro-
vide insight for preparedness plans and disaster management.
Simulations can help identify the possible lag time for intervention
and areas where more refined information may improve public
health preparedness.
The objective of this research was to explore the potential
spread of smallpox via air travel within the US. The purpose is to
determine the likelihood of inter-city dispersal of smallpox follow-
ing secondary infection within Washington, D.C. and the feasibili-
ty of air travel quarantine in disease containment strategies. We
developed a compartmental model on the basis of previous
research concerning the spread of influenza via air travel. 116 US
cities were examined in the analysis with a time horizon of one
year. We present the results of a series of simulations examining
differences in assumptions concerning population susceptibility,
transmission rate, initial city of release, airport closure policies and
season of virus release.
The results of our simulation suggest that: 1) there is a
clear benefit to stopping air travel in and out of cities after one case
of the disease is reported; 2) forecast epidemic peak and total case
magnitude depends upon the initial city of release in addition to
population size; 3) the time lag for action after one case has been
reported is very short; 4) season of release plays a potentially
important role in epidemic spread and expected cases; and 5) the
results of these simulations also highlight the importance of refin-
ing estimates concerning the number of secondary cases produced
from a single index case and the percentage of persons susceptible.
Board 4. Laboratory-Confirmed Influenza Illness in a Highly
Immunized Population 
K. M. McNeill1, B. L. Watts2, M. B. Goldenbaum2, Y. Li3, R. K.
Poropatich4, J. C. Gaydos5
1Bureau of Disease Control, SC Department of Health and
Environmental Control, Columbia, SC, 2Division of Preventive
Medicine, Walter Reed Army Institute of Research, Silver Spring, MD,
3Allied Technology Group, Inc., Rockville, MD, 4Department of
Medicine, Walter Reed Army Medical Center, Washington, DC,
5Department of Defense Global Emerging Infections Surveillance and
Reponse System, Walter Reed Army Institute of Research, Silver
Spring, MD
Background: The Advisory Committee on Immunization
Practices (ACIP) estimates the efficacy of influenza vaccine in pre-
venting influenza in healthy individuals under 65 years of age to be
about 70-90%. The possibility of respiratory illness in individuals
who are currently immunized against influenza is important to con-
sider in assessing the potential value of influenza immunization in
the reduction of influenza-like illness (ILI) that might be confused
clinically with inhalational anthrax. The US military population is
an excellent group in which to study breakthrough illness due to its
high rate of influenza immunization. A recent study of febrile acute
respiratory disease (ARD) in young, healthy soldiers provided
information on breakthrough influenza. Methods: During April 1,
1997-March 31, 1999, virus cultures were performed on 340 Army
soldier trainees (median age 19 years, 80.3% males) hospitalized
with ARD at Fort Gordon, GA. Febrile ARD was defined as fever
(100.5˚ F or higher) with one or more symptoms or signs of a res-
piratory infection (predominantly cough and sore throat). All indi-
viduals had received the current influenza vaccine at least 10 weeks
prior to the onset of their illness. Pharyngeal swabs were submitted
for virus culture on each patient. Results: A virus was cultured
from 164 (48.2%) of the soldiers. A total of 29 (8.5%) individuals
had influenza virus isolates, including 23 with isolates of influenza
A and six with isolates of influenza B. Influenza was second only to
adenovirus (98 isolates, 28.8%) as a cause of febrile ARD. Age,
gender and temperature were similar for patients with an influen-
za virus isolate and others hospitalized with ARD. Conclusion:
Among 340 otherwise healthy young soldiers who had been immu-
nized for influenza and subsequently hospitalized for ARD, 8.5%
had an influenza A or B virus isolated; 39.7% had other viruses iso-
lated. For purposes of comparison, the case definition of febrile
ARD used in this study closely mirrors that of the CDC ILI case
definition (fever of 100˚ F or higher with cough and/or sore throat).
Even though influenza vaccine is highly valued as a public health
intervention in the control of influenza, cases of ARD or ILI may
occur in highly immunized populations. This situation may result
because the vaccine is less than 100% efficacious and many natu-
rally occurring microbes other than influenza are capable of caus-
ing ARD or ILI. Objective clinical and laboratory expertise should
be used in timely fashion to establish the correct diagnoses. These
data support the CDC position that influenza vaccination should
not be advocated for the general population solely to reduce the
incidence of ILI that might be confused clinically with inhalation-
al anthrax. More intensive laboratory-based surveillance for break-
through influenza should be performed in military populations to
monitor vaccine effectiveness.
Board 5. Modularized Service-Oriented Guidelines in a
Distributed Web-Based Environment : A Data Model and
Architecture for Managing Bioterrorism and Its Continuous
Surveillance 
A. Kumar, S. Quaglini, P. Ciccarese, M. Stefanelli
University of Pavia, Pavia, ITALY
The immediate management of the bioterrorism has to be
followed by a long term planning in terms of continuous surveil-
lance for bioterrorism and predetermined management methods.
The amount of human, material and financial resources, utilized in
the management of the current emergencies in bioterrorism clear-
ly determine that a long term expenditure of resources at the cur-
rent scale is either unfeasible or extremely exhaustive at the nation-
al and international levels. The paper defines a new architecture
based on knowledge management concepts, for representing and
implementing clinical practice guidelines, taking the anthrax emer-
gency as the bench-test. They would help in providing a common
platform not only for interaction among different pathologies, but
also between various individuals and institutions involved in the
health care in general, and infectious disease based bioterrorism in
particular.
Health Risk Assessments have always been based on
focused questionnaires which neither provide the complete health
assessment nor such common platform. The classical view of look-
ing at the guidelines is pathology based. For example, usually the
guidelines depict the management of Hepatitis, Anthrax etc. or
certain predetermined combinations.
In the proposed architecture we have divided the knowl-
edge into reusable objects called services. This takes into account
the conventional medical classification into symptoms, signs, labo-
ratory tests, treatment etc., as well as the universal standards of
object orientation in the sector of information technology.
In the non-emergency situations, various reusable guideline
modules would run at the level of different institutions involved in
the health care. In this case the guidelines become the object flow
models, inside which the non-atomic tasks(activities) are divided
into reusable atomic actions.
Further, in this scenario, the role of federal bodies, includ-
ing CDC and ODP, will be to maintain certain guideline reposito-
ries and to define the legal level for the compulsion of the imple-
mentation of a particular guideline by the health care providers in
a particular situation. The emergency guidelines can be released
for the nation-wide use in the situations of certain triggers, which
in turn, could come from different sources, like general practition-
ers, hospitals etc.
To mention the main points, this paper deals with:
I. The basis for the system architecture: conventional view
of guidelines compared with the modular architecture.
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II. The federal action: CDC’s and ODP’s current approach
III. The new system architecture and data model applica-
tion in the present setup, taking the anthrax emergency as the
bench-test.
Board 6. Tularemia Surveillance - United States, 1990-2000 
S. L. Marshall, K. A. Feldman, D. T. Dennis, E. B. Hayes
Centers for Disease Control and Prevention, Fort Collins, CO
Background: Tularemia is a zoonotic disease, caused by
the gram-negative coccobacillus Francisella tularensis. Although
tularemia was removed from the list of nationally notifiable dis-
eases in 1995, it was reinstated in 2000, primarily because of the
potential for F. tularensis to be used as a bioterrorism agent.
However, many states reported tularemia without interruption.
This report summarizes the tularemia cases reported to CDC from
1990 - 2000.
Methods: Reported tularemia cases were submitted elec-
tronically by state health departments to CDC through the
National Electronic Telecommunications System for Surveillance.
As of 2000, tularemia was reportable in 46 states. For surveillance,
confirmed and probable tularemia cases are clinically compatible
illnesses with confirmatory (culture of F. tularensis from a clinical
specimen or 4-fold change in serum antibody titer) or presumptive
(antigen detection by fluorescent assay or single elevated titer) lab-
oratory results, respectively. Reported data included county and
state of residence, age, sex, race, date of illness onset, and case sta-
tus. Incidence rates were calculated using 1995 population esti-
mates. Analysis was performed in Epi-Info.
Results: From 1990-2000, 1368 tularemia cases (average
124 cases annually) were reported from 44 states. Case status was
confirmed for 59% of cases, probable for 6%, and unknown for
35%. The incidence did not decrease substantially during 1995-
1999, but an increase was noted in 2000 when notifiable status was
restored. More than 50% of all cases were reported from four
states (AR, MO, OK, SD). Seventeen percent of U.S. counties
reported at least one case of tularemia during 1990-2000.
Males had a higher incidence than females in all age cate-
gories. The age distribution of reported cases is bimodal, with the
highest incidence in persons aged 5-9 years and 75-84 years.
Incidence was highest among Native Americans (0.50/100,000),
compared with 0.04/100,000 among whites, 0.01/100,000 among
blacks, and <0.01 in Asians and Pacific Islanders. Seventy percent
of cases reported onset of illness in the late spring and summer
months.
Discussion: Although tularemia occurs throughout the
U.S., it is consistently reported in greater numbers from AR, MO,
OK, and SD. Most cases occur in the summer months and are asso-
ciated with tick bites. The bimodal age distribution and prepon-
derance of males may be due to differential exposure to infective
animals or ticks, differential use of personal protective measures,
or to reporting bias. The high incidence among Native Americans
may be due to an increased exposure risk. By understanding the
occurrence of tularemia in the U.S. over the past decade, clinicians
and public health practitioners will be better able to recognize
unusual occurrences of tularemia including possible bioterrorist
events.
Board 7. Albany County Emergency Department
Surveillance: a Pilot Study Using State and Local Public Health
Systems for Rapid Detection and Notification of Bioterrorism
Events and Disease Outbreak 
L. H. Le1, R. G. Westphal1, I. Gotham1, C. Stetson1, T. Q. Nguyen2, J.
Crucetti3
1New York State Department of Health, Albany, NY, 2SUNY at
Albany School of Public Health, Albany, NY, 3Albany County
Department of Health, Albany, NY
Recent infectious disease and bioterrorism events in New
York and elsewhere point out the critical need to strengthen pub-
lic health surveillance systems to provide for rapid detection of dis-
ease outbreaks and timely notification of public health agencies
and health care providers. We have developed an ongoing collabo-
rative project between the New York State Department of Health,
the Albany County Department of Health and the hospitals in
Albany County, instituting a pilot electronic surveillance system
using daily passive reporting of emergency department visit data
via a secure website. Based on signal detection theory, this system
provides for rapid detection and notification of disease outbreaks,
which initiates a hierarchical active surveillance system for more
complete investigation of the triggering event. Experiences from
this pilot study are being used to improve regional and state-wide
surveillance systems and to develop a more robust, multiply-
regressed mathematical model for event detection.
Board 8. Rapid Influenza-like Illness Syndromic Surveillance
is Possible Using ICD-9 Codes from a Large Health
Maintenance Organization
H. Kassenborg1, M. Hadidi1, J. Nordin2, G. Amundson2, B. Miller1,
R. Danila1
1Minnesota Department of Health (MDH), Minneapolis, MN, 2Health
Partners Medical Group (HPMG), Minneapolis, MN
Issue: Potential bioterrorism agents will likely first present
as an influenza-like illness. Conventional infectious disease surveil-
lance mechanisms that rely on passive reporting are too slow and
insensitive to rapidly detect a large scale infectious disease out-
break; the time from patient presentation to specific disease diag-
nosis to reporting of the diagnosis to MDH currently takes days to
weeks. In the event of a large-scale bioterrorism event, the window
of opportunity for initiating effective post-exposure prophylaxis is
extremely short. In order to minimize the damage to public health,
rapid, real-time, syndrome-based surveillance mechanisms are
needed. In order to set up such a system in Minnesota, three cri-
teria needed to be met in order for such a surveillance system to be
practical and effective. First, due to resource limitations, the sur-
veillance data of interest must be collected for reasons other than
bioterrorism and exist in a digital format. Second, the surveillance
data need to be entered into a database in a timely fashion (within
24-72 hours). Third, the data and the method for analysis need to
be capable of detecting an outbreak. Program: HealthPartners is
a large health maintenance orginazation with Health Partners
Medical Group (HPMG) delivering primary care to over 240,000
persons in the Minneapolis/St. Paul metropolitan area. Ninety-
eight percent of patient encounter data including ICD-9 coding








added to the already
functioning guidelines
The non-emergency guidelines already function in a modularised form divided into signs, 
symptoms, tests, treatment, alternate guideline modules and the module specific to that 
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Thirty-one ICD-9 codes that could code for influenza-like illness
were chosen from “check-off” sheets used within HPMG clinics.
Outcome: Non-identifying demographic and ICD-9 data from
encounters that include one of the relevant ICD-9 codes are sent
to MDH after posting to HPMG central database. Each evening,
this data is automatically extracted and sent to MDH File
Transfer Protocol server where the data file is picked up and
processed to analyze the ICD-9 codes and demographic informa-
tion in relation to data from the same year and previous years.
Lessons learned: This system demonstrates that rapid, near
real-time syndromic surveillance can be accomplished using
existing data. Aberration detection methods for outbreak detec-
tion need development and refinement.
Board 9. Differentiation of Bacterial Agents of Bioterrorism
from Routine Clinical Isolates Using Cellular Fatty Acid Analysis 
G. Osterhout1, C. Allan2, S. Redus2, J. Teska3, M. Romagnoli4, J.
Dick4, M. Sasser1
1MIDI, Inc., Newark, DE, 2Anteon Corp., Frederick, MD, 3USAMRIID,
Frederick, MD, 4Johns Hopkins Hospital, Baltimore, MD
Specimens submitted to the clinical microbiology laborato-
ry generally may not be accompanied with a high index of suspicion
for containing potentially contagious/dangerous agents. Routine
microbiology screening protocols including various staining tech-
niques and use of selective/differential media provide preliminary
impressions suggestive of groups of organisms. Rapid biochemical
tests can provide further narrowing of possible bacterial identifica-
tions but this frequently requires extensive workup for confirma-
tion. Fastidious or infrequently encountered bacteria often are
unreactive in these conventional test systems or present with no
discernible pattern. Additionally, many nonpathogenic species, or
species of low pathogenicity may exhibit very similar reactions in
conventional test systems. We developed a database based on cel-
lular fatty acid (CFA) content that can quickly screen for both the
presumptive bacterial agents of bioterrorism (BA) and other less
virulent taxonomic relatives. Reference strains of Bacillus
anthracis (60), Burkholderia mallei (12), B. pseudomallei (16),
Brucella melitensis (22), Francisella tularensis (20), and Yersinia
pestis (12) as well as species genetically related to each agent (e.g.
B. cereus, Y. pseudotuberculosis), were cultured on appropriate
media. Cells were processed to generate methyl esters of fatty
acids, derived from cellular membranes, for analysis by gas liquid
chromatography. Chromatographic peaks were quantified and
identified using pattern recognition software. Composite entries
were generated and a library entry created for each species.
Routine clinical isolates and additional reference strains of each
database entry were processed in an identical manner and used to
challenge the database. All challenge strains of the agents of bioter-
rrorism were successfully identified by the database. Overlap was
noted for several strains of the genetically related species with the
corresponding BA. Additional strains of nondatabase entries were
properly designated as either “No Match” or an unacceptably low
match to the Bioterrorism library. The system allows the simulta-
neous searching of additional libraries consisting of hundreds of
other common clinical species. When searched with the Sherlock®
Microbial Identification Clinical database, these isolates were most
commonly identified as B. megaterium, B. licheniformis, B. sub-
tilis, or B. circulans. Batches of specimens can be automatically
analyzed with a run time for each specimen being ca. 20 minutes.
The same protocol can be applied to all samples minimizing sam-
ple handling and potential exposure. This methodology represents
an effective approach for simultaneous identification of BA and
related organisms.
Board 10. Modeling Results of Exposure to Weaponized
Bacterial and Viral Pathogens During Bioterrorism Attack 
G. H. Yoakum
BioTechnologies, Inc., Windermere, FL
Modeling the effects of Biological Warfare Agents (BWA)
will assist in strategic defense planning and tactical evaluation, if
public health systems are engaged by BWA events. We have devel-
oped a matrix-analysis model of BWA events based on standard
vaccination evaluation data. The Centers for Disease Control
(CDC) and The Johns Hopkins Center For Civilian Biodefense
Studies reviewed the status of preparations for an attack with
aerosol of anthrax spores or smallpox virus as Biological Warfare
Agents. The U.S. has a protein-based vaccine that protects mon-
keys against aerosol anthrax challenge between 8 and 38 weeks fol-
lowing vaccination. This vaccine has been shown to provide exper-
imental animals 88% protection after 100 weeks. A limited supply
of this vaccine is now available for military use. Public health plans
are underway to prepare material for vaccination against smallpox.
Current planning is based on public health data that assess the
response of populations to natural diseases. The protective effect
of immunization results from a decrease in the number of days
needed during secondary response to a disease agent, an increase
in the titer of total antibody bound when challenged by disease
agent, and the length of time the immune system responds to a
new challenge. Natural exposure to pathogens is different from
expectations of BWA events. BWA munitions exposure will fre-
quently involve many more infective particles per exposure, and
may involve enhanced chemical or genetic factors that increase
pathogenic activity. The matrix-model presented here predicts a
substantial decriment of protection by primary immunization, if
populations are exposed to BWA munitions in these tactical cir-
cumstances. This model also develops and applies Q-factors to
identify biologically distinct BWA munitions in the field, and assist
in developing effective defensive measures. Model results indicate
that detections of BWA, at or before exposure, is an important part
of a BWA defense strategy.
Board 11. Rapid Identification of Bacillus anthracis Directly
from Simulated Positive Blood Culture Bottles by PNA FISH 
H. Stender1, G. Haase2, K. Oliveira1, J. J. Hyldig-Nielsen1, J. Coull1
1Applied Biosystems, Bedford, MA, 2University Hospital RWTH
Aachen, Aachen, GERMANY
The definitive diagnosis of anthrax is based on identification
of Bacillus anthracis e.g. in positive blood cultures. However, stan-
dard methods require subculture, overnight incubation and a
series of analysis for phenotypic characteristics and thus take at
least 24-48 hours. Fluorescence in situ hybridization (FISH) using
peptide nucleic acid (PNA) probes targeting rRNA is a novel
method for identification of organisms directly from simulated pos-
itive blood culture bottles. In this study, we applied fluorescein-
labeled PNA probes targeting 23S rRNA of Bacillus anthracis to
PNA FISH to identify B. anthracis directly from simulated positive
blood cultures with gram-positive rods. The PNA probe was added
to smears made directly from the blood culture bottle and incu-
bated for 10 min at 80*C and subsequently for 90 min at 55*C.
Unhybridized PNA probe was removed by washing (30 min) and
the smears were examined by fluorescence microscopy and thus
provided results within 2.5 hours. Evaluation using reference
strains representing eleven Bacillus species, including all other
type strains of the B. cereus complex, i.e. B. cereus, B. thuringien-
sis, B. mycoides, B. weihenstephaniensis and B. pseudomycoides,
and four other bacterium and yeast species commonly found in
blood cultures showed 100% sensitivity and specificity. Studies
using clinical isolates are ongoing. Potentially, PNA FISH will be a
valuable and powerful tool in the bioterrorism preparedness of
clinical microbiology laboratories used for both rapid diagnosis of
anthrax and rapid screening of environmental specimens for spores
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of B. anthracis, since also these morphological forms can be visu-
alized by PNA FISH.
Board 12. Rapid International Assessment of Laboratory
Capacity to Test for Bacillus anthracis via WHO Global Salm-
Surv, 2001 
B. C. Imhoff1, E. D. Mintz1, M. Jouan2, P. Braam3, H. C. Wegener4,
F. J. Angulo1, WHO Global Salm-Surv3
1Centers for Disease Control and Prevention, Atlanta, GA, 2Institut
Pasteur, Paris, FRANCE, 3World Health Organization, Geneva,
SWITZERLAND, 4Danish Veterinary Institute, Copenhagen, DEN-
MARK
Background: Initiated in January 2000, World Health
Organization (WHO) Global Salm-Surv is a network of more than
400 individuals from over 100 countries involved in Salmonella
surveillance. Members include representatives from national and
regional public health, veterinary, and food reference laboratories.
Several free services aimed at enhancing laboratory capacity,
including training, an external quality assurance system, and
enrollment in a moderated electronic discussion group, are avail-
able for WHO Global Salm-Surv members. In response to WHO
Global Salm-Surv member inquiries regarding information about
anthrax, we sent a message listing resources for information about
anthrax (e.g. anthrax laboratory protocol, facts about anthrax) to
the electronic discussion group in October 2001. Also in October
2001, WHO requested WHO Global Salm-Surv conduct a rapid
assessment of its members to identify laboratories that are willing
and able to test environmental specimens for the presence of B.
anthracis. Methods: A ten-question questionnaire was sent to
WHO Global Slam-Surv members via the electronic discussion
group on October 31, 2001. This message requested information
about laboratory capacity to isolate B. anthracis, the methods
used to test for B. anthracis, whether the laboratory was a nation-
al reference laboratory for B. anthracis, and whether the labora-
tory was willing to test samples from countries that do not have
the capacity to test for B. anthracis. Results: Within 23 days, we
received responses from 50 WHO Global Salm-Surv members
from 40 countries; we received most responses within 7 days.
Eighty percent (n=40) of responding laboratories reported capa-
bility to isolate and identify B. anthracis using culture methods.
These 40 laboratories use conventional phenotypic methods
(motility and hemolysis) to identify suspect B. anthracis strains.
Only 66% (n=33) use India ink stain and 32% (n=16) use PCR.
Laboratories from the following regions reported having the
capacity to isolate and identify B. anthracis: 3/3 (100%) from
Africa, 3/3 (100%) from the Eastern Mediterranean, 17/23 (74%)
from Europe, 10/12 (83%) from the Americas, 2/2 (100%) from
South-East Asia, and 5/7 (71%) from the Western Pacific. Of the
40 responding laboratories with the capacity to test for B.
anthracis, 25 (63%) are national reference laboratories for
anthrax testing and 21 (53%) are willing to perform testing for
countries that do not have the capacity to isolate and identify B.
anthracis. Conclusion: The WHO Global Salm-Surv electronic
discussion group proved to be a valuable means to rapidly identi-
fy laboratories willing and able to perform B. anthracis testing.
These data will be used to create bioterrorism preparedness plans
and response systems for regional WHO offices. More informa-
tion is needed to understand these laboratories’ capacities to per-
form confirmatory testing for B. anthracis.
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Board 13. Evaluation of Pulmonary Tuberculosis Status in
Iran: Bijar Pilot 1999-2000 
M. R. Masjedi, M. Yazdanpanah, H. Masjedi, M. Hosseini, S. Salek,
R. Taghizadeh, A. Velayati
National Research Institute of Tuberculosis and Lung Disease, 
Tehran, IRAN
Objectives: According to the annual reports of the
Ministry of Health of Iran the incidence of Tuberculosis and smear
positive pulmonary TB in 2000, were 18.7 per 100,000 and 8.46 per
100,000 respectively. However, WHO has estimated the incidence
of different types of TB in Iran to be 54 per 100000 and the inci-
dence of smear positive pulmonary TB, 31 per 100000.
Accordingly, Iran was evaluated to have a relatively high preva-
lence of TB! Having different reports on the incidence rate of TB
in Iran, and also in order to initiate systematic study of TB in Iran,
a pilot survey was conducted. Method: A survay was conducted in
urban population of Bijar, Kordestan, in March 2000. Cough con-
dition of everyone in the household were asked by visiting all the
households in the city. Then cases with cough ≥ 3 weeks referred
to the city hospital. With these two groups were matched on the
basis of sex, age and neighbourhood, who had no cough or cough ≤
3 weeks. All the referred cases were examined; PPD test, sputum
smear (3 times), chest X-ray and sputum culture were carried out.
Results:In this household survey in Bijar, initially 45,834 were
asked for any cough. 50.9% were male and 49.1% females.
Amongst people who referred to the city hospital, after clinical
examination, PPD test, chest X-ray, sputum smear and sputum cul-
ture, 3 new cases were diagnosed as smear positive pulmonary TB.
And 2 cases as culture positive. Conclusions: According to the
reports of health care system of Bijar, 4 new cases were diagnosed
as smear positive by March 2000. With 3 new cases who were
found in this study, 7 new cases were diagnosed as smear positive
pulmonary TB (March 1999- March 2000). So, the incidence rate
of smear positive pulmonary TB was estimated to be 15.5 per
100,000. Since, there are places with higher and lower incidence of
TB in Iran, it seems that the incidence rate of smear positive pul-
monary TB is about 18-20 per 100,000. And then the rate of dif-
ferent types of TB is estimated to be about 40 per 100,000 nation
wide. Thus the present study reveals that Iran has a relatively low
prevalence of TB.
Board 14. Species Determination of Mycobacteria Isolated
from AIDs Patients in India by 16s rRNA Sequencing 
S. Shahdad
All India Institute of Medical Sciences, New Delhi, INDIA
In developing countries the most common mycobacterial
infection as per reports till now, in persons with AIDS is reported
to be tuberculosis as oppposed to MAI infections in the developed
countries. The diagnosis of tuberculosis in developing countries is
predominantly made after clinical and radiological examination;
microbiology services are often underutilized. Smear examination
alone can only indicate that acid fast bacilli are present and cannot
give any indication of the species of mycobacteria. Since patients
with AIDS may suffer from mycobacterial infection different from
M. tuberculosis, it is essential that the species identification should
be attempted whenever possible. Determination of Species identi-
fication is necessary if we are to avoid misidentification and misla-
beling of cases. Phenotypic methods have proved to be unreliable
















and unambiguous results and be the method of choice, at least in
the reference centers.
Fourteen strains from patients testing positive for HIV anti-
bodies were investigated on this study. Clinically all patients were
suspected to be suffering from tuberculosis and put on antituber-
culosis treatment. PCR amplification of 1 Kb region of 16s rRNA
was positive for all 14 strains. After sequencing of hypervariable
region A and region B using primer 244 and 259 respectively, 7 iso-
lates were identified as M. tuberculosis complex, 3 strains as MAI,
2 strains as M. fortuitum, 1 as M. smegmatis, and one isolate as M.
smegmatis.
Board 15. The Emergence of Tuberculous Meningitis in
Egypt: Clinical and Epidemiological Features 
F. G. Youssef1, M. A. Azab1, S. Afifi1, H. El Sakka1, K. Earhart1, S. El
Oun2, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Ministry
of Health and Population, Cairo, EGYPT, 3Centers for Disease Control
and Prevention, Atlanta, GA
Introduction: Mycobacterium tuberculosis meningitis
(TB-M) has emerged as a significant cause of meningitis in Egypt
with a high rate of complications and death. We report the features
of TB-M in a cohort of Egyptian patients. Methods: TB-M was
studied as part of ongoing surveillance of meningitis in a network
of twelve infectious disease hospitals in Egypt. Patients suspected
of having TB meningitis received lumbar puncture for analysis of
cell count, glucose, protein, and culture on Lowenstein Jensen’s
media. Clinical data from patients with TB-M was compared with
data from patients with other causes of culture positive bacterial
meningitis. Results: Of the 6868 patients evaluated in the surveil-
lance network, 691 had culture confirmed bacterial meningitis
including 106 patients with TB-M. TB-M occurred in all age
groups with a mean age of 22 years (range 5 months to 56 yrs).
60/106 cases (57%) occurred in patients greater than 20 years. In
patients >20 years the causes of bacterial meningitis were S. pneu-
moniae (31.7%), Mycobacterium tuberculosis (28%), Neisseria
meningitides (22%) and all other bacteria (18%). The case fatality
ratio (CFR) for patients with TB meningitis (46.2%) was higher
than that for all other causes of bacterial meningitis (21.7%).
Among patients who survived, the mean length of hospitalization
was 27.5 days (range 1-78) compared to 12 days (range 1 - 71) for
patients with other bacterial causes. Characteristic CSF findings
included elevated CSF WBC count (mean 360 WBC /mm3, range
0-2830), decreased glucose (mean 31.6 mg/ml, range 0 - 100), ele-
vated protein (mean 135 mg/ml, range 15-650) and percent of
WBCs that were lymphocytes (mean 29% range 0-92). Prodrome
prior to admission was much longer in the TB-M cases (mean 13
days, range 1-95). Conclusions: Three clinical and laboratory fea-
tures proved to be most prevalent in cases of TB-M when com-
pared with the non-TB-M culture positive cases: 1) prodrome
interval ≥ 5 days (OR=7.3), 2) CSF leukocyte ≤ 1000 cells/mm3
(OR 10.3), and 3) lymphocytes ≥ 50% (OR=6.8). With enhanced
surveillance and diagnostic capabilities TB-M has emerged as a sig-
nificant cause of bacterial meningitis in Egypt. In adults over age
20, TB-M is second only to pneumococcus as the leading cause of
bacterial meningitis in Egypt.
Board 16. Evaluation of an Automated Method for IS6110
RFLP Fingerprinting of Mycobacterium tuberculosis
K. Dupnik1, J. Hansen2, C. Campus1, T. Dambaugh2, D. Toney1
1Division of Consolidated Laboratory Services, Richmond, VA,
2Dupont Qualicon, Wilmington, DE
Molecular typing of Mycobacterium tuberculosis (Mtb) iso-
lates using IS6110 RFLP is a useful tool for the epidemiologic
tracking of tuberculosis clusters in the community and is currently
considered the “gold standard” for DNA typing of Mtb.
Widespread use by public health laboratories has been limited due
to the considerable time and expertise required to perform the
testing and issues of pattern reproducibility and standardization.
The availability of an automated method for IS6110 RFLP would
eliminate many of the problems associated with manual IS6110
RFLP and would make it more plausible for public health labora-
tories to provide this testing as a routine service for state and local
tuberculosis control programs. The current study investigated the
use of the QualiconTM RiboPrinter® Microbial Characterization
System for IS6110-RFLP analysis of M. tuberculosis. Modification
of the RiboPrinter® platform to include PvuII digestion and
IS6110 probe hybridization allowed for the generation of a RFLP
fingerprint pattern from DNA in 8 hours as compared to an aver-
age of 3-4 days using manual IS6110 RFLP. Automated typing of
75 clinical Mtb isolates resulted in the generation of 51 extractable
patterns, 43 of which represented unique DNA fingerprints.
Failure to extract patterns resulted from either insufficient sample
DNA concentrations or MW marker inconsistencies which pre-
vented the automated extraction of fingerprint data. Repeated
RiboPrinter® typing of 7 Mtb isolates on multiple independent
batch runs (n=3-6) resulted in 100% pattern reproducibility.
Automated typing of Mtb isolates from selected epidemiologically-
linked clusters of tuberculosis generated indistinguishable RFLP
fingerprint patterns for each cluster, strongly supporting the epi-
demiologic findings. Manual IS6110 typing of the same clusters
performed at a reference laboratory also generated an indistin-
guishable fingerprint pattern for each cluster. Comparison of man-
ual and RiboPrinter® IS6110 fingerprint patterns from 15 Mtb iso-
lates resulted in the generation of patterns with the same number
of bands and ratios of distances between bands; however,
RiboPrinter®-generated fingerprints possessed less band separa-
tion and differentiation, especially at the lower molecular weights.
Limitations of this system currently under evaluation include the
inability of the software to allow for user modification of data col-
lection and analysis. The results of this study suggest that automat-
ed IS6110 RFLP of Mtb using the RiboPrinter® System could
provide a fast, efficient, and practical tool for public health labora-
tories to identify, track, and compare clusters of tuberculosis with-
in the community.
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Board 17. Prevalence of 1999 Laboratory-Confirmed
Neurosyphilis Among All 1999 High Titer Syphilis Cases in a
Southeastern Public Hospital System
E. S. Safran, J. R. Drayton, P. Kloda
Morehouse School of Medicine, Atlanta, GA
Neurosyphilis is usually considered a disease of the past.
However, in the largest public hospital system in Atlanta, in 1999,
there were 11 CSF VDRL+ cases. According to the 1998 CDC
guidelines for STDs, a reactive VDRL in CSF is considered diag-
nostic of neurosyphilis. In the same year, there were 184 high titer
laboratory-confirmed syphilis cases — namely, all cases age one
year or older where the RPR titer is greater or equal to 32, and
there is a documented treponemal IgG positive test. Therefore, the
annual prevalence for VDRL+ neurosyphilis in 1999 within this
hospital system is 11/184 or 5.98%. Eight out of the 11 (73%)
VDRL+ neurosyphilis cases were documented HIV+, while the
remaining three cases did not have any HIV testing recorded. Of
these eleven cases, there were three cases of RPR=32, three cases
of RPR=64, four cases of RPR=128 and one case of RPR=256.
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Board 18. Efficacy of Balanites aegyptiaca(L.) DEL
Balanitaceae as Anthelminthic and Molluscicid Used by
Traditional Healers in Burkina Faso
T. H. Hamidou1, H. Kabore1, O. Ouattara1,2, S. Ouédraogo2, I.P
Guissou2, L. Sawadogo3
1Institute for Environmental and Agricultural Research, Ouagadougou,
BURKINA FASO; 2Institute for Health Sciences Research,
Ouagadougou, BURKINA FASO; 3University of Ouagadougou,
Ouagadougou, BURKINA FASO
Fast growing prices of modern veterinary drugs, more
resistance occurring frequently to current medicinal molecules,
commonly used by veterinary practitioners and persistence of
major diseases as constrains to animal production in rural areas in
most of underdeveloped countries, particularly in Burkina Faso
(West Africa), explains the importance given nowadays to indige-
nous knowledge systems about pharmacopoeia both for humans
and animals. The recipes, generally based on plants, are found
around the village or watershed area, very well known by healers,
less expensive, efficient and culturally accepted and integrated by
populations into their day-to-day life. Balanites aegyptiaca is a
sahelian tree of six to nine meters high. Its organs (ie: leaves, bark,
kernel) are widely used in Burkina Faso by vet-healers and live-
stock owners for animal parasitic diseases treatments. The aim of
the present study was to experimentally assess the anthelminthic
and molluscicidal activities of its kernel powder. The in vivo exper-
iment on goats (in village flocks and on - station animals) with doses
of 30 mg/kg, 40 mg/kg and 60 mg/kg showed a partial reduction of
parasitic eggs out-pout in faeces. The in vitro pharmacological
study of acetonic, ethanolic and aqueous extracts of powdered ker-
nels led to a complete helminth eggs development inhibition. Total
larvae mortality was obtained and LC50 values reached 27.24; 5.82
and 129.02 ppm for acetonic, ethanolic and aqueous extracts,
respectively. It also showed a complete lethality on freshwater
snails of Biomphalaria pfeifferi. LC50 values were 60 ppm; 172,40
ppm and 84,15 ppm for crude kernels powder, acetonic and
ethanolic extracts, respectively. Further studies will address confir-
mation of efficacy and therapeutic doses, which are recommended
at village level uses.
Board 19. A Combination of Lamivudine and IFN Adopting
a Different Timing-Schedule in the Treatment of B Chronic
Hepatitis E Antigen-Negative 
G. Tarantino, P. Conca, P. Sorrentino, P. Ragucci, A. Perrella, E.
D’Avanzo
Dpt of Clinical and Experimental Medicine Federico II University
Medical School, Naples, ITALY
B chronic hepatitis e antigen-negative (BCHe-) among
other HBV-related liver diseases is common in our area and is gen-
erally poor responsive to canonical IFN therapy. Recently, lamivu-
dine (L) has been found to be an useful tool in treating virus B
infection alone or in combination, taking in account the possibility
of the so called YMDD variant. To assess the efficacy of a com-
bined regimen, we selected 2 cohorts of BCHe- pts with high viral
replication, non responder (NR) or relapser (R) to a previous IFN
cycle. Fourteen pts (Group A, 7 females, 12 NR) were randomly
enrolled after a histological evaluation (sec. Knodell, grading 6-10
and sec. Scheuer, staging 1-3) and treated by L (100 mg/day) for 6
mths, followed by natural leukocyte IFN alfa-n3 6 MU s. c. at alter-
nate day lasting 12 mths. Group B comprehended 13 pts (8 males,
10 NR), grading (7-9), staging (1-2) and received simultaneously L
and IFN (for 6 mths), followed by a twelve mth-course of IFN, at
the same previously described doses. The response rate was signif-
icantly superior in group A (10/14 versus 2/13) at chi-square, by
measuring the undetectability of HBV DNA (PCR) at the end of
therapy cycle. Noteworthily, at 6 mths serum HBV DNA in group
A was absent in 12/14, meanwhile in group B only 6 out 13 did not
showed a positivity of HBV one. At log regression the negativity of
HBV DNA during the first 6 mths was an independent factor in
foreseeing the complete response (persistently normal ALT levels,
undetectable HBV DNA). None was characterized by a loss of
HbsAg. Significant life-style changes in examined cohorts were not
observed during treatment, nor severest side effects (excluding
some degrees of leukopenia) were faced. Three out 10 responders
underwent successive liver biopsy evidencing a decrease of their
previous grading score (minus 50%). It is our opinion that an abat-
ing of viraemia after L makes IFN, successively administered,
more active because it deals with a very low viraemic levels that last
also in the successive course thanks to an immuno- modulating
action of IFN. During the entire treatment (18 mths) unfortunate-
ly some pts (group A: 2 versus group B: 4), after having had a viral
clearance, displayed a presence of HBV at low-medium levels
more pronounced in group B. YMDD variants were not discovered
probably due to few pts studied.
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Board 20. Two Epidemiological Patterns of Norwalk-Like
Virus Outbreaks: England and Wales, 1992 - 2000 
B. A. Lopman, M. Reacher, G. K. Adak
Public Health Laboratory Service, London, UNITED KINGDOM
Introduction: Norwalk-like viruses (NLVs) cause out-
breaks of acute gastroenteritis via a number of routes including
foodborne and person-to-person transmission. Outbreaks occur in
a range of settings, though outbreaks in healthcare institutions may
be particularly common. NLVs are the number one reported cause
of hospital outbreaks in England and Wales. Methods: Data from
the national surveillance for outbreaks of infectious intestinal dis-
ease in England and Wales will be presented. NLV outbreaks that
occurred in healthcare settings (hospitals and residential facilities)
were compared with outbreaks that occurred in other settings.
Results: From 1992 to 2000, there were 1877 outbreaks reported
that were caused by NLV, the majority of which occurred in hospi-
tals (40%) and residential facilities (39%), affecting 13195 and
15545 persons, respectively. The remaining 21% of outbreaks
occurred in a range of settings including schools (6%), hotels (8%)
and food outlets (6%). Pronounced wintertime seasonality was
observed in healthcare institution outbreaks whereas no such peak
was seen in outbreaks in other settings (p < 0.0001). Person-to-per-
son transmission was more common in healthcare institutions and
outbreaks were smaller, more prolonged and had different attack
rates compared to outbreaks in other settings. Conclusions: There
are two distinct epidemiological patterns of NLV outbreaks: those
that occur in semi-closed healthcare institutions and those that
occur in more open settings. Underlying reasons may include clin-
ical and virological influences. The population at-risk in healthcare
institutions has an annual increase in number in wintertime due to
influenza. And, certain strains of virus may be particularly adapted
















Board 21. Emergence of Resistant Pathogens in Egypt:
Antimicrobial Evaluation of Community and Hospital Acquired
Infections 
K. Earhart1, M. Wasfy1, T. Ismail1, M. A. Maksoud1, F. Mahoney1,2
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Centers
for Disease Control and Prevention, Atlanta, GA
Background: Identifying the emergence of resistant
pathogens is a key component of disease surveillance. Since 1998,
NAMRU-3 has collaborated with the Egyptian Ministry of Health
to establish a surveillance network of infectious disease hospitals to
evaluate patients with meningitis, acute febrile illness, and diar-
rheal disease. More recently, the laboratory has supported the sur-
veillance for patients with hospital-acquired infections. Data from
these studies is reviewed to evaluate antimicrobial resistance pat-
terns throughout Egypt. Methods: Patients with meningitis, acute
febrile illness, and diarrheal disease undergo a standardized clini-
cal and laboratory evaluation. Bacterial isolates are archived and
characterized further at NAMRU-3. Surveillance efforts have been
recently expanded to include support in evaluating nosocomial
pathogens from intensive care units. Respiratory, Intestinal, and
nosocomial pathogens collected are culture confirmed and tested
for antimicrobial resistance by Kirby-Bauer disk diffusion and E-
test methods using standard NCCLS criteria. Strains were classi-
fied as extended spectrum beta lactamase (ESBL) producing
organisms based on a disk diffusion method comparing between
disks with and without clavulanic acid. Results: Antimicrobial sus-
ceptibility data indicates moderate levels of resistance of respirato-
ry and enteric pathogens to commonly used antibiotics for com-
munity-acquired infections (Table 1). Data on nosocomial-
acquired bloodstream infections (BSI) reveals high levels of resist-
ance to broad spectrum antibiotics and the emergence of extended
spectrum beta lactamase producing organisms (ESBL) (Table 2).
ESBLs were present in >30% of K. pneumoniae isolates.
Conclusion: Antimicrobial resistance is emerging as an important
public health problem in Egypt. Surveillance efforts are being used
to guide antimicrobial therapy. The high degree of resistance in
nosocomial pathogens suggests that more accurate molecular
assays at detecting ESBLs would yield even greater presence. The
emergence of ESBLs warrants further investigation and institution
of infection control practices.
Board 22. Outbreak of Pseudomonas aeruginosa Associated
with a Design Change in Specific Models of Bronchoscopes 
D. L. Kirschke1, T. F. Jones2, A. S. Craig2, P. Chu3, G. Mayernick4, P.
Patel4, W. Schaffner3
1CDC/DAPHT/EPO/EIS/State Branch/Tennessee, Nashville, TN,
2Tennessee Department of Health, Nashville, TN, 3Vanderbilt
University School of Medicine, Nashville, TN, 4Skyline Medical
Center, Nashville, TN
Introduction: Pseudomonas species are commonly impli-
cated in endoscope-related nosocomial outbreaks because they
thrive in moist hospital environments. We investigated a series of
reports of Pseudomonas aeruginosa obtained during bronchoscopy
at a community hospital. Methods: We reviewed hospital records
of patients undergoing bronchoscopy at the community hospital
during June-October 2001. Environmental samples were obtained
from bronchoscopes and the hospital endoscopy suite. Pulsed-field
gel electrophoresis (PFGE) was performed on isolates of P. aerug-
inosa. Results: Two new bronchoscopes began use on July 13 and
July 24, respectively; both were associated with positive culture
results on the second day of use. During the period that these
bronchoscopes were used, between July 13 and August 14, 2001,
bronchoscopy was performed on 32 patients; 18 (56%) had speci-
mens that grew P. aeruginosa. Six (33%) specimens with P. aerugi-
nosa also grew Serratia marcescens. Among the 26 procedures per-
formed with the new bronchoscopes, 18 (69%) were associated
with positive cultures for P. aeruginosa versus none of six proce-
dures performed with older models of bronchoscopes during this
period (p<0.01). One case-patient developed pneumonia eight
days after bronchoscopy and the sputum grew P. aeruginosa. P.
aeruginosa and S. marcescens were cultured from a biopsy port of
one of the new bronchoscopes before and after routine disinfection
procedures. P. aeruginosa was cultured from a vacuum trap and
cleaning solution in an endoscopy cleaning room. PFGE patterns
of isolates from the bronchoscopes, patients, and environmental
samples were indistinguishable, and different from strains of P.
aeruginosa from patients elsewhere in the same hospital. In
September, the implicated bronchoscopes were replaced with
identical models. Shortly thereafter, three endoscopy procedures
resulted in positive P. aeruginosa cultures, with a strain matching
the initial cluster. The caps of the biopsy ports on all implicated
bronchoscopes were easily removed by investigators, despite infor-
mation from the manufacturer indicating that they should be per-
manently affixed. The manufacturer had made design changes in
1998 to make that cap easier to remove during repair.
Conclusions: This outbreak of P. aeruginosa, associated with
numerous positive cultures and at least one clinical illness, result-
ed from contaminated bronchoscopes. Environmental contamina-
tion within the endoscopy suite likely led to seeding of the bron-
choscopes. A design change in the bronchoscopes appeared to
allow persistence of contamination in an area not readily amenable
to disinfection.
Board 23. Three Laboratory-Associated Infections of
Escherichia coli O157:H7, New York State 1999-2000 
N. L. Spina1, S. M. Zansky1, N. B. Dumas2, S. F. Kondracki1
1New York State Dept. of Health, Albany, NY, 2New York State Dept.
of Health, Wadsworth Center, Albany, NY
Background: Transmission of shiga-toxin producing
Escherichia coli O157:H7 (EC) occurs mainly by the ingestion of
undercooked beef, raw milk or contaminated water. Laboratory
acquired infection of EC was first documented in 1993. The small
infectious dose (as few as 10 organisms) of EC and its prolonged
survival on environmental surfaces may be contributing factors to
laboratory-acquired infections. This report summarizes three labo-
ratory-associated cases of EC in New York State within a one-year
period. Methods: The investigation included: 1) a review of lab
procedures, 2) case interviews to identify potential sources of expo-
sure and 3) comparison of Pulsed-Field Gel Electrophoresis
(PFGE) results of the case isolates to laboratory isolates temporal-
ly associated with their exposures. Results: Two cases occurred in
Medical Technologists (MT) and a third in a child of a lab worker.
Each case was associated with a different Microbiology laboratory.
Two were temporally related to a large county fair outbreak. MT#1
developed bloody diarrhea 3-4 days after initial exposure to work-
ing with an outbreak patient’s EC isolate. MT#1’s PFGE pattern
matched the isolate of a fair attendee identified in this lab. MT#2
did not become infected herself, but her one-year old son devel-
oped symptoms of fever and diarrhea 7 days following the mother’s
work exposure. The child’s PFGE pattern matched one of the main
outbreak strains tested by this laboratory. No household member
had visited the fair but the child attended a facility-related daycare
where his mother nursed him twice daily. No other children
attending the day care were symptomatic. The mother was asymp-
tomatic and a stool specimen submitted for culture was negative.
MT#3 developed bloody diarrhea 4 days after working with EC iso-
lates. An isolate with a matching PFGE pattern was tested in this
laboratory prior to onset of symptoms. A review of laboratory pro-
cedures showed no obvious breeches in technique. Neither MT#1
or MT# 2 had frequent work exposure to EC prior to the outbreak.
Conclusions: The PFGE patterns of the laboratory-associated
cases of EC were indistinguishable from isolates handled in the
laboratory 3-7 days prior to the onset of illness. We were unable to
identify breeches in lab procedures to explain the infections. These
cases reinforce the need for meticulous adherence to precautions,
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particularly among lab workers who handle large volumes of EC
cultures as in an outbreak situation. Further studies are needed to
identify protocols that decrease the likelihood of transmission in
the laboratory setting.
Board 24. Outpatient Candidemia: A Population-Based
Study in Connecticut 
S. M. Huie1, T. Im1, A. N. Sofair1, R. A. Hajjeh2, M. E. Brandt2
1Yale University School of Medicine, Emerging Infections Program,
New Haven, CT, 2Mycotic Diseases Branch, Centers for Disease
Control and Prevention, Atlanta, GA
Candidemia is currently ranked as the fourth most common
inpatient bloodstream infection in the United States. However,
candidemia as an outpatient infection is not well described. We
conducted a population-based laboratory surveillance study to
identify incident cases of candidemia in Connecticut from October
1, 1998 through September 30, 2000. We were able to distinguish
patients who had outpatient candidemia (defined as a positive
blood culture for Candida at or within 48 hours of admission to a
hospital, or a positive blood culture for Candida without a hospital
admission) from those who had inpatient candidemia. During two
years of surveillance, 464 cases of candidemia were identified, for
an incidence rate of 7.2/100,000. Outpatient candidemia infection
occurred in 28.7% (133/464) of cases. The species of Candida were
different in proportion for outpatient versus inpatient cases.
Among outpatient cases the species were C. albicans 37%, versus
non-albicans 63%. The speciation among inpatient cases were C.
albicans 57% versus non-albicans 43% (p <0.01). There were no
differences in age, race and gender. Among cases, 62% of outpa-
tients and 43% inpatients had required hospitalization in the three
months prior to the diagnosis of candidemia. Although outpatient
candidemia cases were less likely than inpatient cases to have an
indwelling catheter in place at the time of candidemia the propor-
tion was still large (69% versus 96%). Antecedent use of immuno-
suppressive therapy was documented among 32% of outpatient
and 50% of inpatient cases. Pulmonary disease was present in
56% and 81% of outpatient and inpatient cases respectively. A
similar proportion of outpatient candidemia cases and inpatient
candidemia cases had co-existing malignancy, diabetes mellitus,
cardiac, neurological, renal, or liver disease. The median length
of stay for outpatient cases was 11 days (range 0-98 days) com-
pared to 36 days (range 5-497 days) for inpatient cases. The crude
mortality rate was 26% for outpatient and 51% for inpatient cases
(p <0.01). Outpatient candidemia cases are more likely to be non-
albicans, many of which are known to be azole resistant. Although
candidemia does occur among outpatients, our findings (the large
proportions of persons with catheters, underlying illness and
prior hospitalizations) indicate that these infections are still
health-care related. Clinicians need to maintain a high index of
suspicion for candidemia among high risk outpatients.
Additionally, infection control methods that are usually applied in
hospitals need to be applied in the outpatient setting in order to
prevent these infections.
Board 25. Mycobacterial Spondylitis After Intravesicular
Bacille Calmette-GuÈrin Treatment of Bladder Transitional Cell
Carcinoma 
D. S. Smith1, R. Wilson2, M. Burgos3
1Kaiser Permanente, Redwood City, CA, 2Kaiser Permanente Medical
Group, Redwood City, CA, 3Stanford University, Stanford, CA
We report an unusual case of iatrogenic mycobacterial
spondylitis (Pott’s disease) related to the treatment of bladder can-
cer with BCG. A 79-year-old man presented to the urology clinic in
September 1996 with gross hematuria. A diagnostic cystoscopy
revealed papillary transitional cell carcinoma. A cystoscopic
transurethral resection of the bladder tumor (TURBT) was per-
formed in October. In January 1997 cystoscopy showed tumor
recurrence. In March he began a six-week regimen of intravesicu-
lar Bacille Calmette-GuÈrin (BCG) therapy for a total of 18 treat-
ments. The tissue sent in July 1997 revealed mild epithelial hyper-
plasia and small non-caseating granulomas. Special stains of the
bladder tissue for AFB were negative and the granulomas were
attributed to the recent BCG therapy. 15 months after the last
BCG wash, the patient presented to his physician with back pain
diagnosed as radiculopathy and sciatica. He went to physical ther-
apy but had focal weakness, so was referred to neurosurgery clinic.
MRI in March 1999 showed L4-5 disc space obliteration and
extensive scar tissue formation. A CT-guided needle biopsy of a
lesion of L4 and L5 vertebral bodies was consistent with abscess.
The pathology of this tissue sample demonstrated granulomas,
though AFB and Gram stains were negative. A boosted PPD test
was recorded at 15mm. The patient was discharged home on IV
cefazolin, pending results of AFB culture. The AFB preliminary
culture report was positive in May 1999. An AccuProbe test (Gen-
Probe Inc. San Diego, CA) identified Mycobacteria tuberculosis
complex one week later and an anti-tuberculosis regimen with four
drugs was begun. Susceptibility patterns (pyrazinamide resistance)
suggested M. bovis. High Performance Liquid Chromatography
(HPLC) confirmed M. bovis, BCG strain in July 1999. After com-
pleting almost one year of ethambutol, rifampin, and isoniazid he
made an excellent recovery and is now ambulatory with a cane.
BCG therapy has not been associated with Pott’s disease, however,
the cause of our patient’s disease state appears related to the use of
BCG in the bladder washes for the following four reasons: 1) the
spondylitis was temporally related to the exposure, developing
after the bladder treatments, 2) granulomatous changes were
observed in the bladder consistent with pathology induced by
mycobacteria, and later this was seen in the tissue biopsies from
the spine, 3) the organism was isolated and cultured from the
affected tissue, and 4) the patient responded clinically to a drug
regimen designed to treat the disease state. Thus, bone lesions in
the setting of a history of intravesicular BCG therapy should raise
suspicions of M. bovis osteomyelitis.
Board 26. Secondary Transmission of Invasive Group A
Strep in a Group Home for the Disabled 
S. Kondracki1, B. Wallace1, S. Zansky1, D. Schoonmaker-Bopp2
1New York State Department of Health, Albany, NY, 2Wadsworth
Lab, New York State Department of Health, Albany, NY
Background: Although 200 - 300 cases of invasive Group
A Streptococcal disease (GAS) are reported in New York State
each year, secondary transmission is rare. In February 2001, a
group home with 10 residents and 14 employees reported 2 cases
of invasive GAS (one resident, one employee). This report
describes the epidemiologic investigation and use of chemopro-
phylaxis to prevent additional cases. Methods: A site visit was con-
ducted by representatives of the New York State Department of
Health (NYSDOH) to review patient/employee records and inter-
view care providers. Throat cultures were collected from clients
and staff. Positive cultures from the clients and the two invasive
GAS cases were sent to the NYSDOH laboratory for pulse field gel
electrophoresis (PFGE). Results: Two cases of invasive GAS
meeting the CDC case definition were found. Case 1 involved a 40
year old profoundly retarded male who had onset of fever on
February 7th and pneumonia on February 10th, at which time he
was hospitalized. He expired on February 13th due to GAS sepsis.
The patient’s exposure history was unremarkable except for minor
dental work on February 7th. Case 2 involved an otherwise healthy
47 year-old visiting nurse, who assisted in collecting throat cul-
tures of other residents at the group home on February 12th. On
February 13th, she had fever, chills, shoulder pain, and subse-
quently was hospitalized and diagnosed with necrotizing fasciitis.
The wound site was positive for GAS. She recovered and
returned to work. Throat cultures from four (44%) of nine con-
















patterns of the throat cultures matched the two invasive cases.
Control Measures: All residents and employees were treated
prophylactically with penicillin G benzathine and rifampin or
with azithromycin. No additional cases occurred. Conclusion:
Secondary transmission of invasive GAS occurred at a group
home for the disabled involving one resident and one employee.
A follow-up identified four additional residents with throat colo-
nization. All cultures matched by PFGE. No cases occurred fol-
lowing prophylaxis.
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Board 27. An Outbreak of Leptospirosis following a
Houseboat Vacation in California 
E. Meites1, S. Deresinski2, M. Jay3, D. Smith4
1Stanford University School of Medicine, Stanford, CA, 2Division of
Infectious Diseases, Stanford University Medical Center, Stanford
University School of Medicine and Santa Clara Valley Medical
Center, Stanford, CA, 3California Department of Health Services,
Sacramento, CA, 4Department of Medicine, Division of ID, Kaiser
Permanente Redwood City, Redwood City, CA
We describe an outbreak of human leptospirosis that
occurred after a spring houseboating vacation on the New Melones
Lake, a popular recreational reservoir in California. This outbreak
represents the largest reported common-source outbreak of lep-
tospirosis in California in recent years. Only 3 of 8 men who shared
the houseboat reported swimming to a remote cove to hike along a
creek that drained into the main reservoir, where they were
exposed to muddied waters after an overnight thundershower.
Each of these 3 men presented to separate hospitals in Redwood
City 10-15 days later with a constellation of signs and symptoms
including fever, headache, myalgias, nausea and vomiting. Each
developed the salient common clinical feature of renal failure man-
ifested by elevated creatinine levels that in one case required
hemodialysis. Renal pathology in one patient showed acute tubu-
lointerstitial nephritis. 
Serologic studies for a panel of Leptospira serovars per-
formed at the CDC showed the highest titers (1:400 or greater) for
Leptospira serovars georgia, pomona and javanica in two of the
patients. All 3 men received supportive care including antibiotics in
hospital settings, and recovered without sequelae. None of the
other 5 houseboaters became ill. The following month, a multidis-
ciplinary team conducted an epidemiologic and environmental
investigation to determine the source of infection and prevent fur-
ther exposures. Water specimens were collected from the reservoir
and creek using the Moore Swab Technique. Darkfield microscopy
of samples from the area where the patients swam was positive for
spirochetes, though attempts to culture pathogenic leptospires
from these samples were unsuccessful, most likely due to the hot
and dry weather conditions at the time of collection. Overall, epi-
demiologic and environmental evidence strongly suggested that
the tributary had been the likely source of the contamination, with
possible precipitating factors including the recent rain and warm
weather facilitating snowmelt draining through nearby cattle graz-
ing pastures. Public health authorities notified local health care
providers, but no further definitive cases were identified.
Leptospirosis is the most widespread zoonosis in the world, though
it is likely under-diagnosed in the continental United States. The
average incidence in California was 4 reported cases per year in
1955-1964, compared to an average of only 1 reported case per
year in 1985-1994, when leptospirosis ceased to be a reportable ill-
ness. Salient and unusual features in this California outbreak
included high fever with uniform renal impairment and only mild
hepatitis. Because leptospirosis can progress rapidly if untreated,
this re-emerging infection deserves consideration in febrile
patients with a history of freshwater exposure, even in states with a
low reported incidence of infection.
Board 29. An Increase in Gastrointestinal Illness Associated
with Historic Flooding of the Mississippi River: Disease
Surveillance from a Randomized Trial of In-Home Drinking
Water Treatment 
T. J. Wade1, S. K. Sandhu1, C. C. Wright2, S. Lee3, L. M. Katz4, S. E.
Shaw5, M. W. LeChevallier6, D. A. Levy3, J. M. Colford, Jr.1
1University of California Berkeley, School of Public Health and the
California Emerging Infections Program, Berkeley, CA, 2University of
California Berkeley, School of Public Health, Berkeley, CA, 3Centers
for Disease Control and Prevention, Division of Parasitic Diseases,
Atlanta, GA, 4Scott County (Iowa) Health Department, Davenport, IA,
5United States Environmental Protection Agency, Office of Water,
Washington, DC, 6American Water Works Service Company,
Vorhees, NJ
Background: Recent studies have suggested an association
between extreme precipitation and outbreaks of waterborne dis-
ease. Since the most frequently observed manifestation of water-
borne disease outbreaks, gastrointestinal illness, is relatively com-
mon, moderate increases may be difficult to identify. Severe flood-
ing occurred during the spring of 2001 along the Mississippi River.
Although finished water continued to meet all treatment standards,
untreated sewage and wastewater were discharged directly into the
river upstream from the vicinity of Davenport, Iowa for approxi-
mately one month during the flood. Peak total and fecal coliform
levels in the source water increased at least 10-fold during this
period. Since November 2000 we have been collecting daily self-
reported GI illness symptoms from 1296 individuals enrolled in a
randomized, controlled trial of an in-home drinking water treat-
ment (WET study) in this same area. Methods: Rates of illness
were determined for the flood period as well as for prior and sub-
sequent seasons. We considered two illness outcomes: “highly
credible gastrointestinal illness” (HCGI), a composite of several GI
symptoms published previously, and “diarrhea” (three or more
loose stools in one day). To determine the impact of the flood ill-
ness rates, adjusted for the effect of season, Poisson regression was
used. Generalized estimating equations (GEE) were used to
account for repeated measures within individuals and the correla-
tion of individuals within households. The predictor variables were
the presence of flooding and season. Results: The river was above
flood stage (>15 feet) between April 14 - May 23, 2000. Based on
519 person-years of observation, the overall rate of HCGI was 2.52
episodes per person-year; and the overall rate of diarrhea was 0.75
episodes per person-year. The highest rates of both HCGI (3.28)
and diarrhea (0.95) were in the winter (November-February).
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After controlling for season, the flood period was associated
(p=0.006) with elevated levels of HCGI (rate ratio=1.23; 95%
CI[1.06-1.45]). Diarrhea rates were also elevated during the flood
period (rate ratio=1.29; 95% CI[0.98-1.72]), but of borderline sta-
tistical significance (p=0.074). Conclusion: These data suggest
that a significant increase in GI illness occurred during this severe
flood. They do not, however, identify the source of this excess ill-
ness. We are continuing our examination of the effect of the flood-
ing on GI illness using other community data such as hospital
records and a concurrently conducted random digit dialing survey
of the population.
Board 30. Spores of UV- Repair Defective Bacillus subtilus
Strains Exhibit UV Inactivation Kinetics Similar to
Cryptosporidium parvum and Encephalitozoon spp.: Potential
for their Use as a Biodosimetry Assay for Evaluation of UV
Disinfection Systems 
M. M. Marshall
Universtiy of Arizona, Tucson, AZ
Recent reports of protozoan sensitivity to low pressure UV
has generated great interest in the North American water indus-
try. UV has many advantages in that it is a proven technology for
water and wastewater, and is used widely in Europe for drinking
water disinfection. Furthermore, issues related to DBPs do not
appear to be a concern for UV. Recent inactivation studies of
Cryptosporidium parvum oocysts have shown that the oocysts of
five different strains are sensitive to low pressure UV light. The
Iowa, Moredun, Maine, TAMU and Glasgow strains treated with
UV light at 10 mJ/cm2 provided oocyst inactivation at 4 logs.
Studies on Encephalitozoon intestinalis, E. cuniculi and E. hellem
spores treated with UV light at 20 mJ/cm2 also provided inactiva-
tion at 4 logs. Monitoring of UV disinfection systems for optimal
inactivation of protozoan parasites relies on a rapid and repro-
ducible bioassay system. In this study we present the develop-
ment of a UV biodosimeter based on spores of Bacillus subtilus
mutants defective in the repair of UV damage to DNA, which
exhibit UV inactivation kinetics similar to Cryptosporidium
parvum oocysts and Encephalitozoon species spores and which
can be thus used as a surrogate system. These non-pathogenic
organisms have the following advantages for the water industry:
(1) They can be used to evaluate low-pressure UV disinfection
systems in situ without the risk of pathogen contamination; (2)
They provide a shorter turn around time of < 24 hours as com-
pared to animal infectivity which takes 3-4 weeks for results or
cell culture RT-PCR which takes 4-5 days for results; and (3) they
are more cost-efficient and rely on standard bacteriological tech-
niques and equipment already available at many existing facili-
ties. Therefore, spores of B. subtilis UV-Repair mutants can pro-
vide a highly accurate, standardized and reproducible biodosime-
try system suitable for municipal-scale applications.
Board 31. Waterborne Epidemic Infections in Ukraine at 
Last Decade
L. V. Parkhomenko, V. V. Alexeenko, E. V. Murashko
Institute of Epidemiology and Infectious Diseases, Kiev, UKRAINE
Under influences of different ecologic and social factors
during the last ten years there is aggravation of epidemiological sit-
uation in Ukraine in regards to many infections including water-
borne diseases. In August 1991 emerged water outbreak of cholera
in towns Vilkovo and Kiliya, situated on river Dunay, where it was
revealed 41 patients with illness and 115 - of vibrio-carriers. After
that cholera was spread on set of other territories of Nykolaev and
Khersoh regions and all around in Ukraine it was revealed 106
patients with cholera and 179 - of vibrio-carriers. Outbreak begun
as result of spreading of agents with water of Dunay during freshet
from Romania, where cholera was observed. During 1992 - 93
years outbreaks of cholera in Ukraine were not observed. In 1994
year appeared most prominent epidemic of cholera at last 75 years.
At that time 845 patients were hospitalized with illness and 600
vibrio-carriers were revealed. By leading factor of infection trans-
mission was water of river South Bug in Nykolaev region, that was
polluted by sewage water. Most probable the carry the infection
was from Dagestan, where in 1994 year was epidemic of cholera
during which 2500 patients were revealed. This epidemic begun
one month earlier than in Ukraine and carry the infection was by
transport way through Rostov region. In 1995 year there were 525
patients with illness of cholera and 399 of vibrio-carriers and that
was a continuation of previous epidemic. After that the cases of
cholera were only sporadic, however were connected with deep-
seated infection. At that time, there were also continuous out-
breaks of other waterborne infectious diseases such as typhoid
fever - 6, Flexneri dysentery - 10, Sonne dysentery 3, as well as out-
breaks of gastroenterocolitis caused by opportunistic bacteria.
Serious problem for Ukraine represents virus hepatitis A and E.
During last five years emerged 8 outbreaks of hepatitis A, during
which 2972 patients were revealed. All cases were connected with
drink water - water-supplies, from shaft wells and reservoirs. Above
data evidence about serious danger of emergency of waterborne
infection epidemics in Ukraine.
Board 32. Antibodies Against Hepatitis E Virus (HEV)
Proteins in Acute Hepatitis and Blood Donors in India
S. K. Mohanty, S. K. Panda, S. K. Acharya
All India Institute of Medical Sciences, New Delhi, INDIA
Background: Hepatitis E virus (HEV), the major cause of
viral hepatitis is transmitted by contaminated food and water. It
causes large epidemics and sporadic form of disease through out
the world. HEV infection is endemic in India. In such an endemic
area the diagnostic accuracy and kinetics of IgM anti HEV need to
be evaluated. The significance of IgG anti HEV in the endemic
population has not been studied. The magnitude of HEV infection
among patients with sporadic acute viral hepatitis (AVH) has not
been studied as well by sensitive assays for IgM anti HEV detec-
tion. Therefore we developed a sensitive ELISA to detect IgM and
IgG anti HEV and evaluated its efficacy among healthy blood
donors , patients with acute hepatitis in the sporadic and epidemic
set up. Methods: Development of ELISA for detection of IgG and
IgM anti HEV against the 3 recombinant proteins of HEV [full
length open reading frame 2 encoded protein (pORF2), full length
pORF3 and C terminal end of pORF1 protein]. Results: The val-
idation of the test was seen by the high degree of correlation
between presence of IgM anti HEV and HEV RNA in serum
among the icteric patients (72% and 50% in sporadic and epidem-
ic hepatitis respectively with in the first 2 weeks). The IgM anti
HEV was detected against all the 3 proteins in maximum number
of cases i.e. 19 of 200 in healthy blood donors, 185 of 266 in spo-
radic hepatitis, 114 of 221 in epidemic hepatitis and also in 67 of
124 contacts in the epidemic area. The kinetics of IgM anti HEV
was studied from the serial samples of 21 patients with acute HEV
infection. The IgM antibodies last for about 8 weeks. The IgG anti
HEV was found in 30% of normal healthy blood donors and in spo-
radic cases and 70% in epidemics. Conclusion: The IgM anti
HEV against all the three proteins of HEV have maximum sensi-
tivity and usually last for 8 weeks. IgG antiHEV may also be short
lasting. A significant number of subclinical infections is also seen.
In India 45% of acute viral hepatitis is caused due to HEV.
Board 33. Diarrheal Pathogens Other than E. coli in Egypt 
H. Mansour1, M. Wasfy1, T. Ismail1, M. A. Maksoud1, F. G. Youssef1,
F. Mahoney1,2
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Centers
for Disease Control and Prevention, Atlanta, GA
Background: Diarrheal disease is a leading cause of mor-
















have documented changing patterns of antibiotic resistance, par-
ticularly a resurgence of sensitivity to chloramphenicol (C), tetra-
cycline (TCN) and sulfamethoxazole-trimethoprim (SXT). A sur-
veillance system initiated by the Egyptian Ministry of Health &
Population and NAMRU-3 monitors the prevalence of bloody and
watery diarrhea at a number of infectious disease hospitals
throughout the country. We report the laboratory findings from
two hospitals during JAN-JUL 2001. Methods: Stool samples or
rectal swabs were collected from patients admitted with diarrhea.
Samples were cultured on MacConkey, S-S, Hektoen Enteric,
TCBS and Campylobacter blood agars. Sensitivity testing was per-
formed to standard antibiotics using the disk diffusion method.
Results: Of 397 stool cultures processed, 80 (20%) were positive
for enteric pathogens other than E.coli. Etiologies were Shigella
spp. (51.2%) and Salmonella spp. (48.8%). Shigella isolates were
identified as Shigella flexneri (71 %), S. sonnei (23 %), S. dysente-
riae (2.6%) and S. boydii (2.6 %). Salmonellae isolates were iden-
tified Salmonella serogroups B (37%), D (37%), C1 (13%), C2
(8%) and as S. typhi (5%). No V. cholera or Campylobacter iso-
lates were recovered. S. flexneri were resistant to C (63%), ampi-
cillin (AM) (63%), SXT (63%) and TCN (79%). 10% of S. sonnei
were resistant to both C and AM, while most S. dysenteriae and S
boydii were sensitive to all antibiotics tested. While S. typhi was
sensitive to the antibiotic panel used, 21% of the other salmonel-
lae were resistant to C, AM and SXT. No resistance to
ciprofloxacin and ceftriaxone was detected. Conclusion: Shigella
and Salmonella spp are the most common enteric pathogens other
than E. coli in patients presenting to hospitals with diarrhea. S.
flexneri harbors the greatest antibiotic resistance.
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Board 34. Human Exposure to Herpes B Seropositive
Macaques in Bali, Indonesia 
G. A. Engel1, L. Jones-Engel1, M. A. Schillaci1, K. Suaryana2, A.
Putra2, A. Fuentes3, R. Henkel4
1University of New Mexico, Albuquerque, NM, 2Universitas
Udayana, Denpasar, INDONESIA, 3Central Washington University,
Ellensburg, WA, 4Herpes B Reference Laboratory, Atlanta, GA
Herpes B virus is implicated as the cause of nearly forty
cases of meningoencephalitis affecting people in direct or indirect
contact with laboratory macaques. However, the threat of Herpes
B in non-laboratory settings worldwide remains to be addressed.
The present study investigates the potential for exposure to Herpes
B virus among workers at a “monkey forest” in Bali, Indonesia. A
survey eliciting information regarding contact with macaques was
administered to 105 workers at the Sangeh monkey forest in
Central Bali in July, 2000. Nearly half of those interviewed had
either been bitten or scratched by a macaque (M. fascicularis).
Additionally, serum obtained from 31 of 38 Sangeh macaques con-
tained antibodies to Herpes B virus. We conclude that workers
coming into contact with macaques at the Sangeh monkey forest
are at risk for exposure to Herpes B virus. Public health implica-
tions of these findings are discussed.
Board 35. Cryptosporidiosis in Veterinary Technician
Students — An Annual Rite of Passage 
A. S. Craig1, B. Wanamaker2, D. Gibbs3, J. Sanders4, D. Lampley2,
W. Schaffner5
1Tennessee Department of Health, Nashville, TN, 2Columbia State
Community College, Columbia, TN, 3South Central Regional Office,
Tennessee Department of Health, Columbia, TN, 4Maury County
Health Department, Columbia, TN, 5Vanderbilt University School of
Medicine, Nashville, TN
Background: Cryptosporidium parvum has emerged as an
important cause of human diarrheal disease in the past decade.
Cryptosporidiosis has been reported as a cause of commonly
occurring “scours” (diarrhea) in calves. Direct zoonotic transmis-
sion of disease has been reported though uncommonly. We report
an outbreak among veterinary technician students at a local college
who participated in a livestock management course. Student activ-
ities included feeding, grooming, and taking rectal temperatures
on calves three or more days per week. The principal instructor
reported that similar outbreaks occurred each fall among students
in his class shortly after the arrival of the calves. Methods:
Students were interviewed regarding gastrointestinal illness and
exposures to calves cared for by the class. Human and bovine stools
were cultured for Salmonella, Shigella, Campylobacter, and E. coli
O157. All stools were also examined for parasites by standard
microscopic techniques and for Cryptosporidium parvum and
Cyclospora cayetenesis by direct fluorescent antibody (DFA).
Three calves had been replaced due to severe diarrhea before they
could be cultured. Results: Twenty-one (95%) of 22 class mem-
bers were interviewed. Fifteen (71%) of 21 students reported diar-
rhea. The average duration of diarrhea was 8 days. Six sought med-
ical attention for their illness; none were hospitalized. Stool cul-
tures were collected from 10 (67%) of 15 ill students and 9 (64%)
of 14 calves. All cultures for bacterial pathogens were negative.
Three students were DFA positive for Cryptosporidium parvum.
One calf was DFA positive for Cryptosporidium parvum. Five
calves were DFA positive for Giardia lamblia. There was no asso-
ciation between diarrhea and eating or drinking in the barn or
handwashing habits. Conclusions: An outbreak of cryptosporidio-
sis occurred among veterinary technician students at a local col-
lege. The students were exposed to at least one calf with cryp-
tosporidiosis and several with giardiasis. It is likely the students
contracted Cryptosporidium infection via the fecal-oral route due
to poor hygiene. Recommendations to prevent this annual rite of
passage for students include wearing coveralls, boots and gloves,
particularly when caring for ill calves and adhering to meticulous
handwashing after class. Future investigations might include follow
up of future classes and an assessment of the risk in other veteri-
nary schools.
Board 36. VTalumnNET (VTA) of Virginia Tech: A Program of
Distributing Information on Emerging Infectious Diseases (EID)
to Virginia Tech Alumni and the General Public 
T. E. Toth1, S. Turner2, M. Howard1, J. Phillips2, C. Zamboni2
1VA-MD Regional College of Veterinary Medicine, Virginia Tech,
Blacksburg, VA, 2Institute of Distance and Distributed Learning,
Virginia Tech, Blacksburg, VA
VTA is a newly initiated program by the President of
Virginia Tech providing an online virtual gateway to lifelong learn-
ing. VTA allows easy distribution of knowledge through a wide vari-
ety of subjects, asynchronous and instructor led courses to VT
alumni and members of the public at large. EID, a one-credit
course, is the first on-line (Spring 2001), asynchronous course of
the VMRCVM, given by 14 faculty of the VMRCVM and was
adapted to the VTA program (Fall 2001). EID defines and dis-
criminates between emerging and other infectious diseases,
defines spatial and temporal determinants, host and agent charac-
teristics and risk factors, analyzes social, economical and interna-
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tional trade changes, improper uses of antibiotics, multi-drug
resistant infectious agents as factors in emerging diseases of
humans and animals. Selected emerging food-borne, bacterial,
viral and zoonotic diseases of animals and humans are discussed. In
all lectures, whether they discuss human or animal diseases, the
three-way interaction among the infectious agents and these
hosts are emphasized. Content is primarily managed and deliv-
ered through the Blackboard course management system and a
Real streaming server. The lectures (Powerpoint slides narrated
by the instructors) are available by streaming video on RealPlayer
in two versions of audio and image delivery for high-, or low
bandwidth reception and audio only for the worst reception con-
ditions. In the VTA program, the lectures of EID have been
assigned to two main types of self-paced delivery modules:
Knowledge Units (1-1.5 hours of content) which contain selected
single lectures and Mini Courses (4-8 hours of content) which
contain groups of lectures organized to meet pedagogical logic
and by presumed interest groups, such as Public Health workers,
people interested in horses, swine, poultry, and wild animals.
Experience with the reaction of the public to this concept will be
included and analyzed at the presentation of the poster.
VTalumnNET URL: http://alumni. iddl.vt.edu General Public
Direct Link: http://www.vto.vt. edu/vetmed.
Board 37. Prognostic Factors in Moderate to Severe
Leptospirosis: An Experience from Kerala, India
D. Unnikrishnan, R. Pisharody, N. Vijayalekshmi
Medical College, Trivandrum, Kerala, INDIA
Background: Leptospirosis, a worldwide zoonosis, has
increasing incidence in the state of Kerala, South India. Often mild
and self-limited, severe disease can be fatal. Methods: 92 patients
(74 males, 18 females) with moderate-severe leptospirosis, admit-
ted to Trivandrum Medical College, Kerala, during Jun 1995 - Dec
1996 were studied. Diagnosis was by clinical and laboratory fea-
tures, and confirmed by IgM ELISA. Demographic, clinical, labo-
ratory and treatment details were analyzed in relation to outcome
(mortality). Results: 14 of the 92 patients (11 males, 3 females)
died, mortality rate 15.2%. Higher mortality was noted in those
above age 50 (27.7% vs 12.2%). No difference in mortality was
seen when grouped by sex, at-risk occupation or rodent/pet expo-
sure. No significant difference was noted between day of starting
antibiotics after initial symptoms and mortality (mean 7.60 +_ 2.95
days in survivors, 8.57 +_ 3.08 in dead). 12 patients had symptoms
of Jarish-Herxeimer reaction with penicillin, one died. 46 patients
had acute renal failure, 11 underwent hemodialysis. 34 patients
had electrocardiographic (EKG) changes: ectopics (24 patients),
sinus tachycardia (7), T wave changes (17), atrial fibrillation (3),
first-degree block (1), sinus bradycardia (1) and hyperkalemia (1).
Clinical, EKG and echocardiographic features of myocarditis was
present in 9 patients, 4 of whom died. Those with myocarditis and
hypotension had 75% mortality. Abnormal chest X-rays included
nodular (12 patients), reticular (7), ground glass (4), consolidation
(5) and effusion (6). 3 out of 4 patients with respiratory distress
syndrome died. Significant difference (p<0.05) among survivors
and non-survivors was found in serum CPK (mean 246.21 vs
877.71 u/L), serum sodium (mean 138 vs 127 mEq/L), potassium
(mean 4.22 vs 5.21 mEq/L) and platelet count (mean 145,026 vs
80,000/mm3). No significant difference was found in serum biliru-
bin (mean 8.29 vs 14.92 mg/dL), ALT (98.97 vs 175.86 u/L) or cre-
atinine (2.98 vs 4.04 mg/dL). In logistic regression analysis of
organ system dysfunction, bleeding (hemoptysis, gastrointestinal,
epistaxis) [OR 17.45, p=0.003], cardiac (myocarditis, EKG
changes) [OR 15.56, p=0.02] and neurological (seizures, altered
mentation) [OR 22.12, p=0.0003] complications were significant
predictors of mortality. Among laboratory variables, CPK >500
u/L (p=0.0002) and serum sodium < 130 mEq/L (p=0.0059) were
significant as predictors of mortality. Conclusion: High mortality
reflects severe illness in hospitalized patients. Higher numbers of
young male patients results from high occupational risk. Bleeding,
cardiac, neurologic complications, hyponatremia and high CPKs
predict poor outcome. Poor prognostic factors identify patients
who need intensive monitoring and treatment. With efficient
renal support therapy, other organ dysfunctions account for most
deaths in the disease.
Board 38. Acute West Nile Virus Infection of Reptiles 
and Amphibians 
K. Klenk
CDC, Fort Collins, CO
Due to the seasonality of the most important West Nile
virus vector, the mosquito, it is presently unknown how the virus
can survive periods of mosquito inactivity. One theory suggests rep-
tiles and amphibians may serve as West Nile virus hosts by sustain-
ing infectious viremia for long periods during the winter until mos-
quito activity resumes in the warmer months. Some reptiles and
amphibians are known to develop arbovirus viremia and one
species, Rana ridibunda, can produce high viremic titers of West
Nile virus capable of re-infecting mosquitoes. This present study
focuses on the acute viremia titers of three North American species
of reptiles and one North American species of amphibian after
experimental infection with West Nile virus. The representative
species include: Rana catesbeiana (bullfrog), Iguana iguana (green
iguana), Thamnophis radix (garter snake), and Trachemys scripta
elegans (red ear slider). Twenty-one individuals of each species
were infected with West Nile virus (NY99) followed by the sacri-
fice of three individuals of each species each day for viremia deter-
mination during 7 consecutive days. Additional animals were main-
tained longer for evaluation of persistent viremia and/or infection
of tissues. These data will be presented and discussed.
Board 40. Pogosta Disease — A Potentially Chronic Arthritis
Caused by Virus 
A. Toivanen5, M. Laine5, R. Luukkainen5, J. Oksi5, R. Vainionpää5, P.
Kuusisto5
1Department of Medicine, Turku University, Turku, FINLAND,
2Departments of Medicine and Medical Microbiology, Turku
University, Turku, FINLAND, 3Satalinna Hospital, Harjavalta, FIN-
LAND, 4Department of Virology, Turku University, Turku, FINLAND,
5Ilomantsi Health Center, Ilomantsi, FINLAND
A disease characterised by arthritis, rash and fever was
described in the Northern Karelia in Finland 1974 by a local physi-
cian and named, acccording to the region, Pogosta disease. When
analysing the clinical picture during a later outbreak we found that
93% of the patients had joint inflammation, and 40% of them had
polyarthritis. In 8% of the cases the arthritis was severe. Rash was
seen in 88% of patients, and 23% had fever. It has been supposed
that the disease is mild and self-limiting, but in a follow-up study it
turned out that 50% of the patients suffered of chronic joint and
muscle pains even more than 2.5 years. Three out of 26 patients
had fibromyalgia, six had occasional arthralgia and two had chron-
ic arthritis. One patient developed an erosive disease closely
resembling rheumatoid arthritis. There have been several out-
breaks of Pogosta disease in the Northern Karelia, where it is con-
sidered endemic. The outbreaks seem to occur every seven years.
Pogosta disease resembles closely the Ockelbo disease reported
from Sweden, and Karelian fever described in Russia. All these
three diseases are attributed to Sindbis-related arboviruses. So far
the causative virus has not been isolated from Pogosta patients.
The vector spreading the infection are mosquitoes, and the virus
causing Ockelbo disease was isolated from Culiseta late summer
mosquitoes. It has been assumed hat Pogosta disease is locally
restricted as described for Ockelbo disease and Karelian fever.
These diseases affect mainly young to middle aged adults. In an
epidemiological study we analysed antibodies in 2250 serum sam-
















that the prevalence of the disease was much higher than expected,
and that positive sera originated from all parts of Finland. Eleven
% were positive for IgG class and 0.6% for IgM antibodies. To our
surprise, antibodies were frequently found in individuals aged 1 to
20 years. This may indicate that the disease is spreading in an unex-
pected manner. Pogosta disease is an example of a viral disease the
role of which has been underestimated. Pogosta disease may lead
to both acute and chronic arthritis or fatigue symptoms. It’s occur-
rence has not been studied outside Scandinavia and Karelia, but
mosquitoes may spread it also elsewhere. Pogosta disease should
be considered as a differential diagnostic alternative at least in
patients with joint symptoms.
Board 41. Wildlife Tuberculosis, Bovine Tuberculosis and
Zoonotic Tuberculosis ñ Potential Threats to Human Health in
Rural African Communities? 
A. Michel
Onderstepoort Veterinary Institute, Onderstepoort, SOUTH AFRICA
Following the implementation of a National Tuberculosis
Control and Eradication Scheme in 1969, the prevalence of tuber-
culosis in South African commercial cattle herds has dropped
sharply to around 0.0003%. This does, however, not include cattle
herds belonging to rural communities and subsistence farmers. It
further excludes the tuberculosis epidemics currently experienced
in South Africa’s two major game reserves, the Kruger National
Park (KNP) and Hluhluwe-Umfolozi Park (HUP). It is estimated
that bovine tuberculosis spilled over from cattle to African buffalo
(Syncerus caffer) in the KNP via the wildlife-livestock interface
approximately 40 years ago. It has since spread among buffalo
herds in the southern and central regions of KNP and was more
recently also diagnosed in the northern areas. With increasing
prevalence rates in buffalo, which are regarded as maintenance
hosts for tuberculosis, spillover to other animal species such as lion
(Panthera leo), leopard (Panthera pardus), Cheetah (Acinonyx
jubatus) hyena (Crocuta crocuta), chacma baboon (Papio ursinus),
greater kudu (Tragelaphus strepsiceros), warthog ( )and honey
badger ( ) became evident. If uncontrolled, this epidemic is expect-
ed to spread over the entire areas of both the KNP and HUP,
affecting many more species over time. Both parks are mostly bor-
dered by communal farmland of resource poor farming communi-
ties and only few commercial farms. Despite the erection of ade-
quate game fencing over the full length of both parks, this barrier
can only partially prevent contact between wild animals and
domestic livestock. Under these conditions the risk of tuberculosis
spillover into domestic livestock outside the parks is increasing and
cannot be ignored.As mentioned, communal cattle herds are not
regularly tested for bovine tuberculosis. Therefore, once present in
a herd, the infection is allowed to progress into the advanced stages
of disease, with animals developing open lesions and shedding
bacilli mainly in milk and aerosols. These are at the same time the
main routes of transmitting zoonotic tuberculosis, in particular
because milk is primarily consumed unpasteurised. The high inci-
dence of HIV/AIDS in South Africa is a another complicating fac-
tor potentially contributing to the transmission of zoonotic tuber-
culosis. Immunocompromised patients, especially children, are
more likely to contract M. bovis infection than healthy individuals.
Presently the role of zoonotic tuberculosis in humans in South
Africa is unknown, but both the raging HIV/AIDS and wildlife
tuberculosis epidemics urge for a joint veterinary/medical
approach to assess the current situation.
Board 42. Paleoepidemiology of Hantaviruses 
E. J. Bassett
University of Utah, Salt Lake City, UT
Hantaviruses are rodent-borne zoonotic agents with a
genetic diversity indicative of significant antiquity. Although
Hantavirus Pulmonary Syndrome (HPS) has been described as a
re-emergent disease, little is known of past exposure levels. Over
six years, a series of replicative maize storage and processing
experiments were conducted to evaluate the risk prehistoric agri-
culturalists living in the North American southwest would have
faced from virus-contaminated aerosols of rodent excreta. Twenty-
eight traditional, maize pit storage units were constructed and
monitored for a year each. Rodents (mostly Peromyscus sp.)
infested six of the units (21.4%) with excreta quantified through
feces counts and Nessler’s reagent for the presence of urine; maize
stored by traditional methods would have carried a high load of
hantavirus-laden rodent feces, urine, and saliva. Also, areas of
reuse were more likely to be reinfested in subsequent years and
rodent populations increased over time near storage units, possi-
bly due to an increase in both food and predator cover. A series of
replicative maize grinding experiments were conducted to evalu-
ate the potential for aerosolization during maize processing.
Sterilized maize rehydrated to average storage moisture was
ground with prehistoric groundstone to meal consistency, during
which a personal particulate monitor was worn with pre-weighed,
low-ash PVC canister filters. Mean inhalable dust was 36 mg/m3
(range 1.1 to 232 mg/m3). During the initial grinding, most parti-
cles belonged to the extrathoracic fraction but most later dust was
in the respirable fraction with much fugitive dust produced.
Historical data indicates ground maize constituted as much as
70% of the diet over two millennia and that adult females spent up
to 6 hours a day in its preparation. Similar traditions are discussed
for other known areas of HPS, for HFRS in Asia and Eastern
Europe, and for arenaviruses, including Lassa fever. These results
suggest that among prehistoric maize farmers, HPS exposure
would have been very different from the pattern documented dur-
ing modern times, being common and systematic rather than rare
and random; domestic rather than extradomestic; affecting adult
females and children more than adult males; and influenced more
by cultural practices than by natural or climatic episodes. Higher
mortality by reproductive-age females within small breeding pop-
ulations could have had significant demographic consequences
and/or resulted in differential resistance. The clinical recognition
of the Sin Nombre strain among non-Native Americans and
among Navajos (circa. A.D. 1500 non-agricultural arrivals to the
Southwest) and its apparent absence from modern Native
Americans who traditionally practiced maize agriculture should be
investigated in the light of these conclusions.
Board 43. Anthrax In Kazakhstan 
L. Y. Lukhnova, G. A. Temiraliyeva, A. M. Aikimbayev
Kazakh Scientific Center of Quarantine and Zoonotic Diseases,
Almaty, KAZAKHSTAN
During 1995-2001, about 150 human anthrax cases were
registered, of which over 70% happened in the South Kazakhstan,
Jambyl and East Kazakhstan oblasts. These oblasts are known for
its cattle raising farms. The South Kazakhstan oblast ‡t present the
number of cattle was 264,000, 64% of these were covered with
anthrax vaccinations. Sheep and goats numbered 1.·5 million, 29%
of them vaccinated, 65,000 horses (31% vaccinated), over 3,000
camels (29% vaccinated) and 3,500 pigs (100% vaccinated).
Numerous observations point that man can easily get infected with
anthrax through tiny scratches, lesions, etc. This may happen while
slaughtering, dressing and skinning anthrax-infected animals, or
when wearing fur clothes infected with anthrax spores. There are
recorded instances of human infection through the bites of gad-
flies, flies and mosquitoes, which were in contact with animals
infected with anthrax . Basically human anthrax is registered in
spring-summer period from May to November with peak July-
August. That humans are highly susceptible to infection with
anthrax through damaged skin is evidenced by an analysis of an
outbreak of the disease in the South Kazakhstan Oblast during
2000-2001. In 74% of the cases the source of infection was cattle,
in 14% of the cases it was sheep and goats. 3% of the cases seemed
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to get infected through contaminated soil. 9% of the cases had con-
tacts with infected products of animal slaughter. An analysis of data
on the outbreaks of anthrax in the SKO in the summer of 2000-
2001 allows maintaining: that humans are highly susceptible to the
causative agent of anthrax when infected through damaged skin.
All people participating in a forced slaughter of farm animals con-
tracted anthrax. They were infected as a result of direct contact
with the flesh of anthrax-infected animals. It is necessary to take
note of a possibility of getting infected through the transmission
way. In the course of the anthrax outbreak one of the patients who
died of septicaemic anthrax seem to have contracted infection
when using undercooked meat. The possibility of one patient get-
ting infected through the contact with anthrax spores-contaminat-
ed soil may not be ruled out.
Board 44. Epidemiological Features of Tularemia Incidence 
in Kazakstan 
T. N. Kunitsa, A. M. Aikimbayev, T. V. Meka-Mechenko, L. Y.
Lukhnova, G. A. Temiraliyeva, O. Y. Aimanova
Kazakh Scientific Center of Quarantine and Zoonotic Diseases,
Almaty, KAZAKHSTAN
Tularemia is natural-foci zoonotic disease, the wide distri-
bution of that in Kazakhstan is conditioned by the landscape-geo-
graphic peculiarities favourable for the causal agent striking root in
the natural conditions. The landscape complex of focusing is rep-
resented by different types: steppe, flood-lands-marsh, foothills-
stream and tugai. Tularemia is registered almost in all the regions
of Kazakhstan except South-Kazakhstan and Mangistau oblasts.
For the first time tularemia cases were registered in Kazakhstan in
1928 in Uralsk province during the outbreak on the Urals river
connected with the purveyance of water vole (Arvicola terrestris)
skins. From the May 1 till June 9 105 cases in main of bubonic and
ulcerous-bubonic forms were registered. Tularemia etiology of the
given disease was established by Golov D.A., Kniazevski A.N.,
Berednikov V.A. and Tiflov V.Y. In summer 1930 a transmissive
tularemia outbreak in Karatalsk region of the Taldi-Kurgan oblast
(st.Ush-Tobe) was registered. In 1942 16 settlements in the delta
of the Volga were enveloped in tularemia. Especially great out-
break was registered in Gvardeiski region of the Taldi-Kurgan
oblast in 1947 when 658 people fell ill. Contamination took place
as a result of using water from the reservoir infected by water voles
secretions and their corpses. The following great outbreak was reg-
istered in Karatalsk region in July-October 1949, - 152 human
cases were registered. The same year the great outbreak was reg-
istered in Norst-Kazakhstan oblast (200 people). In 1954 the great-
est outbreak took place in Kazakhstan in Pavlodar oblast in the
Irtish flood-lands, 1791 human cases were registered. By its nature
it was mixed type; it was started as the trade one, then it became
of the transmissive character and took place as a water outbreak
type with the considerable number of people who fell ill as a result
of the contacts with contaminated water. The increase of the sick-
ness rate in Tselinograd (now Akmolinsk), Karaganda and
Semipalatinsk oblast, registered in 1954, 1958-1959 years, was
conditioned by the development of long-fallow lands, the migra-
tion of large quantity of the not-immunized against tularemia pop-
ulation from the tularemia favourable places. Then (in 1968, 1972)
the mass cases were conditioned by stings of blood-sucking
Diptera (gnats). The decrease of the sickness rate for some time
past was conditioned by the conducted complex of sanitary-
hygienic and prophylactic measures. Over all in Kazakhstan since
the beginning of the century due to the not total data more than
6000 tularemia cases were registered.
Board 45. Epidemiological Grounds in Russia for Vaccine
Prophylaxis of HFRS 
E. A. Tkachenko1, F. P. Filatov2, C. Schmaljohn3, R. V. Borovick2
1Chumakov Institute of Poliomyelitis and Viral Encephalites RAMS,
Moscow, RUSSIAN FEDERATION, 2Research Center for Toxicology
and Hygienic Regulation of Biopreparations MPH, Serpukhov,
Moscow region, RUSSIAN FEDERATION, 3USAMRIID, Ft. Detrick, MD
Among zoonotic virus infections and all other natural focus
diseases for humans, HFRS with its morbidity rate leads in Russia.
A total of 135,222 cases were registered from 1978 to 2000 from 71
out of 89 administrative regions involving 131,192 cases from the
European part of Russia. Serological and genetic typing of han-
tavirus strains as well as wild rodent lung tissue and HFRS patient
blood in-dicated the circulation of at least 7 hantavirus types on the
territory of Russia: Hantaan, Puumala, Seoul, Dobrava/Belgrade,
Tula, Khabarovsk, and Topografov. The first four of them cause
HFRS dis-ease in humans. HFRS cases in 52 European regions are
etiologically conditioned mainly by Puumala virus type and make
up 97% of total number of HFRS cases registered in Russia while
3% have been registered in 4 Far-Eastern regions where HFRS
cases are caused mainly by Hantaan and less by Seoul virus types.
The sporadic HFRS cases caused by Dobrava/Belgrade virus type
were recently detected in European and West Siberian regions of
Russia. The highest rate of annual HFRS morbidity occurs in the
South East of the European part of Russia, mainly on the territory
of Bashkiria with annual average morbidity rate of 58.3 per 100,000
population. Human epidemics are characterized by cycles with a
frequency of 3 to 4 years. Periodical and massive reproduction of
rodents, with the forming epizootics among them, is the main and
determinative factor that influences HFRS epidemics in humans.
The prevention of the HFRS disease mainly includes measures
aimed at reducing exposure to live rodents and their excreta.
However, rodent control measures are expensive and difficult to
maintain over long periods because it is practically impossible to
eradicate the rodent hosts of the hantaviruses from nature. Hence
it is obvious that the most prospective and effective measure for
decreasing HFRS morbidity in endemic regions of Russia could be
but regular and massive vaccine prophylaxis against the disease.
HFRS morbidity may be used as an indicator to estimate the
required HFRS vaccine doses for vaccination in Russia: 20
European regions with population of about 45 mln as well as 4 Far-
Eastern regions with population of about 5 mln. So, approximately
25% of population of these regions (12.5 mln people) potentially
need the vaccination against HFRS.
Board 46. Dysphagia Presenting as an Early Neurologic
Complaint in a Fatal Case of West Nile Virus Encephalopathy 
R. W. Hampton1, R. Bajaj2, H. K. Walker2, H. M. Blumberg1
1Division of Infectious Diseases, Department of Medicine, Emory
University School of Medicine, Atlanta, GA, 2Department of
Medicine, Emory University School of Medicine, Atlanta, GA
Cases of West Nile virus (WNV) encephalopathy recently
reported in the northeastern United States detail numerous neu-
rologic complaints, the most common being weakness, headache
and altered mental status. Photophobia, slurred speech and
seizures were observed less frequently. Dysphagia was not
described. We report the first case of WNV disease in Georgia
which occurred in August 2001 in a 71 year old female who
resided in inner-city Atlanta. Unlike prior cases, this patient com-
plained of dysphagia early in her clinical course. Interestingly, dys-
phagia preceded decline in the patient’s mental status by approxi-
mately 1 day. The patient subsequently developed an aspiration
pneumonia which undoubtedly contributed to her eventual
demise on hospital day 12. An abnormal barium swallow and EEG
confirmed our clinical impression of initial dysphagia and subse-
quent encephalopathy. WNV diagnosis was confirmed based on
















reduction neutralization assay). The prominence of dysphagia in
this case is remarkable because it provides clinical correlation with
WNV neuropathologic findings. Specifically, involvement of the
brainstem, an area of the brain which is also involved in the swal-
low reflex, has been noted in multiple WNV cases. Secondly, pure-
ly from a clinical viewpoint, this case argues that, in patients in
whom one has a high clinical suspicion of WNV encephalopathy,
early aggressive airway management is important, especially in the
face of unexplained dysphagia.
Board 48. Humoral Immune Responses to Hantavirus Andes
in Humans 
N. Tischler1,2, H. Galeno3, J. Mora3, E. Villagra3, J. Fernández3, M.
Rosemblatt1,2, P. Valenzuela1,2
1Fundación Ciencia para la Vida, Santiago, CHILE, 2Instituto Milenio
de Biología Fundamental y Aplicada, Santiago, CHILE, 3Instituto de
Salud Pública de Chile, Santiago, CHILE
The absence of an effective treatment of Hantavirus
Pulmonary Syndrome causes mortality rates between 30 and 50%.
A number of reports have shown that the passive transfer of neu-
tralizing monoclonal antibodies protects rodents from Hantavirus
infection. This has lead several groups to investigate the humoral
immune response in patients with different clinical development
suggesting that the survival of patients seems to be strongly associ-
ated with the titer of neutralizing antibodies. In this work, sera
from patients infected with Hantavirus Andes were tested for their
neutralizing activity by focus reduction neutralizing tests and
assayed for their ability to react with linear epitopes of viral pro-
teins. These epitopes were identified by the use of 120 peptides,
each of 13 amino acids in length representing the entire nucleo-
protein and the two envelop glycoproteins of the Hantavirus
Andes, Chilean isolate CHI99-7913. Analysis of these sera revealed
antibodies reacting with epitopes covering the whole nucleopro-
tein with three immunodominant regions approximately located at
aa66 - aa78; aa248 - aa260 and aa326 - aa338. The glycoprotein G1
was highly immunogenic in the N-terminal half which could be
divided in four main regions (aa14 - aa26; aa66 - aa104; aa196 -
aa234 and aa287 - aa338) whereas in the glycoprotein G2, the
regions from aa27 - aa65 and aa79 - aa117 showed strong reactivi-
ty with these sera. The production of monoclonal antibodies
against these epitopes is in progress.
Board 49. A Single Genotype of Encephalitozoon intestinalis
Infects Free-Ranging Gorillas and People Sharing Their
Habitats, Uganda 
T. K. Graczyk1, J. Bosco-Nizeyi2, R. B. Innocent2, A. J. DaSilva3, N. J.
Pieniazek3, A. H. Lindquist4, M. R. Cranfield5
1Johns Hopkins University, Baltimore, MD, 2Makerere University,
Kampala, UGANDA, 3Centers for Disease Control and Prevention,
Atlanta, GA, 4U.S. Environmental Protection Agency, Cincinnati, OH,
5The Baltimore Zoo, Baltimore, MD
For conservation purposes and due to ecotourism free-
ranging gorillas of Uganda have been habituated to humans, and
molecular epidemiology evidence indicates that this habituation
might have enhanced transmission of anthropozoonotic pathogens.
Microsporidian spores have been detected by modified trichome
and calcofluor stains in fecal samples of 3 gorillas and 2 people
sharing gorilla habitats. All spore isolates have been identified by
polymerase chain reaction (PCR) with species-specific primers and
fluorescent in situ hybridization (FISH) to be Encephalitozoon
intestinalis. Sequencing analysis of the full length SSUrRNA
amplified from all isolates were identical to E. intestinalis
SSUrRNA GenBank SIU09929. In addition sequences generated
from the intergenic spacer (ITS) of these isolates were identical to
GenBank sequence Y11611 from E. intestinalis isolated from
European HIV-positive individuals. A single genotype in two
genetically distant but geographically united host groups indicates
anthropozoonotic transmission of E. intestinalis. It is unlikely that
infections with genetically identical pathogens were acquired inde-
pendently, and it is much more likely that one of these two host
groups initiated infection of the other group. This may also indicate
that ITS region is not infromative for strain differentiation.
Board 50. A Case of Plague Successfully Treated with
Ciprofloxacin and Sympathetic Blockade for Gangrene 
T. Kuberski, L. Robinson, A. Schurgin
John C. Lincoln Hospital (Deer Valley), Phoenix, AZ
Background: Approximately 1800 cases of human plague
are reported to the World Health Organization each year world-
wide. Roughly 10 cases yearly occur in the southwestern U.S. The
recommended antibiotic for this infection, streptomycin, is diffi-
cult to obtain in the U.S. Ciprofloxacin has shown good activity
against Yersinia pestis in vitro, but has not been systematically
evaluated in humans with Y. pestis infections. This report details
the use of ciprofloxacin in a patient with septicemic plague, and
sympathetic blockade for gangrene of his lower extremities.
Presentation: A 45 year old white male presented with a 2 day his-
tory of increasing fever, myalgias, rigors, headache and weakness.
He had been camping in an area of Arizona known to be endem-
ic for plague, but had no history of rodent exposure or insect bites.
Physical examination revealed an acutely ill man with blood pres-
sure of 85/57 mm Hg, respiratory rate 26, heart rate 117 and tem-
perature 38.5∞C. He had acrocyanosis, severe myalgias and a pur-
puric rash with evolving gangrene of the nose, ears and extremi-
ties. There were no sores, lymphadenopathy or pneumonia. Blood
cultures were negative; however, Gram stain of a peripheral blood
smear showed Gram-negative rods within leukocytes. Direct fluo-
rescent antibody stains of organisms on the peripheral smear by
the Centers for Disease Control were positive for Y. pestis. This
finding was confirmed by seroconversion for Y. pestis using the
passive hemagglutination test, with titers rising from negative to
1:1024. Treatment and Results: The patient was treated empir-
ically for 15 days with ciprofloxacin because of its spectrum of
activity and ability to penetrate leukocytes. He survived with sup-
portive treatment and this antibiotic regimen. He also had pro-
gressive gangrene of the extremities. On the fourth hospital day,
before the gangrene had completely demarcated, a lumbar
epidural infusion catheter was placed. This sympathetic blockade
of the lower extremities brought about almost complete resolution
of the gangrene involving his feet. He sustained gangrenous dam-
age to his nose and fingers, however, which required plastic sur-
gery reconstruction. Discussion: Septicemic plague can be fulmi-
nant and patients often are critically ill when diagnosed; there is a
risk of mortality even when appropriate antibiotic treatment is
started. Our diagnosis was aided by the observation that peripher-
al gangrene is more likely to be associated with septicemia due to
plague than with other organisms. Ciprofloxacin proved well-tol-
erated and effective in treating this patient, warranting further
investigation in septicemic plague. Sympathetic blockade should
be considered for cases of evolving gangrene in patients with good
peripheral blood supply.
Board 51. Detection of West Nile Virus RNA in Human
Clinical Specimens 
M. Dupuis, B. Slater, R. Hull, R. Ferrera, B. Rosen, C. Huang
New York State Department of Health, Slingerlands, NY
West Nile virus (WNV), a member of the Flaviviruses, was
responsible for an outbreak of encephalitis in New York City in
1999. Human WNV infections can be diagnosed by an
immunoglobulin M capture enzyme-linked immunosorbent assay.
Because of antigenic cross reactivity among members of the
Flaviviruses, a plaque reduction neutralization assay is required to
confirm infections by WNV. Reverse transcription-PCR (RT-PCR)
assays have been developed for the selective detection of several
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RNA viruses, including WNV. We have assessed two molecular
approaches, a standard RT-PCR and a real-time (TaqMan) RT-
PCR, with clinical specimens from confirmed human cases from
the New York City outbreak. Thirty-two cerebrospinal fluid (CSF)
samples and 4 brain tissue samples from 23 confirmed cases were
analyzed. WNV sequences were detected in 12 (52%) and 8 (35%)
of patients by two-step RT-PCR and TaqMan assays, respectively.
Analyses of CSF samples collected from 4 fatal cases detected
WNV in only 1 person who was ill and in all 4 persons postmortem
by both standard RT-PCR and TaqMan assays. Analyses of brain
tissue samples from the same 4 fatal cases by standard RT-PCR and
TaqMan assays detected WNV in all samples with both assays. The
quantity of WNV RNA in the brain tissue samples, as determined
by the TaqMan assay with in vitro transcribed WNV RNA, ranged
from 4.8 x 104 to 6.2 x 106 copies per milliliter of 10% brain sus-
pensions. The quantity of WNV RNA in CSF samples from fatal
and nonfatal cases ranged from <50 to 3.1 x 104 copies per milli-
liter. In general, the quantities of WNV RNA in the CSF of nonfa-
tal cases were lower than the quantities detected in fatal cases. Our
results independently corroborate the results of other investigators
concerning a lower success in the detection of WNV in CSF by RT-
PCR and TaqMan compared with serologic detection methods.
Board 52. Clinical and Molecular Investigation of a
Salmonella Typhimurium DT104 Outbreak Due to Consumption
of Raw Beef 
V. Agmon1, D. Zamir2, J. Kopelowitz1, R. Yishai1, E. Khavalevsky1, S.
Scharf2,3, N. Azor3, M. Gdalevich3
1Government Central Laboratories, Public Health Services, Ministry of
Health, Jerusalem, ISRAEL, 2Barzilai Medical Center, Ashkelon,
ISRAEL, 3Ashkelon District Health Office, Public Health Services,
Ministry of Health, Ashkelon, ISRAEL
Background: Salmonella enterica serotype Typhimurium,
definite phage type (DT)104 is a zoonotic pathogen. Since 1990 it
has become an increasingly common cause of human gastroenteri-
tis worldwide. In Israel the first human cases were reported in
1994. This strain is frequently associated with multidrug resistance
to antimicrobial agents. The common R-type in Israel is ACST (A.
ampicillin; C. chloramphenicol; S. streptomycin; T. Tetracycline).
Objectives: To determine the epidemiological, clinical and molec-
ular characteristics of an outbreak of severe gastroenteritis in a
close community of East Asian workers. Materials and Methods:
A comprehensive epidemiological investigation was carried out by
the Ashkelon District Health Office employing interviews and sur-
vey of medical records. Salmonella spp. isolated from clinical
sources and from suspected beef and cow blood samples were
identified and tested by classical laboratory methods (serotyping,
phagetyping and antibiotic resistance typing). The epidemiological
and serological data were complemented by molecular investiga-
tion, using pulse field gel electrophoresis (PFGE). Results: In July
2001, fifty nine individuals of an East Asian group of workers
developed severe diarrhea. Twenty five were hospitalized. Two
patients developed secondary bacteremia. Salmonella typhimuri-
um DT104 was isolated from the stool of all the 25 patients and the
two blood samples. The epidemiological investigation revealed a
suspected common source: Raw beef eaten by all on the day before
onset of symptoms. The estimated attack rate in the exposed pop-
ulation was 100%. The median incubation time was 18h. The same
S. typhimurium DT104 was isolated from samples of the suspect-
ed beef and cow blood. Application of PFGE with the restriction
enzymes XbaI and AvrII to all isolates revealed the same PFGE
pattern for all human and food isolates. The clonality was con-
firmed by a common drug resistance pattern (ACSTN; N. nalidix-
ic acid). Conclusions: The main characteristic of the reported out-
break is its definite focal pattern. We assume that this food borne
outbreak is correlated with the specific food handling practice.
Similar events have been reported worldwide, emphasizing the
global importance of Salmonella typhimurium DT104.
Board 53. Simian Foamy Virus (SFV) Infection in
Occupationally Exposed Humans: Preliminary Results from a
Long-term Follow-up Study 
R. S. Boneva, W. M. Switzer, T. Spira, V. Shanmugam, J. E.
Cummins, V. B. Bhullar, W. Heneine, T. M. Folks, L. E. Chapman
Centers for Disease Control and Prevention (CDC), Atlanta, GA
Background: Simian foamy virus (SFV) infection has been
confirmed by PCR in 11 of 12 seropositive men occupationally
exposed to nonhuman primates (NHPs). SFV is strongly cytopath-
ic in cell culture but is not known to cause a disease in its natural
hosts, NHPs. The purpose of this cohort study was to investigate
whether this infection is transmissibile among humans and
whether it constitutes a zoonotic disease. Methods: SFV-infected
humans and their close contacts are eligible to enroll. Participants
respond to a standard questionnaire about demographics, occupa-
tional exposures, work practices, health status, and opportunities
for transmission. Blood and body fluids (saliva, throat swabs, urine,
and semen) are collected annually for clinical, virological, and
immunologic testing. Enrolled contacts are tested for SFV infec-
tion by serology (Western blot, WB) and PCR. Results: Of 11 eli-
gible persons, 6 enrolled (A-F), 2 refused participation; enrollment
of the other 3 is pending. Reported occupations of the 6 partici-
pants were veterinarian, manager, administrator, animal-care work-
er (two), and researcher. Participants’ mean age at enrollment was
52.5 years (range 41 to 62 years). Reported exposures to NHPs
ranged from 4 to 41 years (mean 23.3±13.4 years). A minimum of
107 person-years of seropositivity was retrospectively documented.
All 6 reported a history of both mucocutaneous exposures to NHP
body fluids and occupational injuries with skin penetration (bites
and/or sharp injuries). Complete blood counts, blood chemistry,
and liver function tests obtained on participants A-F were within
normal limits with the following exceptions: patient D had mild
thrombocytopenia and a mildly elevated hemoglobin and hemat-
ocrit; patient C had a mildly elevated ALT; and patient E, a dia-
betic, had high blood glucose and indicators of impaired kidney
function. SFV was successfully cultured from participants’ A and B
peripheral blood mononuclear cells and from a throat swab from
participant A; viral cultures from other participants were negative.
Four wives of these six participants have been tested and were
PCR and seronegative after a mean documented exposure of 18.3
years (range 12 to 22 years, total 73 person-years). Four recipients
of cellular blood components, donated by participant A, were SFV-
negative by WB and PCR. Conclusions: Interim analysis found no
evidence of disease attributable to SFV infection and no evidence
of person-to-person transmission. Continued follow up (anticipat-
ed minimal duration of 5 years) should provide more information
regarding the transmissibility and pathogenicity of SFV infection
and whether any of the identified minor clinical abnormalities in
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Board 54. Outbreak of Aseptic Meningitis Associated with
the Emergence of Echovirus 13 
D. L. Kirschke1, T. F. Jones2, S. C. Buckingham3, W. Schaffner4
1CDC/DAPHT/EPO/EIS/State Branch/Tennessee, Nashville, TN,
2Tennessee Department of Health, Nashville, TN, 3University of
Tennessee Health Science Center, Memphis, TN, 4Vanderbilt
University School of Medicine, Nashville, TN
Background. The largest reported outbreak of aseptic
meningitis associated with echovirus 13 occurred in Memphis,
Tennessee between April 15 and August 15, 2001. Before this out-
break, echovirus 13 accounted for only 65 of approximately 45,000
reported enteroviral isolates in the United States in the past 30
years. Several smaller outbreaks occurred in Europe in 2000. We
describe the epidemiology of the outbreak among children in
Memphis and the clinical manifestations of those with laboratory
confirmed echovirus 13 infection. Methods. We examined dis-
charge diagnoses to identify cases of aseptic meningitis at a chil-
dren’s tertiary medical center during the epidemic period. We
reviewed the charts of patients with laboratory confirmed
echovirus 13 and interviewed the parents by telephone. Historical
data from this and five other area hospitals were reviewed. Results.
We identified 303 cases of aseptic meningitis at the children’s med-
ical center during the epidemic period. The number of hospital-
izations peaked in May. Twenty-six percent of cases occurred in
infants aged <4 months and 63% were male. Black children had
hospitalization rates 2.3 times greater than those of white children
(p<0.01). Echovirus 13 was isolated in specimens from 37 (80%) of
46 patients with positive viral cultures; 27 from cerebrospinal fluid
(CSF) and 10 from stool. Echovirus 18 was isolated in eight speci-
mens and echovirus 6 in one specimen. Of those with laboratory
confirmed echovirus 13, 35 (95%) had fever, with a mean maxi-
mum temperature of 38.9∞C. Other common symptoms were irri-
tability (88%), vomiting (53%), diarrhea (35%), and cough (29%) in
infants; and headache (100%), vomiting (85%), stiff neck (75%),
and photophobia (45%) in older children. Thirty-five (95%)
patients had normal blood leukocyte counts. The median CSF
leukocyte count was 230 with a predominance of polymorphonu-
clear cells in 23 (62%) patients. Thirty-six (97%) had CSF glucose
levels >40 mg/ml and 34 (92%) had CSF protein levels <100
mg/dL. One infant had hepatitis as well as echovirus 13 meningitis.
There were no objectively verified sequelae and no deaths. We
estimated the hospital charges associated with this outbreak to be
$900,000. Conclusions. This outbreak, and others associated with
echovirus 13 in the United States and Europe, occurred earlier
than is typical for enteroviruses in temperate climates. With these
outbreaks, echovirus 13 has emerged as a predominant strain of
enterovirus associated with aseptic meningitis. Past experience
indicates that echovirus 13 will likely spread to other areas of the
United States and the world during the next few years.
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Board 55. Survival and Growth of Alkali-Stressed Listeria
monocytogenes on Beef Frankfurters and Thermotolerance in
Frankfurter Exudates 
P. J. Taormina, L. R. Beuchat
Center for Food Safety, University of Georgia, Griffin, GA
Contamination of processed, ready-to-eat foods with
Listeria monocytogenes as a result of exposure to processing envi-
ronments is a concern. Survival of L. monocytogenes in these envi-
ronments suggests that some cells may survive exposure to chemi-
cal cleaners and sanitizers. Surviving cells may be injured as a
result of this exposure but subsequently resuscitate, contaminate
processed meat products, and grow. Routine washing of food pro-
cessing equipment, floors, walls, or drains with water and applica-
tion of cleaning chemicals, often with alkaline pH, is followed by
application of sanitizers. The influence of alkaline pH on viability
of L. monocytogenes and development of cross protection against
other environmental stresses such as vacuum packaging of meat
has not been reported. This study was done to determine the
behavior of L. monocytogenes on frankfurters after exposure to two
commercial alkaline cleaners used in meat processing environ-
ments. A second objective was to determine the thermotolerance
of alkaline stressed L. monocytogenes cells suspended in frank-
furter exudates. Cells of L. monocytogenes exposed at 4°C to 1%
solutions of two alkaline cleaners or alkali-adapted in tryptose
phosphate broth (pH 10.0) at 37°C for 45 min, followed by 4°C for
48 h, were inoculated onto beef frankfurters containing high fat (16
g) and high sodium (550 mg) or low fat (8 g) and low sodium (250
mg) per 57-g serving. Frankfurters were surface-inoculated (2.0
log10 CFU/g), vacuum packaged, stored at -20, 4, or 12°C, and
analyzed for populations of L. monocytogenes at 2-day to 2-week
intervals. Populations did not change significantly on frankfurters
stored at -20oC for up to 12 weeks. After storage at 4oC for 6
weeks (1 week before the end of shelf life), populations of control
cells and cells exposed to alkaline cleaners were ca. 6.0 log10
CFU/g of low fat, low sodium (LFLS) frankfurters and ca. 3.5 log10
CFU/g of high fat, high sodium (HFHS) frankfurters. Growth of
alkali-adapted cells on both types of frankfurters was retarded at
4°C but a delay in growth of alkali-adapted cells on HFHS and
LFLS frankfurters was evident during the first 9 and 6 days,
respectively. Alkali-adapted cells had a significantly (P≤ 0.05) lower
logistic D59°C value than alkaline cleaner exposed cells but the
D59°C value was not different than that of control cells. Growth
characteristics of L. monocytogenes inoculated onto the surface of
frankfurters may be altered by previous exposure to alkaline envi-
ronments. Differences in growth characteristics of L. monocyto-
genes on HFHS versus LFLS beef frankfurters stored at refrigera-
tion temperature indicate that composition influences the behavior
of both alkaline stressed and control cells.
Board 56. Mild Heat Treatment of Lettuce Enhances Growth
of Listeria monocytogenes During Subsequent Storage at 5oC
or 15oC 
Y. Li1, R. E. Brackett2, J. Chen1, L. R. Beuchat1
1Center for Food Safety, University of Georgia, Griffin, GA, 2U. S.
Food and Drug Administration, Washington, DC
Listeria monocytogenes has been isolated from a wide
range of raw vegetables. Because of the widespread distribution of
L. monocytogenes in soil and on plant surfaces, it is important to
understand the ability of the pathogen to survive and grow under
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conditions associated with processing, distribution, and storage of
raw fruits and vegetables. Researchers have observed that dipping
fresh-cut lettuce in water at 45°C or 55°C inhibits phenylalanine
ammonia lyase activity, which leads to brown discoloration. We
have studied the survival and growth of Escherichia coli O157:H7
inoculated onto cut lettuce before or after heating in chlorinated
water. Mild heat treatment retarded discoloration but growth of E.
coli O157:H7 was enhanced. Investigations to determine the effect
of mild heat treatment on survival and growth of L. monocytogenes
have not been reported. We undertook a study to determine the
effects of heat treatment, storage temperature, and storage time on
the survival and growth of L. monocytogenes inoculated onto cut
iceberg lettuce. The efficacy of treatment of lettuce with 20 mg/l
free chlorine in killing the pathogen was also determined. Before
or after inoculation with L. monocytogenes, cut iceberg lettuce
leaves were dipped in water (20°C or 50°C) containing or not con-
taining 20 mg/l chlorine for 90 sec, then stored at 5°C for up to 18
days or 15°C for up to 7 days. The presence of 20 mg/l chlorine in
treatment water did not significantly (P £ 0.05) affect populations
of the pathogen, regardless of other test parameters. The popula-
tion of L. monocytogenes on lettuce treated at 50°C steadily
increased throughout storage at 5°C for up to 18 days. At day 10
and thereafter, populations were 1.7 - 2.3 log10 CFU/g higher on
lettuce treated at 50°C after inoculation compared to untreated
lettuce or lettuce treated at 20°C, regardless of chlorine treatment.
The population of L. monocytogenes increased rapidly on lettuce
stored at 15oC. At 2 and 4 days, significantly higher populations
were detected on lettuce that had been treated at 50°C, compared
to respective samples that had been treated at 20°C, regardless of
inoculation before or after treatment or the presence of 20 mg/l
chlorine in the treatment water. Results clearly demonstrated that
mild heat treatment of cut lettuce leave enhances the growth of L.
monocytogenes during subsequent storage at 5°C or 15°C. Mild
heat treatment of cut lettuce may result in a prolonged shelf life as
a result of delaying the development of brown discoloration.
However, heat treatment also facilitates the growth of L. monocy-
togenes during storage at refrigeration temperature, thereby
increasing the potential risk of causing listeriosis.
Board 57. Epidemiologic Analysis of Statewide Restaurant
Inspection Scores in Tennessee 
T. F. Jones1, B. Pavlin2, T. Pilate1, W. Schaffner2
1Tennessee Department of Health, Nashville, TN, 2Vanderbilt
University School of Medicine, Nashville, TN
Background: Virtually every licensed restaurant in the
United States is inspected regularly to ensure adherence to food
safety guidelines. Despite this, few data exist regarding restaurant
inspection scores or their correlation with foodborne illness.
Methods: We analyzed restaurant inspection data from July 1993
through June 2000. Routine inspections of all restaurants holding
permits during this period for preparing and serving food were
included in the analysis. Inspections were performed by state or
regional health department employees using standardized forms
with a scale of 0-100. Data were entered in a centrally-maintained
database. Results: In Tennessee, over 19,500 hours of inspector
time are spent each year on routine inspections of approximately
17,000 restaurants. The average scores of individual inspectors
were distributed in a bell-shaped curve with a median of 82 and a
range from 69 to 92. Mean scores by county ranged from 75 to 88.
From 1993 to 2000, the mean inspection score rose steadily from
80.2 to 83.8, and the average number of violations cited per inspec-
tion fell from 11.1 to 9.9. None of the 12 most commonly cited vio-
lations were among those designated as “critical” food safety haz-
ards. While restaurants with a score over 60 tended to have fairly
stable scores on subsequent inspections, establishments scoring
under 60 had a mean improvement of 16 points on the subsequent
routine inspection, with an additional mean increase of 5 on the
following inspection. Fast-food restaurants (mean score=79.9) had
slightly lower mean scores than independent (80.9) or chain (82.1)
full-service restaurants. Some variation was noted in mean scores
of restaurants serving certain types of cuisine, such as barbecue
(82.9), pizza (82.3), Chinese (77.7) and Mexican (77.4) foods.
Conclusions: Restaurant inspection scores vary substantially over
time and by region and inspector. The most commonly cited viola-
tions are not those believed to be most important in maintaining
food safety. Being cited for a poor score does appear to lead to
some sustained improvement. These data suggest that restaurant
inspections may not be performed uniformly even within a single
state, and that substantial resources may be invested in monitoring
issues which do not directly affect food safety. A recent study in
Dade County found that restaurant inspection scores did not pre-
dict outbreaks there. Given the tremendous resources expended in
regulating this huge industry, food safety agencies should consider
ways to improve the utility of restaurant inspections in preventing
foodborne illness.
Board 59. Demographic Factors Associated with the
Consumption of Sprouts Among California Women 
J. C. Mohle-Boetani, S. B. Werner, D. J. Vugia
California Department of Health Services, Berkeley, CA
Background: Alfalfa sprouts are considered by many to be
a healthful food and the consumption of sprouts has increased
greatly in the United States in the past 30 years. Ironically, in
California in the past 5 years, there have been more than 10 out-
breaks of salmonellosis or E. coli O157:H7 infections due to con-
taminated alfalfa or clover sprouts and involving predominantly
adult women. Methods: To evaluate demographic factors associat-
ed with alfalfa sprout consumption, we used data from the 1999
California Women’s Health Study Survey (CWHS), an on-going
monthly telephone survey which collects information on a wide
variety of health-related behaviors and attitudes from a sample of
randomly selected adult women who reside in California. We con-
ducted a logistic regression using the software Stata. Eating alfalfa
sprouts in the past year was the outcome variable. Results: Of the
3858 women in the study, 45% ate sprouts in the 12 months prior
to the interview. Consumption of sprouts varied by race/ethnic
group: among whites 52% ate sprouts vs. 39% of Blacks, 31% of
Hispanics, and 48% of Asians. The proportion consuming alfalfa
sprouts increased with household income. Consumption of sprouts
also varied by age group with the highest sprout consumption in
the middle age groups (median age 44). Overall 23% had heard
that sprouts can cause foodborne illness. In the logistic regression
model we found that, for all race/ethnic groups other than Asian,
increasing income is associated with a greater odds of eating
sprouts. For Asian women there is no income effect. At lower
income levels Asians and Whites have a higher odds of eating
sprouts than Hispanics while at the highest income level (>$50K)
there is no race/ethnicity difference. Among 44 year olds at the
lowest income level (<$10K), Asians have a higher odds of eating
sprouts than whites (OR=2.35, 95% CI= 1.1-5.3), but at the high-
est income level, they have a lower odds of eating sprouts
(OR=0.67, 95% CI= 0.47-0.97). Knowledge of the risk of the con-
sumption of sprouts did not significantly improve the logistic
regression model. Discussion: Sprout-related outbreaks in
California have involved predominantly adult women. Our study
shows that, among California women, sprout consumption increas-
es with higher incomes and is more common among Asians and
whites compared to Hispanics. However, knowledge of sprouts as
a hazardous food did not correlate with consumption. Better pre-
















Board 60. Microbiological Quality of Food in Relation to
HACCP and Food Hygiene Training in Catering and Retail
Premises in the United Kingdom 
C. L. Little1, I. A. Gillespie2, R. T. Mitchell1
1Environmental Surveillance Unit (PHLS CDSC), London, UNITED
KINGDOM, 2Gastrointestinal Division (PHLS CDSC), London, 
UNITED KINGDOM
There is growing acceptance in many countries of the value
of hazard analysis and critical control point (HACCP) principles in
ensuring the microbiological safety of foods. Most of the product
specific European Community (EC) directives as well as the
Directive on the Hygiene of Foodstuffs (93/43/EEC), place obliga-
tions on industry and food business operators to adopt HACCP
principles as the basis for their product safety management sys-
tems. Food hygiene training and instruction for all staff handling
food is also a legal requirement. Catering and retail premises in
five UK food microbiological studies (butchery products and
butchers’ premises; cold ready-to-eat meats from catering premis-
es; ready-to-eat quiche from retail premises; ready-to-eat burgers
sampled at the point of sale; ready-to-eat food to which spices have
been added) carried out between 1997 to 1999 were surveyed to
determine the microbiological quality of food and the extent to
which they comply with the legal requirements. Among the 11,044
premises visited, almost three-quarters (74%; 8222) were catering
premises and 25% (2822) were retail premises. Significantly almost
twice as many samples of ready-to-eat foods from catering premis-
es (21%; 1822/8568) were of unsatisfactory or unacceptable micro-
biological quality compared to those from retail premises (11%;
516/4705) (P<0.0001). Almost two-thirds (64%; 1809/2822) of
retail premises visited had hazard analysis in place compared with
53% (4398/8222) of catering premises visited (P<0.0001). In most
(82%; 2315/2822) retail premises visited the manager had received
some form of food hygiene training compared with 76%
(6254/8222) of catering premises visited (P<0.0001). Food safety
procedures such as the hazard analysis system were more likely to
be in place where the manager of the premises had received some
form of food hygiene training. Retail premises where the managers
had received some form of food hygiene training were more likely
to have hazard analysis systems in place, either documented or
undocumented, in premises compared to managers of catering
premises that had not received food hygiene training (P<0.0001).
Evidence from these studies suggests that the lower microbiologi-
cal quality of ready-to-eat foods from catering premises compared
with those collected from retail premises, may reflect differences
in management food hygiene training and the presence of a hazard
analysis system. Government initiatives across the food chain have
encouraged food businesses to introduce HACCP based controls.
However, in some sectors the levels of HACCP awareness, under-
standing and uptake remain low. The importance of adequate
training for food handlers and managers as a pre-requisite for
effective HACCP based controls is recognised.
Board 61. Detection of Viral Contamination in Food 
S. Le Guyader1, L. Haugarreau1, L. Maunula2, C. Von Bonsdorff2, M.
Pommepuy1, M. Koopmans3
1IFREMER, Nantes, FRANCE, 2University Central Hospital, Helsinki,
FINLAND, 3RIVM, Bilthoven, NETHERLANDS
International spread of viruses through foodstuff has been
increasingly recognized especially since sensitive detection meth-
ods have been introduced. In particular, Norwalk-like virus (NLV)
and hepatitis A have been found to cause infections via fresh pro-
duce like vegetables and berries. Especially frozen raspberries
seem to have caused numerous outbreaks. Transnational outbreaks
due to international food distribution have been documented by
tracing the virus in the population and epidemiological study.
However, the pathogen detection in the incriminated food, other
than shellfish, is still rare. Based on previously described methods
for shellfish analysis, different protocols were compared on artifi-
cially contaminated lettuce and raspberries. For lettuce, elution
and PEG precipitation and then extraction using Qiagen plant kit
gave the best results (one log more sensitive than direct extraction
using trizol). For berries, different elution buffers were compared
(PBS, Tris/NaCl/CaCl2, glycin buffer pH12), and then nucleic acid
extraction using tripure or Qiagen plant kit. Several problems were
encountered (low pH, pectin from the seeds, viscosity.) and thus
the sensitivity is still very low. Even if some improvements are still
needed the development of such methods will help to further mon-
itor global food safety in coordination with surveillance of viral gas-
troenteritis outbreaks.
Board 62. Decline in Staphylococcal Foodborne Disease
Outbreaks in the United States, 1973-1997 
A. C. Sulka, S. J. Olsen, P. S. Mead
Centers for Disease Control and Prevention, Atlanta, GA
Background: Staphylococcus aureus, a gram-positive coc-
cus, is a well recognized cause of foodborne outbreaks in most
regions of the world. S. aureus produces an endotoxin that, when
ingested, can cause rapid onset of illness characterized by severe
nausea and vomiting. When S. aureus is present in food that is kept
at room temperature, the organisms multiply and produce the
toxin. Methods: We reviewed S. aureus outbreaks reported
through CDC’s Foodborne Disease Outbreak Surveillance System
between 1973 and 1997. Etiologic confirmation of an S. aureus
outbreak requires either isolation of S. aureus of the same phage
type from stool or vomitus of two or more ill persons or detection
of enterotoxin in epidemiologically implicated food. Trends were
analyzed using least squares regression. Results: Between 1973
and 1997, 462 S. aureus foodborne disease outbreaks were report-
ed in the United States. These outbreaks resulted in 20,389 ill-
nesses and 5 deaths. The number of outbreaks per year declined
significantly from 19 in 1973 to 10 in 1997 (slope -1.33, p <0.0001).
The median number of cases per outbreak remained fairly stable;
50 in the 1970s, 36 in the 1980s, and 33 in the 1990s. Meat prod-
ucts, including beef, poultry and pork, were identified as the con-
firmed vehicle in 50% of S. aureus outbreaks, with ham or ham
products implicated as the vehicle in 24.7% of outbreaks, and poul-
try products implicated in 13.4%. The location of food preparation
was reported for 452 outbreaks; preparing the food item(s) at home
(23%) or in a restaurant (25%) was most frequently reported com-
pared with preparing the food item(s) in a delicatessen, cafeteria,
institution or by a caterer. Among the 452 outbreaks that reported
one or more contributing factors, 322 (71%) were attributed to
improper food storage or handling and 145 (32%) to poor person-
al hygiene of a food worker. Conclusions: In the United States,
reported staphylococcus foodborne outbreaks have declined sub-
stantially, dropping by almost 50% between 1973 and 1997. A sim-
ilar decline in the number of S. aureus foodborne outbreaks has
been documented in Japan between 1970 and 2000. Although the
cause of the decline remains unknown, improved methods in food
handling and food storage may be partly responsible for the decline
in S. aureus foodborne outbreaks.
Board 63. Environmental Health Specialists Network (EHS-
Net) — The Development and Implementation of a Systems
Approach To Investigate Foodborne Illness
R. Lee1, C. W. Hedberg2, D. Niutta1, C. A. Selman1, The EHS-
Networking Group 3
1Centers for Disease Control and Prevention — National Center for
Environmental Health, Atlanta, GA, 2University of Minnesota —
School of Public Health, Division of Environmental and Occupational
Health, Minneapolis, MN, 3The EHS-Networking Group, GA
The Environmental Health Specialists Network (EHS-Net)
is composed of environmental health specialists and epidemiolo-
gists located at the federal, state and local levels. Based on a sys-
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tems approach, this collaboration is to improve the understanding
of the underlying causes and interactions of factors that lead to
foodborne illness and to use the knowledge gained to prevent
future cases of such illness. The EHS-Net activities are conducted
in conjunction with the Centers for Disease Control and
Prevention’s (CDC) Foodborne Diseases Active Surveillance
Network (FoodNet). A component of CDC’s Emerging Infections
Program (EIP), FoodNet is a collaborative project of CDC, nine
EIP sites, the U.S. Department of Agriculture, and the Food and
Drug Administration (FDA). FoodNet consists of active surveil-
lance and studies designed to help public health officials gain a bet-
ter understanding of the epidemiology of foodborne diseases in the
United States. The EHS-Net is a combined effort between the
FDA, CDC, and eight of the nine EIP sites. In collaboration with
FoodNet activities, EHS-Net projects will provide insights to
understanding the environmental causes of foodborne illness.
Current EHS-Net activities describe food safety systems in restau-
rants and other establishments where food is eaten outside the
home. Survey tools have been designed by EHS-Net to collect data
in both outbreak and non-outbreak settings. Data collection
encompasses the entire food preparation process from delivery of
ingredients, through preparation and cooking, to the actual service
of the food item. Both univariate and multivariate analyses are used
to assess potential risks present in food establishments. By docu-
menting the entire food preparation process, such as bare-hand
contact with food, preparation of raw meats and poultry, and egg
handling practices, we will be able to analyze the role of food han-
dling and preparation practices, in foodborne illness. On the basis
of this information, data may support existing food handling guide-
lines as well as suggest revision of current guidelines and policy
where necessary to improve food handling and preparation prac-
tices. The data gathered will provide a unique opportunity to
explore associations between eating outside the home and the
occurrence of foodborne illness from agents such as E. coli
O157:H7, Salmonella, and Campylobacter. Thus, the EHS-Net
project will aid in understanding FoodNet results and provide a
more effective approach to reducing foodborne-related illness.
Board 64. Genetic Diversity of Salmonella and E.coli in
Irrigation Water and Sediments Along the Texas-Mexico Border 
L. Lu1, S. Endley1, M. Hume2, K. Williams3, M. Garcia3, S. D. Pillai1
1Texas A & M University, College Station, TX, 2USDA-ARS, College
Station, TX, 3Bureau of Laboratories, Texas Department of Health,
Austin, TX
The Texas-Mexico border region along the Rio Grande
River is one of the most heavily impacted regions in the United
States as a result of increasing human population. The Rio Grande
serves as the primary source of drinking water and irrigation water
in this region. Vegetable production in Texas is concentrated in this
region and is supported by a large network of open canals and
drains. The objective of this study was to determine the genetic
diversity of Salmonella and E.coli isolates isolated from selected
irrigation water, canal sediment and vegetable samples adjacent to
specific population centers. The underlying hypothesis was that
multiple sources of contamination exists even within a single loca-
tion and that microbial contaminants can persist for extended peri-
ods of time within the irrigation system. Thirty three (33)
Salmonella isolates and 50 E.coli isolates collected from irrigation
water and sediments were genotyped using PFGE. Additionally, 33
Salmonella isolates from carrots (field, truck and packing shed)
were also genotyped and classified on their basis of similarities.
The isolates were obtained over a period of 4 months. There were
6 defined Salmonella genotypes (<90% similarity) from Weslaco
compared to 4 genotypes in Laredo, and 12 genotypes in Presidio.
There were 25 different E.coli genotypes in Weslaco, 11 genotypes
in Presidio and 4 genotypes in the El Paso region. Some isolates
obtained on successive months showed similar genotype patterns.
Among carrot samples, the farm isolate was significantly different
compared to the truck and packing-shed isolates. There were 3 dis-
tinct genotypes among the truck samples. These results indicate
that the irrigation water and the sediment are contaminated and
potentially serve as a source of produce contamination. There are
multiple sources of contamination and data suggest that the con-
taminants can persist for prolonged periods. The results indicate
that produce can get contaminated at the field, during transport,
and in the packing shed. Management practices that limit pathogen
contamination needs to be carefully implemented.
Board 65. Effects of Climate on Prevalence of
Campylobacter spp. in Humans and Broilers in Denmark 
M. C. Evans1, L. E. Christiansen1, A. Wedderkop1, P. Gerner-Smidt2,
H. C. Wegener1
1Danish Veterinary Institute, Copenhagen V, DENMARK, 2Statens
Serum Institut, Copenhagen S, DENMARK
Introduction: In Denmark, rates of human campylobacte-
riosis have risen steadily since 1992, reaching a peak of 82 cases per
100,000 population in 2000. Studies have shown poultry to be a
source of Campylobacter infection in humans. A recent survey of
Danish broiler flocks found a prevalence of nearly 40%. Both
human and broiler infections appear to follow the same seasonal
trend. We investigated the role of climate on the number of report-
ed human Campylobacter cases and the prevalence of
Campylobacter in Danish broilers at slaughter. Methods: Reports
of human Campylobacter cases between 1991 and 2000 were pro-
vided by the Statens Serum Institut. Since 1998, the Danish
Veterinary Institute has examined ten birds from every broiler
flock for Campylobacter by cloacal swabs at slaughter. National cli-
mate data (maximum and mean temperature, mm of precipitation,
% relative humidity, and hours of sunlight) by week was provided
by the Danish Meterological Institute. Number of human cases
and broiler prevalence were compared to climatic factors using lag
dependence functions, locally fitted linear models, and cross-vali-
dation methods. Results: Humans: A model including maximum
temperature and precipitation 3-4 weeks prior to reported
Campylobacter infection showed that the highest incidence
occurred during temperatures above 20°C and precipitation
around 20mm per week. Maximum weekly temperature 3-4 weeks
before infection was the best single predictor. Using cross-valida-
tion, average temperature 6-8 weeks before infection was the best
predictor, explaining 85% of the variation. Adding precipitation to
the model only slightly improved the result. Broilers: A model
including maximum temperature, precipitation and relative
humidity three weeks prior to slaughter was the best estimator of
broiler prevalence. Maximum weekly temperature 4 weeks prior to
slaughter was the best single predictor. Using cross-validation,
average temperature was the best single predictor and a model
including average temperature and either precipitation or maxi-
mum temperature 3-4 weeks prior to slaughter further improved
the estimate, explaining 81% of the variation. Conclusion: As
shown in previous studies, we found that temperature does play a
role in Campylobacter infections in both humans and broilers. To
our knowledge, this is the first time that the combined effect of
temperature with other climatic factors such as precipitation and
relative humidity was shown to predict infection; however, more
work is needed to support these findings. Future research should
address conditions in the broiler environment that may be suscep-
tible to climate, and examine micro-climatic data on and around
broiler farms. Investigations into the effect of climate on human
infections must take into account the role of broilers as a source of
Campylobacter, as well as food consumption or preparation prac-
















Board 66. Sources of Human Campylobacter Infection—The
Contribution of Strain Typing to a Challenging Problem
J. A. Frost, R. T. Thwaites, J. F. Richardson, J. M. Logan; Central
Public Health Laboratory, London, UNITED KINGDOM
Campylobacter has been the most commonly reported
cause of bacterial gastro-intestinal infection since 1981.
Campylobacter spp. were the most commonly isolated bacterial
pathogens in the study of Infectious Intestinal Disease carried out
in England between 1993 and 1996, being found in 12% of cases
but only 0.7% of controls. This study estimated that, for every case
reported to national laboratory surveillance, there were a further
seven cases not reported: approaching 500,000 cases per annum.
In contrast, the widespread carriage of campylobacter in food pro-
ducing animals is rarely accompanied by any pathology. The wide-
spread distribution of Campylobacter spp. through the food chain,
and the low number of reported outbreaks of campylobacter infec-
tion make tracing sources and vehicles of human infection difficult.
The extraordinary range of variation seen in this organism com-
pounds these difficulties. Both microbiological and epidemiologi-
cal studies indicate that poultry is not the only source of human
infection. Although a wide range of typing techniques has been
applied to C. jejuni and C. coli, few have been applied systemati-
cally on a large scale. All methods however indicate that isolates
from human infection consist of a small number of stable clones
which are widely distributed on a global scale, a large number of
isolates which can be uniquely identified in any particular study,
and the majority of isolates which comprise a number of closely
inter-related ëtypes’. The implications of these observations for
epidemiological studies aimed at characterising isolates from
human infection will be described with reference to studies carried
out in the Campylobacter Reference Unit (CRU). Since 1997
between 7,000 and 12,000 isolates from human infection in the
United Kingdom have been referred to CRU each year for typing.
Approximately 5,000 isolates from foods and food animals have
been studied during the same time period. All have been serotyped
and phagetyped and screened for resistance to a range of antimi-
crobial drugs. A proportion have also been typed by Pulsed Field
Gel Electrophoresis, Single enzyme Amplified Fragment Length
Polymorphism and Fluorescent Amplified Fragment Length
Polymorphism. The necessity for large scale studies, the choice of
method and the sampling strategy employed will be discussed with
reference to the above experience.
Board 67. The Microbiological Status of Ready to Eat Fruit
and Vegetables 
R. T. Mitchell
CDSC, London, UNITED KINGDOM
In the year 2000, six of 95 (6%) foodborne general out-
breaks of infectious intestinal disease reported to the PHLS
Communicable Disease Surveillance Centre were associated with
consumption of salad, fruit and vegetables. Two notable outbreaks
occurred: in August 174 cases of infection caused by S.
Typhimurium DT 104 associated with the consumption of lettuce
in food items bought from fast food outlets and 124 cases of S.
Typhimurium DT 204b infection linked with the consumption of
lettuce. The latter outbreak appeared to be part of an internation-
al outbreak also affecting Iceland, Scotland, the Netherlands and
Germany. In response to these two large outbreaks the PHLS
organised a number of studies of ready-to-eat salad items in col-
laboration with the Local Authority Co-ordinating Body on Food
and Trading Standards (LACOTS). No pathogens were recovered
from a study of 3,200 of Ready to Eat Organic Fruit and
Vegetables. The majority (99.5%) of samples were found to be of
satisfactory/acceptable microbiological quality whilst only 15
(0.5%) were of unsatisfactory microbiological quality.
Unsatisfactory results were due to Escherichia coli and Listeria
spp. (not L. monocytogenes) levels in excess of 100 c.f.u. g-1. The
absence of pathogens (L. monocytogenes, Salmonella,
Campylobacter, and E. coli O157) and the low incidence (1.5%) of
E. coli and Listeria spp. associated with these organic vegetables
indicates that overall agricultural, hygiene, harvesting, and produc-
tion practices were good. As a follow up, two further studies were
conducted in 2001: A study of 3,581 Retail Prepared Prepacked
Ready-to-Eat Salad Vegetables detected Salmonella spp. in 5 sam-
ples. No E.coli O157 or Campylobacter spp. were detected.
L.monocytogenes was recovered at very low levels (<20 c.f.u. g-1) in
25% of samples. A small number of cases of Salmonella Newport
occurred linked with one of the affected products but swift
removal of this product prevented a much larger outbreak. No
pathogens have so far been found in a subsequent study of around
4,000 Open Prepared Ready-to-Eat Salad Vegetables from
Catering & Retail Premises. The results of both latter studies are
still being collected and analysed and will be presented.
Board 68. Prevalence of Escherichia coli O157:H7 in
Ground Beef, United States, 1995-2000 
K. A. Orloski1, W. C. Cray, Jr.2, P. Levine3, E. D. Ebel4
1USDA, Food Safety Inspection Service, Fort Collins, CO, 2USDA,
Food Safety and Inspection Service, Athens, GA, 3USDA, Food
Safety and Inspection Service, Washington, DC, 4USDA, Food Safety
and Inspection Service, Fort Collins, CO
Escherichia coli O157:H7 is an important human pathogen
that can be transmitted by food, water or person-to-person.
Ground beef has been implicated in foodborne disease outbreaks
and as a risk factor for sporadic cases of E. coli O157:H7 infection.
In 1994, the United States Department of Agriculture, Food Safety
and Inspection Service (FSIS) began testing ground beef for E. coli
O157:H7. Raw ground beef samples obtained from federally
inspected processing facilities and retail outlets were analyzed
through an ongoing FSIS monitoring and surveillance program.
Information regarding the date of sample collection, geographic
location of the sampled facility, and test result was available for
each sample. From 1995-1997, 25-gram samples of ground beef
were tested for the presence of E. coli O157:H7 using enrichment,
screening ELISA and culture. In 1998, the sample size increased
to 325 grams, and in September 1999, immunomagnetic antigen
capture techniques and the use of a highly selective plating medi-
um were implemented. Descriptive statistical analyses were com-
pleted for tests performed during 1995-2000 for samples from pro-
cessing facilities and retail outlets. For processing facilities, 47
(0.29%) of 16,366 samples tested positive. The annual prevalence
of positive samples for 1995-2000 was 0.08%, 0.09%, 0.09%,
0.22%, 0.28%, and 0.50%, respectively. The number of samples
tested annually increased from approximately 1,000 during 1995-
1997 to 4,000 during 1998-2000. The prevalence of positive sam-
ples varied from 0.0% - 0.52% for 9 geographical regions of the
U.S. During June-September 1998-2000, E. coli O157:H7 was
detected in 27 (0.64%) of 4,228 samples, compared to 17 (0.20%)
of 8,667 samples collected during October-May 1998-2000 (p =
0.0001). For retail outlets, 19 (0.24%) of 7,885 samples tested pos-
itive. During 1995-2000, E. coli O157:H7 was detected in 0.07%,
0.0%, 0.0%, 0.10%, 0.35% and 0.86% of samples, respectively;
1,000-2,000 samples were tested annually. At retail sites, preva-
lence in 9 regions of the U.S. varied from 0.0% to 0.57%. During
June-September 1998-2000, 10 (0.60%) of 1,665 samples tested
positive, compared with 8 (0.25%) of 3,180 obtained during
remaining months (p = 0.10). This is the first report of a national
estimate of the prevalence of E. coli O157:H7 in ground beef from
processing facilities and retail outlets. An increase in the preva-
lence of E. coli O157:H7 was observed over time. This increase
may be due to enhanced sensitivity of the surveillance system due
to larger sample sizes and improved test methodology. A seasonal
peak in the prevalence of E. coli O157:H7 in ground beef was
observed for both processing facilities and retail outlets during
June-September. This seasonal peak follows a similar pattern
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observed in both the incidence of reported human cases and the
prevalence of carriage by cattle.
Board 69. Trends in Foodborne Disease Outbreaks Due to
Scombrotoxin and Ciguatoxin in the United States, 1973-1997 
N. A. Tucker, S. J. Olsen, P. S. Mead
Centers for Disease Control and Prevention, Atlanta, GA
Background: The per capita consumption of fish in the
United States has increased by approximately 50% since 1970. In
addition, climatic changes have produced warmer waters during
the 1990s compared with the previous 2 decades, potentially
increasing the range of warm water dinoflagellates that produce
toxin. Reported scombroid and ciguatera outbreaks were reviewed
to identify temporal trends. Methods: We reviewed scrombroid
and ciguatera outbreaks reported to CDC’s Foodborne Disease
Outbreak Surveillance System between 1973 and 1997. Etiologic
confirmation required either demonstration of histamine or cigua-
toxin in epidemiologically implicated fish or the appropriate clini-
cal syndrome among persons who had eaten a type of fish associat-
ed with this illness. Trends were analyzed using least squares
regression. Results: Between 1973 and 1997, there were 361
scombroid (2072 illnesses) and 337 ciguatera (1450 illnesses) out-
breaks. The number of scombroid outbreaks increased significant-
ly from 12 in 1973 to 22 in 1997 (slope 0.36, p= 0.028); there was
no distinct trend in ciguatera outbreaks. Among scombroid out-
breaks, the median number of illnesses was 2 (range 1-232). One
fatality occurred in 1988. Among ciguatera outbreaks, the median
number of illnesses was 3 (range 1-69). Three fatalities were
reported in 1981. California, Florida, Hawaii, New Jersey, New
York and Washington reported 10 or more scombroid outbreaks.
California, Florida, Hawaii, Puerto Rico, and the Virgin Islands
reported more than one ciguatera outbreak. Ciguatera and scom-
broid outbreaks demonstrated a marked seasonality, peaking in
August. However, seasonality varied by geographic region.
Outbreaks of scombroid in Pacific coastal states were bimodal,
peaking in March and then again in August through September; in
Atlantic coastal states outbreaks peaked in August. Outbreaks of
ciguatera in Hawaii peaked between July and September, whereas
outbreaks in Florida peaked in May; those in tropical regions
demonstrated less seasonality. Of the 361 scombroid outbreak
investigations reported, 311 (86%) implicated a food vehicle. Ten
families of fin fish were identified; Scombroidae (tuna, mackerel
and bonitos) accounted for 160 (51%) outbreaks and
Coryphaenidae (mahi-mahi) accounted for 89 (29%). Of the
337ciguatera outbreak investigations reported, 247 (73%) implicat-
ed a food vehicle. Seventeen fish families were identified;
Carangidae (ulua, amberjack) accounted for 65 (26%) outbreaks.
Conclusions: From 1973 to 1997, scombroid fish poisoning out-
breaks increased, while no trend in ciguatera outbreaks was
observed. Scombrotoxin and ciguatoxin continue to be a cause of
foodborne disease outbreaks in the United States, particularly in
coastal areas. Continued monitoring and enforcement of regula-
tions for temperature logs and product testing from commercial
fishing operations may help reduce illness.
Board 70. Risk factors for fatal Vibrio vulnificus infection in
the United States, 1997-2000 
C. A. Crowe, S. J. Olsen, P. S. Mead, J. A. Painter
Centers for Disease Control and Prevention, Atlanta, GA
Background: Vibrio vulnificus is a natural inhabitant of
marine and estuarine environments all over the world. Human
infection with this gram-negative bacteria occurs in compromised
hosts and is associated with an approximate 30% fatality rate.
Methods: To determine risk factors for fatal V. vulnificus infec-
tions we analyzed data from the Vibrio Surveillance System at
CDC. Participation in this surveillance system is voluntary. Each
surveillance report includes the species of Vibrio, the site of isola-
tion, patient demographics, clinical history including underlying
illness and exposure history. We analyzed V. vulnificus infections
reported between 1997 and 2000. The analysis was limited to
patients who had V. vulnificus isolated from blood or wound (i.e.,
patients at greatest risk for death). Antimicrobial agents were clas-
sified as tetracyclines, any cephalosporins, third and fourth gener-
ation cephalosporins, aminoglycosides, and quinolones (including
fluoroquinolones). Antibiotic dose and duration was not reported.
Results: Between 1997 and 2000, 287 laboratory-confirmed V.
vulnificus infections from 23 states were reported. Of these, 203
had complete information and were included in the analysis: 112
(55%) were classified as sepsis and 91 (45%) as wound infections,
184 (91%) were male, the median age was 54 years (range, 13 to
94), and 70 (34%) died. Overall, 195 (96%) patients received
antimicrobial treatment and 77 (38%) received at least three
antimicrobials. All eight patients who did not receive any antimi-
crobials died, 21 (25%) of 84 taking quinolones died, 26 (25%) of
102 taking tetracyclines died, 16 (39%) of 41 taking aminoglyco-
sides died, 29 (28%) of 102 taking any cephalosporins died, and 23
(28%) of 82 taking third or fourth generation cephalosporins died.
On univariate analysis, residing in a Gulf Coast state (RR=.67, 95%
CI=.46-.98) and treatment with quinolones (RR=.61, 95% CI=.39-
.95) or tetracylines (RR=.58, 95% CI=.38-.88) were significantly
protective against death, whereas age below 54 years (RR=2.09,
95% CI=1.39-3.15), non-white race (RR=1.76, 95% CI=1.21-2.57),
and underlying liver disease or alcoholism (RR=3.56, 95%
CI=2.08-6.08) were significant risk factors for death. In a logistic
regression model, use of tetracyclines remained significantly pro-
tective against death (OR=.45, 95% CI=.21-.93) and underlying
liver disease or alcoholism remained a significant risk factor
(OR=5.26, 95% CI=2.34-11.81). Conclusion: This analysis sug-
gests that use of tetracyclines during an illness associated with V.
vulnificus may be therapeutic. However, without data on antimi-
crobial dose and duration and antimicrobial resistance, these data
should be interpreted with caution. Surveillance data may need to
be expanded to capture these data. Public health prevention mes-
sages should continue to target persons with underlying liver dis-
ease or alcoholism.
Board 71. Investigation of a Senegalese Foodborne
Outbreak Caused by Vibrio parahaemolyticus in Shrimps 
A. Aidara-Kane1, C. Rogier2, A. Tall1, F. Grimont3
1Institut Pasteur, Dakar, SENEGAL, 2IMTSSA, Marseille, FRANCE,
3Institut Pasteur, Paris, FRANCE
Foodborne diseases continue to present a major challenge
to public health authorities in carrying out the core functions of
outbreak detection and control, which rely on timely disease sur-
veillance. Epidemiologic studies have made crucial contribution to
the understanding of how outbreaks of food-borne deseases occur
and how they can be prevented. On April 14th 1993, Pasteur
Institute in Dakar was asked to investigate an outbreak of diarrheas
in a hotel with restaurant located a hundred kilometers far from
Dakar, Senegal. The main objective of this investigation was to pro-
vide informations for the development of appropriate measures for
the prevention of future outbreaks. Background:The number of
consultation for diarrhea done by the resident doctor increased
from 1 per week usually to 6 per day on april 12th and april 13th.
One hundred fifty seven (157) guests were staying at the hotel dur-
ing the outbreak, most of them coming from foreign coutries: 108
arrived on april 11th, 29 on april 12th or later and 20 arrived before
april 11th. The outbreak affected persons working at the hotel, res-
ident guests and persons who did not stay at the hotel butate at the
restaurant on april 11th and april 12th. Methods: A case-control
on-site investigation was undertaken in order to determine the
extent of the outbreak and identify its suspected source.
Epidemiological investigation of the outbreak included informa-
tions on the number of affected people, causal agents, incriminat-
















to the outbreak. Stool and food samples were collected for micro-
biological analysis including phenotypic and molecular characteri-
sation of the suspected pathogen. Results: Statistical analysis of
epidemiological data including determination of odd-ratios
revealed that shrimps was the food vehicle. Vibrio parahamolyticus
was isolated from suspected shrimps (4 strains from four different
samples) and from a stool sample of a guest suffering from diar-
rhea. Molecular characterization of these strains revealed that all
five strains belonged to the same ribotype.
Board 72. A Study of Cleaning Standards and Practices in
UK Food Premises 
C. L. Little1, S. K. Sagoo1, C. J. Griffith2, R. T. Mitchell1
1Environmental Surveillance Unit (PHLS CDSC), London, UNITED
KINGDOM, 2Food Safety Group, University of Wales Institute Cardiff,
Cardiff, UNITED KINGDOM
During September and November 2000 a study was under-
taken to determine the microbiological status of surfaces used in
the preparation of ready-to-eat foods, and to assess cleaning stan-
dards and practices in food premises. Food contact surface samples
(6533) were examined from 1502 premises. Cleaning cloths (1132)
and chopping board surfaces (2033) were more heavily contami-
nated with bacteria (Aerobic Colony Count (ACC),
Enterobacteriaceae, E. coli, and Staph. aureus) compared to work-
top (2009) and food container (1359) surfaces. Campylobacter spp.
and Salmonella spp. were also detected in two (0.2%) and one
(0.1%) of the cleaning cloths. Higher levels of bacteria were found
on surfaces that were visually dirty, wet, or cleaned more than 24
hours previously (P<0.0001), and boards that were scored or dam-
aged (P<0.0001).
A documented hazard analysis system was in place in half
(52%) of premises visited. Significantly more samples (surfaces of
chopping boards, worktops, and food containers, and cleaning
cloths) with ACC levels in excess of 103 cfu/cm2, swab or ml were
from premises where there was no hazard analysis system in place
(39%) compared to those where a hazard analysis system was in
place (27%) (P<0.0001). Most managers (89%) had received food
hygiene training. Documented cleaning schedules and cleaning
records were present in approximately half (55% and 44%, respec-
tively) of the premises. Sixty-one percent of premises had physical-
ly separate areas for raw and ready-to-eat food. However, most did
not have separate cleaning materials for raw and ready-to-eat food
areas (67%), or stored cleaning equipment for high risk areas from
those used in low risk areas (70%). Deficiencies in the correct use
of cleaning products were identified. Surface samples and cleaning
cloths with ACC levels in excess of 103 cfu/cm2, swab or ml were
also associated with premises types as well as premises where man-
agement did not have food hygiene training or where cleaning
schedules or records were not implemented. Recommendations
for improving cleaning standards are provided.
Board 73. Examining Publication Bias in Foodborne
Outbreak Investigations: Implications for Food Safety Policy 
S. J. O’Brien, I. A. Gillespie, M. A. Sivanesan, G. K. Adak
Public Health Laboratory Service, London, UNITED KINGDOM
Background: Systematic national surveillance of general
outbreaks of infectious intestinal disease (IID) (i.e. those affecting
more than one household) was introduced in England and Wales in
1992, comprising a minimum dataset for each completed investi-
gation. It was designed to provide unbiased information on
causative organisms, sources or vehicles of infection and modes of
transmission. We compared the information from the surveillance
system for general outbreaks of IID between 1st January 1992 and
31st March 1999 with that which appeared in the peer-reviewed
literature during the same time period in order to assess the effect
of publication bias and consequent implications for food safety pol-
icy. Methods: We abstracted data on foodborne outbreaks of IID
from the national surveillance dataset for England and Wales. We
searched PubMed for publications from 1992 onwards using the
MESH headings “disease outbreaks” and “food”. We excluded out-
breaks originating outside England and Wales and family out-
breaks. Results: Between 1st January 1992 and 31st March 1999
1347 foodborne outbreaks of IID were reported to the Public
Health Laboratory Service (PHLS). Forty-five foodborne outbreak
reports appeared in the peer-reviewed literature. The minimum
interval between outbreak occurrence and the appearance of a
peer-reviewed paper was 7 months (maximum 71 months; median
21 months). The minimum interval between outbreak occurrence
and receipt of a completed outbreak surveillance form by the
PHLS was 1 month (maximum 20 months; median 13 months).
Foodborne outbreaks of Shiga toxin-producing Escherichia coli
O157, campylobacter and unusual Salmonella species tended to be
over-represented in the peer-reviewed literature compared with
the national dataset (16% versus 3%; 9% vs. 2% and 13% vs. 4%
respectively). Foodborne outbreaks due to Norwalk-like Virus
infection were under-represented in the peer-reviewed literature
compared with the national dataset (2% vs. 6%). Outbreaks in the
peer-reviewed literature overestimated the impact of milk and
dairy products and miscellaneous food items, whilst underestimat-
ing the impact of poultry, eggs, red meat and fish and shellfish.
Conclusion: Few of the foodborne outbreaks reported to the
PHLS led to peer-reviewed publications. In the quest for original-
ity publications in peer-reviewed journals tend to favour the unusu-
al or novel event. In order to develop rational policies, however,
policy-makers and enforcers need to know what is usual as well as
what is unusual. It is in dealing with the usual that the greatest
health gains are to be made. In the absence of systematic surveil-
lance knowledge of causative organisms, sources or vehicles of
infection and modes of transmission in foodborne disease out-
breaks gleaned from the peer-reviewed literature would have the
potential to distort food safety policy.
Board 74. Knowledge, Attitudes and Practices Regarding
Use of Irradiated Meats and Pasteurized Eggs in Health Care
Institutions, Universities, and Restaurants in Connecticut 
J. L. Hadler1, A. Chan2, M. Chan2, S. Chemerynski2, J. Hahn2, K.
Marshall2, Q. Phan1, T. McCarthy1, T. Rabatsky-Ehr3
1Connecticut Department of Public Health, Hartford, CT, 2School of
Epidemiology and Public Health, Yale University, New Haven, CT,
3Connecticut Emerging Infections Program, Yale University, New
Haven, CT
Background: Contaminated meats and eggs have been
implicated as a major source of foodborne diseases. In recent
years, several significant food safety technologies have been
approved for commercial use: irradiation of meats and pasteuriza-
tion of both egg-product and in-shell eggs. Widespread use could
reduce the occurrence of Shiga toxin-producing Escherichia coli
infection, salmonellosis, campylobacteriosis, listeriosis and toxo-
plasmosis by an average of 50%. As a prelude for a public health
initiative to promote their use, a survey was undertaken to deter-
mine the extent to which these technologies are currently being
used in Connecticut. Methods: A standardized questionnaire was
developed to assess the knowledge and attitudes toward the use of
irradiated meats and pasteurized eggs and the extent to which they
are currently being purchased and used. The surveys were mailed
in February 2001 to the food services of all universities and acute-
care hospitals and a representative sampling of long-term care
facilities (LTCF) and restaurants in Connecticut. A second mailing
to non-respondents was conducted in March 2001. Results: Of
the 391 surveys sent, 211 (54%) were returned: 24/34 (71%) from
hospitals, 113/167 (68%) from LTCFs, 17/40 (43%) from universi-
ties and 57/150 (38%) from restaurants. Nearly all respondents
reported using hamburger, chicken, and eggs in their operations.
Seventy-five percent (75%) of facilities use pasteurized egg prod-
uct (PEP), but no facility currently uses irradiated hamburger or
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poultry, and only 16% use pasteurized in-shell eggs (PSE).
Restaurants (14%) and universities (56%) were less likely than
LTCF or hospitals (96% each) to use PEP. The majority of respon-
dents requested more information concerning PSE (66%) and
most (79%) would be willing to consider buying irradiated meat
products if given additional information. Significant predictors
(p<0.05) of willingness to buy irradiated meat products include
being a hospital or LTCF (88% vs 62%), having a manager with
>20 years food service experience (89% vs 66%), believing that
irradiation kills harmful bacteria (89% vs 63%), and believing that
a person will not get irradiation exposure from eating irradiated
meat (94% vs 63%). Significant predictors associated with the cur-
rent use of PSE include having received prior information (44% vs
6%) and belief that consumers will accept the product (22% vs
7%). While 53% of respondents thought that DPH should encour-
age use of PSE, only 17% thought that DPH should encourage use
of irradiated meats. Conclusions: Pasteurized egg product is
already widely used in hospitals, LTCFs and universities in CT.
There is considerable potential to improve the use of irradiated
meats and pasteurized in-shell eggs in food service establishments,
beginning with provision of more information.
Board 75. Multistate Outbreak of Salmonella Poona
Infections Associated with Precut Melon 
K. K. Carter1, K. Cummings2, B. Sun1, S. B. Werner2, J. Rosenberg2,
S. Abbott2, A. Sokoloff1, J. L. Thomas1, C. A. Myers1, M. T. Jay1
1California Department of Health Services, Sacramento, CA,
2California Department of Health Services, Berkeley, CA
Imported cantaloupes or watermelon have been implicated
in several outbreaks of salmonellosis in the United States. There
were multistate outbreaks of Salmonella serotype Poona (SP) asso-
ciated with imported cantaloupe in 1989, 2000, and 2001. In June
2001, a multistate outbreak of SP infections with isolates indistin-
guishable by pulsed-field gel electrophoresis (PFGE) was identi-
fied in 23 case-patients in the U.S; 19 were residents of one of 11
California counties. Four case-patients were out-of-state residents;
three of them had traveled to California during the week prior to
the onset of illness. Symptom onsets ranged from June 1 to July 4,
2001. Four patients were hospitalized, but no deaths were report-
ed. The median age of case-patients was 7 years (range 1-88 years)
and 13 (56.5%) were female. A case-control study, utilizing a stan-
dardized questionnaire telephone-administered to 12 case-patients
and 24 age- and telephone prefix- matched controls, found an asso-
ciation between illness and precut melon (cantaloupe, honeydew,
or watermelon) consumption. The percentage of case-patients who
ate precut cantaloupe (54.5%), precut honeydew (40.0%), or pre-
cut watermelon (50.0%) was higher than that of controls (4.2%,
0%, 8.3%, respectively). Exact methods in the statistical software
package Egret® were used to calculate the odds ratio (OR, maxi-
mum likelihood estimate), 95% confidence intervals (CI), and 2-
sided p-values for the test that the OR=1. For precut melon, the
OR, CI, and p-values were: infinite, 2.0-∞, p=0.006 (cantaloupe);
infinite,1.3-∞, p=0.03 (honeydew); and infinite,1.5-∞, p=0.02
(watermelon). Eating honeydew in general was also implicated;
however, all case-patients who recalled the form of honeydew
eaten ate precut honeydew. A traceback investigation identified
multiple sources of precut melon mixes. The results of this out-
break investigation parallel those of other SP outbreaks and
demonstrate the importance of assessing the manner of food
preparation, in addition to the type of food consumed, when ana-
lyzing food histories. Additional research into safe melon handling
and processing procedures is needed to provide science-based
guidelines to reduce the risk of Salmonella infection.
Board 76. Evaluation of Factors Contributing to
Environmental Contamination with Cryptosporidium 
parvum from a Dairy Herd 
J. J. Ward1, R. D. Smith2, M. S. Kuhlenschmidt2
1Hunterdon County Department of Health, Flemington, NJ, 2University
of Illinois, Urbana, IL
Cryptosporidium parvum is an important protozoan
pathogen that infects over 75 species of mammals, including
humans. C. parvum is common in dairy cattle wastes and trans-
mission from cattle to humans has been extensively documented.
Little is known about the public health risk posed by animal waste
and how that risk is affected by storage and disposal procedures.
Assessing the potential role of cattle in human exposure requires
understanding the dynamics of factors contributing to environ-
mental contamination. These include host and temporal patterns
of shedding, survival of the organism in animal waste, and waste
management strategies. The goal of this study was to determine
whether dairy cattle significantly contribute to environmental con-
tamination with Cryptosporidium parvum oocysts under condi-
tions typical of Illinois dairy farms. A one-year study was conduct-
ed to determine the prevalence of Cryptosporidium parvum
oocysts shedding in fecal samples at a dairy, and identify any sea-
sonal or temporal shedding patterns. In addition, an experiment
was performed to determine the survival rate and viability of C.
parvum oocysts in compost over time. The information gathered
was incorporated into a computer simulation model to evaluate the
interaction of relevant factors that can be used to predict environ-
mental load of C. parvum oocysts. We concluded that dairy herds
may be a significant source of environmental contamination with
C. parvum, depending on the occurrence of specific events. The
actual level of contamination varies over time and is affected by
calving pattern, seasonal incidence, and the effectiveness of com-
posting. Based on our model, compost management may be the
most important critical control point in preventing environmental
contamination with C. parvum oocysts. In addition, the actual
human health risk is dependent upon a unique sequence of events
subsequent to environmental contamination.
Board 77. The Outbreak Investigation at Square One:
Submit a Specimen
M. E. Huddle, S. O. Olsen, K. M¯lbak
Centers for Disease Control and Prevention, Atlanta, GA
Background: Despite the discovery of new agents of food-
borne disease and improvements in laboratory detection methods,
a large percentage of foodborne disease outbreaks in the United
States are of unknown etiology. Methods: Data from the CDC
Foodborne Disease Outbreak Surveillance System were used to
characterize foodborne disease outbreaks of unknown etiology that
occurred in the United States between 1973 and 1997. A food-
borne disease outbreak was defined as the occurrence of two or
more cases of a similar illness resulting from the ingestion of a
common food. Outbreaks are investigated by local and state health
officials and reported to CDC on a standard form. Any outbreak
that met the criteria needed for confirmation of a foodborne dis-
ease outbreak for one of the many known agents was defined as an
outbreak of known etiology [MMWR 2000; 49(SS-1): 54-61]. All
other foodborne disease outbreaks were defined as outbreaks of
unknown etiology. Results: There were 12,846 foodborne disease
outbreaks reported; 8,227 (64%) were of unknown etiology. This
percentage remained relatively constant when comparing decades:
64.8% from 1973-1979, 63.1% from 1980-1989, 64.6% from 1990-
1997. The percentage of foodborne disease outbreaks of unknown
etiology varied from month to month with the highest percentage
occurring between December and February (range, 71.9% to
74.1%) and the lowest percentage occurring between July and
September (range, 53.8% to 54.7%). The median number of per-
















[interquartile range: (IQR): 3 to 22 persons] compared with 12 per-
sons (IQR: 4 to 34) in outbreaks of known etiology. In 1010 (15.1%)
outbreaks of unknown etiology patients were hospitalized and in 20
(0.28%) at least one person died compared with 2125 (56.1%) and
177 (4.4%) in outbreaks of known etiology, respectively. In 2801
(34.1%) foodborne outbreaks of unknown etiology patients sub-
mitted specimens for testing compared with 3278 (71.0%) out-
breaks of known etiology (RR=0.57, p<.0001). In 2341 (28.5%)
outbreaks of unknown etiology a vehicle was identified compared
with 3307 (71.6%) outbreaks of known etiology (RR=0.51,
p<.0001). Conclusions: Foodborne disease outbreaks of unknown
etiology were generally smaller than outbreaks of known etiology
but contributed to the overall morbidity of foodborne illness.
There was a strong association between the collection of a patient
specimen and a known etiology as well as between known etiology
and an increased likelihood of identifying the vehicle. Health care
workers should be encouraged to collect specimens at the begin-
ning of an outbreak investigation. In addition, further work is need-
ed to identify barriers to obtaining specimens.
Board 78. Risk Factors for Sporadic Campylobacter
Infections in Maryland 
L. A. Klatka1, M. A. Hawkins1, M. A. Pass2, F. J. Angulo3, D. D.
Rohn4, J. G. Morris1, and the EIP FoodNet Working Group3
1University of Maryland School of Medicine, Baltimore, MD, 2Johns
Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Centers
for Disease Control and Prevention, Atlanta, GA, 4Maryland
Department of Health and Mental Hygiene, Baltimore, MD
Background: Campylobacter is the leading cause of bacte-
rial diarrhea in the United States and among CDC’s Foodborne
Diseases Active Surveillance Network (FoodNet) sites. Data from
FoodNet show that Maryland has a remarkably low incidence of
culture-confirmed Campylobacter infections, where it is the third
reported most common cause of diarrhea. In this analysis, we
sought to examine risk factors for sporadic infection in Maryland to
determine if differences in exposure may explain the difference
between Maryland and other FoodNet sites. Methods: Between
March 1998 and February 1999, a Campylobacter case-control
study was conducted in FoodNet sites (Connecticut, Georgia,
Minnesota, Oregon, and selected counties in California, Maryland,
and New York). A case was defined as a person with
Campylobacter infection identified by a clinical laboratory; and
diarrhea, with onset <10 days before the positive stool culture.
Each case was matched with a control from the same age range and
telephone exchange. Subjects were interviewed regarding diet,
kitchen practices, travel, and animal exposure in the 7 days prior to
illness onset (cases) or interview (controls). Risk factors among
Marylandës cases and controls were compared using «2 analysis.
Results: Of 157 cases identified by surveillance in the Baltimore
metropolitan area of Maryland, 119 were enrolled. The mean age
of the cases was 35.6 years (range 2 months to 93 years); 17 (14.3%)
cases were hospitalized. Cases were more likely than controls to be
white (p<0.01), to have recently eaten in a restaurant (p=0.01),
traveled internationally (p=0.01); eaten chicken luncheon meat
(p=0.03), or ham (p<0.01); had contact with a puppy (p=0.01), dog
(p=0.03) or cat (p=0.02); or visited a petting zoo (p=0.04). Cases
were less likely than controls to have purchased (p=0.01), stored
(p=0.01), or cooked (p=0.01) raw chicken. Cases who purchased
chicken reported leakage from the package onto other items in
their grocery bag more often than controls (p<0.01). The remain-
der of kitchen practices did not differ between groups.
Conclusions: Except for the handling of raw chicken, Maryland’s
site-specific analysis identified similar risk factors for
Campylobacter infection as the analysis of FoodNet-wide data, and
previously published reports, suggesting that exposure to poultry
and animals, eating outside the home, and international travel are
risk factors for disease. The reason for the unusually low incidence
of Campylobacter infections in Maryland remains unexplained, but
suggests exposure to contaminated chicken may be lower. Other
factors, including those leading to identification of Campylobacter
as the etiologic agent in a case of diarrhea, warrant further study to
clarify the low incidence of Campylobacter infections in Maryland.
Board 79. Foodborne Outbreak Surveillance in Georgia: The
Impact of State and Federal Funding, 1995-2000 
K. M. Lane, P. Blake, S. Lance-Parker, K. McCombs, S. Thomas
Georgia Division of Public Health, Atlanta, GA
Background: Georgia has experienced a dramatic increase
in the number of recognized foodborne disease outbreaks at the
state level from 1995-2000. The number of reported foodborne
outbreaks increased more than tenfold, from 3 in 1995 to 43 in
2000. New federal grants targeting emerging infectious diseases
epidemiology and laboratory capacity have provided increased
resources to support activities at the state level. New state funding
has also boosted epidemiologic capacity in the 19 health districts,
providing support for masters trained epidemiologists for 13 dis-
tricts.
Methods: We calculated the amount of funding received
from state and federal sources that focused on general infectious
disease investigation and control. Foodborne disease outbreaks
reported to the Georgia Division of Public Health during 1995-
2000 were compared with the number of infectious disease (ID)
epidemiologists at the state level.
Results: Before 1994, federal grant money was focused on
specific infectious diseases such as sexually transmitted diseases
(STDs), tuberculosis, and AIDS. The amount of federal funding to
Georgia devoted to general infectious diseases drastically increased
from $63,000 in 1995 to over $1.4 million in 2000. The number of
ID epidemiologists increased from 3.5 in 1995 to 16.5 in 2000.
During 1995-2000, a total of 106 foodborne outbreaks were report-
ed to the Georgia Division of Public Health. Of these, 3 outbreaks
were reported in 1995, 4 outbreaks were reported in 1996, 4 out-
breaks were reported in 1997, 17 outbreaks were reported in 1998,
34 outbreaks were reported in 1999, and 43 outbreaks were report-
ed in 2000.
Conclusion: Increased federal and state funding has great-
ly improved the foodborne disease outbreak surveillance system in
Georgia. These funds have allowed an increase in the number of
ID epidemiologists at the state and local levels, which in turn has
increased the number of reported outbreaks in Georgia each year.
This increase is primarily due to improved communication
between state, district, and county health departments, and to bet-
ter ascertainment and reporting of outbreaks at all levels. County,
district, and state public health personnel are striving to improve
foodborne outbreak reporting, and to develop stronger collabora-
tion and communication between epidemiologists, environmental
health specialists, and laboratorians to conduct better outbreak
investigations.
Board 80. Interventions at Critical Points Along the Shell Egg
Supply Chain to Mitigate Egg-Associated Salmonella Enteritidis
in the United States — A Descriptive Analysis 
G. A. Mumma, P. M. Griffin, M. I. Meltzer, C. R. Braden, R. V. Tauxe
Centers for Disease Control and Prevention, Atlanta, GA
Background: Salmonella Enteritidis (SE) emerged as a
major cause of foodborne illness in humans in the U.S. in the 1980’s.
Programs to mitigate SE have focused on reducing SE infection and
growth in shell eggs. There is a need to evaluate their effectiveness.
However information with which to do so is incomplete.
Objectives: Collect data on SE control programs aimed at
reducing SE infection and detering SE growth in eggs, describe
them, and identify data that would be needed to evaluate their
effectiveness.
Methods: We collected national and state-specific time
series data on SE control programs designed to reduce SE infec-
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tion at the primary and multiplier-breeding flocks level, shell egg
production, and deter SE growth at the retail level. We used these
data to describe the programs over time and analyzed them to
identify gaps that needed to be filled in order to adequately evalu-
ate their effectiveness. Data were obtained from CDC, USDA,
FDA, SE vaccine producers, National Restaurant Association
(NRA), and state agricultural and public health officials.
Results: Chicken breeding flocks in the USDA’s program
to eliminate SE at the breeding level increased from 70% in 1990
to 100% in 1997. The top-twenty egg-producing states in the U.S.
produced 81% of eggs between 1995 and 1999. By 1999, 15 of 50
states had adopted EQAPs and they produced 26% of U.S. eggs.
The number of doses of SE vaccine for chicken sold in the U.S.
increased by 1400% between 1992 and 1999. The proportion of
layers that were of one breed of chicken, thought to be relatively
resistant to SE, increased from 25% to 77% between 1980 and
1999. Funding for USDA traceback activities was withdrawn in
1995, and the work was taken over by the FDA in 1996. Between
1976 and 1999, states requiring refrigeration for shell eggs at retail
increased from 5% to 73%, and those requiring refrigeration at
more stages along the egg supply chain increased from 3% to 40%.
The number of annual ServSafe Certificates issued by the NRA
increased by 892% between 1987 and 1999.
The following data were found to be incomplete and limit-
ing to potential evaluation of programs for effectiveness: state-spe-
cific time series data for the source and destination of eggs, eggs
produced under each EQAP, compliance rates for each EQAP’s
requirements and for temperature requirements, SE infection
rates in layer flocks and eggs, SE vaccine usage, layer strains, and
evidence of training for food service professionals that could be
compared to SE reductions. USDA SE Task Force reports from
1993 to 1995 were incomplete, and FDA provided trace back data
aggregated around regions.
Conclusions: Although many SE control strategies were
instituted since the late 1980’s in response to the epidemic of SE
illness, records relating to major egg safety programs are difficult
to obtain. More complete data and time series analyses are need-
ed to assess the impact of these programs on SE infections and
growth in eggs.
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Board 81. NASA Remote Sensing Data for
Epidemiological Studies 
N. G. Maynard1, G. A. Vicente2
1NASA Goddard Space Flight Center, Greenbelt, MD, 2George
Mason University — GMU, Fairfax, VA
In response to the need for improved observations of envi-
ronmental factors to better understand the links between human
health and the environment, NASA has established a new program
to significantly improve the utilization of NASA’s diverse array of
data, information, and observations of the Earth for health appli-
cations. This initiative, lead by Goddard Space Flight Center
(GSFC) has the following goals: (1) To encourage interdisciplinary
research on the relationships between environmental parameters
(e.g., rainfall, vegetation) and health, (2) Develop practical early
warning systems, (3) Create a unique system for the exchange of
Earth science and health data, (4) Provide an investigator field sup-
port system for customers and partners, (5) Facilitate a system for
observation, identification, and surveillance of parameters relevant
to environment and health issues. The NASA Environment and
Health Program is conducting several interdisciplinary projects to
examine applications of remote sensing data and information to a
variety of health issues, including studies on malaria, Rift Valley
Fever, St. Louis Encephalitis, Dengue Fever, Ebola, African Dust
and health, meningitis, asthma, and filariasis. In addition, the
NASA program is creating a user-friendly data system to help pro-
vide the public health community with easy and timely access to
space-based environmental data for epidemiological studies. This
NASA data system is being designed to bring land, atmosphere,
water and ocean satellite data/products to users not familiar with
satellite data/products, but who are knowledgeable in the
Geographic Information Systems (GIS) environment. This paper
discusses the most recent results of the interdisciplinary environ-
ment-health research projects and provides an analysis of the use-
fulness of the satellite data to epidemiological studies. In addition,
there will be a summary of presently-available NASA Earth science
data and a description of how it may be obtained.
Board 82. Coordinated Regional Surveillance for West Nile
Virus in Metropolitan Washington 
M. Stoto1, V. Foster2, I. Cheung2, L. Estrada3, L. Mele4, M. Smith2
1RAND, Arlington, VA, 2George Washington University, Washington,
DC, 3Prince William Health District, Manassas, VA, 4George
Washington University, Rockville, MD
In support of the activities of the Metropolitan Washington
Council of Government’s West Nile Virus coordinating committee,
a geographical information system was set up and analytical maps
prepared to describe the evolution of West Nile virus activity in
birds during the summer and early autumn of 2001. The region
covered by the maps includes the District of Columbia, three
counties in Maryland, and five cities, counties, and health districts
in Virginia. The maps were intended to inform state and local
health departments in the Washington metropolitan area regarding
risk and possible cases in humans as well as mosquito spraying
decisions, and to inform the public. The exercise was also intend-
ed to illustrate benefits of collaboration between academic institu-
tions and public health agencies, and between epidemiology and
geography. A geographical information system database was built
combining data on dead birds reported, tested, and found positive
for West Nile virus in the metropolitan area. Differences across the
states and local areas with respect to surveillance and testing pro-
cedures were harmonized to the extent possible. Maps were pre-
pared with a greater degree of geographical detail for the health
officers of the jurisdictions concerned, and in less detail for the
general public so that the specific locations where birds were found
were not disclosed. The analyses revealed two clusters of West Nile
positive birds in the metropolitan area: a major cluster in the
District of Columbia, extending into adjacent parts of two
Maryland counties, and a smaller cluster at the border of Arlington
County and the City of Alexandria in Virginia. The concentration
of birds at this point was such that human risk seemed likely. A
comparison of positive and negative birds in the region provided
evidence that this cluster was not the result of reporting biases.
The first positive bird was found in early July at what would
become the center of the major cluster. While the pattern spread
throughout the season, it remained centered at this point. The
extent and dynamics of the epidemic would not have been appar-
ent without a geographical analysis of this sort. Collaborating
across jurisdictional lines provided additional information that
















Board 83. Analysis of the Spatial Distribution of
Cryptosporidiosis in AIDS Patients in San Francisco Using
Density Equalizing Map Projections (DEMP) 
A. Khalakdina1,2, S. Selvin3, D. W. Merrill4, C. Erdmann4, J. M.
Colford, Jr.1
1University of California Berkeley (Hellman Family Faculty Fund),
Berkeley, CA, 2San Francisco Department of Public Health, San
Francisco, CA, 3University of California Berkeley, Berkeley, CA,
4Environmental Energy Technologies Division, Lawrence Berkeley
National Laboratory, Berkeley, CA
Background: Environmental transmission of cryp-
tosporidiosis has occurred repeatedly in defined spatial areas dur-
ing outbreaks of disease attributed, for example, to drinking water
contamination. Little work has been done to investigate the possi-
bility of cryptosporidiosis infection in defined spatial areas in non-
outbreak (i.e. endemic) settings. This study applies a novel
approach to the investigation of the spatial distribution of cryp-
tosporidiosis in AIDS patients in San Francisco. Methods: Density
equalizing map projection (DEMP) maps were created for nine
race/ethnicity-age groups of AIDS patients based on census tract of
residence. This technique is illustrated for one category: White,
male AIDS cases 10-29 years old in the Figure where (a) shows
cases plotted in their respective census tracts on a geopolitical map
of San Francisco, and (b) shows the same cases plotted randomly
within the same census tracts on a DEMP map.
The study population included 906 AIDS patients with
cryptosporidiosis and 15,138 AIDS patients without cryp-
tosporidiosis; the DEMP maps were created using the entire study
population. In addition to testing for spatial randomness, census
tracts with a “high density” of cryptosporidiosis cases were identi-
fied by applying smoothing techniques to the DEMP maps, and
included as a covariate in multivariate Poisson regression analyses
of other known risk factors for cryptosporidiosis. Results: These
analyses suggest: (1) cases of cryptosporidiosis among Black and
Hispanic AIDS patients, but not among Whites, show a significant
non-random spatial distribution (p < 0.05) even after adjustment
for the underlying spatial distribution of AIDS patients for these
demographic groups and (2) the risk of residence in these high
density census tracts adjusted for other known risk factors,
although slightly elevated, was not statistically significant (relative
risk=1.27, 95% confidence interval 0.15, 10.53). Conclusions: The
results of this investigation do not support an independent effect of
spatial distribution on the transmission of cryptosporidiosis among
AIDS patients in San Francisco.
Board 84. Predicting Geographic Variation in the Risk of
Cutaneous Leishmaniasis Throughout Colombia 
R. J. King1, D. H. Campbell-Lendrum2, C. R. Davies2
1Division of Vector-Borne Infectious Diseases, Centers for Disease
Control and Prevention, Fort Collins, CO, 2Department of Infectious
and Tropical Diseases, London School of Hygiene and Tropical
Medicine, London, UNITED KINGDOM
Cutaneous leishmaniasis is a notifiable disease in Colombia,
with around 6000 cases reported to the Ministry of Health annual-
ly — representing a several-fold increase over the last 20 years. As
in other endemic countries, case notifications are likely to signifi-
cantly underestimate true incidence, and the geographic distribu-
tion of reported cases will be biased by the effectiveness of local
health services. In this paper, using data from 1994, we investigate
the extent to which the geographic distribution of cases (amongst
1080 municipalities of Colombia) can be explained by spatial vari-
ability in both land use (using data derived from remotely sensed
images) and altitude. Firstly we use logistic regression analysis to
model the probability that a municipality has at least one case
reported; and then we investigate the extent to which we can pre-
dict the variability in incidence amongst these “positive” munici-
palities. Model fits were tested on data from geographic localities
not used to generate the models being tested. As cutaneous leish-
maniasis in Colombia is caused by more than one parasite species,
and is transmitted by several sandfly vectors, we tested whether the
“binary model” fit could be significantly improved by generating
separate models for each regionally defined ecotype. The results of
the analyses allow us (i) to quantify the effect of changes in land use
(such as deforestation); and (ii) to identify areas where we suspect
significant under-reporting of cases. The utility of risk maps for
determining control decisions depends on the sensitivity and speci-
ficity of the predictions. In this paper, we derive these parameter
values for different threshold incidence levels (above which control
should hypothetically be implemented). To our knowledge this is
the first reported study to demonstrate that remotely sensed
images can accurately predict the risk of leishmaniasis across a
wide geographic area.
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Board 85. Is Crow Density Reporting Predictive of Human
West Nile Virus Cases in Florida? 
L. Conti1, C. Blackmore2, R. Oliveri1, L. Stark3, S. Wiersma1
1Florida Department of Health, Tallahassee, FL, 2Florida Department
of Health, Jacksonville, FL, 3Florida Department of Health, Tampa, FL
Florida implemented a dead bird reporting and testing sys-
tem in April 2000 as a response to the identification of West Nile
(WN) virus in the New York City area during 1999. This activity
was in addition to Florida’s traditional arbovirus surveillance meas-
ures of maintaining sentinel chickens, and reporting human and
equine vector-borne disease incidence.
The new system first successfully detected WN in a dead
crow in North Florida during July 2001. Overall, fewer dead birds
were reported once WN was identified in Florida compared with
New York State, despite similar state populations. Crow mortality
as a proportion of dead bird reports also appears to be lower in
Florida (12%) than New York (33% during 1999, and 25% in 2000)
and Connecticut (40% in 2000). Avian virus isolation rates were
lower in Florida than in the Northeast. In New York, 32% of all
birds tested (n=3,976) during 2000 were positive. In comparison,
WN virus was isolated in 10% of the birds tested (n=7,163) in
Florida during 2001. WN virus was detected in approximately half
of the crows tested in both Florida and New York.
The 11 human cases of disease reported from eight of
Florida’s 67 counties were preceded by crow mortality reports in
each instance. Although higher rates of reported crow mortality
occurred in counties with intensive WN virus activity, as a general
rule, dead crow densities were not useful for estimating the risk for
human disease in Florida during 2001.
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Board 86. Epidemiology of Neisseria meningitidis Infections
in New York City, 1989-2000 
D. Weiss1, A. Moura2, A. Pablos-Mendez2, M. Layton1
1New York City Department of Health, New York, NY, 2Mailman
School of Public Health, Columbia University, New York, NY
National trends in meningococcal disease have demonstrat-
ed a shift in the epidemiology with an increasing median age and
proportion of sergroup Y. We undertook an analysis of meningococ-
cal disease in New York City (NYC) over the past 12 years to exam-
ine for similar trends. Methods- All reports from January 1, 1989 to
December 31, 2000 that met the definition for a confirmed case
(isolation of N. meningitidis from a normally sterile site) were
included in the review. Additional case finding was performed by
reviewing records of the NYC Public Health Laboratory and by
searching the vital records system for meningococcal deaths.
Information abstracted included demographics, outcome and
serogroup. Incidence rates were computed using US census esti-
mates for 1990 and 2000. Pearson’s Chi Sq, Fischer’s exact test and
Kruskal-Wallis were used to assess statistical significance of cate-
gorical variables and mortality risk. Analyses were performed using
SPSS and Epi Info. Results- There were 578 confirmed cases of
meningococcal disease in NYC during the period for an average
annual incidence of 0.63/100,000. Ninety-six case-patients died for
a case fatality ratio of 16.6%. One serogroup C institutional out-
break of three cases occurred in 1998. Meningococemia was the
most common presentation accounting for 56% of cases with
meningitis in 41%, arthritis in 2% and pneumonia in 1%. The medi-
an age increased from 16 years in 1989-1991 to 30.5 years in 1998-
2000 (p< 0.001), as a result of a decline in the incidence among
young children. Of the 420 (73%) with a known serogroup; 2% were
serogroup A, 32% were serogroup B, 27% were serogroup C, 7%
were serogroup W135, 28% were serogroup Y and 4% were other
or ungroupable. Serogroup Y increased from 4% of serogrouped
cases in 1989-1991 to 48% in 1998-2000. The mortality was lowest
in the 5-19 year old group (reference group) and the risk ratio of
death was significantly greater for the following age groups: 20-44
years (RR=2.5, 95% CI 1.1-8.1), 45-64 years (RR=3.7, 95% CI 1.6-
13.2) and 65 years and older (RR=4.5, 95% CI 2.2-17.4). Children
0-4 years old had a three times greater mortality if they had menin-
gitis (RR=3.1, 95% CI 1.1-9.0) whereas adults over 45 years had a
three times greater mortality when presenting with meningococ-
cemia (RR=3.0, 95% CI 1.3-64.0). Conclusion- New York City
experienced a trend similar to the national change in the epidemi-
ology of meningococcal infections with an increase in the median
age and increasing proportion of serogroup Y. While the incidence
rate is low, the case mortality ratio exceeds national levels. Possible
explanations for this finding include the exclusion of probable cases
from the analysis, differential reporting of severe cases, the pres-
ence of virulent clones in the population and factors relating to the
timely access of medical care. Further epidemiologic investigation
is necessary to evaluate excess meningococcal mortality in NYC.
Board 87. Guide to Surveillance and ReportingóAn Example
of Technical Assistance for Local Health Departments in
Massachusetts 
A. Hackbarth, et al.
Massachusetts Department of Public Health, Boston, MA
Issue: Limited resources have impaired the capacity of
many local health departments to conduct adequate surveillance
for many infectious diseases. Technical assistance by state health
departments can help expand capacity. In Massachusetts, technical
assistance in the form of a comprehensive reference manual
addressing reporting, investigation and control has been developed
for local health departments. Provision of this reference manual, in
combination with training, has strengthened local capacity, hope-
fully leading to more timely recognition and containment of infec-
tious diseases.
Project: The Guide is a comprehensive manual for local
health departments on how to do surveillance for the infectious
diseases reportable to the Massachusetts Department of Public
Health (MDPH). It is organized alphabetically into 57 chapters by
disease; each contains step-by-step instruction on reporting, inves-
tigation and control, including state requirements and an emphasis
on those diseases that have higher priority, such as those that are
vaccine-preventable or caused by bioterrorist agents. The Guide
contains an overview of the MDPH infectious disease surveillance
system and a copy of case report forms. The Guide describes who
should be responsible for surveillance and emphasizes a team
approach within the local health department and the local commu-
nity. It was distributed to all local health departments in March
2001. This was followed-up with daylong training programs held at
seven locations statewide. The Guide also has been posted on the
MDPH website.
Results/Lessons Learned: It is clear that a certain level of
expertise is needed to carry out infectious disease surveillance. By
involving local health departments in the development of this
guide and through the statewide daylong training program, the
state health department has experienced an increase in timeliness
and completeness of reporting, and the ability of some local health
departments to handle more on their own. Communication can
improve when the state health department provides technical assis-
tance proactively rather than in response to cases or outbreaks. A
step-by-step reference manual that emphasizes collaboration
(among members of a local health department, among bordering
towns, and with the state health department) was adapted from a
previous reference manual developed by MDPH (Foodborne
Illness Investigation and Control Reference Manual) that has
proved to be successful in improving foodborne illness response
and control.
Board 88. Bacteriological Profile of Septic Abortion Clients:
A Study in Southern India 
S. K. Korlagunta
S. V. Medical College, Tirupati, INDIA
Objective: To study the bacteriology associated with
attempted abortions admitted with sepsis.
Design: Case Study
Participants: 100 respondents admitted for post-abortion
sepsis.
Place of study: Government Maternity Hospital, Tirupati
town, Chittoor district, Andhra Pradesh, India.
Materials: A total of 100 specimens (pus/exudate/tissue)
collected from cases of septic abortion admitted for treatment in
maternity hospital.
Methods: Specimens were incubated on blood and
Macconckey’s agar plate and in Nutrient broth for aerobic organ-
isms, on Neomycin and Robert Cooked Meat medium for anaero-
bic culture. Organisms were identified by their morphological,cul-
tural and biochemical characterestics.
Results: Anaerobes were isolated from 10% of cases ,while
mixed infections involving both aerobes and anaeorobes was
observed in 37.5% of cases. Aerobes alone were encountered in
52.5% of specimens. Of anaerobes, anaerobic cocci were predom-
inant (65.6%) followed by bacteroides (25.5%) and different
Clostridium species (8.7%). Among aerobes, E.coli (50%) and
Staphylococcus pyogenus (29.2%) were dominant.
Conclusions: The prevalence of bacteroides poses a problem
in India, as these strains are resistant to less expensive penicillins .
Implication: Alternative cost-effective drugs like metron-
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Board 91. Radiographic Findings and Risk Factors for
Bronchiectasis Among Alaska Native Infants Hospitalized with
RSV as Infants: 5 Year Follow-Up 
R. J. Singleton1, L. Bulkow1, G. J. Redding2, T. C. Lewis3, P.
Martinez4, J. Butler1, H. Peters1, J. Gove1, B. Morray2
1Arctic Investigations Program - Centers for Disease Control and
Prevention, Anchorage, AK, 2University of Washington, Seattle, WA,
3University of Michigan, Ann Arbor, MI, 4Yukon Kuskokwim Health
Corporation, Bethel, AK
Background: Bronchiectasis has become rare in devel-
oped countries and is labeled an orphan disease; however, preva-
lence of bronchiectasis in one Alaska Native region remains high at
16 cases per 1,000 persons born in 1980-1989. Since infants in this
region also have an extremely high rate of RSV hospitalization, we
hypothesized that early RSV hospitalization and early repeated
pneumonias were risk factors for development of bronchiectasis.
Methods: In 1993-96 we conducted a case control study to
evaluate risk for RSV hospitalization. A total of 102 RSV hospital-
ized cases and 122 non-hospitalized controls were recruited in
infancy and studied again 5 years after RSV hospitalization. Chest
films since birth were reviewed by two of us (GJR, TCL). If chest
films were missing, the radiologist report was reviewed. Chest film
diagnosis of bronchiectasis required saccular changes or cylindri-
cal outlines of airways that widened as airways extended into the
lung periphery.
Results: 1200 chest films were available from study partic-
ipants. 102/102 former RSVcases and 89/122 controls had at least 1
chest film (median 4 per child, range 1-42 per child). 24 children
(11%) had chest film evidence of bronchiectasis at ≥2 years of age.
Former RSV-hospitalized cases were not more likely than controls
to have bronchiectasis (13% vs. 9%, p=.393). 124 (56%) of the par-
ticipants had ≥ 1 infiltrate < 2 yrs of age. These children were more
likely to have bronchiectasis on chest film than children with no
infiltrates < 2 years of age (16% vs. 4%, p=.004). Also, presence of
infiltrates ≥ 3 yrs. of age (67% vs. 18%, p<.001), multiple infiltrate
≥ 3 yrs. of age (38% vs. 6%, p<.001), and atelectasis >3 yrs. of age
(50% vs. 5%, p<.001) were more common in children with
bronchiectasis. For all chest films, pulmonary infiltrates were more
common in chest films taken <2 yrs of age than ≥2 yrs. of age (51%
vs. 45%, p=.042), while bronchiectasis was more common in chest
films > 2 yrs. of age than < 2 yrs of age (12% vs. 2%, p<.001). The
24 children with bronchiectasis were more likely than other partic-
ipants to have cough > 1 month (29% vs. 9%, p=.010), productive
cough (58% vs. 33%), wheezing (41% vs. 19%), or albuterol use
(39% vs. 17%) in the past year, but were not more likely to have
environmental and socioeconomic factors such as ≥ 6 persons in
the house, household smokers, and flush toilets.
Conclusions: Alaska Native children experience a high
prevalence of bronchiectasis. While bronchiectasis was not more
common in children hospitalized with RSV as infants, it was more
common in children with pulmonary infiltrates before 2 yrs. of age,
and those with infiltrates or atelectasis after 3 yrs. of age.
Board 92. The Health and Economic Burden of Helicobacter
pylori on the US Military 
D. A. Blasiole, C. J. Hansen, M. Ryan, K. L. Russell
Naval Health Research Center, San Diego, CA
Background: Helicobacter pylori, a bacterial pathogen, is
a recognized etiological agent in gastric cancer, chronic gastritis,
and peptic ulcer disease. The worldwide infection rate is estimated
at nearly 50%, with prevalence ranging from 70-90% in developing
countries and 17-20% in developed countries. A review of data on
H. pylori-related diagnoses among US military personnel and their
families was conducted to assess its operational and economic bur-
den in this healthy, young population. Methods: Comprehensive
medical information systems available to the US military provided
detailed information on all inpatient and outpatient medical visits
at military and civilian treatment facilities by military families.
Cases of H. pylori were captured using the International
Classification of Diseases, 9th edition, Clinical Modification (ICD-
9-CM) code 041.86. The period prevalence of H. pylori diagnoses
among military personnel was calculated for calendar year 2000.
The pharmaceutical cost for treatment was estimated using the
average military price of standard triple therapy regimens.
Results: H. pylori was diagnosed in 2429 total cases among mili-
tary personnel and their families. In active duty military only, 802
cases were diagnosed, yielding a period prevalence of 2.1 cases per
100,000 in the year 2000. The specific diagnosis of H. pylori was
most commonly associated with diagnoses of gastritis, gastroin-
testinal hemorrhage, diseases of the esophagus, duodenal ulcer,
and gastric ulcer. Using an average cost of pharmaceutical treat-
ment of $106.90 per case, the estimated cost to the US military for
2429 total cases was nearly $260,000. Conclusion: This analysis
provides a very conservative estimate of the burden of H. pylori
disease in the US military community. Presumptive treatment for
conditions associated with H. pylori likely occurs without docu-
mentation of specific H. pylori diagnoses. Presumptively treated
cases, the cost of maintenance therapy for these and confirmed
cases, and the costs of healthcare encounters and diagnostic proce-
dures for H. pylori-related illnesses were not included in this analy-
sis. Despite these limitations, available data demonstrate that H.
pylori appears to have a significant impact on the healthcare sys-
tem of the US military.
Board 93. Association of Chlamydia pneumoniae, but not
CMV,with Incident Myocardial Infarction in Male Military
Personnel 
C. M. Arcari1, K. E. Nelson1, M. Krauss2, C. A. Gaydos3
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD,
2Walter Reed Army Institute of Research, Silver Spring, MD, 3Johns
Hopkins School of Medicine, Baltimore, MD
Despite the progress in prevention, diagnosis, and treat-
ment, coronary heart disease (CHD) still remains the leading cause
of death in the United States, and established risk factors are
unable to explain fully half of all CHD cases. The role of infections
in the pathogenesis of CHD has been postulated. This study
addresses the hypothesis that previous C. pneumoniae or CMV
infection, is a significant independent risk factor for CHD. This
cohort is a valuable resource to study the association of previous
chronic infections and CHD due to the young age and generally
healthy status of the population. Data and specimens were collect-
ed from an ongoing and well-established prospective cohort of
United States Military active-duty personnel. A nested case-control
study was conducted using 300 cases and 300 matched controls.
Cases were male, 30-50 years of age, with a medically documented
first time hospitalization for acute myocardial infarction (MI), with
no history of hospitalization due to CHD. Cases had a serum spec-
imen drawn prior to the time of the acute MI and a health risk
appraisal available. Controls were chosen from the same Military
active-duty cohort and were individually matched on age, race, and
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military rank. Controls had no record of hospitalizations due to car-
diovascular reasons prior to the date of the case event. Incidence
density sampling was used to identify eligible controls. To be eligi-
ble, controls had to have a serum specimen available within 1
month of the date of the case serum. All serum specimens were
part of the Department of Defense serum repository. Evidence of
past infection with C. pneumoniae was based on a ≥1:16 IgG anti-
body titer, as measured by microimmunofluorescence. Past infec-
tion with CMV was measured qualitatively using enzyme
immunoassay (Wampole) for IgG antibodies. A total of 300 indi-
vidually matched pairs were studied. Median age of the pairs at
time of case MI was 40.2 years. The race/ethnicity was 29% Black,
59% White, and 12% Other. Serum cholesterol and smoking status
was significantly different between cases and controls (p< 0.05).
Overall prevalences of C. pneumoniae (≥1:16) and CMV antibod-
ies in the population were 77% and 57% respectively. Crude analy-
sis using a cut off of ≥1:256 showed an odds ratio of 1.53 (95% C.I.:
1.004, 2.326) for C. pneumoniae and 0.89 (95% C.I.: 0.637, 1.244)
for CMV. Further multivariate analysis to assess whether high cho-
lesterol level, smoking, hypertension, obesity, and diabetes modify
the relationship between C. pneumoniae and CMV is ongoing.
Results of this study to date demonstrate a significant association
between high titer antibody to C. pneumoniae and acute MI, but
no association between past infection with CMV and acute MI in
this cohort. An important challenge is to identify new modifiable
risk factors for CHD, which could be used in prevention strategies
to reduce the morbidity and mortality associated with CHD.
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Board 94. Patterns of Measles Current Epidemic Process in
Rural Areas 
N. Z. Ninashvili
Public Health Department, MoH, Tbilisi, GEORGIA
Introduction: Vaccination against several infectious dis-
eases not only have reduced morbidity rates but also have given
us the possibility to eliminate most of them. However, their
resurgence in different countries requires consideration of the
current epidemic process with its social, geographical and demo-
graphical patterns.
After introduction of immunization against measles it
became a common infection among adults and already vaccinated
persons, including children, especially in rural areas.
According to available literature study of immunization
issues in urban and rural areas simultaneously is not highlighted
respectively. The lack of such studies is still important.
Methods and Objectives: analytical epidemiological stud-
ies using seroepidemiological data were carried out in order to
study: 1. Patterns of measles current epidemic process in rural and
urban areas; 2.Duration vaccine induced immunity; 3.
Immunological efficacy of measles vaccines, simultaneously used in
rural and urban areas; 4. Epidemiological effectivnes of vaccination.
Results: Although measles was very frequent among chil-
dren everywhere in pre-immunization era, the process of “growing
up” appeared to be characteristic only in urban areas. Hence, in
the category of children’s respiratory infectious diseases (such as
measles, mumps, pertussis, chicken pox and scarlet fever), measles,
which took the first place in the pre-immunization period in rural
areas, has moved to the second place after chicken pox in the late
1990s. The number of measles cases has reduced only two-fold
(from 56.5% to 27.8%). As for the urban areas, measles took the
third place (instead of the first in the pre-immunization era) after
scarlet fever and mumps. Despite the low herd immunity against
measles in rural areas the infection was more frequently registered
among previously immunized persons (48.4%) there than in urban
areas (38.6%) where the immunity level was higher.
According to the serological data, the majority of the
seronegative persons were from rural areas. Duration of vaccine-
induced immunity was longer in urban areas than in rural areas.
After 11-15 years since immunization dates the proportion of the
previously immunized persons in urban areas was 31.4+2.5%, in
rural - 9.5+1.7%. Although immunological efficacy of measles vac-
cines was equally high in both areas.
Conclusion: High incidence of measles among immunized
persons, high level of seronegative persons in rural areas along with
other objective reasons are mainly due to shortcomings in vaccina-
tion practice there.
Recommendations: 1. Immunizing children in rural areas
mostly during the cool period of a year. 2. Reviewing vaccine dis-
tribution schedules in accordance with season and electricity sup-
ply conditions. 3. Provision rural vaccination points mainly with
single dose vaccines.
Board 95. Public Health Laboratories and HIV/AIDS in Sub-
Saharan Africa: Efforts in Zimbabwe 
B. R. Lall1, K. V. Shah1, B. Wilcke, Jr.2
1Association of Public Health Laboratories, Washington, DC,
2Vermont Department of Health, Burlington, VT
The Association of Public Health Laboratories (APHL) in
cooperation with the Centers for Disease Control and Prevention’s
Global AIDS Program (GAP) has initiated efforts towards working
on the laboratory component of the HIV/AIDS epidemic. Our
involvement includes strengthening laboratory support for surveil-
lance, diagnosis of HIV/STD/TB and opportunistic infections, and
disease monitoring.
APHL has worked on identifying the priority training and
functional needs for public health laboratories in Zimbabwe, Cote
d’Ivoire, Botswana, and India. This involves in-depth assessment
and implementation reports, creating networking opportunities for
country laboratory directors abroad and in the U.S., evaluating cur-
rent methodologies for HIV testing, reviewing laboratory pro-
grams, and training laboratory scientists in HIV testing methodolo-
gies and quality assurance program plans.
The Zimbabwe Public Health Laboratory System is com-
prised of 70+ laboratories that need support in several key labo-
ratory areas including quality assurance, management, and train-
ing. APHL has provided technical assistance to both the National
Microbiology Reference Laboratory and the National TB
Reference Laboratory in Zimbabwe. Technical assistance to these
laboratories has included the development of Standard Operating
Procedures for HIV testing and TB as well as provision of train-
ing to laboratorians in U.S. public health laboratories. Assistance
has also been provided in Quality Assurance for the public health
laboratory system through supplying documents such as CAP
checklists for laboratory general services, microbiology, and clin-
ical microscopy.
Setting: The scope of CDC’s Global AIDS Program is to
support HIV/AIDS prevention program development and techni-
cal assistance for 24 countries. These 24 countries were targeted
due to the severity of the HIV/AIDS epidemic. APHL’s approach
towards this effort in Zimbabwe utilizes a multi-faceted APHL
team consisting of technical experts, state laboratory directors, and
APHL staff to work with in-country partners to further laboratory
assistance in Zimbabwe.
Partners: CDC, WHO, and Ministries of Health in project
countries.
Conclusions: By assisting with the development of public
















public health laboratories’ HIV/AIDS surveillance capabilities and
their ability to perform HIV/AIDS testing with the support of qual-
ity assurance measures. This sustainable approach to laboratory
assistance will lead to better seroprevalence data and thus will aid
in the prevention and containment of the HIV/AIDS epidemic.
Additional Authors: Kajari V. Shah, MPH; Burton
Wilcke, Jr. PhD
Board 96. Cluster Investigation of Swollen Joints at an Air
Force Base in Louisiana 
K. M. Neuhauser1, J. C. Feig1, M. J. Rodriguez1, W. W. McGriff1, K.
J. Forde2, J. S. Neville1
1AFIERA/RSRH, Brooks AFB, TX, 22MDOS/SGOAM, Barksdale
AFB, LA
From April to June 2001, six children enrolled in a daycare
center on a United States Air Force Base in Louisiana were med-
ically evaluated for joint pain and swelling. All children were
between seven months and four years of age. Concern was raised
that these illnesses may be related to a common exposure at the
daycare center. Method: A case-cohort investigation was conduct-
ed. Through a survey administered at the daycare center or by tele-
phone, other potential cases were identified. A case was defined as
any adult or child in the daycare center with joint pain or swelling,
or any sibling of a child enrolled in the daycare center with joint
pain or swelling from April to July 2001. Titers were obtained for
lymphocytic choriomeningitis, measles, mumps, cytomegalovirus,
Eastern Equine Encephalitis, California Encephalitis, St. Louis
Encephalitis, Western Equine Encephalitis, Adenovirus, Influenza
Types A and B, Varicella, Coxsackie A and B, Echovirus, Herpes
Simplex Virus 1 and 2, Parvovirus, Epstein-Barr Virus, and Lyme
Disease. Geographic Imaging System (GIS) software was used to
map out room assignments and home addresses of the cases.
Environmental assessments were conducted of the daycare center
grounds and the Heating, Ventilating, and Air Conditioning
(HVAC) system. Results: Respondents included 200 enrolled chil-
dren and daycare workers (N=262) and three siblings. The survey
identified 16 additional cases. Multivariate analyses of responses
indicated that joint pain and swelling was associated with exposure
to ill persons, being febrile, having malaise, and being an adult.
There was no association with bug bites, travel history, pets, group
activities, or the presence of a rash. Blood samples were obtained
for 13 cases; only five had both acute and convalescent titers. Of
these, one case seroconverted to cytomegalovirus and another to
both Parvovirus and Epstein-Barr virus. GIS identified some clus-
tering of cases in Room 7 of the daycare center (N=4) and by res-
idential zip code. There was no evidence of rodents, ticks, or mos-
quitoes on the daycare grounds and the HVAC system was in good
condition. Conclusion: Although the characteristics of this out-
break are consistent with Parvovirus B19, this could not be con-
firmed. There were no new cases after 3 June 2001 and the condi-
tion was self-limited; hence, the urgency of finding a more defini-
tive etiology waned. Clustering in Room 7 may have been related
to age clustering since children were assigned to classrooms by age.
It was not necessary to close the daycare to contain the spread of
infection, only to stress the importance of good handwashing and
hygiene practices.
Board 97. Assessment of Non-Vaccine Acute Respiratory
Disease Prevention Interventions (NOVARDPIs) in the US Army 
T. Lee1, R. N. Nang2, N. N. Jordan1, J. L. Sanchez3, J. C. Gaydos4
1U.S. Army Center for Health Promotion and Preventive Medicine,
Aberdeen Proving Grounds, MD, 2U.S. Army, Fort Leavenworth, KS,
3U.S. Navy Medical Research Center Detachment, Lima, PERU, 4DoD
Global Emerging Infections Surveillance & Response System, Silver
Spring, MD
Introduction: Vaccines have been used extensively to pro-
tect against respiratory disease agents such as influenza viruses and
adenoviruses. However, vaccines are not always available or may
not be effective against the agent threatening an outbreak.
NOVARDPIs like personal hygiene (eg, handwashing), administra-
tive controls (eg, allotting adequate floor space/person), engineer-
ing controls (eg, indoor air dilution) and personal protective meas-
ures (eg, protective face masks) are often considered and some-
times recommended even though scientific evidence of their effi-
cacy is often lacking. The US military has decades of experience
with prevention methods, particularly in recruit (initial entry)
training. Many strategies were tested and employed in the 1950s
and ’60s, until the routine use of adenovirus vaccines markedly
decreased respiratory disease rates. Since 1999, however,, these
vaccines have been depleted and have resulted in recurring out-
breaks. The loss of adenovirus vaccines, as well as the potential for
non-vaccine epidemic influenza strains to circulate, have renewed
interest in NOVARDPIs in the US military.
Methods: We reviewed >140 reports on NOVARDPIs.
Interventions covered included handwashing, control of ventila-
tion, barrier protection, prophylactic antibiotics, isolation of indi-
viduals and groups, and other methods. Additionally, we surveyed
5 US Army recruit training centers to determine how many had
implemented or planned to implement 10 different non-vaccine
interventions (handwashing, antimicrobial wipes, 2 space manage-
ment methods, limiting contact between military units (cohorting),
antibiotic prophylaxis, indoor air dilution, increased air filtration,
ultraviolet lights and face masks).
Results: Most of the literature addressed theory with some
laboratory findings, anecdotes and uncontrolled comparisons. A
Navy study found frequent handwashing decreased respiratory dis-
ease rates by 45%. An Air Force study noted that antimicrobial
wipes decreased respiratory disease clinic visits by 33 to 40%. At
each of the 5 surveyed sites, 2 to 7 NOVARDPIs had been or were
to be implemented. Costly interventions were avoided. Indoor
space management was not possible because of inadequate space.
All centers were implementing or planned to implement hand-
washing programs. None were using or planned to use handwipes.
Conclusion: The effectiveness of NOVARDPIs is poorly
addressed in written reports. The many variables that impact on
the occurrence of respiratory disease are complex and difficult to
study. Costly NOVARDPIs are unlikely to be implemented in the
absence of credible effectiveness data. Space limitations prevent
space management to reduce crowding. Encouraging frequent
handwashing and implementing handwipes to augment handwash-
ing may offer benefits in respiratory disease control, but deserve
further study to document efficacy.
Board 98. Evaluating Vulnerabilities and Preparedness for
Emerging Infectious Diseases in the Air National Guard 
A. M. Likos1,2, J. Neville3, J. C. Gaydos4,5
1Maryland Air National Guard; 175th Medical Squadron, 175th
Wing, Baltimore, MD, 2Johns Hopkins Bloomberg School of Public
Health, Baltimore, MD, 3Air Force Institute for Environmental, Safety
and Occupational Health Risk Analysis, Brooks Air Force Base, San
Antonio, TX, 4Department of Defense Global Emerging Infections
Surveillance and Response System, Silver Spring, MD, 5Henry M.
Jackson Foundation, Rockville, MD
Background: Air National Guard (ANG) military units
have considerable responsibility for global missions. People in
these units live and work in civilian communities but assume mili-
tary roles one weekend a month or for periods of a week or longer.
Even for short periods, ANG members fly to remote parts of the
world for humanitarian or other missions. Once their military work
is completed, they rapidly return to their civilian communities. We
examined demographic and deployment data to assess the extent to
which ANG members were exposed to overseas areas, and possibly
to novel infectious disease agents. We looked at surveillance and
response procedures to determine if an outbreak in an ANG unit
would be rapidly detected and an appropriate response would
I C E I D  2 0 0 2  A B S T R A C T Spage 62
occur. We focused on medical people who have close contact with
ill natives on humanitarian missions.
Methods: Demographic and deployment data were
obtained from the Air Force Personnel Center, the National Guard
Bureau and the ANG Readiness Center (ANG-RC). Procedures
for medical surveillance and outbreak response were identified in
interviews with people from the ANG-RC, the Air Force Medical
Operations Agency and the Air Force Institute for Environmental,
Safety and Occupational Health Risk Analysis. Pertinent docu-
ments were studied.
Results: During 1996-2000, ANG medical personnel had
88,976 person-days of overseas exposure; 13,489 (15.2%) person-
days were for humanitarian missions. There were 106,433 total
ANG members in 91 ANG units, spread over 54 geographical
areas. Residence data revealed 9.6% of members did not live in the
same state as their assigned unit. The ANG did not participate in
Air Force surveillance activities, such as laboratory-based influen-
za surveillance. Outbreaks occurring while deployed would likely
be detected, reported and receive a response. Civilian public
health authorities had responsibility for outbreak detection and
response after members returned to their communities. Outbreaks
occurring after ANG members returned home could be geograph-
ically dispersed and undetected. Military-civilian communication
was not well established.
Conclusions: ANG members have many opportunities for
exposure to novel agents, like influenza or drug resistant enteric
organisms, in many areas of the world. An outbreak in an ANG
unit, after members have returned to civilian status, could be
widely dispersed with delayed detection and response. Reliance
upon civilian public health agencies in these situations could
result in the ANG unit headquarters not knowing that an outbreak
was occurring that might prevent the unit from performing its mil-
itary mission. ANG units should be included in the military labo-
ratory-based respiratory disease surveillance program.
Additionally, ANG public health officers should establish commu-
nication links with civilian public health authorities in areas where
ANG members live and work.
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Board 100. A Unique Medical Surveillance System for
Soldiers in Korea that May Have Application in Civil
Emergencies
K. J. Hoffman1, G. Pant2, J. C. Gaydos3
1Military and Veterans Health Coordinating Board, Washington,
DC, 2Template Health Systems, London, UNITED KINGDOM,
3Global Emerging Infections Surveillance and Response System,
Silver Spring, MD
Introduction: Military forces in Korea may face naturally
occurring infectious agents and agents developed by humans. We
determined if data could be captured at the lowest medical care
level, the battalion aid station (BAS) operated by medical corps-
men, and at the time illness occurred in soldiers in the field. Data
collected would be used to identify sentinel events and for ongoing
surveillance. Methods: BAS activities, e.g., medical documenta-
tion and reporting, were analyzed with the goal of making modifi-
cations to improve efficiency and eliminate wasteful activities.
Next, application of available technology was considered for BAS
and field use, and an implementation plan was drafted. Finally, a
proof-of-concept system prototype was developed and application
of the technology was tested. This occurred in populations served
by two BASs in Korea over 4 months. Results: At the BASs, corps-
men followed a detailed Ambulatory Patient Care (APC) algorithm
and documented symptoms and severity on a standard medical
form that was placed in the paper chart. The existing surveillance
system used diagnostic information that was independently coded
on an ICD9/CPT code bubble sheet and scanned into a central
database. The existing data management method was unacceptable
for accurate, rapid surveillance because it lacked timeliness, com-
pleteness, appropriateness and effectiveness. To improve this situ-
ation, a one-write electronic health record that automated the APC
algorithm through screen flows was created. A method was also
devised to collect information from soldiers on field missions using
existing hand-held transmitters. Those who became ill could self-
report, or another soldier could report the event, which was plot-
ted by time and location in a Geographic Information System
(GIS). All data were rapidly transmitted to a central location for
evaluation. Through electronic tracking of events in the BASs and
among soldiers in the field, health status could be followed in near
real time in a large, command-wide GIS system. The BAS was the
epidemiologic unit; all soldiers served by the BAS were the denom-
inator for rate calculations. The standard state of health for the
population was defined over time. Deviations from the standard
indicated possibly significant health events that required investiga-
tion. Conclusion: Medical processes in the BASs were made more
efficient, benefiting both the primary medical care system and the
public health surveillance effort. Corpsman in the BASs and sol-
diers in the field rapidly adapted to new technologies. Data from
the field and from the BASs were married to form a complete pic-
ture that helped in determining if a medical event needed rapid
and in-depth diagnostic measures. The proof-of-concept test was a
success. This military system may have application in medical care
systems hastily established for civil emergencies.
Board 101. Developing an Electronic Laboratory
Surveillance Network for the Caribbean 
E. V. Boisson1, C. Z. Ali2
1Caribbean Epidemiology Centre, Port of Spain, TRINIDAD AND
TOBAGO, 2Caribbean Epidemiology Centre, Port-of-Spain, TRINIDAD
AND TOBAGO
Objective: To strengthen the laboratory surveillance sys-
tem in the Caribbean, in order to improve national and regional
capacity for enhanced disease surveillance. Design and Methods:
The Caribbean Epidemiology Centre (CAREC/PAHO/WHO), a
regional center with a mandate for disease surveillance in 21
Caribbean countries, has been collaborating with the US Centers
for Disease Control and Prevention (CDC) and the Walter Reed
Army Institute of Research (WRAIR) to develop an appropriate
infrastructure. The Public Health Laboratory Information System
(PHLIS) software, originally developed by CDC for managing and
utilizing laboratory data for surveillance was customized for use in
the Caribbean. A feasibility assessment was conducted in each
country, to determine the needs and logistics for establishing
PHLIS. During training sessions, PHLIS was installed and cus-
tomized at designated sites and data transmission was tested. Sites
then transmitted data on a weekly basis. In 2000, an advanced level
PHLIS workshop was convened for selected Ministry of Health
employees in order to build national capacity and assure the poten-
tial for regional programme sustainability. In 2001, an evaluation of
the PHLIS programme was conducted in each country in the net-
work. Results: There are currently 11 countries participating in
the PHLIS programme in the Caribbean and this year the pro-
gramme was evaluated in eight of these countries. Feasibility
assessments were conducted in another five countries. CAREC has
developed three modules, namely Dengue, HIV and Enterics and
has established a PHLIS helpdesk. Customization and usage of the
















specimen management and laboratory capacity. The programme
initially experienced data transmission problems due to problems
with hardware and telephone lines, but these were all successfully
resolved. As at November 16, 2001 the PHLIS database contained
1,829 records. There were 182 dengue records, the majority (91%)
of unknown serotype as they were confirmed by IgM. There were
75 HIV records and 1,572 Enteric records (62% Parasites, 26%
Salmonella, 10% Shigella and 2% Campylobacter). A serotype was
identified in 202 (50%) Salmonella records and the greatest pro-
portion of these were Salmonella Enteritidis (35%). Conclusions:
The countries of the Caribbean can successfully utilize the
CAREC customized version of PHLIS for surveillance of laborato-
ry data and improved communication between Laboratories and
Epidemiology Departments. Ministries of Health and CAREC
now have more readily available to them organized laboratory sur-
veillance data, though this is limited by the capacity of the labora-
tories in the programme. PHLIS however, was not intended to, and
cannot function as a laboratory management system
Board 102. A National Surveillance System for West Nile
Virus in Zoological Institutions 
D. Travis1, T. McNamara2, A. Glaser3, G. Campbell4, D. Gubler4
1Lincoln Park Zoo, Chicago, IL, 2Wildlife Conservation Society, New
York, NY, 3Population Medicine and Diagnostic Science, College of
Veterinary Medicine, Cornell University, Ithaca, NY, 4Centers for
Disease Control and Prevention, Division of Vector-Borne Infectious
Diseases, Fort Collins, CO
In June 2001, the National Zoological Surveillance Working
Group* was formed incorporating both human and veterinary
health experts from the Centers for Disease Control and
Prevention, local and state public health agencies, the United
States Department of Agriculture, the American Zoo and
Aquarium Association and the American Association of Zoo
Veterinarians. A nation-wide surveillance system for detection of
West Nile virus in zoos was outlined in a set of guidelines entitled
Surveillance for West Nile Virus in Zoological Institutions. A one-
year pilot study was initiated in September 2001 and is being
implemented in two phases. Phase I consists of the collection and
testing of samples from systemically ill or dead at-risk animals on
zoo grounds; at-risk animals are defined as animals (from any taxa)
housed outside for at least part of the time that may be regularly
exposed to mosquitoes. Phase II will be implemented in the winter
of 2001 and will consist of surveying archived serum samples from
at-risk animals from selected institutions. The Cornell University
Veterinary Diagnostic Lab is performing all virus isolation, serolo-
gy and RT-PCR tests for the system. Preliminary results from the
first three months of phase I include data from over 200 animals
from 35 participating institutions in 20 states representing all
regions of the country. Samples from 150 birds of over 36 species
were submitted with 34 sero[or test-]positives still being confirmed
and characterized. Forty-five mammals including equids and other
hoof stock, big cats, marine mammals, primates and others were
tested, as well as 5 reptiles. One hoofed mammal and 1 reptile
were seropositive and are being further characterized. All positive
animals were from known epizootic areas on the East Coast. These
initial results show promise for both increasing the effectiveness of
existing national surveillance systems by providing data from previ-
ously untapped sources, and for increasing the quality of health
monitoring in zoos in the face of a rapidly spreading emerging dis-
ease. *Bruce Akey, VA Dept. Agriculture; Wilbur Amand,
American Association of Zoo Veterinarians; Robyn Barbiers,
Lincoln Park Zoo; Bobby Brown, CDC; Grant Campbell, CDC,
DVBID; Pamela Diaz, Chicago Department of Public Health;
Cindy Driscoll, MD Dept. Nat. Res.; Ed DuBovi, Cornell College
of Veterinary Medicine; Millicent Eidson, NY State Dept. of
Health; Amy Glaser, Cornell College of Veterinary Medicine;
Thomas Gomez, USDA, APHIS, VS; Duane Gubler, CDC,
DVBID; Nicholas Komar, CDC, DVBID; Laura Kramer, NY State
Dept. of Health; Bob McLean, USGS, National Wildlife Health
Center; Rita McManamon, Zoo Atlanta; Tracey McNamara,
Wildlife Conservation Society; Hayley Murphy, Zoo New England;
Eileen Ostlund, USDA, NVSL; Mary Grace Stobierski, MI Dept.
of Community Health; Scott Terrell, Disney's Animal Kingdom;
Kristin Vehrs, American Zoo and Aquarium Association.
Board 104. Using Technology in the Department of Veterans
Affairs (VA) to Enhance Screening and Assessment of Patients
for Risk of an Emerging Infectious Disease, Hepatitis C 
G. A. Roselle1,2,3, L. H. Danko1,2, S. M. Kralovic1,2,3, L. A.
Simbartl1,2
1Department of Veterans Affairs Central Office, Washington, DC, 2VA
Medical Center, Cincinnati, OH, 3University of Cincinnati College of
Medicine, Cincinnati, OH
Hepatitis C disease is of major importance to the United
States and specifically the Department of Veterans Affairs (VA).
Currently, in over 70,000 unique persons served by the VA are
reported as positive for hepatitis C virus antibody (HCVAb). A sys-
tem of screening and assessment of risk for hepatitis C for each
patient coming into the VA system was needed. Therefore, an auto-
mated computerized reminder system was implemented at the
level of delivery of clinical care with national roll-up of the local
data. In the reminder system, there are seven discrete options for
resolution. Three are passive and include a previous positive test
for HCVAb, a previous negative test for HCVAb or an ICD-9-CM
code for hepatitis C infection. If none of these can be found in the
local VA computer system, a reminder that the hepatitis C risk
assessment needs to be completed is generated at the point of clin-
ical care. Then, a data entry screen providing the 4 remaining res-
olution options can be utilized by the clinician delivering care.
These 4 options are a previous assessment of risk factors for HCV
infection (either outside the VA [e.g. had testing done elsewhere]
or within the VA but not captured by the computerized system
from the electronic medical record [e.g. contained in a written
record]), risk factors for HCV infection are present, no risk factors
for HCV infection are present, or the patient is unwilling to discuss
the subject. The data entry screen complements delivery of clinical
care by generating documentation for the clinical note as data
entry is completed. Automated roll-up of these data nationally are
available for three federal fiscal years from October 1998 through
September 2001 and are shown in the table. This yields a total of
1,602,334 unique persons served by VA who have extractable doc-
umentation of risk assessment for hepatitis C in the VA electronic
medical record nationally. Therefore, a combination of passive and
active data collection into a computerized system is effective in
documenting assessment of patients for risk for hepatitis C infec-
tion in the VA nationally. 
New Patients with Risk Assessment Completed
Resolution FY 99 FY 00 FY 01 Totals
1. Declined 150 4,126 17,741 22,017
2. No risk 5,520 113,775 574,473 693,768
3. Previous assessment 5,565 35,849 42,501 83,915
4. Has risk 3,221 37,652 239,031 279,904
5. HCV Ab+ 30,359 31,943 23,536 85,838
6. HCV Ab- 95,061 154,358 157,194 406,613
7. HCV infection/ICD-9-CM 6,855 14,420 9,004 30,279
Total 146,731 392,123 1,063,480 1,602,334
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Board 105. New York's Experience with Electronic 
Reporting of Communicable Disease Test Results from a
National Laboratory 
H. H. Chang1, D. Meyer2, C. Noonan-Toly1, M. Davisson1, D. L.
Morse1, P. F. Smith1
1New York State Department of Health, Albany, NY, 2Laboratory
Corporation of America Headquarters, Burlington, NC
Background: An electronic clinical laboratory reporting
system (ECLRS) was begun in New York in early March 2001.
Laboratory Corporation of America (LabCorp) was the first large
national laboratory that used the Health level 7 (HL7) format and
Logical Observation Identifier Names and Codes (LOINC) codes
as standards to report test results directly to ECLRS starting in the
middle of June. Objectives: To examine the usefulness of LOINC
in specifying communicable diseases for public health surveillance,
and to assess the completeness and timeliness of electronic report-
ing from a large national laboratory to New York State compared
with paper-based reports. Methods: Electronic reportable com-
municable disease laboratory data performed by LabCorp for cases
residing in New York State were obtained for specimens collected
between July 1 and October 31, 2001. Laboratory tests were coded
with LOINC and test results were coded with LOINC and
Systemized Nomenclature for Medicine (SNOMED). LOINC
codes were reviewed to assess their accuracy in identifying specif-
ic communicable diseases. The paper reports of test results from
the same laboratory during the same time frame were matched
with the electronic reports using the specimen accession number.
Reports reported by paper but not reported through electronic
reporting were evaluated. The proportion of reports missing gen-
der, birth date or address, and time from specimen collection date
to report date were compared between paper and electronic
reports. Results: There were 10,452 records received electronical-
ly from LabCorp for specimens collected between July 1 and
October 31, 2001. LOINC codes identifying a specific disease were
used for 9,409 (90%) records; 938 (9%) reports had both LOINC
and SNOMED codes; and 105 (1%) reports had generic LOINC
or missing codes. The proportion of paper reports matched against
electronic reports increased from 62% in July to 87% in October.
The electronic reports were completed 99% of the time for gender,
96% for birthdate, and 61% in patient's zip-code; where the paper
reports were completed 95% for birthdate and 80% for patient's
zip-code. The median duration from specimen collection date to
report receipt date improved from 13 days for paper reports to 6
days for electronic reports. Conclusion: Our data indicated that
the use of LOINC codes for one laboratory's test results could
identify a specific disease in 90% of the reports, while the use of
both LOINC and SNOMED codes improved the identification of
reportable conditions to 99%. The more timely reporting seen with
electronic reports could facilitate implementation of more rapid
disease control measures.
Board 106. Functional Structure of Epizootic Process at Plague 
L. A. Burdelov
Kazakh Scientific Center of Quarantine and Zoonotic Diseases,
Almaty, KAZAKHSTAN
The existence of the natural plague focus as parasitic system
is limited by processes of three types: reservation of Yersinia pestis,
periodic magnification its number (accumulation) and distribution
on territory. From here all potential participants of epizootic
process execute appropriate functional roles, that allows to speak
about the carriers, accumulators and distributors of infection. The
significance of microbe reservation carriers and vectors carriers is
close. The accumulation more effectively happens in mammals
organism, however in a quantitative sense infected fleas it happens,
as a rule, on the order it and more. The distributors can be only
warmblood animals. But just vectors, the first of all the most mass
parasites, integrate all potential participants of epizootic process in
wohle complex. At such approach the polyfunctionality participat-
ing in epizootic process of animals is obvious: specimens of the
same kind can be referred to different classification categories, and
representatives of different kinds - to one. The functional status of
any concrete species herewith it is necessary to consider as a vec-
tor of the sum of functional loads of separate specimens, which
directedness can vary depending on oscillations of own number,
microbe sensitivity, intensity of intraspecific and interspecific con-
tacts, and also their environments. All above-mentioned testifies
about to some indeterminacy of the offered concept. However rea-
sons of it are quite objective and conceal in complexity, multi-level
of a phenomenon natural plague nudility and probable character
epizootic process. Therefore there are basis to consider that
Heisenberg’s indeterminacy principle which is known for physi-
cists, is apply and to epizootic process. From mathematics point
sights epizootic the process is a complicated biological system of an
open type, which represents a typical indistinct multitude.
Board 107. Web-Based Outbreak Information Exchange 
for Southeast Asia: Advancing Outbreak Response Capabilities
for the Region 
A. L. Corwin1, R. P. Larasati1, C. H. Simanjuntak2, S. S. Suparmanto2,
W. K. Alexander1, J. R. Campbell3, H. J. Beecham, III1
1U.S. NAMRU-2, Jakarta, INDONESIA, 2National Institute of Health
Research and Development, Ministry of Health of the Republic of
Indonesia, Jakarta, INDONESIA, 3Navy Bureau of Medicine,
Washington, DC.
The United States Naval Medical Research Unit No. 2
(NAMRU-2), based in Jakarta, Indonesia, in cooperation with the
Indonesian Ministry of Health, is introducing a new, Web-based
information exchange, to be recognized as ASEAN-Net, to facili-
tate dissemination of regional outbreak information. As a WHO
Collaborating Center for Emerging Diseases, ASEAN-Net repre-
sents the culmination of an overall NAMRU-2 strategy in promot-
ing outbreak recognition and response activities, throughout
Southeast Asia, as part of the Department of Defense‘s Global
Emerging Infections System (GEIS) initiative. Recently adopted
by the ASEAN Secretariat for regional implementation, ASEAN-
Net will provide respective, host-national institutions with menu
driven options for passing sensitive disease information "across
borders", training opportunities, regional (and country-specific)
centers of diagnostic excellence, new field appropriate, rapid diag-
nostics, etc. It is hoped that ASEAN-Net will forge greater coop-
eration and regional stability between ASEAN member countries,
through outbreak recognition and response activities.
Board 108. Merlin – The Florida Department of Health’s Web-
based Communicable Disease Reporting System: The First Year 
K. S. Teates, D. Ward, S. Wiersma
FL Department of Health, Tallahassee, FL
Florida’s electronic communicable disease reporting system
replaced a paper-based reporting system January 1, 2001. Since that
time, Merlin has been operating as the Florida Department of
Health’s electronic disease reporting system and hepatitis registry.
Working closely with a contractor, the basic system was designed,
developed, and implemented in less than one year. All 67 counties
use the system to enter reportable diseases, laboratory results, and
submit electronic case report forms for acute viral hepatitis and bac-
terial meningitis cases. Additional screens for submitting case
report forms online will be added in the coming year. The system is
well received by the county users and allows them to access their
own data for simple analysis and reports, which was not possible
with the paper-based reporting system. Merlin has the capacity to
manage large amounts of data in multiple formats within the SQL 7
database. The flexibility of the system also allows other bureaus
within the Department of Health, like Immunization and the
















data entry screens easily. Merlin is Florida’s early warning surveil-
lance system allowing epidemiology staff to monitor the data before
it has been reported. Future plans include hospital connection,
electronic transfer of laboratory results, and an outbreak module.
Board 109. Mortality Surveillance for Emerging Infection-
Related Deaths in the Armed Forces 
L. A. Pearse, R. N. Potte
Armed Forces Institute of Pathology, Rockville, MD
Mortality Surveillance for Emerging Infection-Related
Deaths in the Armed Forces, Pearse LA, Potter RN. Office of the
Armed Forces Medical Examiner, Armed Forces Institute of
Pathology (AFIP), Washington, DC. The Office of the Armed
Forces Medical Examiner and the Department of Defense Global
Emerging Infections Surveillance and Response System recently
initiated a mortality surveillance system to obtain baseline mortali-
ty data on military members, monitor mortality trends and detect
deaths possibly related to emerging infections or bioterrorist
attacks. Mortality surveillance through the medical examiner‘s
office has provided advantages over a passive system relying on
death certificates. These include improved timeliness of notifica-
tion and receipt of specific information, leading to more rapid
intervention when necessary, improved accuracy of cause of death
and access to the legal authority of the medical examiner. That
authority, traditionally used for homicide, suicide and aviation
accident cases, has been extended to obtain additional specimens
and testing for infectious causes and to perform more extensive
investigations if indicated. Among young, healthy members of the
armed forces, infectious disease deaths are usually sudden and
unexpected, and have the potential to be sentinel events. The sur-
veillance system has a component that attempts to rapidly identify
confirmed or possible infection-related deaths for immediate eval-
uation and follow-up. Data are systematically and routinely collect-
ed from uniformed service casualty offices and supplemented by
direct contact with local pathologists and clinicians. When infec-
tious etiologies are identified or suspected, specimen collection
and processing are immediately reviewed and additional speci-
mens are often requested for more thorough evaluation at the
Armed Forces Institute of Pathology and elsewhere. Educational
initiatives to raise awareness for infectious agents among the
pathology community and syndromic protocols to standardize test-
ing for infectious agents are being developed. Reporting is being
audited for completeness and accuracy. During January 1-
December 15, 2001, 654 cases were evaluated; five were studied
extensively. Three are still under study. One case, a P. falciparum-
related death, led to the rapid identification of a malaria outbreak
and implementation of control measures. Infectious disease deaths
are rare in the military. However, this surveillance system is a pru-
dent financial investment in the military public health infrastruc-
ture because it is producing useful data not only on infectious dis-
ease deaths, but also on vehicular, training injury and all accidental
and sudden deaths.
Board 110. Rapid Detection of Nosocomial Infections Using
Automated Typing and Data Mining 
C. Arnold, G. Jackoway, G. Osterhout, M. Sasser
MIDI, Inc., Newark, DE
Nosocomial infections are responsible for ca. 90,000
deaths annually in the U.S. with an associated medical care cost of
ca. 3.5 billion dollars. Despite being the fourth leading cause of
death, there has been limited development of rapid, integrated
tools for determination of hospital-acquired infections.
Nosocomial infections should be largely preventable by health
care personnel aided by rapid, precise diagnosis and by better pre-
vention and treatment regimens. Currently, the time to notice a
potential outbreak, perform typing and then institute control
measures may take days or weeks. Subjective decisions are often
required for initiating such control measures, followed by time
consuming molecular confirmation. Cellular fatty acid analysis by
gas chromatography has been extensively used for bacterial taxon-
omy and identification of organisms. Standardized protocols have
enabled strain tracking and typing capabilities with this methodol-
ogy, using principal component and dendrogram analyses.
Currently these analyses are performed retrospectively. More
advanced algorithms were developed to generate immediate mul-
tivariate clustering of fatty acid analysis data. A sequential, single-
link clustering algorithm was developed to automatically compare
a just-analyzed sample with data from previously analyzed sam-
ples. Comparisons can be restricted to user defined time intervals
(week, month, year). A year‘s worth of data (2181 samples)
acquired from a collaborating hospital was analyzed with this algo-
rithm. Among the clusters generated was a group of suspect resist-
ant Staphylococcus aureus strains from a hospital ward. In addi-
tion to clustering these strains, the system provided a correct iden-
tification of S. caprae. Since an estimated 60,000 profiles can be
searched in less than one minute, rapid estimation of prior occur-
rence would have been possible. By the addition of patient infor-
mation, antibiotic susceptibility profiles, hospital location, etc.,
common characteristics of isolates can be determined about that
cluster. These software algorithms can be integrated into the cur-
rent Sherlock® Microbial Identification System as a fully auto-
mated real-time epidemiology tool. Hospital infection-control
personnel will be able to use the output to immediately imple-
ment infection control measures, and thus reduce the impact of
nosocomial infections. The information can be readily disseminat-
ed by electronic means to participating hospitals, state health lab-
oratories and the CDC facilitating global recognition of outbreaks.
Board 111. Evaluation of Active Bacterial Core Surveillance
Methodology for Invasive Group A Streptococcus Infection and
Effects on Incidence Rates 
S. Burnite1, K. Gershman1, C. Van Beneden2, E. Zell2, &. ABCs Team3
1Colorado Dept. of Public Health & Environment, Denver, CO,
2Centers for Disease Control and Prevention, Atlanta, GA, 3Members
of the ABCs/Emerging Infections Program Network, Atlanta, GA
Background: A primary goal of CDC’s Active Bacterial
Core Surveillance (ABCs) is to determine the incidence and epi-
demiologic characteristics of five invasive bacterial infections based
on active, population-based surveillance. The ABCs case definition
for Group A Streptococcus (GAS) is more inclusive than for the
other four pathogens; in addition to sterile sites isolates, tissue iso-
lates collected during surgical procedures and wound infections
accompanied by necrotizing fasciitis or toxic shock are included as
cases. We investigated the possible effect of variability in surveil-
lance methods on GAS incidence rates. Methods: Distributions of
GAS cases by source of bacterial isolate (e.g. blood, joint, surgical
specimen) were compared among ABCs areas for 2000 (eight
areas) or 2000/2001 (one area began surveillance July 2000). For
two of three ABCs areas that conduct GAS surveillance statewide,
rates for the main metropolitan area were calculated. Age and race
adjusted incidence rates were calculated for GAS cases identified
through blood cultures for the eight metropolitan areas.
Qualitative assessment of GAS surveillance methods was per-
formed by telephone interviews of ABCs staff in each area. For one
area, the distribution of emm types among blood isolates was com-
pared to isolates from other sources. Results: Incidence rates of
invasive GAS ranged from 1.9 to 8.0 per 100,000 persons among
the nine ABCs areas (median=3.4). The proportion of GAS cases
isolated from blood ranged from 49% to 89% (median=77%). The
ABC’s area with the highest GAS rate had the highest proportion
of surgical specimen/aspirate isolates; the two areas with the lowest
GAS rates had no surgical specimen/aspirate isolates. Age and race
adjusted incidence rates of GAS identified through blood cultures
among the eight metropolitan surveillance areas ranged from 2.2 to
4.7 per 100,000 (median=2.9). In the area with the highest pro-
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portion of non-blood isolates, the distributions of emm types of
blood isolates versus all other isolate sources were significantly dif-
ferent (Chi-Square, P=.05). Qualitative assessment of surveillance
indicated substantial variability among ABCs areas in the degree to
which invasive GAS tissue isolates are actively ascertained; this
roughly correlated with the proportions of surgical specimen/aspi-
rate isolates among surveillance areas. Conclusions: Although
variability in GAS incidence rates among ABCs surveillance areas
is multifactorial, differences in surveillance methods appear to be
one important factor. Current surveillance for GAS may underesti-
mate the true incidence of invasive infection due to under-ascer-
tainment of invasive tissue infections diagnosed through surgically
obtained tissue specimens. ABCs surveillance for GAS should be
better standardized to more accurately ascertain the incidence and
epidemiology of this important bacterial disease.
Board 112. DALY — Disability Adjusted Life Years as an
Effectiveness Indicator in Health and Sanitation 
M. H. Brachowicz, Sr., J. G. Bellido, Sr., C. Das Neves, Sr
Federal University of Rio de Janeiro, Rio de Janeiro, BRAZIL
This study applies Cost-Effectiveness analysis for evalua-
tion of projects in the field of health and sanitation programs. The
Cost Effectiveness Analysis is indicated when dealing with projects
in which the benefits are difficult to be expressed in monetary
units. As main indicator for effectiveness in the Cost-Effectiveness
Analysis, we have chosen the DALY: Disability Adjusted Life Years,
to study the impact of sewage projects in morbidity caused by
fecal-oral diseases in children between 0-4 years old, in the munic-
ipality of Volta Redonda of Rio de Janeiro State, in Brazil. DALY is
an indicator that measures the burden of diseases, and use the for-
mula: DALYs(x) = (D)(C x e-b x)(e-r (x-a)) where: D = weights for
incapacity levels, from 0 = dead, 1 = healthy, (we assumed here D
= 0.5 for the health status associated to children from 0 - 4 years
old, with fecal-oral diseases); C = 0.16243 (fixed); r = discount rate
(recomended = 0.03); b = 0.04 (fixed); e = 2.71 (neperian value); x
= age; a = year that happened the incapacity. We made the calcu-
lations for children of 0 - 4 years old with incapacity due to fecal
oral diseases followed by total recuperation. See following table 1.
Table 1 - DALYs missing by incapacity due fecal - oral diseases, fol-
lowed by complete recuperation, of 0 - 4 years old children of Volta
Redonda, from 1992 to 1998. (D=0.5) 
Year Cases with Cases with DALYs DALYs DALYs by
fecal-oral fecal-oral estimated estimated by incapacity
diseases for diseases for for boys for girls and total
boys of girls of 0 - 4 0 - 4 recuperation -
0 - 4 0 - 4 years old years old both sexes
years old years old
1992 695 596 284.48 243.95 528.43
1993 707 684 289.39 279.97 569.36
1994 634 617 259.51 252.55 512.06
1995 436 406 178.46 166.18 344.65
1996 112 76 45.84 31.11 76.95
1997 58 49 23.74 20.06 43.80
1998 65 58 26.61 23.74 50.35
From: SIH/DATASUS-hospital internation of children of
0-4 years old with fecal-oral diseases, and DALYs estimated. The
focus in this study was to apply the technique recomended by the
experts of the world bank in this situation, (see Murray J. L. and
Lopez D. A. 1996, in The Global Burden of Disease — A com-
prehensive assessment of mortality and disability from diseases,
injuries, and risk factors in 1990 and projected to 2020;
Washington, D.C. Vol.1 World Health organization, Harvard
School of Public Health, World Bank. Library of congress), The
results of this study have shown a decrease in the DALYs value for
the municipality of Volta Redonda, and we noticed that the popu-
lation health was improved when the local company of water and
sewage had increased the sanitation services, specially in water
and sewage treatments.
Board 113. How Laboratory Surveillance is the New Model
for Detecting Emerging Infectious Diseases, Thailand, 2000
S. Guharat1, L. Patinawin1, T. Permvong2, P. Prasertthaichareon2, 
V. Sritong2
1Division of Epidemiology, Ministry of Public Health, THAILAND,
2Ubon Ratchathani Provincial Health Office, THAILAND
Introduction: In the past, there has used the laboratory
data in two kinds for specific treatment of individual case and activ-
ities summary in the quarter or annual report. Mostly use of quar-
ter or annual report has been for budgeting. But we know this data
is very useful for improve medical service and public health aware-
ness. Then we conducted a pilot study in the whole province in the
north-east part of Thailand. Objectives: To establish the laborato-
ry surveillance for food-water-born diseases (FWBD), to monitor
trends of bacterial pathogens and antibiotics susceptibility, to
describe epidemiological information of bacterial pathogens and
antibiotic-resistant bacterial pathogens and to detect abnormal
bacterial pathogens (EIDs) Methodology: Research and
Development. This system has based on the existing passive case
surveillance and conducted the whole province since April 2000.
Inclusion criteria for FWBD are admitted diarrhea, watery diar-
rhea and mucous-bloody diarrhea. Results: Ubon Ratchthani has
25 districts which has one community hospital in each district.
They have been divided into 4 zones for administration. Then we
set 4 zonal hospitals to be sentinel sites of this project. A year of
project was during April 1, 2000 - March 31, 2001. There was
26,709 cases of FWBD and 2,659 (9.96 %) collected specimens of
culture, male and female ration was 1:1.23. In-patient was 65 %
(1,712 cases), out-patient was 22.2 % (590 cases), and community
patient was 9 % (238 cases). Median of age was 38 years (1 month
- 95 years). The most cases were acute diarrhea (68.4 %). Specimen
collection were 71.7 % of RSC, 23.8 % of stool culture and 4.4 %
hemo-culture. Bacterial isolation was 7.9 % of pathogens, 82.6 %
of non-pathogens and 9.5 % of no growth. Pathogen bacteria was
49 % (102 cases) of vibrio parahemolyticus, 26 % (55 cases) of
shigella spp., 9 % (19 cases) of salmonella spp., 8 % (16 cases) of
vibrio choleae. VP was the main bacterial pathogen for FWBD,
affected to all age group and occurred all the year. 94 % of VP resis-
ted to ampicillin. Discussion: We succeeded setting the new lab-
oratory surveillance system in provincial level. It based on the pas-
sive case surveillance then it can easily to continue and it can sup-
port to detect EIDs. The obstacles were data entry and analysis by
laboratory technicians or district epidemiological workers. It spent
more time and workload. Action Taken: After the pilot project
was finished. They commit to 1) continue this project by them-
selves 2) feedback the analytic information to doctors, nurses, ICN,
pharmacists and health care workers in health centers every month
3) If this system is strong, then they plan to expand to others
pathogen in other human systems.
Board 114. SentinelCASE: A Customizable Internet Based
System for Rapid Epidemiologic Alert 
A. Flahault, A. Valleron; Inserm, Paris, FRANCE
Background: Communicable disease control needs pro-
motion of rapid and efficient tools for data collection, analyses, and
information feed-back. In case of an epidemic outbreak from any
origin, the likelihood that the existing local health information sys-
tem will allow for real-time collection and analysis of data is low.
Available tools which may be customized to any epidemic situa-
tions are then required. Methods: SentinelCASE is based on a 17
yr-experience in France, with the daily participation of general
















available on the Internet 24-hrs a day (http://www.u444.
jussieu.fr/sentiweb). The server has been developed on a PC with
a Linux OS, an Apache HTML server, Java code, a MySQL rela-
tional database. Clients are microcomputers with Internet connec-
tion. Results: Health professionals are collecting data on
SentinelCASE through a securized web interface. After having
identified the notifier, the system allows data to be stored into a
MySQL relational database. Any authorized persons (or the world
wide public if no access restrictions is considered) can consult on
a real-time basis all entered data on maps, graphs, and tables. Row
data may be downloaded on a spreadsheet for further analyses.
The engine of SentinelCASE is currently in use at an internation-
al level for the ongoing global surveillance of Influenza (FluNet)
or dengue (DengueNet, see on http://oms.u444. jussieu.fr/). It has
been chosen by WHO-HQ because of its easyness, flexibility,
rapid implementation, and low cost. SentinelCASE may equip
within a few weeks any networks of health professionals. Although
a good knowledge in Linux and Apache is required for the local
implementation and management of the server, no specific com-
puter skills are required for the database management, or for cus-
tomization of the surveillance system. Through an Internet inter-
face, the system is easily and rapidly customizable. The autorized
user defines items to be monitored. SentinelCASE may be used
for epidemiologic purpose, but also for entomologic surveillance
or for monitoring any environmental indicator. The use of the sys-
tem is self-understandable. None of the 1270 French sentinel
GPs, nor the 110 national influenza centres have been specifically
trained for its use. Conclusion: Inserm (French Institute of
Health and Medical Research) provides a user-friendly tool which
allows for a rapid impementation of epidemiologic surveillance in
any part of the world.
Board 116. Use of the Web To Enhance Disease Surveillance
and Bioterrorism Preparedness 
N. M. M'ikanatha1, D. Welliver2, D. Rohn3, J. Rankin1
1Pennsylvania Department of Health, Harrisburg, PA, 2Hershey
Medical Center, Hershey, PA, 3Maryland Department of Health and
Mental Hygiene, Balitmore, MD
Background: Timely reporting of notifiable diseases is
critical to early detection and response to outbreaks or bioterror-
ism (BT) attacks. Previous studies indicate some clinicians are
unaware of what, when, how or where to report diseases. The Web
offers an unprecedented opportunity to provide high quality,
accessible information and also a means to report disease and BT
related syndromes. Objectives: To evaluate accessibility and use-
fulness of Web-based information on infectious diseases reporting
(DR) and BT preparedness, and to suggest areas for improvement.
Methods: (1) In November 2001, we surveyed 57 jurisdictions
that report notifiable diseases to the Centers for Disease Control
and Prevention (CDC) through the National Electronic
Telecommunication System for Surveillance (NETSS). An E-mail
questionnaire asked epidemiologists about availability of
reportable diseases lists (RDL) on their Web sites, and plans to use
the Web for DR and syndromic surveillance. (2) In December
2001, we used the Google search engine to locate online DR infor-
mation. We used a standardized instrument to collect data on avail-
ability of reportable diseases lists and reporting instructions, capa-
bility for online disease reporting, and information on six CDC BT
Category A agents. Results: (1) Fifty-six of the 57 jurisdictions
responded by email or subsequent phone interview. Forty-nine
(88%) indicated that they have online RDL, and 42 (75%) of those
are current. Sixteen (29%) provide means for electronic reporting
of notifiable diseases; four provide Web-based reporting. Three
have Web-based syndromic surveillance in use; nine plan to start in
the next six months. (2) We located 45 (90%) of the 49 Web sites
with DR information. Eleven (24%) of the jurisdictions require
reporting of all Category A agents while at other sites BT agents are
reportable only as “unusual conditions.” Thirty-three 33 (73%) pro-
vide a telephone number for DR, 18 (40%) provide a fax number,
and 14 (31%) had an online DR card. Forty-five (90%) indicate the
required time frame for reporting different diseases, and 36 (80%)
explained the basis for reporting. Conclusions: The Web is being
used to promote DR but its potential for facilitating timely report-
ing of diseases and syndromes has not been fully realized. Up-to-
date DRL, telephone and fax numbers for reporting, on online DR
cards and instructions could readily be provided on jurisdictions’
Web sites. Some states already have recognized the benefits of
Web-based systems. The Web offers a cost-efficient way to
enhance surveillance and BT preparedness.
Board 117. Time Series Modeling and Space-Time Clustering
of DoD-GEIS Data For Early Outbreak Detection 
H. S. Burkom1, J. Lombardo1, F. Mostashari2, Y. Elbert3, J. Pavlin3, P.
Kelley3
1Johns Hopkins Applied Physics Laboratory, Laurel, MD, 2New York City
Department of Health, New York, NY, 3DoD/GEIS, Washington, DC
The objective of this effort is the capability for early indica-
tion of the spatial location and extent of an outbreak of disease. The
exigency of responding to recent terrorist activity and advances in
database technologies are increasing the timely availability of sur-
veillance data while presenting the problem of how to analyze the
growing volume of data for prompt outbreak recognition.
The U.S. Department of Defense Global Emerging
Infections System (DoD-GEIS) has developed the Electronic
Surveillance System for Early Notification of Community-based
Epidemics (ESSENCE) to enable outbreak alerting using syn-
dromic surveillance. This system reduces the surveillance of out-
patient visits to the inspection of counts in a manageable number
of syndromes, defined as logical groupings of ICD9 codes.
Researchers at DoD-GEIS and the Johns Hopkins Applied Physics
Laboratory have calculated time series predictions for background
levels of daily visits expected in each monitored region for the var-
ious syndromes. Autoregressive modeling and other time series
methods have yielded predictions that account for temporal pat-
terns of consumer behavior. Small spatial resolution is needed for
early alerting so that increases in visits at the neighborhood level
are not masked by normal variability at the state or county level.
We have used the patient-residence zipcodes provided by the
ESSENCE system to perform spatial-temporal cluster analysis of
the variations of daily data from the levels predicted by the mod-
els. The resulting clusters indicate approximate regions of outbreak
for further investigation by human expertise or by other automat-
ed means. To seek potential clusters, we employ Kulldorff’s space-
time scan statistic because it gives a p-value for each cluster along
with the component zipcodes and avoids selection bias as well as
the zipcode resolution allows. Applications have located unlikely
clusters of syndrome visits using model-based expectations. We
have also clustered visits for single ICD9 codes based on the rep-
resentation of each zipcode in the ESSENCE system. The result-
ing clusters may be inspected using GIS plots. Simulations have
been used to assess the utility of this approach for early detection
of a point-source outbreak. We used the Sartwell lognormal model
to estimate the epidemic curve for diseases regarded as biowarfare
threats, and we estimated the spatial case dispersion to inject cases
into authentic background data. Simulations are parametrized by
the total infected to determine how severe an outbreak may be
detected according to time after exposure.
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Board 1. Mutational Analysis of Position Arg164 in TEM-1
and SHV-1: Two Highly Similar ß-Lactamases 
F. K. Majiduddin, T. G. Palzkill
Baylor College of Medicine, Houston, TX
Resistance to ß-lactam antibiotics is a serious threat to the
effective treatment of infectious disease. Several mechanisms are
involved in resistance, the most prevalent being the production of
ß-lactamases. The TEM-1 and SHV-1 ß-lactamases are important
contributors to resistance to ß-lactam antibiotics in Gram-nega-
tive bacteria. These enzymes share 68 % amino acid sequence
identity and their atomic structures are nearly superimposable.
Extended spectrum cephalosporins were introduced, in part, to
avoid the action of TEM -1 and SHV-1 ß-lactamase. However, the
widespread use of these antibiotics has lead to the evolution of
variant TEM and SHV enzymes that can hydrolyze extended
spectrum antibiotics. Interestingly, despite being highly similar in
structure, the TEM and SHV enzymes have evolved somewhat
differently in response to the selective pressure. Examples of this
are at residues Arg164 and Asp179, two positions that form a salt
bridge at the base of an omega-loop structure. Among TEM vari-
ants substitutions are only found at position 164 while substitu-
tions are only found at position 179 among SHV variants. To
explain this observation, we examined the effects of mutations at
position 164 in both TEM-1 and SHV-1 on antibiotic resistance
and catalytic efficiency. In addition, competition experiments
were carried out between mutants to understand why certain
substitutions preferentially evolve due to the selective pressure of
antibiotic therapy. Based on these competition assays, the SHV
Arg164Ser variant is more fit than wild-type SHV-1, but is unable
to compete effectively versus the SHV Asp179Gly variant. Among
the TEM variants, the Asp179Gly variant is more fit than strains
expressing the parental TEM-1 enzyme, but this mutant is unable
to compete effectively against its Arg164Ser counterpart. This
explains why only mutants at position Asp179 exist in SHV
enzymes and Arg164 mutants in TEM enzymes in the clinical set-
ting. Subtle unseen differences in the structures of TEM-1 and
SHV-1 may account for the divergent evolutionary paths these
two enzymes are undertaking.
Board 2. Synthetic Peptide Antibiotics: Solutions for the
New Millenium
D. Wade
Helsinki University, Helsinki, FINLAND
The current public health problems of antibiotic resistant
microorganisms, and bioterrorism, necessitate the development of
new antibiotic strategies and therapeutics. During the past two
decades, a new category of antibiotics has been discovered, the
gene-encoded peptide antibiotics of the animal, plant, and bacter-
ial kingdoms. Research interest in these peptide antibiotics has
grown exponentially, and there is a hope that they may provide a
partial solution to the problems mentioned above. Several hundred
new, naturally occurring, peptide antibiotics have been isolated,
and one of the most prolific sources of these new antibiotics has
been the skin of frogs and toads (anurans). One group of these
antibiotics, the temporins and temporin-like peptides, are com-
posed of 31 different peptides from 8 species of frogs. Surprisingly,
there are an additional 8 peptides with very similar structures to
the frog peptides that have been isolated from the venoms of
wasps. One of the frog skin peptides, temporin A (TA), has been
shown to have antibacterial activities against antibiotic resistant
bacteria. Synthetic manipulations of the structure of TA has shown
that it is possible to improve its antibiotic properties and reduce its
toxicity, and they have provided information about the structural
features of TA that endow it with antibiotic properties. It is expect-
ed that further work with the temporins, and the other members of
the new class of gene encoded peptide antibiotics, will eventually
provide at least a partial solution to the problem of antibiotic resist-
ant microorganisms.
Board 3. Growth Inhibition by Cisplatin in Group-I Intron
Containing Pathogens: A Study in Candida albicans 
K. Chandrasekhar, R. Malathi
Dr.ALM Post Graduate Institute of basic Medical Sciences, University
of Madras, Taramani Campus, Chennai, INDIA
We previously reported that antitumor agent cisplatin,
which has been clinically used in treatment of wide range of can-
cer has been found to inhibit group-I intron splicing invitro from
Tetrahymena thermophila1. Interestingly this has been found to
arrest the growth of C.albicans, an opportunistic human fungal
pathogen that has become a major cause of morbidity and mortal-
ity in immunocompromised as well as cancer and HIV patients2,3.
This gains lot of significance from clinical point of view since
C.albicans is known to possess this group-I intron in 25s rRNA and
their absence in human will pave way for an alternative target site,
in addition to the well known cell-membrane therapeutic agents
which are gaining resistance in present conditions. Recently we
have carried out an invitro-screening assay using ATCC and 4 clin-
ical strains and the parameters include disk diffusion method,
growth curve analysis, RNA isolation and a fluorescence micro-
scopic study using a new staining method “Ethidium Bromide” in
order to analyse the morphological features. The above experi-
















C.albicans strain. The results have indicated that, in growth curve,
cis-DDP at 60µg concentration shows a remarkable inhibition of
multiplication of C.albicans cells with respect to control after 10
hour incubation period while analyzing O.D values at 600nm
range. On the other hand low molecular weight RNA [25s, 18s
rRNA] from the culture was isolated, analysed using agarose gel
electrophoresis and the results suggest that cis-DDP might have
completely abolished the 25s rRNA with high efficiency. While the
microscopic study has clearly shown that the cis-DDP treated cells
at 60µg concentration shows inhibition of hyphae growth as well as
enlargement of ovoid cell irrespective of the control whose ovoid
cells are smaller and the hyphae with many branches/budding visu-
alized under 40X and 100X of Nikon Fluorescence Microscope and
the same experiment was also carried out to compare with EtBr
stain using normal C.albicans stain, the results were similar. These
findings suggest that cis-DDP if properly oriented /targeted with
epitope/liposome delivery, could possess antifungal property
besides their antitumor activity especially in cancer patients.
Moreover as pathogens continue to evade therapeutic targets
search of novel agents with new target site is becoming a serious
problem in persistence of human life, not only for fungal pathogens
but also for other pathogenic organism. Reference: 1.Malathi R.
and Chandrasekar K. Journal of Biosciences. 1999 suppl.11, 96.
2.Chandrasekar.K, Shyla J., and Malathi,R. Journal of Clinical
Microbiology. 2000 vol.10 (38). 3.Leibowitz M.J., Antimicrobial
Agents and Chemotherapy. 2000, Vol.44, No.4, 958-966.
Board 4. Hemolytic and Non-Hemolytic Vancomycin-
Resistant Enterococcus faecalis from Imported Beef in Malaysia 
N. H. Fifadara1, G. R. Rusul2, S. Radu3, Z. Hassan2, L. R. Beuchat1
1University of Georgia, Griffin, GA, 2University Putra Malaysia,
Serdang, MALAYSIA, 3Department of Biotechnology, UPM, Serdang,
MALAYSIA
Twenty-two strains of vancomycin resistant Enterococcus
faecalis were isolated from 9 (6%) of 150 imported beef samples.
12 strains (54.5%) were b-hemolytic and all strains harbored vanA
gene. Hundred percent of the strains tested were resistant to 10 of
the antibiotics including vancomycin and teicoplanin. Strains were
95.4% resistant to trimethoprim-sulfamethoxazole, 68.8% resistant
to chloramphenicol and 41% resistant to ampicillin and penicillin.
Small sized plasmids ranging from 1.5 to 5.8 Kb were detected in
8 (36.4%) strains. The twenty-two isolates were differentiated into
twenty RAPD-types. It was concluded that vancomycin-resistant
Enterococcus faecalis with different clones is widespread among
isolates from imported beef in Malaysia.
Board 5. Phenotypic Typing and Molecular Fingerprinting of
Fluoroquinolone-Resistant Campylobacter Species Isolated
from a Treated Broiler Flock 
H. A. Wadda1, G. Domingue2, D. J. Griggs3, M. Siccardi2, M.
Johnson3, J. A. Frost1, T. Humphrey4, L. J. Piddock3
1Campylobacter Reference Unit, Central Public Health Laboratory,
London, UNITED KINGDOM, 2Public Health laboratory Service,
FMRU, Exeter, UNITED KINGDOM, 3Antimicrobial Agents Research
Group, University of Birmingham Medical School, Birmingham, UNIT-
ED KINGDOM, 4Department of Clinical Veterinary Science, University
of Bristol, Bristol, UNITED KINGDOM
Aim: To investigate the incidence, types and mechanisms of
resistance in Campylobacter spp. during therapeutic treatment of
a poultry flock. Background: Antimicrobial resistance in campy-
lobacter isolated from human infections has increased over the
years. Monitoring this increase is important for those severe infec-
tions where antimicrobial therapy is essential. It is known that
resistance can be spread from one ecosystem to another ie. trans-
fer of resistant strains from farm animals to humans, humans to
environment, environment to animal and vice versa. Poultry meat
consumption is thought to be one of the main routes of transmis-
sion to humans. Methods: Samples were taken from one poultry
flock before, during and at 1 and 2 weeks after fluoroquinolone
treatment. A total of 66 chickens tested positive for Campylobacter
spp. and 3 picks were isolated from each bird. These isolates were
speciated and characterised using serotyping, phagetyping and bio-
typing methods at the Campylobacter Reference Unit. Drug resist-
ance screening using 12 antibiotics was performed using the
method developed as part of the NCCLS working party on
Campylobacter susceptibility testing. Pulsed Field Gel
Electrophoresis (PFGE) and Amplified Fragment Length
Polymorphisms (AFLP) were used for more detailed strain charac-
terisation. Mutations in gyrA and gyrB was determined with
DHPLC. Results: Both Campylobacter jejuni and Campylobacter
coli were isolated in all three of the treatment phases. Resistant
C.jejuni were isolated mostly pre-treatment and during treatment,
whilst resistant C.coli were seen in the post-treatment phase (no
resistant C.coli were isolated in pre-treatment). Results indicated
that 17.4% of the positive chickens at the pre-treatment phase
were fluoroquinolone-resistant, 100% during the treatment phase
and 82.8% at the post-treatment phase. Phenotypic analysis of the
resistant strains showed C. jejuni HS27/PT67 to be the predomi-
nate strain at the pre-treatment stage, but this was not seen in the
other two phases. C.jejuni HS31/PT1 was the predominant resist-
ant strain during treatment but less commonly detected at the
post-treatment phase. More C.coli strains were seen in the post-
treatment phase where C.coli HS56/PT44 was the predominant
strain. Isolates examined to date all had a substitution of Thr86 in
gyrA. Conclusion: An increased proportion of resistant strains
were seen during treatment, these persisted post treatment.
Changes in species and subtype prevalence also occurred during
the course of this study. The resistant mechanism observed so far
is the substitution of Thr86 in gyrA.
Board 6. Enhanced Surveillance for Antimicrobial Resistance
Among Enteric Bacteria: NARMS Retail Food Study 
J. E. Stevenson1, D. G. White2, D. J. Torpey, III3, A. S. Craig4, K. E.
Smith5, M. M. Park6, M. A. Pascucilla7, A. D. Anderson1, . and the
NARMS Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA, 2U.S. Food
and Drug Administration, Laurel, MD, 3University of Maryland,
Baltimore, MD, 4Tennessee Department of Health, Nashville, TN,
5Minnesota Department of Health, Minneapolis, MN, 6Georgia Public
Health Laboratory, Atlanta, GA, 7Connecticut Emerging Infections
Program, New Haven, CT
Background: The food supply, including meat and
poultry, is an important source of enteric bacteria, including
Campylobacter, E. coli, Salmonella and possibly enterococci.
Antimicrobial resistance among these foodborne bacteria is not
uncommon and often is associated with the use of antimicrobial
agents in food animals. Retail food represents the point of exposure
that is closest to the consumer and, when combined with data from
slaughter plants and on-farm studies, provides a more representa-
tive picture of the prevalence of resistance in foodborne pathogens.
To focus efforts to mitigate antimicrobial resistance and to better
understand the contribution of the food supply to antimicrobial
resistance among enteric bacteria, the National Antimicrobial
Resistance Monitoring System (NARMS) for Enteric Bacteria is
extending surveillance of antimicrobial resistance to bacteria iso-
lated from food. Program Description: The NARMS Retail
Food Study is a collaborative effort between the Centers for
Disease Control and Prevention (CDC), five FoodNet sites
(Connecticut, Georgia, Maryland, Minnesota and Tennessee) and
the U.S. Food and Drug Administration (FDA). The NARMS
Retail Food Study has adopted a standard method to monitor the
prevalence of antimicrobial resistance among Campylobacter, E.
coli, Salmonella and enterococci isolated from a convenience sam-
ple of meat and poultry from selected grocery stores in the United
States. Data collection will begin January 1, 2002. Each site will
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visit at least one grocery store per month, not returning to the same
store for at least two months, and purchase packages of meat or
poultry including 10 packages of chicken breasts, 10 packages of
pork chops, 10 packages of ground turkey and 10 packages of
ground beef. Isolation procedures have been adapted from the
FDA’s Bacteriological Analytical Manual. Each site will culture the
rinse from each sample for the presence of Salmonella and
Campylobacter. In addition, Georgia, Maryland and Tennessee will
culture the rinse for E. coli and enterococci. Isolates will be for-
warded to FDA for antimicrobial susceptibility testing.
Conclusion: This collaborative surveillance project will provide
data and isolates useful for focusing efforts to mitigate antimicro-
bial resistance in enteric bacteria. Enhanced efforts are needed to
mitigate the increasing prevalence of antimicrobial resistance
among foodborne bacteria. By examining the prevalence of antimi-
crobial-resistant enteric bacteria we will better understand the
extent of antimicrobial resistance in the food supply and will be
better equipped to implement mitigation strategies.
Board 7. Multidrug Resistance Among Human Non-Typhoidal
Salmonella Isolates in the United States: NARMS 1999-2000 
S. Rossiter, K. Joyce, J. E. Stevenson, T. Barrett, A. D. Anderson, and
the NARMS Working Group;
Centers for Disease Control and Prevention, Atlanta, GA
Background: An estimated 1.4 million Salmonella infec-
tions occur in the United States annually. Emerging antimicrobial
resistance, including multidrug resistance, contributes to the
human health burden of Salmonella and threatens the utility of
antimicrobial agents, including third generation cephalosporins
(e.g., ceftriaxone). The National Antimicrobial Resistance
Monitoring System (NARMS) for Enteric Bacteria was established
in 1996 as a collaborative effort among the Centers for Disease
Control and Prevention (CDC), participating state and local health
departments, the U.S. Food and Drug Administration (FDA), and
the U.S. Department of Agriculture (USDA). NARMS data are
helpful in directing applied research and mitigation efforts.
Methods: In 1999 and 2000, 17 participating public health
laboratories forwarded every tenth non-typhoidal Salmonella iso-
late to CDC. Salmonella isolates received at CDC were tested by
broth microdilution (Sensititre®) for minimum inhibitory concen-
trations (MIC) to 15 antimicrobial agents including ampicillin (A),
chloramphenicol (C), kanamycin (K), streptomycin (S), sulfon-
amides (Su), and tetracycline (T), using NCCLS interpretive stan-
dards. Isolates with decreased susceptibility to ceftriaxone (MIC ≥
16 µg/ml) were tested by E-test (AB Biodisk).
Results: Of the 2876 human Salmonella isolates tested in
1999-2000, 26% (743) were resistant to ≥ 1 agent; 21% (601) were
multidrug-resistant (resistant to ≥ 2 agents). Three multidrug-
resistant strains, S. Typhimurium R-type ACSSuT, S. Typhimurium
R-type AKSSuT, and S. Newport R-type ACSSuT accounted for
10% (278/2876) of non-typhoidal Salmonella isolates, 37%
(278/743) of the resistant isolates, and 46% (278/601) of multidrug-
resistant isolates. S. Typhimurium R-type ACSSuT was present in
all sites, ranging from 12% of Salmonella from Washington to 5%
of Salmonella from California. S. Typhimurium R-type AKSSuT
was present in 16 of the 17 sites; it was most prevalent in
Washington where it was 9% of Salmonella. S. Newport R-type
ACSSuT was present in all sites, ranging from 8% of Salmonella in
Kansas to <1% of Salmonella in New York State. Among human
Salmonella isolates, ceftriaxone resistance was present in 2%
(3/170) of S. Typhimurium R-type ACSSuT isolates, 3% (2/63) of
S. Typhimurium R-type AKSSuT isolates, 71% (32/45) of S.
Newport R-type ACSSuT isolates, and <1% (16/2764) of other
Salmonella isolates.
Conclusion: Three multidrug-resistant strains account for
nearly half of multidrug resistance among human Salmonella iso-
lates; ceftriaxone resistance also is common among multidrug-
resistant Salmonella Newport and present in some multidrug-
resistant Salmonella Typhimurium. Further studies are needed to
determine sources for these multidrug-resistant strains and sup-
port prevention efforts.
Board 8. Expanded-Spectrum Beta-Lactam Resistance among
Human Clinical Enterobacteriaceae in the United States: Results
and Characterization of 2000 NARMS Surveillance 
J. M. Whichard1, K. Joyce1, P. D. Fey2, J. McClellan1, F. J. Angulo1, T.
Barrett1, and the NARMS Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA, 2University
of Nebraska Medical Center, Omaha, NE
Background: Third-generation cephalosporins are useful
for the treatment of invasive salmonellosis and other severe pedi-
atric infections. The National Antimicrobial Resistance Monitoring
System (NARMS) for Enteric Bacteria has identified increased
cephalosporin resistance in human bacterial enteric pathogens; in
1999 1.5% of isolates tested exhibited intermediate or resistant
minimum inhibitory concentrations to expanded-spectrum
cephalosporins. Preliminary molecular characterization of resist-
ance determinants in the 2000 NARMS collection is presented.
Methods: As NARMS participants, the 17 state and local public
health laboratories submitted every 10th non-typhoidal
Salmonella, every 10th Shigella and every 5th E. coli O157:H7
received in 2000 to the Centers for Disease Control and
Prevention for antimicrobial susceptibility testing. Minimum
inhibitory concentrations (MIC) were determined for 17 antimi-
crobials using broth microdilution (Sensititre®). Isolates were cho-
sen for further study based on an intermediate or resistant MIC for
the expanded-spectrum cephalosporins: cefoxitin (≥16 µg/ml), cef-
tiofur (≥4 µg/ml) or ceftriaxone (≥16 µg/ml). ß-lactamases were
characterized using isoelectric focusing and pcr for blaCMY-2.
Results: Of the 2236 isolates tested in 2000, 57 (2%) met the MIC
criteria and were selected for further study. These 57 isolates com-
prised 3% (46/1378) of the non-typhoidal Salmonella isolates test-
ed, 2% (7/451) of Shigella, and 1% (4/407) of E. coli O157:H7.
Overall, 52 (91%) of the 57 isolates produced a ß-lactamase with a
pI≥8.4, consistent with an ampC-type ß-lactamase. Forty-four
(77%) were pcr-positive for a blaCMY gene. All 4 E. coli O157:H7
isolates tested produced an enzyme with a pI≥8.4 and were also
pcr-positive for a blaCMY gene. All 7 Shigella isolates tested were
S. sonnei and produced an enzyme with a pI≥8.4, but were nega-
tive by pcr for blaCMY. Forty of the 46 Salmonella isolates tested
produced an enzyme with a pI≥8.4 and were pcr-positive for a
blaCMY gene. Notably, 24 of the 40 blaCMY positive Salmonella
were serotype Newport. Seven of the 57 isolates (12%) produced
additional ß-lactamases, including 4 Salmonella and 3 Shigella son-
nei. One isolate (Salmonella serotype Nienstedten) produced
enzymes of pI 5.4 and 8.0. Conclusion: The presence of isolates
exhibiting intermediate or resistant MIC to expanded-spectrum
cephalosporins increased in 2000. The major determinant in the
2000 NARMS collection appears to be a blaCMY-type ß-lacta-
mase. S. Newport is the predominant organism among the 2000
NARMS isolates exhibiting this resistance. Additional ß-lactamases
are expressed in over 10% of the isolates as well. Because of the
pervasive ß-lactam resistance phenotype conferred by the ampC-
type enzymes, these additional enzymes would not have been iden-
tified by susceptibility testing alone.
Board 9. Irrigation Water and Associated Sediments as a
Source of Integron Bearing Enteric Bacteria 
E. Vega, M. T. Roe, S. D. Pillai
Texas A&M University, College Station, TX
Use of antibiotics in humans and animal feed is thought to
be responsible for the increased prevalence of antibiotic resistant
bacteria in the environment. The Texas-Mexico border region is
significantly impacted by anthropogenic activities. The Rio Grande
















Considering the numbers and types of possible sources of fecal
contamination of irrigation water, we hypothesized that irrigation
water and agricultural fields harbor a large number of integron-
bearing enteric bacteria. Antibiotic resistance in Gram-negative
bacteria is primarily thought to be mediated by gene cassettes
within the integron gene sequence. E. coli was isolated from sedi-
ment and water at 11 sampling sites along the Texas-Mexico bor-
der. Antibiotic resistant profiles were determined using the agar
dilution method for E. coli. Out of 326 E.coli isolates, only 31 iso-
lates (9.5%) were determined to be resistant to more than one
antibiotic. The isolates were characterized using PCR primers spe-
cific for the variable region of the class I integron gene sequences.
Of the 31 E. coli multiple drug resistant isolates, only 5 isolates
(16.1%) indicated the presence of the class I integron sequence.
Sequencing E.coli cassettes verified the presence of the aadA gene
in three isolates and dhfr XII gene and aadA genes in one isolate.
The results indicate that agricultural fields harbor low numbers of
integron-bearing E.coli. It is, however, critical to understand
whether integron elements are involved in horizontal gene transfer
of antibiotic resistant genes on fresh produce especially those that
are consumed raw or minimally processed.
Board 10. Infections Caused by Rapidly Growing
Mycobacteria: Experience of Infectious Diseases Consultants 
M. A. De Groote1, L. J. Strausbaugh2,3, D. B. Jernigan4, L. A.
Liedtke2,3
1National Jewish Hospital, Denver, CO, 2VA Medical Center,
Portland, OR, 3IDSA Emerging Infections Network, Portland, OR,
4CDC, Atlanta, GA
Background: Because non-tuberculous mycobacterial
infections are seldom reportable, their epidemiology remains poor-
ly understood. Although the National Jewish Medical and
Research Center has appreciated an increase in the number of
infections due to rapidly growing mycobacteria (RGM); it is not
known whether this experience reflects that of the nation. To
examine this question, we surveyed members of the Infectious
Diseases Society of America Emerging Infections Network (EIN)
about their recent experiences with RGM. Methods: In October
2001, a questionnaire was distributed to all 797 infectious diseases
consultants participating in the EIN. Results: Overall, 374 (47%)
of the 797 members responded. Of the respondents, 183 (49%)
had encountered 559 cases of RGM during 2000-2001. Moreover,
17% had noted more cases in recent years. EIN members from all
nine regions of the US (especially the South Atlantic, Pacific and
Mid-Atlantic) reported seeing increased numbers of cases.
Respondents noted a wide spectrum of RGM disease, including
pulmonary, cutaneous, and, to a lesser extent, disseminated and
lymphatic. By region, 23 to 54% of EIN members reported seeing
M. chelonae cases, 14 to 44% M. abscessus cases, and 23 to 54%
M. fortutium cases. Fifty-six (31%) of respondents described envi-
ronmental exposures associated with infection: medical procedures
(45%), soil or water (21%) and trauma (29%). Predisposing host
conditions included immunocompromise (steroids, HIV, and
malignancy) and chronic lung diseases (emphysema and cystic
fibrosis). Some EIN members expressed concern about distin-
guishing colonization from infection and establishing the need for
treatment. Most respondents (79%) use in vitro susceptibility test-
ing to guide therapy. EIN members indicated that a diverse array
of facilities, including several national reference laboratories, per-
form RGM identification and susceptibility testing. Conclusions:
RGM infections are frequently seen by infectious diseases consult-
ants in all regions of the country. They appear to be increasing in
some areas, especially in coastal states. Clinical features of member
cases suggest that RGM are opportunistic pathogens, frequently
acquired from environmental sources. Since numerous laborato-
ries isolate RGM, consistent methods for identification and sus-
ceptibility testing will help define the epidemiology and proper
therapy of these emerging pathogens.
Board 11. Outbreak of Community-Acquired Methicillin-
Resistant Staphylococcus aureus (MRSA) Skin Infections Among
Alaska Natives, 2000 
H. C. Baggett1, T. Hennessy1, D. Bruden1, C. Hamlin1, R. Leman2, A.
Reasonover1, R. Sparks1, R. Donlan3, S. McAllister3, P. Martinez4, J.
Butler1
1CDC, Anchorage, AK, 2Indian Health Service, Albuquerque, NM,
3CDC, Atlanta, GA, 4Yukon Kuskokwim Health Corporation, Bethel, AK
Background: Reports of MRSA-infected patients without
hospital exposure indicate that MRSA infection is now acquired in
both healthcare and community settings. In August 2000, an
MRSA skin infection outbreak among patients without hospital
exposure was reported in southwestern Alaska. We investigated
these community-acquired MRSA infections and potential risk fac-
tors for disease. Methods: Using ICD9 codes, we determined the
percentage of clinic visits for skin infection to the regional hospital
from January 1998-July 2000. We reviewed charts of all patients
with a positive S. aureus culture from May-July 2000. Community-
acquired MRSA was defined as culture-confirmed illness in some-
one without hospitalization, surgery, dialysis, admission to a long-
term care facility, or presence of an indwelling catheter in the prior
year. In one village, we conducted a case-control study using 34
case-patients with MRSA skin infections and 94 controls with no
history of skin infection. MRSA nasal carriage was assessed for
case-patients, controls and their household members. We conduct-
ed an environmental assessment of traditional saunas, which have
been linked to skin infections in prior outbreaks. Pulsed-field gel
electrophoresis (PFGE) was performed on available clinical, car-
riage, and environmental MRSA isolates. Results: During March
1999 through July 2000, the number of MRSA skin infections at
the regional hospital increased from 5 to 56 per month (p<0.01),
and visits for skin infections increased from 1% to 3% of outpatient
visits (p<0.01). In the peak three months of the outbreak (May-July
2000), 85% (142/168) of S. aureus skin infections were MRSA and
75% (107/142) of these were community-acquired. In the case-
control study village, 5.1% (39/760) of residents had confirmed S.
aureus skin infections during a 5-month period, and all S. aureus
isolates from that village were MRSA. Case-patients used more
antibiotics than controls in the year before the outbreak (median
4.0 vs. 2.0 courses, p=0.01). Sauna use was reported by 85% of
case-patients and was not more common than among controls
(89%). However, MRSA was cultured from 8 (17%) of 47 saunas,
and 44% of case-patients and 13% of controls used MRSA-positive
saunas (OR=5.6, p<0.01). MRSA in biofilms were identified in
sauna wood. A single PFGE pattern was seen in 71 (89%) of 80
MRSA isolates from clinical, carriage, and environmental sources;
an additional 7 (9%) isolates differed by only 2 bands.
Conclusions: A large outbreak of community-acquired MRSA
skin infections occurred among Alaska Natives in southwestern
Alaska. Illness was associated with antibiotic and sauna use.
Response has included judicious antibiotic use education and a
sauna disinfection efficacy study.
Board 12. National and Regional Susceptibility Patterns 
of Staphylococcus aureus and Methicillin-Sensitive and
Methicillin-Resistant Staphylococci: Results of the Antimicrobial
Resistance Management (ARM) Program 
J. G. Gums
Univ. of Florida, Gainesville, FL
Background: The ongoing ARM program was developed
to document susceptibility patterns, including for S aureus, methi-
cillin-sensitive S aureus (MSSA) and methicillin-resistant S aureus
(MRSA) in inpatient and outpatient isolates. Since 1987, more than
10 million isolates have been collected on 19 organisms and 46
antibiotics from 105 US hospitals in 5 regions (Northeast, North
Central, Southeast, South Central, Southwest). Methods:
Antibiograms and sensitivity reports of S aureus, MSSA, and
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MRSA isolates were reviewed for susceptibility to fluoroquinolone
(ciprofloxacin, levofloxacin, ofloxacin, trovafloxacin) and other
antibiotics (vancomycin, clindamycin, erythromycin, and naf-
cillin/oxacillin). Results: Total number of isolates and percentage
of isolates susceptible to each antibiotic were determined both
nationally and regionally. Nationally, S aureus isolates were as sus-
ceptible to ciprofloxacin (62.3%, n=194,937) as to levofloxacin
(62.2%, n=78925), with a greater sensitivity to ciprofloxacin seen in
North Central (60.9% vs 58.7%), Southeast (62.7% vs 62.2%), and
Northeast (60.7% vs 52.8%). These data suggest cross-resistance
between ciprofloxacin and levofloxacin. Susceptibility to lev-
ofloxacin was greater than to ciprofloxacin in South Central (82.9%
vs 72.4%) and Southwest (80.4% vs 54.3%). S aureus isolate sus-
ceptibility to erythromycin nationally was 32.5% (n=272,184),
accounted for primarily in Southeast (22.9%); it was higher in all
other regions: North Central (53.4%), Northeast (54.3%), South
Central (61.1%), Southwest (67.1%). Compared with erythromy-
cin, S aureus isolates had a much greater susceptibility to clin-
damycin (75.9%, n=33180). This difference was seen in every
region, with the smallest comparative difference noted in South
Central (61.5% vs 70.3%). Susceptibility to nafcillin/oxacillin
nationally was 64.9% (n=256,121); this ranged from 63.2% in
North Central to 78.0% in South Central. The majority of change
in susceptibility to nafcillin/oxacillin and ciprofloxacin nationally
over the past decade has occurred in the last 3 years (1998 to 2000),
with ciprofloxacin sensitivity declining with increasing levels of
MRSA; however, there is a lack of correlation regionally. For exam-
ple, in Southeast, S aureus susceptibility to ciprofloxacin declined
15.8%, while MSSA declined 0.5%. Nationally and regionally, per-
centages of S aureus and MRSA isolates susceptible to vancomycin
were similar (S aureus, range 99.6% to 99.9%; MRSA, range 99.4%
to 100%). Conclusions: Nationally and regionally, the majority of
S aureus and MRSA isolates remain sensitive to vancomycin. For S
aureus, nafcillin/oxacillin, ciprofloxacin, and levofloxacin show sim-
ilar rates of susceptibility; however, as sensitivity to ciprofloxacin
has decreased, MRSA levels have increased nationally.
Board 13. The Association Between Individual Treatment
with Oxytetracycline and Antibiotic Resistance and Virulence
Factors in Commensal E. coli in Cattle 
A. O'Connor1, K. Ziebell2, C. Poppe3, S. McEwen4
1Iowa State University, Ames, IA, 2Laboratory for Foodborne
Zoonoses, Health Canada , Guelph, ON, CANADA, 3Laboratory for
Foodborne Zoonoses, Health Canada, Guelph, ON, CANADA,
4Department of Population Medicine, University of Guelph, Guelph,
ON, CANADA
Commensal enteric bacteria may undergo selection pres-
sure and represent a reservoir of resistance or virulence genes for
potentially pathogenic bacteria. We examined the effect of individ-
ual antibiotic treatment on the prevalence of resistance to antibi-
otics in commensal fecal E. coli isolates from cattle. The E. coli
were also tested for the presence of verotoxin (VT) genes and two
accessory virulence factors: intimin (eae) and enterohemolysin
(hlyA). Fecal samples were collected between October and
December 1998 from bulls treated with injectable oxytetracycline
for respiratory disease. For each treated bull, samples were col-
lected from 2 untreated pen mates. From 26th December 1998,
for 16 days, all bulls received in-feed chlortetracycline. Final post-
treatment samples were collected in February 1999. Five E. coli
were isolated from each sample and tested for resistance to 19
antibiotics. Fecal samples were tested by a generic polymerase
chain reaction (PCR) capable of detecting all vt genes; when posi-
tive the 5 E. coli were further subtyped for the presence of vt1, vt2,
eae and hlyA genes. The unit of observation and analysis were the
isolate and the bull respectively. Wilcoxon‘s rank test compared the
distribution of the ranked prevalence of resistance between indi-
vidually treated and untreated bulls. To determine the effect of
time of sampling on the prevalence of VT an exact test for the bino-
mial distribution of the discordant pairs was used, the null hypoth-
esis being p = 0.5. Discordant pairs refer to bulls initially positive
(Oct to Dec) then negative at the second test (Feb) or visa versa.
This tests the concept that if time of sampling was unrelated to
becoming positive, then an equal number of bulls should change
from positive to negative for VT as change from negative to posi-
tive. Fishers exact test for comparison of multiple proportions
examined the effect of individual treatment on the distribution of
the counts of the paired outcomes for each virulence gene. From
83-paired samples 39 were individually treated and 44 were
untreated. Individual treatment was associated (p<0.05) with
increased prevalence of resistance to chloramphenicol and sul-
fisoxazole. 23 bulls were positive for VT at both samplings. The
point estimate and 95% confidence interval for the binomial distri-
bution of the discordant pairs tested for VT was 0.64, 0.46-0.80
(p=0.12). Among these 23 bulls, individual treatment was not asso-
ciated with increased prevalence of virulence genes. Therefore,
individual animal treatment appears to be associated with a change
in the prevalence of select antibiotics but unassociated with the
prevalence of genes. We also noted an effect of timing of sampling
on the prevalence of VT and resistance. Two factors that varied
between sampling times were mixing of the cattle and the addition
of chlortetracycline. The individual effects of these cannot be dif-
ferentiated given the study design.
Board 14. Analysis of the Aminolgycoside 6'-N-
Acetyltransferase Type Ib [AAC(6')-Ib] AcetylCoA Putative
Binding Site 
R. Sarno, G. Wisedchaisri, M. Petri, S. Delira, K. Kantardjieff, M.
Tolmasky
California State University Fullerton, Fullerton, CA
Aminoglycoside antibiotic use is threatened by inactivating
enzymes that eliminate the antibiotic‘s biological activity. The
pJHCMW1 plasmid, isolated from a clinical Klebsiella pneumoniae
strain, carries the transposon Tn1331, which confers resistance to
a wide variety of aminoglycosides as well as beta-lactam antibiotics.
The resistance to several aminoglycosides such as amikacin,
kanamycin, tobramycin, sisomicin, and netilmicin is due to the 6‘-
N-acetyltransferase type Ib [AAC(6‘)-Ib] which belongs to the
GCN5-related acetyltransferase superfamily. These proteins
include 4 conserved regions (motifs A - D). We performed a study
on amino acids present in motif A, a region that has been implicat-
ed in binding the donor acetylCoA molecule. Site-directed muta-
genesis was used to substitute the highly conserved Gly129, and
Gly131 amino acids of this motif. Substitutions of Gly131 for Tyr,
Ile, Lys, Val, Thr, Ala, or Gln and substitutions of Gly129 for Ile,
Leu, Pro, Phe, or Asn resulted in proteins with dramatically dimin-
ished ability to confer resistance to kanamycin or amikacin. Only
the Asn129 derivative was able to confer reduced but substantial
resistance to both antibiotics. These results suggest that the Gly
residues at this position play important roles in the enzymatic activ-
ity of AAC(6‘)-Ib. Hybrid fold recognition methods have been used
to generate a 3-D model of the AAC(6')-Ib which includes motifs
C, D, and A. This model is considered to have the correct fold at
the 99% confidence level. Our mutations occur in a proposed helix
loop region flanking the acetylCoA binding site. Altered activity
profiles may be explained by putative conformational changes that
would result from modified acetylCoA binding to accomodate
mutated side chains.
Board 15. Integron Gene Sequences on Retail Chicken Products 
M. T. Roe, C. M. Haas, S. D. Pillai
Texas A&M University, College Station, TX
Integron gene sequences have been shown to provide a
mechanism for the lateral gene transfer of antibiotic resistance
genes between bacteria. Previous work done in our lab has shown
















throughout all stages of poultry production. From this we hypothe-
sized that the integron gene sequence would be further present on
retail chicken products. In this study we examined the prevalence of
two classes of the integron gene sequence within the microflora of
retail chicken. A total of 15 chicken products (legs, breasts, and
thighs) were purchased from 5 retail markets and examined for total
heterotrophic bacterial loads, and the presence and characteristics
of integron sequences. Total microbial community DNA was
extracted and tested for the presence of the class 1 and class 2 inte-
gron gene sequence by PCR. All samples showed as expected high
levels of total heterotrophic bacteria (> 1x 105 CFU/ml). Further,
all samples 15 out of 15 (100%) showed the presence of the class 1
integron gene sequence and 8 out of 15 (53.3%) samples showed
the presence of the class 2 integron gene sequence. A number of
the class 1 integron variable regions were amplified and further
characterized by sequencing. Results indicate that the integron
gene sequence is prevalent within on-shelf poultry and serve as a
reservoir for antibiotic resistance gene cassettes. Studies to eluci-
date the potential for these gene cassettes to participate in gene
transfer events on chicken products are needed.
Board 16. Community-Onset and Healthcare-Associated
Methicillin Resistant Staphylococcus aureus in Minnesota, 2000 
K. LeDell1, T. Naimi1,2, S. Borchardt1, D. Boxrud1, J. Adams1, A.
Glennen1, K. Como-Sabetti1, S. Fridkin2, R. Danila1, R. Lynfield1
1Minnesota Department of Health, Minneapolis, MN, 2Centers for
Disease Control and Prevention, Atlanta, GA
Background: Community-onset (CO) methicillin resistant
Staphylococcus aureus (MRSA) is increasingly recognized among
patients outside the hospital setting who lack traditional MRSA risk
factors. To assess and characterize MRSA in MN, we initiated
prospective surveillance in 2000. The object was to compare CO
and healthcare-associated (HA) MRSA patient and isolate charac-
teristics. Methods: 12 sentinel MN hospital laboratories were
selected to represent different geographic regions. Sentinel sites
reported all cases of MRSA. Case information was collected;
MRSA isolates were obtained. Antimicrobial susceptibility testing
and pulsed-field gel electrophoresis (PFGE) subtyping was done
on all CO-MRSA isolates and 25% of HA-MRSA isolates. CO-
MRSA cases were patients with a positive MRSA culture obtained
within 48 hours of admission and no permanent indwelling
catheters or percutaneous devices, no history of hospitalization,
surgery, long-term care residence or dialysis in the prior year, and
no history of MRSA infection or colonization. Patients that met the
CO-MRSA case definition by chart review were interviewed to ver-
ify their medical history. Results: 4612 patients with positive S.
aureus cultures were identified; 25% (1164/4612) were MRSA
(range 9-50%). Of all MRSA cases, 85% (991/1164) were HA-
MRSA, 11% (133/1164) were CO-MRSA, and 3% (37/1164) could
not be classified. After interview, 13% of presumed CO-MRSA
cases were reclassified as HA-MRSA. CO-MRSA patients were
younger than HA-MRSA patients (median age 23 yrs vs. 68 yrs).
CO-MRSA patients were more likely to have MRSA isolated from
skin compared to HA-MRSA patients (74% vs. 40%; p <0.001).
Among all MRSA isolates, 119 distinct PFGE patterns and 5 clon-
al groups containing 3 or more isolates were identified. CO-MRSA
isolates (71%) were more likely than HA-MRSA isolates (18%) to
be clonal group A (OR 10.9; CI 6.3-18.9). CO-MRSA isolates were
more likely than HA-MRSA isolates to be susceptible to all of the
following: ciprofloxacin, clindamycin, TMP-SMX, and gentamicin
(OR=17.6; 95% CI 9.4, 33.0). Of CO-MRSA patients for whom
information was available, 63% (67/107) received a beta-lactam
antibiotic as initial therapy. Conclusions: Differences in age, site of
infection, antimicrobial susceptibilities, and PFGE patterns were
observed between CO-MRSA and HA-MRSA cases. CO-MRSA
strains have distinct features that may have led to their emergence
in the general population and may require new approaches for pre-
vention and control. CO-MRSA has important clinical conse-
quences, since isolates are resistant to beta-lactam agents, the most
common empiric therapy for outpatient infections. Studies are
needed to determine risk factors for CO-MRSA infection.
Continued surveillance will further define the epidemiology of CO-
MRSA and shape guidelines for prevention and control.
Board 17. Antimicrobial Resistance Pattern of Isolated
Bacterial Pathogens Obtained from Diarrheic Patients in
Indonesia
B. A. Oyofo1, P. J. Tjaniadi1, D. S. Subekti1, C. H. Simanjuntak2, W.
K. Alexander1, A. L. Corwin1, M. Lesmana1,3
1U.S. Naval Medical Research Unit No.2, Jakarta, INDONESIA,
2National Institute of Health Research and Development, Jakarta,
INDONESIA, 3Medical Faculty Trisakti University, Jakarta, INDONESIA
Antimicrobial resistance of emerging and reemerging
pathogens is of increasing concern to health care physicians. The
use of antibiotics has a well documented risk factor for infection or
colonization with resistant bacterial pathogens. The antimicrobial
susceptibility pattern for 1892 bacterial pathogens isolated from
diarrheal patients admitted to hospitals and community health cen-
ters located in the cities of Jakarta, Padang, Medan, Denpasar,
Pontianak, Makassar and Batam, Indonesia, were analyzed by the
disk diffusion method from 1995 to 1999, to determine their
changing trends in response to 9 antibiotics. Using routine culture
methods, Vibrio cholerae O1 (46.7%) was the pathogen most fre-
quently detected, followed by Shigella spp. (17.8%), Salmonella
spp. (14.5%), Vibrio parahaemolyticus (8.2%), Salmonella typhi
(4.9%), Campylobacter jejuni (3.4%), Vibrio non O1 (2.8%), and
Salmonella paratyphi A (1.0%). Of the 339 Shigella spp. isolated,
found were: Shigella flexneri (84%), Shigella sonnei (12%) and
Shigella dysenteriae (4%). The reemergence of Shigella dysenteri-
ae was noted in 1998 after an absence of 15 years. All V. cholerae
O1 were resistant to colistin. Shigella spp. were resistant to ampi-
cillin, trimethoprim/sulfamethoxazole, chloramphenicol and tetra-
cycline. Salmonella typhi was susceptible to all antibiotics tested,
while Salmonella spp. showed various resistance patterns according
to the species grouping. Campylobacter jejuni showed increasing
multiple resistance to ceftriaxon, norfloxacin and ciprofloxacin. All
bacterial isolates were susceptible to ciprofloxacin and norfloxacin,
with the exception of Campylobacter spp. and Salmonella group C.
Campylobacter jejuni was susceptible to erythromycin. This study
shows the emergence of resistant bacterial pathogens to
quinolones in Indonesia.
Board 18. Prevalence of Aminoglycoside Resistance Among
Enterococci Isolated from Poultry and Swine
C. R. Hudson, P. J. Fedorka-Cray, J. B. Barrett, S. R. Ladely
USDA-ARS-ARRU, Athens, GA
In this study, the prevalence of resistance to three amino-
glycosides (gentamicin, kanamycin, and streptomycin) in entero-
cocci isolated from poultry and swine was examined. One hundred
and sixty-two enterococci from poultry and 444 enterococci from
swine were isolated and speciated. The predominant species
identified were Enterococcus faecium (n=105), followed by
Enterococcus faecalis (n=40), and Enterococcus durans (n=8)
from poultry and Enterococcus durans (n=175), followed by
Enterococcus faecalis (n=120), and Enterococcus faecium
(n=106) from swine. Approximately 74% of the poultry enterococ-
ci and 60% of the swine enterococci were resistant to at least one
aminoglycoside. Using PCR, the isolates were also examined for
the presence of 12 aminoglycoside resistance genes (ant(6)-Ia,
ant(6)-Ib, ant(9)-Ia, ant(9)-Ib, ant(4‘)-Ia, ant(3’)-Ia, aph(3‘)-IIIa,
aph(2’)-Ib, aph(2’)-Ic, aph(2’)-Id, aac(6‘)-Ie-aph(2’)-Ia, and
aac(6‘)-Ii). Eight of these resistance genes were identified in the
isolates, most frequently aac(6‘)-Ii and ant(6)-Ia from E. faecium
from both poultry and swine samples. E. faecium also contained
the highest combination of resistance genes for both poultry and
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swine. Thirty-seven percent of E. faecium from poultry contained
aac(6‘)-Ii-ant(6)-Ia-aph(2’)-Ic while 21% from swine contained
aac(6‘)-Ii-ant(6)-Ia-aph(3’)-IIIa. Seven isolates exhibiting high-
level resistance to all three antimicrobials (MIC ≥ 1024 µg/ml)
were negative for all genes tested. These data suggest that entero-
cocci from animal sources contain diverse and potentially uniden-
tified aminoglycoside resistance genes.
Board 19. The Gene bolA Ensures Survival by Linking 
Cell Wall Metabolism with Cell Division: Implications or
ß-Lactam Resistance
J. M. Santos1,2, M. B. Lobo1, A. P. Alves de Matos3,4, C. M. Arraiano1
ITQB/ Universidade Nova de Lisboa, Oeiras, PORTUGAL,
2Universidade de Aveiro, Aveiro, PORTUGAL, 3Hospital Curry
Cabral, Lisboa, PORTUGAL, 4Faculdade de Medicina Dentária/
Universidade de Lisboa, Lisboa, PORTUGAL
The gene bolA has been shown to trigger the formation of
osmotically-stable round cells when overexpressed in stationary
phase. Our results show that in poor growth conditions bolA is
essential for normal cell morphology in stationary-phase and in
response to sudden carbon starvation. We also show an unprece-
dented bolA-related phenotype in exponentially-growing cells
based on transmission electron microscopy results. In exponential
growth bolA promotes round morphology through a mechanism
which is exclusively dependent on the two main E. coli D,D-car-
boxypeptidases PBP 5 and PBP 6. We show that somehow bolA
controls the levels of transcription of dacA (PBP 5), dacC (PBP
6), and ampC (AmpC), a class C ß -lactamase, thus connecting for
the first time PBPs and ß -lactamases at the level of gene regula-
tion. Furthermore, PBP 5 and PBP 6 are shown to be regulated
and to have distinct effects on the the peptidoglycan layer.
Presented evidence demonstrates that bolA can confer resistance
to ß -lactams by two different pathways: a stress-mediated mech-
anism and a stress-independent route, which involves aquired
tolerance to these antibiotics. bolA seems to be a regulator of cell-
wall biosynthetic enzymes with different roles in cell morphology
and cell division.
Board 20. Detection of Antibiotic-Resistant Enteric Bacteria 
in Groundwater in the Vicinity of Swine Farms in Eastern
North Carolina 
M. E. Anderson, M. D. Sobsey
University of North Carolina at Chapel Hill, Chapel Hill, NC
About half of the antibiotics produced globally flow into the
agricultural industry. Antibiotics are used heavily by the United
States commercial swine industry for growth promotion and dis-
ease treatment. This use of antibiotics has led to high proportions
of multiply antibiotic-resistant enteric bacteria being fecally shed
by swine and other agricultural animals, and growing concerns
about the spread of these bacteria into environmental media. A
study was conducted to determine enteric bacterial occurrence and
extent of release of antibiotic-resistant bacteria from swine farms
into groundwater. Four study sites with known groundwater flow
paths were screened for enteric bacteria and coliphages. These
sites include two swine farms with lagoons and land application of
the swine waste, one farm with land application of swine wastes but
no swine present, and a farm with only crops and no land applica-
tion of swine wastes or swine present. Of a total of 48 study wells,
25% were positive for enterococci, 17% were positive for
Escherichia coli and only one well (~2%) was positive for both
somatic and male-specific coliphages. Of the total of 115 entero-
cocci isolates, 34% were Enterococcus faecium, and 5% were E.
faecalis, both of which are species associated with fecal contamina-
tion, and can be pathogenic. Of 45 presumptive E. coli isolates,
89% were confirmed by biochemical testing. The bacterial isolates
were tested for antibiotic resistance using a panel of 17 drugs that
are typical of human and veterinary use. The enterococci isolates
were predominantly resistant to four or fewer antimicrobials,
including streptomycin, gentamicin, neomycin and clindamycin; a
few were pan-resistant and the predominant resistance patterns of
the isolates differ among study sites. For example, one swine farm
isolate was resistant to ten antimicrobials: vancomycin, chlortetra-
cycline, tetracycline, trimethoprim, chloramphenicol, erythromy-
cin, ampicillin, florfenicol, tylosin base, and clindamycin. The
majority of the E. coli isolates were resistant to three or more
antimicrobials (e.g., tetracycline, tylosin base and clindamycin),
with a few also showing pan-resistance to eight or nine drugs and
differences in antimicrobial resistance among the study sites. For
example, one swine farm isolate was resistant to nine antimicro-
bials: chlortetracycline, tetracycline, trimethoprim, chlorampheni-
col, gentamicin, ampicillin, florfenicol, tylosin base, and clin-
damycin. The results of this study demonstrate that antibiotic-
resistant enteric bacteria are present in groundwaters of swine
farms that have the lagoon and land application system for waste
management. The extent to which such contamination of ground-
water with multiple antibiotic-resistant enteric bacteria poses risks
to human health is uncertain and deserves further investigation.
Board 21. Risk Factors for Emerging Antimicrobial
Resistance in Helicobacter pylori Infection in the United States 
W. M. Duck, B. D. Gold, J. M. Pruckler, Q. Song, A. Sulka, B.
Swaminathan, J. Sobel and the HARP Working Group
Centers for Disease Control and Prevention, Atlanta, GA
Introduction: Helicobacter pylori (HP) infection is the
principal cause of primary gastritis, peptic ulcer disease, and is
strongly associated with gastric adenocarcinoma. Therapy entails
complicated multi-antimicrobial dosing regimens administered for
at least two weeks. Widespread use of antimicrobials for various ill-
nesses may induce antimicrobial resistance among HP isolates. The
Helicobacter pylori Antimicrobial Resistance Monitoring Project
(HARP) is the only prospective, multi-center U.S. network tracking
regional and national prevalence rates of HP resistance. Methods:
Beginning in 1998, 11 U.S. medical centers submitted HP isolates
obtained at diagnostic upper endoscopy to CDC for antimicrobial
resistance testing. Each isolate is linked to a case report form with
clinical and epidemiologic patient data. Susceptibility testing was
performed using agar dilution methodology, with validated quality
controls strains and standardized break points according to NCCLS
guidelines. Univariate analysis was performed with SAS version 8.2.
Results: From December 1998 until May 2001, 352 HP isolates
were submitted by participating sites. Susceptibility testing was per-
formed on 325 isolates; 99 isolates (30.5%) were resistant to 1
antimicrobial, and 15 (4.6%) were resistant to 2 antimicrobials.
Among 325 isolates, 73 (22.5%) were resistant to metronidazole
(MET), 24 (7.4%) to clarithromycin (CLA), and 2 (0.6%) to amoxi-
cillin (AMOX). Of 15 isolates resistant to 2 antimicrobials, 1 (6.6%)
was resistant to CLA and AMOX and 14 (93.3%) were resistant to
CLA and MET. One-hundred ninety-four patients (63.0%) were
male and 114 (37.0%) were female, the median age was 58 range, (3-
94), 122 (40.3%) were white, 165 (54.5%) were black, and 10 (3.3%)
were Asian. In univariate analysis, factors associated with infection
by resistant HP were: antacid use in 12 months preceding endoscopy
(OR=1.8, 95% CI, 1.1-3.1); use of ZantacR or TumsR in 30 days pre-
ceding endoscopy (OR=2.7, 95% CI, 1.2-6.1 and OR=3.3, 95% CI,
1.3-8.8, respectively); non-white race (OR=1.7, 95% CI, >1.0-2.7);
earnings > $30,000/yr; (OR=1.8, 95% CI, 1.1-3.2); and residence in
rural or farm area (OR=3.5, 95% CI, 1.2-10.8). Conclusions: HP
antimicrobial resistance to CLA, AMOX, and MET is prevalent
among endoscopy patients at HARP project sites and is associated
with preceding antacid use. Association of demographic and soci-
coecomonic factors with resistance requires further evaluation, and
has potential future implications for screening and treatment strate-
gies. Expanding HARP to increase project population representativ-
ness will enhance monitoring HP resistance on a regional and
















Board 22. The Epidemiology of Community-Onset
Methicillin-Resistant Staphylococcus aureus (MRSA) Infection/
Colonization in the Atlanta Metropolitan Area, 2001
V. H. Rego1, J. C. Hageman2, J. Sitz1, W. Baughman1, M. M.
Farley3, J. A. Jernigan4, S. K. Fridkin2
1Atlanta VA Med Ctr and Georgia Emerging Infections Program,
Decatur, GA, 2Centers for Disease Control and Prevention, Atlanta,
GA, 3Emory Univ Sch of Med and Atlanta VA Med Ctr, Atlanta, GA,
4Centers for Disease Control and Prevention and Emory Univ Sch of
Med, Atlanta, GA
Background: Methicillin resistance in Staphylococcus
aureus is becoming a public health concern because of its emer-
gence in the community setting. Most reports have been hospital-
based and limited to medical record review. Objectives: To deter-
mine the epidemiology of community-onset (CO) MRSA infec-
tions/colonizations in the 8 county Atlanta metropolitan area, pop-
ulation approximately 3.1 million. Methods: Prospective review of
laboratory reports of MRSA isolates from hospital laboratories and
reference laboratories serving 32 hospitals and many outpatient
settings. A case of MRSA is considered healthcare (HC)-associated
(HCA) if ANY of the following criteria are present: hospitalized >
48 hrs prior to MRSA culture; previous MRSA isolation; dialysis,
surgery, or hospitalization in the past year; or a percutaneous or
indwelling device in place at the time of culture. Cases are initial-
ly screened by consulting hospital personnel and reviewing medical
records. If no HCA criteria are documented, the case is inter-
viewed to identify previously unrecognized HC associations. If no
HCA criteria are present, it is considered a CO case. Results: Data
for January 1 through June 30, 2001 identified 2041 incident cases
of MRSA. On initial screen, 141 (6.9%) of the cases met no docu-
mented HCA criteria and required a telephone interview. 42 of the
141 have been interviewed; 29/42 (69%) were confirmed as CO. 21
of the 29 (72.4%) had clinically relevant infections: skin infection
(10), sinusitis (3), soft tissue infection (2); and one each of
osteomyelitis with secondary bacteremia, endocarditis, primary
bacteremia, conjunctivitis, diverticulitis, and bronchitis. 1 (3.5%)
was considered a contaminant; 7 (24.1%) were of indeterminate
relevance. The median age for CO cases was 39.5 yrs compared
with 69 yrs for HCA cases (p<0.01). 69% of the CO cases were
male compared with 48% for HCA cases (p=0.02). At the time of
interview, HC exposures were identified that fell outside of the
HCA criteria in 18 (62%) of the 29 CO cases: 15 cases received
antibiotics and 3 were employed in the HC sector in the previous
year; 9 had been hospitalized in the prior 2-5 years. Conclusion:
Preliminary results indicate that CO MRSA represents < 7% of all
MRSA in Atlanta. CO cases were more common in younger males
and involved skin and soft tissue infections in more than half of the
clinically relevant cases. Healthcare exposures were identified dur-
ing the interview that may provide insight into the acquisition of
MRSA in the community.
Board 23. Transmission of the blaCMY-2 gene from
Salmonella enterica Serotype Newport in the Dairy Farm
Environment
S. C. Rankin, H. Aceto, R. Munson, J. Cassidy, J. P. Holt, D. S.
Munro, C. E. Benson
University of Pennsylvania, Kennett Square, PA
Background: The incidence of multiple drug resistant
strains of Salmonella enterica serotype Newport isolated from farm
animals in Pennsylvania has increased in the past 12 months.
Isolates are most frequently bovine in origin and primarily come
from dairy facilities. The organism is resistant to cephalosporin
antibiotics due to the presence of the blaCMY-2 gene on a large
plasmid. The predominant 140kb resistance plasmid has been
shown to be non-conjugative, but it can be mobilized. This study
was designed to determine whether transfer of the resistance plas-
mid, and thus the blaCMY-2 gene, occurred readily between
organisms from a dairy farm environment. Methods: In
September 2001 the Field Investigation Group were invited to visit
a 350 cow dairy farm that had recently suffered calf and cow mor-
talities due to Salmonella Newport infection. Prior to serotype
identification, animals on this farm were being treated for diarrheal
disease with ceftiofur. Thirty-five samples were obtained from a
variety of sources that included individual cows and calves, feed,
drinking water, pooled fecal samples from the calf and cow pens,
bird feces, cat feces and a variety of additional environmental sam-
ples. All samples were held at 4ºC overnight and delivered to the
Salmonella Reference Center for processing. Following pre-
enrichment in buffered peptone water, samples were sub-cultured
to MacConkey agar (MAC), deoxycholate citrate agar, sodium
selenite broth and Rappaport Vassiliadis broth. Four colonies that
were classified as non-salmonella by visual identification were sub-
cultured from the initial MAC plates to a fresh MAC plate. A cef-
tiofur disk (30µg) was added to identify resistant organisms. All
resistant organisms were identified using Sensititre AP80 Gram
negative identification plates and tested for the presence of the
blaCMY-2 gene by PCR. Results: Twelve of the 35 samples (34%)
were positive for Salmonella Newport. Of 140 non-salmonella-like
colonies tested 29 (21%) were resistant to ceftiofur. One isolate was
positive by PCR for the presence of the blaCMY-2 gene and this
isolate was subsequently found to be Salmonella Newport. Other
genera identified included Enterobacter, Citrobacter, Providencia,
Proteus, and Pseudomonas. The alternate mechanism(s) of
cephalosporin resitance are under further investigation.
Conclusions: Multiple drug resistant Salmonella Newport was iso-
lated from sick cows and environmental samples from a
Pennsylvania dairy farm. Cephalosporin resistance was observed in
other genera but, in this instance, there was no evidence to support
transfer of the blaCMY-2 gene from Salmonella Newport to other
organisms in the environment.
Board 24. Susceptibility Testing Practices for Streptococcus
pneumoniae, 2000:Are Laboratories Prepared To Monitor
Antibiotic Resistance? 
I. Chuang1, N. L. Barrett2, D. R. Feikin3, A. Reingold4, K. Gershman5,
K. McCombs6, L. H. Harrison7, S. Johnson8, J. R. Hibbs9, P. R.
Cieslak10, A. Craig11, J. Jorgensen12, C. G. Whitney13
1Centers For Disease Control & Prevention, Atlanta, GA, 2Connecticut
Department of Public Health, Hartford, CT, 3Centers for Disease
Control and Prevention, Atlanta, GA, 4California Emerging Infections
Program, Berkeley, CA, 5Colorado Emerging Infections Program,
Denver, CO, 6Georgia Department of Human Resources, Atlanta,
GA, 7Epidemiology and Medicine, Pittsburgh, PA, 8Minnesota
Emerging Infections Program, Minneapolis, MN, 9New York
Emerging Infections Program, Albany, NY, 10Oregon Emerging
Infections Program, Portland, OR, 11Tennessee Emerging Infections
Program, Nashville, TN, 12University of Texas Health Science Center
at San Antonio, San Antonio, TX, 13Centers for Disease Control &
Prevention, Atlanta, GA
Background: Pneumococcus causes 63,000 invasive infec-
tions and 6,100 deaths per year in the US. A high proportion of
pneumococci have become resistant to antibiotics. Because antibi-
otic susceptibility results are increasingly important for guiding
therapy decisions and for monitoring emerging resistance patterns,
we conducted a survey to assess laboratory practices for suscepti-
bility testing in 2000. Methods: The survey was sent to clinical lab-
oratories located in the nine Active Bacterial Core surveillance
(ABCs) areas in 2000. Survey questions addressed the susceptibil-
ity testing methods used for invasive isolates, compliance with cur-
rent National Committee for Clinical Laboratory Standards
(NCCLS) guidelines, selection of antibiotics for routine testing,
and methods for reporting susceptibility results. Results: Of 659
laboratories surveyed, 547 (83%) responded. Three hundred and
fifty-three (65%) laboratories reported doing at least some suscep-
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tibility testing of pneumococcal isolates in-house. More than half
(n = 188, 53%) of the laboratories performed oxacillin disk screen-
ing before doing confirmatory minimum inhibitory concentrations
(MICs) testing for invasive isolates, a practice discouraged by
NCCLS because it delays reporting of the MIC results. Nearly all
(n = 351, 99%) of the laboratories performed MIC either in house
or at a reference laboratory. Of the 250 laboratories performing in-
house MIC testing, the majority (n = 222, 88%) of laboratories
used appropriate MIC methods for penicillin susceptibility testing.
Most laboratories (n = 190, 76%) performed susceptibility testing
for penicillin, cefotaxime or ceftriaxone, and vancomycin on iso-
lates from patients with life-threatening infections as recommend-
ed by NCCLS. Only 39% (n = 98) of laboratories performed sus-
ceptibility testing against fluoroquinolones, a first-line agent for
community-acquired pneumonia. Some laboratories reported
either the exact MIC values (n = 35, 14%) or the interpretations
(i.e., susceptible [S], intermediate [I] or resistant [R]; n=66, 26%),
rather than reporting both (n = 137, 55%) as recommended.
Conclusions: Although the majority of clinical laboratories were
using appropriate methods for pneumococcal susceptibility testing,
there were some inconsistencies with NCCLS guidelines. Because
of the recent increase in fluoroquinolone use, both to treat pneu-
monia and in response to the recent anthrax attack, more laborato-
ries should consider testing isolates for fluoroquinolone resistance. 
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Board 25. Brucellosis among Persons at High-Risk
Occupation 
A. M. Abou-Eisha
Suez Canal University, Ismailia, EGYPT
Brucellosis is considered one of the most important zoonot-
ic diseases constituting a public health problem throughout the
world, particularly in the developed countries. This study was to
determine the prevalence of brucella infections among persons at
high- risk occupation. A total of 1316 persons (886 at high-risk and
430 of city dwellers), from Ismailia and Port Said provinces, Egypt,
was first screened for brucella antibodies by Rose Bengal test
(RBT) to measure the exposed rate. Reactive sera were further
analyzed by the standard tube agglutination test (STAT). The
prevalence of brucella infections among the examined persons was
5.1% (67 out of 1316 human sera). The highest infection rates were
recorded among veterinary assistants (44.4%) followed by veteri-
narians (23.5%) then abattoir workers (11.6%), farmers and their
families (3.1%), and lastly the city dwellers (1.6%) that were not in
contact with the farm animals. The seroprevalence among farmers
and city dwellers was not influenced by sex. All isolates were iden-
tified and biotyped as Brucella melitensis biovar3 (4 isolates) that
isolated from human blood of four seropositive persons at high-risk
occupation had STA-antibody titers of ≥1:1280. The current study
found a very high risk associated with assisting in animal parturition
and contact with the blood of infected animals but no significant
risk associated with other direct animal contact. Such findings
could be used as means to locate cases of human brucellosis and
design measures to control brucellosis in man and animals.
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Board 26. Bioterrorism-Related Anthrax: CDC’s International
Response 
C. S. Polyak, J. T. Macy, M. Irizarry-De La Cruz, J. E. Lai, J.
McAuliffe, T. Popovic, E. D. Mintz, and the EOC International Team
Centers for Disease Control and Prevention, Atlanta, GA
Immediately following reports of the intentional release of
Bacillus anthracis in the United States, epidemiologists, microbiol-
ogists and clinicians around the world were called upon to respond
to widespread political and public concerns. Specific threats, hoax-
es and incidents in other countries directly affected citizens and
expatriate U.S. government employees, businessmen, journalists
and travelers. The Centers for Disease Control and Prevention
(CDC) established an international team in the Emergency
Operations Center to respond to inquiries for assistance from other
countries regarding anthrax and bioterrorism.
During 12 October - 12 December, CDC’s international
team received 128 requests from 68 countries and 2 territories. An
average of 3.3 requests per day (peak 9 requests on October 19)
were received by email (56.3%) and phone (43.8%). Of the 128
requests, 52 (40.6%) were laboratory related; 51 (39.8%) were gen-
eral requests for bioterrorism information; 14 (10.9%) were for
environmental or occupational health guidelines; and 11 (8.6%)
were about developing bioterrorism preparedness plans. Ninety-
one (71.1%) of the requests were from persons or agencies affiliat-
ed with Ministries of Health; 15 (11.7%) were from other public
health or medical professionals; 13 (10.1%) were from private citi-
zens; and 9 (7.0%) were from international organizations. Europe
and Central/South America each accounted for 25% of the total
requests; followed by Asia (17.2%) and Africa (11.7%).
Of the 68 countries and 2 territories, 55 (78.6%) countries
received phone and/or email consultation regarding issues con-
cerning bioterrorism events and/or preparedness. The remaining
15 (21.4%) countries received a high level of support including
CDC testing of specimens (n=10). CDC confirmed three isolates
from outside of the U.S. as B. anthracis. Two of these isolates were
recovered from State Department mail pouches sent to the U.S.
embassy in Peru. The other isolate was obtained from Chile in a
letter sent to a private physician; this isolate was a different subtype
from the strain isolated in the U.S.
The team disseminated documents on anthrax and bioter-
rorism preparedness to 130 CDC employees stationed in 41 coun-
tries and to epidemiologists and microbiologists in 111 countries
through the Training Programs in Epidemiology and Public Health
Interventions Network (TEPHINET) and World Health
Organization (WHO) Global Salm-Surv listservs. The team collab-
orated with the WHO and the CDC International Emerging
Infections Program in Thailand to develop and support a training
course in anthrax management held in Bangkok and attended by
representatives from 14 countries.
The information and technical support provided by CDC’s
international team helped allay fears, prevent unnecessary antibi-

















Board 27. Emergency Department and Walk-in Center
Surveillance for Bioterrorism: Utility for Influenza Surveillance
N. M. Bennett, J. Konecki
University of Rochester School of Medicine & Dentistry, Rochester, NY
Emergency departments (ED’s) and ambulatory care set-
tings often identify unusual occurrences of communicable disease.
Immediately following the identification of the first case of anthrax,
the New York State Department of Health asked local health units
to establish ED-based surveillance. The Monroe County
Department of Health established ED and walk-in center surveil-
lance that included tracking of influenza-like illness (ILI), as well
as total numbers of visits and unusual illness or clusters.
Methods: The Health Director convened a meeting of the
directors of all the local ED’s to discuss the need and rationale for
BT surveillance and to request that they institute the system with-
in one week. A form was developed, for submission by fax or e-
mail, which included number of total and ILI visits per 24-hour
period, as well as information regarding any unusual illnesses. The
form also included phone and pager numbers for consultation with
public health physicians. The surveillance covered the five acute
care hospitals that serve a population of approximately 1.25 million
people in the Rochester, NY region. In addition, several geograph-
ically separated walk-in clinics reported respiratory vs. non-respi-
ratory disease visits. Patterns of ED and clinic use are compared to
laboratory reporting of influenza cultures and results of sentinel
site surveillance and absenteeism.
Results: All ED’s and the walk-in clinics instituted surveil-
lance on the requested date (10/8/01). Two ED’s reported by e-
mail and three by fax or phone by noon each day. Compliance has
required occasional reminders, but data are complete. ED’s with-
out electronic triage data have developed systems to identify ILI.
ED visits to all hospitals averaged 4435 (SD=227) per week with an
average of 8% (SD=1%) for ILI at baseline. Clinic visits averaged
173 (SD=16) for respiratory illness and 282 (SD=32) for non-res-
piratory illness. The sensitivity and specificity of the system for
identifying influenza will be studied during the winter of 2002.
Conclusion: Baseline use of ED’s and walk-in clinics is
remarkably consistent suggesting the usefulness of these data for
tracking unusual communicable disease activity, including influen-
za, in the community. In addition to improving ED and LHU com-
munication to assure the early identification of a BT event, this sys-
tem has been useful to track influenza and thus, to manage care in
a community with insufficient ED and hospital capacity.
Board 28. PHLS Response to the Threat of Bioterrorism in
England & Wales 
N. Asgari-Jirhandeh, N. Lightfoot, J. Kramer, D. Cooper, S.
Gregor, E. Collins, A. Nicoll, On behalf of PHLS Deliberate
Release Response Teams
Public Health Laboratory Service, Various Locations, UNITED 
KINGDOM
The Public Health Laboratory Services (PHLS) is a nation-
al network organisation set up in 1939 initially to provide defence
against biological warfare during World War Two. It delivers gen-
eral and specialist microbiological services, surveillance and public
health support for communicable disease control and health pro-
tection. Its two main centres are the Communicable Disease
Surveillance Centre and the Central Public Health Laboratory are
in London but the network extends throughout England & Wales.
The PHLS has been preparing for bioterrorism for a number of
years and accelerated its work since September 11th and the delib-
erate releases of anthrax in the USA. The PHLS has been both
proactive and reactive in its management of the situation. Its work
supporting the UK’s national response to bioterrorism have been in
the following categories:
• Assessing, identifying and strengthening appropriate refer-
ence labs for specific diseases
• Preparing detailed peer- reviewed guidelines for clinicians
and health professionals
• Rapidly establishing laboratories with additional testing
capacity
• Technical information on deliberate release on a single
web-site platform at
www.phls.co.uk/facts/deliberate_releases.htm
• Devising alert and surveillance mechanisms for hospitals
to detect potential cases of key infections
• Testing the potential of a pre-existing primary care tele-
phone system (‘NHS Direct’) to detect large scale events
• Identifying and tracking any potentially exposed people
from abroad who may come to UK
• Supporting other agencies to provide cohesive plans in the
event a deliberate release of unknown substances
• Providing expert advice to the Department of Health and
the Cabinet Office
• Acting as a point of information for healthcare providers
• Auditing current organisational procedures in order to
improve their effectiveness
In the six weeks following the first anthrax case in the USA,
the volume of phone calls by concerned health care professionals
and public to CDSC increased by over 600% with a peak in
October, while the number of press enquiries to PHLS jumped by
400%. In response to the needs of the health professionals, by the
third week of October, the number of original postings at the
PHLS website had increased by over 600% compared to before
October 2001.
During this period, PHLS has been working with other
organisations to arrange appropriate levels of laboratory support
and division of labour for various biological agents. This was useful
particularly during follow up of exposed people where serological
confirmation was essential. Furthermore, during an epidemic of
‘white powder incidents’ in UK, PHLS in conjunction with police
and other government organisations was able to increase the
national anthrax-testing laboratory capacity and respond to the
needs of the emergency services.
Board 29. Urgent Prophilaxis in an Epidemic Focus 
V. P. Batmanov, V. I. Ilyukhin
Volgograd Plague Control Research Institute, RUSSIAN FEDERATION
Urgent prophylaxis (preventive treatment) constitutes a com-
plex of medical measures to prevent the development of the disease
in humans in case of suspicion of contagion with dangerous infection
agents. Urgent prophylaxis should be conducted immediately after
establishing a fact of bacterial or viral infection, or appearance of
dangerous infectious disease cases among population, and also in
case of massive infectious diseases of unidentified etiology, and it
assures prompt protection of infected persons.
Urgent prophylaxis is divided into general and special.
General urgent prophylaxis should be conducted before identifica-
tion of the type of agent. After the final diagnosis, special urgent pro-
phylaxis should be conducted (vaccines, sera, bacteriophages,
immunoglobulins). We believe that as means of general urgent pro-
phylaxis it is reasonable to use easily available antibiotics with diverse
mechanism of action, active against the majority of known dangerous
infectious diseases. Duration of the course of general urgent pro-
phylaxis is governed by probable incubation period and the time
necessary for identification of the etiological agent and determina-
tion of its susceptibility to antibiotics, and averages 2 - 5 days.
Efficiency of the measures of urgent prophylaxis largely
depends on the right selection of drug combinations and their
timely use. Urgent prophylaxis should be conducted virtually for all
the exposed or infected population, taking into account the usual
counterindications. If urgent prophylaxis for the public is required
in case of unidentified agent, one of the following combinations
can be recommended:
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1. Doxicycline + rifampicin
2. Ciprofloxacin (or ofloxacin, or pefloxacin) + rifampicin
3. Co-trimoxazole + rifampicin
These preparations should be prescribed in maximal allow-
able daily doses recommended by the manufacturers.
These preparations, with diverse mechanisms of antibacter-
ial action, inhibit formation of resistance and act on the strains
which probably have resistance to one of these preparations. The
above combinations can be efficacious against the following dis-
eases: plague, tularemia, anthrax, brucellosis, pseudotuberculosis,
legionellosis, cholera, glanders, and melioidosis.
Board 30. Clinical Validation Study of the EMS 911
Syndromic Surveillance System for Bioterrorism or Pandemic
Influenza in New York City 
J. A. Greenko, F. Mostashari, A. Fine, M. Layton
New York City Department of Health, New York, NY
Introduction: Since March 1998, New York City has used
citywide Emergency Medical Services (EMS) ambulance dispatch
data to monitor for a community-wide rise in influenza-like illness
(ILI), which could be an early marker of a large outbreak caused
by bioterrorism (e.g. inhalational anthrax) or influenza. This syn-
dromic surveillance system analyzes data from seven of 52 call-
types, which were selected because they were markers for respira-
tory and/or viral symptoms thought to have the highest sensitivity
for detecting increases in ILI. This study sought to clinically vali-
date this novel surveillance system.
Methods: A retrospective review of all visits to six selected
high-volume emergency departments (EDs) was conducted for a
24-hour period on January 19, 1999. The objectives were to vali-
date whether or not these call types accurately capture patients
with ILI, and to compare ILI patients arriving by ambulance to
those presenting to the ED by other means. These cross-sectional
surveys were conducted using standardized data extraction forms
and a standard case definition of ILI consisting of fever AND
cough or sore throat.
Results: A total of 2294 ED visits were reviewed, with 522
patients (23%) meeting the case definition for ILI, 64 (12%) of
whom came by ambulance. The combination of selected call types
had a sensitivity of 72% for clinical ILI, and a Predictive Value
Positive (PVP) of 24%. When compared to individuals not brought
in by ambulance, those who utilized the EMS system were older,
more likely to complain of chest pain and shortness of breath, have
abnormal lung sounds, receive a chest X-ray, be diagnosed with
pneumonia, and be admitted to the hospital (p<0.05 for all com-
parisons). A third of those brought in by ambulance had been sick
for one day or less. However, the median time since onset of symp-
toms was similar for the two groups (48 hours).
Conclusion: This ambulance dispatch data-based syn-
dromic surveillance system is sensitive for early detection of ILI.
Individuals with symptoms that might occur during the prodromal
phase of inhalational anthrax (chest pain, shortness of breath) were
more likely to utilize the EMS system, and usually did so early in
the course of illness. This population-based surveillance system has
the potential to assist in the early detection of a bioterrorist attack
or a significant respiratory event and would facilitate prompt pub-
lic health intervention.
Board 31. Enhanced Passive Surveillance for Anthrax, New
York City, 2001 
S. Balter1, A. Fine1, D. Weiss1, M. Phillips1,2, K. Bornschlegel1, C.
Van Beneden3, M. Fischer2, D. Feikin2, B. Nivin1, P. Thomas1, M.
Layton1, The NYCDOH-CDC Anthrax Surveillance Team1,2
1New York City Department of Health, New York, NY, 2Centers for
Disease Control and Prevention, Atlanta, GA, 3Centers For Disease
Control and Prevention, Atlanta, GA
Background: Following the terrorist attacks on the World
Trade Center on Sept. 11th 2001, and the subsequent announce-
ment of a case of inhalational anthrax in Florida on Oct 4th, 2001,
the New York City Department of Health (NYCDOH) initiated
enhanced passive surveillance for a biologic agent attack including
anthrax in New York City. Methods: On Sept. 12, the NYCDOH
began sending broadcast fax alerts promoting bioterrorism aware-
ness to all New York City Hospitals. On October 4th, all hospital
Emergency Departments, Infection Control Departments and lab-
oratories in New York City were called to alert them to the Florida
case and request immediate reporting of suspect cases.
Laboratories were instructed to call and submit any isolate that was
a non-motile, non-hemolytic gram-positive bacilli. A broadcast fax
alert on clinical recognition, diagnosis and reporting of anthrax was
sent to Emergency Departments, laboratories, Infection Control
Directors, Infectious Disease Directors, Radiology Departments
and intensive care units via broadcast fax and e-mail. Broadcast
alerts were faxed and e-mailed 1-2 times/week to update providers
and posted on the NYCDOH website. An anthrax hotline for med-
ical providers was staffed 24 hours a day. Hotline numbers were
publicized in the weekly alerts and on the web. Providers reporting
suspect cases were transferred to a 24-hour on-call communicable
disease physician. Dermatology consultation was arranged at two
academic dermatology clinics so cutaneous cases could be quickly
assessed. Suspect cases were triaged over the phone as a)highly
suspect b)additional evaluation needed by provider, c)not likely to
be a case. Highly suspect cases were actively managed by NYC-
DOH personnel including: physical examination and/or digital
photographic examination, interview, chart review, and submission
of specimens to the NYC Public Health Laboratory and CDC.
Frequent follow-up occurred to monitor clinical status and to relay
laboratory results. Results: Seventeen broadcast alerts were sent
in Oct. and Nov.; the communicable disease hot-line received >
600 calls reporting suspected cases of anthrax. Ninety-four cases
were highly suspect. Seven cases of cutaneous anthrax and 1 case
of inhalational anthrax were identified: 3 were reported by infec-
tious disease physicians (including the inhalational case), 1 by a
dermatologist, 1 by a public health doctor, 1 by an emergency
physician and 2 patients self-reported. Conclusion: This outbreak
highlighted the need for public health agencies to develop proto-
cols for rapid implementation of enhanced surveillance in response
to terrorism attacks including several modalities--broadcast fax,
hotlines, websites, e-mail-- to facilitate communication with
healthcare providers to rapidly identify new cases.
Board 32. Response to Anthrax Terror Attacks in the 
Winter Season 
A. Flahault, F. Carrat, C. Viboud, T. Hanslik, A. Valleron
Inserm, Paris, FRANCE
The fear to suffer from anthrax rather than influenza even
after having detected influenza outbreak in the area may lead to
panic attitudes. We recommend that all potentially exposed per-
sons should be preventively vaccinated against influenza, such as
health professional, municipal employees, postmen and post-
women and other people who may be involved at any stage in the
control process of bioterrorism.
An appropriate search for risk factors of anthrax exposure
may be practiced in all influenza-immunized persons consulting
with ILI and in all non previously immunized persons with ILI (i.e.
having received or handled a suspicious mail, or having been in a
place of known exposure to Anthrax as determined by public health
authorities). These two simple measures (influenza vaccination in
risk groups and individual search for risk factor to anthrax expo-
sure), may avoid antibiotics supplies to shorten, desorganization to
occur, and true victims of anthrax not to receive appropriate care.
These attitude may also dissuade the temptation for such a confu-
sion by the terrorists. Even if ILI due to other natural viral origins
















against ILI has been estimated to be around 66% IC95% [52%-
79%], ranging from 16% and 83% depending on the age, influen-
za vaccination may limit extensive usage of antibiotics in viral dis-
eases and may also help people to decrease their acute perception
of risk of a bioterrorist consequence on their health in this highly
sensitive period of the year. It may also help preparedness plan for
the next months. As an example, in a large urbanized city with
about 10 million people, it may be expected that between 170,000
and 1 million inhabitants will suffer from ILI in the absence of
influenza vaccination and consult their GP for that reason during
winter in Northern hemisphere. If a bioterrorist attack was to
occur at that time, mass influenza vaccination coverage would
allow to reduce by 60% people consulting with ILI next winter and
then the undue utilization of antibiotics.
Board 33. Syndromic Surveillance for Bioterrorism – New
York City, Oct-Dec 2001 
A. Karpati1,2, F. Mostashari1,3, R. Heffernan1, J. Leng1, P. Thomas1, D.
Weiss1, J. Ackelsberg1, S. Balter1, D. Das1, S. Young1, K.
Bornschlegel1, B. Cherry1, A. Fine1, M. Layton1
1New York City Department of Health, New York, NY, 2Centers for
Disease Control and Prevention, Atlanta, GA, 3OutbreakDetect, Inc.,
New York, NY
Background: Syndromic surveillance for bioterrorism is
aimed at identification of population-level outbreaks in their early
stages, when patients might present to the health-care system with
mild, non-specific illness. Early detection of a bioterrorist event
would allow public health authorities to expedite public health
interventions (e.g, mass prophylaxis) to help lessen morbidity and
mortality. The recent World Trade Center disaster and anthrax
attacks have heightened the need for such systems.
Methods: In October 2001, the NYCDOH instituted a
syndromic surveillance system using hospital emergency depart-
ment (ED) data. Each morning, 7 days per week, hospitals elec-
tronically transfer a line list of all patients seen in the ED in the
previous 24 hours. Each dataset includes the patients' chief com-
plaints, home zip codes, and ages. The data are compiled and the
chief complaints are computer-coded, using key words, into dis-
tinct clinical syndromes (e.g., respiratory illness, non-specific
febrile illness, gastrointestinal illness) corresponding to likely pro-
dromal manifestations of illness caused by potential bioterrorism
agents. Using a modified, temporal-spatial "scan" statistic, propor-
tions of all visits due to the syndromes of interest are compared to
the previous 14-days' values, and a quantitative measure of geo-
graphic and/or temporal clustering is obtained. Unusually elevated
rates, or "alarms", defined statistically as clustering in time or space
with probability due to chance of <0.01-0.05, prompt an immedi-
ate epidemiologic and/or clinical investigation by the Department
of Health. Results: The NYCDOH receives daily reports from 29
hospitals in all five NYC boroughs (approximately 5000-6000
records per day) via e-mail or file-transfer protocol (FTP). From
November 1 - December 4, 2001, statistical "alarms" that prompt-
ed further investigation occurred 16 times on 10 separate days
(including alarms for respiratory, non-specific febrile, and gastroin-
testinal illness at each geographic level: citywide, hospital, and zip
code). Responses to these alarms have included reviews of the cur-
rent-day ED logs to verify whether the previous day's increase had
been sustained, outreach to hospital emergency departments and
infection-control departments for intensified surveillance and diag-
nostic activities, and chart reviews and telephone contact of
patients in the clusters. One citywide outbreak of viral gastroin-
testinal illness has been detected. Conclusions: Electronic report-
ing of chief complaint data from emergency departments is a
viable, though labor-intensive, method for conducting syndromic
surveillance in a large urban area. Key optimization issues for the
future include balancing sensitivity with specificity in statistical
thresholds for response, and in developing sustainable protocols
for rapid investigation of elevated rates.
Board 34. Towards a Theoretical (and Practical) Framework
for Prodromic Surveillance 
F. Mostashari1,2
1New York City Department of Health, New York, NY,
2OutbreakDetect, Inc, New York, NY
When syndromic surveillance seeks to detect an increase in
mild symptoms that presages an outbreak of potentially fatal ill-
ness, this can be termed "prodromic surveillance" and has particu-
lar applicability to the timely detection of new and emerging infec-
tious diseases, whether naturally occurring or intentional. Based on
our experience with developing, implementing, and evaluating
prodromic surveillance for biologic terrorism over the last 3 years,
the authors conclude that:
1. Prodromic Surveillance is only one component of bioter-
rorism surveillance
• Prodromic surveillance aims to identify population-level
increases in mild illness, not one or several cases of unusu-
al severe illness. It is unknown, and perhaps unknowable,
whether the first detectable signal from a large-scale
bioterrorist attack will come through prodromic surveil-
lance or reporting from the astute clinician.
• If the bioterrorist attack is first detected through diagnosis
of a single individual with severe illness, prodromic sur-
veillance still can provide critical information on the mag-
nitude of the outbreak, location and timing of release, and
case finding.
2. Data sources must be carefully considered. Many possi-
bilities have been examined (e.g., pharmaceutical sales, school and
work absenteeism, nurse's hotline calls, ambulance dispatches,
emergency department visits). Ideal characteristics include:
• Routinely collected for other purposes, imposing no addi-
tional burden on data collectors.
• Computerized.
• “Syndromic”— can be categorized into illness categories
(e.g. respiratory, non-specific febrile, gastrointestinal)
• Includes geographic information (e.g., zip code).
• Secure and timely electronic transmission possible
3. Outbreak detection algorithms are needed that are epi-
demiologically informed and statistically sound, such that:
• We move away from "the eyeball".
• Algorithms detect clustering in space as well as time.
• Different analytic approaches are used, depending on
potential confounders and the availability of baseline data.
• Once an algorithm is developed, alarm thresholds are set
according to how many alarms the epidemiologists are
willing and able to investigate.
4. Prodromic surveillance must be complemented by a
rapid epidemiologic response capability:
• Health departments must be able to support investigations
365 days per year.
• An important first step is distinguishing natural variability
from an illness outbreak. Has the increase been sustained
in the last 12 hours, or returned to baseline?
• The key goal of the investigation is to quickly move from the
syndromic "signal" to specific diagnosis. This requires
enhancing surveillance for severe illness as well as enhanced
diagnostics among individuals with mild illness-clinical tests
in individuals who would not normally receive them.
Board 35. Public Health, Bioweapons and the Canadian-
American Border: Present Problems and Future Policies 
D. H. Avery, II
University of Western Ontario, London, ON, CANADA
This paper will examine the connection between immigra-
tion, infectious diseases and bioweapons within a historical and
contemporary framework. Or, more specifically, it will examine the
question of why immigrants coming from Canada are now per-
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ceived, by many American government officials and members of
Congress, as representing a serious health and security threat to
the United States. While these concerns have been evident during
the past five years, the events of September 11 greatly intensified
fears about the capabilities of terrorist organizations to move across
the 49th parallel, possibly armed with bioweapons.
In many ways this is a timely topic because of the on-going
attempts by Washington to convince Canadian authorities to adopt
more stringent health and security measures in the new
Immigration Act, and thereby establishing conformity with
American screening standards. At the same time that these talks
are proceeding, there is increased cooperation between public
health officials in the two countries. This was evident during the
November meetings in Ottawa between Tommy Thompson, US
Health and Human Services Minister, and Allan Rock, the Minister
of Health Canada, to discuss the possibilities of collaboration in the
large scale development of smallpox vaccines. In addition, the long
and extensive inter-action between bioweapons specialists of the
Canadian Armed Forces, and their counterparts in the United
States Army Medical Research Institute of Infectious Diseases, has
also been greatly expanded.
The goal of this study is to provide an analytical framework
for the on-going discussion of how Canada and the United States
can deal with the threat of bioterrorism, and the spread of infec-
tious diseases while at the same time maintaining the relatively
'open' border. Although some reference will be made to earlier
border controversies, including the 1962 smallpox incident involv-
ing a Canadian visitor, most of the emphasis will be placed on
developments since 1995 when the threat of bioterrorism has
become a matter of grave concern for both counties. Indeed, the
Canadian government has recently demonstrated that it appreci-
ates the grim warnings of the United States Commission on
National Security in the 21st Century that "the most serious threat
to our security may consist of unannounced attacks on American
cities by sub-national groups using genetically engineered
pathogens."
In this project I will utilize a wide range of sources within a
comparative framework. I have written extensively about contem-
porary attempts to reconcile Canadian and American immigration
policies, as well as how the two countries have cooperated in the
field of bioweapons defensive research, and civil defense coordina-
tion. As well, I am involved in a multi-disciplinary study on
Canada's broader international role in dealing with public health
issues associated with bioterrorism.
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Board 40. The Isolation of Yellow Fever Virus of
Haemagogus leucocelaenus Mosquitoes Lots Obtained Near
the Argentina Border at Rio Grande do Sul State, Brazil, 2001
P. F. Vasconcelos1, A. Sperb2, H. O. Monteiro1, M. N. Torres2, M. R.
Souza1, H. B. Vasconcelos1, L. Mardini2, S. G. Rodrigues1
1Instituto Evandro Chagas/FUNASA, Belém, Pará State, BRAZIL,
2Secretaria de Saúde do Rio Grande do Sul, Porto Alegre, BRAZIL
Following monkey's (Alouatta fusca) death in the munici-
palities of Garruchos and Santo Antonio das Missões, in Rio
Grande do Sul state, Brazil, near Uruguay river in the Argentina
border, two strains of yellow fever virus (YFV) were isolated into
suckling mice from lots of Haemagogus leucocelaenus mosquitoes.
The minimal infection rate obtained of the infected species was
8.7%. YFV in this species was only reported in two prior occasions:
in the 30's years in Brazil in the same region (Shanon et al., 1938),
and 40's in the Amazon region of Colombia (Bugher et al., 1941).
No human cases were reported, but YFV antigen was detected by
immunohistochemistry in a monkey liver fragment of a death ani-
mal. The YFV isolation, and the absence in the area of
Haemagogus janthinomys, the most important YFV vector in
Brazil, suggest that Haemagogus leucocelaenus, considered unim-
portant secondary YFV vector in Brazil, play an important role in
the disease epidemiology in the Southern Cone, perhaps being the
main vector.
This work was supported by IEC/FUNASA, Secretaria de
Saúde do Rio Grande do Sul, and CNPq (process 521294/97-5
Board 41. Characterization of the Major Antigenic Protein 2
of Ehrlichia canis and E. chaffeensis and Its Application for the
Serodiagnosis of Ehrlichiosis 
T. T. Knowles1, H. L. Sorenson2, D. C. Marciano1, E. Breitschwerdt3,
S. Harrus4, A. F. Barbet1, A. R. Alleman2, M. Bélanger1
1University of Florida, College of Veterinary Medicine, Dept. of
Pathobiology, Gainesville, FL, 2University of Florida, College of
Veterinary Medicine, Dept. of Physiological Sciences, Gainesville, FL,
3North Carolina State University, College of Veterinary Medicine,
Dept. of Companion Animal and Special Species Medicine, Raleigh,
NC, 4The Hebrew University of Jerusalem, Rehovet, ISRAEL
Ehrlichioses have been identified globally as important
emerging tick-transmitted diseases. Canine ehrlichiosis (CE),
caused by Ehrlichia canis, may result in extensive morbidity and
mortality. Clinical and hematologic abnormalities are often non-spe-
cific during E. canis infections. Co-infections with other tick-trans-
mitted agents, such as E. chaffeensis, the causative agent of human
ehrlichiosis, may be common. Thus a definitive diagnosis may be dif-
ficult to reach. Currently, the indirect fluorescence antibody (IFA)
assay is the method most widely used to diagnose E. canis or E. chaf-
feensis infections. It is considered the “gold standard”, however
results are often subjective and non-specificity is observed due to
cross-reacting epitopes between species. Although currently not
available, a rapid, in-house method for serological diagnosis, using
the recombinant antigens of E. canis and E. chaffeensis, would be a
useful tool for clinical diagnoses and epidemiological studies.
Previously, we cloned and expressed the Major Antigenic Protein 2
(MAP2) of E. chaffeensis and E. canis. We developed two indirect
ELISAs using the rMAP2 from both species. No cross-reactivity was
observed with eight other important canine-infecting microorgan-
isms in the E. canis rMAP2 ELISA. However, cross-reactivity
between E. canis rMAP2 and E. chaffeensis-positive serum has not
been tested. Results of the present study show that the E. chaffeen-
sis rMAP2 ELISA failed to differentiate between E. canis and E.
chaffeensis infections. In addition, we further characterized the
MAP2 by determining if the map2 gene is conserved among various
geographic isolates of E. canis and E. chaffeensis, and if a single copy
gene encodes the MAP2. Sequences of the map2 gene of four geo-
graphically different isolates of E. chaffeensis (Arkansas, Wakulla,
Osceola, and Liberty) and five isolates of E. canis (Oklahoma,
Florida, Israel, DJ, and Jellybean) were compared. The sequences of
the map2 gene were found to be highly conserved among the vari-
ous isolates of each respective bacterial species. Genomic Southern
blot analysis with a DIG-labeled species-specific map2 gene probe
suggested that the map2 is a single copy gene. Thus, sequence con-
servation between isolates, the absence of multiple copies of the
gene, as well as previous results obtained with the rMAP2 ELISA
suggests that the MAP2 of E. chaffeensis and E. canis is a potential
antigen for the serodiagnosis of Ehrlichiosis. However, because sig-
nificant differences in the MAP2 amino acid composition between
E. canis and E. chaffeensis were observed, we believe that mono-
clonal antibodies against a specific epitope of the rMAP2 of E. canis
or E. chaffeensis could be used to develop a competitive ELISA, thus
















Board 43. Fifty-five Years of Tularemia in Alaska, 1946-2001 
L. Castrodale
Alaska Division of Public Health, Anchorage, AK
The first documented human case of tularemia in Alaska
occurred in 1946; eight more cases occurred in the next two
decades. Since 1972, Alaska has recorded approximately one case
each year. Although the disease occurs infrequently, health care
providers must remain alert for the clinical presentation of
tularemia as wildlife and environmental reservoirs for the bacte-
ria persist.
Tularemia results following the introduction of Francisella
tularensis into the body through the bite of certain arthropods
(e.g., ticks or deer flies); exposure of pre-existing or new wounds to
contaminated water or carcasses; inhalation of dust from contami-
nated hay or soil; or consumption of inadequately cooked infected
meat. Three to five days later, six presentations of tularemia -
ulceroglandular, glandular, oropharyngeal, typhoidal, pneumonic
or oculoglandular - may develop depending upon several factors,
including the portal of entry or the virulence of the infecting strain.
Most cases respond well to appropriate antibiotic therapy; less than
4% of cases are fatal.
From 1946 to 2001, Alaska recorded 33 cases of tularemia.
Complete data for all cases were not available. Males accounted for
76% (19 of 25) of case-patients. Eighty-six percent (25 of 29) of
case-patients were white, and 14% (4 of 29) were Alaska Native.
The median age was 36 years (range 18-54 years, data available for
24 persons). Onset dates for the majority of cases (63% or 15 of 24)
were in June-August. Sixty-seven percent (22 of 33) of case-
patients resided in centraleastern Alaska; 24% (n=8) in the greater
Anchorage area; 6% (n=2) in north-western and 3% (n=1) in south-
eastern Alaska.
No Alaska cases of tularemia were fatal. Ulceroglandular
presentations were most common (84% or 16 of 19) with two
typhoidal cases and a single pneumonic tularemia case also report-
ed. Of case-patients with detailed exposure histories (n=19), 17
(89%) had direct contact with animals - 16 with a known wildlife
reservoir, e.g., snowshoe hare or muskrat, and one received a cat
bite. Among Alaska wildlife, F. tularensis has been directly cultured
from ticks; and detected indirectly through serologic testing of var-
ious animals, e.g., bears and hares.
Cases of tularemia are reportable in Alaska to public health
authorities by laboratories and health care providers. Tularemia is
enzootic in Alaska so that sporadic human cases are expected,
especially among persons who skin hare or muskrat. Impervious
gloves worn while skinning animals are an effective means of dis-
ease prevention. Case reports receive immediate attention from
the Alaska Section of Epidemiology to ensure that appropriate
antibiotics are prescribed, laboratory personnel performing tests
are kept safe, and information is funneled in a timely manner to
bioterrorism surveillance personnel due to the concern that F.
tularensis could be weaponized.
Board 44. Arbovirus Activity and Surveillance in Australia –
Changes and Challenges 
R. C. Russell
University of Sydney, Westmead, AUSTRALIA
More than 75 arboviruses are recorded for Australia with 13
implicated in human disease. The most common (>5000 cases p.a.)
is the alphavirus Ross River, widely endemic with frequent out-
breaks of polyarthritis. Most severe is the flavivirus Murray Valley
encephalitis with a few cases almost annually in the endemic north
and rare epidemics in the south. In recent years other local and
exotic viruses have 'emerged': the alphavirus Barmah Forest has
frequent widespread activity and local epidemics; the flavivirus
Kunjin (a West Nile subtype) has occasional widespread low level
activity in northern and southern regions; Dengue viruses are fre-
quently introduced and locally transmitted with risks for endemic-
ity and haemorrhagic fever; Japanese encephalitis virus established
in the northeast may spread southwards through extensive feral pig
populations and a competent local vector. Also, the establishment
of an exotic vector of Japanese encephalitis across northern
Australia, a Dengue vector being repeatedly imported, and a
potential vector of West Nile gradually moving northwards, have
caused further concern.
Arbovirus surveillance is undertaken variously in most
States. Monitoring includes mosquito populations for abun-
dance/virus isolation, sentinel animals for seroconversion, weather
data, and reports of human cases. Data are reported directly to
state health authorities who contact local operatives for action.
Surveillance programs are detecting increased urban activity of
Ross River, increased activity of other flaviviruses such as Edge Hill
and Stratford, and changing status among vectors. There is no
national funding and no national uniformity in surveillance, but a
state arbovirus website (http://www.arbovirus.health.nsw.gov.au/) is
being expanded to serve as a national site for data coordination/dis-
semination and a national government expert advisory committee
was recently formed.
There are a number of surveillance and control issues being
addressed, such as problems of remote locations, selection of
appropriate animal sentinels, relative importance of mosquito
monitoring and sentinel chickens, and significance of wetlands and
irrigation practices in maintaining reservoir and vector habitat.
Predicted climate change is likely to enhance virus transmission in
some areas, and there are substantial and poorly understood com-
munity costs associated with the infections. The potential for
increased incidence reinforces the need for efficient surveillance
and control but, with no therapeutics or vaccines for the indige-
nous viruses, vector management is critical to disease manage-
ment. Mosquito control is not well organised in many risk areas and
there are serious concerns for control of widespread epidemics.
There is an urgent need for commitments by state and local
authorities for funding and organization of mosquito control to
reduce disease risks.
Board 45. Survey for Rickettsia, Ehrlichia, and Borrelia
Organisms in Ticks from Mississippi 
J. Goddard1, C. Paddock2, W. Nicholson2, J. Sumner2, J. Shen2, 
J. Piesman3
1Mississippi Department of Health, Jackson, MS, 2Centers for Disease
Control and Prevention, Atlanta, GA, 3Centers for Disease Control
and Prevention, Fort Collins, CO
Objective: Objective of this study was to search for three
disease agents in ticks from Mississippi -spotted fever group rick-
ettsiae, Ehrlichia chaffeensis, and Borrelia-like spirochetes.
Methods: From Nov 1999 to Oct 2000, ticks were collected for
analysis from vegetation as well as deer, dogs, and humans. Ticks
were cut longitudinally to make smears on three microscope slides.
Remaining tick pieces were frozen at -65°C for additional testing.
Tick smears were stained by direct immunofluorescence assays
(FA) for Rickettsia and Borrelia, while indirect FA (IFA) was used
for Ehrlichia. The tests for each pathogen group are not specific
for a single species. The corresponding tick for each positive smear
by FA/IFA was removed from the freezer and sent to the CDC for
PCR analysis. Results: A total of 149 adult ticks (four species)
were collected from eleven collection sites from southwestern to
northern Mississippi. Amblyomma americanum was most com-
monly collected (n=68), followed by Ixodes scapularis (n=53). The
bird tick, Ixodes brunneus, (usually rare) was the third most com-
monly collected tick (n=17). Eleven Dermacentor variabilis were
also collected. FA test results on the 149 ticks were sometimes
ambiguous due to non-specific staining of tick tissues and other
bacterial contaminants. None of the 149 ticks tested were FA pos-
itive for Borrelia-like organisms. However, smears of 30 (20%)
and 32 (22%) ticks reacted with anti-E. chaffeensis sera and anti-
R. rickettsii sera, respectively. None of the ticks staining with the
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IFA for Ehrlichia revealed DNA of E. chaffeensis by using PCR;
however, 23 (72%) of 32 FA-positive ticks for SFG rickettsiae
yielded amplicons of the appropriate size when tested by using a
PCR assay for SFG rickettsiae, corresponding to an overall infec-
tion rate among the collected ticks of 15%. Incidentally, smears of
12 (71%) of 17 I. brunneus revealed abundant bacilliform bacte-
ria. PCR amplification of DNA from a single I. brunneus that con-
tained bacilliform bacteria was performed using universal primers
for the 16S rRNA gene as well as Borrelia-specific primers. PCR
using the Borrelia-specific primers was negative. The predomi-
nant sequence obtained using the universal primers did not match
any known sequence in GenBank, but showed 91% identity with
an endosymbiont of Acanthoamoeba. Conclusions: Borrelia-like
spirochetes were not detected in Mississippi. SFG rickettsiae are
commonly associated with Mississippi ticks-especially A. ameri-
canum. An as-yet-unidentified bacterium apparently infects a
large portion of I. brunneus ticks. Further study will be needed to
identify this species.
Board 46. Detection of Yersinia pestis and a Novel
Bartonella Genotype in Prairie Dogs and Their Fleas Using
Multiplex PCR 
H. L. Stevenson1, B. Ying2, M. Y. Kosoy1, J. A. Montenieri1, J. L.
Lowell1, M. C. Chu1, K. L. Gage1
1CDC, DVBID, Fort Collins, CO, 2Yunnan Institute of Endemic Disease
Control and Research (YIEDCR), Dali, Yunnan, CHINA
We developed a multiplex polymerase chain reaction (PCR)
assay that simultaneously detects three types of flea-associated
microorganisms. The targets for the assay were sequences encod-
ing from the gltA, 17 kDa antigen, and pla genes of Bartonella spp.,
Rickettsia spp., and Yersinia pestis, respectively. A total of 260 flea
samples containing blood meal remnants were analyzed from fleas
collected from abandoned burrows at the site of an active plague
epizootic in Bear Creek Lake Park, Jefferson County, Colorado.
Results indicated that 34 (13.6%) fleas were positive for Bartonella
spp., 0 (0%) were positive for Rickettsia spp., and 120 (46.1%) were
positive for Y. pestis. Twenty-three (8.8%) fleas were coinfected
with Bartonella spp. and Y. pestis. A second group of 295 blood
meal-containing fleas were analyzed from abandoned burrows at
Red Lion Wildlife Area, Logan County, Colorado where an epi-
zootic had occurred 2-4 months before the time of sampling. Of
these 295 fleas, 7 (2.3%) were positive for Bartonella spp., 0 (0%)
were positive for Rickettsia spp., and 46 (15.6%) were positive for
Y. pestis. Coinfections were not observed in fleas from the older
(Logan County) epizootic site. No positives were identified among
the 100 unfed fleas examined from each site. The multiplex PCR
also was used successfully to identify Y. pestis and Bartonella in the
tissues of prairie dogs. Although plague is routinely identified in
prairie dogs and prairie dog fleas, this report represents the first
identification of Bartonella from these animals and their fleas. In
order to further characterize these agents, selected Bartonella
PCR amplicons from prairie dogs and prairie dog fleas were
sequenced. Phylogenetic analyses indicate that the sequences of
these prairie dog and prairie dog flea bartonellae cluster tightly
within a clade that is distinct from those containing other known
Bartonella genotypes. The ability of the multiplex PCR to simulta-
neously test flea samples and rodent tissues for multiple pathogens
should save time and sample material, serve as an efficient screen-
ing technique, and provide more ecological information on the
presence of coinfections or other topics.
Board 47. Molecular Identification of Crimean-Congo
Hemorrhagic Fever Virus in Human Clinical Cases in
Southern Russia 
A. E. Platonov1, L. S. Karan1, S. B. Yazyshina1, E. M. Krasnova2, N.
V. Rusakova2, V. V. Lazorenko2, V. A. Antonov3, M. M. Shvager4, M.
V. Govorukhina4, I. L. Obukhov5, G. A. Shipulin1, V. V. Maleev1
1Central Research Institute of Epidemiology, Moscow, RUSSIAN FED-
ERATION, 2State Center for Sanitary and Epidemic Control,
Volgograd, RUSSIAN FEDERATION, 3Anti-Plague Institute, Volgograd,
RUSSIAN FEDERATION, 4State Center for Sanitary and Epidemic
Control, Rostov, RUSSIAN FEDERATION, 5State Institute for Control of
Veterinary Products, Moscow, RUSSIAN FEDERATION
Crimean hemorrhagic fever (CHF) was diagnosed in the
Russian Federation since 1944. 334 human cases were registered
in the Rostov region from 1963 to 1971 years, 51 cases (15%) were
fatal [1]. CHF outbreaks have been reported also in the Republics
of Kalmykya and Dagestan, the Stavropol, Astrakhan and
Krasnodar regions of the Southern Russia. After the period of rel-
ative composure the CHF epidemic situation has become worse
last years. In 2000-2001 more than 80 CHF cases with 10 deaths
were serologically confirmed in Russia [2]. Both old endemic
regions and new region (Volgograd) were affected. In the latter
region there were 15 CHF cases in 2000 and 9 cases in 2001; the
Crimean-Congo hemorrhagic fever virus (CCHFV) antigen was
found in the ticks.
The Central Research Institute of Epidemiology has devel-
oped the specific RT-PCR-based assay for prompt diagnosis of
CHF. To date 15 CHF clinical cases, occurred in the South Russian
regions, were confirmed by this assay. Nine isolates were charac-
terized by direct sequencing of the gene fragment (215
nucleotides) locating in RNA small (S) segment and coding nucle-
oprotein. These data (AF432115-AF432121) were compared with
other CCHFV sequences available in GenBank. Pairwise
nucleotide p-distance ranged from 0 to 0.038 within recent
Southern Russian isolates, whereas the p-distance between
Russian isolates and the isolates from Africa, China, and
Kazakhstan was greater than 0.11. Russian variant of CCHFV
appeared to be rather stable, because the difference between
recent isolates and strain Drosdov, isolated in 1967 in Astrakhan,
varied from 0.024 to 0.033. Interestingly, the strains isolated in
2001 in Kosovo belonged also to Russian or, possibly, "European"
genovariant. Although the number of observations was low, there
were probably Stavropol and Volgograd topovariants within
Russian CCHFV isolates; in Rostov region, which located in
between Stavropol and Volgograd, both topovariants were present-
ed. Most nucleotide substitutions within Russian CCHFV isolates
did not result in the amino acid change. One of the isolates from
Rostov-2001 had one amino acid substitution and Drosdov strain
had two substitutions.
1. Aristova VA, Kolobukhina LV, Schelkanov MI, Lvov DK.
Vopr Virusol 2001, 46(4): 7-15.
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Board 48. Waterborne Diseases: A Global View 
W. Pasini
WHO Collaborating Centre, Rimini, ITALY
The WHO estimates that at the beginning of the 21 centu-
ry about 1.1 billion people haven’t got access to safe and clean
drinking water (Bartram and Hueb,2000). Waterborne disease
transmission occurs by drinking contaminated water. This has
taken place in many dramatic outbreaks of faecal-oral diseases such
as cholera and typhoid fever. Outbreaks of waterborne disease con-
tinue to occur across the developed and developing world. Water-
washed disease occurs when there is a lack of sufficient quantities
of water for washing and personal hygiene. Diarrhea is the most
important public health problem affected by water and sanitation
and can be both waterborne and water-washed. Approximately 4
billion cases of diarrhea each year cause 2.2 million death, mostly
among children under the age of five. Intestinal worms infect
about 10% of the population of the developing world. 200 million
people in the world are infected with schistosomiasis of whom 20
million suffer severe consequences. Diarrhea is by far the com-
monest cause of illness in travellers. It affects an estimated 20-50%
of all the travelers. It may cause anything from embarrassment and
inconvenience to disruption of travel and business plans. For vul-
nerable people it may even be fatal, if not promptly and effective-
ly treated. Waterborne and foodborne diseases are transmitted by
consumption of contaminated drinks and food. Dehydration is the
clinical effect of diarrhea and it can be serious, expecially in chil-
dren. Dehydration may also be caused by a inadequate intake of
water. A book on Hydration and Health has been written in late
2001 and will be distributed to the medical community in 2002 in
many countries, including Europe, North and Latin America. The
books covers all the benefits of a proper hydration, the risks of
dehydration, the waterborne diseases and chemical pollutants,
water and children, water and seniors and many other aspects.
Outbreaks of diseases associated with recreational water are
reported from all parts of the world. Surface water including rivers,
lakes and oceans, swimming pools and hit pools put health risks to
humans through microbial pollution (Hunter 1997). Pesticides and
nitrates in drinking water and recreational water constitute a seri-
ous problem worldwide. Freshwater can contain hazardous con-
centration of lead, arsenic, fluoride and radioactivity (WHO 2001).
Adequate quantities of safe water and good sanitation are neces-
sary conditions for healthy living, but their impact will depend
upon how they are used.
Board 49. Outbreak of Legionellosis in Stavanger, Norway 
H. H. Blystad1, M. Holm2, O. Natas3, E. Bjorlow4,1, P. Aavitsland1
1Norwegian Institute of Public Health, Oslo, NORWAY, 2Medical
Health Office, Stavanger Municipality, Stavanger, NORWAY, 3Central
Hospital of Rogaland County, Stavanger, NORWAY, 4European
Programme for Intervention Epidemiology Training, Oslo, NORWAY
Background: Indigenous legionellosis is a rare disease in
Norway with only a handful of sporadic cases diagnosed every year.
Prior to this outbreak, no clusters or outbreaks have been docu-
mented in Norway. Several studies, however, have shown the pres-
ence of various Legionella (L) species in cooling towers at hospitals
and hotels. We report here an outbreak of legionellosis in the city
of Stavanger (population 100,000) on the west coast of Norway.
Methods: For the descriptive study, a case was defined as a person
staying in the city of Stavanger within two years prior to September
2001 with a clinical or radiographic diagnosis of pneumonia and a
confirmed laboratory diagnosis of L pneumophila serogroup 1
(LpS1) confirmed by culture, by a fourfold or greater rise in spe-
cific serum antibody titre seroconversion by indirect immunofluo-
rescent antibody test or by microagglutination or a single high titre,
using reagents to LpS1 or other L species and serogroups, or by
antigen detection of specific L antigen in urine. Patients, relatives
or the patients' doctor were interviewed. Based on these inter-
views, 81 water samples were taken from suspected sources.
Isolates from patients were compared with environmental isolates
by genotyping using the AFLP method. Results: From 18 July to
7 September 2001, 26 cases were reported to NIPH. All cases had
been staying in Stavanger within a ten days period prior to the
onset of symptoms. The case fatality ratio was 23% (6/26). The age
range was from 16 to 94 years (median 54). The median age of fatal
cases was 84 years. The sex ratio (M/F) was 3.3 (20/6). One case
was a British tourist identified through the reporting system of the
European Working Group for Legionella Infections (EWGLI). All
cases had been in a limited area in the city center within a 500m
radius within ten days prior to the onset of symptoms. Three of the
patients had been staying in a hotel in the same area. Water sam-
ples taken from the cooling tower of this hotel subsequently
showed presence of LpS1. The air outlet of the cooling tower was
situated five metres above ground level, close to a bus terminal.
The onset of symptoms of the last reported case occurred nine days
after the cooling tower in the hotel was taken out of service and dis-
infected on 29 August. Nine isolates from patients and five isolates
from the cooling tower were genetically compared and showed
similarities, and were different from other known Norwegian L iso-
lates. Discussion: Close cooperation between local health authori-
ties, the local microbiological laboratory, and NIPH was essential
in this investigation of a classic outbreak of Legionnaires' disease.
To prevent further outbreaks, an information programme aimed at
hotels, engineering consultants, and health professionals will be
implemented. Current Norwegian prevention guidelines will be
updated in accordance with the forthcoming European prevention
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Board 50. An Outbreak of Blastomycosis in Minnesota 
J. Bender1, R. Danila2, T. Naimi2, L. Sundberg3, B. Juni2, J. Bartkus2,
J. Lindquist3
1University of Minnesota, Saint Paul, MN, 2Minnesota Department of
Health, Minneapolis, MN, 3St. Louis County Department of Public
Health, Duluth, MN
Background: Blastomycosis outbreaks are infrequently
identified and thus opportunities for epidemiologic investigation
are limited. In August 2000, a cluster of blastomycosis cases was
reported from a small town in northern Minnesota. This report
summarizes the investigation of a large outbreak, risk factors for
cases, and climatic/environmental conditions contributing to the
outbreak. Methods: Active surveillance for human cases was done
by contacting hospitals and laboratories in the area and encourag-
ing submission of clinical specimens from suspect cases. Active sur-
veillance for cases in dogs was done by contacting veterinarians. A
human case was defined as one in which Blastomyces dermatitidis
was cultured or visualized from sputum or bronchial lavage. Serum
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samples were collected from humans and tested for B. dermatitidis
A antigen by immunodiffusion and complement fixation. A case
control study examining risk factors for disease was conducted
comparing cases to healthy neighborhood controls. A case in a dog
was identified as one in which B. dermatitidis was cultured or visu-
alized from sputum, skin lesion, or bronchial lavage; a suspect case
had either a chronic cough or unresolving skin lesion and lived in
the affected neighborhood. Soil samples from the area were tested
by mouse assay. Available human and dog isolates were examined
by RAPD PCR and sequencing the ITSI region. Historical precip-
itation, humidity, and temperature data were reviewed. Results:
Eighteen human cases were identified. All cases lived in a single
neighborhood of approximately 200 households. The median age
was 38 years (range, 7 to 70). Thirteen (72%) cases were female.
Ten (56%) were hospitalized 1 to 22 days. Onset of illness ranged
from 7/11/00 to 9/7/00. Serologic testing did not identify addition-
al cases. Only 2 patients developed an antibody response. Cases
were younger (p= 0.08), had a history of a chronic medical condi-
tion (OR=2.6, p=0.08), reported other family members ill
(OR=6.8, p<0.01), and lived closer to a recent excavation site than
controls (p<0.05). Nineteen confirmed and 4 suspect canine cases
lived in the same neighborhood with onsets ranging from 8/23/00
to 10/23/00. All soil testing was negative for B. dermatitidis. All of
the outbreak isolates (human and dog) were the same genotype.
The preceding months had above average precipitation (p<0.05),
humidity (p<0.01), and temperature (p<0.01). Conclusions:
Weather conditions and recent disruption of vegetation and soil
contributed to this outbreak. Improved diagnostics are needed for
blastomycosis as evidenced by the lack of serologic response in cul-
ture confirmed cases. RAPD PCR was useful in linking outbreak
related cases.
Board 51. The Emerging Diarrhoeal Pathogen: Cyclospora
cayetanensis and HIV Seropositive Individuals in Lagos,
Nigeria
E. G. Alakpa
Nigerian Institute of Medical Research, Lagos, NIGERIA
The advent of the Human Immunodeficiency Virus (HIV)
infection and detection has spontaneously changed the spectral of
infectious disease management and has lead to the reclassification
of some once accepted non infectious agent as pathogenic agent
with the subsequent increase in the number of supposed newer
pathogen. One of these ‘newer’ agents is the emerging diarrhoeal
protozon, Cyclospora cayetanensis whose involvment as an emerg-
ing diarrhoeal pathogen has been globaly reported. We report the
first documented isolation of this pathogen form HIV individuals
from the first ever study conducted in Nigeria and the West coast
of Africa. Stool and blood samples were obtained from 182 con-
firmed HIV seropositive individuals from some government
accredited HIV screening centers in Lagos. Stool samples were
screened parasiologically. Seven (3.8%) stools were confirmed
positive for the presence of the pathogens’ oocyst and all positive
stools were form diarrhoeal patients. Confirmation of oocyst was
done at the SMP Reference Laboratory, Glasgow, UK.
Bacteriology was negative in these positive stools. The result was
significant (p < 0.05), and of interest as patients whose stools
were positive, have been diarrhoeic for over 3 weeks despite hav-
ing been on antidiarrhoeal drugs. Also, majority of the health
workers and physicians in the State and country were completely
ignorant of the existence of this pathogen. The need for more
studies and education of health practitioners can not be over
emphases as this study has shown the existence of this pathogen
in this state and country. Key words: Cyclospora cayetanensis
HIV, diarrhoea, Lagos, Nigeria
Board 52. Prevalence of Virulence Factors in Aeromonas
hydrophila and Aeromonas caviae Isolates from Groundwater
and Human Stool Samples 
V. C. Ardi1, M. A. Borchardt2, J. H. Standridge3, B. H. Olson1
1UC Irvine, Irvine, CA, 2Marshfield Med. Res., Marshfield, WI, 3U of
Wisconsin, Madison, WI
The US Environmental Protection Agency has added
Aeromonas hydrophila to the contaminant candidate list for drink-
ing water, because of its suspected pathogenic importance and
ubiquitous occurrence in water. One study estimated aeromonads
to cause 13% of the reported gastroenteritis cases in the US. A.
hydrophila was identified as the causative agent in 36% of diar-
rheal patients at a long-term care facility with ingestion of contam-
inated food or water as the potential source. The pathogenicity of
A. hydrophila and A. caviae is related to production of adherence
factors, enterotoxins, and toxin activators (serine proteases). A pre-
vious report compared Aeromonas spp. isolates from diarrheal
patients and their drinking water for relatedness by DNA finger-
printing. One could hypothesize that DNA fingerprints would be
similar between the clinical and groundwater isolates if water was
the source of infection, but no relatedness among these isolates
were found. To determine if the linkage between pathogenicity and
disease potential might be better understood by comparing viru-
lence factors in these samples, we screened the 17 human clinical
(fecal) and 78 groundwater isolates for the toxin and toxin activat-
ing genes. These virulence factors were detected using PCR with
consensus sequence primers derived from multiple DNA
sequences for hemolysin and cytolytic enterotoxin genes from A.
hydrophila and A. caviae (GenBank), aligned using Clustal W. The
PCR product is a 224 bp amplicon. Since no serine protease
sequence has been published for A. caviae, the three reported acti-
vator sequences from A. hydrophila were used to develop primers
with a 175 bp amplicon. Of the 10 fecal and 46 water isolates iden-
tified as A. hydrophila, none of the clinical and 29 (63%) of the
water isolates contained enterotoxin genes. Of the remaining iso-
lates, 1 clinical and 10 water isolates also had at least one virulence
gene. To date, 6/17 A. caviae from water origin are positive. The
prevalence of hemolysin/cytolytic enterotoxin genes was 5.9%
(1/17) and 50% (39/78) for fecal and environmental isolates,
respectively. Our findings support the previous work suggesting lit-
tle relatedness among clinical and water isolates as determined by
virulence factor occurrence. Our data suggest that 94.1% of
Aeromonas from these clinical sources do not have the
hemolysin/cytolytic enterotoxins reported in the literature. Other
enteropathogenic microbes including Salmonella, Campylobacter,
and Cryptosporidium, were found in 5/17 clinical isolates. Our
findings suggest either Aeromonas was not the caustive agent, the
enterotoxin traits were on a plasmid that had been deleted, or a
LPS-toxin that dissolves the lipid bilayer of cells, not tested for,
may be responsible. The mechanism of pathogenicity is an impor-
tant to resolve, since 50% of water isolates possessed enterotoxin
genes suggesting potential pathogenicity.
Board 53. Bordetella pertussis Infection in US Military
Recruit Populations 
J. C. Sammons, C. Le, J. M. Fuller, S. Poddar, M. K. Ryan, K. L. Russell
Naval Health Research Center, San Diego, CA
Background: Pertussis (whooping cough) is a highly con-
tagious respiratory disease caused by infection with Bordetella per-
tussis. Some epidemiological evidence suggests that the prevalence
of pertussis infection is on the rise among adolescents and adults,
potentially due to waning vaccine-acquired immunity. Confined
populations, including those in daycare centers, nursing homes,
and military camps, are particularly at risk. The extent to which B.
pertussis infection contributes to acute respiratory disease among
military trainees has not been extensively studied. Therefore, sur-
















in 1999. Objective: Measure the proportion of prolonged-cough
illness attributable to B. pertussis infection among US military
trainees. Methods: Recruits at four military training sites meeting
the case definition of seven or more days of cough were eligible to
participate. One nasopharyngeal swab (NP), one throat swab, and
15 cc each of acute and convalescent sera were collected. The NP
specimens were cultured on Regan-Lowe with cephalexin and
Bordet-Gengou without cephalexin. The NP and throat specimens
underwent PCR assay for a 153-bp region with primers for a B.
pertussis repeated genome sequence. Serologic assays were per-
formed using the MarDx PT/FHA EIA kit. This kit tests collec-
tively for IgG, IgM and IgA specific antibodies against pertussis
toxin (PT) and filamentous hemagglutanin (FHA). An individual
was considered a positive B. pertussis case if they were culture pos-
itive, PCR positive, or sero-converted from negative to positive in
their paired sera. Results: Of 130 specimens tested by all three
methods, 10% (13) were identified as B. pertussis positive. One
(0.78%) individual was positive by culture and PCR, 9 (7%) were
PCR positive from NP and/or throat specimens, and 3 (2%) were
positive by sero-conversion. Conclusions: This study demon-
strates that pertussis infection is potentially an important pathogen
among military recruits, accounting for 10% of prolonged-cough
illness. If acellar pertussis vaccine becomes available to young
adults in the US, immunization with this product may be warrant-
ed in this population. Additional surveillance may address the value
of such a practice in the future.
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Board 54. Etiology of Leucorrhoea in HIV Seropositive
and HIV Seronegative Women with Special Reference to
Bacterial Vaginosis
V. A. Palan, III
B Y L Nair hospital & T N Medical college, Mumbai, INDIA
200 HIV seropositive female patients with multiple sex
partners and 100 seronegative female patients with single sex part-
ners presenting with chief complaint of leucorrhoea were studied
over a period of 2 years.Multiple STD'S were seen more common-
ly in former group with significant P=0.0176 when compared
between two groups.Common multiple STD was Candida albicans
with Trichomoniasis. Bacterial vaginosis was also found more com-
monly in HIV seropositive patients.Prevotella - Porphyromonas
group was associated in 93.2% of patients with bacterial vagi-
nosis.Among the Amsel's and Nugent's criteria used for diagnosing
bacterial vaginosis, χ2=0.0043; Df=1; P=0.9476{NS} Amsel’s
Criteria v/s Nugent’s Criteria: Kappa Agreement Test=0.0618
(kappa < 0.60 indicates moderate agreement). There was increase
in incidence of non albicans Candida particularly C.glabrata among
HIV seropositive patients.
Board 55. HIV Infection in Northwestern Russia: An
Epidemic Unfolding 
E. Bjørløw1, A. Chernev2, A. Gavrilov3, A. Tulisov4, P. Aavitsland5
1European Programme for Intervention Epidemiology Training, Oslo,
NORWAY, 2Regional State Sanitary and Epidemiological Control
Center, Murmansk, RUSSIAN FEDERATION, 3Republican AIDS
Centre, Petrozavodsk, Republic of Karelia, RUSSIAN FEDERATION,
4State Sanitary and Epidemiological Control Center, Archangel,
RUSSIAN FEDERATION, 5Norwegian Institute of Public Health, Oslo,
NORWAY
Background: In the mid nineties an explosive spread of
HIV infection was noted in the Russian county of Kaliningrad on
the Baltic coast. From 1999, a similar explosive increase has been
observed in the city of St. Petersburg and surrounding Leningrad
County and in other parts of the central Russian Federation. The
epidemic has been driven by unsafe injecting practices among
injecting drug users (IDU). Norway borders to Murmansk county
(1.0 million inhabitants) and has also close links with the two other
Russian counties in the Barents region, Archangel (1.5 million) and
the republic of Karelia (0.8 million). Our objective was to assess the
spread of HIV in these parts of the Russian Federation. Methods:
In the Russian Federation, newly diagnosed cases of HIV infection
is reportable by name on a specific form to the State Sanitary and
Epidemiological Control Centre in the county. Cases diagnosed
after anonymous testing are not reported. We reviewed cases
reported up to October 31 2001. Results: In Murmansk, a cumu-
lative total of 173 cases had been reported up to 2001. During the
first ten months of 2001, 387 cases (37 per 100,000) were reported
compared to only 70 cases for the whole of year 2000. 92% of the
cases in 2001 were reported to have been infected by injecting
drug use. In Archangel, 37 cases (2.5 per 100,000) inhabitants were
reported in by October 31 2001 compared to 11 for the whole of
year 2000. 17 of the cases were infected by injecting drug use. In
the Republic of Karelia, 58 cases (7.5 per 100,000) were reported
by October 31 2001 compared to 51 for the whole year of 2000.
Discussion: The Russian HIV epidemic is driven by injecting drug
use and has unfolded during 2001 in the far northern county of
Murmansk and may be starting in neighbouring Archangel and
Karelia in 2002. The rate of spread in Murmansk is comparable to
the rate metropolitan St. Petersburg (50 per 100,000). In neigh-
bouring Norway, the annual rate of newly diagnosed HIV infection
is 3 per 100,000, possibly making the Norwegian-Russian border
the international border with the highest HIV rate gradient in the
world. The epidemic may currently constitute the biggest threat to
public health in Murmansk. In the future, the epidemic may
spread by sex to the larger heterosexual population and vertically to
newborns. Preventive measures are urgently needed to save young
Russians from this grave infection.
Board 56. Genetic Analysis of Perinatal Transmission of HIV-
1 Subtype C Isolates from India 
S. R. Das1, S. Sehgal2, S. Gopalan2, N. Ahmad3, S. Jameel1
1ICGEB, New Delhi, INDIA, 2PGIMER, Chandigarh, INDIA,
3University of Arizona College of Medicine, Tucson, AZ
The HIV epidemic in India is at critical levels with an esti-
mated 3.5 million Indians presently infected. It is known that HIV-
1 subtype C is responsible for majority of infection in India. The
dynamics of perinatal transmission and the viral factors responsible
for it have not been worked out in this situation. The actual mech-
anisms of perinatal transmission are unknown but theoretically it
occurs at three stages: prepartum (transplacental passage), intra-
partum (exposure of infants skin and mucus membrane to mater-
nal blood and vaginal secretion) and postpartum (breast feeding).
To date, there are no clearly defined factors, viral or host, associat-
ed with maternal transmission of HIV-1. Host factors like low
CD4+ lymphocyte counts, maternal immune response, high viral
load or disease progression may contribute to transmission. Some
studies on HIV-1 subtype B have shown that only minor variants
found in the genetically heterogeneous population of viruses in the
mother are transmitted to the infants. Whether it is cell free or
cell-associated HIV-1 that is transmitted, the envelope glycopro-
tein(s) will play an important role on account of its interaction with
CD4 receptor and one of the co-receptors. Mutations in the enve-
lope V3 region could potentially affect mother-infant transmission
of HIV-1, since this region is an important determinant for cellular
tropism and virus neutralization. To study the relationship between
transmission and genetic diversity, we are analyzing the HIV-1
envelope sequences in perinatally infected mother-child pairs by
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examining the proviral sequences. After PCR amplification the C2
through V5 region of ~650 bp, it was cloned in pGemT Easy vec-
tor. For each pair, 20 clones from the mother and 20 clones from
the child were sequenced. After alignment of the sequences and
phylogenetic analysis we have observed that the predominant vari-
ant from the mother is not the dominant one in the child. Rather,
a minor variant from the mother was dominant in the child. Thus,
perinatal transmission for subtype C Indian isolates appears to fol-
low a pattern similar to HIV-1 subtype B, where the minor variants
are transmitted to the child. The data from multiple mother-child
pairs, its analysis and implications will be presented.
Board 57. Addressing Emerging Sexually Transmitted
Diseases (STDs) in the US Military
V. H. MacIntosh1, S. L. Ludwig2, K. T. McKee, Jr.3, P. O. Renzullo4,
W. B. Calvert, III5, C. E. Bader6, M. Malakooti7, J. C. Gaydos8,4
1Air Force Medical Operations Agency, Washington, DC, 2Office of
the US Coast Guard Commandant, Washington, DC, 3US Army
Medical Research Institute of Infectious Diseases, Ft. Detrick, MD,
4Henry M. Jackson Foundation, Rockville, MD, 5Naval Environmental
Health Center, Norfolk, VA, 6J4 Medical Readiness Division, JCS,
Pentagon, Washington, DC, 7Navy Environmental Health Center,
Norfolk, VA, 8Department of Defense Global Emerging Infections
Surveillance and Response System, Silver Spring, MD
Background: Sexually transmitted diseases (STDs) remain
significant problems for the military services. Department of
Defense (DoD) study panels and civilian consultants have identi-
fied inadequate reporting, complacency and inconsistent clinical
practices as possible contributing factors to persistence of these
problems. Additionally little attention has been given to the viral
STDs, human papillomavirus (HPV) and herpes simplex virus
(HSV) infections. Methods: Surveillance data from service (Army,
Navy, Marine Corps, Coast Guard and Air Force) reportable
events systems, as well as data from available peer-reviewed publi-
cations were reviewed. Surveillance systems were assessed using
published guidance for evaluating surveillance systems. Results:
Service surveillance systems were uniformly passive. Although
based upon identical reportable disease lists, data reported by the
different service systems were not standardized. Laboratory test
results and tests used were often unknown. Herpes simplex virus
(HSV) and human papillomavirus (HPV) were not reported. No
studies of reporting completeness and validity of STD diagnoses
were available. Disease rates/100,000 persons (or person-years)
ranged from 73-340 for N. gonorrhea (GC), 54-1127 for C. tra-
chomatis (CT), and 2-9 for syphilis. Only 1 installation reported
antibiotic resistance data for GC. Peer reviewed studies, conduct-
ed on selected populations, tended to yield more uniform data.
Limited prevalence data were available for GC (0-3%) and syphilis
(0.02%). Among basic trainees, CT prevalences of 9-11% in Army
and Marine females, and 5% in Army males, were found. Among
military members who had completed basic training, CT preva-
lences ranged from 3-7% in Navy women, 7-12% in Army women,
and 3-5% in male Marines. Trichomonas vaginalis prevalences had
been reported only for female Marine recruits (2%) and an Army
female clinic population (6%). HPV had been studied only among
Army women seeking care (45-51% prevalence). No reports on
HSV were found. Large population-based studies of incidence
were lacking. Conclusions: Surveillance data on STDs in the mil-
itary are inconsistent and inadequate. Wide variations in STD rates
exist among services and within individual services over time.
Reasons for variations could not be determined, but lack of stan-
dardization and reporting deficiencies probably contributed.
Attention must be given to validating completeness and accuracy of
data submitted to the surveillance systems. All recruits should have
STD screening and periodic exams mandated for high-risk service
members. Steps must be taken to capture data on antibiotic resist-
ance and viral STDs.
Board 58. Prevalence of the Ist/Aids in the Laboratory of the
Health Center King Baudouin of Guediawaye in Senegal 
I. Nidr
Health Center King Baudouin Of Guediawaye, Dakar, SENEGAL
Objectives: The prevalence of the IST/AIDS at patients
that present themselves to the laboratory for the tracking of an
ist/aids. 
Methodology: A retrospective survey based on the exam of
patient files that is presented themselves to the laboratory during
the year 1999 for the tracking of an IST/AIDS. 
Results: * Vaginal prelevement: the IST find out on 857
taking is : - Vaginose bacterienne : 383 (44,7%); - Vaginal candi-
dose: 316 (36,8%); - Vaginal trichomonose : 86 (10%); - Vonococcie
: 02 (0,2%).
*Verologie chlamydienne : on 388 patients,175 patient have
a serology positive (45%) . The indications most frequent clinics
are - The pelvic pains (28,5%); - The secondary barrenness
(27,4%); - The primary barrenness (17,7%). *Recherche of
mycoplasmes patient : surs 263 ,198 have a positive research
(75%). Indications the most frequent clinics are : - The secondary
barrenness (26,3%); - The primary barrenness (22%); - The pelvic
pains (21,7%). * Syphilitic serology : on 2164 patient ,47 had a RPR
positif and confirmed by a spécific serology (TPHA) either 2% .
Most of patients came for a prenatal balance. * Retroviral serology:
on 215 patient presenting themselves to the laboratory for a retro-
viral serology, 56 had a positive serology : HIV 1 (44 patients),
HIV2 (4 patients), HIV1+2 (8 patients). The mean of age is 26
years. It is about of patient symtomatiquess or having greatly jour-
ney either of partners of people living with the VIH. 
Conclusion: Seen the prevalencess of the IST/AIDS as in
the Center of Health King Baudouin of Guediawaye, we put in
&#339;uvre of struggle modes to master the fast development of the
IST/AIDS as to know : IEC, the adapted management of the cases
diagnostiques, the systematic depistage of the syphilis at the preg-
nant woman and proposition of the test VIH at the pregnant woman.
Board 59. A Large Military Chlamydia Testing Program
Demonstrates the Need for Increased Screening 
L. C. Canas, A. T. McComb, C. Otremba, V. R. Carpenter, L. Bock,
B. Delgado, Jr.
Brooks Air Force Base, San Antonio, TX
Chlamydia trachomatis continues to be the most common
bacterial sexually transmitted disease (STD) in the United States.
The burden of this infectious disease to the US military has great
impact both in terms of health care dollars and lost training/work
time. Following the recommendations of the Centers for Disease
Control and Prevention (CDC) concerning guidelines for cost
effective screening programs, the Armed Forces Epidemiological
Board (AFEB) has recommended routine chlamydia screening for
new female recruits within the first year of service, all female mil-
itary service members under the age of 25 during each recom-
mended routine Papanicolaou Smear, and male military personnel
with identifiable risk factors or symptoms. Screening is also con-
sidered to be the standard of care for obstetrics patients. Many
chlamydia infections are asymptomatic and are particularly prob-
lematic in females often leading to pelvic inflammatory disease,
infertility, ectopic pregnancy, and neonatal transmission. The
Brooks Air Force Base (BAFB) virology laboratory in San Antonio
routinely conducts diagnostic chlamydia testing for those military
medical treatment facilities (MTF) that choose to send the test out
rather than do it on site. Reasons for this decision are mainly due
to a shortage of trained personnel or too few requests to make on
site testing cost effective. The BAFB laboratory now averages
>8,000 clinical specimens/month and performs testing using the
ligase chain reaction test (Abbott Laboratories, Chicago, IL). This
nucleic acid amplification test is approved for both female and
















8100 patient samples from 69 MTFs around the world were
processed and results were reported. Of those, 84.5% (6844/8100)
were females and 5.9% (401/6844) of those results were positive
for C. trachomatis. Urine samples accounted for only 2.2%
(180/8100) of the female specimens but made up 3.5% (14/401) of
the female positive results. By contrast, only 15.5% (1219/8100) of
the specimens were from males, but 22% (273/1219) of those were
positive. Urine samples accounted for 20% (242/1219) of the male
samples of which 8.7% (21/242) of those urines were reported to
be positive. The military has recognized the value of chlamydia
screening programs to detect disease presence and prevent asymp-
tomatic transmission.
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Board 60. The Selectiv Extraction Method of B. anthracis
Capsul Antigen 
B. M. Suleimenov, Sr.1, I. S. Arakelyan, Sr.2, E. E. Li, Sr.2, E. E. Li, Sr.2
1Kazakh science Center for quarantine and zoonotic diseases,
Almaty, KAZAKHSTAN, 2Kazakh Scientific Center of Quarantine and
Zoonotic Infections, Almaty, KAZAKHSTAN
The B. anthracis capsule antigen detects at 36º C and it’s
the most perspective antigen for creating of diagnostic prepara-
tions as compared with O- antigen or lipopolysaccharide of the cell
wall. We were detected 4 preparations which are in different inten-
sity of minor concentration selectively extracts with B. anthacis
capsule antigen. On the based was devised the technique of cap-
sule antigen selective extraction with the most peculiar and sensi-
tive production of capsule antigen by Zenkovsky’s vaccine strain.
Peculiarity and sensitivity of antigen were tested in indirect hemag-
glutination and erythrocytic immunoglobulin diagnosticum in the
reaction of immuno-fluorenscenses. The devised technique has no
lacks of E. Baker’s (1952) technique with using the high concen-
tration of sulfate ammonium and is no complicated on the fulfill-
ment and is perspective for production of native B. anthracis cap-
sule antigen.
Board 61. Detection and Characterization of Swine Hepatitis
E Virus from Herds in Costa Rica 
J. A. Kase1, M. T. Correa2, C. Luna3, M. D. Sobsey1
1University of North Carolina, Chapel Hill, NC, 2North Carolina
State University, Raleigh, NC, 3National University of Costa Rica,
Heredia, COSTA RICA
Recent findings, including the discovery of almost geneti-
cally indistinguishable swine and human Hepatitis E virus (HEV)
strains, have suggested a potential role of swine in the transmission
of HEV. Routes of human exposure to swine HEV are uncertain
but may include direct and indirect animal contact and exposure to
swine fecal matter. Serological evidence indicates that HEV is
enzoonotic in swine regardless of the status of human HEV
endemicity. Although swine HEV isolates from North America,
Europe, and Asia have been genetically characterized, little is
known about the strain presumed to be circulating in swine from
South and Central America. The virus is known to circulate among
the population in Costa Rica as shown by a seroprevalence study
conducted in 2000. In addition, the extent to which HEV may be
present in fecal waste generated from intensive swine operations
found globally, is largely unknown. In this study, four commercial
swine production sites served by the Veterinary School in Costa
Rica were surveyed for fecal HEV in freshly passed swine feces
collected from individual barns. A questionnaire was presented in
Spanish to all farm managers to elicit information on swine demo-
graphics and waste management strategies. Methods for concen-
tration and purification of HEV from stool suspensions consisted of
clarification, solvent extraction of sedimented solids, and polyeth-
ylene glycol precipitation. Because HEV cannot be cultivated, viral
genomic RNA was extracted and RT-PCR, with primers located in
ORF2, was utilized for the detection of viral RNA. Of the samples
analyzed, 7/21 produced a product of the expected size following
two rounds of (i.e. semi-nested) amplification. Five of the seven
positive samples were from swine between the ages of 1-1/2 to 3
months of age. Notably, samples from swine aged 1 month and 4
months were negative. Our data corroborate the previous finding
of seroconversion, based upon the detection of anti-HEV antibod-
ies, occurring in piglets approximately three months of age. The
identity of all RT-PCR products was confirmed by nucleic acid
sequencing and all isolates were found to be genetically similar.
Based upon GenBank sequence comparisons with characterized
swine and human HEV strains and phylogenetic analysis of nucle-
ic acid regions amplified by ORF2 primers, our isolates closely
resembled and clustered with the US swine and human strains
(nucleic acid identity >90%). The majority of the nucleotide
changes resulted in no differences at the amino acid level. Our data
provide further insight into the natural ecology of HEV in swine
and raise further public health concerns about occupational as well
as off-farm exposures, such as via fecally contaminated surface
water or food and xenotransplantation.
Board 62. Laboratory Diagnosis and Antibiotic Sensitivity
Testing of Brucella Species in Egyptian Patients 
T. Ismail1, M. Wasfy1, F. G. Youssef1, M. Abdel-Maksoud1, K. C.
Earhart1, M. Rakha2, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Central
Public Health Lab, Ministry of Health, Cairo, EGYPT, 3Centers for
Disease Control and Prevention, Atlanta, GA
Introduction: Brucellosis is a zoonotic infection that rep-
resents an important health problem in Egypt. In a surveillance
study on acute febrile illness (AFI) in Egypt, a blood culture sys-
tem was established in 12 fever hospitals throughout the country
and Brucella isolates were received for quality control purposes.
The objective of this study was to test the in vitro antibiotic activi-
ty of 80 Brucella strains against 6 antibiotics commonly used to
treat brucellosis. Methods: Brucella strains were characterized by
PCR using B. melitensis specific primers. Antimicrobial sensitivity
was obtained using Kirby-Bauer disk diffusion and E-test methods.
Results: All isolates were confirmed as Brucella melitensis by stan-
dard microbiological methods and a Polymerase Chain Reaction
(PCR) technique. The average Minimum Inhibitory Concentration
(MIC’s) obtained by the E-test [MIC100] were tetracycline (TCN)
(0.125 mic/ml), doxycycline (0.19 mic/ml), trimethoprim-sul-
famethoxazole (SXT) (0.25 mic/ml), gentamicin (Gn) (1.5 mic/ml),
rifampicin (R) (2.0 mic/ml) and streptomycin (SM) (2.0 mic/ml).
Zone diameters obtained by Kirby-Bauer techniques showed a
high reverse correlation with the MIC’s of TCN, R, SXT, Gn and
ceftriaxone. The ‘r’ values were -0.98, -0.98, -0.93, -0.92 and -0.97,
respectively. Conclusion: Brucella melitensis is the major cause of
Brucellosis in Egypt. Our in vitro findings support the current
empirical regimen for the treatment of brucellosis with either
doxycycline and streptomycin or septra and tetracycline. Sensitivity
results supports a treatment role for all six antibiotics. The close
correlation between inhibition zone size with the MIC suggests the
Kirby-Bauer method could be standardized for Brucella. Further
study and standardization of antibiotic susceptibility of Brucella
species may prove particularly important in situations such as
relapse or treatment failure.
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Board 63. The Development of an In vitro Replication System
for Nipah Virus 
K. Halpin, B. Harcourt, W. J. Bellini, P. A. Rota; CDC, Atlanta, GA.
A new member of the family Paramyxoviridae emerged in
Malaysia in late 1998. Nipah virus (NV) was responsible for the
deaths of over 100 people, and also caused a respiratory disease in
pigs, which devastated the country’s pig farming industry. Initial
characterization of NV showed that it is very closely related
Hendra virus (HV). NV and HV represent a new genus within the
Paramyxoviridae, which has some unique genetic properties.
However, the biocontainment classification of NV (BSL-4) restricts
the type and frequency of work conducted on this virus. Therefore,
alternatives to the use of live virus for further characterization
experiments are highly desirable. Here we report the establish-
ment of a system to study NV replication that does not require the
use of infectious virus. A minigenome was constructed to encode
an NV genome-sense RNA analogue containing the gene for chlo-
ramphenicol acyltransferase (CAT) under the control of the puta-
tive NV transcription motifs and flanked by faithful copies of the
NV genomic termini. Transfection of plasmids encoding the NV
minigenome, nucleocapsid protein (N), phosphoprotein (P) and
the polymerase protein (L), each under the control of T7 promot-
er, into CV1 cells infected with a vaccinia virus recombinant
expressing the T7 RNA polymerase gave rise to detectable CAT
activity. The levels of CAT expressed by the NV mini-genome repli-
cation system were equivalent to those expressed by a well-charac-
terized, measles mini-genome system. This replication system will
now be used to study transcription and replication of NV and to
investigate the functional significance of the unique genetic prop-
erties of NV.
Board 64. Functional Properties of the Fusion and
Attachment Glycoproteins of Hendra and Nipah Viruses 
A. Tamin, B. Harcourt, P. E. Rollin, T. G. Ksiazek, W. J. Bellini, 
P. A. Rota
CDC, Atlanta, GA
Hendra virus (HV) and Nipah virus (NV) are recently
emergent, related viruses that are capable of causing severe disease
in humans and animals. The goal of this study was to examine the
immunogenic and functional properties of the fusion (F) and
attachment (G) glycoproteins of NV and HV. Vaccination of mice
with recombinant vaccinia viruses (rVV) expressing either the F
(rVV/NV-F) or the G (rVV/NV-G) proteins of NV induced neutral-
izing antibody responses to NV, with higher titers produced after
vaccination with rVV/NV-G. Co-infection of Vero cells with
rVV/NV-F and rVV/NV-G produced multi-nucleated giant cells,
which were not visible in cells infected with either of the rVVs indi-
vidually, and cell fusion was inhibited by antibodies to either NV-G
or NV-F. When the homologous pairs of G and F proteins from
either HV or NV were co-expressed in a transient expression sys-
tem, extensive syncytia formation was observed within 24 hours.
An equivalent amount of syncytia formation was observed when
the heterologous pairs of F and G proteins from HV and NV were
co-expressed. Therefore membrane glycoproteins of HV and NV,
like the membrane proteins of other paramyxoviruses, are able to
induce a neutralizing antibody response, and both proteins are nec-
essary for cell fusion.
Board 65. The Laboratory Diagnostics of Plague Patients
in Kazakhstan 
B. M. Suleimenov, Sr.1, B. B. Atshabar, Sr.2
1Kazakh science Center for quarantine and zoonotic diseases,
Almaty, KAZAKHSTAN, 2Kazakh Scientific Center of Quarantine and
Zoonotic Infections, Almaty, KAZAKHSTAN
In the natural plague foci of Kazakhstan mainly are regis-
tered bubonic and bubonic-septic forms of plague. In single cases
are dermal, anginouse-bubonic and pneumonic forms. The com-
plex of plague laboratory diagnostics consists of three stages: the
express-method with native material; accelerated methods (the
crop of material on nutritious mediums, the infection of white
mice and research after 10-15-24 hours); developed method (bac-
teriological and biological). Mandatory for the research, are blood,
material from tonsil, the type of another material depends on dis-
ease forms. 10 ml of blood take in two tubes - 3-4 ml for the serum
deriving, remaining with 20-30 unite heparin for other methods.
From contents vesicle and pustule make washing by a syringe with
a physiological solution. There is investigate differentiate the cor-
tex from dermal ulcer, separated ulcers, punctate of an edge of an
ulcer. Separately - right and left the tonsile, patch on tonsil and
purulent tap. At the first 24-72 hours is investigate punctate of the
center of central inflammation of bubon. In 72 hours after melting
of tissue study punctate of an edge of the center. Differentially
take contents fluctuating of the center and separated bubon of
availability of a fistula. From the phlegm - traces of blood, pus. The
feces of septic and anginouse forms. At meningitis syndrome is
investigate the liquor. At a corpse - besides from parenchymatous
organs, marrow (if necessary), surface lymphatic gland, is neces-
sary mesenteritic lymphatic gland. For increase of possibility of
isolation microbe from material to make crop of 4-6 samples of the
same material. For the serological research to F&#1075;&#1072; 1
to use at once three variants of sample - are native and in titers
1:10, 1:100. These methods used in practice during many tens
years. The last cases of people’s plague in Kazakhstan were regis-
tered on station Saksaulsk (Kyzylorda oblast, August, 2001). At
first in this region two patients at the ages of 13 and 41after great
number of fleas bites was registered with bubonic-septic forms of
plague with thigh localization of bubo. One of them is died (late
hospitalization). After 24 hours in blood and bubo punctate was
observed continuous growth. The Fra 1 from bubo punctate is
1:81920, from blood is 1: 320. The white mice died from plague in
2-3 days. The microbe was isolated from lymphatic gland and lungs
(2 colonies). The Fra 1 was founded only in lymphatic gland -
1:5120. During medical treatment of second patient were founded
the antibodies to Fra1 after 8 days - 1:320, 10 days -1:2560. In 1999
the rare anginouse-bubonic form of plague was registered. Y.pestis
was isolated only from right tonsil with marked center of inflam-
mation and from faces. The titer of antibodies is 1:320 on the 7th
and 1:80000 on the 15th days. The devised scheme of plague lab-
oratory diagnostic is simple in execution, effective and adapt to
local conditions.
Board 66. Efficiency Improved Enterotoxic Antigen
Erithrocyte Immunoreagents in Cholera Diagnostics 
B. M. Suleimenov, Sr.1, I. S. Arakelyan, Sr.2, E. E. Li, Sr.2, I. B.
Utepova, Sr.2, R. S. Mussagalieva, Sr.2, T. Khamzin, Sr.3
1Kazakh science Center for quarantine and zoonotic diseases,
Almaty, KAZAKHSTAN, 2Kazakh Scientific Center of Quarantine and
Zoonotic Infections, Almaty, KAZAKHSTAN, 3Atyrau Antiplague sta-
tion, Atyrau, KAZAKHSTAN
The registration of specific antibodies to enterotoxic -
choleragen with allowance of regional features of cholera epidemi-
ology, represents not only diagnostic, but also preventive value.
The regular research of serums of patients blood with acute intes-
tinal infections, in regions with often cholera diseases of people, it
is rationally for information maintenance of preventive measures.
Therefore it is necessary the availability of a highly sensitive and
specific preparation for registration of antibodies to choleragen.
The most active is commercial enterotoxic antigen erythrocyte
preparation, registers maximum titer of antibodies in patients
blood in cultivation of serum 1:10 000. We advance the method of
production choleragen by following parameters: there is construct-
ed the new selective medium for production choleragen and the
optimum conditions are developed for production of deriving ery-
















569B of type Inaba, V. cholerae 680 of type Ogava, V. cholerae O-
139, V. cholerae 505 non 01. All these strains, except V. cholerae
569B we were isolated from the patients. All antigen erythrocyte
preparation obtained on the bases of choleragen from different
strains have the high specificity and sensitivity. All of them gave
negative results in Reaction of Indirect Hemagglutination (RIHA)
with commercial agglutinative serums &#1054;, Ogava and Inaba.
The liquid variants antigen preparation till to lyophilization, regis-
tered specific antibodies in serum of cholera patients (&#1054;-
139) for 20 day of disease in the range of 1:500 000-1:1000 000.
After the lyophilization were registered the positive results of reac-
tions in the range of this serum of 1:125 000-1:500 000. In 2001
(September) was investigated about 300 serums of patients infect-
ed by cholera Eltor type of Inaba in Aktau, Mangyshlak oblast. The
range of positive reactions of RIHA from the patients in critical
period of process changed from 1:20 to 1:160000. In control reac-
tions with commercial preparations the titer of positive reactions
did not exceed 1:10 000 Obtained preparations are perspective in
cholera diagnostics and in realization of prophylaxis measures.
Board 67. Case of Hantavirus Pulmonary Syndrome in Europe 
P. Caramello1, F. Lipani1, R. Balbiano1, F. Canta1, L. Bonino2, C.
Moiraghi2, F. Navone2, V. Gay2
1Malattie Infettive A, Osp. Amedeo di Savoia, Torino, ITALY,
2Medicina d'urgenza, Ospedale Molinette, Torino, ITALY
A young Romanian man was admitted for malaise, fever,
headache, blurred vision, conjunctival injection, abdominal and
back pain lasting for about two days. He arrived to Italy after a 20
days makeshift trip through the Balkans. Laboratory exams
showed:PTL: 9,000/mm3; WBC: 21,000/mm3 with immunoblasts;
Htc: 61,9%, Hb:20,8 g/dl, INR:1,81, Creat: 2,2 mg/dl; Urea: 137
mg/dl; proteinuria: 3.4 g/24 h; LDH: 770 UI, AST/ALT: 74/131 UI.
ARDS developed needing non invasive ventilation support. A com-
plete clinical and radiological recovery was obtained on 18th day. A
diagnosis of Hantavirus Pulmonary Syndrome (HPS) due to a virus
of the Puumala group was made on the serologic results.
Hantaviruses were known as the agents of HFRS and Epidemic
Nephritis (EN) in the Eastern Hemisphere. Since 1993, new
strains of hantavirus (mostly SNV) have been emerging in the US
as the cause of an acute respiratory disease now termed Hantavirus
Pulmonary Syndrome. Eurasiatic hantaviruses are classified in two
subfamilies, depending on the host: murinae (HTN, DOB, SEO)
and arvicolinae (PUU), while American hantaviruses belong to sig-
modontinae. Phylogenetic trees show two major lineages of han-
taviruses, one leading to HTN, SEO, Thailand and DOB, and one
leading to PUU, SN, Prospect Hill, Andes and other New World
hantaviruses. HTN and SEO are the most genetically homoge-
neous and stable in nature, PUU virus isolates vary the most. Both
HFRS and HPS can be divided into distinct clinical subtypes, and
the viral strain seems to be a key determinant of the severity and
nature of the clinical abnormalities. Pathogenesis of HFRS and
HPS is the same, consisting in a functional impairment of vascular
endothelium. Clinical differences depend on different comparti-
mentalization of the selective immune response: in both forms of
illness, renal and pulmonary involvement may occur, even if the
degree of severity varies. In HFRS, slight pulmonary involvement
is sometimes reported, although a severe pulmonary syndrome is
rarely observed. Because of Puumala virus is the most phylogenet-
ically similar to American hantavirus, a predominant pulmonary
involvement is not surprising and has to be referred to the genetic
polimorphism and to the intrinsic characteristics of the strain.
Hantavirus outbreaks have been associated with changes in the
host rodent population density and contact with humans. The
observation of a case of HPS substained by Puumala virus, could be
the expression of an accidental contact between rodent population,
carrying Hantavirus with prevailing pulmonary trophism (and usu-
ally murine restricted), and humans. That could reflect the change-
ments in social and economical conditions and massive migrations.
Public health must be prepared to face unusual health problems,
due to immigration from endemic countries. Hantavirus have to be
kept in mind as a differential diagnosis in case of acute respiratory
distress even in Europe.
Board 68. West Nile Virus Activity in Israel In 2001: Human
and Mosquito Infections 
H. Bin1, M. Hindiyeh1, U. Shalom2, H. Pener3, L. Orshan2, L.
Shulman1, H. Shcnur3, D. Gandacu4, L. Weiss1, S. Schlezinger1 and
E. Mendelson1,5
1Central Virology Laboratory, Public Health Services, Ministry of
Health, Chaim Sheba Medical Center, Tel-Hashomer, ISRAEL, 2Ministry
of the Environment, Jerusalem, ISRAEL, 3Laboratory of Entomology,
Central Laboratories Jerusalem, Public Health Services, Ministry of
Health, ISRAEL, 4Department of Epidemiology and Infectious Diseases,
Public Health Services, Ministry of Health, ISRAEL, 5Faculty of Life
Sciences, Bar-Ilan University, Ramat Gan, ISRAEL
Background and Objectives: Following an outbreak of
West Nile (WN) fever in 2000 the virus activity was closely moni-
tored in humans and mosquitoes in 2001. We present laboratory
results of the human and mosquito testing. Methods: The case
definition for laboratory diagnosis in 2001 included only meningi-
tis and encephalitis cases. Human infections were monitored by
testing for IgM antibodies primarily in adults age 18 y and above.
RT-PCR was attempted on CSF and pre-seroconversion sera.
Between April 24 and November 14, mosquitoes were collected in
high-risk areas. 534 mosquito pools were tested for presence of
WN virus genome by real-time RT-PCR, TaqMan., identifying the
ENV and NS5 regions. Virus isolates were compared to the year
2000 isolates. Results: In 2001, 44 out of 1358 patients were posi-
tive (3.2%) and 3 patients died (case fatality rates: 6.8%). The fatal
cases were confirmed by positive TaqMan results. In 2000, 439 out
of 1600 patients (27%) were positive and 29 died (case fatality rate:
6.6%). 20 out of 534 mosquito pools (3.7%), containing 899 out of
19499 (4.6%) of Culex pipiens and Culex perexigus species had
WNV sequences. Virus was isolated from 8 pools, and molecular
analysis of the PrM/M/ENV genes revealed 2 lineages. Similar to
2000 findings, one most closely related to the 1999 New-York iso-
lates, and the other to the 1997 Romanian isolate. These lineages
were reported by others in Israel in birds and horses since 1998 as
well. The geographic distribution of the clinical cases and the pos-
itive mosquito pools was partially overlapping. Two main geo-
graphic foci of WN fever in 2000 were not affected in 2001.
Conclusions: Given the narrow case definition for WN laboratory
testing in 2001, and the high activity of Echo4 causing aseptic
meningitis during the same months as the WNV activity, we have
not yet enough evidence to determine if the 2001 activity repre-
sents an outbreak or normal endemic situation. However, the pres-
ence of the same WN genomic lineages in birds, humans and mos-
quitoes for more than 3 years is suggestive of endemic activity. 
Board 69. Environmental Risk Factors and Campylobacter
infection – An Ecological Approach Using a Geographical
Information System 
K. Nygård1, Y. Andersson2, Å. Svensson2, J. Lindbäck2, T.
Kistemann3, J. Giesecke2
1European Programme for Intervention Epidemiology Training,
Swedish Institute for Infectious Disease Control, SWEDEN, 2Swedish
Institute for Infectious Disease Control, Stockholm, SWEDEN, 3Institute
of Hygiene and Public Health, University of Bonn, GERMANY
Campylobacter spp is the most common cause of acute bac-
terial gastroenteritis in Sweden. Case-control studies to identify
risk factors have been conducted in several countries during the
90s, but still many cases remain unexplained. The geographic dis-
tribution of Campylobacter infections varies substantially, and
there are many environmental factors that may influence the
observed pattern, but few studies have investigated the influence






of these factors. Geographical Information Systems (GIS) offers an
opportunity to use routinely available surveillance date in ecologi-
cal studies in order to investigate the association betweens vari-
ables showing a geographic pattern and disease incidence. This
method can complement traditional approaches to the investiga-
tion of risk factors for Campylobacter infections, both in outbreak
situations and for sporadic cases. We conducted an ecological study
on the association between environmental variables related to
water and livestock and Campylobacter incidence in Sweden 1998
- 2000. Information on cases and environmental factors were col-
lated and plotted using GIS. Pearson correlation coefficients and
multiple Poisson regression were used to estimate the strength of
the associations. Positive ecological associations were found
between Campylobacter incidence and average water-pipe length
per person, with ruminant density, and a negative association with
percentage of people having public water supply. This indicates
that drinking water and contamination from livestock may be
important factors in explaining part of the sporadic human
Campylobacter cases.
Board 70. Induction of Cellular Angiogenic Factors in
Macrophages by Bartonella henselae
S. I. Resto-Ruiz, M. W. Schmiederer, C. Newton, D. Sweger, T. W.
Klein, H. Friedman, B. E. Anderson
University of South Florida College of Medicine Department of
Medical Microbiology and Immunology, Tampa, FL
Bartonella henselae is a bacterial human pathogen whose
natural reservoir is the domestic cat. The emerging zoonotic syn-
dromes associated with B. henselae are cat-scratch disease (CSD)
and bacillary angiomatosis (BA). CSD is the primary manifestation
of B. henselae infection in the immunocompetent individual and
the most common cause of chronic, benign adenopathy in children.
However, in the immunocompromised individual, infection tends
to be systemic and includes fever with bacteremia. In addition, B.
henselae-induced angiogenesis or BA is the primary manifestation
of infection in HIV-positive, immunosuppressed individuals, and
chronic alcoholics. The mechanism by which BA developes
remains unclear. We hypothesize that B. henselae-infected
macrophages may induce the production of cellular angiogenic fac-
tors that may in turn cause endothelial cell (EC) proliferation. The
induction of angiogenic factors in differentiated human promono-
cytic THP-1 cells upon infection with live or killed B. henselae was
evaluated. Supernatants analyzed by ELISA demonstrated that
both, vascular endothelial growth factor (VEGF), a direct positive
regulator of angiogenesis, and interleukin-1 beta (IL-1ß), a poten-
tiator of VEGF, were induced in THP-1 upon infection with live or
UV-killed bacteria. Similar results were observed when
macrophages were pre-treated with cytochalasin D, a phagocytosis
inhibitor, suggesting that bacteria-cell attachment is sufficient for
VEGF and IL-1ß induction. Neither VEGF nor IL-1ß was pro-
duced when heat-killed (70º or 100º C) bacteria were used. In addi-
tion, conditioned medium from infected macrophages induced the
proliferation of human microvascular endothelial cells (HMEC-1)
thus demonstrating angiogenic activity. The data suggests that
VEGF and IL-1ß are linked to a paracrine angiogenic loop pro-
moting the development of bacillary angiomatosis during B. hense-
lae infection.
Board 71. A Case of Fatal Autochthonous Acquired
Angiostrongylus cantonensis Infection in Jamaica 
G. Codrington1, J. F. Lindo2, C. Escoffery2, C. Cunningham-Myrie3,
D. Ashley3, M. L. Eberhard4
1National Public Health Laboratory, Kingston, JAMAICA, 2University
of the West Indies, Kingston, JAMAICA, 3Ministry of Health, Kingston,
JAMAICA, 4CDC, Atlanta, GA
Human infection with Angiostrongylus cantonensis can be
serious and life threatening. Once thought to occur only in
Southeast Asia and Pacific islands, infection in both man and rats,
the normal definitive host, appears to be spreading. Infected rats
have been reported from Egypt and the Caribbean. Recently,
human infection has been recognized in the United States
(Louisiana), Australia, Africa and Jamaica. We report the occur-
rence of a fatal infection with A. cantonensis in a 14-mo-old male
Jamaican child who, until the time of his illness was developing
normally. Initial complaints were itching and restlessness progress-
ing to poor appetite, abdominal distention, and fever. The child
was admitted to hospital, where his condition progressively deteri-
orated, marked by respiratory stridor, poor head control, weakness
of limbs, and decreasing consciousness. Differential diagnosis
included encephalitis, Guillian-Barre syndrome, and meningitis.
Treatment with antibiotics and dexamethasone was started but
death occurred on day 35 post-admission. Examination of stained
sections of the brain and lungs revealed intense inflammation,
eosinophilic meningo-encephalitis and numerous sections of
worms identified as A. cantonensis. The child had not traveled out-
side of Jamaica. This is the first case of fatal A. cantonensis infec-
tion recognized in Jamaica. The case in conjunction with a recent
outbreak in a group of travelers to Jamaica and the finding of the
parasite in rats and snails on the island indicate that A. cantonensis
is well established in Jamaica and poses risk of infection to both
residents and travelers alike.
Board 72. The Incursion of West Nile Virus into Canada 
in 2001 
M. A. Drebot1, I. Barker2, R. Lindsay1, P. Buck3, H. Weingartl4, F.
Hunter5, G. Ebel6, L. Kramer6, R. Lanciotti7, P. Sockett3, H. Artsob1
1Zoonotic Diseases and Special Pathogens, Health Canada,
Winnipeg, MB, CANADA, 2University of Guelph, Guelph, ON,
CANADA, 3Bureau of Infectious Diseases, Health Canada, Ottawa,
ON, CANADA, 4Canadian Food Inspection Agency, Winnipeg, MB,
CANADA, 5Brock University, St. Catharines, ON, CANADA,
6Arbovirus Laboratories, New York State Department of Health,
Albany, NY, 7Division of Vector-Borne Infectious Diseases, Centers for
Disease Control and Prevention, Fort Collins, CO
West Nile (WN) virus was first detected in the Western
Hemisphere during a 1999 outbreak of viral associated illness and
death among humans, animals, and birds in New York state. As of
December 14th, 2001 the virus had spread to 26 additional states,
the District of Columbia, the Cayman Islands and Canada (this
report). To undertake surveillance for the possible incursion of WN
virus into Canada, an avian surveillance system was put into place
the spring of 2001. Kidney and brain tissues from dead birds
(Corvid species) collected at various sites in Saskatchewan,
Manitoba, Ontario, Quebec, and the Atlantic Provinces were
homogenized in tissue culture medium and RNA isolations per-
formed. Purified RNA was screened for the presence of WN virus
genome by TaqMan and one-step reverse transcriptase (RT)-PCR
diagnostics. Confirmation of WN virus infection within bird tissues
was carried out by viral isolation and immunohistochemical (IHC)
procedures using WN virus specific antisera. To date a total of 2828
Canadian birds have been analysed for WN virus infection in a
variety of tissue types. PCR based diagnostics revealed the pres-
ence of viral genome in a crow collected in Windsor, Ontario on
August 8/ 2001. Virus isolation, IHC analysis, and amplicon
sequencing confirmed that this bird was infected with the North
American strain of WN virus that was responsible for the
1999/2000 outbreaks in north eastern United States. From mid-
August onward, WN virus has been detected in a total of 127 birds
(106 crows, 21 blue jays) from 12 different health units in southern
Ontario. The latest date documented for finding a WN virus infect-
ed bird was October 29. Dead bird submissions from other
Canadian provinces have thus far shown no evidence of infection.
In addition to dead bird surveillance a study was undertaken to
determine the occurence of WN virus in various mosquito species
















August and September. A total of 1092 pools of mosquitoes (5852
individuals) were screened for the presence of WN virus genome
by RT-PCR. Three Culex pipiens pools were found to be positive
for viral RNA. Sequencing of capsid and membrane protein encod-
ing regions of a number of Canadian WN virus isolates showed
nucleotide sequence changes when compared to various genotypes
currently circulating in the US. Further genetic characterization is
ongoing to determine the extent of sequence divergence that
presently exists among Canadian and American isolates.
Board 73. Intestinal Heterophyidiasis: An Emerging Parasitic
Zoonosis In Southern Philippines 
V. Y. Belizario, Jr.
University of the Philippines College of Public Health, Manila, PHILIPPINES
Heterophyidiasis is an infection of the small bowel caused
by heterophyid flukes. In the Philippines, the prevalence of het-
erophyidiasis has been noted to be low. In in connnection with an
outbreak of intestinal capillariasis in Southern Philippines, com-
munity surveys showed heterophyid infection rates of 16.7% and
15.7% in 1998 and 1999, respectively. An active case detection was
conducted in San Isidro, Monkayo, Compostela Valley in the early
part of May 2000 by a team from College of Public Health,
University of the Philippines Manila. An interview of patients with
a history of bowel disturbance in the past 4 weeks prior to the sur-
vey was conducted, and stool specimens from the same patients
were examined using Kato-Katz method and/or Formalin ether
concentration technique. With Kato-Katz method, heterophyid
eggs were counted, and a frequency distribution was prepared
using a proposed scheme for classification of intensity. Key inform-
ant group interviews were also conducted to help describe prac-
tices of food preparation and eating habits that possibly expose
local residents to infection. Possible intermediate hosts were also
collected from the field and were forwarded to the Institute of
Marine Biology of the University of the Philippines for specimen
identification and examination of the larval stages of heterophyid
fluke and other helminths. A total of 87 patients in Barangay San
Isidro, were diagnosed to have heterophyidiasis. Overall infection
rate was 36.0%. Infection rates were higher in age groups 5 years
old and over, although infection rate in children less than 5 years of
age may not be considered insignificant. Males 60 years old and
younger had higher infection rates compared with females in the
same age groups. To determine efficacy of treatment, stool speci-
mens were collected from patients who were diagnosed to have
heterophyids 7 to 14 days after treatment with praziquantel. Cure
rate among those with heterophyidiasis was excellent at 97.1%.
Collected samples of possible intermediate hosts, which included
freshwater fishes and other aquatic animals were examined and
found to be infected with various parasites in different life cycle
stages. Parasites were found in the scales, gills, muscles, intestines,
and caeca. The high incidence of parasites in freshwater fishes may
have an important impact on the health of the community as a
whole considering that fish is a major source of food in the area.
Early diagnosis and treatment of heterophyidiasis are important to
ensure prompt resolution of infection, hence, decreased morbidity
and decreased chances for complications like heart or brain
involvement. This study illustrated the importance of recognition
of the possible problem of heterophyidiasis and other food-borne
parasitoses, accurate laboratory diagnosis, and recognition of possi-
ble intermediate hosts that will be crucial for control and preven-
tion of this health problem.
Board 74. Expansion of WNV Activity in Massachusetts
During 2001 
B. G. Werner, R. Konomi, Z. Berrada, M. Cumming, D. Hoffman, P.
Zarcone, A. Clain, S. Hennigan, W. N. V. Response Team
Massachusetts State Laboratory Institute, Boston, MA
Following the emergence of West Nile Virus (WNV) in
New York City in 1999, the Massachusetts Arbovirus Surveillance
Program was expanded to track not only Eastern Equine
Encephalitis Virus but also WNV. In 2000, the virus was found pri-
marily in birds, especially crows. During the 2001 season, however,
virus was associated with three human cases, (ages 70, 72 and 89),
including one fatality, with onsets from mid-September through
early November. The record breaking warm weather during the fall
is thought to have played a role in the extension of this arboviral
season. Another striking feature of the reappearance of WNV was
an outbreak in horses; 37 clinical cases were laboratory confirmed
with onsets between August 28 and October 15. Only one clinical
case and a second infection were documented previously in the
state. Once again large numbers of dead birds were reported, and
1104 tested positive for WNV by RT-PCR. The total increased over
the 849 found positive in 2000, even though the routine collections
were suspended in many towns during September and October
and not all submissions were tested. Crows and blue jays account-
ed for 93% of the positives, but 18 additional avian species were
also virus positive. Geographically, the virus spread throughout
eastern Massachusetts. A total of 25 mosquito pools were WNV
positive in cell culture and/or RT-PCR compared to 4 isolates the
previous summer. Mosquito trapping will resume in the spring, but
human and veterinary surveillance testing continues.
Board 75. Epidemiological Survey of Bacterial Colonization
in Poultry Production Workers and a Human Referent
Population 
J. P. Furuno
Department of Epidemiology and Preventive Medicine, University of
Maryland School of Medicine, Baltimore, MD
Background: Cases of human disease have been attrib-
uted to bacterial infections associated with consumption of poultry
products. Few studies have addressed the possible transfer of
microorganisms from agricultural production into the human com-
munity through other (non-food) pathways. We conducted an epi-
demiological survey of bacterial colonization in poultry production
workers and a human referent population. Methods: This was a
pilot, cross-sectional study in the Delaware/Maryland/Virginia
(Delmarva) region; an area with high-density chicken growing and
processing. Poultry industry workers and community residents >18
yrs were enrolled; persons working in health care and those with
recent foreign travel were excluded. Exposure assessment was per-
formed using questionnaires administered by trained interviewers
in English or Spanish. Additional exposure assessments were con-
ducted by visits to chicken houses in Delmarva. Each participant
provided a fresh stool sample. Aliquots of specimens were incubat-
ed at 42o C in enrichment broth and transferred to blood agar
plates under microaerophilic conditions. Campylobacter jejuni
were identified biochemically as oxidase and catalase positive
colonies that hydrolyzed both hippurate and indoxyl acetate.
Results: Thirty-four subjects were enrolled in the study, including
whites, African Americans, and Hispanics. A high prevalence of
campylobacter colonization was found: among community resi-
dents 100% (9/9) were positive; among workers in contact with live
chickens 41% (7/17) were positive; and among workers in poultry
processing plants 63% (5/8) were positive for campylobacter.
Conclusions: These results suggest a high prevalence of campy-
lobacter exposure among residents in Delmarva living near poultry
growing and processing facilities. Furthermore, they suggest that
there are likely other pathways of exposure in rural communities in
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addition to occupational exposures. These data highlight the
importance of studying the prevalence of colonization in commu-
nities with a high likelihood of exposure. Research supported by a
contract with US FDA, CVM.
Board 76. Reverse Genetics for Bunyaviridae: Rescue of
Crimean-Congo Hemorrhagic Fever Virus (CCHF) Minigenomes 
R. Flick1, H. Feldmann1, F. Elgh2
1Canadian Science Centre for Human and Animal Health, Special
Pathogens Program, Winnipeg, MB, CANADA, 2Swedish Institute for
Infectious Disease Control, Centre for Microbiological Preparedness,
Stockholm, SWEDEN
In order to manipulate the viral RNA genomes of different
members of the family Bunyaviridae, we have used an RNA poly-
merase I expression system based on the approach recently pub-
lished for Uukuniemi virus (J. Virol. 75: 1643-1655). A cDNA con-
sisting of the CAT- or GFP-ORF in the antisense orientation
flanked by the 5` and 3` terminal non-coding sequences (S-seg-
ment) of a Crimean-Congo Hemorrhagic Fever (CCHF) virus was
inserted between an RNA polymerase I promoter and terminator.
Following transfection, the cellular RNA polymerase I generated
an artificial vRNA segment (minigenome) without any end modifi-
cation, e.g. CAP structure, poly(A)-tail. The viral proteins neces-
sary for transcription and replication of this RNA minigenome
were provided by CCHF-superinfection, which was performed
under biosafety level 4 conditions. Using this approach, CAT activ-
ity/GFP fluorescence was observed, demonstrating that the helper
virus was able to recognize the pol I transcript as an artificial
genome segment. Our data further suggests that the RNA poly-
merase I expression system can be used for the manipulation of
genomes of bunyaviruses with a high efficiency, despite the fact
that the replication cycle of these viruses takes place exclusively in
the cytoplasm of the cell. Different strategies to optimize the pro-
duction of recombinant virus will be discussed. This is the first step
towards the successful rescue of a human-pathogenic member of
the family Bunyaviridae. In future we will use the RNA pol I sys-
tem in combination with expression plasmids encoding the viral
proteins which will allow us to rescue infectious CCHF particles
without the need of a helper virus. We believe that the continued
improvement of this system will facilitate the development of
attenuated, recombinant CCHF viruses that can be used for study-
ing the pathogenesis and the host immune response of this impor-
tant viral pathogen.
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Board 77. Surveillance and Genotyping of Norwalk-like
Virus (NLV) in Specimens of Viral Gastroenteritis Outbreaks in
New York State (NYS) Over a Twenty-Month Period 
M. E. Fuschino1, M. P. Kleabonas1, K. Rush-Wilson1, T. Church1, N.
K. Chatterjee1, D. Morse2
1Wadsworth Center, New York State Dept. of Health, Albany, NY,
2Office of Science and Public Health, New York State Dept. of
Health, Albany, NY
NLVs have been recognized as one of the leading causes of
viral gastroenteritis with an estimated 23 million cases nationwide
per year. Based on trend analysis of 1979-1995, approximately
3,000 adult deaths occurred annually from an estimated 267 mil-
lion disease episodes. But an etiologic agent could be detected in
<10% of these cases due to unavailability of sensitive and specific
diagnostic tests. Molecular methods now available enable the
detection of NLVs in clinical specimens. Consequently, NLV
strains can be identified and linked to outbreaks in multiple loca-
tions, tracing them to their sources in contaminated food and
water. The endemic disease burden caused by NLVs remains
unknown. Furthermore, contributions by other diarrhea-causing
viruses like rota, enteric adeno and some enteroviruses have not
been thoroughly investigated. In a collaborative study with the
CDC and other EIP sites, this investigation was designed to assess
the contribution of viruses to gastroenteritis outbreaks in NYS.
From January 2000 to August 2001, we tested approximately 180
non-bacterial stool specimens received from 43 gastroenteritis out-
breaks throughout the state. Methods used were RT-PCR and
nucleotide sequencing for detecting NLVs; ELISA for rota-; and
tissue cultures (RhMK, A549, RD) with IFA and neutralization for
entero- and enteric (types 31, 40, 41) adenoviruses. Two primer
sets and automated nucleotide sequencing analyzed the strains
from both genogroups I and II of NLV in these outbreaks. The
patients, mostly adults, with the majority female (54% : 43%)
exhibited symptoms such as diarrhea, nausea, vomiting, fever,
abdominal cramps and headache. NLVs were the sole viral agent
detected in 54% (81/150) of all specimens tested from 30 out of 43
outbreaks (70%). Genogroup II NLV strains predominated in
>90% of the outbreaks, including Spykenisse and Gwynedd. The
outbreaks appeared to be more frequent (69% in 2000, 61% in
2001) in the 6 warm weather months, perhaps relating to increased
outdoor activities involving food. Interestingly, two NYS counties
experienced multiple outbreaks during 2000 and 2001. In one
county, the same genogroup II virus caused more than one out-
break, while in the other, viruses of different genogroups were
responsible. Thus, it is evident that NLVs are a predominant
pathogen of non-bacterial gastroenteritis in NYS. Furthermore,
trends of NLV-infections can now be investigated both among and
within regions across the counties in NYS with a focus on connec-
tions between genogroups and geographic location. (Supported in
part by a CDC/EIP Viral Gastroenteritis Project Grant).
Board 78. Acute and Long-Term Mortality Associated with
Foodborne Bacterial Gastrointestinal Infections: A Registry
Based Study 
M. Helms, P. Vastrup, P. Gerner-Smidt, K. Mølbak
Statens Serum Institut, Copenhagen, DENMARK
Background: Despite marked improvements in the living
conditions and hygienic standards, foodborne bacterial infections
have a major impact on the public health and economy of the
industrialized countries. We conducted a registry based, matched
cohort study to determine the excess mortality associated with
infections with Salmonella, Campylobacter, Yersinia enterocolitica
and Shigella spp and to address the issue of interaction with pre-
existing illness. Method: By using data from the National Registry
of Enteric Pathogens and the Danish Civil Registration System, we
were able to estimate the long-term effect on survival. Additionally
we collected data on admission and discharge diagnoses from The
Danish National Patient Registry and the Cancer Registry, thereby
allowing us to control for pre-existing illness. By survival analysis
(conditional proportional hazards regression) we estimated one-
year-mortality among patients compared with a sample of the gen-
eral population in Denmark, matched by age, gender and county of
residence. Results: A total of 48,857 patients, distributed over
26,974 Salmonella-cases, 16,180 Campylobacter, Yersinia 4,045
and Shigella 1,658 were registered in the National Registry of
Enteric Pathogens. Among patients 1,026 (2.10%) deaths were
registered up to one year after infection. 3,353 (0.69%) deaths
were identified among 487,150 people in the reference group.
Patients infected with one of the four enteric pathogenic species
had a 3.2 times higher mortality than referents (95 % confidence
interval (CI) 3.0-3.5). After adjusting for co-morbidity this was
reduced to 2.3 (95 % CI 2.2-2.5). The relative mortality within the
















terial groups (Salmonella: RR 11.8, Campylobacter: RR 5.0,
Shigella: RR 31.8 and Yersinia: RR 4.7), compared with the refer-
ence group. Furthermore we found an excess long-term mortality
up to six month after infection with a Campylobacter (RR 1.6) or
Yersinia (RR 2.1) species, and up to 1 year in Salmonella species
(RR 1.3). In the group of patients without known pre-existing ill-
ness, we found an excess mortality among Salmonella (RR 2.4) and
Yersinia (RR 2.8) infected patients up to one year after infection
compared to the reference group. Conclusion: The four food
borne bacterial species were all associated with a significant acute
mortality, even when pre-existing conditions were taken into
account. As a new finding, Salmonella, Campylobacter and Yersinia
were associated with a significant long-term excess mortality. Only
a part of this excess mortality could be explained by co-morbidity,
in particular HIV-infection, metastatic cancer and leukemia. Our
data suggest that current estimates of the burden of foodborne dis-
eases underestimate the number of deaths from bacterial gastro-
intestinal infections.
Board 79. Meningococcemia-Liked Syndrome (Streptococcus
suis type 2) is New Emerging Zoonotic Disease in Thailand,
1999 - 2000
S. Guharat
Ministry of Public Health, Nonthaburi, THAILAND
Background: On August 27, 2000, local epidemiologist in
Lumpun Provincial Health Office (PHO) was notified from com-
munity hospital in Lumpun province where is in the northern
part of Thailand that there was two suspected meningococcal
meningitis cases. Then the rapid response team investigated this
event during August 27 - September 30, 2000. Objectives: To
verify diagnosis and the outbreak, to describe the outbreak, to
determine mode of transmission and risk behaviors, to recom-
mend prevention, control and further surveillance.
Methodology: Reviewed medical record of both cases. Active
cases finding by interview physicians, review medical records in
previous year and search for contact case in community. The def-
inition of the case was high grade of fever, severe myalgia and
petichiae/echymosis with S. viridans or S. suis finding from blood
or CSF or urine culture. And environmental survey was conduct-
ed within that village. Results: Two cases were male, 44 and 40
years old. Dates of onset were August 21, 2000 and August 25,
2000. The places at illness were different subdistrict but in the
same district. Both of them died from sepsis and shock on August
26, 2000 and August 27, 2000, respectively. Clinical signs and
symptoms were fever, severe myalgia and echymosis at face and
trunk. The laboratory finding from hemo-culture of both cases
were Streptococcus suis type 2. Medical record reviewing during
Jan 1999 - July 2000, eight cases that met case definition were
found. All of them were male, 44 years old mean of age (40 - 50
years old), all died. Date of onset of first case was 26 March,
1999. From epidemic curve, it showed 3 times of outbreak and
the last time showed common source outbreak. 7/10 cases had
history of few days taking raw pork or raw pork’s blood before ill
and had history of heavy alcoholic consumption more than 10
years. All of them had no history of feeding or contact with lived
or dead pigs for 30 days before ill. Discussion: Previously in
Thailand, there had no document of severe S. suis type 2 infec-
tion. From these outbreaks, we suspected meningococcemia and
we could verify diagnosis and outbreak that caused from S. viri-
dans or S. suis. The mode of transmission was taking raw pork or
raw pork’s blood and the risk was heavy alcoholic consumption.
Action Taken: Health education was done in communities. In
Lumpun province, the new surveillance for seeking meningococ-
cemia-like syndrome from S. viridans or S. suis has been con-
ducted the whole province and expand to adjacent provinces.
Then we can find this syndrome in another two provinces.
Board 80. Investigation of an Escherichia coli O111:NM
Outbreak in a Daycare in South Dakota 
C. D. Carlson
South Dakota State Public Health Laboratory, Pierre, SD
Background: Escherichia coli O111:NM is one of many
non-O157 shiga toxin producing E. coli (STEC) known to cause
diarrheal illness in humans. Very few outbreaks of non-O157 STEC
have been reported in this country. Surveillance conducted by the
State Public Health Laboratory (SPHL) the past two years has
shown that this is one of the more common non-O157 serotypes
isolated in SD. The SD Department of Health initiated the inves-
tigation after receiving a report of a shiga toxin positive, stool spec-
imen. Methods: The index case was detected through the state’s
passive surveillance system on September 28, 2001. The initial
investigation revealed that the patient attended a home daycare.
Further investigation identified two additional symptomatic chil-
dren from the same daycare. Stool samples tested at the SPHL
were positive for shiga toxin by EIA on both additional sympto-
matic children. Stool samples were plated using standard culture
methods. Individual colonies were tested for shiga toxin produc-
tion by EIA. Toxin positive isolates were typed by pulsed-field gel
electrophoresis (PFGE) using the standard PulseNet protocol for
E. coli and sent to the Centers for Disease Control and Prevention
(CDC) for serotyping. Results: The onset date of the initial case
was Sept. 20, 2001. Possible sources of exposure identified includ-
ed pet rabbits and the father’s occupation at a feed mill. Little
information was obtained from the food history. No other family
members were ill. The second case had an onset of Sept. 25, 2001
with this child’s brother becoming ill on Oct. 3, 2001. The only risk
factor observed for these cases was contact with the index case at
the daycare. The shiga toxin positive isolates on all three cases were
identified by the SPHL as Escherichia coli and all had indistin-
guishable pulsed-field gel electrophoresis patterns. Laboratory
results from CDC indicated all were serotype O111:NM. They
were also positive for several virulence factors by PCR including
shiga toxin 1 and 2, enterohemolysin and the attaching and effac-
ing gene. All cases had positive stool samples for at least 3 weeks
after onset of illness. Conclusions: This is the first identified out-
break of the O111:NM serotype in South Dakota. The source of
this outbreak has not been clearly identified. The length of time
from the onset of illness to diagnosis (8 days) resulted in a poor
food history. The length of time between onset dates and the typi-
cal incubation period of STEC would suggest person to person
transmission resulted in the 2 additional cases. Efforts need to be
made to increase awareness of this type of organism and decrease
the time between onset and reporting.
Board 81. Stool Specimen Practices in Clinical Laboratories,
FoodNet Sites, 1995-2000 
A. C. Voetsch1, T. Rabatsky-Ehr2, S. Shallow3, S. M. Thomas4, P. M.
Cassidy5, E. Swanson6, T. Root7, D. E. Gerber8, M. A. Hawkins9, P. J.
Shillam1, J. G. Wells1, F. J. Angulo1, P. M. Griffin1, and the EIP
FoodNet Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA,
2Connecticut Emerging Infections Program, Yale University, New
Haven, CT, 3California Emerging Infections Program, San Francisco,
CA, 4Georgia Division of Public Health, Atlanta, GA, 5Oregon
Department of Human Services, Portland, OR, 6Minnesota
Department of Health, Minneapolis, MN, 7New York State
Department of Health, Albany, NY, 8Tennessee Department of Health,
Nashville, TN, 9University of Maryland School of Medicine,
Baltimore, MD
Background: Clinical laboratory practice influences
pathogen isolation rates and may affect the interpretation of labo-
ratory-based surveillance data trends. To determine laboratory
practice in the Centers for Disease Control and Prevention's
Foodborne Diseases Active Surveillance Network (FoodNet) sites,
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microbiologists at clinical laboratories which process stool speci-
mens from FoodNet residents were surveyed in 2000 and results
were compared to previous surveys conducted in 1995 and 1997.
In 2000, FoodNet sites included Connecticut, Georgia, Minnesota,
and Oregon and select counties in California, Colorado, Maryland,
New York, and Tennessee. Methods: We ascertained laboratory
methods for routine testing of stool specimens for Salmonella,
Shigella, Campylobacter, Escherichia coli O157:H7, Yersinia, and
Vibrio species, and estimated the number of stool specimens
processed per year by clinical laboratories. FoodNet conducted
active surveillance in those laboratories for all culture-confirmed
cases of those pathogens. Results: Four hundred fifty-six laborato-
ries processed stool specimens from FoodNet residents; the labo-
ratories processed an estimated 440,000 stool specimens per year.
The number of stools processed per 100,000 persons in all sites was
1504(range, per site, 823 to 2675 per 100,000 persons.) These lab-
oratories reported routinely testing for Salmonella, Shigella, and
Campylobacter; only 63% of laboratories routinely tested for E.
coli O157:H7, 50% for Vibrio, and 49% for Yersinia. Among all
stools submitted, the mean isolation rate for Campylobacter was
1.2% (range: 0.8% to 1.7%), 0.9% for Salmonella, (range: 0.5% to
1.1%), 0.4% for Shigella (range: 0.2% to 0.5%), and 0.2% for E. coli
O157:H7 (range: 0.1% to 0.4%). Among the 160 laboratories sur-
veyed in all three years, the proportion that reported routinely test-
ing for E. coli O157:H7 increased from 59% in 1995 to 68% in
2000. Discussion: Variation in the identified rate of culture-con-
firmed illness caused by these pathogens may be explained, in part,
by variation in laboratory practice; other potential factors include
variation in physician practice and rates of illness in the population.
Adherence to recently published IDSA/CDC guidelines for diag-
nosis and management of diarrheal diseases may help to balance
concerns for patient management and public health surveillance in
the era of managed health care.
Board 82. Surveillance for Guillain-Barré Syndrome 
in Oregon 
B. Shiferaw1, K. Steingraber2, W. Chapin2, C. Finnegan2, M.
Kennedy3, P. Cieslak1, and the EIP FoodNet Working Group3
1Oregon Department of Human Services, Portland, OR, 2Oregon
Health Sciences University, Portland, OR, 3Centers for Disease
Control and Prevention, Atlanta, GA
Background: Guillain-Barré syndrome (GBS) is an acute
demyelinating condition that may complicate Campylobacter or
upper respiratory infections. GBS is not reportable in Oregon, and
its incidence is not known in that state. We sought to determine the
burden and the proportion of GBS cases attributable to
Campylobacter infection in Oregon. Methods: Campylobacter
infections reported in Oregon during 1997 were reviewed. Oregon
1997 hospital discharge data (HDD) were queried for ICD-9 code
357.0. Hospitals with cases so identified were asked to review their
own records for additional cases. Duplicates due to repeat admis-
sions were removed. Data were abstracted from discharge sum-
maries and laboratory records. Cases were classified as definite,
probable, possible or non-cases according to published criteria.
Results: Eighty-two cases of GBS were identified through the ini-
tial HDD query, including 24 cases identified by hospitals. Four
medical charts were unobtainable. Twenty-two (28%) of the
remaining 78 were classified as definite cases, 12 (15%) were prob-
able cases, 10 (13%) were possible cases, and 34 (44%) were non-
cases. Treatment modalities included plasmapheresis (32%), and
IVIG (54%). The majority of the patients were discharged home
(64%), 32% were discharged to extended-care facilities, and one
person died. The mean number of days in the intensive care unit
was 13 days. The statewide incidence of definite, probable, and
possible cases was 1.4/100,000. Persons ≥ 65 years of age older had
a higher incidence than younger persons (2.1 vs 1.3/100,000). Men
had higher rates than women (1.6 vs 1.2). Of the 44 definite, prob-
able or possible cases, 8 (18%) reported preceding gastrointestinal
illness; 3 (7%) had confirmed Campylobacter infection. Seven-
hundred thirty-seven cases of laboratory-confirmed campylobacte-
riosis were reported in Oregon during 1997. Conclusion: GBS
caused 1 death and substantial morbidity in Oregon in 1997.
Diagnosed Campylobacter infection was associated with at least
7% of GBS. About 0.4% of laboratory-confirmed Campylobacter
infections were complicated by GBS. Efforts to prevent campy-
lobacteriosis are likely to result in a decreased incidence of this
serious complication.
Board 83. Trends in Indigenous Foodborne Disease (IFD) and
Deaths, England and Wales - 1992 to 2000 
G. K. Adak, S. M. Long, S. J. O'Brien
Public Health Laboratory Service, London, UNITED KINGDOM
Background: Commitment to food safety is evidenced by
high profile governmental initiatives around the globe. To measure
progress towards targets policy makers need to know the baseline
from which they started. Aim: To describe the burden (mortality,
morbidity, new presentations to general practice, hospital admis-
sions and hospital occupancy) and trends of indigenous foodborne
disease (IFD) in England and Wales between 1992 and 2000.
Methods: Routinely available surveillance data, special survey
data, hospital episode statistics (HES) and National Statistics mor-
tality data were collated and arithmetic employed to estimate the
burden and trends of IFD in England and Wales. Adjustments
were made for underascertainment of disease through national sur-
veillance and for foreign travel. The final estimates were compared
with those from the United States of America. Results: In 1995
there were an estimated 2,365,909 cases, 21,138 hospital admis-
sions and 717 deaths in England and Wales due to IFD. By 2000
this had fallen to 1,338,772 cases, 20,759 hospital admissions and
481 deaths. In terms of disease burden the most important
pathogens were campylobacters, salmonellas, Clostridium perfrin-
gens, Verocytotoxin-producing Escherichia coli (VTEC) O157 and
Listeria monocytogenes. The ratio of food-related illness in the
USA to IFD in England and Wales in 2000 was 57:1. Taking into
account population rates this ratio fell to 11:1 and converged when
aetiology and disease severity were considered. Conclusion:
Reducing IFD in England and Wales means tackling campylobac-
ter. Lowering mortality rates, however, also requires better control
and prevention of salmonellas, Cl. perfringens, L. monocytogenes
and VTEC O157.
Board 84. Outbreak of Multidrug-resistant Salmonella
Newport Associated with Consumption of Italian-style Soft
Cheese, Connecticut 
T. McCarthy1, Q. Phan2, P. Mshar2, R. Mshar2, R. Howard2, J. L.
Hadler2
1Centers for Disease Control and Prevention, Atlanta, GA,
2Connecticut Department of Public Health, Hartford, CT
Background: In the previous few years, multidrug-resist-
ant Salmonella Newport (MDR-SN) has emerged in multiple
states as an important cause of human illness. In Massachusetts
where a sustained increase has been seen, infection with MDR-
SN was associated with exposure to dairy farms. In April 2001,
the Connecticut (CT) Department of Public Health (DPH)
Epidemiology Program noticed through routine surveillance an
increase in reports of S. Newport isolates and began an investiga-
tion. Initial typing by pulsed-field gel electrophoresis (PFGE)
suggested that the increase was caused by a single MDR strain,
indistinguishable from the Massachusetts strain. Methods: To
determine the magnitude and source of the outbreak, we
reviewed previous surveillance data and conducted a case-control
study and an environmental investigation. A case-patient was
defined as a person reported to the DPH with illness onset April
1-25 and an isolate of the same PFGE type as the initial cases.
















through progressive digit-dialing matching on local prefix and age
group. Environmental investigation included collecting raw milk
and cheese samples from the subsequently implicated cheese
manufacturer and leftover cheese from ill cheese consumers.
Samples were cultured for S. Newport and assayed for alkaline
phosphatase. Results: Before April, only sporadic cases of S.
Newport with a matching PFGE pattern were reported, averag-
ing one every 2-3 months since January 2000. From April 1
through May 31, 26 MDR-SN isolates were reported. Case-
patients lived in five CT counties; median age was 56 years
(range: 15-88); 20 (77%) were female. Twenty-three case-patients
received antibiotics for their illness. Eight cases were hospital-
ized, none died. The 15 case-patients included in the case-control
study were more likely than their 40 controls to have consumed
any of three fresh soft Italian style cheeses (100% versus 38%,
p<0.0005). Results from consumption of basket cheese revealed
the strongest association (73% versus 0%, p<0.00001). The impli-
cated cheese maker obtained raw milk from a large multistate
consortium. The cheese making process involved a heating step
but not a formal pasteurization step. The outbreak strain was iso-
lated from a sample of raw milk, but not cheese. Alkaline phos-
phatase was detected in four of eight cheese samples obtained
from ill persons during the outbreak period. Conclusions: This
outbreak was most likely caused by periodic inadequate heat
treatment of contaminated raw milk used to make soft cheese.
Beginning the on-site cheese making process with raw milk might
add an unnecessary element of risk to cheese making, particular-
ly for fresh soft cheese. The emergence of an MDR strain of S.
Newport as a cause of human illness associated with dairy farm
contact and/or consumption of dairy products appears to be a
growing problem in the U.S.
Board 85. An Outbreak Of Typhoid Fever In Florida
Associated With An Imported Frozen Fruit 
D. J. Katz
Florida Department of Health, Miami, FL
An outbreak of typhoid fever involving at least 16 persons in
Florida during the winter of 1998-99 was investigated using case
control, environmental and laboratory methods. The genomic pro-
files of the 15 confirmed cases were identical. Consumption of fruit
shakes made with frozen mamey, a tropical fruit, was significantly
associated with illness (matched odds ratio=7.6, 95% confidence
interval, 1.4 to 81.3). Laboratory testing showed the fruit was heav-
ily contaminated with fecal coliforms; no Salmonella enterica
serovar Typhi (S. Typhi)was isolated. The frozen mamey was pre-
pared in plants in Guatemala and Honduras. No further cases
occurred after the frozen product was recalled. As our nation's
food sources become increasingly globalized, outbreaks of exotic
diseases linked to contaminated imported food will become
increasingly common. This outbreak highlights the need for new
approaches to ensuring the safety of our food supply.
Board 86. Higher Incidence of Listeria Infections among
Hispanics: FoodNet, 1996-2000 
J. C. Lay1, J. K. Varma1, R. Marcus2, T. Jones3, S. F. Tong4, C.
Medus5, M. Samuel6, P. M. Cassidy7, F. P. Hardnett1, C. R. Braden1,
and the EIP FoodNet Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA,
2Connecticut Emerging Infections Program, Yale University, New
Haven, CT, 3Tennessee Department of Health, Nashville, TN,
4Maryland Department of Health and Mental Hygiene, Baltimore,
MD, 5Minnesota Department of Health, Minneapolis, MN, 6California
Emerging Infections Program, San Francisco, CA, 7Oregon
Department of Human Services, Portland, OR
Background: Listeriosis, a disease caused by infection
with Listeria monocytogenes, carries high morbidity and mortality.
Infection with L. monocytogenes has been most commonly associ-
ated with the consumption of unpasteurized milk, soft cheeses, hot
dogs, and deli meats. Prominent outbreaks among Hispanic com-
munities in Los Angeles and North Carolina have been associated
with the consumption of Mexican-style soft cheese made with
unpasteurized milk. We sought to determine if people of Hispanic
ethnicity have an increased rate of listeriosis in general. Methods:
Active surveillance for listeriosis has been conducted in FoodNet
sites since 1996. In 2000, listeriosis surveillance was conducted in
eight FoodNet sites (California, Connecticut, Georgia, Maryland,
Minnesota, New York, Oregon, Tennessee) encompassing approxi-
mately 29.5 million persons, or 11% of the US population. We ana-
lyzed demographic data on all cases of culture-confirmed listerio-
sis identified by FoodNet from 1996 to 2000. Results: From 1996
to 2000, a total of 474 culture-confirmed cases of listeriosis were
reported in FoodNet sites. The five year average incidence for all
sites was 0.4 per 100,000 population, ranging from 0.3 in MN to 0.7
in CT. The average incidence was 0.2 per 100,000 among non-
Hispanics and 0.7 among Hispanics during the study period.
Among non-Hispanics, the incidence was 0.2 in Native Americans,
0.2 in blacks, 0.2 in whites, and 0.4 in Asians. Although the inci-
dence remained higher in Hispanics across almost all age groups,
the disparity between Hispanics and non-Hispanics was greatest
among infants < 1 year of age (11.9 per 100,000 vs. 1.0 per 100,000
respectively) and among Hispanic women of childbearing age (15-
39 years, 1.1 per 100,000 vs. 0.1 per 100,000 respectively). The
highest incidence of illness among Hispanic women of childbear-
ing age was observed in the 30-34 age group (2.7 per 100,000).
When comparing incidence by gender, Hispanic females (0.9 per
100,000) had a notably higher incidence than Hispanic males (0.5
per 100,000); incidence was similar by gender for non-Hispanics.
Conclusion: In FoodNet sites from 1996 to 2000, there was a
higher incidence of listeriosis among Hispanics compared with
non-Hispanics, particularly in infants and women of childbearing
age. Hispanic infants had a 12-fold greater incidence of listeriosis
than their non-Hispanic counterparts; for Hispanic women 30-34
years of age, the incidence was 13-fold greater than for non-
Hispanic women in the same age group. Additional studies of lis-
teriosis focusing on these groups are needed to determine specific
risk factors for infection. To reduce the burden of listeriosis, pre-
vention strategies and educational campaigns that focus on pro-
tecting infants and women of childbearing age should be targeted
towards the Hispanic community.
Board 87. Comparability of FoodNet and United States
Populations 
F. P. Hardnett, R. M. Hoekstra, M. H. Kennedy, F. J. Angulo, and the
EIP FoodNet Working Group
Centers for Disease Control and Prevention, Atlanta, GA.
Background: A key objective of the Centers for Disease
Control and Prevention's Foodborne Disease Active Surveillance
Network (FoodNet) is to estimate the burden of foodborne illness
in the United States. FoodNet activities, however, are conducted
within selected state health departments. The selection of these
sites was not chosen to be representative of the U.S. population.
We therefore evaluated the comparability of the FoodNet popula-
tion to the U.S. population on the basis of several demographic
characteristics and health indicators. Methods: Using 1996 U.S.
Census data, we performed a demographic comparison of the orig-
inal FoodNet population (Minnesota, Oregon and selected coun-
ties in California, Connecticut and Georgia) and U.S. population
on the basis of age, gender, race and urban residence (metropoli-
tan statistical area (MSA) distribution). Using Community Health
Status Indicator (CHSI) Project data, we also compared the two
populations on the basis of population density (persons per square
mile) and percent at or below poverty. For the purpose of this
investigation, poverty is defined as having a household income less
than the poverty thresholds established by the U.S. Census
Bureau. These thresholds vary by family size and composition.
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Results: The original FoodNet (count: 14,281,096) and U.S.
(count: 265,189,794) populations had similar age and gender dis-
tributions, but differed slightly with regard to race. The Asian pop-
ulation was overrepresented (FoodNet: 6%, U.S.: 4%). The Black
and Hispanic populations were underrepresented (FoodNet: 11%
and 6%, U.S.: 13% and 12%, respectively). The populations also
differed in their proportion of urban residents (FoodNet: 99%,
U.S.: 80%). County-level comparison indicated a lower population
density among the 135 FoodNet counties (FoodNet: median= 31
persons per square mile; U.S.: median= 41 persons per square
mile). The FoodNet population also had a smaller percentage of
persons living at or below poverty (FoodNet: 11%; U.S.: 15%).
Conclusions: The generalizability of FoodNet studies is some-
what limited due to slight demographic differences (e.g., Hispanic
and Asian populations). Despite these differences, however, the
distribution of the FoodNet population across several other demo-
graphic factors and health indicators is similar to that of the U.S.
population. These data support the generalizability of FoodNet
data to the U.S. population for the purpose of understanding the
epidemiology of foodborne illness. Every year since its inception,
the FoodNet catchment area has increased from approximately 14
million in 1996 to 34 million in 2001. Further analysis is being con-
ducted to compare the expanding FoodNet population with the
U.S. population.
Board 88. Age, Ethnic and Racial Disparity in Salmonella
sertotype Enteritidis (SE): FoodNet, 1998-2000 
R. Marcus1, T. Rabatsky-Ehr1, J. C. Lay2, J. Mohle-Boetani3, M. M.
Farley4, C. Medus5, B. Shiferaw6, M. A. Hawkins7, S. M. Zansky8, T.
F. Jones9, J. L. Hadler1, and the EIP FoodNet Working Group2
1Connecticut Emerging Infections Program, Yale University, New
Haven, CT, 2Centers for Disease Control and Prevention, Atlanta, GA,
3California Department of Health Services, San Francisco, CA,
4Georgia Emerging Infections Program, Atlanta, GA, 5Minnesota
Department of Health, Minneapolis, MN, 6Oregon Department of
Human Services, Portland, OR, 7University of Maryland School of
Medicine, Baltimore, MD, 8New York State Department of Health,
Albany, NY, 9Tennessee Department of Health, Nashville, TN
Background: Salmonella serotype Enteritidis (SE)
emerged as the most common Salmonella serotype in the United
States in the mid-1990s, reaching a peak in 1995. SE infections are
most often associated with consumption of raw or undercooked
shell eggs. The objective of this analysis is to describe the variation
in SE incidence rates among the CDC’s Foodborne Disease Active
Surveillance Network (FoodNet) sites by state, age group, race,
and ethnicity to determine where prevention efforts might be tar-
geted. Methods: Since 1996, FoodNet sites have been conducting
active laboratory-based surveillance at clinical laboratories for
selected foodborne pathogens including Salmonella. Clinical labo-
ratories forward Salmonella isolates to public health laboratories
for serotyping. In 2000, FoodNet sites included Connecticut,
Georgia, Minnesota, and Oregon, and selected counties in
California, Tennessee, Maryland, and New York (29.5 million);
11% of the U.S. population. Results: In 1998-2000, 11,657
Salmonella cases were ascertained, of which 12% (1425) were SE.
Enteriditis was the 2nd most common serotype. SE incidence rates
were 1.9 per 100,000 in 1998, 1.7 in 1999 and 2.0 in 2000. Average
annual incidence was highest in Maryland (4.8/100,000), followed
by Connecticut (3.7) and was lowest in Georgia (0.9). The average
annual age-specific incidence of SE was highest among children <5
years of age (4.2/100,000) and 5-9 years of age (2.1/100,000). There
was no difference in age-specific incidence rates by gender. Of the
939 (66%) SE cases over 3 years of age whose race/ethnicity was
known, average annual incidence was highest among Blacks
(2.0/100,000) followed by Hispanics (1.2), and Whites (1.1).
Incidence among Blacks was highest in Maryland (3-year average
7.4/100,000). Conclusions: Incidence of SE varied by site with the
highest incidence in Maryland and Connecticut. Children under 5
years of age had an incidence of SE twice as high as other age
groups. The incidence of SE in Blacks was higher than in other
racial or ethnic groups. These differences in SE incidence warrant
further study to identify risk factors for infection that may explain
these variations. Surveillance data are useful for identification of
groups for targeted educational programs to reduce the incidence
of SE infection.
Board 89. A Pilot Study in FoodNet of the Use of Stool
Collection Kits Delivered to the Home to Improve Confirmation
of Etiology in Gastroenteritis Outbreak Investigations 
R. L. Garman1, T. F. Jones1, S. N. Bulens2, S. F. Tong3, R. A. Meyers3,
S. S. Gettner4, P. S. Mead2, U. D. Parashar2, and the EIP FoodNet
Working Group2
1Tennessee Department of Health, Nashville, TN, 2Centers for Disease
Control and Prevention, Atlanta, GA, 3Maryland Department of
Health and Mental Hygiene, Baltimore, MD, 4California Department
of Health Services, Berkeley, CA
Background: In 68% of foodborne disease outbreaks
reported to the Centers for Disease Control and Prevention
(CDC), no etiologic pathogen is identified. In two-thirds of out-
breaks of unconfirmed etiology, no stool specimens are submitted
for laboratory testing. We studied the utility of using stool collec-
tion kits delivered to the homes of patients to improve rates of
specimen submission and identification of an etiology in food-
borne disease outbreaks. Methods: CDC and Foodborne
Diseases Active Surveillance Network (FoodNet) sites in
California, Maryland, and Tennessee initiated a prospective pilot
project to collect stool specimens using kits during gastroenteritis
outbreaks. Each site designed, implemented, and evaluated easy-
to-use kits specific to the needs of their populations and health
department laboratories. All kits included instructions, shipping
labels, transport and packaging material, and a stool collection
“hat” for the toilet. Two sites used a single specimen collection
container, and one site used separate bacterial and viral collection
containers with different media. The sites employed commercial
and health department couriers and U.S. mail to deliver and
retrieve the kits. Results: From April 1 to October 31, 2001, stool
collection kits were deployed in 12 outbreaks (7 in Tennessee, 4 in
Maryland and 1 in California), involving 248 ill persons. Kits were
distributed to 59 ill persons, and 42 (71%), which included > 1
specimen from 11 of the 12 outbreaks were returned to state lab-
oratories. Of these, 28 were returned via courier and 14 by U.S.
mail. “Inability to produce a specimen” after receiving the kit from
the health department was the most common reason for non-sub-
mission. The mean time from start of the outbreak investigation to
receipt of specimens at the laboratory was 4.9 days. Of the 11 out-
breaks for which kits were returned, an etiologic organism was
confirmed in eight (72.7%); 6 Norwalk-like virus, 1
Staphylococcus aureus, and 1 Salmonella serotype Enteritidis.
Conclusion: In over two-thirds of gastroenteritis outbreaks in
which these stool collection kits were successfully deployed, an
etiologic organism was identified. Delivery of kits to patients
homes to improve rates of stool collection in outbreaks in which
specimens might otherwise not be submitted could substantially
reduce the number of outbreaks with an unknown etiology.
However, these preliminary findings are based on a small number
of outbreak investigations. The cost-effectiveness and feasibility of
















Board 90. Eating in Restaurants: A Risk Factor for Foodborne
Illness? Findings from FoodNet to Be Explored by EHS-Net 
T. F. Jones1, D. J. Vugia2, C. Selman3, F. J. Angulo3, and the EIP
FoodNet Working Group3
1Tennessee Department of Health, Nashville, TN, 2California
Department of Health Services, Berkeley, CA, 3Centers for Disease
Control and Prevention, Atlanta, GA.
Background: Over 80% of Americans eat out at least once
per week, and 46% of the U.S. food dollar is spent on food away
from home. The Centers for Diseases Control and Prevention’s
Foodborne Disease Active Surveillance Network (FoodNet) pro-
vides a unique opportunity to investigate the potential relationship
between foodborne illness and consumption of food outside the
home. Methods: We compiled results of a random digit dialing
telephone survey and several multi-state case-control studies, per-
taining to consumption of food outside the home as a risk factor for
foodborne illnesses. Results: Among 12,755 respondents to the
1998-1999 population survey, 83% said that they eat out at least
once per week, and 16% ate out an average of 5 or more times per
week. In a case-control study of Salmonella serotype Enteriditis
with 182 cases enrolled, among persons with no recent interna-
tional travel, consumption of chicken outside the home was asso-
ciated with a matched odds ratio (mOR) of 2.1 (95% CI 1.2-3.4)
and a population attributable risk of 25%. In a case-control study
of E. coli O157:H7 with 200 cases enrolled, among persons con-
suming ground beef, eating a hamburger at a restaurant that was
not part of a major fast-food chain was associated with a mOR of
10 (CI 1.3-82). In a case-control study of Salmonella serotype
Heidelberg with 44 patients enrolled, illness was associated with
eating eggs prepared outside the home (mOR=6.2, CI 1.2-31.7),
particularly runny eggs (mOR=11.1, CI 1.22-63.1), with popula-
tion attributable risks of 33% and 56%, respectively. In a case-con-
trol study of 64 persons with fluoroquinolone-resistant
Campylobacter, among persons without recent international trav-
el, illness was associated with eating chicken or turkey at a com-
mercial establishment (mOR 4.3, CI 1.2-15). Conclusions:
Findings from a number of FoodNet case-control studies suggest
that consumption of food outside the home is associated with
increased risk of specific foodborne illnesses. Refining data on the
period of exposure for common risk factors will be important in
better understanding this issue. The CDC’s Environmental
Health Specialist Network (EHS-Net) is a new program devel-
oped to improve our understanding of environmental causes of ill-
ness. Its initial focus will be evaluating risk factors associated with
eating outside the home. Given the numbers of persons eating in
restaurants regularly, further study is warranted to better under-
stand the nature of those risks.
Board 91. Drinking Water Exposures and Perceptions
among 1998-1999 FoodNet Survey Respondents 
S. H. Lee, D. A. Levy, A. W. Hightower, B. C. Imhoff, and the EIP
FoodNet Working Group
Centers for Disease Control and Prevention, Atlanta, GA
Background: In 1996, Congress mandated that EPA and
CDC produce a report to define a national estimate of waterborne
illness attributable to municipal drinking water. As part of the
report process, it was determined that there was a need to better
characterize the drinking water consumption, behaviors, and expo-
sure outcomes of the U.S. population. Methods: The Emerging
Infections Program's Foodborne Diseases Active Surveillance
Network (FoodNet) conducts population surveys that collect
demographic, medical and food consumption information. EPA
and CDC integrated water consumption and exposure questions
into FoodNet surveys administered via random digit dialing to
households within 7 FoodNet sites from February 1998 through
February 1999. Results: Among 12,755 respondents, 63.8% iden-
tified municipal water, 17.8% bottled water, and 15.0% private well
water as their primary source of drinking water. Residents of rural
or farm areas were more likely to drink private well water than
municipal or bottled water (p=0.001). Reasons for drinking bottled
water included improved taste or odor (49.1%), avoiding chemicals
(28.0%), and avoiding germs (16.5%). Bottled-water drinkers with
children were more likely to express concern about germs in water
(p=0.02). Thirty percent of tap water drinkers treated their water.
The most cited treatment method, filtration (76.0%), was associat-
ed with higher income and higher education (p<0.001). Those with
annual incomes less than $15,000 who treated their water favored
pitcher filters or boiling their water. The reasons for choosing to
treat water did not vary by income or education. Respondents
(65.0%) did not know if their filter removed Cryptosporidium.
Respondents did not consistently use the primary source of drink-
ing water to prepare beverages. One-third of those who drank bot-
tled or treated tap water reported using untreated tap water to pre-
pare cold beverages. Diarrheal episodes (3 or more stools lasting 1
day or more or impairing daily activity, except episodes linked with
chronic illness) did not show any significant associations with water
exposures by univariate analysis. Conclusion: The results from the
1998-1999 population survey indicate socioeconomic factors and
geographic location may influence the type of drinking water
source and selection of treatment. Responses generally indicate
that the public chooses water treatment for palatability, rather than
to prevent harm from possible chemical or microbial contaminants.
Continued data collection will indicate whether these patterns and
beliefs remain temporally and geographically consistent as more
FoodNet sites are included and will assist in the development of a
national estimate of waterborne illness.
Board 92. Population-based Incidence of Infection with
Selected Enteric Bacterial Pathogens for Children under 5 Years
of Age, FoodNet, 1996-1998 
K. M. Koehler1, T. Lasky2, S. B. Fein1, S. M. Delong3, M. McGavern4,
T. Rabatsky-Ehr5, S. M. Ray6, B. Shiferaw7, E. Swanson8, D. J. Vugia9,
and the EIP FoodNet Working Group3
1Center for Food Safety and Applied Nutrition, Food and Drug
Administration, College Park, MD, 2FoodSafety and Inspection
Service, U.S. Department of Agriculture, Washington, DC, 3Centers
for Disease Control and Prevention, Atlanta, GA, 4Maryland
Department of Health and Mental Hygiene, Baltimore, MD,
5Connecticut Emerging Infections Program, Yale University, New
Haven, CT, 6Emory University School of Medicine, Atlanta, GA,
7Oregon Department of Human Services, Portland, OR, 8Minnesota
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Background: Previous studies have shown that the disease
burden of bacterial enteric infections falls disproportionately on
children under 5 years old. This study describes population-based
incidence rates of laboratory-confirmed infections with
Campylobacter, E. coli O157, Listeria, Salmonella, Shigella, and
Yersinia in children < 5 years of age in the CDC's Foodborne
Diseases Active Surveillance Network (FoodNet), 1996-1998.
Methods: Culture-confirmed cases of infection with these 6
pathogens were ascertained through active laboratory surveillance.
The FoodNet catchment area included Minnesota, Oregon, and
selected counties in California, Connecticut, Georgia, Maryland
and New York. Incidence rates for each pathogen per person-year
of observation (py) were calculated by year, site, season, sex, and
age. Age-specific postcensus estimates for the 3-year period were
used to calculate the FoodNet population. Incidence rate ratios
and 95% confidence intervals (CIs) were used to estimate relative
risk (RR) in those < 5 years. Results: There were 3,488,746 py for
children < 5 years and 51,115,328 total py for all ages; children <5
accounted for 7% of total py. For children < 5 years, there were
5,210 cases of infection with any of the 6 pathogens, accounting for
21% of cases for all ages. By pathogen, the number of cases and
percent of cases for < 5 years out of all reported FoodNet cases
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was: Campylobacter 1505 (13%); E. coli O157 359 (29%); Listeria
25 (10%); Salmonella 1941 (27%); Shigella 1133 (28%); Yersinia
247 (53%). Culture-confirmed cases per 100,000 py for those < 5
were 43.1 for Campylobacter, 10.3 for E.coli O157, 0.7 for
Listeria, 55.6 for Salmonella, 32.5 for Shigella, and 7.1 for
Yersinia. For age < 5, RRs compared with age 5 and older for the
respective pathogens were 2.1 for Campylobacter, 5.7 for E. coli
O157, 1.4 for Listeria, 5.1 for Salmonella, 5.4 for Shigella, and
15.3 for Yersinia. Incidence rates varied widely across the 7
FoodNet sites. In general, for the 5 pathogens other than Listeria,
sites with higher incidence rates for age < 5 also had high rates for
age 5 and older, compared with other sites. However, for
Campylobacter, E. coli O157 and Shigella, sites with higher rates
for age < 5 also had a greater contrast between age < 5 and age 5
and over than did other sites. Conclusion: This population-based
study confirmed a disproportionate disease burden for these
enteric bacterial infections in children < 5 as both percent of cases
and per 100,000 py. The absolute and relative disease burden for
age < 5 years differed by pathogen and by FoodNet site. This dis-
ease burden suggests that investigation of risk factors specific to
this age group and a review of current prevention and control
strategies and their enhancement specifically for young children
might lead to appreciable reductions in illness.
Board 93. Changing Epidemiological Patterns of
Salmonella serotype Enteritidis in Barbados: Implications 
for Tourism and Trade 
L. Indar1, P. N. Levett2, R. Knight3, M. Ingram3, E. Commissiong1, G.
Baccus-Taylor1, P. Prabhakar4, J. Hospedales4
1Univ of the West Indies, St.Augustine, TRINIDAD AND TOBAGO,
2Univ of the West Indies, Sch Clin Med & Res, Bridgetown, BARBA-
DOS, 3Min of Health, Bridgetown, BARBADOS, 4CAREC, Port of
Spain, TRINIDAD AND TOBAGO
Objective: To determine the etiology, sources and risk fac-
tors for Salmonella Enteritidis (SE) infections in Barbados, to com-
pare its epidemiology with that of SE infections in Trinidad and to
develop preventive measures. Methods: Retrospective (1996-
1998) and prospective (August 1998-November 2000) descriptive
epidemiological studies were conducted to determine the occur-
rence, distribution and potential risk factors for SE infections in
Barbados. To determine the etiology for SE infections, a matched
case control study of 30 cases and 60 age- and neighborhood-
matched controls was conducted between February 1999 to
November 2000. Standard written questionnaires were used for
the prospective and case control studies, administered through
face to face interviews. SE outbreaks were also investigated.
Salmonella isolates were serotyped and phagetyped using standard
methods. Data was analyzed in Epi Info version 6.04c software.
Findings: The isolation rate per 100,000 population of SE
increased from 1.1 in 1990 to 10.0 in 1999. Children < 10 years
were most susceptible to SE infections (44 % cases, 39 infections
per 100,0000). No distinct seasonal pattern was observed in the
occurrence of SE cases. SE infection was found to be associated
with the consumption of undercooked eggs (matched odds ratio
[mOR]=43.5, 95% confidence interval [CI]=6.79-
1737,p<0.00001) and undercooked chickens (mOR 8.23, 95%CI
=1.57-73.6, p<0.01). In particular soft boiled eggs (mOR = 29.0,
p<0.0001), scrambled eggs with soft yolks (mOR=8.39, p<0.001)
and caesar salad (mOR =10, p<0.001) were the main implicated
undercooked egg-containing foods. Three hotel SE outbreaks,
involving visitors and 6 family outbreaks were investigated. Caesar
salad, soft boiled and scrambled eggs, and undercooked chickens
were implicated. Of the 60 isolates phagetyped, PT8 was most
prevalent (33 cases, 55%), followed by PT4 (19 cases, 32%), PT2
(6 cases, 10%), PT24a (1 case) and PT11 (1 case) Ten cases (17%)
were hospitalized , and 2 died (case fatality rate 6.7%).
Conclusion:. This is the first reported analytical study of SE
infections in Barbados. It highlights that in Barbados, the con-
sumption of undercooked eggs and undercooked chickens are the
major vehicles for SE infections, unlike our previous findings in
Trinidad. SE PT8 and PT4 predominate. This is the first time that
undercooked chicken has been associated with SE infection in the
Caribbean, and it is also the first time that PT2 has been identified
in the Caribbean. The findings of this study have important impli-
cations for public health, food safety, trade and tourism in
Barbados. It has demonstrated the increasing impact of SE infec-
tion in local and visitor population which requires a "Farm to
Table" for effective prevention and control.
Board 94. Hospitalizations Among Cases with the Most
Common Serotypes of Salmonella: FoodNet, 1996-2000
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Infections Program, Yale University, New Haven, CT
Background: Salmonella is a leading cause of gastroin-
testinal illness in the United States. Although there are over 2000
known serotypes of Salmonella, four serotypes account for the
majority of reported infections. This analysis assessed severity of
illness among the major serotypes of Salmonella cases reported to
the Centers for Disease Control and Prevention’s Foodborne
Disease Active Surveillance Network (FoodNet), as measured by
hospitalization rates and duration. Methods: A case of salmonel-
losis was defined as the isolation of a Salmonella species from any
clinical source in a resident of the FoodNet catchment area during
the years 1996-2000. In 1996, the catchment area included
Minnesota, Oregon, and selected counties in California,
Connecticut, and Georgia; subsequently, selected counties in New
York, Maryland (1998) and Tennessee (1999) were added. The top
four reported Salmonella serotypes were abstracted from the data
set and analyzed for hospitalization and length of hospital stay. The
median duration of hospitalization was calculated for each serotype
and the proportion of hospitalized cases was compared, by
serotype, using the chi-square test. Results: Between 1996 and
2000, 15,931 cases of Salmonella infection were reported to
FoodNet. One hundred ninety-two cases with incomplete hospi-
talization data were excluded from this analysis. Of the 15,739
remaining, 2671 (17%) were hospitalized. Four Salmonella
serotypes (S. Typhimurium, S. Enteriditis, S. Heidelberg, and S.
Newport) comprised 53% of the hospitalized cases. Hospitalized
patients with one of these serotypes had a median hospital stay of
3 days (range 1-157). S. Typhimurium accounted for 4015 (26%)
cases; 778 (19%) were hospitalized and had a median hospital stay
of 3 days. There were 2144 (14%) cases of S. Enteriditis; of which
322 (15%) were hospitalized with a median hospital stay of 4 days.
S. Heidelberg represents 961 (6%) cases; 207 (22%) were hospital-
ized and had a median hospital stay of 4 days. There were 1045
(7%) cases of S. Newport, of which 102 (10%) were hospitalized
with a median hospital stay of 3 days. Conclusion: The propensity
of individual Salmonella serotypes to cause hospitalization among
residents of FoodNet sites varies, ranging from 10% (S. Newport)
to 22% (S. Heidelberg). However, the median duration of hospi-
talization among cases infected with the most frequent serotypes of
Salmonella is similar, suggesting similar recovery rates independ-
ent of the serotype causing infection. Further studies are needed
to determine reasons for the elevated hospitalization rates between
















Board 95. Restaurant-Associated Behavior from the FoodNet
Population Survey, 1998-99 
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Background: A large proportion of foodborne outbreaks
reported in the United States are associated with restaurants, but
little is known about risk factors for sporadic acute gastrointestinal
illness associated with restaurants. It is estimated that 46% of the
average U.S. household’s food-dollar is spent in restaurants.
Methods: From March 1998 through February 1999, the Centers
for Disease Control and Prevention’s Foodborne Diseases Active
Surveillance Network (FoodNet) conducted a random-digit dialing
telephone survey to better understand factors potentially associat-
ed with acute diarrheal illness. The survey was performed in
Connecticut, Minnesota, and Oregon and selected counties within
California, Georgia, Maryland, and New York (population 21 mil-
lion persons). We attempted to interview 150 persons each month
in each state. Persons of all ages were eligible. Respondents were
asked about restaurant patronage in the past 7 days and food pref-
erences. Results: The questionnaire was administered to 12,755
persons. Of these, 463 (4%) reported eating at a fast food or sit-
down restaurant frequently (≥7 times in the past 7 days). Among
males, 7% ate out frequently as compared to 3% of females
(p<0.001). Over 10% of persons between the ages of 16 and 25
years of age and 6% of young adults (26-45 year-olds) ate out fre-
quently. Blacks (7%) were more likely to eat out ≥7 times in the
previous week than whites (4%, p<0.001). Of all respondents, 10%
ordered their restaurant hamburgers cooked rare or medium-rare.
Of these, 87% considered a hamburger having pink on the inside
to be cooked, compared to 20% of those who ordered medium,
medium-well, or well-done restaurant hamburgers (p<0.001). One
third (33%) of rare or medium-rare hamburger eaters cut their
hamburgers to check how they were cooked as compared with two-
thirds (66%) of non-rare hamburger customers (p<0.001).
Conclusions: A large proportion of this survey’s respondents ate
≥7 meals per week at fast food and sit-down restaurants. A sub-
stantial number of respondents admit to preferring established
higher-risk foods, such as undercooked hamburgers, when they eat
out. Further studies are necessary to explore the association
between frequent restaurant patronage and acute diarrheal illness.
Board 96. Marked Regional Variation in the Incidence 
of Laboratory-Confirmed Bacterial Foodborne Illness:
FoodNet, 2000 
F. J. Angulo1, T. F. Jones2, M. A. Hawkins3, S. Hurd4, P. Smith5, D. J.
Vugia6, S. Johnson1, M. H. Kennedy1, P. M. Griffin1, and the EIP
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Program, Yale University, New Haven, CT, 5New York State
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Background: Each year in the United States, an estimated
5 million persons contract bacterial foodborne illnesses. The
Foodborne Diseases Active Surveillance Network (FoodNet) is the
principal foodborne disease component of the CDC’s Emerging
Infections Program. FoodNet strives to monitor the burden of
foodborne illnesses and interventions designed to reduce them.
Methods: In 2000, FoodNet conducted population-based active
surveillance for laboratory confirmed cases of Campylobacter, E.
coli O157, Listeria, Salmonella, Shigella, Vibrio, and Yersinia infec-
tions in Connecticut, Georgia, Minnesota, and Oregon, and select-
ed counties in California, Maryland, New York, and Tennessee
(total population 29.5 million). FoodNet contacts approximately
450 clinical laboratories at least monthly to ascertain cases.
Results: 12,125 cases were identified; 4640 Campylobacter, 4237
Salmonella, 2324 Shigella, 631 E. coli O157, 131 Yersinia, 101
Listeria, and 61 Vibrio. The incidence per 100,000 population was
highest for Campylobacter (15.7), followed by Salmonella (14.4),
and Shigella (7.9). Lower incidences were reported for E. coli
O157 (2.1), Yersinia (0.4), Listeria (0.3) and Vibrio (0.2).
Substantial variation in incidence was reported among sites. The
incidence of Campylobacter infections ranged from 6.6 per
100,000 in TN to 38.2 in CA. The incidence of Salmonella infec-
tions was less variable ranging from 8.9 in OR to 18.0 in GA. Rates
for infections with specific Salmonella serotypes also varied; infec-
tions with S. Typhimurium ranged from 1.9 in CA to 3.7 in TN, S.
Enteritidis from 1.0 in NY and TN to 5.1 in MD, and S. Newport
from 0.3 in OR to 3.5 in TN. Shigella infections ranged from 1.1 in
NY to 18.8 in MN. E. coli O157 infections ranged from 0.5 in MD
to 4.6 in MN. Incidence also varied by age, especially for
Campylobacter and Salmonella infections; for children <1 year of
age, the incidence was 88.4 and 33.6, respectively, substantially
higher than for other age groups. Conclusion: Campylobacter was
the most frequently diagnosed pathogen; however, substantial
regional variation occurred. The incidence of Campylobacter and
Salmonella among infants is particularly high. Focused research
into the reasons for these local differences may provide informa-
tion about prevention that is of general use. Further prevention
efforts are needed to meet the Healthy People 2010 objectives for
Campylobacter (12.3/100,000 population), Salmonella (6.8/100,000
population), and E. coli O157 (1.0/100,000).
Board 97. The Burden of Diarrheal Illness in FoodNet, 
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D. L. Morse6, K. G. McCombs7, A. K. Courtney8, C. Medus9, B.
Shiferaw10, B. C. Imhoff2, and the EIP FoodNet Working Group2
1University of Maryland School of Medicine, Baltimore, MD, 2Centers
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Background: An estimated 76 million food-related illness-
es occur annually in the United States. Since 1996, the Centers for
Disease Control and Prevention’s Foodborne Disease Active
Surveillance Network (FoodNet) has conducted periodic surveys
of the population to determine the prevalence of diarrheal illness,
and frequency at which persons with diarrhea seek medical care
and submit stool specimens. These data are useful in determining
the burden of foodborne diseases. Methods: The FoodNet popu-
lation survey was designed to ascertain demographic, health, and
food preference information among residents of Connecticut,
Georgia, Minnesota, Oregon, and select counties in California,
New York, Maryland, and Tennessee (population 29.5 million).
The 131-item questionnaire was administered by telephone using
standard Behavioral Risk Factor Surveillance System methodology.
One member of each household contacted was randomly selected
to complete the interview. Participants were asked about activities
in the month prior to interview. We attempted to interview 150
persons per month in each of the FoodNet sites between March
I C E I D  2 0 0 2  A B S T R A C T Spage 100
2000 and February 2001. We defined acute diarrheal illness as ≥ 3
loose stools in 24 hours with impairment of daily activities or dura-
tion of diarrhea >1 day. Results: Of the 14,647 persons inter-
viewed, 5761 (39%) were male; the median age was 41 years. Of
the 14,046 respondents who denied a chronic gastrointestinal dis-
ease, 659 (5%) reported an acute diarrheal illness during the
month prior to the interview. The prevalence of illness was high-
est among children less than 5 years (9%) and lowest among those
over 65 years (2%). Rates of illness were similar among education,
income, gender, and residence groups but ranged from 2% in
Asian/Pacific Islanders to 10% in those of mixed race. Of those
with an acute diarrheal illness, 18 (3%) reported blood in their
stool, 152 (23%) sought medical care; of those seeking medical
care 26 (17%) were asked to submit a stool specimen, and 73
(48%) were prescribed antibiotics for their illness. Only 7 (27%) of
the 26 who submitted stool samples were prescribed antibiotics.
Discussion: Diarrheal illness continues to impose a large burden
of disease with a marked prevalence and high proportion of ill per-
sons seeking medical care. However, few persons seeking medical
care submitted a stool specimen, illustrating that there are many
more ill persons for each laboratory-confirmed infection.
Including a factor of 0.7 to account for test sensitivity, these data
indicate there are roughly 36.5 cases of diarrheal illness for each
diagnosed infection. This is similar to multipliers used to develop
recent estimates, and suggests that changes in reported incidence
may reflect changes in illness rates rather than changes in health
seeking behavior.
Board 98. Isolation and Characterization of Campylobacter
jejuni Isolates Obtained from Asymptomatic Human Volunteers 
D. Torpey, N. Golden, M. A. Hawkins, J. Ruark, D. Acheson, 
J. G. Morris, Jr.
University of Maryland School of Medicine, Baltimore, MD
Background: Campylobacter jejuni is the foremost cause
of bacterial gastroenteritis in the United States. It is also demon-
strating increased resistance to antibiotics, especially the fluoro-
quinolones. In Maryland, the incidence of gastrointestinal disease
due to C. jejuni (6.8 cases/100,000 population) is significantly less
than that caused by Salmonella (17.7 cases/100,000 population). In
order to ascertain if there is an asymptomatic state for
Campylobacter that might contribute to the decreased incidence
of symptomatic disease, the Centers for Disease Control and
Prevention‘s Foodborne Diseases Active Surveillance Network‘s
(FoodNet) University of Maryland site analyzed fecal specimens
from healthy human volunteers. Methods: Stool specimens were
collected from Maryland residents who had not experienced a sig-
nificant episode of diarrhea nor had taken antibiotics in the six
months prior to specimen donation. Specimens were processed by
adding an aliquot of stool into 5 ml of Campylobacter enrichment
broth. Following a 48 hr incubation at 420C, an aliquot of the
enrichment culture was transferred to a Campylobacter blood agar
plate and incubated an additional 48 hr at 420C in a
microaerophilic environment. Colonies were identified as C. jejuni
if they were Gram negative rods, grew at 420C on the selective
media, were both oxidase and catalase positive, and hydrolyzed
both hippurate and indoxyl acetate. Results: Stools from 27 of the
222 asymptomatic volunteers (12.2%) yielded colonies that were
identified as C. jejuni. Six of these asymptomatic isolates, along
with 12 clinical isolates obtained from hospitalized patients, were
analyzed for the presence of two putative virulence genes using the
polymerase chain reaction. None of the asymptomatic isolates were
positive for the presence of cytolethal distending toxin (CDT)
genes, while 8/12 clinical isolates contained CDT genes. In vitro,
CDT induces cell cycle arrest at the G2 phase and ultimately cell
death. In addition, the CiaB gene (associated with secretion of bac-
terial virulence factors) was not amplified in any of the asympto-
matic isolates but was amplified in 11/12 clinical isolates.
Conclusion: C. jejuni may be found in the gastrointestinal tract of
individuals who do not have overt signs of disease nor a recent his-
tory of significant diarrheal illness. Currently the remaining asymp-
tomatic isolates are undergoing analysis for the presence of CDT,
CiaB and other putative virulence genes. Functional cell invasion
assays and antibiotic susceptibility tests are also being performed to
better characterize the differences between isolates that cause clin-
ical disease and those that do not.
Board 99. Comparison of Disease Severity Between
Outbreaks of Known and Unknown Etiology with ≥ 10 Ill
Persons, FoodNet Sites, 1999-2000 
S. M. DeLong1, T. F. Jones2, M. McGavern3, Q. Phan4, M. Samuel5,
W. Keene6, K. M. Lane7, R. F. Woron8, F. J. Angulo1, and the EIP
FoodNet Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA, 2Tennessee
Department of Health, Nashville, TN, 3Maryland Department of
Health and Mental Hygiene, Baltimore, MD, 4Connecticut Department
of Public Health, Hartford, CT, 5California Emerging Infections
Program, San Francisco, CA, 6Oregon Department of Human
Services, Portland, OR, 7Georgia Division of Public Health, Atlanta,
GA, 8New York State Department of Health, Albany, NY
Background: Approximately 550 foodborne disease out-
breaks are reported to CDC annually and two-thirds of these have
an unknown etiology. Several factors, including disease severity
and specimen collection and testing, are thought to contribute to a
successful investigation. Methods: To compare disease severity
between outbreaks of known and unknown etiology with ≥10 ill
persons, we reviewed outbreak data collected in FoodNet sites in
1999 and 2000. FoodNet, the CDC’s Foodborne Diseases Active
Surveillance Network, includes Connecticut, Georgia, Minnesota,
and Oregon and portions of California, Maryland, New York, and
Tennessee, representing approximately 29 million persons (11 % of
the United States population). A foodborne outbreak is defined as
two or more cases of a similar illness resulting from ingestion of a
common food. Etiology was determined using the guidelines for
confirming a foodborne disease outbreak [MMWR 2000; 49(No.
SS-1):54-61]. Results: From 1999 to 2000, 185 foodborne disease
outbreaks with ≥10 ill were reported from FoodNet sites. Six out-
breaks of ≥10 ill persons per million population were reported in
FoodNet (range 2 per million persons in TN to 11 per million per-
sons in MN.) Of these, 96 (52%) were outbreaks with a known eti-
ology. Among these, 57 (59%) were due to Norwalk-like virus, 17
(18%) to Salmonella spp., 6 (6%) to Escherichia coli O157, and 16
(17 %) to other etiologies. Among the 96 outbreaks of known eti-
ology, the median number of persons with vomiting was 12 (range
0 to 186), with diarrhea was 18 (range 0 to 243), and with fever was
9 (range 0 to 148). Among the 89 outbreaks of unknown etiology,
the median number of persons with vomiting was 11 (range 0 to
72), with diarrhea was 14 (range 1 to 72), and with fever was 5
(range 0 to 30). In 18 (19%) outbreaks of known etiology, 50% or
more of those ill sought health care; this compares to 2 (2%) out-
breaks of unknown etiology. Outbreaks with a known etiology were
also more likely to be outbreaks where ≥50% of those ill were hos-
pitalized [4 (4%) outbreaks vs. 0 (0%) outbreaks] and where≥ 25%
of those ill had bloody diarrhea [14 (15%) vs. 1 (1%)].
Conclusions: A little more than half of the foodborne disease out-
breaks with ≥10 ill persons reported to FoodNet from 1999 to 2000
had a known etiology. Outbreaks of known etiology were more like-
ly to result in health care visits, hospitalizations, and bloody diar-
rhea, possibly prompting a more aggressive investigation including
microbial testing. Additional efforts are needed to determine the
etiology of outbreaks with less severe symptoms. The use of couri-
er services and mail-in kits to increase the number of clinical spec-
imens submitted for etiologic testing during outbreaks may
increase pathogen yield in outbreaks where patients are less likely
















Board 100. Outbreak of Salmonella Enteritidis Among
Scandinavian Tourists Returning from Greece: The Need
for Communication in the Detection of Outbreaks in 
Tourist Destinations
P. J. Guerin1,2, K. Nygard3,4, L. Vold1,2, M. Kuusi5, O. Alvseike1, A.
Siitonen5, J. Lassen1, Y. Andersson3, P. Aavitsland1
1Norwegian Institute of Public Health, Oslo, NORWAY, 2EPIET
(European Programme for Intervention Epidemiology Training), Oslo,
NORWAY, 3Swedish Institute for Infectious Disease Control,
Stockholm, SWEDEN, 4EPIET (European Programme for Intervention
Epidemiology Training), Stockholm, SWEDEN, 5Finnish National
Public Health Institute, Helsinki, FINLAND
Background: Greece is a popular holiday resort for
Scandinavians. By July 2001, the Norwegian Institute of Public
Health (NIPH) had received notifications of an unusually high
number of cases with Salmonella Enteritidis among tourists return-
ing from Greece. The National Reference Laboratory for
Enteropathogens at NIPH noticed a cluster of cases with uncom-
mon Salmonella Enteritidis (S.E.) of phage type 14b. An increase
in the same phage type was also registered at the Swedish Institute
for Infectious Disease Control (SMI) and the Finnish National
Public Health Institute (KTL). In previous years, only sporadic
cases infected by S.E. phage type 14b have been reported to
Scandinavian surveillance systems. Methods: For the descriptive
study, a case was defined as a person living in Norway, Sweden or
Finland with a positive finding of S.E. phage type 14b after travel-
ling to Greece within the incubation period for Salmonella
Enteritidis. In addition, in order to identify possible source(s) of
infection, case-control studies were conducted in Norway and
Sweden. The Norwegian case control study was restricted to
tourists who had been in the same area of western Crete between
30 July and 2 September. Twenty-five cases were matched with 45
controls by time of travel and tour operator. Isolates from patients
were characterised by standard biochemical assays and phage typ-
ing methods at the reference laboratory. Results: The first case
was reported in Norway on 28 May 2001. The first peak of cases
was observed in mid-August, corresponding to the summer holi-
days in Scandinavia, and a second peak in mid-October correspon-
ding to the autumn holiday. By 1 December, 301 cases had been
reported in Scandinavia, 89 in Norway, 149 in Sweden and 63 in
Finland. Fifty-one percent of the cases had been infected in Crete.
The median age was 35 years and the sex ratio (M/F) was 0.9. In
the Norwegian case control study, consumption of chicken was
associated with illness (OR = 3.3, 95% CI: 1.0 - 11.3). Results from
the Swedish study and the environmental investigation in Greece
are not yet available. Discussion: Because the place of infection is
not included in most salmonella notification systems, it is likely that
the S.E. phage type 14b outbreak reported in Scandinavia repre-
sents only "the ears of the hippopotamus" of a larger outbreak in
Europe. Poultry was the probable vehicle of infection.
Collaboration among national institutes of public health can be an
important tool in the detection and alert of outbreaks that occur in
tourist destinations. Infections are often reported only in the
tourists’ home country, because they often prefer to seek medical
care after returning. Therefore public health authorities in the
tourist destinations may not be aware of the problem.
Board 101. Foreign-Travel-Associated Salmonellosis and
Shigellosis: Oregon 2000-2001 
T. E. McGivern1, B. Shiferaw2, M. Cassidy1, S. Mauvais1, P. Cieslak2
1Oregon Department of Human Services, Oregon Public Health
Laboratory, Portland, OR, 2Oregon Department of Human Services,
Office of Disease Prevention and Epidemiology, Portland, OR
Introduction: Salmonellosis and shigellosis are important
enteric diseases, and both are reportable in Oregon; during 2000
the incidences were 8.4 confirmed cases/100,000 population and
2.4 per 100,000 (excluding outbreak cases), respectively. Efforts to
reduce their incidence by making food safer are under way.
However, the extent to which salmonellosis and shigellosis in
Oregon are attributable to foreign travel (FT) is unknown.
Methods: Oregon's FoodBorne Diseases Active Surveillance
Network (FoodNet) program has conducted active, laboratory-
based surveillance for Salmonella and Shigella since 1996. Clinical
laboratories report Salmonella and Shigella cases to local public
health officials and submit all isolates to the Oregon State Public
Health Laboratory for subtyping. Local health department case
investigations are submitted to the Oregon Department of Human
Services Office of Disease Prevention and Epidemiology for analy-
sis. The case-investigation forms solicit information on FT during
the five days before illness onset for non-typhoidal salmonellosis,
three days for shigellosis, and 21 days for typhoid fever. We evalu-
ated case travel histories by pathogen for the years 2000-2001 and
compared them to travel histories reported during the same years
in a FoodNet telephone survey of a stratified random sample of
Oregonians. Results: Excluding outbreak cases, from January
2000 through October 2001, 518 salmonellosis and 168 shigellosis
cases were reported from Oregon residents, for a total of 686 spo-
radic cases. Case-investigation forms were submitted for 665 (97%)
of these. 59 (11%) of the salmonellosis cases and 46 (27%) of the
shigellosis cases were associated with FT. FT was associated with 9
(82%) of 11 cases with Salmonella Typhi and 21 (32%) of 65 with
Salmonella Enteritidis, but only 4 (3%) of 144 with Salmonella
Typhimurium. 22 (31%) of 72 of Shigella sonnei cases and 16
(19%) of 86 Shigella flexneri cases were associated with foreign
travel. Of the 105 FT-associated cases, 55 (52%) had traveled to
Mexico; 24 (23%) to Asia; 9 (9%) to Africa; 8 (8%) to other Latin
American countries; 5 (5%) to Europe; and 4 (4%) to other areas.
In the 2000-2001 FoodNet population survey of 1,600 Oregon res-
idents, only 1% reported FT in the seven days before the interview.
Conclusions: 15% of sporadic salmonellosis and shigellosis
reported in Oregon are associated with FT. Some of this may
reflect a bias as to who is cultured; nevertheless, the striking dif-
ferences in reported FT by Salmonella serotype suggest that much
of the observed association is real. Studies are needed to identify
the sources of these infections abroad.
Board 102. Restaurant-Associated Foodborne Outbreaks in
Oregon, 1996-2001 
L. E. Lee, J. Mack, B. Shiferaw, P. R. Cieslak
Oregon Department of Human Services, Portland, OR
Background: Food preparation errors in restaurant
kitchens expose the general population to viruses, bacteria and par-
asites. Much is known about the food preparation errors in restau-
rant (and other) kitchens that produce foodborne illness. Less is
known about the proportion of restaurant-associated foodborne
outbreaks attributable to these errors. Methods: We reviewed in
detail summaries of foodborne outbreaks investigated by Oregon
state and local health department epidemiologists from 1996
through 2001. We defined an outbreak as two or more non-house-
holders who develop similar gastrointestinal illness at about the
same time and are epidemiologically linked to a common source.
Foodborne outbreaks were grouped by where the food was pre-
pared (restaurants, private kitchens, institutions, or other settings).
We then idenified restaurant-associated outbreaks that could have
been prevented in the restaurant's kitchen. Results: From 1996-
2001, Oregon epidemiologists investigated a total of 135 foodborne
outbreaks. Of these, 64 (47%) occurred among restaurant patrons,
29 (22%) among persons who ate food prepared in institutions, 20
(15%) among persons who ate food prepared in private kitchens,
and 22 (16%) among persons who ate food prepared in other set-
tings. Of the 64 restaurant-associated foodborne outbreaks,
causative agents were confirmed by laboratory testing in 19 (30%)
and a food was convincingly implicated in 19 (30%). Four out-
breaks were the result of eating products contaminated before they
reached the restaurant; in 26 outbreaks food preparation errors
I C E I D  2 0 0 2  A B S T R A C T Spage 102
were not documented on the investigation summaries. Thirty-two
outbreaks (50%) could have been prevented in the restaurant
kitchen. These outbreaks were attributed to food handlers with
Norwalk virus preparing food eaten raw (n=22); food not appro-
priately "hot-held" or thoroughly cooked (n=9); and cross-contam-
ination of an uncooked food with a raw ingredient of animal origin
(n=1). Conclusions: Restaurant-associated foodborne outbreaks
account for nearly half of all outbreaks investigated. This may
reflect the fact that such outbreaks are more likely to be reported
than outbreaks originating in other settings. The most common
cause of preventable outbreaks in restaurants was Norwalk virus,
which has a human reservoir and which spreads as a result of poor
food handler hygiene. Prevention research should focus on within-
restaurant changes that make it difficult for food handlers not to
wash their hands after using the toilet.
Board 103. Clinical and Molecular Investigation of a
Salmonella Typhimurium DT104 Outbreak Due to Consumption
of Raw Beef 
V. Agmon1, D. Zamir2, J. Kopelowitz1, R. Yishai1, E. Khavalevsky1, S.
Scharf2,3, N. Azor3, M. Gdalevich3
1Government Central Laboratories, Public Health Services, Ministry of
Health, Jerusalem, ISRAEL, 2Barzilai Medical Center, Ashkelon,
ISRAEL, 3Ashkelon District Health Office, Public Health Services,
Ministry of Health, Ashkelon, ISRAEL
Background: Salmonella enterica serotype Typhimurium,
definite phage type (DT)104 is a zoonotic pathogen. Since 1990 it
has become an increasingly common cause of human gastroenteri-
tis worldwide. In Israel the first human cases were reported in
1994. This strain is frequently associated with multidrug resistance
to antimicrobial agents. The common R-type in Israel is ACST (A.
ampicillin; C. chloramphenicol; S. streptomycin; T. Tetracycline).
Objectives: To determine the epidemiological, clinical and molec-
ular characteristics of an outbreak of severe gastroenteritis in a
close community of East Asian workers. Materials And Methods:
A comprehensive epidemiological investigation was carried out by
the Ashkelon District Health Office employing interviews and sur-
vey of medical records. Salmonella spp. isolated from clinical
sources and from suspected beef and cow blood samples were
identified and tested by classical laboratory methods (serotyping,
phagetyping and antibiotic resistance typing). The epidemiological
and serological data were complemented by molecular investiga-
tion, using pulse field gel electrophoresis (PFGE). Results: In July
2001, fifty nine individuals of an East Asian group of workers
developed severe diarrhea. Twenty five were hospitalized. Two
patients developed secondary bacteremia. Salmonella typhimuri-
um DT104 was isolated from the stool of all the 25 patients and the
two blood samples. The epidemiological investigation revealed a
suspected common source: Raw beef eaten by all on the day before
onset of symptoms. The estimated attack rate in the exposed pop-
ulation was 100%. The median incubation time was 18h. The same
S. typhimurium DT104 was isolated from samples of the suspect-
ed beef and cow blood. Application of PFGE with the restriction
enzymes XbaI and AvrII to all isolates revealed the same PFGE
pattern for all human and food isolates. The clonality was con-
firmed by a common drug resistance pattern (ACSTN; N. nalidix-
ic acid). Conclusions: The main characteristic of the reported out-
break is its definite focal pattern. We assume that this food borne
outbreak is correlated with the specific food handling practice.
Similar events have been reported worldwide, emphasizing the
global importance of Salmonella typhimurium DT104.
Board 104. Salmonella Newport in Georgia, 1998-2000 
K. G. McCombs1, S. M. Thomas1, S. D. Segler2, M. R. Bates3, K. E.
Lee3, W. R. MacKenzie1, S. Lance-Parker1
1GA Division of Public Health, Atlanta, GA, 2GA Emerging Infections
Program, Atlanta, GA, 3GA Public Health Laboratory, Atlanta, GA
Background: The rate of reported serotyped Salmonella
infection in GA between 1998 and 2000 was 16.4 *10-5
person/years (p/y), which is one of the highest rates in the United
States. S. Typhimurium is the most common serotype in GA and in
the country, but S. Newport, the second most common serotype in
GA, is 16% of Salmonella isolates in GA compared to only 8% in
the United States. Understanding the descriptive epidemiology of
S. Newport in GA will guide development of targeted environ-
mental studies and hypothesis-testing epidemiologic studies.
Methods: S. Newport data were collected through GA
Emerging Infections Program's (EIP) active surveillance system
and through passive reporting to the Georgia Division of Public
Health (GDPH). Only reports that included Health District (HD),
age and Salmonella serotype were used in the analysis. A three-
year average rate for each of the nineteen Health Districts (HDs)
was calculated. Analysis was done with EpiInfo 6 and Excel.
Results: The three-year overall rate of S. Newport in GA
was 2.66*10-5 p/y. Most HDs have a rate less than 4.5*10-5 p/y
except for two adjoining south-central GA HDs where the rates
were 16.23*10-5 and 13.66*10-5 p/y. More than 50% of GA S.
Newport cases were children <5 years old. The three-year average
rate of S. Newport in children <5 years old was 19.40*10-5 p/y
compared to a rate for those 5 years old and older of 1.33*10-5 p/y.
These data have encouraged focus on the south-central GA HDs
and on those <5 years old. The rate of S. Newport in these south-
central districts in children 5 years old and older is 6.3*10-5 p/y
which is still high for the state but low compared to the rate in chil-
dren <5 years old of 123.45*10-5p/y. Although cases of S. Newport
occur throughout the year, an increase is seen in July with a peak
in September or October. This increase is also marked in the two
south-central GA HDs with high rates of S. Newport infection.
Conclusion: The high rate of reported S. Newport in two
south-central GA HDs suggests that studies in these areas focusing
on activities, habits and food consumption of children less than 5
years old will be most useful. Environmental studies should also be
considered in this geographic region of the state during late sum-
mer and early fall. Targeted environmental and epidemiologic stud-
ies may identify the route of transmission of S. Newport to young
children in south GA and result in effective prevention programs.
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Board 105. The Thrombospondin Related Autonomous
Protein (TRAP) from P. falciparum Interacts with the Liver 
D-glucuronyl C5-epimerase in Humans
S. K. Lal, J. Shrivastava, S. Tyagi, V. S. Chauhan
International Centre for Genetic Engg. & Biotechnology, New Delhi,
INDIA
Malaria remains one of the major infectious diseases of the
world, affecting the health of hundreds of millions of people. A
series of molecular and cellular interactions occur during passage
of the parasite through human blood and liver cells. The sporozoite
binds to specific receptors on liver cells that include glycoamino-
glycan chains of heparin sulfate proteoglycans. The co-receptor on
sporozoites involves, in part, the thrombospondin domains on the
















autonomous protein). Using Plasmodium falciparum pfTRAP as
“bait” in the yeast two-hybrid system, we have screened a human
liver cDNA library for interacting proteins. We have found that D-
glucuronyl C5-epimerase (gC5E) interacts with pfTRAP. A molec-
ular dissection of this interaction shows that a 79 amino acid region
of pfTRAP, containing the unique RGD region interacts with
gC5E. We have tested this interaction using the full-length cloned
gC5E using various in-vivo and in-vitro methods. Finally, we have
shown that the pfTRAP-gC5E interaction is unique to pfTRAP and
not to another closely related protein Plasmodium cynomolgi
TRAP, in which the RGD region is absent. The uniqueness of this
interaction and its implications in parasite invasion are discussed.
Board 106. Reemergence of Malaria Related to Climatic
Factors in U.S. Forces and Republic of Korea Soldiers and
Civilians 1993-2000 
B. J. Killenbeck1, J. Gaydos2, J. Pavlin3, A. Anyamba4, T. Klein5, 
H. C. Lee5
1U.S. Navy, Environmental Health Officer, Bowie, MD, 2U.S. DOD,
GEIS, Walter Reed Army Institute of Research, Silver Spring, MD,
3U.S., DOD, GEIS, Walter Reed Army Institute of Research, Silver
Spring, MD, 4NASA Goddard Space Flight Center, Biospheric
Sciences Branch, Greenbelt, MD, 5Preventive Services, 18th Medical
Command, REPUBLIC OF KOREA
In 1948, the World Health Organization (WHO) estimated
the prevalence of Malaria at about 300 million people infected,
possibly causing 3 million deaths per year. The Republic of Korea
(ROK) enjoyed several Malaria-free decades and the WHO
declared the ROK malaria free in 1979. But, in 1993 P. vivax
reemerged near the western edge of the Demilitarized Zone
(DMZ) and cases tripled in 1995 and quadrupled in 1997. The
cause of this reemergence is unknown. Many studies have used sin-
gle or multiple remote sensing techniques to derive models to
evaluate climatic variables that directly/indirectly influence envi-
ronmental factors that may independently or collectively influence
the transmission of vector-borne diseases. Factors like vegetation
cover, landscape structures, and water bodies that may be potential
breeding sites can be measured to see if these variables are associ-
ated with the rate of human cases. Instruments used for these stud-
ies have been Landsat‘s Multispectral Scanner and Thematic
Mapper, the National Oceanic and Atmospheric Administration‘s
Advanced Very High Resolution Radiometer, and France‘s
Systeme Pour l‘Observation de la Terre. Validating such studies
present many confounding variables that have to be controlled or
explained, for example, the interaction of socio-economic changes
and mobility of populations are difficult to quantify. Additionally,
documenting changes in public health practices and systematic
data collection are very challenging obstacles. Methods: We ana-
lyzed metrological data for Korea provided by the Global Historical
Climatology Network and the National Climatic Data Center along
with Outgoing Longwave Radiation (OLR) anomaly time series
1981 to 2000. Results. Results: from this analysis indicate several
observable shifts over time of increasing surface temperature cou-
pled with a series of corresponding increased positive OLR anom-
alies, which imply decreased cloud coverage indicating decreased
precipitation. Conclusion: We conclude that the observed trends,
particularly increasing temperature may have enhanced the para-
site development inside of mosquitoes, therefore changing the
feeding frequency and allowing the vector to transmit the disease
earlier and longer in its life cycle. This may help to explain the
increase in malaria cases along the DMZ in the ROK.
Board 107. Non Pharmacological Methods to Prevent
Malaria in an Urban Community in India : Is It Working ? 
G. Srinivas
Tn.Dr.MGR Medical University, Chennai 32, INDIA
Background: Chennai city in accounts for over 70% of the
urban malaria in this southern state of India. This is inspite of wide
spread use of anti-mosquito like personal protection measures. The
question arises whether these are really effective.
Objective: To measure the protection from malaria of the
personal protection measures used against mosquito bites
Design: Case-Control Study Setting: The corporation
health clinics, which serve as primary level malaria clinics for
Chennai.
Participants: New febrile patients with blood smear posi-
tive or negative for malarial parasites were grouped as cases and
controls respectively. 84 cases and 87 controls were studied.
Main Outcome Measure(s): Proportion exposed to pro-
tective measures in cases and controls.
Results: OR of 0.97(0.53,1.78)(p=0.940) was detected, for
the use of self-protective measures against malaria. The usage of
coil showed 7% protection (0.41,2.09) (p=0.849). Logistic regres-
sion analysis showed 19% (0.40,1.65) (p=0.572) protection on the
use of netted windows in houses. The power of the study was 63%.
Conclusions: The protective measures used by the popu-
lation do not appear to offer any protection against malaria. The
reasons for the lack of protection need to be studied further with
regard to the quality and duration of action of the repellants, the
nocturnal biting habits of mosquitos.
Board 109. Target Based In vitro Assays for New
Antimalarial Drug Development 
B. L. Tekwani1, A. K. Tripathi1, J. A. Ogunbanwo1, S. I. Khan1, L. A.
Walker1, M. A. Avery2
1National Center for Natural Products Research, University of
Mississippi, University, MS, 2Department of Medicinal Chemistry,
School of Pharmacy, University of Mississippi, University, MS
Malaria remains a major global health problem with over 40
% world’s population at the risk of the disease. The problem has
been further aggravated due to spread of the drug resistance.
Identification of novel lead molecules, which are active against the
resistant strains of the parasite, is highly necessary for new anti-
malarial drug development. Current approaches of combinatorial
chemistry generate large number of novel chemical entities.
Improved technologies for isolation and identification of novel
compounds from natural resources has provided promising new
molecules. Target based in vitro assays may expedite the process of
new lead identification and optimization. We have developed and
standardized some in vitro assays which are based on some vital
molecular functions of malaria parasite.The target functions show
significant selectivity for the malaria parasite.
During intraerythrocytic proliferation large amount of
hemoglobin is degraded by malaria parasite. This process generates
toxic free heme. Malaria parasite is equipped with distinct metabol-
ic process for detoxification of heme through its conversion to a
crystalline black brown pigment commonly known as hemozoin.
Biosynthesis of hemozoin (b-hematin) is a target for action of sev-
eral blood schizontocidal antimalarials. We have developed a filtra-
tion based micro plate assay for in vitro b-hematin formation. The
assay is highly robust and cost-effective. Sensitivity of this assay is
almost similar to the tedious and expensive radiometric assay. The
assay has been validated with several standard antimalarials.
The erythrocytes infected with malaria parasites are contin-
uously exposed to oxidative stress. Reduced glutathione is a major
antioxidant which plays essential role in defense of malaria parasite
to the oxidative stress. This is kept in the functional state by a FAD
containing enzyme, glutathione reductase (GR). The enzyme from
Plasmodium falciparum shows distinct differences over the mam-
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malian counterparts. The selective inhibitors of GR may be the
promising antimalarials. Recombinant P. falciparum as well human
glutathione reductases have been prepared from the E. coli cul-
tures. The enzymes have been purified by affinity chromatography.
A spectrophotometric microplate assay for GR has been standard-
ized. The assay has been validated with some standard GR
inhibitors. The purified malarial and human GR proteins may be
used for high throughput screening and identification of selective
enzyme inhibitors. Recently we also identified a putative gene for
glutathione s-transferase (GST) from the P. falciparum genome
data-base. The gene has been cloned by PCR and over expressed
in E. coli cultures. GST may have important role in drug resistance
in malaria parasite. Assays for several other target functions are
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Board 108. Echovirus Type 13 Associated Outbreak of Viral
Meningitis in Israel, 2000 
R. Handsher1, D. Sofer1, L. Shulman1, B. Abramovitz1, I. Silberstein1,
E. Somech2, T. Shohat3, E. Mendelson1,4
1Chaim Sheba Medical Center, Tel-Hashomer, ISRAEL, 2Wolfson
Medical Center, Holon, ISRAEL, 3The Israel Center for Disease
Control (ICDC), Tel-Hashomer, ISRAEL, 4Bar-Ilan University, Ramat-
Gan, ISRAEL
In the summer and fall of 2000 an outbreak of viral menin-
gitis due to Echovirus type 13 (Echo13) occurred in the central,
most populated region of Israel. Similar outbreaks due to Echo 13
where reported at the same time in Germany, England and Wales1,2
and a year later in the USA3. Echo 13 did not cause outbreaks in
these countries previously, and had been isolated very rarely. We
report here the history of Echo 13 activity in Israel for the last 20
years and describe characteristics of the cases diagnosed by the
Central Virology Laboratory (CVL). Between 1980 and 1999 Echo
13 was isolated only twice: from a healthy contact of an AFP case
in 1998 (a 5 years old), and from an AFP case in 1999 (an 11 years
old). Between July and October, 2000 the laboratory isolated Echo
13 from 91 patients with aseptic meningitis hospitalized in 6 med-
ical centers in the central region of Israel, from Hadera in the
North to Rehovot in the South. The Monthly distribution of the
laboratory confirmed enteroviral infections during the outbreak
period are summarized in the table below. 
Month | CSF | Stool
No. No. No. Total No. No. No. Total
samples Echo other No. of samples Echo other No. of
13 (%) entero isolates 13 (%) entero isolates
viruses (%) viruses (%)
July 113 33(29) 3 36(32) 25 4(16) 4 8(32)
Aug 160 28(17.5) 2 30(18.7) 40 6(15) 3 9(22.5)
Sept 92 11(12) 1 12(13) 26 1(3.8) 0 1(3.8)
Oct 55 7(12.7) 1 8(14.5) 30 1(3.3) 0 1(3.3)
Total 420 79(18.8) 7 86(20.5) 121 12(9.9) 7 19(15.7)
The age distribution of 72 patients was 40 (55%), 28
(38.9%), 2 (2.8%) and 2 (2.8%) in age groups 0-4y, 5-14y, 15-19y
and 20-41y, respectively. Females were 44% and males were 56%.
The age distribution was similar to those reported in Germany and
the US (app 95% of the cases were below 15y) but different from
the outbreak reported in England and Wales where 68% of the
cases were in patents over age 15y1, 2,3. A preliminary sequence
analysis of the 5'UTR of the Israeli 1998 and 1999 isolates and 12
isolates from July 2000 revealed a 97.4% homology between the
1998 and 1999 isolates, and 98.7% homology between the 2000 iso-
lates (which were all nearly identical) and each of the 1998 and
1999 isolates. Comparatively, the 5'UTR homology between the
Echo 13 isolates and an Echo 7 isolate from 2000 was in the range
of 91.5 and 94 %. A more detailed molecular and antigenic analy-
sis of Echo 13 isolates worldwide may lead to the understanding of
the emergence of this virus as the causative agent of viral meningi-
tis outbreaks. 1. Eurosurveillance Weekly 2000;4 at <http:www.
eurosurv.org/> 2. Comm. Dis. Rep CDR Wkly 2000:10277,
280.MMWR 14, 2001 50:36, 777-780.
Board 110. Molecular Detection of Human Calicivirus 
in Young Children with Acute Gastroenteritis in Spain, 
During 1997 
N. Negredo1, E. Roman2, R. M. Dalton1, I. Wilhelmi3, A. Sánchez
Fauquier1
1Centro Nacional de Microbiología, Madrid, SPAIN, 2Servicio de
Pediatría, Hospital Severo Ochoa, Leganés, Madrid, SPAIN,
3Servicio de Microbiología, Hospital Severo Ochoa, Leganés,
Madrid, SPAIN
Human Calicivirus are increasingly being recognized as one
of the viral aetiological agents that cause acute gastroenteritis.
However, to date routinely detection has not been possible. HuCV
can be categorized into two genera named Norwalk-like virus
(NLV) and Sapporo like viruses (SLV). NLV is the major cause of
outbreak and sporadic gastroenteritis in adults. SLV has been asso-
ciated mainly to gastroenteritis in non-hospitalisated children. To
establish the importance of HuCV among Spanish children a large
prospective study has been carried out in children attended in a
hospital’s pediatric emergency room. A total of 822 stool specimens
were collected from children under 4 years during the period of a
year. Samples in which no enteric pathogen was detected (neither
bacterial nor viral) by routine diagnosis test were analysed by NLV
specific RT-PCR. This infectious agent was detected in 54 (27%) of
201 samples tested by RT-PCR. A selection of this samples are
being analysed by sequence analysis of a fragment POL coding
region for their phylogenetic grouping (genotype). From this study,
we could estimate the annual incidence rate of sporadic acute gas-
troenteritis due to HuCV. This rate was calculated in 4,23 annual
cases/1000 children under 4 years. In addition, hospitalisation inci-
dence rate of HuCVs infected children was 0,52 annual
cases/1000children under 4 years. In this study the annual inci-
dence rate of sporadic acute gastroenteritis closed to HuCVs was
4,23 annual cases/1000 children under the age of 4 years. In addi-
tion, hospitalisation incidence rate of HuCVs infection was 0,52
annual cases/1000children under the age of 4 years.
Board 111. Seroprevalence of SEN Virus Among Individuals
at High or Low Risk for Infection with Blood–Borne Pathogens
in Manitoba
M. R. Dawood1, G. Smart2, L. A. Forrester3, A. Giulivi3, K. D. Kaita4
1Univeristy of Manitoba, Winnipeg, MB, CANADA, 2Cadham
Provincial Laboratory, Winnipeg, MB, CANADA, 3Health Canada,
Ottawa, ON, CANADA, 4University of Manitoba, Winnipeg, MB,
CANADA
Objectives: 1- To determine the seroprevalence of SEN-V
among individuals at high or low risk for infection with blood-
borne pathogens (BBP). 2- To compare the nucleotide sequences
of different SEN-V isolates in Manitoba. Methods: Twenty
patients with no known risk factors for infection with BBP, 10 from
















in the study. Participants were assigned study codes and were
asked to complete a questionnaire regarding their history of liver
related diseases, injection drug use (IDU), blood transfusion (BT)
and hospitalization. DNA was extracted from serum samples using
Qiagen DNA Mini kit followed by PCR amplification. The oligonu-
cleotide primers were able to amplify a 348 bp segment from the
different SEN-V genotypes and other related viruses. Amplicons
were analyzed on 2% agarose gel electrophoresis. The 348 bp seg-
ments from positive cases were subject to nucleotide sequence
analyses using ABI Prism 310 genetic analyzer and nucleotide
sequences were compared to sequences in the gene bank database.
Results: SEN-V was detected in forty cases. The positivity rates
among individuals from 2 clinics with no known risk factors are
10% and 60%. The positive patients from these 2 clinics have only
history of hospitalization. The SEN-V prevalence rates among indi-
viduals seen in the hepatology or the HIV clinics are 60% and 54%
respectively. Nucleotide sequence analyses was performed on all
the positive specimens. The sequence analyses of the amplicons
indicated close relation to SEN-V but not to TTV, YONBAN or
SANBAN viruses. Isolates from individuals at low risk of SEN-V
infection indicated that one patient has mixed genotype infection
and six of genotypes B (1), C (1), D (1), F (1) and H (2). The
nucleotide sequence analyses of the 33 specimens from high risk
individuals indicated that 22 patients are infected with more than
one genotype. The other 11 individuals were infected with geno-
types A (2), B (1), F (1), H (4) and 3 do not match the sequences
of the published SEN-V genotypes. Conclusion: The high preva-
lence of SEN-V among individuals with low risk for blood-borne
pathogen infection may indicate that the virus can be transmitted
by other means other than IDU or BT. The nucleotide sequences
demonstrate that 86% and 33% of patients with low and high risk
respectively are infected with single genotype. The infection with
more than one genotype may indicate that infection with one geno-
type may not protect against infection with other genotypes.
Board 112. The Characteristic of the Francisella tularensis
Mediaasiatica 
A. M. Aikimbayev, T. N. Kunitsa, G. A. Temiraliyeva, B. A.
Atshabar, L. Y. Lukhnova
Kazakh Scientific Center of Quarantine and Zoonotic Diseases,
Almaty, KAZAKHSTAN
There are 4 types of tularemia natural foci in Kazakhstan:
foothills-stream, flood-lands-marsh, steppe, tugai. Into the first
three foci F.tularensis holarctica circulate. Masgut Aikimbayev
[1966, 1967] in 1965 studying the fermentative activity of 56
tularemia microbe strains, isolated in the natural tugai foci of
Kazakhstan, found out that some of these strains reiterate only a
number of features of two subspecies of tularemia microbe (hol-
arctica, nearctica). Possessing ferment -citrulline ureidase and
making acid from glycerol, its can’t make acid from glucose and
maltose, are little pathogenic for the laboratory rabbits. The author
proposed to isolate the given variety as subspecies F.tularensis
mediaasiatica. Besides these signs it has been determinated, that
strains F.tularensis mediaasiatica in comparison with F.tularensis
holarctica are susceptible to erythromycin and macrolides. All the
strains of tularemia microbe of the F.tularensis mediaasiatica sub-
species are agglutinated by the licensed tularemia serum, received
from immunisated by F.tularensis holarctica animals. The microbe
is well coloured with tularemia luminescent serum both in smears
out of the bacterial culture and in smears from the animals’
organs. The circulation of the given tularemia microbe subspecies
in general takes place among Meriones tamariscinus and Lepus
tolai Pall.; the epizootic process often involves Ondatra zibethica,
small mice-like rodents and Rhombomis opimus. The main carri-
ers are ticks — D.dagestanicus, Rhipicephalus pumilio. F.tularen-
sis mediaasiatica does not posses oxidase activity, and are catalase
positive (oxidase-, catalase +). The majority of strains of tularemia
microbe of the F.tularensis mediaasiatica subspecies produce
tularecins and at the same time are sensible both to their own
tularecins and to tularecins produced by other subspecies of
tularemia microbe. The literature cites data concerning the use of
olegonucleotide hybridization analysis under the study of
tularemia microbe of the F.tularensis mediaasiatica. On the basis
of an oligonucleotide hybridization analysis that detects a single
base substitution in 16S rRNA, Sandstrom et al.[1972] have
determined that F.tularensis mediaasiatica generally share signifi-
cant identity to F.tularensis tularensis. For identification of
tularemia microbe subspecies at the taxonomic level the multilo-
cus VNTR- analysis is especially important.
Board 113. Molecular Epidemiology of an Outbreak Caused
by Salmonella enterica Serovar Newport in Argentina 
M. G. Pichel1, N. C. Castaneda1, M. I. Caffer1, M. C. Monzón2, L.
A. Merino3, N. Binsztein1
1Instituto Nacional de Enfermedades Infecciosas ANLIS "Carlos G.
Malbran", Buenos Aires, ARGENTINA, 2Hospital "Juan Pablo II",
Corrientes, ARGENTINA, 3Instituto de Medicina Regional,
Universidad Nacional del Nordeste, Resistencia, ARGENTINA
Between July 28 and August 25 2001, a total of 70 cases of
gastroenteritis were reported at the “Juan Pablo II” Pediatric
Hospital, in the Province of Corrientes, Argentina. Among these
cases, Salmonella spp. was isolated as the only pathogen from the
stools of 52 infants under 8 years old. All these isolates were sus-
ceptible to 12 antimicrobial agents assayed. The strains were sub-
mitted to the National Reference Laboratory, where the biochem-
ical and serological tests were performed and the isolates were
identified as Salmonella enterica serovar Newport. In our country,
S. Newport is not frequently isolated, being Enteritidis and
Typhimurium the most prevalent serovars up to now. In order to
establish the genetic relationship among the S. Newport isolates, a
total of 25 isolates were analyzed by pulsed field gel electrophore-
sis (PFGE) using the restriction enzyme XbaI. For comparison
purposes, 16 strains of S. Newport isolated from sporadic cases in
different time periods and from distinct regions of the country
were included in the study. The genotypic analysis revealed that all
the isolates from the children in the Province of Corrientes showed
an identical PFGE profile, confirming that the outbreak was
caused by a single strain. In contrast, the isolates from sporadic
infections exhibited different DNA band patterns, that shared
between 7.4% and 80.4% of the bands with the outbreak profile.
Board 114. Isolation and Molecular Subtyping of Listeria
monocytogenes from Pristine, Urban, and Agricultural Sources 
B. D. Sauders, K. G. Evans, K. Nightingale, M. Wiedmann
Cornell University, Department of Food Science, Ithaca, NY
Although previous reports describe the ecology and trans-
mission of Listeria monocytogenes (Lm) in and among food pro-
cessing environments, there are few reports describing the occur-
rence of Lm among environments outside those used for food pro-
duction. These few reports suggest that Lm is distributed ubiqui-
tously and transmission dynamics may be difficult to assess. To
assess the occurrence and molecular diversity of Lm in different
environments in New York State (NYS), we cultured pristine,
urban, and agricultural environments for Lm. Lm subtypes were
compared with all reported Lm from animal and human listeriosis
in the prior five years. Samples were obtained from soil, plant
materials, and water from all environments. In addition contact
and floor sponges were taken from urban areas and stool speci-
mens were obtained from all farms. Four separate sites each were
chosen for urban and pristine environments. Agricultural sites
were sampled when bovine or goat cases were reported to the
Cornell University Veterinary Diagnostic Laboratory. One control
farm (without reported listeriosis) was chosen for each case farm.
Samples were enriched in Listeria Enrichment Broth for 24 and 48
hours at 30 ºC and then streaked for isolation on Oxford medium.
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Typical colonies were confirmed as Lm biochemically and by poly-
ermase chain reaction detection of the hly gene. All Lm isolates
were genetically characterized by automated ribotyping
(Qualicon™). There were 7/176 (4%) Lm positive urban speci-
mens, 2/163 (1%) Lm positive pristine specimens, and 45/238
(19%) Lm positive farm specimens. Urban isolates were repre-
sented by five different ribotypes. DUP-1038B accounted for 13%
of the human and 2% of the animal listeriosis in NYS in the 5 years
prior. DUP-1045B accounted for 3% of the human cases and <1%
of the animals cases. DUP-1039 was found only in <1% of animal
listeriosis cases. Both 116-702-S-3 and 116-704-S-5 were unique
ribotypes that were not previously described. Among pristine iso-
lates, there were 2 ribotypes. DUP-1045A represented <1% of all
human and no animal cases. DUP-1053C was not found in any
clinical cases. From 31 farm isolates, there were 12 ribotypes. Five
of the 12 were found previously among both human and animal
cases, 4 were found only among human cases, 2 were found only
among animal cases, and 1 was never found among either animal
or human cases. While this study was aimed at determining the
genetic diversity of Lm among different environmental sources
outside the normal conceptualized foodborne transmission route,
we found that a much higher proportion of Lm was readily cul-
tured from farm and urban environments than from pristine envi-
ronments. Our results show that a considerable diversity of Lm
genotypes exists in non-food related environments and that high
density animal populations (such as farms) may provide a favorable
environment for the survival and transmission of Lm.
Board 115. UPGMA: Are We Correctly Describing the
Relationships Between Bacterial Isolates? 
A. G. Fonseca Pacheco1, L. H. Harrison2
1University of Pittsburgh Graduate School of Public Health, Pittsburgh,
PA, 2Infectious Diseases Epidemiology Research Unit, University of
Pittsburgh Graduate School of Public Health and School of Medicine,
Pittsburgh, PA
Introduction: Genetic relatedness clustering techniques
for bacterial isolates, such as the unweighted pair group method
using arithmetic averages (UPGMA), are used for the study of phy-
logenetic trees. Even though UPGMA is used to describe the rela-
tionships among the isolates and yield an unequivocal dendrogram,
distortions of the original data can occur and more than one den-
drogram can be obtained form the same dataset — tie dendro-
grams. In this study, we present a procedure to address these issues.
Methods: Three articles with published distance matrices for clus-
ter analysis with bacteria were selected from the literature to serve
as an example for the techniques described. For each distance
matrix, the order of the isolates was shuffled 1,000 times and all pos-
sible dendrograms were constructed. In the case of more than one
dendrogram, the ones that presented the least distortion in the orig-
inal distance structure, measured by the cophenetic coefficient
(CC) were chosen. If more than one tie dendrogram had the small-
est CC, an isolate-wise analysis was performed to compare the spe-
cific differences between them. The distortion in the original dis-
tance in each dendrogram was compared using two parameters to
check if: 1) the original distance between an isolate in one cluster
and all isolates not in that cluster is smaller than the cluster height
and 2) the original distance between the isolates within a cluster is
bigger than the height of the next cluster. Results: All three
datasets yielded more than one dendrogram — 2, 3 and 8 respec-
tively. In the first, the CC was around 0.97, and the published den-
drogram was retrieved in 50% of the replications. In the second, the
CC was around 0.70, and the published dendrogram could not be
reproduced. In the last one, the CC was around 0.91 and the pub-
lished dendrogram appeared in 10.3% of the replications. The iso-
late-wise distortion was much greater for the example with the
smallest CC, and so were the differences between specific isolates
in the tie dendrograms. Discussion: Multiple dendrograms can be
obtained for the same dataset, depending on the presence of tied
distances. The great majority of statistical packages yield only one
dendrogram, which is arbitrarily chosen depending on the order of
the data. Although it is believed that a CC greater than 0.70 is suf-
ficient to guarantee a low rate of distortion, we show that even val-
ues as high as 0.90 can present significant isolate-wise distortions.
The examples presented illustrate the necessity of a closer analysis
of results drawn from dendrograms constructed with UPGMA, to
check for severe distortions, and to check for tie dendrograms. We
suggest that whenever UPGMA is employed, the analysis should
include all possible dendrograms obtained from the data, along with
their CC, and a refined isolate-wise analysis of the dendrograms
with the highest CC should be performed.
Board 116. Development of a Multilocus Sequence Typing
(MLST) Scheme for Listeria monocytogenes 
S. C. Smole1,2, F. Pagotto3, S. Lute1, J. Farber3
1Boston VA Medical Center, Boston, MA, 2State Laboratory Institute,
Boston, MA, 3Health Canada, Ottawa, ON, CANADA
The foodborne pathogen, Listeria monocytogenes, is
responsible for a number of outbreaks of listeriosis worldwide.
The high fatality rate associated with this foodborne pathogen
combined with its ability to grow at refrigerated temperatures
have prompted the FDA and FSIS (USDA) to establish a zero tol-
erance for ready-to-eat foods. These periodic outbreaks result in
costly outbreak investigations and large food recalls. To investigate
the population biology of this organism and to aid in the develop-
ment of a molecular typing tool based on nucleic acid sequence,
multilocus sequence typing (MLST) was set up by choosing eight
different metabolic genes of which 450-550 bp of sequence were
obtained. A diverse set of 140 isolates were chosen from a large
collection of clinical, environmental, and food isolates represent-
ing sporatic episodes and food outbreaks from 1971-2000. This
diverse set of isolates represents serotypes (1,1a, 1b, 1c, 1/2a, 1/2b,
1/2c, 3b, 4, 4b, 4d, 4e, 6b, and 7) and, for comparison, these iso-
lates were all characterized by pulsed-field electrophoresis using
Asc I and, if necessary, Apa I. Geographically, the isolates were
obtained from North America, South America, and Europe. This
typing method will provide a ongoing view into the population
structure of this species as well as a better understanding of its
global epidemiology.
Board 117. PFGE Diversity Among Salmonella Heidelberg in
the United States 
F. W. Virgin, Jr., K. A. Kubota, E. M. Ribot, S. B. Hunter
Centers for Disease Control and Prevention, Atlanta, GA
PulseNet is the national network of public health laborato-
ries that perform molecular subtyping using pulsed-field gel elec-
trophoresis (PFGE) on foodborne bacterial pathogens. PFGE pat-
terns are shared and compared for the purpose of cluster identifi-
cation through a national database located at the at the Centers for
Disease Control and Prevention (CDC). PFGE patterns are sub-
mitted by U.S. Public Health Labs, food regulatory agencies, as
well as Canadian public health laboratories through PulseNet
North. The PulseNet national database for Salmonella serotype
Heidelberg was established in 1998. In addition to the S.
Heidelberg isolates submitted by PulseNet laboratories, the
national database also includes PFGE patterns from retrospective
isolates from 1985, 1990, and 1995 that were sent to CDC. All iso-
lates were PFGE typed using PulseNet standardized protocol for
Salmonella. XbaI is used as the primary restriction endonuclease to
digest total DNA. The endonuclease BlnI was also used for some
of the isolates. Gel images were analyzed using Molecular Analyst
v 1.5 (Bio-Rad, Hercules, CA) and dendrograms were calculated
using the Dice coefficient and UPGMA. Within the S. Heidelberg
database there were 85 unique XbaI PFGE patterns. Five hundred
twenty-eight isolates in the database which were restricted with
















five (56%) of those isolates were designated pattern JF6X01.0022.
Of the 295 isolates, 104 were digested with BlnI. Out of the 104
isolates, 82% were indistinguishable and were assigned the pattern
number JF6A26.0001. The remaining 19 isolates were assigned 10
different pattern numbers represented by 1 to 5 isolates. Isolates
with patterns JF6X01.0022 and JF6A26.0001 were seen in 1985,
1990, and 1995. Although there appears to be PFGE pattern diver-
sity within S. Heidelberg, a predominant clone has emerged circu-
lating among strains in the U.S. This data supports a previous study
showing the continual presence of this clonal strain since 1985. It
appears that PFGE is useful in two ways. Since there are over 80
unique patterns within the Heidelberg database, PFGE can be
used to distinguish among isolates that are not patterns
JF6X01.0022 and JF6A26.0001. Finally, it can also be useful in
identifying the predominance of the clonal strain.
Board 119. Correlation of Epidemiologic Trends in
Meningococcal Infection with the Strains of Neisseria
Meningitidis Causing Invasive Disease 
M. McEllistrem1, P. Pass2, J. A. Kolano1, L. H. Harrison1,2
1University of Pittsburgh, Pittsburgh, PA, 2Johns Hopkins Bloomberg
School of Public Health, Baltimore, MD
Background: The incidence of meningococcal disease in
persons 15-24 years of age increased from 1990-97, before declin-
ing in 1998-99. An increase in this age group is characteristic of a
clonal outbreak of meningococcal disease. From 1990-99, the inci-
dence of meningococcal disease steadily increased among persons
at least 25 years old. Methods: Pulsed-field gel electrophoresis
(PFGE) was performed on N. meningitides isolates obtained from
active, laboratory based surveillance from Maryland during 1992-
99. PFGE-based clonal groups were defined as strains at least 80%
genetically related by dendrogram. The degree of genetic related-
ness between strains was calculated using the mean of the Dice
coefficients. Results: Among the 84% (246/293)of the cases with
known serogroups, 46% (29/62) of persons 15-24 years old were
infected with a serogroup C strain compared to 21.5% (20/93) of
adults at least 25 years old (p < 0.01). Likewise, 32% (19/62) of per-
sons 15-24 years old were infected with a serogroup Y strain com-
pared to 44% (41/93) of adults at least 25 years old (p = 0.09). From
1992-97, the mean of the Dice coefficients was 83.7 for persons 15-
24 years old versus 67.1 for children < 15 (p < 0.01) and 66.8 for
persons at least 25 years old (p < 0.01). During 1999, 88% (7/8) of
the serogroup C infections in persons 15-24 years old were due to
an unique PFGE pattern which was not present in previous years.
Seventy-six (58/76) percent of the serogroup Y strains could be
classified into 2 clonal groups (1 and 2). The proportion of clonal
group 2 strains increased from 11% (1/9) in 1992 to 57% (12/21) in
1999 (p = 0.01, Chi square for trend); this trend was seen among
adults atleast 25 years old, but not in the < 15 and 15-24 year age
groups. Conclusion: During the rise in meningococcal incidence
in persons 15-24 years old, serogroup C strains were more geneti-
cally related in this age group than in the other two age groups.
Interestingly, during the decline of meningococcal disease, a
serogroup C clone emerged in persons 15-24 years of age. Among
adults at least 25 years old, the increase in meningococcal disease
was partially due to an increase in one serogroup Y clonal group.
31 New or Rapid 
Diagnostics I
Monday, March 25, 10:00 a.m.
Grand Hall East
Board 120. A Rapid Modified Antibody-Capture Enzyme-
Linked Immunosorbent Assay (ELISA) for Detection HSV-1
Primary Infection in Human 
M. Ravanshad1, M. Roostaee1, A. Mostafaee2, F. Sabahi1
1Virology Department, Medical Sceinces School,Tarbiart Modarres
University, Tehran, IRAN (ISLAMIC REPUBLIC OF), 2Medical Faculty,
Kermanshah University, Kermanshah, IRAN (ISLAMIC REPUBLIC OF).
Objective: Development and application of an enzyme-
linked immunosorbent assay (ELISA) for detection and measure-
ment of IgM antibody to herpes simplex virus type 1 (HSV-1) in
human sera. Methods: An antibody-capture ELISA based on the
reaction between anti-human IgM, prepared in rabbits, and IgM of
serum samples and HSV-1 conjugated with horesradish peroxidase
was developed and applied. Five hundred sera from healthy per-
sons and 26 sera from persons with primary HSV-1 infection were
tested for the presence of IgM antibody against HSV-1. The speci-
ficity and sensitivity of the test were compared with a commercial
test kit, and was acceptable. Results: Based on the results obtained
from this method, it was shown that this method is suitable to
detect IgM to HSV-1. Seven point three percent of healthy sera
were positive for IgM. The sensitivity and specificity of the test was
measured and were 94.4% and 93.91% respectively. Conclusion:
Detection of HSV-1 IgM provides a sensitive, rapid and economic
method for the diagnosis of HSV-1 primary infection. The ELISA
test developed in this study had acceptable sensitivity and is a suit-
able method for the detection of HSV-1 primary infection.
Board 121. Evaluation of Eight Rapid Screening Tests for
Acute Leptospirosis in Hawaii 
P. V. Effler1, A. K. Bogard1, H. Y. Domen1, A. R. Katz2, H. Y. Higa1,
D. M. Sasaki1
1State of Hawaii Department of Health, Honolulu, HI, 2John A. Burns
School of Medicine, University of Hawaii, Honolulu, HI
Leptospirosis is a major public health problem throughout
the world. Clinical recognition of leptospirosis is challenging and
the definitive serologic diagnostic assay, the microscopic agglutina-
tion test (MAT), is time-consuming and difficult to conduct.
Various serologic screening tests have been developed but their
performance among ill persons in the US has not been established.
Eight screening tests were compared on 379 sera obtained from a
series of 236 patients (33 with confirmed infection) collected in
1998 and 1999. The median number of days between illness onset
and specimen collection was nine. The overall sensitivity, by speci-
men, for each test was as follows: IHA (MRL Diagnostics-Cypress,
Calif.): 29%; INDX Leptospira Dip-S-Tick™ (PanBio InDx, Inc.,
Baltimore, MD): 52%; Biognost™ IgM IFA test (Bios GmbH
Labordiagnostik, Gräfelfing, Germany): 40%; Biolisa™ IgM
ELISA (Bios GmbH, Labordiagnostik, Gräfelfing, Germany):
48%; Leptospira IgM ELISA™ (Pan Bio Pty Ltd., Brisbane,
Australia): 36%; SERION ELISA classic Leptospira™ (Institut
VirionoSerion GmbH, Würsburg, Germany): 48%; LEPTO
Dipstick™(Organon-Teknika, Ltd, Amsterdam, The Netherlands):
34%; Biosave™ latex agglutination test (LATEX) (Bios GmbH
Labordiagnostik, Gräfelfing, Germany): 86%. Test specificity
ranged from 85% to 100% among all tests except LATEX which
was significantly lower, at 10%. Test sensitivity was particularly low
(<25%) for all tests (except LATEX) on specimens collected during
the first week of illness. This is the most comprehensive field trial
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of leptospirosis screening tests reported to date. The data indicate
that IgM detection tests have limited utility for diagnosing lep-
tospirosis during the initial evaluation of patients seen in Hawaii, a
time when important therapeutic decisions are made. Improved
leptospirosis screening tests are needed.
Board 122. Enhancing Surveillance for Influenza Virus by
Incorporating Newly Available Rapid Diagnostic Tests 
P. Effler, M. Ieong, M. Nakata, T. Tom
State of Hawaii Department of Health, Honolulu, HI
Objectives: To determine the effect of incorporating
influenza rapid testing into public health virologic influenza sur-
veillance activities.
Methods: Beginning with the 1999-2000 influenza season,
physicians throughout Hawaii ordering a viral culture for patients
with suspected influenza were also offered influenza rapid testing.
We compared the number and results of viral respiratory cultures
sent to the Hawaii Department of Health (HDOH) and the num-
ber of providers who participated in influenza surveillance over
consecutive influenza seasons. Data from 37 virology laboratories
elsewhere in the United States were reviewed for comparison.
Results: HDOH received 306, 396, 1112, and 2169 speci-
mens for influenza culture during the 1997-1998, 1998-1999, 1999-
2000 and 2000-2001 influenza seasons, respectively, and the num-
ber of influenza isolates recovered was 73, 64, 137, and 491 respec-
tively. The number of Hawaii providers submitting one or more
influenza cultures rose from 34 to 196 between the 1998-1999 and
1999-2000 seasons; the number of cultures submitted at compari-
son laboratories rose just 5% during this same period.
Conclusions: In our setting, incorporating rapid tests
into public health surveillance greatly increased the number of
specimens submitted for viral culture and the number of
influenza isolates recovered. Coupling rapid tests with cultures
appears to be an effective incentive for physicians to participate
in virologic surveillance.
Board 123. New Express Method of Virus-Cell Interaction
Dynamic Monitoring and Diagnostics.
A. S. Fedchuk1, O. P. Fedchuk2, A. O. Fedchuk2, P. O. Fedchuk3
1Ukraine Antiplague Research Institute, Odesa, UKRAINE,
2I.I.Mechnikov Odesa National University, Odesa, UKRAINE, 3Odesa
State Academy of Refrigeration, Odesa, UKRAINE.
We propose new original and objective express-method for
virus-cell interaction dynamic monitoring. Fractal approach was
chosen because it is stated experimentally that main systems and
organs of human organism beginning from cellular level have frac-
tal structure. Samples of Hep-2 cells cultivated for 24 and 48 hours
were used as the substrate for further infection with Herpes sim-
plex virus of US-1 strain. The substrates were pretreated with E-
aminocaproic acid (EACA) and tested 8, 16, 24 and 48 hours after
infection. The non-pretreated cell culture samples were tested as
well. Thickness and homogeneity of samples were checked using
interferometric techniques. Diffraction patterns (DP) of the spec-
imens containing system of virus-cell interacting particles were
generated due to the specific changes of their optical density and
afterwards registered by VZM 1000 Color LabVideo system. Thus
obtained DP were transmitted to Intel Pentium III 600 MHz PC
and processed using original image processing software elaborated
in our group. As a result of few minutes long PC work, one could
obtain an objective parameter — fractal dimension D, which is
much more sensitive than those obtained using regular techniques
such as direct counting of pre-colored infected cells in optical
microscope. All types of specimens under consideration in present
work were tested as well through traditional techniques and the
results were compared with one another. Sufficient differences in
D values were registered even at early stages (8 hours and even
less) of viral infection. We could state that proposed method will be
of exceptional need in drug design research and clinical practice
because of its sensitivity and express nature.
Board 124. New NAT Assays for Quantitative Detection of
Non-Enveloped Model Virus, PPV, in Blood Product Safety
Studies
G. G. Prikhod'ko, H. Reyes, I. Vasilyeva, H. Xue, J. He, A. Ralston,
T. F. Busby
American Red Cross Holland Laboratory, Rockville, MD
Improvement in donor selection and plasma screening has
resulted in a tremendous reduction of risk in transfusion- and plas-
ma product-transmitted infections over the past two decades. In
1999, European Union regulators began to require that all plasma
be tested by nucleic acid amplification technology (NAT) assays for
HCV if derivatives made from such plasma were to be sold in
Europe. This announcement provoked and accelerated the devel-
opment and implementation of NAT assays for blood and plasma
screening in the United States and other developed countries.
Virtually all whole blood and plasma donations collected in the
United States are been screened for both HCV and HIV-1 by NAT
assays. Moreover, recently evaluated NAT assays for detection of
HBV and B19 in plasma pools are expected to reduce the risk of
viral transmission via transfusion and plasma products. Still the
blood supply remains vulnerable to new and reemerging infec-
tions, since several hepatitis and other viruses have been discov-
ered. For this reason, current US and European guidelines and
regulations recommend using at least 2 viral clearance techniques
to create plasma products that more closely approach zero risk for
pathogen transmission. Porcine parvovirus (PPV) has been recog-
nized as a model virus for non-enveloped human viruses like par-
vovirus B19 and HAV in viral inactivation/removal studies. The
standard, cell-based PPV-specific (TCID50) assay provides a quan-
titative analysis of PPV-containing samples within 6 to 7 days with
a sensitivity of approximately 2 log10 TCID50. However, neither a
referenced method for the quantitative PPV NAT assay nor a kit for
quantification of PPV has been published or become available on
the market. We developed two PPV NAT assays (a PPV-specific
nested-Q-PCR assay and a PPV-specific LightCycler nested-PCR
assay) that are designed to be used with widely distributed PCR
systems from companies such as Perkin Elmer, MJ Research and
Roche Molecular Biochemicals. Both assays are simple and repro-
ducible, and provide an accurate quantification of PPV (single copy
of PPV per PCR run) within several hours. The assays contain a
PPV DNA standard, against which all PPV controls can be cali-
brated, and the proof test of the PPV-specificity of amplified prod-
ucts. PPV NAT assays were evaluated in PPV inactivation studies,
quantification of PPV in human plasma and in nanofiltration of α
1-proteinase inhibitor (API) spiked PPV samples.
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Board 125. Behavioral Environmental Influence on
Pathology and Outcome of Chronic Viral Hepatitis 
Y. Shcherba
St.Petersburg State Medical University, Scientific Research Institute of
Influenza of the RAMS, Saint Petersburg, RUSSIAN FEDERATION
Background/Objectives: Nowadays it is well known that
behavioral environmental epidemiology can predict acute and
















including the newly emerging or re-emerging infections. In this
investigation we have undertaken to assess the influence of under-
lying or superimposed drug abuse on the pathomorphogenesis of
chronic viral hepatitis and evaluate its possible prognostic signifi-
cance. Methods: Prospective and retrospective epidemiological,
clinical and histoenzymological investigation of liver tissue
obtained with the help of liver biopsy in 400 patients with chronic
hepatitis B, C or B and C with and without intravenous opiate and
ephedrine addiction. Results: In chronic viral hepatitis patients
without drug abuse an increase in the number of capillarized sinu-
soids, marked by enzymes alkaline phosphatase and 5-nucleoti-
dase, and decrease in the activity of the second link tissue oxidation
enzyme NAD-diaphorase were determined in the blood-hepato-
cytic barrier. The changes were much greater in the group of asso-
ciate B and C etiology. In chronic viral hepatitis patients with drug
abuse the number of capillarized sinusoids was very large and the
enzyme activity was persistently very low, regardless of the partic-
ular etiology — B, C or B and C respectively. Discussion/
Conclusions: The data obtained are in accordance with the fact of
severe deleterious drug interference with the oxidation-reduction
process in living tissues and intensive capillarization of the liver
sinusoids, being especially expressed in opiates. Simultaneous B
and C viral infection of the liver in association with drug abuse,
both being the very consequences of the behavioral environmental
influences, can cause greater alteration and subsequent structural
damage to the blood-hepatocytic barrier. The study demonstrated
that the quantitative data obtained correlated sufficiently well with
the severity and outcome of chronic hepatitis B, C or B and C (the
extent of inflammation, fibrosis and cirrhotic transformation).
Board 126. Bioecological Assessment and Environmental
Control by Women's Reproductive Function Indices 
E. Ailamazyan1, T. Belyaeva2
1St.Petersburg Institute of Obstetrics and Gynecology, Saint
Petersburg, RUSSIAN FEDERATION, 2St.Petersburg State Medical
University, St.Petersburg Institute of Obstetrics and Gynecology, Saint
Petersburg, RUSSIAN FEDERATION
Objectives: To sustantiate a new method of bioecological
assessment and environmental control by women’s reproductive
function indices. Methods: More than 250000 women with and
without pregnancy and 50000 newborn infants have been exam-
ined prospectively and retrospectively. The women’s clinical, bio-
chemical, hormonal, immunologic, instrumental data testifying to
their reproductive function in the areas with and without various
unfavourable ecological influences (industrial, agricultural and
sanitary) have been compared. Results: The most informative
women’s reproductive function criteria for the assessment of and
monitoring the ecological situation in the region in this respect
were selected. They included: the rates of the hazard of inter-
rupted pregnancy (incompetent pregnancy), gestosis, premature
delivery, labor activity anomalies, hypogalactia, fetal hypotrophy,
chronic intrauterine hypoxia, in-delivery fetal hypoxia and asphyx-
ia, perinatal mortality, newborn morbidity, ovarian hormonal
insufficiency, menopausal age, osteopenia degree in early post-
menopause, and climacteric syndrome degree. The quantitative
values of the criteria selected can be used for the assessment of
the ecological situation of the region in this respect as being
favourable/unfavourable. Conclusions: Making use of the sug-
gested criteria and corresponding indices gives the possibility to
ensure and carry out ecological regional cartography and individ-
ual prophylaxis of ecologically dependent obstetric, gynecologic,
perinatal and neonatal pathological conditions.
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Campylobacter coli – What’s the Big Deal? 
S. J. O'Brien, G. K. Adak, S. M. Long, I. A. Gillespie, J. A. Frost
Public Health Laboratory Service, London, UNITED KINGDOM
Background: In the 1980s campylobacters emerged as the
most common bacterial cause of acute gastroenteritis in North
America and Western Europe. Routine surveillance and special
studies have consistently shown that, within the genus,
Campylobacter coli lies second to C. jejuni as a cause of human ill-
ness. Data on the impact of C. coli infection were scarce because
strains were infrequently speciated and incidence studies were
lacking. However following the completion of the Study of
Infectious Intestinal Diseases in England and the Sensor Study in
the Netherlands, incidence data are now available for two industri-
alized countries. The development of a method for estimating the
impact of food-related illness by the United States Centers for
Disease Control and Prevention (CDC) has made it possible to
explore the impact of C. coli infection within the context of all
food-related disease. Methods: We refined the CDC method for
quantifying the impact of food-related disease to correct for
imported infection. We estimated the number of illnesses, presen-
tations to primary care physicians (presentations), hospitalizations,
days of care in hospital (days) and deaths due to indigenous food-
borne C. coli in England and Wales in 2000 and compared these
data with those for other pathogens. Results: Indigenous food-
borne C. coli infection resulted in 24560 illnesses, 11695 presenta-
tions, 990 hospitalizations (for 5500 days) and 6 deaths. C. coli
infection led to more hospitalizations than all foodborne pathogens
other than C. jejuni and Salmonella enterica serotype Enteritidis
and more illness and presentations than Shiga-toxin producing
Escherichia coli, Salmonella enterica serotype Typhimurium or
Listeria monocytogenes. Conclusion: The importance of C. coli as
a foodborne pathogen has been underestimated, possibly because
it lies in the shadow of C. jejuni. This is the first time that the
impact of illness due to this pathogen has been considered against
the background of all other causes of food-related infectious intes-
tinal disease on a national scale. Our analyses show that C. coli is
an important pathogen in its own right and that control of this
pathogen is a necessary part of any strategy that is developed to
reduce the burden of food-related illness. However in order to
control C. coli we must learn more about its epidemiology and
microbiology.
Is Drinking Water a Risk Factor for Endemic Cryptosporidiosis
in the Immunocompetent General Population of the San
Francisco Bay Area? 
A. Khalakdina1,2,3, D. J. Vugia2,4, J. Nadle2, J. M. Colford, Jr.1,2
1Division of Public Health Biology and Epidemiology, Centers for
Family & Community Health and Occupational & Environmental
Health, School of Public Health, University of California at Berkeley,
Berkeley, CA, 2California Emerging Infections Program, Oakland,
CA, 3Community Health Epidemiology and Disease Control, San
Francisco Department of Public Health, San Francisco, CA, 4Division
of Communicable Disease Control, California Department of Health
Services, Berkeley, CA
Background: Cryptosporidiosis is a protozoan enteric ill-
ness that has received much attention in immunocompromised
persons and in outbreak settings (frequently waterborne). There
are, however, no population-based studies on the risk factors for
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community-acquired cryptosporidiosis in the immunocompetent
general US population. Methods: We undertook a case-control
study in 8 counties in the San Francisco Bay Area as part of a
national study to ascertain the major routes of transmission for
endemic cryptosporidiosis in this population. Our specific goal was
to evaluate any risk associated with drinking water. Cases were
recruited from among those identified by a population-based,
active surveillance system that is in place in the region. At least two
age-matched controls per case were recruited using random-digit
dialing schemes for three possible types: household, neighborhood
and different water district. Cases (n=26) and controls (n=62) were
interviewed by telephone using a standardized questionnaire that
included extensive questions about the following exposures in the
2-week period prior to the onset of illness in the index case: drink-
ing water, recreational water, food items, travel, animal contact,
and person-to-person fecal contact. For adults, additional ques-
tions were asked about sexual practices. Results: In multivariate
conditional logistic regression analyses the major risk factor for
cryptosporidiosis was travel to another country (matched
OR=24.12; 95% CI: 2.64-220.62) (Table). Conclusions: Our study
found a high association between foreign travel and cryp-
tosporidiosis. No significant association with drinking water was
detected. These findings can be used both to design larger studies
of endemic cryptosporidiosis and to guide the analyses of national
data that have already been collected.
Cryptosporidiosis among the immunocompetent, San Francisco
Bay Area: Multivariate OR (95% CI)
Exposure All Controls(n=62) Neighborhood Controls(n=45)
Drink boiled water 1.00 (reference) 1.00 (reference)
Drink filtered or bottled water 2.29 (0.11–46.52) 2.11 (0.08–54.71)
Drink tap water 3.56 (0.11–46.52) 2.91 (0.15–-54.91)
Travel to another country 34.66 (3.58–27.96) 24.12 (2.64–20.62)
Washington Clinical Laboratory Initiative – Assessment of
Laboratory Practice 
J. M. Counts
University of Washington, Seattle, WA
The University of Washington Clinical Laboratory Initiative
is a demonstration project, that is part of the National Laboratory
System (NLS), funded by CDC. The goal of the NLS is to
strengthen critical laboratory testing for public health surveillance
and investigations through systematic assessments of laboratory
practice, focused training, improvement of diagnostic testing
through the promotion of consensus testing standards and respon-
sive laboratory delivery systems that provide diagnostic testing for
the diagnosis, treatment and surveillance of infectious diseases.
The Initiative is conducted in collaboration with the CDC,
Foundation of Health Care Quality and numerous other stake-
holders in the state of Washington as a quality improvement initia-
tive. The current focus of the Initiative is the assessment of labora-
tory practice that addresses antimicrobial susceptibility testing in
public health, hospital, commercial, and physician office laborato-
ries. National studies have indicated that antimicrobial susceptibil-
ity testing (AST) may not be of the quality necessary to ensure
appropriate patient care and effective surveillance. Data will be
presented from studies, conducted by the Clinical Laboratory
Initiative, which identified serious deficiencies in laboratory prac-
tice such as utilization of outdated NCCLS tables, failure to
respond appropriately to case studies, which address contemporary
AST issues, and failure to utilize appropriate number and type of
antimicrobials in AST which may contribute to erroneous results
leading to treatment failures and false assumptions about antimi-
crobial resistance.
Real-Time International Surveillance of Antimicrobial
Resistance by the Enter-net Surveillance Network
I. S. Fisher1, N. Gill1, B. Reilly2, H. Smith3, J. Threlfall3, on behalf of
the Enter-net participants4
1PHLS Communicable Disease Surveillance Centre, London, UNITED
KINGDOM, 2Scottish Centre for Infection and Environmental Health,
Glasgow, UNITED KINGDOM, 3PHLS Central Public Health
Laboratory, London, UNITED KINGDOM, 4Enter-net surveillance hub,
London, UNITED KINGDOM
Background: Many fora and reports have highlighted the
importance of surveillance of antimicrobial resistance across a
range of organisms over the last few years. Illness from enteric
pathogens often presents with self-limiting symptoms, but this is
not always the case, particularly for the immunocompromised or
those with severe infection. With no new antimicrobials on the
immediate horizon it is vital to monitor the efficacy of current
treatments and identify the emergence of resistance to those cur-
rently in use. However international surveillance of resistance has
always been dogged by the question of comparability of results. In
1998 Enter-net — the international surveillance network for the
enteric pathogens salmonella and shiga-toxin producing E.coli —
undertook an international study to compare the qualitative (resist-
ant, intermediate resistance or sensitivity) results of antimicrobial
susceptibility testing to ascertain whether international surveil-
lance could successfully be achieved. Forty-eight strains were sent
to each of the 18 National Reference Laboratories in the network
to be tested using their own methods against the panel of 11
antimicrobials recommended by Enter-net so that the results could
be analysed and the degree of concordance (or non-concordance)
between them could be determined. Over 8,500 tests for antimi-
crobial susceptibility were undertaken and, with the exception of
low-level resistance to ciprofloxacin, it was clear that there was a
great deal of concordance between the results, over 99% of the
tests for resistance yielded the same results. Therefore data on
antimicrobial resistance were incorporated into the specification
for the international databases created by Enter-net. Results
Provisional data for 2000 (the last full year for which data are avail-
able) show that in the salmonella database antimicrobial suscepti-
bility testing results are available for almost 18,000 strains. Of these
6,098 (47.1%) were fully sensitive, 5,343 (41.2%) showed resist-
ance to between one and four antimicrobials, and 1,513 (11.7%)
strains were resistant to five or more antimicrobials. Conclusion:
International surveillance of antimicrobial susceptibility results has
been achieved. Comparable data on these results are being collat-
ed in the international Enter-net databases. Although the inclusion
of data on testing results has begun relatively recently, its true value
will be seen in the course of the next few years as the data become
more complete and significant, and trends and the emergence of
newly resistant strains are identified. In addition the exchange of
antimicrobial resistance data has proved invaluable in confirming
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The Emergence of Rift Valley Fever in the Arabian 
Peninsula, 2000 
H. El Sakka1, R. Graham1, E. Mohareb1, D. Salma1, S. Lewis1, A. El
Kholy2, M. Ibrahim2, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Field
Epidemiology Training Program, Egyptian Ministry of Health and
Population, Cairo, EGYPT, 3Centers for Disease Control and
Prevention, Atlanta, GA
Background: On September 17 2000, the Yemen Ministry
of Agriculture and Irrigation (MoAI) and Ministry of Health
(MOH) received reports about the occurrence of disease compati-
ble with Rift Valley Fever (RVF) in the Tihama region of Yemen.
Under terms of a cooperative agreement to rapidly respond to out-
breaks, a WHO mission was quickly organized to provide assistance
in the outbreak investigation. The Saudi Arabian Ministry of
Health has described a simultaneous outbreak of RVF in the Jizan
region of KSA.
Methods: Using standardized case investigation forms and
mobile surveillance teams, a computerized database was estab-
lished to monitor the outbreak. Laboratory capacity was developed
to perform serologic assays for IgM-class antibody to Rift Valley
Fever virus. A cross-sectional survey was conducted to evaluate
attack rates and risk factors for disease.
Results: Case finding - Between August 7 to December 31,
2000, 1358 suspect case-patients were identified including 147
(11%) persons who died. The mean age of suspect case-patients
was 31.4 years (range 1 month- 95 years). Among 555 case-patients
with serological testing, 142 (26%) had IgM class antibody to RVF
virus, 20 (4%) were weakly reactive. The clinical spectrum of dis-
ease was typical of RVF and included patients with benign and
complicated disease (eg hemorrhagic disease, hepatitis, retinitis,
and encephalitis). Overall, laboratory confirmed disease occurred
in 14 districts in 5 different governorates. The majority of case-
patients (>75%) reported exposure to sick animals, handling an
abortus or slaughtering of animals in the week prior to illness.
Among the 721 persons tested in the cross-sectional survey, 151
(21%) had serologic evidence of past or recent infection with RVF
virus. Risk factors for disease included exposure to animal abortus
(OR 3.3; P < 0.05), animal contact, (OR 3.1; P <0.05) and contact
with sick family members (OR 2.2; P <0.05). Thirty six percent of
participating households reported a similar outbreak in 1998 with
waves of abortions and sudden death in the farm animals.
Conclusions: The outbreak response was highly effective
in mobilizing resources in a rapid manner. Surveillance efforts
documented widespread disease among humans and animals
throughout the northern Tihama. Enhanced surveillance efforts
are ongoing to monitor the potential for RVF virus to become
endemic in the region.
Microheterogenicity of the Volgograd Clone of West Nile Virus 
A. E. Platonov1, L. S. Karan1, S. B. Yazyshina1, K. O. Mironov1, E.
M. Krasnova2, V. V. Lazorenko2, N. V. Rusakova2, A. N. Zhukov2, V.
A. Antonov3, I. L. Obukhov4, G. A. Shipulin1
1Central Research Institute of Epidemiology, Moscow, RUSSIAN FED-
ERATION, 2State Center for Sanitary and Epidemic Control,
Volgograd, RUSSIAN FEDERATION, 3Anti-Plague Institute, Volgograd,
RUSSIAN FEDERATION, 4State Institute for Control of Veterinary
Products, Moscow, RUSSIAN FEDERATION
In August and September 1999, an outbreak of West Nile
(WN) encephalitis/fever occurred in the Volgograd region of South
Russia (> 600 human clinical cases). WN clinical cases were diag-
nosed in Volgograd region in 2000 and 2001 also (31 and 15
patients). Brain specimens from non-survivors were positive in
specific RT-PCR assays confirming the presence of WN virus. We
have sequenced the fragment of WN viral envelope (E) gene
obtained from the brain tissue samples of 16 Volgograd patients
with clinical and pathomorphological signs of aseptic meningoen-
cephalitis. Fourteen patients died from September 3 to September
7, 1999. Nucleotide substitutions occurred at 5 of the 512 positions
of the E gene fragment of 14 isolates. So 5 genovariants (VLG-1,
AF412270; VLG-2, AF412271; VLG-3, AF412272; VLG-6,
AF412273; VLG-11, AF412274) were presented. Variant VLG-1,
found in 9 isolates, prevailed significantly (p = 0004, chi-square
test). Within group mean p-distance was equal 0.0019 ± 0.0009
(pairwise p-distance ranged from 0 to 0.0059). All substitutions
were in third codon, only one of them lead to amino acid change
(Met-Ile in VLG-3). As far as all patients contracted the disease at
the same time and at the same place, these isolates appeared
belonging to the same clone. Minor differences might arise as a
result of “genetic noise" or adaptation to host or vector. After addi-
tional analysis of GenBank WN sequences submitted from the
USA 1999-2000 and Israel 1999-2000, we suggested to define con-
ventionally the WN clone as the group of strains having within
group mean p-distance less than 0.005 and the maximal pairwise p-
distance less than 0.015 for nucleotide sequence. The E gene frag-
ment of two WN isolates from Volgograd 2000 were identical to
VLG-1 genovariant, that argued for the endemicity of this clone
for the region. The nearest relatives of the Volgograd WN clone
are the mosquito isolates from Romania-1996 [AF260969] and
Kenya-1998. Their mean p-distances from the Volgograd clone
were equal 0.006 ± 0.003, pairwise distance ranges from 0.0020
(one substitution without amino acid change in VLG-3 isolates in
comparison to Romania-1996M isolate) to 0.0078 (four substitu-
tions). According to our definition, Volgograd, Romanian and
Kenyan strains belong to the same clone. The comparison of the
complete genome of one Volgograd isolate [AF317203] and
Romania-1996M isolate confirmed this hypothesis. The strains dif-
fered from each other in 46 nucleotide positions, 43 of them were
located in coding region. 35 mutations were silent so the strains
differed in 8 amino acid only. So the homology of WN-Volgograd-
4 and WN-Romania-1996M strains was 99.77% for aa sequence
and 99.58% for nt sequence. Although Volgograd-1999/2000,
Romania-1996M, and Kenya-1998-mosquito isolates demonstrate
an unusual degree of similarity, the exact mode of the clone intro-
duction into Russia remains unclear.
Rapid Screening and Identification of West Nile Virus in
Captive and Wild Birds Using Non-Invasive Environmental
Samples and a Portable TaqMan RT-PCR
J. D. Callahan1, T. S. McNamara2, A. L. Glaser3, M. Turell4, K.
Gaffney1, S. Ellis1, W. M. Nelson1
1Tetracore, Inc, Gaithersburg, MD, 2Wildlife Conservation Society,
NY, NY, 3Cornell University, Ithaca, NY, 4US Army Medical Research
Institute of Infectious Diseases, Fort Detrick, MD
Zoo animal populations in large cities could serve as excel-
lent sentinels for the epidemiological surveillance of West Nile
(WN) virus or other diseases if sample collection and screening for
pathogens could be made easier and faster. Current rapid testing
methods for WN include RT-PCR amplification of viral RNA from
tissues, which is useful only if infected animals die. We describe the
development of a Taqman RT-PCR assay for the specific real-time
detection of WN and Kunjin (KUN) viruses suitable for environ-
mental samples that can be performed in less than two hours on a
portable instrument. A set of oligonucleotide primers and a single
fluorogenic probe were designed to target a conserved area within
of the 3’noncoding region common to all known sequences of WN
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and KUN. Preliminary evaluation and optimization of the assay
were performed on cell culture derived stock viruses representing
WN, KUN and multiple flaviviral near neighbors. The assay suc-
cessfully detected all WN and KUN strains tested but did not
amplify closely related flaviviruses. Archived RNA samples from tis-
sues, blood, cloacal and orpharyngeal swabs, and guano represent-
ing zoo and wild birds populations as well as serially collected serum
and guano from birds experimentally infected with WN were
obtained for evaluation of the assay. RNA was extracted from the
later sample set using the Qiagen, QIAamp viral RNA mini kit.
Testing of archived RNA samples from captive and wild animal pop-
ulations previously identified as infected with WN and control ani-
mals indicated that the Taqman assay had 100% correlation with
viral isolation and gel based RT-PCR results for all sample types and
species tested. Testing of serum and guano samples from experi-
mentally infected crows revealed a 100% correlation between
Taqman and viral isolation and plaque assay results for serum and
guano for all samples with viral titers of at least 10e+3.0 PFU/ml.
These results indicate that the assay may be suitable for testing for
WN in guano samples from live birds. Preliminary results appear
promising and highlight the potential use of this assay for screening
for WN or KUN. The ability to test multiple sample types including
non-invasive guano samples from live birds facilitate the potential
use of the assay as a rapid tool for the epidemiological surveillance
and diagnostic investigation of West Nile and Kunjin viruses.
West Nile Virus First Transmission Season in Florida, 2001 –
More than 400 Horse Cases and 170 Chicken Seroconversions
but Only Sporadic Human Disease
C. Blackmore1, L. M. Stark2, R. L. Oliveri3, L. A. Conti3, S. T.
Wiersma3
1Florida Department of Health, Jacksonville, FL, 2Florida Department
of Health, Tampa, FL, 3Florida Department of Health, Tallahassee, FL
With endemic St. Louis Encephalitis virus and Eastern
Encephalomyelitis virus transmission in Florida, the state has a
well established arbovirus surveillance program mainly by using
sentinel chicken flocks, monitoring equine arboviruses and by
enhanced passive human encephalitis case investigation. In antic-
ipation of the arrival of West Nile (WN) virus in the state, an inter-
agency task force was formed and, based on the experience from
states in the North East, protocols for additional surveillance
using dead bird reporting, dead bird testing and horse testing
were established.
After the virus was first detected in Florida in early July
2001, intensive surveillance efforts over the following 4 months
uncovered evidence of WN virus infections in 763 wild birds, 404
horses, 175 sentinel chickens and 11 people. West Nile virus
infected wild birds were found in 65 of the 67 Florida counties.
However, unlike the predominantly urban 1999 and 2000 epi-
zootics in New York and other northeastern states, the epicenter of
the Florida epizootic was in the mostly rural north and north cen-
tral Florida. Only 7% of WN virus positive dead birds, 4% of WN
virus positive horses and 17% of WN virus positive chicken found
statewide, were from counties in the central and southern parts of
the state, the focus of SLE virus transmission in Florida.
Eight human cases were diagnosed from 7 north and north
central Florida counties. Three additional cases were diagnosed in
Monroe County (the Florida Keys). Seven case-patients were
males, median age was 50 years and onset dates ranged from July
13 to October 28, 2001. Seven were hospitalized with no fatalities.
All human cases were preceded by detections of virus infections in
animals in the state. However, only seven of the eleven cases were
preceded by reports of WN virus detection in birds or horses in the
local county.
The reasons for the limited number of human WN virus
cases are unclear.
Surveillance data and disease prevention messages were
publicized on the web, in news letters and in regular state and local
press releases, measures that have been shown to increase the pub-
lic awareness of the need to protect themselves against mosquito
bites in previous outbreaks. In addition, extensive mosquito control
efforts were undertaken in counties with mammalian virus trans-
mission. Ecological and behavioral characteristics of the local mos-
quito vector(s) may also be of importance. Mosquito collection data
suggest the human disease vectors may be one or several local
species in the Culex family. Virus isolations have also been made
from Anopheles atropos, Culiseta melanura, Ochlerotatus atlanti-
cus and Oc. taeniorhynchus.
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A Molecular Approach to the Epidemiology of Giardia 
guodenalis in a Peruvian Shantytown 
P. J. Hoover1, C. Reed1, G. D. Sturbaum1, R. H. Gilman2, C. R.
Sterling1
1University of Arizona, Tucson, AZ, 2Johns Hopkins University,
Baltimore, MD
Giardia duodenalis is a protozoan parasite that causes
severe diarrhea, abdominal pain and rapid weight loss. As the most
common intestinal parasite of humans in developed countries, G.
duodenalis has been named in several U.S. outbreaks occurring in
daycare centers and small communities. The situation, however, is
far worse in developing countries where living conditions are often
crowded and sanitation is poor. In fact, these conditions create an
environment where people are continually exposed to infection.
This setting has proven especially devastating for children, whose
immune systems are not developed enough to fight off repeated G.
duodenalis infections. Children with multiple infections early in
life do not develop equally with their age-matched counterparts.
While infectious from person to person, controversy remains as to
whether or not the organism is transmissible from animals to
humans. Furthermore, transmission patterns within an endemic
community are poorly understood. This study attempts to provide
insight into these issues by examining an endemic locality in Peru.
Because the organism is passed in the feces, stool samples were
collected from 12 households and their dogs living in a shantytown
outside of Lima, Peru from May 20 to July 31, 2001. Households
consisted of five to nine members, and their ages ranged from 0 to
58 years. Fecal samples were collected weekly from 81 humans and
4 dogs. Samples were microscopically screened for G. duodenalis,
and positive fecal samples were purified using differential cen-
trifugation techniques. G. duodenalis DNA was extracted from
purified samples using a QIAamp DNA Stool Mini Kit. To identify
different strains of G. duodenalis affecting the shantytown, a
genomic region variable among G. duodenalis strains was analyzed.
The small subunit ribosomal (SSU) RNA gene was targeted utiliz-
ing the polymerase chain reaction and primers RH4 and RH11. A
292-bp product was produced from positive samples and
sequenced to compare strains. Infections were tracked graphically
taking into consideration each participant’s age, infection duration,
and the infecting G. duodenalis strain. During the study, 37 of 81
human participants microscopically screened positive for G. duo-
denalis, while one of four dogs screened positive. Comparison of
the SSU-RNA sequences from human isolates reveals the predom-
inance of two distinct genotypes within the endemic locality (the
dog isolate could not be sequenced). However, only a single G.
















same household during the study. These results suggest that infec-
tion may occur from a single source, and that transmission is likely
to occur among household members.
Increasing Detection of Malaria in U.S. Hospitals Using the
OptiMAL Rapid Diagnostic Test 
C. J. Palmer1, J. A. Bonilla1, D. A. Bruckner2, E. Barnett3, N. S.
Miller4, J. Masci5, M. A. Haseeb6
1University of Florida, Gainesville, FL, 2UCLA Medical Center, Los
Angeles, CA, 3Boston Medical Center, Boston, MA, 4Washington
Hospital Center, Washington, DC, 5Elmhurst Hospital Center,
Elmhurst, NY, 6Kings County Hospital, Brooklyn, NY
There are greater than 1,000 cases of malaria diagnosed
each year in the United States. While most cases are imported,
U.S. malaria cases have also been attributed to blood transfusion or
local mosquito transmission. Reported numbers, however, may be
artificially low because most U.S. hospital laboratory technologists
have limited experience in identifying malaria parasites and are
only infrequently requested to screen for this disease. In this study,
a rapid malaria diagnostic test, the OptiMAL (Flow Inc., Portland,
OR) was introduced to selected U.S. hospitals in an effort to assist
and increase the identification of malaria cases. The OptiMAL test
is an immunochromatographic test that both identifies and speci-
ates malaria parasites based on detection of parasite lactate dehy-
drogenase (pLDH) from a drop of patient blood. Results are visu-
ally read as colored bands on a nitrocellulose strip. In this study, a
total of 83 patients with suspect malaria were tested by both
microscopy and OptiMAL. Patients reporting to these hospitals
had recently traveled from Nigeria, Kenya, Uganda, Senegal,
Gambia, Ghana, Sudan, Iraq, India, Ecuador, Indonesia, or
Bangladesh. Results indicated that 19 were positive for malaria by
bloodfilm (13 falciparum, 6 vivax) while 18 were positive by
OptiMAL (13 falciparum, 5 vivax). Initially, there was one dis-
crepant sample wherein the bloodfilm was positive and the
OptiMAL was negative. However, further evaluation of the patient
blood sample by that state’s Dept. of Health revealed that the
patient was infected with Babesia spp. and not malaria. Thus the
OptiMAL was correct and the initial blood film reading was incor-
rect. To date, we report 100% sensitivity and 100% specificity in
the U.S. hospital study using the OptiMAL with eight additional
months left in the study. Participating hospitals have reported that
the OptiMAL rapid malaria test was well accepted and enthusias-
tically welcomed by those working in their diagnostic laboratories.
Integration of the OptiMAL rapid malaria diagnostic test into the
U.S. healthcare infrastructure can provide an important and easy to
use diagnostic tool for the detection of malaria.
Incidence and Type Distribution of Astrovirus Among 
Spanish Children 
R. M. Dalton1, E. Roman2, N. Negredo1, I. Wilhelmi3, A. Sánchez
Fauquier1
1Centro Nacional de Microbiología, Madrid, SPAIN, 2Servicio de
Pediatría, Hospital Severo Ochoa, Leganés, Madrid, SPAIN,
3Servicio de Microbiología, Hospital Severo Ochoa, Leganés,
Madrid, SPAIN
Our understanding of the epidemiology of astrovirus-asso-
ciated acute gastroenteritis is changing markedly with each
improvement in detection methods. The incidence of astrovirus
infection in children less than 4 years of age diagnosed with acute
gastroenteritis in a hospital of Madrid during one year was deter-
mined by the combination of two methods (EIA and RT-PCR). In
this study, faeces from 822 children diagnosed in a Hospital’s pae-
diatric emergency room were analysed. In every sample, the pres-
ence of astrovirus was analysed by EIA (IDEIA, DAKO). Besides,
samples in which no enteric pathogen was detected (neither bacte-
rial nor viral) were analysed by astrovirus specific RT-PCR.
Astrovirus was detected in 36 (4.38%) of 822 specimens tested by
EIA (IDEIA, Dako) and in 50 more specimens (6.08%) by RT-
PCR. This represents 10.5% (86) of all children tested for enteric
pathogens, including viral and bacterial, over the survey period.
Using RT-PCR as a method of detection of astrovirus this viral
agent can be considered as the second cause of acute gastroenteri-
tis of viral origin. A selection of the 86 astrovirus positive samples
of this study are being analysed by RT-PCR and nucleotide
sequencing of 348pb within the capsid protein precursor region of
the genome for their phylogenetic grouping (genotype).
Preliminary results point out that HAst-1 could be the predomi-
nating genotype in this study.
Detection and Typing of Enterovirus in Cerebrospinal Fluid 
B. I. Rosen, B. Slater, M. Dupuis, R. Hull, R. Ferrera, C. Huang
New York State Department of Health, Slingerlands, NY
Enteroviruses are the most common cause of acute aseptic
meningitis and meningoencephalitis. Reverse transcription-poly-
merase chain reaction (RT-PCR) assays have recently been devel-
oped for the detection of enterovirus RNA directly from clinical
samples. The primers used in most of these assays are targeted to
conserved sequences within the 5’ noncoding region (5’ NCR) of
the enterovirus genome. Primers targeted to the VP1 sequence of
enteroviruses have facilitated the molecular typing of enterovirus-
es. We have assessed RT-PCR assays with primers targeted to two
genomic regions (5’ NCR and VP1). Cerebrospinal fluid (n =1545)
received at our encephalitis PCR laboratory since July 1997 were
examined. Each clinical sample was assayed for the presence of 11
different viruses, including enterovirus. Primers targeted to the
conserved 5’ NCR of the enterovirus genome were used routinely
for diagnostic detection. PCR products were visualized on agarose
gels stained with ethidium bromide. Amplicons of the expected
size were recovered and sequenced to confirm the identity of the
viruses. A total of 207 cases of enterovirus infections were identi-
fied. Seventy percent of all cases occurred during the months of
August, September, and October. Molecular typing of enterovirus
was performed with degenerate primers targeted to the VP1
region. The sequences of the amplicons were compared with a
database containing the sequences of all 66 human enterovirus
serotypes. Of 83 cases examined for the presence of VP1
sequences, 49 (59.1%) were echovirus 18, 23 (27.7%) were
echovirus 13, 8 (9.6%) were echovirus 30, 2 (2.4%) were echovirus
6, and 1 (1.2%) was coxsackie A9. Our data suggests that (1) RT-
PCR with primers targeted to the enterovirus 5’ NCR region pro-
vides a rapid and sensitive procedure for routine laboratory diag-
nosis of enterovirus infections, and (2) RT-PCR with primers tar-
geted to VP1 provides a useful tool for the identification of
enterovirus. The typing of enteroviruses is important for epidemi-
ologic studies of enterovirus disease outbreaks.
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38 First Encounters with 
New Diseases: The 
Clinician’s Perspective
Monday, March 25, 11:30 a.m.
Regency Ballroom VI/VII
39 Zoonotic Diseases
Monday, March 25, 1:00 p.m.
Centennial Ballroom I
Shared Animal and Human Influenza Viruses: A Role in 
the Next Pandemic? 
K. F. Shortridge
The University of Hong Kong, Hong Kong, HONG KONG SPECIAL
ADMINISTRATIVE REGION OF CHINA.
The H5N1 virus that infected chicken and humans in
Hong Kong in 1997 had poor human-to-human transmissibility.
Would it have given rise to a full-blooded rather than an incipi-
ent pandemic if had it undergone prior reassortment with a pre-
vailing human influenza virus in a pig to acquire the gene(s) that
facilitate this? Does the H5N1 virus still pose a pandemic threat
given the isolation of different genotypes from fatal infections of
chicken in Hong Kong in 2001? Does the H9N2 virus pose a
greater pandemic threat than H5N1 given the isolation in Hong
Kong recently of one lineage from children with influenza-like
illness and another from pigs? The recent isolation of H4N6
virus from pigs with pneumonia in Canada extends the range of
known avian H subtypes isolated from naturally infected pigs.
Could the pig play a consolidating role in a chain of events as a
mixing vessel for the reassortment of avian and human influenza
viruses in the genesis of the next pandemic virus?
The Emergence of Infectious Diseases Among Wildlife and 
the Origin of Human Zoonoses
P. Daszak
Consortium for Conservation Medicine, Palisades, NY
Using the criteria that define emerging infectious diseases
(EIDs) of humans, we can identify a significant group of EIDs
affecting wildlife, many that have caused mass mortality events and
population declines. A key example is chytridiomycosis, a recently
discovered fungal disease of amphibians implicated in global pop-
ulation declines and species extinctions. Our research strongly sug-
gests that the causative agent has been disseminated international-
ly via globalized trade in amphibians. House finch mycoplasmal
conjunctivitis; canine distemper in lions, African wild dogs and
marine mammals, infectious salmon anemia and the majority of
wildlife EIDs have been driven by anthropogenic introduction of
hosts and/or pathogens to new geographic regions (“pathogen pol-
lution”). What can these phenomena teach us about disease emer-
gence in human populations? The majority of human EIDs are
zoonotic, either classically or in the broadest sense due to recent
pathogen evolution following a host jump. The complex multi-host
life cycles of some pathogens and abundance of unknown
pathogens with zoonotic potential presents a serious challenge to
surveillance and prediction of emergence. This requires analysis of
the factors that alter contact and transmission rates between popu-
lations. Our analysis shows that for wildlife EIDs these factors are
almost entirely anthropogenic environmental changes. They
include close parallels of commonly cited drivers of human EIDs
and reflect a historically unprecedented level of interaction
between humans, domestic animals and wildlife. Many are poorly
understood, but clearly have the potential to alter transmission and
contact rates and promote zoonotic emergence. These include
habitat fragmentation, urban sprawl, blocking of wildlife migration
routes, deforestation, encroachment, overfishing and others.
Ecologists and conservation biologists have developed a wealth of
knowledge on the direct impacts of these changes on wildlife pop-
ulations, but have largely ignored their impact on pathogen trans-
mission. We propose that predicting zoonotic emergence will be
possible for some pathogens, but only by a fusion of these
approaches and closer collaboration between disciplines. This inte-
gration requires us to step outside the security of our narrow fields
and tackle complex issues in related disciplines. For medics and
public health researchers, this means understanding ecosystem
processes, conservation biology and wildlife population biology.
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42 Public Health 
Policy/Law
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Centennial Ballroom IV
Legal and Policy Issues To Consider Before a Bioterrorist Attack
R. E. Hoffman
University of Colorado Health Sciences Center, Denver, CO
A bioterrorism attack has the potential to overwhelm pub-
lic health agencies, hospitals, and health care providers, especially
if the bioterrorist agent may be transmitted from person to person.
The response will require coordination among these groups as well
as local, state, and federal political leaders, public information spe-
cialists, emergency managers, public safety workers, law enforce-
ment officials, and mental health workers. The key to an effective
response is assuring that all possible workers and support staff are
given adequate personal protective equipment and organized into
teams of sufficient numbers with efficient communications. To this
end, it is recommended that existing legal authority be reviewed
and revised or drafted as necessary. Consideration should be given
to assessment of emergency public health powers as well as reduc-
tion or elimination of legal obstacles that prevent private entities
and public agencies from working together in a public health crisis
for the welfare of the community. Laws, regulations, executive
orders, and emergency plans should be flexible and not unduly
















use the best laboratory methods, forensic science, and epidemiolo-
gy to adapt rapidly to highly unusual circumstances facing the com-
munity and nation. The response to an attack can be optimized
through detailed planning and training. Issues surrounding the use
of restrictive measures, such as isolation and quarantine, for large
numbers of persons will be discussed. Examples of Colorado
bioterrorism response laws, regulations, and draft executive orders
will be presented.
West Nile Virus in New York City 
W. Lopez
New York City Department of Health, New York, NY
In late August of 1999 a cluster of encephalitis cases was detected
in Queens County, New York City, through the fortuitous combi-
nation of early notification to the City Health Department by a
treating physician and amazing detective work on the part of city
epidemiologists. Quick consultations ensued between the city
Department of Health (CDOH), the state Department of Health
(SDOH) and the federal Centers for Disease Control and
Prevention (CDC), and human specimens were submitted to
them for laboratory analysis. In the days that followed those dis-
cussions were expanded to include the Mayor’s Office of
Emergency Management (OEM), the state Department of
Environmental Conservation (DEC), and the federal
Environmental Protection Agency (EPA). The city responded
immediately by applying larvicide to standing bodies of water and
by spraying the pesticide Malathion in northern Queens by heli-
copter to control adult mosquitoes. A few weeks later the
causative agent was determined to be West Nile virus (WNV), a
type of encephalitis that had never before been transmitted in the
western hemisphere.
New York City’s experience as the epicenter of WNV offers
many lessons for the practitioners of public health and of public
health law. WNV reminds us all of the need to maintain a public
health infrastructure that does not lose sight of the old threats, and
of how they were brought under control, even in the face of new
emerging threats such as bio-terrorism. Nuisance control and
abatement is one of the oldest public health mandates, and one of
the most traditional uses of the police power to protect the public
from the neglect and/or abuse of the individual. WNV requires the
re-engineering, re-invigoration, and also the re-learning, of nui-
sance control practice and of its underlying laws, all in an age of
needed environmental conservation. Indeed, WNV has forced the
public health and environmental governmental establishments to
work together in ways that have sensitized both to the importance
of the other’s role. In the end, the mission of both, as with all of
government, is similar and complimentary; i.e., to provide for the
health, safety and welfare of the public.
Perhaps the most fundamental lesson of the WNV experi-
ence is the reaffirmation of the fact that the public health practi-
tioner, today, cannot implement public health policy and interven-
tions without sound legal advice that is cognizant of not only the
nuances of traditional public health law, but also of the law that
governs kindred agencies. In effect, public health law is broader
and more complicated than in the past. The WNV experience in
New York City shows how closely law intertwines with policy and
programmatic initiatives. Hopefully, it also shows how law, instead
of being an obstacle to sound policy, can be a vehicle that facilitates
a better public health outcome.
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Emergence of Canine Visceral Leishmaniasis in Dogs in 
North America
Z. Duprey1, P. M. Schantz2, F. Steurer2, J. Jackson3, J. Rooney4, E.
Rowton5, M. Gramiccia6, E. Breitschwerdt7
1Division of Parasitic Diseases, NCID, CDC, Atlanta,, GA, 2Division
of Parasitic Diseases, NCID, CDC, Atlanta, GA, 3Walter Reed Army
Institute of Research, Silver Spring, MD, 4Virginia State Department of
Health, Richmond, VA, 5Walter Reed Army Institute of Research,
Washington, D.C., DC, 6Institute of Public Health, Rome, ITALY,
7College of Veterinary Medicine, North Carolina State University,
Raleigh,, NC
Beginning in the late summer of 1999, foxhounds at a hunt
club in Dutchess Co., NY, developed illness with manifestations
that included bleeding, wasting, seizures, hair loss, skin lesions,
kidney failure, and swollen limbs and joints; several dogs died.
Leishmania spp. was isolated from lymph nodes and other tissues
of 15 seropositive dogs. investigation was expanded and screening
of foxhounds in other states has revealed evidence of widespread
infection. Through April, 2001, sera from more than 10,000 fox-
hounds and other hunting dogs throughout North America have
been tested and positive titers were detected in 1.8%. At least one
seropositive dog was detected in 60 different kennels of foxhounds
in 21 U.S. states and 2 Canadian provinces. The organisms isolat-
ed from 40 hounds in multiple states and provinces were typed at
the Institute of Public Health (Rome) and determined to be L.
infantum MON1. The routes of transmission in these dogs remain
unclear. Phlebotomine species exist in most of these areas, how-
ever, vector transmission has not been demonstrated and epi-
demiologic characteristics of the infection do not support vector
transmission. Serotesting of pet dogs (n~600) and wild canids
(n=300), many of them from geographic localities close to infect-
ed foxhounds, have not revealed evidence of infection. Foxhounds
commonly live in close contact with each other and mixing of dogs
from hunt clubs in different states is common; therefore, direct
dog-to-dog transmission may occur. To date there have been no
cases of autochthonous human visceral leishmaniasis reported in
the United States. Investigations are continuing to identify infec-
tions in dogs and other potential hosts, to determine how the
infection is being transmitted, and to determine the potential pub-
lic health significance.
Detection and Genetic Analysis of Swine Hepatitis E Virus in
Farm Waste 
T. L. Cromeans1,2, A. S. Foust1,2, A. E. Fiore1, M. D. Sobsey2, B. P.
Bell1, H. S. Margolis1, B. H. Robertson1
1CDC, Atlanta, GA, 2University of North Carolina, Chapel Hill, NC
Hepatitis E virus (HEV), an unclassified calici-like virus,
was first detected in hepatitis outbreaks caused by gross fecal con-
tamination of water supplies in endemic countries. Increasing evi-
dence suggests that HEV may be a zoonotic agent whose full range
of natural hosts has yet to be defined. Serologic evidence indicates
that antibodies to HEV are present in swine from Australia,
Canada, China, Germany, Korea, Nepal, New Zealand, Taiwan,
Thailand, the United States (US) and Vietnam. Evidence of HEV-
related antibodies have also been reported in rats, rhesus monkeys,
chickens, dogs, sheep, goats, and cattle. The sequences of HEV-
like viruses from swine and chickens have recently been published;
swine virus is closely related to human isolates of HEV, while the
chicken related HEV is genetically different. Swine HEV has pre-
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viously been detected in individual or pooled fecal samples by RT-
PCR. Barn waste that is composed of fecal matter, urine and other
substances and is commonly stored in pits or lagoons, also may con-
tain HEV shed from animals, but sHEV detection in such materi-
al has not been reported. HEV presence in such waste would have
implications for swine waste management systems. We processed 5
liters of liquid barn waste (lagoon-type) collected in the fall of 2000
(2 liters) and in the spring of 2001 (3 liters) from a midwestern
facility in the US for the detection of sHEV. Each one-liter sample
was separated into solid and liquids by a low speed centrifugation.
The liquid fraction was concentrated, extracted, and reconcentrat-
ed to produce ~ 10 ml samples. The solids were re-extracted to
produce two fractions: liquid and solid. Each of these fractions was
processed separately to produce 2 more 10 ml samples, for a total
of three ~10 ml concentrates from each liter of liquid manure.
RNA extracts of the concentrates were analyzed by RT-PCR for
sHEV with primers specific for sHEV from the ORF-2 region of
the genome. All fifteen samples were RT-PCR positive and serial
10-fold dilutions revealed that concentrates averaged ~10 5 per ml.
Sequencing of amplified DNA yielded two different sequences
corresponding to the fall and spring collection times, respectively.
Comparison with available sequences in this HEV ORF 2 region
revealed that these sequences were genotype III. This genotype
contains the previously published swine HEV sequence (US- Sw1,
also from the Midwestern US) and two sequences from sporadic
human cases recently identified in the US. In summary, we have
isolated from liquid swine manure waste two different sequences
of sHEV that are distinct from the other published midwestern
sHEV. The concentration method used will be useful for detection
of sHEV in mixed waste from different barns, farms, or herds.
Enhanced Laboratory-based Surveillance of Shiga Toxin-pro-
ducing Escherichia coli O157, the Netherlands
Y. T. Van Duynhoven, Sr.1, C. M. De Jager1, A. E. Heuvelink, Sr.2,
W. K. Van der Zwaluw1, H. M. Maas1, W. Van Pelt, Sr.1, W. J.
Wannet, Sr.1
1National Institute of Public Health and the Environment, Bilthoven,
NETHERLANDS, 2Inspectorate for Health Protection and Veterinary
Public Health, Zutphen, NETHERLANDS
In January 1999 an enhanced surveillance of Shiga toxin-
producing Escherichia coli (STEC) O157 was implemented in the
Netherlands. All laboratories report positive cases to the public
health services and submit isolates for typing to the reference lab-
oratory. Public health services collect clinical and risk factor infor-
mation of patients. In February 2000, a questionnaire was sent to
all laboratories to assess the criteria for testing, diagnostic tools
used, and participation in the surveillance. Between January 1999
and June 2001, 93 symptomatic cases were reported, 25% aged 0-
4 years. Based on O-, H- and stx-typing, two types dominated:
O157:H7, stx2 (47%) and O157:H-, stx1, stx2 (24%). Distributions
of types were similar for HUS and non-HUS patients. However,
less stx1-positive strains (mainly also stx2-positive) were isolated
from hospitalised cases (30% vs 41% for non-hospitalised cases, not
significant) and urination problems were less often reported by
patients with stx1-positive strains (20% vs 49%, Chi2=4.5, p=0.03).
Pulsed-field gel electrophoresis, using Xba I, showed 17 clusters of
isolates with at least 95% fragments in common. Although several
had a known relationship (mainly household), 13 clusters (also)
included isolates with an unknown epidemiological link. Within 6
clusters, based on the interval between dates of onset of illness, a
common source for the infections was imaginable. Of all patients,
52% reported a known risk factor, such as contact with farm ani-
mals or manure, consumption of raw or undercooked beef, raw
milk, raw-milk cheese or contact with a symptomatic individual.
Compared to data from control persons from a general practice-
based study on gastroenteritis, especially contact with farm animals
(manure) was reported clearly more often by STEC patients (21%
vs 7%), suggesting that this might be an important risk factor for
STEC O157 in our country. For a 1-year old boy, this could be con-
firmed: indistinguishable PFGE patterns were obtained for isolates
from the boy and goats at the petting zoo that he visited. Response
to the laboratory survey was high (97%). Ninety-five percent of lab-
oratories tested for STEC O157. The majority (88%) used culture
on (CT-)SMAC as detection method. Confirmation was primarily
performed with commercially available latex agglutination assays
(95% of laboratories) and biochemical characterisation with the
API 20E test (42%). Most laboratories (92%) used selection crite-
ria for testing: bloody diarrhoea and other clinical information were
reported by 81% of laboratories and young age by 10%. It is con-
cluded that STEC O157 seems a limited public health problem in
the Netherlands. However, testing is mainly performed selectively
using clinical and age criteria. PFGE results suggest that small
clusters regularly occur, but often go unnoticed. Molecular typing
is a useful tool for cluster identification in routine surveillance.
Outbreaks of Multidrug-Resistant Salmonella Serotype
Typhimurium Infections Associated with Small Animal Veterinary
Facilities in Idaho, Minnesota and Washington, 1999 
J. G. Wright1, K. E. Smith2, L. Tengelsen3, J. Grendon4, D. Boxrud2,
B. Holland1, A. D. Anderson1
1Centers for Disease Control and Prevention, Atlanta, GA, 2Minnesota
Department of Health, Minneapolis, MN, 3Idaho Department of
Health and Welfare, Boise, ID, 4Washington State Department of
Health, Olympia, WA
Background: An estimated 1.4 million persons are infect-
ed with Salmonella annually in the United States. While the major-
ity of these infections are acquired from eating contaminated
foods, Salmonella also is transmitted through contaminated water
and contact with reptiles, farm animals, and pets. Outbreaks of
human Salmonella infections associated with veterinary facilities
have been infrequently reported and most such outbreaks
occurred in large animal (e.g., cattle, horses) facilities. Outbreaks
associated with small animal (e.g., dog, cat) facilities are rare.
Methods: Routine laboratory-based Salmonella surveillance was
conducted in Idaho, Minnesota, and Washington; clinical laborato-
ries forwarded Salmonella isolates to the state public health labo-
ratories for serotyping. Field investigations were conducted by the
state health departments. Selected Salmonella isolates were for-
warded to CDC for phage typing and antimicrobial susceptibility
to 17 antimicrobial agents using broth microdilution (Sensititre®).
Selected Salmonella isolates from the state veterinary diagnostic
laboratory in Minnesota also were forwarded to the state public
health laboratory for pulsed-field gel electrophoresis (PFGE).
Results: In 1999, outbreaks of Salmonella serotype Typhimurium
associated with small animal veterinary facilities were reported in
Idaho, Minnesota, and Washington. In Idaho, 10 of 20 employees
of a veterinary clinic became ill after employees cared for kittens ill
with diarrhea; ill employees reported no other common exposures.
Specimens were not collected from the kittens, but stool speci-
mens from five ill persons yielded S. Typhimurium resistant to
ampicillin, chloramphenicol, sulfonamides, streptomycin and tetra-
cycline (R-type ACSSuT). In Minnesota, S. Typhimurium DT104
R-type ACSSuT was isolated from 9 cats at an animal shelter that
died from enteritis. These isolates were indistinguishable by PFGE
from isolates from 7 ill persons, 6 of whom reported a connection
with the animal shelter. In Washington, S. Typhimurium DT104 R-
type ACSSuT was isolated from three ill employees or clients of a
veterinary facility. Specimens from 14 cats associated with the facil-
ity also yielded S. Typhimurium DT104 R-type ACSSuT.
Conclusion: Three states reported outbreaks of multidrug-resist-
ant S. Typhimurium infections among employees or clients of small
animal facilities. In each facility, employee or client illness followed
illness in animals. These outbreaks demonstrate the need for
increased hygiene within small animal facilities and at home, espe-
















An Outbreak of Salmonella Javiana Associated with
Amphibian Contact – Mississippi, 2001 
P. Srikantiah1, J. C. Lay1, J. A. Crump1, S. Hand2, J. Campbell2, V.
Janakiraman1, H. Fletemier1, R. Middendorf1, S. Van Duyne1, M.
Currier2, P. S. Mead1, K. Molbak1
1CDC, Atlanta, GA, 2Mississippi State Department of Health, 
Jackson, MS
Background: Although Salmonella Javiana is the fifth most
commonly isolated Salmonella serotype among humans in the
United States, the risk factors and sources for infection are largely
unknown. Infection with S. Javiana occurs primarily in infants and
young children and appears to be restricted to specific geographic
regions of the country. During the summer of 2001, an outbreak of
S. Javiana infections occurred among young children in greater
Jackson, Mississippi, providing an opportunity to examine risk fac-
tors for infection. Methods: We conducted a case-control study to
identify risk factors for infection. We defined a case as infection
with S. Javiana between August and September 2001 in a
Mississippi resident. Two age-and county- matched controls per
case were randomly selected from the Mississippi state birth reg-
istry and through sequential digit dialing. Pulsed-field gel elec-
trophoresis (PFGE) was performed on all S. Javiana isolates from
stool cultures. Results: We enrolled 55 case patients and 109 con-
trols. Among patients, thirty-three (58%) were female and the
median age was 24 months (range 3 months to 70 years).
Symptoms included fever (85.5%), abdominal pain (82.6%), and
bloody diarrhea (44%). The median duration of illness was 7 days.
Nine (16.4%) patients were hospitalized; none died. Molecular
subtyping of 51 isolates yielded 18 distinct PFGE patterns, sug-
gesting multiple sources of infection. The most common pattern
was found in 20 (39%) isolates. Thirty-two (58%) case-patients
reported exposure to amphibians (frogs, toads and turtles), defined
as owning an amphibian, touching an amphibian, or seeing an
amphibian on one’s property, compared with 32 (31%) controls
(matched odds ratio 3.3, p=0.003). In addition, consumption of
watermelon was associated with S. Javiana infection, but the fre-
quency of this exposure was low and could only account for six
(12%) infections. Conclusions: Amphibians may be a reservoir for
S. Javiana. In our study, contact with amphibians and and their
environments was a risk factor for infection. Such exposures may
be more common among toddlers, who are likely to have increased
hand to floor contact, potentially explaining why S. Javiana dispro-
portionately affects young children. Interestingly, the geographic
distribution of certain amphibian species mimics that of S. Javiana
infection; both cluster in the Southeastern United States. Public
health officials should promote proper hand washing after contact
with amphibians to decrease the risk of infection with S. Javiana.
Outbreaks of Salmonellosis at Elementary Schools Associated
with Dissection of Owl Pellets 
F. Anderson1, C. Medus2, F. Leano2, J. Adams2, K. Smith2
1Washington County Department of Public Health and Environment,
Stillwater, MN, 2Minnesota Department of Health, Minneapolis, MN
Background: On May 22, 2001 the Washington County
Department of Public Health and Environment (WCDPHE)
received reports from two physicians of children from the same
elementary school with acute febrile gastroenteritis. Symptoms
included high fevers and bloody stools, and Salmonella had report-
edly been cultured from the stool of one child. The school nurse
reported high absenteeism rates during the same week. Methods:
Staff from the WCDPHE and Minnesota Department of Health
interviewed students from the elementary school about illness his-
tory, meals at school, and school-related activities. Food service at
the school was evaluated. A case was defined as a school attendee
who developed diarrhea (≥3 stools in a 24-hour period) and fever
on or after May 14. Animals and animal materials used in school
activities were cultured. Salmonella isolates were subtyped by
pulsed-field gel electrophoresis (PFGE). Results: Of 352 stu-
dents, 205 (58%) were interviewed. Of students interviewed, 39
(19%) met the case definition. Salmonella Typhimurium was cul-
tured from the stool of 27 cases; all but one isolate had an indistin-
guishable PFGE pattern (designated TM353). Dates of illness
onset ranged from May 17 to May 25. Illness was associated with
being a member of the science club (odds ratio [OR], 38.0; 95%
confidence interval [CI], 5.0-308; p<0.001) and being a member of
the after-school latchkey program (OR, 7.0; 95% CI, 3.0-17.0;
p<0.001). On May 16, science club members dissected owl pellets
(i.e., regurgitated indigestible fur, bones, from a recent meal) on a
table in the school’s cafeteria. Concurrently, the latchkey program
was being held in the cafeteria. The same table was used for snacks
for the latchkey children following science club and for lunch the
next day before it was sanitized. Subsequent to this outbreak, an
outbreak was identified among science club members at a second
elementary school. In this outbreak, seven of nine students became
ill after dissecting owl pellets on May 24; S. Typhimurium TM353
was recovered from six of these students. The pellets in both out-
breaks originated from a single barred owl that was housed at a
local nature center. Cultures of left over pellets and fresh feces
from the owl yielded S. Typhimurium TM353. The owl shed S.
Typhimurium in its feces for at least 4 months (when culturing was
discontinued). Prior to the outbreaks, the owl’s diet consisted of
mice and chicks from commercial sources; TM353 was recovered
from all four chicks left over from the shipment used to feed the
owl prior to and during the outbreaks. Conclusions: These are the
first reported outbreaks of salmonellosis due to contact with owl
pellets. As with all animal-derived materials, handling of owl pel-
lets should be followed by sanitation of contact surfaces and thor-
ough hand washing. Sterilized owl pellets for use in educational
activities can be obtained from commercial sources.
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Public Health Laboratory Response to an Anthrax Incident 
in Connecticut 
D. Barden, T. Brennan, G. Budnick, E. Gaynor, A. Kinney, D. R.
Mayo, M. Ridley, K. Kelley
CT State Health Department, Hartford, CT
In mid-November of 2001, a case of anthrax was confirmed
in a 94-year-old woman in Connecticut. The Connecticut
Department of Public Health (DPH) laboratory had been process-
ing various kinds of specimens up to that point but the number of
specimens processed, the urgency to produce results and the
demand for data increased dramatically after the incident. The
Bio-Response Action Team (BRATs, a volunteer group of microbi-
ologists) was fully activated along with considerable administrative
support. We will present our practical experience as well as data on
the numbers, variety and temporal distribution of the greater than
2100 specimens we have processed to date as well as descriptive
information on the technical changes that were made in the labo-
ratory to accommodate the changing demands. We hope that this
information will help other state health laboratories to better pre-
pare for a similar incident
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Rapid Molecular Identification of B. anthracis in New York
State in Response to Recent Bioterrorism Incidents 
K. Musser, M. Kelly, S. Davis, C. Egan, N. Dumas, A. Waring, T.
Halse, P. Maupin, K. Hechemy, J. Hibbs, D. Morse, R. Limberger
New York State Department of Health, Albany, NY
In the three years prior to September 11th, 2001, the NYS-
DOH received and tested an average of six suspect bioterrorism
specimens a year for Bacillus anthracis. From September 11th
until December 14th, 850 specimens were received for Bacillus
anthracis testing. Our response plan to this crisis included modifi-
cations to our existing protocols as well as the decision to use ger-
mination followed by the polymerase chain reaction (PCR) as the
primary method for detection of B. anthracis and culture as a con-
firmatory method. Three separate PCR assays were developed
which required prior assessment of sensitivity, specificity, as well as
overcoming potential PCR inhibitors often found in environmental
samples. We found that our PCR assays can detect <25 bacteria
and have 100% specificity when tested against Bacillus spp., and
other non-Bacillus bacteria. Analysis of past bioterrorism speci-
mens revealed that a significant number of samples contained
inhibitors to PCR which necessitated methods to inactivate
inhibitors in environmental specimens. A total of 26 substances
were analyzed for PCR inhibition including common household
powders, laboratory agents, soil, blood samples, several envelope
types, photographs, and past bioterrorism samples. The majority of
PCR inhibitors were removed by a DNA extraction together with
a modification of the components of the PCR reaction mix. When
tested on biothreat samples, only 30 of the 838 specimens contain-
ing PCR inhibitors that were not removed. The samples that
demonstrated persistent inhibition in PCR assays as well as PCR-
positive samples were cultured. An integral part of our identifica-
tion/confirmation scheme for B. anthracis includes phage sensitiv-
ity and direct fluorescent antibody of both the cell wall and cap-
sule. Of the 850 specimens received, 838 were processed; 778 were
negative by PCR and 47 were negative by culture for B. anthracis.
Additionally, 11 samples were positive by both PCR and culture,
one sample was positive by PCR but negative by culture, and one
sample was negative by PCR and positive by culture, with only one
colony of B. anthracis isolated. The new streamlined protocol has
improved our turn-around time for ruling out B. anthracis from
two to five days before this crisis to our current 7-18 hours. The
current protocol also can now accommodate close to 200 speci-
mens per day if necessary whereas previous methodology limited
our laboratory capacity to testing 5 specimens per day. We are also
working on incorporating new CDC-developed ABI Prism 7700
and Smart Cycler assays that should further increase capacity
and/or decrease turn-around time. This experience demonstrates
the need to build a strong public health infrastructure in order to
increase laboratory surge capacity as well as advanced training to
deal with the increasing threat of bioterrorism events.
Laboratory Response in the Commonwealth of Virginia to the
Intentional Release of Bacillus anthracis
D. A. Pettit, J. V. Carroll, E. M. Basinger, M. R. Ettinger, S. S.
Walker, T. L. York, J. L. Pearson
Division of Consolidated Laboratory Services, Richmond, VA
The intentional release of Bacillus anthracis in the United
States has resulted in increased laboratory testing to identify and
confirm the presence or absence of B. anthracis in clinical speci-
mens and environmental samples. To address an unprecedented
demand to process, test and store a large number of potentially
infectious legal samples, the Division of Consolidated Laboratory
Services (DCLS) in the Commonwealth of Virginia, rapidly
reviewed and revised protocols for sample collection, transport,
submission, chain-of-custody, triage, and evidence storage and
retrieval. Pathways to establish communication of test results to
law enforcement and local public health departments were rede-
fined. The Laboratory Response Network (LRN) protocols,
reagents, and control organisms, were used to process over 800
samples consisting of 127 clinical samples, 614 suspicious mail
items and/or powders, and 84 other environmental samples. Three
of 47 clinical isolates submitted for confirmation were positive for
B. anthracis, as determined by gamma phage lysis, M’Fadyean
staining, and direct fluorescent antibody tests for B. anthracis cell
wall-associated polysaccharide and capsule. In addition, B.
anthracis specific DNA was amplified from these isolates using
three independent real time polymerase chain reactions. No B.
anthracis colonies were obtained from environmental samples sub-
mitted for testing. However, 101 isolates containing gram positive
rods with characteristics that were morphologically indistinguish-
able from B. anthracis on sheep blood agar plates were detected.
All of these isolates were non-hemolytic and 78% were non-motile.
None of the 101 isolates exhibited gamma phage lysis and all iso-
lates requiring further characterization were negative by direct flu-
orescent antibody tests for B. anthracis cell wall-associated poly-
saccharide and/or capsule and real time PCR for B. anthracis.
Further characterization of B. anthracis-like colonies is on going.
Spores were detected by malachite green staining in six letters that
contained a visible powder. Cultures of the powder yielded beta-
hemolytic, motile, gram positive rods that were further character-
ized as being in the B. cereus group. These activities allowed
DCLS to process high volumes of samples in an accurate and time-
ly manner.
Monitoring of Human Exposure to Bacillus thuringiensis after
Aerial Applications for Insect Control
D. B. Levin, G. V. de Amorim
University of Victoria, Victoria, BC, CANADA
Aerial applications of Foray 48B, which contains Bacillus
thuringiensis (Bt) strain HD1 (Btk HD1), were carried out on May
09-10, May 19-21, and June 08-09, 1999 to control European gypsy
moth, Lymantria dispar, populations in Victoria, British Columbia,
Canada. An assessment of the health impact of Btk was conducted
by the Office of the Medical Health Officer of the Capital Health
Region, during this period. Environmental (air and water) and
human (nasal swab) samples, collected before and after aerial
applications of Foray 48B, both in the spray zone and outside of the
spray zone, were analyzed for the presence of Btk HD1-like bacte-
ria. Random Amplified Polymorphic DNA (RAPD) analysis, cry
gene specific polymerase chain reaction (PCR), and Dot-blot DNA
hybridization techniques were used to screen over 11,000 isolates
of bacteria. We identified bacteria with genetic patterns consistent
with those of Btk HD1 in 9,102 of 10,659 (85.4%) isolates obtained
from the air samples, 13 of 440 (2.9%) isolates obtained from the
water samples, and 131 of 171 (76.6%) isolates from the nasal swab
samples. These analyses suggest that bacteria applied from air-
planes over urban areas result in both extensive environmental
contamination and human exposure, even if individuals are in
doors at the time of the application.
Threat Letter Menace: The Fiji Experience 
K. Kishore1, E. Buadromo2, S. Singh2
1Fiji School of Medicine, Suva, FIJI, 2Colonial War Memorial
Hospital, Suva, FIJI
Objective: To process and identify the suspected material
sent in threat letters to embassies and other local offices.
Methods: Pathology laboratories at the CWM hospital
serves as the referral laboratory for the country. Microbiology lab
processes the routine diagnostic specimens it receives from the
hospital. It also provides its services to the police for its forensic
investigations. Threat letters were sent to embassies, government
offices, and offices of the prominent citizens. They were reported
to police, who cordoned off the premises, obtained the specimens
















biology lab for identification, and sealed the office where these let-
ters were opened. Microbiology lab processed these specimens,
identified them with available lab resources, and advised the police
accordingly. Offices where these letters were opened remained
sealed during this period.
Results: A total of 11 specimens were sent to lab for pro-
cessing. First of these was sent to an embassy, and the letter origi-
nated from overseas. Rests all sent to local offices and persons and
were sent locally. All of these contained white powder, which
immediately drew the suspicion of possible anthrax spores. They
were processed as per CDC guidelines, and other reference text-
books. Microbact TM, API 20 E TM and API 50 CH TM were
used for confirmation for their identity. None of them were found
to be containing spores of B. anthracis.
Conclusions: Following the events of September 11 in
USA and subsequent anthrax scare, similar tactics was used for
creating panic and confusion among the people. Although possibly
of anthrax spores sent to any one remained a remote possibility, is
succeeded in creating a sense of apprehension, scare, and height-
ened state of alert. It also resulted in enormous waste in terms of
work hours for the offices where these were sent, and extra bur-
den in lab processing, resulting in resource drains on facility of
limited resources.
Enhanced Emergency Department Surveillance System
Following the World Trade Disaster – New York City,
September 14 to October 10, 2001 
D. Das1, D. Weiss1, S. Balter1, T. Treadwell2, J. McQuiston2, L.
Hutwagner2, A. Karpati2,1, F. Mostashari1, K. Bornschlegel1, B.
Cherry1, S. Mathew2, A. Fine1, M. Layton1
1New York City Department of Health, New York, NY, 2Centers for
Disease Control and Prevention, Atlanta, GA
Background: After the events of September 11, 2001, the
NYCDOH was under a heightened alert status for bioterrorist
attacks in the city. As a result, an Emergency Department (ED)
syndromic surveillance system was implemented with the assis-
tance of CDC to monitor for an increase in disease syndromes that
might represent a bioterrorist event. The system included the
largest deployment of Epidemic Intelligence Service Officers in
CDC history. Methods: From September 13th - 29th, CDC staff
were stationed at 15 sentinel EDs on a 24-hour basis (“full
staffing”) and between September 30th and October 10th sta-
tioned at 12 EDs on an 18-hour basis due to resource limitations
(“part staffing”). A standardized form was used to classify each visit
into one of 12 distinct syndrome categories and to obtain demo-
graphics. Six of these syndrome categories represented prodromal
manifestations of illness that may be caused by bioterrorist agents.
Visits were classified by the ED physician, nurse, or EIS officers
and based on discharge diagnosis and data was entered on-site.
Data and ED census numbers were transferred to the NYCDOH
every 24 hours. Data was analyzed daily for individual hospital and
geographically-based statistical increases (“alarms”) by syndrome.
Retrospective analysis of the data was completed using SAS 8.0 to
detect trends of syndromes and differences in reporting between
coverage hours. Results: The NYCDOH received daily reports
from 12 EDs during the entire surveillance period. Comparison of
total visits recorded with ED census data indicated 85% of visits
were recorded during “full staffing” while 75% of visits were
recorded during “part staffing” (µ2=997, p<0.0001). Statistical
“alarms” occurred 16 times with an “alarm” size of 2 to 105 visits.
Each “alarm” was investigated by chart review through on-site
CDC staff and no infectious disease outbreaks were detected. Of
the total visits classified, 12.8% of visits were trauma related, 5.5%
were related to exacerbation of an underlying respiratory condi-
tion, and 1.5% were associated with an unexplained death with his-
tory of fever. All other syndromes accounted for less than 1% of all
ED visits. Conclusions: Daily analysis of the ED visits provided
the opportunity for timely detection of increases in clinical syn-
dromes citywide. On-site CDC staff promptly investigated statisti-
cal “alarms”. The system was sensitive, detecting small increases in
syndromes, but required 53 to 83 full-time staff to function opti-
mally. The usefulness of implementing this type of surveillance in
response to a high profile event should be further evaluated to
assess the validity of syndromic coding and the timeliness of
“alarm” investigations.
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Failure to Detect C. pneumoniae in Atherosclerotic Specimens
from Major Arteries of 93 Patients
J. Bishara1, S. Pitlik1, A. Vojdani2, A. Kazakov1, G. Sahar1, M.
Haddad1, S. Rosenberg3, Z. Samra3
1Rabin Medical Center; Beilinson Campus, Petach-Tikva, ISRAEL,
2Immunosciences Lab, Inc., Drew University School of Medicine and
Science, Los Angeles, CA, 3Chlamydia and Mycoplasma National
Center, Department of Microbiology. Rabin Medical Center, Beilinson
Campus, Petach-Tikva, ISRAEL
Background: Seroepidemiological studies have indicated a
possible association between chronic Chlamydia pneumoniae (Cp)
infection and atherosclerosis. Several studies, using different diag-
nostic methods have demonstrated Cp or its components in ather-
osclerotic lesions. Interestingly, these findings have not been con-
firmed by all researchers. Methods and Results: Punch speci-
mens of the aortic wall of 61 patients undergoing coronary-aortic
bypass graft, and carotid atheromas of 32 patients undergoing
carotid endarterectomy, were examined for Cp by cell culture
(HEp-2 cells), and two PCR assays in two different laboratories.
Anti Cp IgG antibodies were found by MIF and ELISA in 67.5%
and 55.4% of patients’ serum specimens; IgA in 22.7%, and 35%
respectively. Anti Cp IgM was found in one patient only. All cul-
tures and PCR tests for Cp were negative. Conclusions: In our
study population, we found no evidence that Cp exists within
atheromatous arteries. The speculated association between Cp
infection and atherosclerosis remains controversial and warrants
further investigation
Prevalence of Hepatitis C and other Chronic Liver Disease
Etiologies in Primary Care Practices 
T. St. Louis1, V. Navarro1, A. Sofair1, B. Bell2
1Connecticut Emerging Infections Program, New Haven, CT, 2Centers
for Disease Control and Prevention, Atlanta, GA
Background: Little is known of the prevalence of chronic
liver disease (CLD) in general, and hepatitis C in particular, in pri-
mary care patient populations. We conducted a cross-sectional
study among primary care practices in Waterbury, CT to estimate
CLD prevalence and its attributable causes among patients seek-
ing primary care and to explore primary care practitioners’ (PCPs)
CLD-diagnosis documentation and referral habits. Methods: All
46 PCPs located within the Waterbury city limits were invited to
participate. Patient charts were selected from each participating
practice’s active patient roster according to a simple weighted, ran-
dom sampling scheme. Demographic and clinical data, substance
use history, diagnosis of CLD, and referrals to gastroenterologists
were recorded. A diagnosis of CLD was assigned using standard
definitions for probable and possible CLD. Standard criteria were
used to assign CLD etiologies where appropriate. Results: Of the
46 Waterbury PCPs, 31 (67%) participated, comprising 11 prac-
tices (7 group, 4 solo). A total of 1,610 charts (range 65-608 per
practice) were screened. The median patient age was 42 years
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(range 18-96); 39% were male. A total of 60 patients met our defi-
nition for CLD, making the overall prevalence in our sample 3.7%
(95% CI: 2.8-4.7%). The age, gender, and racial distributions of
CLD cases were similar to the remaining 1,550 screened patients.
Sufficient clinical data were available to assign an etiology for CLD
in 38 (63%) cases. Of these, 18 (30%) had fatty liver and 15 (25%)
had hepatitis C. Hepatitis B, alcohol-related liver disease, autoim-
mune hepatitis, hemochromatosis, and primary hepatic malignant
disease each accounted for 2%. Of the 28 (47%) patients docu-
mented as having CLD by the PCPs, 12 (43%) were referred to
gastroenterologists in a median period of 14 months after diagno-
sis (range 0-64 months). Hepatitis C was the most common etiolo-
gy for which CLD patients were referred to gastroenterologists (6,
50%). Of the 48 patients who were not referred to gastroenterolo-
gists, 17 (35%) had fatty liver and 9 (19%) had hepatitis C.
Conclusions: In our study of a primary care patient population,
we found a CLD prevalence of 3.7% and 0.9% of patients had rec-
ognized hepatitis C. However, these figures most likely reflect min-
imum estimates because not all patient charts contained sufficient
clinical information to determine if a CLD diagnosis was appropri-
ate, including testing for chronic hepatitis C virus infection. Fatty
liver and hepatitis C were the most common etiologies for CLD.
More than half of CLD cases were not documented as such or
referred by the PCP, indicating the possibility of under-diagnosis
and limitations in access to subspecialized care for CLD patients.
This is especially important in cases of hepatitis C, where curative
therapy is available.
Intestinal Anaerobic Bacteria in Early Rheumatoid Arthritis 
R. Manninen1, S. Vartiainen1, J. Jalava1, R. Luukkainen2, T. Möttönen3,
E. Eerola1, P. Toivanen1
1Department of Medical Microbiology, Turku University, Turku, FIN-
LAND, 2Satalinna Hospital, Harjavalta, FINLAND, 3Division of
Rheumatology, Department of Medicine, Turku University Central
Hospital, Turku, FINLAND
The etiology of rheumatoid arthritis (RA) has remained
unknown. Recently, increasing attention has been paid to the nor-
mal intestinal flora as a potential source of etiological agents.
Clinical studies have indicated that changes in the intestinal flora,
due to fasting or diet, may accompany reduction of disease activity
in RA. Changes in the flora reflect improvement of the patients
when they are divided into high and low-responders. Based on
analysis of bacterial fatty acids, evidence has been presented that
composition of the intestinal flora in the early RA is different from
that of non-RA controls. The difference was due primarily to
anaerobic bacterial species. The present study was designed to
compare the fecal microbiota of the patients with early RA with the
microbiota of the control patients using 16S rRNA oligonucleotide
probes, detecting a variety of anaerobic bacteria in the normal
intestinal flora. Fecal samples of 25 early, disease modifying
antirheumatic drugs naive RA patients and 23 control patients suf-
fering from non-inflammatory pain were investigated. The contri-
bution of five bacterial groups was determined by using whole cell
hybridization with seven fluorescently labeled 16S rRNA-targeted
oligonucleotide probes. These probes cover one third to a half of
the total bacteria in the human intestine. Patients with early RA
had significantly less bacteria belonging to the Bacteroides,
Prevotella and Porphyromonas genera than the controls (4.7% vs.
9.5%, p=0.00005). The finding was confirmed with a probe specif-
ic for bacteria of the Bacteroides fragilis group (1.6% vs. 2.6%,
p=0.02). The samples of RA patients and the controls did not dif-
fer significantly when five other oligonucleotide probes were
applied. They were detecting bacteria in the genera Atobium,
Coriobacterium, Collinsella, Bifidobacterium and Fusobacterium,
and in the Eubacterium rectale-Clostridium coccoides group. We
conclude that the content of anaerobic bacteria in the intestinal
flora of the patients with early RA is significantly different com-
pared with the controls. The number of bacteria belonging to the
Bacteroides-Prevotella-Porphyromonas group was, on the average,
in RA patients only half that of the controls. If this finding can be
confirmed, together with a recent suggestion that certain
Bacteroides species are required for fortification of the barrier
function in the intestinal epithelium, it adds further evidence to
the hypothesis that intestinal bacterial flora plays a role in the
etiopathogenesis of RA.
Postdiarrheal Hemolytic Uremic Syndrome in New York State 
B. Tserenpuntsag, H. H. Chang, M. Kacica, P. F. Smith, D. L. Morse
New York State Department of Health, Albany, NY
Objectives: To estimate the number of Hemolytic Uremic
Syndrome (HUS) cases in New York State exclusive New York
City; to assess the sensitivity of the Communicable Disease
Surveillance System in New York State for HUS; and to describe
the epidemiologic and clinical features of HUS cases. Methods
and Materials: Medical records for patients with HUS as a pri-
mary or any secondary discharge diagnosis (ICD-9-CM code
283.11) from the Statewide Planning and Research Cooperative
System (SPARCS) between January 1998 and December 1999
were reviewed and matched with the postdiarrheal HUS cases that
were reported to the Communicable Disease Surveillance System
for the same period. Capture- recapture method was used to esti-
mate the total number of postdiarrheal HUS cases and to evaluate
the sensitivity of HUS reporting to the surveillance system. Cases
identified in SPARCS were matched to the surveillance cases by
last name and date of birth. Data abstracted from medical records
were analyzed to describe the epidemiologic and clinical charac-
teristics of HUS patients. Results: From January 1998 to
December 1999, a total of 36 confirmed postdiarrheal HUS cases
were reported to the surveillance system. From 246 discharges
coded as HUS in SPARCS, 54 cases were identified as confirmed
postdiarrheal HUS after chart review. The estimated total number
of reportable HUS cases in 1998-99 was 65 (95% CI: 59, 70) and
the surveillance sensitivity was 55% (39% in 1998 and 67% in
1999). From the medical record review of the 54 confirmed cases,
the highest rate of HUS was observed among children in the 3-10
year age group with a rate of 1.4 per 100,000. Females were more
likely to develop HUS than males (RR=2.0, 95% CI: 1.0, 4.0). The
median length of hospital stay was 11 days. Death occurred in 5
(8%) cases. 93% of the cases had an acute or bloody diarrhea (75%
of them bloody). Stool samples were tested for any pathogen in
84% of the patients and E. coli was isolated in 68% of the tested
samples. Renal dysfunction was present with protein- or hematuria
in 50 (79%). The mean serum creatinine was 4.2 mg/dl, and mean
blood urea nitrogen (BUN) was 74 mg/dl. Thrombocytopenia
(platelet <150,000/ml) was present in 90% of the patients, and 76%
had hemolytic anemia with microangiopathic changes on peripher-
al blood smear. Hemodialysis was necessary for 30% of the cases
and anemia was treated with blood transfusion in 60% of the cases.
Conclusions: The 55% sensitivity of the communicable disease
surveillance system for HUS indicates that the incidence of disease
is higher than suggested by the number of HUS reports received.
Since HUS is a leading complication of E. Coli 0157:H7 infection,

















Outbreak of Cryptococcus neoformans var. gattii in a
Restricted Zone in British Columbia 
M. Starr1, M. Fyfe1, W. Black1, P. Kibsey2, L. MacDougall1, S. Mak1,
M. Pearce3, J. Isaac-Renton1, M. Romney1, L. Stein1, C. Stephen4, D.
Patrick1
1University of British Columbia Centre for Disease Control, Vancouver,
BC, CANADA, 2Victoria General Hospital, Victoria, BC, CANADA,
3Capital Health Region, Victoria, BC, CANADA, 4Centre for Coastal
Health, Nanaimo, BC, CANADA
Background: Cryptococcus neoformans var. gattii (CNVG)
is a human and animal pathogen which is distinct from the more
common C. neoformans var. neoformans (CNVN). It more com-
monly causes disease in immunocompetent individuals. The preva-
lence of CNVG has been shown to be highest in geographically
restricted areas in tropical and subtropical regions. The incidence of
CNVG in endemic areas like Australia is approximately 1 case per
million per year. A specific association between CNVG and partic-
ular species of eucalyptus trees has been identified. Infection has
not been known to be endemic in Canada, where there are few
eucalypts. Moreover, an outbreak of CNVG infection has not previ-
ously been described. Since January 1999, 38 patients with crypto-
coccal disease have been identified on the east coast of Vancouver
Island, giving an estimated incidence of 27 cases per million per
year. Methods: Clinical histories for the 38 patients with pul-
monary disease or meningitis due to CN were reviewed over the
past 36 months. Epidemiological features were collected and ana-
lyzed for each case. Microbiological isolates were retrieved and clas-
sified as CNVG or CNVN by serological methods. Geographic
Information Systems (GIS) technology was used to map the distri-
bution of cases. Environmental samples were collected from the
gardens of the cases’ homes as well as the surrounding areas.
Results: All of the patients in the outbreak were diagnosed with
laboratory confirmed (culture and/or histopathology) cryptococcal
lung disease and/or meningitis. Of the 38 cases, 64% had no evi-
dence of underlying immunodeficiency per se, although 25% were
taking steroids in doses exceeding 20mg per day. 82% were smok-
ers. None of the patients were HIV positive. Of the 15 microbio-
logical isolates, 14 were identified as CNVG, and one as CNVN.
GIS mapping revealed a distribution of cases confined to a single
biogeoclimatic zone. Environmental samples have not yielded a
source for the outbreak as yet. Conclusions: We report the emer-
gence of CNVG disease in a temperate region not previously known
to harbour this fungus. This unique outbreak of cryptococcosis in
predominantly immunocompetent hosts and companion animals
allows for further elucidation of the epidemiology of CN infections.
A seroepidemiological case-control study examining possible expo-
sures and reservoirs, molecular typing of the clinical isolates, and an
investigation into animal cases are all ongoing.
Tuberculosis Gene Deletion Typing, Not YATM ("Yet Another
Typing Method") 
Y. Goguet
Stanford University, Stanford, CA
Yves-Olivier Goguet de la Salmonière, Charlie Kim, Mary Sloan
Siegrist and Peter Small
Molecular epidemiology is useful in assisting classical epi-
demiology. It allows better outbreak tracking, understanding of
transmission dynamics, and helps tuberculosis management such
as cross-laboratory contamination investigation or hospital organi-
zation improvements. Many different typing methods for M. tuber-
culosis exist, but few are frequently used. RFLP typing with the
IS6110 marker remains the gold standard; although it is time con-
suming. Spoligotyping is also appreciated for its simplicity, rapidity
and discriminatory power for some strains.
Recently, a new approach for genetically analyzing strains
has been developed using a whole genome microarray for detect-
ing genomic deletions (Kato-Maeda et al., 2001, 11:547-554). This
technique has now been applied to over 100 strains of MTB, but
cannot be applied for large typing studies because of the prohibi-
tive cost and the technical complexity of this approach. So far, more
than fifty different DNA deletions have been detected by hybridiz-
ing DNA from clinical strains with the “DNA chip,” representing
the genome of H37Rv. More deletions will be identified as more
strains are analyzed. By using the deletions detected as markers in
a reverse line blotting method, we created a new typing method
that is both straightforward and inexpensive, even affordable for
some developping countries. This approach will be easily standard-
ized, encouraging international collaborations. We have developed
MTB membranes that can interrogate 43 of these regions simulta-
neously. Preliminary data suggest that this simple reproducible
method promises to be helpful for different typing purposes while
also providing biological information. Given the nature of the
markers used, it will yield reliable phylogenetic information. In
addition this technique generates information about genome genes
content that provides a new way of correlating genotype with the
biological properties of individual strains.
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Outbreak of Viral Gastroenteritis and an Ill Baker Who 
Should Have Known Better: Novel Application of Email for
Rapid Investigation 
M. Widdowson1, M. A. de Wit2, H. Vennema2, M. Koopmans2
1Centers for Disease Control, Atlanta, GA, 2National Institute of
Public Health and the Environment, Bilthoven, NETHERLANDS
Introduction: On 18 January 2001, a Dutch municipal
health authority received a report that more than 200 of about 850
government staff developed vomiting and diarrhea within 24 hours
of a reception in a restaurant. An investigation was conducted to
determine the source of the outbreak and to implement control
measures. Methods: The restaurant provided a food list and infor-
mation about restaurant staff who were ill. Food-inspection service
staff visited the kitchens, took food samples, and implemented gen-
eral hygiene measures. Fecal samples were requested from both
restaurant and government staff who became ill. An electronic
questionnaire was emailed to all government employees to ascer-
tain the number who became ill and the foods they had consumed.
A case was defined as an employee attending the reception who
developed vomiting or diarrhea (>2 times/24h) within 72 hours.
Data on returned questionnaires were analyzed as a case-control
study. Results: Of 550 (response approximately 65%) government
staff who returned questionnaires, 231 met the case definition
(attack rate [AR] among respondents = 42%). The occupational
physician estimate of the total number of cases was around 240
(estimated overall AR = 28%). Viral etiology was suspected since
76% of cases reported vomiting and diarrhea and recovery gener-
ally within 2-3 days. An additional 5 of 8 food handlers reported
onset of illness after the reception. Food and fecal samples were
negative for common bacterial pathogens, but 24 (62%) of 39 fecal
samples were positive for Norwalk-like virus (NLV) by RT-PCR; all
the NLV-positive specimens contained the same genotype, which
had not previously been identified. A rapid assessment of 150 ques-
tionnaires within 6 hours demonstrated that all 39 cases had eaten
at least one roll, compared with 103 of 111 controls (p=0.11).
Further analysis with all 550 questionnaires failed to indicate a sig-
nificant association of disease with any particular roll, but did show
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a strong association with increasing number of rolls eaten
(p<0.001). Additional investigation found that the baker had had
diarrhea and had vomited in the bakery sink while baking and slic-
ing the rolls. A fecal sample from the baker was positive for the out-
break strain of NLV. Strict hygiene measures were implemented in
the bakery. Conclusions: This investigation shows that contami-
nated bread was the probable cause of this large outbreak of NLV
illness and underscores the ease with which food can be contami-
nated. Use of email and electronic questionnaires allowed for rapid
data collection, and identification of the vehicle and source of the
outbreak. Awareness of food handlers and food health authorities
of the transmissibility of NLVs needs to be improved. Of interest,
10 outbreaks in the subsequent 6 months in the Netherlands were
attributed to this strain, suggesting that this outbreak may have
been a seeding event.
Challenges in the Interpretation of Classical and Molecular
Epidemiology Results; Two Calicivirus Outbreaks Due to
Oysters; Denmark at New Year 2000 
F. X. Hanon1, S. Corbet1, B. Böttiger1, A. C. Schultz2, P. Saadbye2, A.
Perge2, K. Mølbak1
1Statens Serum Institut, Copenhagen, DENMARK, 2National Food
Agency, Søborg, DENMARK
Objective: Oysters are a recognized source of foodborne
Calicivirus outbreaks. We evaluated sequencing of the Calicivirus
polymerase gene as a typing method to compare strains between
patients and oysters causing outbreaks in Denmark, 2001.
Background: We investigated two Calicivirus outbreaks. January
3, 2001, two incidents of gastrointestinal illness were reported. Two
and five persons were ill, and the attack rate was 100% among indi-
viduals who ate oysters. Oysters from several origins were on the
Danish market at that time, but the patients incriminated a single
batch of imported oysters (recalled January 4). From January 3 to
16, 297 cases of oyster-associated illness were reported from all
over the country; one patient was hospitalized. In an epidemiolog-
ical study, we estimated the attack rate among exposed to be 80%.
Late in February, two restaurants reported gastrointestinal illness
among 6 and 3 patrons, following the consumption of oysters; two
patients were hospitalized. The attack rate was 90%. The oysters
were imported from the same producer, but were not from the
same batch as the one causing the New Year outbreak. Testing:
Nested Reverse Transcriptase PCR for the polymerase of
Calicivirus were positive in 6 of 15 oyster samples from the impli-
cated batches. None of the employees at the importer’s facility
reported being sick prior to handling the implicated batch. One of
18 environmental samples taken on the premises was positive using
RT-PCR. Stools samples from 17 patients were available;
Calicivirus was detected in 13 patients using electronic microscopy
and RT-PCR with JV12 and JV13 primers. The analysis of 285 bp
of the polymerase gene from patients’ samples revealed various
strains, different from those in oysters. In one incident, two
patients sharing the same meal shed different strains. In one
patient, different strains were found in the same sample. Other
patients, who independently ate oysters from the same batch, were
infected with similar strains. Finally, a patient-strain from the New
Year outbreak had 100% similarity with a patient-strain from the
February outbreak, although the oysters were from a different
batch. Discussion: By using classical tools of epidemiology, we
concluded that the disease was associated with consumption of
contaminated oysters. However, sequencing data demonstrated a
wide heterogeneity of strains circulating in the outbreaks. This sug-
gests that sewage contamination of the sites where the oysters were
harvested or stored was the likely cause. Our observations indicate
that molecular typing is not sufficient to link exposure (food item)
to patient material, nor does differences between strains preclude
such a link. To better understand why a given patient harbors one
strain rather than another, and under which conditions Calicivirus
mutate and re-combine, we recommend examining different
strains from the same sample. Part of EU project QRLK1 99 594
Coordinating Environmental Public Health Practice with
Epidemiology and Laboratory Analysis: A Waterborne
Outbreak of "Norwalk-like Virus" in the Big Horn Mountains
of Wyoming 
S. A. Seys1, H. M. Mainzer2, A. G. Heryford1, A. D. Anderson3,4, S.
S. Monroe4, G. S. Fout5, J. P. Sarisky2, K. J. Musgrave1
1Wyoming Department of Health, Cheyenne, WY, 2Environmental
Health Services Branch, Division of Emergency and Environmental
Health Services, National Center for Environmental Health, CDC,
Atlanta, GA, 3Epidemic Intelligence Service, Epidemiology Program
Office, CDC, Atlanta, GA, 4Respiratory and Enteric Virus Branch,
Division of Viral and Rickettsial Diseases, National Center for
Infectious Diseases, CDC, Atlanta, GA, 5National Exposure Research
Laboratory, U.S. Environmental Protection Agency, Cincinnati, OH
Background: In February 2001, the Wyoming
Department of Health received reports of acute gastroenteritis
among persons who had recently been on a snowmobiling vacation
in the Big Horn Mountains. Initial interviews and laboratory test-
ing suggested that exposure to a "Norwalk-like virus" in drinking
water from a lodge was responsible for the illness. Methods:
Environmental health specialists and epidemiologists from several
state and federal agencies coordinated an investigation of environ-
mental risk factors and system failures. The environmental assess-
ment of the three lodges in the area included food service opera-
tions, water supply systems, and sewage disposal. A retrospective
cohort study was conducted among 82 persons identified from
guest registers to identify risk factors associated with illness. Stool
and water system samples were collected for laboratory analysis.
Results: Statistical analysis from the retrospective cohort study
suggested that illness was associated with water consumption at
one lodge (RR=3.3, 95% C.I.=(1.4, 7.7)). A chi-square test for lin-
ear trend showed that risk of illness increased significantly with the
number of glasses of water consumed (p=0.0003). The consump-
tion of individual food items was not statistically associated with ill-
ness. Reverse transcriptase-polymerase chain reaction (RT-PCR)
testing on 13 stool samples yielded 8 positives for "Norwalk-like
virus" (NLV) genogroup II, with 3 distinct sequence types detect-
ed. Fecal contamination of one of three operating wells was also
found and one of the samples tested positive for NLV genogroup
II. The environmental assessment of the property revealed that an
inadequately installed sewage system was delivering effluent into
shallow soil with poor filtering capacity. This effluent likely con-
taminated drinking water of an overloaded water system.
Conclusion: This event represents the largest waterborne out-
break ever reported in Wyoming. It illustrates the potential for
waterborne transmission of viral gastroenteritis and the advantages
of coordinating environmental public health practice with tradi-
tional epidemiologic and laboratory investigations. It is essential
that personnel representing each of these entities participate fully
in outbreak investigations and that environmental health specialists
receive training in systems analysis and sampling methodologies.
Outbreak investigations should address all of the systems of a facil-
ity including food service, water supply, and sewage systems.
Sesame-Seed Paste Caused an International Outbreak Due to
Salmonella Typhimurium DT104 – The Investigation in Norway 
O. Alvseike1, P. J. Guerin1,2, T. Stavnes1, P. Aavitsland1
1Norwegian Institute of Public Health, Oslo, NORWAY, 2EPIET
(European Programme for Intervention Epidemiology Training), Oslo,
NORWAY
Background: The incidence of domestically acquired sal-
monellosis is generally low in Norway. The last three years up to 12
annual sporadic domestic cases due to S. Typhimurium definitive
phage type 104 with R-type ACSSuT (DT104) have been diag-
















(NIPH) had received notifications of an unusual cluster of cases
with DT104. Oriental names were over-represented among cases.
Methods: Isolates from patients were characterised by standard
antimicrobial drug assays and phage typing methods at the
Reference Laboratory of Enteropathogenic Bacteria (RLEB). A
case was defined by the isolation of DT104 from a person living in
Norway while being ill. Descriptive epidemiological analyses were
undertaken. Meanwhile, the Swedish Food Authority detected
DT104 from helva, a Turkish sesame-seeds paste with different
flavours. This enabled a more directed case-control study to inves-
tigate the association between cases and helva. The cases were
matched with controls for age, sex, region and “ethnic back-
ground.” The questionnaire contained colour pictures of helva
products and other food items from a shop to ease the communi-
cation. We collected data from 18 cases and 20 controls. The data
were analysed by stratified exact logistic regression. Results: The
first case recorded in Norway had onset on 3rd November 2000,
months before the positive batch from Sweden was distributed for
retail sale. By July 31st, 28 cases had been reported in Norway.
Twenty-two cases (79%) belonged to minority ethnic groups from
Eastern-Mediterranean countries. On average, 3.1 cases per
month were recorded. The median age was 23 years. In the case
control study, consumption of helva the week before onset was
associated with illness (ORe = 8.8, 95% CI: 1.2-394). DT104 was
later also isolated from helva leftovers from two patients and from
two retail sale packages, all from the same factory in Turkey.
Discussion: Because the Norwegian notification system records
place of acquisition, we were able to discover this outbreak of
domestic DT104, a rare infection in Norway, and launch an inves-
tigation. The pictures of food items in the questionnaire partially
solved language barriers. The association between disease and
helva consumption was clear. The group of ethnic minorities was
more likely to be infected because of food habits, but none of the
six cases with Norwegian names had consumed helva. This number
is however within the range of what could be expected from spo-
radic cases. Related outbreaks were reported from Sweden,
Australia, Germany and the UK.
Changing Epidemiological Patterns of Salmonella serotype
Enteritidis in Barbados: Implications for Tourism and Trade 
L. Indar1, P. N. Levett2, R. Knight3, M. Ingram3, E. Commissiong1, G.
Baccus-Taylor1, P. Prabhakar4, J. Hospedales4
1Univ of the West Indies, St.Augustine, TRINIDAD AND TOBAGO,
2Univ of the West Indies, Sch Clin Med & Res, Bridgetown, BARBA-
DOS, 3Min of Health, Bridgetown, BARBADOS, 4CAREC, Port of
Spain, TRINIDAD AND TOBAGO
Objective: To determine the etiology, sources and risk fac-
tors for Salmonella Enteritidis (SE) infections in Barbados, to com-
pare its epidemiology with that of SE infections in Trinidad and to
develop preventive measures. Methods: Retrospective (1996-
1998) and prospective (August 1998-November 2000) descriptive
epidemiological studies were conducted to determine the occur-
rence, distribution and potential risk factors for SE infections in
Barbados. To determine the etiology for SE infections, a matched
case control study of 30 cases and 60 age- and neighborhood-
matched controls was conducted between February 1999 to
November 2000. Standard written questionnaires were used for
the prospective and case control studies, administered through
face to face interviews. SE outbreaks were also investigated.
Salmonella isolates were serotyped and phagetyped using standard
methods. Data was analyzed in Epi Info version 6.04c software.
Findings: The isolation rate per 100,000 population of SE
increased from 1.1 in 1990 to 10.0 in 1999. Children < 10 years
were most susceptible to SE infections (44 % cases, 39 infections
per 100,0000). No distinct seasonal pattern was observed in the
occurrence of SE cases. SE infection was found to be associated
with the consumption of undercooked eggs (matched odds
ratio [mOR]=43.5, 95% confidence interval [CI]=6.79-
1737,p<0.00001) and undercooked chickens (mOR 8.23, 95%CI
=1.57-73.6, p<0.01). In particular soft boiled eggs (mOR = 29.0,
p<0.0001), scrambled eggs with soft yolks (mOR=8.39, p<0.001)
and caesar salad (mOR =10, p<0.001) were the main implicated
undercooked egg-containing foods. Three hotel SE outbreaks,
involving visitors and 6 family outbreaks were investigated. Caesar
salad, soft boiled and scrambled eggs, and undercooked chickens
were implicated. Of the 60 isolates phagetyped, PT8 was most
prevalent (33 cases, 55%), followed by PT4 (19 cases, 32%), PT2
(6 cases, 10%), PT24a (1 case) and PT11 (1 case) Ten cases (17%)
were hospitalized , and 2 died (case fatality rate 6.7%).
Conclusion: This is the first reported analytical study of SE infec-
tions in Barbados. It highlights that in Barbados, the consumption
of undercooked eggs and undercooked chickens are the major
vehicles for SE infections, unlike our previous findings in
Trinidad. SE PT8 and PT4 predominate. This is the first time that
undercooked chicken has been associated with SE infection in the
Caribbean, and it is also the first time that PT2 has been identified
in the Caribbean. The findings of this study have important impli-
cations for public health, food safety, trade and tourism in
Barbados. It has demonstrated the increasing impact of SE infec-
tion in local and visitor population which requires a “Farm to
Table” for effective prevention and control.
Health Impact of the Salmonella enterica Serotype Enteritidis
Phage Type 4 Epidemic 
G. K. Adak, S. M. Long, S. J. O'Brien, L. R. Ward
Public Health Laboratory Service, London, UNITED KINGDOM
Background: In the 1980s Salmonella enterica serotype
Enteritidis emerged as a major foodborne pathogen. Rising levels
of human disease were linked to a developing panzootic in poultry.
During the 1990s the UK Government and industry introduced a
range of measures to reduce contamination in chicken meat and
eggs, culminating in a flock vaccination program starting in 1996.
We examined the impact of S. Enteritidis phage type (PT) 4 and
the effect of control measures on human health in England and
Wales. Methods: We refined the United States Centers for
Disease Control and Prevention (CDC) method for quantifying
the impact of food-related disease to correct for imported disease
and to describe trends. We estimated the number of illnesses, pre-
sentations to primary care physicians (presentations), hospitaliza-
tions, days of care in hospital (days) and deaths due to indigenous
foodborne S. Enteritidis PT4 (IFSE4) over 20 years. Results:
Between 1981 and 2000 IFSE4 infection resulted in an estimated
586000 illnesses, 418000 presentations, 18000 hospitalizations
(104000 days) and 1300 deaths in England and Wales. In 1981
there were 750 illnesses, 540 presentations, 20 hospitalizations
(130 days) and 2 deaths. Infection rates rose to reach a plateau
between 1990-7. In 1993 there were 59000 illnesses, 42000 pre-
sentations, 1800 hospitalizations (10400 days) and 130 deaths.
Annual rates of IFSE4 infection have fallen by over 70% since
1997. In 2000 there were 15000 illnesses, 11000 presentations, 470
hospitalizations (2800 days) and 30 deaths. The fall in IFSE4 has
meant 88000 less illnesses, 63000 less presentations, 2700 less hos-
pitalizations (16000 less days) and 190 fewer deaths in three years.
Conclusion: In the last 20 years no single strain of foodborne
pathogen has impacted on human health in England and Wales in
the way that S. Enteritidis PT4 has done. However our analyses
suggest that the introduction of flock vaccination has had a major
effect in rapidly reducing the burden of disease attributable to this
pathogen. The refinements that we have made to the CDC method
for measuring the impact of food-related disease enable both the
impact of pathogen emergence and the effectiveness of interven-
tions to be objectively assessed.
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Antibiotic Susceptibility and the Mechanisms of Macrolide
Resistance in Invasive Group B Streptococcus, Minnesota,
1998 and 2000
J. Bartkus, C. Morin, S. Vetter, E. Thompson, A. Glennen, R. Lynfield
Minnesota Department of Health, Minneapolis, MN
Background: Group B Streptococcus (GBS) is the leading
cause of invasive neonatal infections in the U.S. Intrapartum
antibiotic prophylaxis with penicillin or ampicillin is recommended
to prevent neonatal disease. For women allergic to β-lactam antibi-
otics, clindamycin (C) or erythromycin (E) is recommended.
Although resistance to penicillin has not been confirmed, resist-
ance to macrolides and lincosamides is well described. In GBS,
resistance is typically conferred either by methylation of the 23S
ribosomal subunit (erm) or by efflux pumps (mefA, mefE).
Methylation usually results in cross-resistance to macrolides, lin-
cosamides and streptogramin B (MLS phenotype) while the efflux
mechanism confers resistance only to macrolides (M phenotype).
Few studies have evaluated MLS resistance mechanisms in GBS.
Our objectives were to determine the prevalence of E and C-resist-
ance and to characterize the resistance mechanisms among inva-
sive GBS isolates. Methods: Invasive GBS infection is reportable
in Minnesota. Cases are reported to MDH through a statewide
active surveillance system. Surveillance includes collection of epi-
demiologic data and submission of isolates to MDH for antimi-
crobial susceptibility testing by broth microdilution. Resistant
strains were evaluated by PCR and isolates were tested for
inducibility of the MLS phenotype for the mef and erm genes.
Results: Among the 101 isolates tested in 1998, 21 (21%) were E-
resistant and 8 (8%) were C-resistant. Among the 220 isolates test-
ed in 2000, 50 (23%) were E-resistant and 27 (12%) were C-resist-
ant. All C-resistant strains were E-resistant. Sixty-four of the 71 E-
resistant GBS isolates were evaluated by PCR. Of the 20 1998 iso-
lates, 7 with an MLS phenotype contained ermB (3) or ermTR (4).
One MLS resistant strain failed to yield products with the primers
tested. Twelve 1998 isolates had M phenotype; all contained
mefE. Of the 44 year 2000 isolates, 18 had M phenotype and 26
had MLS phenotype. All 44 isolates contained the ermB gene. E
minimum inhibitory concentration values were higher in ermB-
containing strains (p<0.02). Twelve MLS phenotype isolates test-
ed were of the constitutive MLS type, while 15 of the M pheno-
type (by broth microdilution) isolates from 2000 were of the
inducible MLS type. Three M phenotype isolates, all of which
contained mef as well as ermB, failed to induce MLS resistance.
Conclusion: Although there was no increase in E-resistance in
invasive GBS between 1998 and 2000, there was a trend towards
increased C-resistance. This was accompanied by an increase in
the prevalence of the ermB gene in both MLS and M phenotype
isolates. The reason for this shift in resistance determinants in not
known, but could be a consequence of selective pressure by use of
these antibiotics. E and C resistance have important implications
for prophylaxis and treatment of GBS disease; these susceptibility
patterns need to be monitored.
Multi-Drug Resistant Neisseria gonorrhoeae with Decreased
Susceptibility to Cefixime, Hawaii, 2001 
S. A. WANG1, M. V. Lee2, C. J. Iverson1, N. O'Connor3, R. G.
Ohye2, J. A. Hale4, J. S. Knapp1, P. V. Effler2, H. S. Weinstock1
1CDC, Atlanta, GA, 2Hawaii Dept of Health, Honolulu, HI, 3Hawaii
Dept of Health State Laboratory, Pearl City, HI, 4Seattle GISP
Laboratory, Seattle, WA
Background: Gonorrhea, the second most commonly
reported communicable disease in the United States, increases
HIV transmission and causes pelvic inflammatory disease, which
can lead to ectopic pregnancy and infertility. Over the years,
Neisseria gonorrhoeae (GC) have readily acquired resistance to
various antibiotics, including sulfanilamide, penicillin (pen), tetra-
cycline (tet), spectinomycin (spec), and ciprofloxacin (cipro).
Report: We report on 3 patients in Hawaii who were diagnosed
with multi-drug resistant GC that also had markedly decreased sus-
ceptibility to cefixime (cfx). Patient A, a 36 year old white male,
presented in 2/2001 with urethritis and was treated with cfx 400 mg
and azi 1 gm. Subsequently, his culture grew GC which was spec
sensitive, but resistant to pen (Minimum Inhibitory Concentration
[MIC] of 8.0 mg/L), tet (MIC 8.0 mg/L), and cipro (MIC 8.0
mg/L), and had decreased susceptibility to azi (MIC 0.25 mg/L)
and cfx (MIC >0.125 mg/L). The patient returned in 4/2001 with
urethritis and was treated with spec 2 gm and doxycycline 100 mg
BID x 7 days. His second culture grew GC with the same antibi-
ogram as his first. A test-of-cure performed 3 weeks later was neg-
ative. Patient A reported having 2 female sex partners, both of
whom visited Hawaii from Japan. One sex partner could not be
located; the second, Patient B, presented in 5/2001. Patient B was
a 27 year old Japanese female who reported having yellow vaginal
discharge since 2/2001, having only Patient A as a sex partner, and
having sex with Patient A once in 2/2001 and once in 4/2001. She
was treated with ceftriaxone 125 mg and azi 1 gm. Her culture
grew GC which was spec sensitive, but resistant to pen (MIC 4.0
mg/L), tet (MIC 2.0 mg/L), cipro (MIC 16.0 mg/L), and had
decreased susceptibility to azi (MIC 0.25 mg/L) and cfx (MIC 0.25
mg/L). Patient C was a 30 year old Pacific Islander male who pre-
sented in 3/2001 with urethritis and was treated with cfx 400 mg
and azi 1 gm. His culture grew GC which was spec sensitive, but
resistant to pen (MIC 4.0 mg/L), tet (MIC 8.0 mg/L), and cipro
(MIC 8.0 mg/L), and had decreased susceptibility to azi (MIC
0.125 mg/L) and cfx (MIC >0.125 mg/L). A test-of-cure performed
3 months later was negative for GC. Patient C reported having one
female sex partner who could not be located. These first reports of
multi-drug resistant GC with decreased susceptibility to cfx in the
United States are worrisome because their existence and spread
may further limit treatment options for GC.
Shigella dysenteriae Serotype 1 in West Africa: Intervention
Strategy for an Outbreak in Sierra Leone, 1999-2000 
P. J. Guerin1,2,3, C. Brasher4, E. Baron4, D. Mic4, F. Grimont5, M.
Ryan6, P. Aavitsland3, D. Legros1
1Epicentre, Paris, FRANCE, 2EPIET (European Programme for
Intervention Epidemiology Training), Oslo, NORWAY, 3Norwegian
Institute of Public Health, Oslo, NORWAY, 4Médecins Sans Frontières,
Paris, FRANCE, 5Centre National de Référence de Typage
Moléculaire Entérique. Unité Biodiversité des Bactéries Pathogènes
Emergentes. Institut Pasteur, Paris, FRANCE, 6Department of
Communicable Disease Surveillance and Response, World Health
Organisation, Geneva, SWITZERLAND
Background: Bacillary dysentery has been a disease affect-
ing poor and crowded communities throughout history, and con-
tinues to be a major cause of morbidity and mortality in developing
countries. In the past two decades, large outbreaks due to Shigella
dysenteriae serotype 1 (Sd1) have been reported in Central and
Southern Africa. In November 1999, a Médecins Sans Frontières
















trict) reported an increased number of cases of bloody diarrhoea.
We describe the investigation of the outbreak and report the out-
come of cases treated with a 5 day regimen of ciprofloxacin.
Methods: A case was defined as a person living in this region, pre-
senting blood in the stools, observed by a health worker, from
December 1999 to March 2000. Microbiological confirmations at
Institut Pasteur, Paris, were performed for the early cases. Mobile
teams visited the affected area and referred patients at high risk of
death from dysentery (children less than 5 years old, adults 50
years of age or older, malnourished older children and adults) to
medical facilities for isolation and a 5 day treatment of
ciprofloxacin. Other patients received Oral Rehydration Salts and
were referred to isolation centres if needed. Hygiene advice was
given. Results: A total of 4,218 cases of dysentery was reported in
Kenema district from December 1999 to March 2000. The overall
attack rate was 7.5%. The attack rate was higher among children
under 5 years compared to the rest of the population (11.2% vs
6.8%). The case fatality ratio was 3.1% (131/4,218), also higher for
children under 5 years (6.1% vs 2.1%). Most deaths occurred at the
beginning of the outbreak. The strain isolated was resistant to
common antibiotics (amoxicillin, amoxicillin + clavulanic acid,
tetracycline, trimetoprim-sulfamethoxazole and choramphenicol),
and was sensitive to nalidixic acid, ciprofloxacin and ceftriaxone.
583 patients considered at higher risk of death were treated with
ciprofloxacin in isolation centres. The treatment compliance was
99.7% and the case fatality ratio was 0.9% (5/583). Discussion: This
is the first time a large outbreak caused by Sd1 has been reported
in West Africa. The disease is not yet well known by local health
care workers and health authorities of the region should be warned
of the potential epidemic risk. In this setting, with poor medical
facilities, a 5-day ciprofloxacin regimen was highly effective in the
most severe bloody diarrhoea cases and the case fatality ratio was
less than that observed with nalidixic acid treatment during previ-
ous outbreaks in Central Africa. Treatment with ciprofloxacin
should be restricted to isolation units and directly observed in
order to delay emergence of resistance.
The Acquisition of Ciprofloxacin Resistance in Travel-
Associated and Home-Acquired Campylobacter jejuni
Infection: A Case-Case Comparison
I. A. Gillespie1, S. J. O'Brien2, J. A. Frost2
1Public Health Laboratory Service, London, UNITED KINGDOM,
2Public Health Laboratory Service, London, UNITED KINGDOM
Aim: To determine factors independently associated with
the acquisition of a ciprofloxacin resistant Campylobacter jejuni
infection. Background: Campylobacter enteritis is usually an
unpleasant but self-limiting disease. Management is typically limit-
ed to maintaining fluid balance. Where antimicrobial therapy is
indicated the treatments of choice have tended to be erythromycin
or ciprofloxacin. However, the emergence of resistance against flu-
oroquinolones, and ciprofloxacin in particular, has become a major
public health problem worldwide. Methods: Human campylobac-
ter isolates referred from laboratories within a sentinel surveillance
system (population ~12.5 million) were speciated and sub-typed.
Antimicrobial resistance was determined by an agar dilution
method supported by minimum inhibitory concentrations for
ciprofloxacin and erythromycin. Epidemiological information, cap-
tured by self-completion postal questionnaire, was linked with the
typing data using the patients’ surname and date of birth. The
exposures of cases infected with a ciprofloxacin resistant C. jejuni
infection (‘cases’) were compared with those infected with a sensi-
tive strain (‘controls’) using single risk variable analysis and logistic
regression. The analysis was restricted by travel status to control for
the confounding effect of foreign travel. Results: Nineteen per-
cent of strains were resistant to ciprofloxacin. Over half (55%) of
the campylobacter infections acquired abroad were resistant to
ciprofloxacin, compared with 10% of UK strains (relative risk 5.31;
95% Confidence Interval (CI) 4.69-6.02; P<0.001). Amongst trav-
el-associated cases of C. jejuni infection, ciprofloxacin resistance
was independently associated with the consumption of chicken
(Odds Ratio (OR) 2.45; 95%CI 1.28-4.70; P=0.007) and bottled
water (OR 2.09; 95%CI 1.15-3.81; P=0.016) in the two weeks prior
to illness. Indigenous cases who were infected with a ciprofloxacin-
resistant strain of C. jejuni were more likely to report the con-
sumption of pre-cooked cold meats (OR 2.13; 95%CI 1.44-3.13;
P<0.001) than cases infected with a sensitive strain.Conclusions:
The risk of acquiring antimicrobial resistant campylobacter infec-
tion was strongly associated with foreign travel. Restricting our
analyses by travel status revealed different sets of risk exposures for
acquiring a resistant C. jejuni strain, suggesting that different inter-
vention strategies might be required. Case-case comparisons
proved to be a useful tool for the generation of hypotheses for
campylobacter infection from surveillance data.
Prevalence and Consequences of Fluoroquinolone-Resistant
Campylobacter Infections: NARMS 1997-2000 
J. McClellan, S. Rossiter, K. Joyce, K. Stamey, A. D. Anderson, and
the NARMS Working Group
Centers for Disease Control and Prevention, Atlanta, GA
Background: Campylobacter causes 2.4 million infections
each year in the United States. Fluoroquinolones (e.g.,
ciprofloxacin) commonly are used in adults with Campylobacter
and other infections. Fluoroquinolones also are used in livestock
and poultry. Human infections with fluoroquinolone-resistant
Campylobacter have become increasingly common and are associ-
ated with consumption of poultry. These, and other data, prompt-
ed FDA to propose withdrawal of fluoroquinolone use in poultry in
2000. Methods: In 1997, the National Antimicrobial Resistance
Monitoring System (NARMS) for Enteric Bacteria began monitor-
ing antimicrobial resistance among Campylobacter in the
Foodborne Disease Active Surveillance Network (FoodNet) sites;
by 2000, the number of sites had increased to 9. Additionally, a
case-control study of sporadic Campylobacter infections was con-
ducted in 7 FoodNet sites between 1998-1999. Isolates collected
from individuals with Campylobacter infections were forwarded to
CDC for speciation using hippurate test and PCR, and susceptibil-
ity testing to ciprofloxacin using the E-test. Results: NARMS test-
ed 1202 Campylobacter isolates from 1997-2000; 1145 (95%) were
C. jejuni, 44 (4%) C. coli, 7 (0.6%) C. upsaliensis, and 6 (0.5%)
other Campylobacter species. Fourteen percent of isolates
(163/1202) were ciprofloxacin-resistant (MIC ≥ 4 µg/ml); 13%
(155) of C. jejuni isolates, 16% (7) C. coli, and 0.6% (1) C. upsalien-
sis. Among 775 patients in the FoodNet Campylobacter case-con-
trol study, 11% (85) had ciprofloxacin-resistant infections. Among
421 persons with a Campylobacter infection who did not take a
strong antidiarrheal medication (e.g., Imodium, Lomotil, or pre-
scription), persons with ciprofloxacin-resistant infections had a
longer duration of diarrhea than persons with ciprofloxacin-sus-
ceptible infections (8 vs 7 days, p=0.05). Of these 421 persons, 126
(30%) took fluoroquinolones and no other antimicrobial agent for
their illness. Among the 126 persons who took fluoroquinolones,
the mean diarrhea duration was longer in patients with
ciprofloxacin-resistant infections than in patients with
ciprofloxacin-susceptible infections (8 vs 6 days, p=0.04).
Conclusions: NARMS surveillance data illustrates emerging fluo-
roquinolone resistance of Campylobacter in humans. Persons with
ciprofloxacin-resistant Campylobacter infections have a longer
duration of diarrhea than persons with ciprofloxacin-susceptible
Campylobacter infections. Fluoroquinolones commonly are used
to treat human infections; additional efforts are needed to protect
the efficacy of fluoroquinolones.
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High Prevalence of Antibiotic Resistance in Enterotoxigenic E.
coli (ETEC); Minnesota 2000 - 2001 
J. M. Besser, K. Smith, C. Taylor, P. Gahr, C. Medus
Minnesota Department of Health, Minneapolis, MN
Background: Enterotoxigenic E. coli (ETEC) is a leading
cause of morbidity and mortality worldwide. It is the primary
cause of traveler’s associated diarrhea, and can acquired from
imported produce. Antibiotics, such as ciprofloxicin (CIP),
trimethoprim-sulfamethoxazole (SXT), and doxycline (DOX) are
often prescribed to travelers for self-administration in case of ill-
ness. Recent studies have shown a high incidence of CIP resist-
ance among cases of Campylobacter jejuni, another travel-associ-
ated diarrheal agent. Limited information is available about
antibiotic resistance in ETEC, the more common cause of travel-
er’s diarrhea. Methods: The population examined were patients
presenting with diarrhea at a large HMO serving a predominate-
ly urban population, and at a hospital serving a predominately
rural population during 2000 and 2001. Travel, antibiotic use,
exposure histories, and demographic data were collected by case
interviews. Samples were cultured on SMAC agar, and colony
sweeps were examined using a CYBR-green PCR assay. Three
primer sets were used for detection of the LT gene (eltB) and the
ST alleles STa1 (estA1) and STa2-STa3 (estA2 and estA3), and iso-
lates were biochemically identified. Fifty-five isolates of ETEC
were tested for susceptibility to a standard antibiotic battery,
which includes CIP, SXT, and tetracycline (TE) using NCCLS
disk diffusion protocols. Results: Thirty-two of the 55 patients
(58.2%) reported travel outside the U.S. One of 55 (1.8%) isolates
were resistant to CIP, 14/55 (25.5%) to SXT; and 27/55 (49.1%) to
TE. The single case with a CIP resistant isolate had traveled to
Thailand, and had been treated with multiple, unspecified med-
ications. Travel and antibiotic use histories were available for
13/14 (92.9%) cases with SXT resistance. Reported travel includ-
ed South America (2), Mexico (3), India (1), Central America (2),
Europe (1), and no travel (4). None of these cases (0/13) report-
ed SXT use. Ten patients were <18 years old, and of those 3/10
(33%) had isolates resistant to SXT. Two patients treated with TE
prior to illness had TE-resistant isolates. Temporal trends were
not observed in any of the 12 antibiotics tested. The sources of
domestic acquisition were not determined. Conclusions: This
study examined cases of ETEC acquired in MN and in foreign
countries. The prevalence of resistance to CIP continues to be
very low, but should be further monitored due to increasing use
of this drug. The prevalence of SXT resistance was high, and like-
ly global in nature. The prevalence of DOX resistance, represent-
ed by TE, was very high. These data, when taken with C. jejuni
susceptibility data, suggest that current recommendations for
treatment of traveller’s diarrhea need to be re-evaluated.
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Board 1. High Frequency of Metronidazole and
Clarithromycin Resistance in Helicobacter pylori isolates from
Alaska Natives 
M. G. Bruce1, T. W. Hennessy1, B. J. McMahon2, F. D. Sacco2, A. L.
Reasonover1, J. M. Morris1, D. J. Parks1, D. A. Hurlburt1, C. E.
Hamlin1, A. J. Parkinson1
1CDC/NCID/Arctic Investigations Program, Anchorage, AK, 2Alaska
Native Medical Center, Anchorage, AK
Background: Helicobacter pylori (H. pylori) infection is
common (75% seroprevalence of IgG antibodies) among Alaska
Natives (AN). In this population, it is a major cause of gastritis and
peptic ulcer disease, and may be associated with rates of gastric
cancer that are over twice the national average. Elsewhere in the
United States, H. pylori cure rates are high (85-95%) and reinfec-
tion rates are low (< 5% over a 2-year period); however, prelimi-
nary data from an ongoing study in Alaska indicate markedly lower
eradication rates (60-70%), and higher reinfection rates (16.3% at
2 years) among AN. Methods: We analyzed H. pylori data from
CDC’s sentinel site surveillance in Alaska to determine: 1) the rate
of culture positivity of biopsy specimens from AN adults undergo-
ing routine upper endoscopy, and 2) the susceptibility of H. pylori
isolates to metronidazole, clarithromycin, tetracycline and amoxi-
cillin. We cultured clinical specimens obtained from biopsies of AN
patients undergoing upper endoscopy from 7/99 through 7/01 at
medical facilities located in Anchorage, Bethel, and Dillingham.
Susceptibilities of all culture-positive H. pylori isolates were deter-
mined by Agar dilution. Results: Of 643 biopsy specimens
obtained from 435 AN patients, 302 (47%) were culture positive,
representing 222 (51%) patients. Females were more likely to be
culture-positive compared to males (173 (49%) of 355 vs. 129
(45%) of 288, OR 1.2, p = .35). Mean age of culture-positive and
culture-negative patients was 50 years. AN living in Western Alaska
were more likely to test positive by culture when compared to
those who lived in other regions of Alaska (86 (67%) of 129 vs. 216
(42%) of 514, OR=2.8, p < .001). 46% of isolates had a minimum
inhibitory concentration (MIC) of > 8 µg metronidazole/ml, 33%
had an MIC of > 1 µg clarithromycin/ml, 2% of isolates had an
MIC of > 1 µg amoxicillin/ml and no isolates were resistant to
tetracycline (> 2 µg tetracycline/ml). Resistance to metronidazole
(MtzR) and clarithromycin (ClaR) varied by region (ranges, 39-
46% and 24-46%, respectively). Females were more likely than
males to show MtzR (56% vs. 33%, OR=2.9, p < .01) and ClaR
(36% vs. 29%, OR=1.4, p = .22). No difference in mean age was
observed for MtzR (mean age resistant 48.5 yrs vs. mean age sen-
sitive 51.2 yrs, p = .21) or ClaR (mean age resistant 50.3 yrs vs.
mean age sensitive 49.7 yrs, p = .65). Conclusions: Rates of resist-
ance to metronidazole and clarithromycin are elevated among AN
when compared with the rest of the United States. A high preva-
lence of infection with H. pylori in AN, combined with a high fre-
quency of antibiotic resistance in H. pylori isolates could result in
















Board 2. Trends in the Use of Azithromycin/Clarithromycin
and the Quinolones for Selected Infectious Diseases in
Ambulatory Care Settings in the US, 1993/94-1999/2000 
L. F. McCaig, C. W. Burt
National Center for Health Statistics, CDC, Hyattsville, MD
Background: The increased use of antibiotics has coincid-
ed with the emergence of antimicrobial resistance. With thousands
of Americans taking antibiotics because of the recent anthrax out-
break, there is a renewed urgency to monitor antibiotic prescrib-
ing. We examined data from the National Ambulatory Medical
Care Survey (NAMCS) and National Hospital Ambulatory Medical
Care Survey (NHAMCS), annual national probability surveys of
office-based physicians and hospital emergency departments
(ED’s) and outpatient departments (OPD’s), respectively, in the
US to describe trends in the prescribing of specific antibiotics for
selected infectious diseases seen in ambulatory care settings and to
provide a baseline in the use of ciprofloxacin. Methods: Data were
analyzed from the 1993-2000 NAMCS and NHAMCS and were
weighted to produce national annual estimates. Two years of data
were combined to provide more reliable estimates. Each year,
~2500 physicians and ~500 hospitals were in the NAMCS and
NHAMCS samples, respectively, and data were collected on
~25000 visits in each setting. A drug prescribing rate was calculat-
ed which was defined as the number of antimicrobial drugs pre-
scribed divided by the number of visits. Rates for the quinolones
(including ciprofloxacin), azithromycin/clarithromycin, and the
erythromycins were calculated for all 3 settings combined (i.e.,
physician office, OPD, and ED) for sinusitis, bronchitis, pneumo-
nia, and urinary tract infection (UTI). Results: From 1993/94-
1999/00, the azithromycin/clarithromycin prescribing rates for
sinusitis, bronchitis, and pneumonia in ambulatory care settings in
the US increased on average by 128%, while there was a corre-
sponding decrease in the erythromycin prescribing rates of about
65%. The quinolone prescribing rate for the 3 respiratory diseases
combined (sinusitis, bronchitis, and pneumonia) and for UTI
increased by 123% and 58%, respectively. The overall ciprofloxacin
prescribing rate increased by 23%, (from 6.1 prescriptions per
1000 visits to 7.5). Conclusions: The shift from the use of nar-
rower spectrum antibiotics (erythromycins) to broader spectrum
drugs (azithromycin/clarithromycin) raises concern and the appro-
priateness of their use need to be assessed. Establishing a baseline
of prescriptions for ciprofloxacin prior to the anthrax outbreak of
2001 is important to allow for the detection of unusual patterns of
prescribing subsequent to the bioterrorist attack. It is expected that
ciprofloxacin prescriptions will continue to rise in 2001.
Board 3. Ecological and Human Health Impacts of
Agricultural Use of Antimicrobials 
S. J. DeVincent
Alliance for the Prudent Use of Antibiotics (APUA), Boston, MA
In 1999, APUA instituted its Facts about Antimicrobials in
Animals and the Impact on Resistance (FAAIR) project. The spe-
cific objectives of FAAIR have been to:
• Review and analyze scientific evidence pertaining to
antimicrobial use in agriculture
• Increase public awareness of related human health issues
• Foster communication among stakeholders concerning
benefits and risks
• Influence policy makers to implement measures for
improved use
• Develop an ecological perspective on the issue of antimi-
crobial resistance
To meet these goals, APUA convened a Scientific Advisory
Panel of nationally-recognized experts to examine evidence rele-
vant to policy debates on this issue. The Panel developed a com-
prehensive report, The Need to Reduce Antimicrobial Usage in
Agriculture: Consequences of Use on Ecological and Human
Health. This report considers concerns expressed by stakeholder
groups as well as comments made by outside reviewers from gov-
ernment and industry.
The FAAIR Report begins with analyses of the extent of
antimicrobial use in food animal production and plant agriculture.
It then addresses the origin, spread, and persistence of resistance
genes. There is a review of the epidemiological evidence for a link
between the use of antimicrobials in food animals and the inci-
dence of infection due to resistant foodborne pathogens in
humans. The final sections of the report deal with risk assessment
and evidence that the agricultural use of antibiotics imposes a bur-
den on human health.
Some key findings of the FAAIR Report include:
• Use of antimicrobials in agriculture creates selective pres-
sure for the emergence of antimicrobial resistance in bac-
teria of food animals.
• These resistance determinants contribute to an environ-
mental reservoir of resistance. They can be transmitted to
humans through the food supply or by contact with the
animals or their environment.
• This increase in resistance can result in human health con-
sequences.
The report includes a series of Conclusions and Policy
Recommendations intended to improve public policy on the agri-
cultural use of antimicrobials. In this section, the Panel suggests
practical strategies to encourage more appropriate use of antimi-
crobials in agriculture and to preserve the effectiveness of these
drugs for the treatment of human disease.
Board 4. The Economics of Appropriate Antimicrobial Use in
Treating Acute Pharyngitis in Adults 
K. Roy, M. I. Meltzer, R. E. Besser, J. T. Weber
Centers for Disease Control and Prevention, Atlanta, GA
Background: Although viruses are the most common
cause of pharyngitis in adults, antimicrobials are prescribed in 76%
[Gonzales, et al., JAMA 1997] of all cases. Such inappropriate use
of antimicrobials may exacerbate the growing problem of antimi-
crobial resistance. Objective: To conduct an economic evaluation
of both recommended and practiced treatment strategies. The
evaluation balances the consequences of untreated Group A β-
hemolytic streptococcal (GABHS) pharyngitis, which causes 5-
15% of all cases, against decreases in inappropriate antimicrobial
use. Methods: A decision tree, with a societal perspective (direct,
indirect, and productivity costs included), was used to determine
the most cost-effective (lowest $/case correctly diagnosed and
treated) strategy from the following options: 1) Prescribe antimi-
crobials to all patients with sore throat; 2) Current practice of pre-
scribing antimicrobials to 70-100% of patients based on physician’s
discretionary use of clinical criteria and diagnostic tests; 3) Use
Centor’s (1980) clinical decision rules [to treat patients if > 3 symp-
toms, not treat if < 2 symptoms, and treat after further diagnostic
tests if 2-3 symptoms] and diagnostic tests that use both rapid anti-
gen testing (RAT) and throat culture (TC) for negative RAT [Note:
TC involves delays in optimal treatment while waiting for results];
4) Use clinical decision rules and RAT only; 5) Use clinical decision
rules and TC only; 6) No prescription and no tests. Values for the
input variables were obtained from published literature, existing
databases and expert opinion. Reductions in probabilities of
antimicrobial prescription (PRscript) were calculated but no valua-
tion was placed on such reductions. Sensitivity analyses were con-
ducted to determine when one strategy would be changed for
another. Results: The most cost-effective strategy depended upon
the probability of GABHS (PRGABHS) in the community. If 0% <
PRGABHS < 5% - choose no prescription and no tests (PRscript = 0%);
if 5% < PRGABHS < 30% - choose clinical decision rule plus RAT
(PRscript = 18-32%); if 30% < PRGABHS<50%choose clinical decision
rule plus RAT and TC (PRscript = 34-46%); if PRGABHS > 50% -
choose treat all (PRscript = 100%). Conclusions: Among healthy
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adults with acute pharyngitis typically antimicrobials should be
only prescribed after employing decision rules and RAT (strategy
4). Compared to current practice (strategy 2), this will reduce the
probability of antimicrobial prescription from 70% to 23%; while
the proportion of infections not treated remain the same (4-5%) for
both strategies. Only if the probability of GABHS is >50% should
antimicrobials be prescribed indiscriminately to all without appro-
priate laboratory test(s). These results support recently published
guidelines for treating acute pharyngitis in adults.
Board 5. Comparison of Animal and Human Multidrug-
Resistant Isolates of Salmonella Newport in Minnesota 
K. Smith1, J. Bender2, S. Stenzel1, C. Lindeman2, J. Adams1, F. Leano1
1Minnesota Department of Health, Minneapolis, MN, 2University of
Minnesota College of Veterinary Medicine, Saint Paul, MN
Background: Multidrug resistance, including resistance to
ceftriaxone, has been emerging among human clinical S. Newport
isolates submitted to the Minnesota Department of Health (MDH)
since 1999. Of 56 S. Newport isolates submitted during 1999-2000,
13 (23%) were resistant to ≥ 5 antimicrobials, and 12 were resist-
ant to ceftriaxone. The objective of this study was to evaluate
antimicrobial resistance and molecular subtype characteristics of
clinical S. Newport isolates from animals from a veterinary diag-
nostic laboratory in Minnesota and to compare them with human
clinical S. Newport isolates in Minnesota. Methods: S. Newport
isolates from clinically ill or dead animals submitted to the
Minnesota Veterinary Diagnostic Laboratory from January 2000
through September 2001 were forwarded to MDH. Animal isolates
were subtyped by pulsed-field gel electrophoresis (PFGE) and
tested for antimicrobial resistance at MDH using the same meth-
ods used to test human clinical isolates submitted to MDH through
routine surveillance. Antimicrobial resistance testing was done by
disk diffusion; Etest for ceftriaxone was done on isolates with
intermediate susceptibility by disk diffusion. Results: Isolates
from 33 animals (all from different farms or homes) were tested,
including 22 cattle, 5 swine, 2 horses, 1 deer, 1 dog, 1 owl, and 1
iguana. Of the 33 isolates, 25 (76%) were resistant to > 5 antimi-
crobials, and 24 had resistance to at least ampicillin, chloram-
phenicol, streptomycin, sulfamethoxazole, and tetracycline (R-type
ACSSuT); these isolates were recovered from cattle (n=19), swine
(n=2), a horse, a dog, and a deer. Of the 24 ACSSuT isolates, all
were also resistant to cephalothin (Cf), 23 to ceftriaxone (Cro), 20
to kanamycin (K), and 19 to gentamicin (Gm). Nineteen of 33 ani-
mal isolates (58%) were resistant to 9 antimicrobials (R-type
ACSSuTCfCroKGm), including 16 isolates from cattle. PFGE sub-
typing of the 33 animal isolates yielded 16 subtype patterns. Nine
PFGE subtypes represented 16 cattle isolates that were at least
penta resistant; 5 of these 9 subtypes have been associated with
clinical illness in humans in Minnesota. Isolates belonging to this
group of 5 PFGE subtypes were also recovered from horses (2 iso-
lates), a pig, a dog, and a deer. Conclusions: Clinical animal iso-
lates of S. Newport submitted to the Minnesota Veterinary
Diagnostic Laboratory during 2000-2001 were highly multidrug-
resistant; over one half of isolates were resistant to 9 antimicrobials,
including ceftriaxone. Cattle were the primary host from which
multidrug-resistant strains of S. Newport isolates were recovered.
PFGE subtyping revealed indistinguishable subtypes between
human and animal (particularly cattle) isolates. Future studies to
determine specific risk factors for infection with multidrug-resist-
ant S. Newport in humans should include investigation of cattle as
a potential reservoir.
Board 6. Antimicrobial Susceptibility Among Enterotoxigenic
Escherichia coli (Etec) and Shigella sp. Isolated from Rural
Egyptian Children with Diarrhea. 
S. D. Putnam1, T. Wierzba2, R. Frenck2, M. Riddle3, S. Savarino1, Z.
Mohran2, A. ElGendy2, M. Rao4, J. Clemens5
1Naval Medical Research Center, Silver Spring, MD, 2Naval Medical
Research Unit No. 3, Cairo, EGYPT, 3Uniform Services University
Health Sciences, Bethesda, MD, 4National Institute of Child Health
and Human Development, Bethesda, MD, 5International Vaccine
Institute, Seoul, REPUBLIC OF KOREA
Antibiotic susceptibility testing (AST) was conducted on
1,203 ETEC and 193 Shigella sp. isolates collected from 875 rural
Egyptian children. Children were enrolled in one of three prospec-
tive diarrhea studies conducted near Alexandria from 1995 through
2000. For each study subject, twice weekly home visits were con-
ducted and a stool sample and rectal swab were collected if a
‘loose, liquid, or bloody stool’ was reported. Rectal swabs were
inoculated into Cary-Blair transport medium, and along with the
stool sample, placed in an ice chest, and transported to a field lab-
oratory. Aliquots of stool were inoculated into Buffered-Glycerol-
Saline tubes and all clinical specimens were transported thrice
weekly to the microbiology labs at NAMRU3 in Cairo. Standard
laboratory procedures were used for the isolation and identification
of ETEC, Shigella sp., Salmonella sp., and Campylobacter sp. AST
was conducted by the disk diffusion method and interpreted
according to NCCLS guidelines. Some of the antibiotics tested
include, ampicillin, amikacin, aztreonam, cefepime, ceftriaxone,
ceftazidime, gentamicin, nalidixic acid, ciprofloxacin, tetracycline,
and sulfamethoxazole/trimethoprim (SXT). The overall rates of
resistance for ETEC and Shigella in our study population were:
ampicillin (62.6% & 55.4%), SXT (51.0% & 44.6%) and tetracy-
cline (40.3% & 75.1%), respectively. Over the length of the study,
ETEC demonstrated slight statistical increases in resistance to
SXT, while demonstrating minor decreases in resistance to ampi-
cillin, tetracycline, and multi-drug resistant isolates. Among
Shigella, there was a slight statistical increase in resistance to SXT,
while all other drugs generally showed a decrease or had no dis-
cernible change in resistance over the study. Little resistance
(~1%) among ETEC and Shigella were noted for all other antibi-
otics. In this region of the Middle East, antibiotic resistance to
commonly available antibiotics was quite high, but overall demon-
strated a slight statistical decrease during the six-year period, with
the sole exception of SXT. This study also suggests that in vitro
resistance to newer antibiotics is very low, possibly reflecting limit-
ed use among the general population in this rural area.
Board 7. Advantages of a Coordinated System of
Independent Global Surveillance Databases: A Report from the
Global Advisory on Antibiotic Resistance Data (GAARD) 
J. Stelling1, K. U. Travers2, R. Jones3,4, L. Miller5, D. Sahm6, B.
Souder2, T. O’Brien2,1, S. Levy2,4
1Brigham and Women's Hosp., Boston, MA, 2Alliance for the Prudent
Use of Antibiotics, Boston, MA, 3The Jones Group, North Liberty, IA,
4Tufts Univ., Boston, MA, 5GlaxoSmithKline, Collegeville, PA, 6Focus
Technologies, Inc., Herndon, VA
Background: Though antimicrobial resistance (AMR) is
recognized as a serious public health threat, a coordinated global
AMR surveillance system is not in place. Despite a demonstrable
role in AMR control, independent surveillance program data have
not been systematically compared, suggesting the utility of a coor-
dinated approach.
Methods: Aiming to serve as a comprehensive global infor-
mation resource for AMR surveillance, GAARD analyzed data sub-
mitted by three major surveillance programs: the Alexander
Project, SENTRY, and The Surveillance Network (TSN). Data,
from 1997-1999, were derived from reference-quality minimum
















analysis as project manager, and identified issues important to fur-
ther collaborative projects.
Results: SENTRY, Alexander, and TSN provided MIC
data for 4248, 1306, and 12,960 S. pneumoniae isolates, respec-
tively. Comparison was complicated by recent changes in interpre-
tive criteria. Also, the use of differing dilution ranges, isolate
sources, and sampling and testing methods among the programs
required careful consideration.
Conclusion: The coordination of AMR surveillance pro-
grams requires significant expertise and cooperation to handle
inevitable protocol discrepancies. Susceptibility testing against suf-
ficiently broad ranges of antibiotic dilutions facilitates program
integration. GAARD exemplifies the capabilities inherent in well-
integrated longitudinal collaborative surveillance efforts that will
substantially guide future international AMR interventions.
Board 8. Resistance to Penicillin in U.S. S. pneumoniae
Isolates Collected from 1997-1999: A Report from the 
GAARD Project 
J. Stelling1, K. U. Travers2, R. Jones3,4, L. Miller5, D. Sahm6, B.
Souder2, T. O'Brien1,2, S. Levy2,4
1Brigham and Women's Hosp., Boston, MA, 2Alliance for the Prudent
Use of Antibiotics, Boston, MA, 3The Jones Group, North Liberty, IA,
4Tufts Univ., Boston, MA, 5GlaxoSmithKline, Collegeville, PA, 6Focus
Technologies, Inc., Herndon, VA
Background: GAARD was created to supplement the sig-
nificant public health benefits of independent antibiotic resistance
(AMR) surveillance programs. Coordination and comparison of
methods and data strengthen problem-solving capacity and conse-
quent AMR control efforts. Methods: GAARD member organiza-
tions Alexander Project, SENTRY, and The Surveillance Network
(TSN), reported penicillin susceptibility data from U.S. isolates of
S. pneumoniae from 1997-1999 to the project manager, APUA.
Alexander and SENTRY reported data for consecutively collected
isolates sent to central laboratories for testing, while TSN reported
data collected directly from hospital laboratory information sys-
tems. The MIC and categorized susceptibility data were analyzed
longitudinally for trends associated with time period and surveil-
lance system. Results: Over the three-year period, the annual pro-
portions of S. pneumoniae isolates not susceptible to penicillin
were 29%, 28%, 32% in SENTRY; 34%, 34%, 41% in Alexander;
and 50%, 47%, and 44% in TSN. SENTRY and Alexander data
suggested a trend toward higher non-susceptibility in 1999; that
trend was statistically significant in the Alexander data (p<0.02).
Significantly higher non-susceptibility was noted overall among
TSN isolates (p<0.001). Conclusion: GAARD surveillance data
documented potentially important trends toward greater penicillin
resistance in U.S. S. pneumoniae isolates. The program-specific
differences in susceptibility may be due to different sampling
methods, network sizes, and institution type. These conclusions
have greater public health importance given the collaborative
analysis of the joint data.
Board 10. Ability of Proteolytic Inhibitor E-aminocaproic
Acid to Amplify Antimicrobial Action of Antibiotics Against
Emerging Infectious Diseases Agents 
Y. A. Boschenko, I. Y. Dronova, V. P. Lozitsky, V. A. Pushkina, A. N.
Yurdanova, A. S. Fedchuk, N. N. Mankovskaya, L. I. Shitikova
Ukrainian I.I.Mechnikov Research Institute of Emerging Diseases,
Odesa, UKRAINE
We have shown previously that proteolysis inhibitors
demonstrate antiviral and antimicrobial activity towards dangerous
infectious agents such as influenza virus, herpes simplex virus, ade-
noviruses, toxoplasmosis, etc. The scope of the present work is the
study of the proteolysis inhibitor E-aminocaproic acid
(E-ACA) influence on the sensitivity of emerging diseases
agents (Francisella tularensis and Vibrio cholerae) to various
antibiotics. We have studied the antimicrobial action of 18 repre-
sentatives of 10 antibiotics classes combined with addition of 5 %
of E-ACA to the nutrition medium. Standard discs containing
needed quantity of antibiotics under testing. Two strains of
Francisella tularensis: vaccine strain 15 (FT 15) and virulent strain
29 (FT 29) and three strains of Vibrio cholerae: strain 569 (VCC
569), El-Tor strain 754 (VCEl 754), Non-1 strain 146/11 (VCNon-
1 146/11) were used as the infectious agents. We have discovered
that all studied infectious agents are resistant to E-ACA action
taken apart from antibiotics. It was discovered that FT 15 strain
was resistant to carbenicillin and ofloxacin. Lysis zones around the
discs containing these antibiotics were totally absent. Addition of
E-ACA leaded to the increase of FT 15 sensitivity towards antibi-
otics. Diameter of inhibition zones were equal to 16 mm in the case
of carbenicillin and to 28 mm in the case of ofloxacin. FT 29 was
totally non-sensitive to cefotaxim and ceftriaxon. Addition of E-
ACA caused the effect of FT 29 becoming highly sensitive to these
antibiotics. E-ACA addition has transformed VCNon-1 146/11
strain resistant to cefatoxim, ceftriaxon, erithromycin, norfloxacin
and tetracyclin into highly sensitive one to these antibiotics. Zones
of growth hindering for VCNon-1 146/11 due to the mentioned
antibiotics combined with E-ACA were in the range of 11 to 25
mm. It was shown that E-ACA addition increased this strain sensi-
tivity to canomycin, ofloxacin and lomefloxacin. Addition of E-ACA
solution caused the sensitivity increase of VCC 569 to ampicillin,
gentamycin, sizomycin, vancomycin, canomycin. This strain was
totally resistant to erithromycin. After E-ACA addition the growth
hindering zone diameter was increased up to 28 mm. Strain VCEl
754 became much more sensitive to the antibiotics of penicillin
class, aminoglycosides, norfloxacin and tetracyclin after combined
application of E-ACA. Analysis of the experimental results has
shown that various strains of emerging diseases infectious agents
become more sensitive to known groups of antibiotics being
applied in combination with E-ACA. Addition of this preparation
being tested and classified as non-toxic one in great majority of
countries leads to great enhance of efficacy of antibiotics antimi-
crobial therapy in laboratory testing cycle. The use of E-ACA as the
promotor of antibiotics antimicrobial action could be recommend-
ed for clinical trial.
Board 11. Epidemiology of Community-onset Methicillin-
resistant Bloodstream Infection with Staphylococcus aureus in
Connecticut, 2000-2001 
S. Smolenski1, C. Morin2, N. L. Barrett1, J. L. Hadler1
1Connecticut Active Bacterial Core Surveillance Project, Emerging
Infections Program, Dept Public Health, Hartford, CT, 2Minnesota
Dept Health, Minneapolis, MN
Background: A previous Connecticut (CT) study demon-
strated that community-onset (CO) bloodstream infection with
methicillin-resistant Staphylococcus aureus (MRSA) is an impor-
tant public health problem. Starting in 2000, laboratories were
required to report all bloodstream MRSA isolates in CT residents.
In 2001, the system was expanded to include all invasive (sterile
site) MRSA isolates. The objectives of the surveillance system are
to determine the incidence, epidemiology, trends and risk factors
for CO-MRSA. Methods: A case of CO-MRSA was defined as a
person with an isolate of MRSA obtained as an outpatient or no
later than 2 days after admission to a hospital and who was not a
resident of a long-term care facility (LTCF) or a hemodialysis
patient. A standardized medical record review was done for all CO-
MRSA. Patients were further classified as either a) healthcare asso-
ciated (HA) if they had a hospital admission, outpatient surgery,
previous MRSA infection, or resided in a LTCF in the past year, or
b) community-acquired (CA). In addition, they were independent-
ly classified as either having an underlying illness (UI) predispos-
ing to SA infection or not. Individuals identified as CA-MRSA are
being interviewed using a standard questionnaire to determine if
other risk factors exist. Results: In 2000, 676 reports of MRSA
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bloodstream isolates were identified; 128 (19%) were CO-MRSA.
Medical record review for year 2000 is complete on 117 (91%).
Overall incidence of CO-MRSA was 3.8 per 100,000 population.
The rate of CO-MRSA was highest in individuals over 65 years of
age (14.9), residents of towns >100,000 in size (4.9), blacks (4.7)
and males (4.4). Only one case was <18 years old. For 2001 as of
December 1, 220 additional persons with CO-MRSA were identi-
fied, of whom 164 (75%) had bloodstream isolates. The projected
year 2001 rates for all invasive CO-MRSA and for bloodstream
cases are 7.0 and 5.3 per 100,000, respectively. Medical record
reviews have been completed for 240 (69%) cases of CO-MRSA
from years 2000 and 2001 combined. Of these, 205 (85%) were
both HA and had UI, 5 (2%) were HA only, 29(12%) appeared to
be CA with UI, and 1 was CA with no UI. Of the 210 HA cases, 180
(86%) had been hospitalized and 126 (60%) had undergone sur-
gery. UIs were present in 233 of the cases; status of one case was
unknown. The most common UIs were heart disease (44%) and
diabetes (39%). HIV was present in 5%; underlying injection drug
use was present in 6%. Conclusions: CO-MRSA is common and
appears to be increasing in CT. The epidemiology is similar to that
found in a previous pilot study. Rates are highest among those over
65 years and residents of urban areas. Most CO-MRSA is health-
care-associated. Invasive community-acquired MRSA in persons
without underlying conditions is rare. Continued surveillance and
examination of risk factors in those with apparent community-
acquired MRSA is needed.
Board 12. Trends in Invasive Pneumococcal Disease,
Connecticut, 1996-2000
N. L. Barrett1, Z. Fraser1, P. Mshar2, J. Jorgensen3, J. L. Hadler1
1Connecticut Active Bacterial Core Surveillance Project, Emerging
Infections Program, Dept Public Health, Hartford, CT, 2Connecticut
Active Bacterial Core Surveillance, Emerging Infections Program,
Dept Public Health, Hartford, CT, 3University of Texas Health Science
Center, San Antonio, TX
Background: Since 1995, the CT ABCs project has con-
ducted statewide active population-based surveillance for invasive
pneumococcal disease (IPD), monitored antimicrobial resistance
and, since 1998, serotype trends. Our objectives were to assess the
5 year trends in rates of IPD, antimicrobial resistance and
serotypes covered by vaccine by demographic subgroups.
Methods: Case data was obtained by medical record
review. IPD isolates were sent to a reference laboratory for antimi-
crobial testing and to CDC for serotyping. Rates of IPD were
determined per 100,000 population-specific groups. Vaccine cov-
erage of serotypes was determined based on the 7-valent vaccine
(PCV) for 0-4 year olds and the 23-valent vaccine (PPV) for >4 year
olds. Results: Over 5 years, the rate of IPD decreased from 24 to
20.3 cases per 100,000. Between 1999 and 2000, when PCV was
introduced for infants, the largest drop in rates was in the <2 year
age group (23%). Comparing 2000 rates to the 1996-99 average,
rates in <2 year olds decreased most in Hispanics (31%) and whites
(22%) but less in blacks (7%). Blacks <2 years still have the highest
rate of IPD (250 cases/100,000). Penicillin-resistant IPD (PRSP)
increased from 11% to 13.6% of isolates over 5 years. Percentage
(%) that were resistant increased for all antimicrobials, except for
vancomycin (still 0%). The largest increases in % resistant were for
erythromycin (5.2 to 15%), amoxicillin (4.3 to 12%), cefotaxime
(3.4 to 7.2%), and meropenem (2.1 to 6.4%). Percentage resistant
to erythromycin (ERSP) increased in both penicillin susceptible
(2.2% to 4.8%) and non-susceptible isolates (19.2% to 52.7%). The
% of isolates that are ERSP increased in all age groups. The % that
were ERSP and that were PRSP were significantly lower in blacks
than whites (5.4% vs. 10.8%; 8.4% vs. 13.5%, p 17 years old. At
least 86% of serotypes in CT IPD isolates have been covered by
PCV (children) or PPV (adults). No distinct age-specific decrease
in % of isolates with serotypes covered by vaccines was seen from
1998-2000. When resistant were compared to susceptible isolates
for % vaccine coverage, ERSP were less likely than ESSP isolates
to be covered (77% vs 88%, p<.00001), unlike PRSP compared to
PSSP isolates (92% vs 88%, p>.05) Conclusions: In CT, overall
IPD rates may be decreasing. Distribution of PCV may already be
having an effect on IPD incidence in infants, but use among blacks
may be lagging. Antibiotic-resistant IPD is progressively increas-
ing, especially erythromycin resistance. Fluoroquinolone resist-
ance may be emerging. The association between erythromycin
resistance and having a lower percentage of serotypes contained in
the vaccines needs further exploration.
Board 13. Erythromycin Resistance Among Invasive Group A
Streptococcal Infections in the United States, 1999 
C. A. Van Beneden1, R. Facklam1, R. Lynfield2, L. Shealey1, B. Juni3,
A. Reingold4, N. L. Barrett5, M. M. Farley6, L. Harrison7, N. M.
Bennett8, K. Stefonek9, C. Whitney1,10
1Centers for Disease Control and Prevention, Atlanta, GA, 2Minnesota
Emerging Infections Program (EIP), Minneapolis, MN, 3Minnesota
Department of Health, Minneapolis, MN, 4California EIP, Oakland,
CA, 5Connecticut EIP, Hartford, CT, 6Georgia EIP, Atlanta, GA,
7Maryland EIP, Baltimore, MD, 8New York EIP, Albany, NY, 9Oregon
EIP, Portland, OR, 10for the Active Bacterial Core Surveillance
(ABCs)/ Emerging Infections Program (EIP) Network, Atlanta, GA
Background: Group A streptococcus (GAS) is a common
cause of both invasive and noninvasive infections. Although GAS
has remained universally sensitive to penicillin, macrolides are
often used as alternate therapy. Resistance to erythromycin and
other macrolides has risen to high levels in many countries outside
of North America (20% to 60%). We sought to determine percent
of erythromycin resistance among invasive isolates in geographical-
ly diverse regions of the United States using CDC’s Active
Bacterial Core Surveillance (ABCs) system. Methods: ABCs con-
ducts active laboratory- and population-based surveillance for inva-
sive GAS infections. Bacterial isolates obtained from invasive GAS
infections identified by participating ABCs sites (CA, CT, GA, MD,
MN, NY, OR) in 1999 were tested for resistance to penicillin,
ampicillin, erythromycin, clindamycin, vancomycin and cefotaxime
by broth microdilution. According to NCCLS guidelines, strains
with mean inhibitory concentrations (MIC) of 0.5 mg/ml and > 1.0
mg/ml to erythromycin were defined as intermediate (EryI) and
resistant (EryR), respectively. Emm typing was performed on iso-
lates using standard methods. Results: In 1999, 772 cases of inva-
sive GAS were identified; 547 (71%) isolates were available for
antimicrobial susceptibility testing. Of these, 6.4% (n=35) were
EryR and four were EryI. Significant variation in % EryR was
noted among sites: 0% (GA), 2.8% (CT), 3.9% (MN), 5.5% (MD),
7.7% (NY), 13.7% (CA) and 13.8% (OR). Upon comparison of
patients with EryR to patients with EryS isolates, no significant
differences were noted for the following variables: sex, race, hos-
pitalization, outcome, and type of infection. Age > 18 years was
associated with having an EryR infection (P=0.028); persons age
35-49 years had the highest % EryR (10.3%). Emm typing was
completed on 521 (95%) of the available GAS isolates. EryR was
identified among 12 of the 50 different emm types identified but
was most common in types emm114 (13 of 16 strains), emm83 (4
of 7 strains), and emm58 (4 of 8 strains). Twelve of 16 emm114
isolates were from GAS cases in CA and OR; nine (75%) were
EryR. The remaining four emm114 strains, found elsewhere
(MD=1, MN=3), were EryR. Conclusion: Erythromycin resist-
ance among invasive GAS isolates shows significant geographic
variation, with the greatest resistance noted in ABCs sites located
in two states. Resistance is more common in certain emm types;
predominance of resistant strains of emm 114 in the western U.S.
could be due to expansion of a resistant clone, although local
















Board 14. Rapid Detection of Methicillin-Resistant
Staphylococcus aureus by Real-Time PCR Using 
LightSpeed Probes 
H. Perry-O'Keefe, M. Fiandaca, J. Coull, H. Stender
Applied Biosystems, Bedford, MA
The emergence of methicillin-resistant Staphylococcus
aureus (MRSA) has become an important cause of nosocomial
infections and is associated with increased morbidity, mortality and
hospital costs. Furthermore, the lack of rapid methods for identifi-
cation of MRSA often leads to empirical treatment of S. aureus
infections with vancomycin which can lead to the development of
vancomycin-resistant enterococci, another important antimicro-
bial-resistant pathogen. Here we describe a simple 40-minute real-
time PCR method for detection of the methicillin resistance gene,
mecA, in MRSA using LightSpeed probes. LightSpeed probes are
dual-labeled peptide nucleic acid probes with a fluorescent dye
and quencher molecule bound to the opposing termini. Upon
hybridization, the fluorophore and quencher are spatially separat-
ed and the LightSpeed probe becomes fluorescent. The test is per-
formed as a homogeneous sealed tube assay, where the formation
of amplicons is detected on-line by an increase in fluorescence.
The performance of the test was initially established using seven
reference strains representing both MRSA and MSSA and showed
100% accurate discrimination. Evaluation using 16 clinical isolates
showed 81% (13/16) agreement with antimicrobial susceptibility
testing. Discrepancies are being examined further.
Board 15. Antimicrobial Susceptibility and Serotype Patterns
of Invasive Group B Streptococcus Isolates from Georgia,
Minnesota, New York and Oregon, 1996- 2000 
M. L. Castor1,2, C. Whitney2, R. Facklam2, P. Cieslak3, M. Farley4, 
N. Bennett5, S. Lewis2, S. Johnson1, P. Ferrieri6, K. Como-Sabetti1, 
R. Lynfield1
1Minnesota Department of Health, Minneapolis, MN, 2Centers for
Disease Control and Prevention, Atlanta, GA, 3Oregon State Health
Department, Portland, OR, 4Emory University, Atlanta, GA, 5Monroe
County Health Department, Rochester, NY, 6University of Minnesota
Medical School, Minneapolis, MN
Background: Maternal carriage of Group B Streptococcus
(GBS) poses a risk for vertical transmission to neonates.
Intrapartum GBS chemoprophylaxis recommendations imple-
mented in the 1990’s reduced invasive early-onset neonatal disease
by 65% (1.7 to 0.6 per 1000 livebirths during 1993-1998).
Nonetheless, GBS remains the leading cause of neonatal invasive
disease and is an important pathogen for peripartum women and
nonpregnant adults. Identifying susceptibility and serotype trends
is critical for guiding chemoprophylaxis recommendations and vac-
cine formulation. Methods: Active population-based surveillance
for GBS was conducted in four states during 1996-2000. Case-
patients were defined by isolation of GBS from a sterile site; analy-
ses were performed on perinatal (neonates and pregnant women)
and adult case-patients. Isolates were tested for susceptibility by
broth microdilution and serotyped. Preliminary Results: Of 3,399
case-patients; 1,043 (31%) had susceptibility data and 1,638 (48%)
were serotyped. No isolates were resistant to penicillin, van-
comycin, cephalothin, or cefazolin. Clindamycin resistance was
found in 110 (11%) and erythromycin resistance in 196 (19%) iso-
lates. Comparing 1996-1998 with 1999-2000, erythromycin resist-
ance increased from 16% to 21% (p=0.025) and clindamycin resist-
ance from 8% to 12% (not significant). Perinatal isolates were com-
monly serotype III (40%), Ia or Ia/c (27%) and V (17%). Adult iso-
lates were most often serotype V (30%). Serotype V was associated
with clindamycin or erythromycin resistance among perinatal
(p<0.001 for both) and adult isolates (clindamycin, p=0.009; eryth-
romycin, p=0.02). Conclusions: Clindamycin and erythromycin
are alternatives to penicillin for intrapartum prophylaxis in peni-
cillin-allergic women; however, resistance to both was found.
Cefazolin or vancomycin may be preferable alternative agents.
Clindamycin or erythromycin resistance was associated with
serotype V. Vaccine strategies should consider predominant
serotypes and/or serotypes associated with resistance.
Board 16. Phenotypic and Genotypic Comparison of
Salmonella Strains Collected from Humans and Swine in North
Carolina 
W. Abebe Gebreyes1, L. Wolf2
1North Carolina State University, Raleigh, NC, 2North Carolina Public
Health Laboratory, Raleigh, NC
Background: Multiple antimicrobial resistant Salmonellae
are an emerging problem at the global scale. In the ICEID 2000
symposium, we reported that multi-drug resistance with distinct
pentaresistant pattern was common among Salmonella enterica
isolates collected from swine in North Carolina. We found that
36.2% of 484 Salmonella serovar Typhimurium (including
Copenhagen) isolates from swine were of phage type DT104,
which commonly exhibits pentaresistance (R-type ACSSuT).
Provided this phage type has been increasingly reported from
human outbreaks in most parts of the world and the state of North
Carolina is one of the leading in pork production, there has been a
growing concern that clinical Salmonella isolates identified from
humans in the swine producing counties would more likely be sim-
ilar or identical strains as that of the swine. Methods: In order to
test this hypothesis, we compared frequency of resistance as well as
the genotypes of isolates collected from swine and humans. We
received 179 isolates from the North Carolina Public Health
Laboratory between the year 2000 and 2001. We tested antimicro-
bial susceptibility of isolates for 12 antimicrobial agents using
Kirby-Bauer disk diffusion method. To discern similarity between
human and swine isolates, we used genotyping by Pulsed Field Gel
Electrophoresis (PFGE). Results: Antimicrobial susceptibility
tests revealed that 81% of the isolates from human clinical sam-
ples did not exhibit resistance to any of the antimicrobial agents
tested. On the other hand more than 85% of isolates from swine
were resistant to at least one antimicrobial agent. Among
Typhimurium isolates from human, 6% exhibited consistent
pentaresistance pattern as that of DT104. We found higher fre-
quency of multi-drug resistance among serovar Heidelberg iso-
lates from humans ranging between 4 and 19% per antimicrobial
agent. Serovar Heidelberg often exhibited either no resistance or
only tetracycline resistance among isolates collected from swine.
None of the human isolates were found to be resistant to
ciprofloxacin, amikacin and gentamicin. However, 2% of the iso-
lates showed reduced susceptibility to a third generation
cephalosporin, ceftriaxone. None of the swine isolates exhibited
resistance to third generation cephalosporins or ciprofloxacin.
PFGE comparison of isolates with similar resistance pattern
showed disparity of fingerprints (with less than 75% pearson pair-
wise correlation) between human and swine isolates. Conclusion:
Our findings so far, do not warrant that human clinical isolates are
similar to those commonly found in swine. Rarely, similar finger-
prints have been noticed. The common finding of disparity in
resistance pattern as well as DNA fingerprints may imply that
there could be other common reservoirs of human infection more
important than the swine-human transmission cycle.
Board 17. Detection of a Class I Integron in Multi-Drug
Resistant Salmonella niakhar 
J. D. Tankson1, P. J. Fedorka-Cray1, C. R. Hudson1, J. T. Gray1, J. B.
Barrett1, M. Headrick2
1USDA/ARS/ARRU, Athens, GA, 2FDA-CVM, Athens, GA
In the United States, Salmonella enterica serotype niakhar
is a rarely isolated serotype of Salmonella. Between 1997 and 2000,
the animal arm of the National Antimicrobial Resistance
Monitoring System — Enteric Bacteria (NARMS) at USDA-ARS
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in Athens, GA assayed for antimicrobial resistance a total of 22,383
Salmonella isolates from various animals (swine, cattle, chickens,
turkeys, cats, and dogs). Isolates originated from on-farm studies,
veterinary diagnostic laboratories, or raw product collected from
federally inspected slaughter and processing plants. Only 5 (0.02%)
of these isolates were identified as niakhar (designated A-E). Of
the five, B - D isolates were isolated in the Midwest (dairy cattle),
A and E were isolated in the Southern United States (dairy cattle
and dog). Antimicrobial resistance testing indicated that isolates A,
B, and E were susceptible to all antibiotics tested; whereas iso-
late C was only resistant to ampicillin. Isolate D was resistant to
ampicillin, chloramphenicol, ciprofloxacin, kanamycin, nalidixic
acid, streptomycin, sulfamethoxazole, tetracycline, and
trimethoprim/sulfamethoxazole. Class I integrons (intI1) in
Salmonella are known to harbor multiple resistance genes. Using
PCR primers to the 5’conserved segment of intI1, a 568-bp frag-
ment was amplified from isolate D. The integron from this iso-
late was localized to a ~ 12 kb XbaI fragment using PFGE.
Further characterization of all isolates is ongoing. This is a first
report of ciprofloxacin resistant Salmonella from NARMS as well
as the first identification of intI1 in Salmonella niakhar.
Board 18. Assessment of the Etest™ System for Determination
of Antibiotic Susceptibilities of Bacillus anthracis Strains
Representative of World-Wide Diversity
N. Sirianni1, P. Coker2, P. Turnbull3, M. Hugh-Jones2, L. Peruski1
1Naval Medical Research Center, Silver Spring, MD, 2Louisiana State
University, Baton Rouge, LA, 3Arjemptur Technologies, Salisbury,
UNITED KINGDOM
Twenty-five Bacillus anthracis strains representative of the
geographic diversity of this pathogen were evaluated for resistance
to nine clinically relevant antibiotics using the Etest™ system (AB
Biodisk, Solna, Sweden) by standard methods. Relative suscepti-
bility and minimum inhibitory concentrations (MIC) were deter-
mined for azithromycin, cefotaxime, cefotaxime/clavulanic acid,
ciprofloxacin, erythromycin, gentamicin, penicillin, tetracycline,
and vancomycin. Initial analysis of these 25 isolates revealed that
the level of resistance to azithromycin was consistently 4-12 times
greater than that previously noted (Turnbull et al., unpublished
results) ranging from 1.5 to 12 mg/L with a median range of 4 to 6
mg/L. All strains were susceptible to cefotaxime, cefotaxime/clavu-
lanic acid, ciprofloxacin, and erythromycin, in good agreement
with prior reports using different methodologies. Of the remain-
ing antibiotics, sensitivity to penicillin was greater than previously
reported with over 90% of the strains having MICs between 0.012
to 0.032. One of these strains, ASC 32, previously reported as
penicillin resistant had a markedly higher MIC to this antibiotic
(24 mg/L) than did the other strains but this value was less than
that reported in a study be Lightfoot and co-workers (64 mg/L).
The MICs for gentamicin ranged from 0.019 to 0.5 mg/L while
those for vancomycin ranged from 0.75 to 3.0 mg/L. We propose
that the Etest™ method provides an effective, simple alternative
to the disk-diffusion and broth dilution methods for the direct
quantification of B. anthracis susceptibility. The relevance of our
findings to the therapeutic uses of different antibiotic classes in
human clinical cases will be discussed. Further studies are under-
way to assess the susceptibility of these and other selected strains
to additional antibiotics.
Board 19. National Department of Defense Surveillance for
Streptococcus pneumoniae: Update on Antibiotic Resistance
and Serotype Distribution 
C. A. Cameon, A. W. Hawksworth, C. P. Barrozo, J. M. Fuller, B.
Smith, J. C. Sammons, M. K. Ryan, K. L. Russell
Naval Health Research Center, San Diego, CA
Background: Streptococcus pneumoniae is commonly
associated with pneumonia, bacteremia, meningitis, and otitis
media. Recent emergence of antibiotic resistant S. pneumoniae is
a growing concern among military and civilian health practitioners.
Surveillance for antibiotic resistance and serotype distribution
among pneumococcal isolates can provide critical information for
the effective use of antibiotics and vaccines. Methods: S. pneumo-
niae clinical isolates were systematically collected from seven large
military hospitals between August 1997 and May 2001. Antibiotic
susceptibility testing was completed with E-test gradient strips.
Isolates were serotyped by latex agglutination with diagnostic anti-
sera and confirmed with the Quellung test. Basic demographic and
clinical information was available from existing sources in the
health care centers. Results: Three hundred four isolates were
evaluated for antibiotic resistance. One hundred seven (35.2%)
had intermediate or high-level resistance to penicillin. Seventy-
three (24.0%) of the isolates had multi-drug resistance to penicillin
and any two of the following: erythromycin, sulfamethoxizole/
trimethoprim, or ceftriaxone. All isolates were sensitive to lev-
ofloxacin and vancomycin. To date, we have successfully serotyped
250 of the 304 isolates, and 20 different serotypes were identified.
The most common were serotypes 14(27.6%), 9V(13.6%),
19F(10.4%), 6B(12.0%), 4(9.2%) and 23F(8.8%). Serotypes 18C
and 4 were significantly more likely to be penicillin sensitive
(p=0.017, and p≤0.001, respectively), while 9V was more likely to
be penicillin resistant (p=0.045). Serotype 4 was significantly more
likely to be multidrug sensitive (p=0.003) while serotypes 19F and
23F were more likely to be multidrug resistant (p=0.004, and
p=0.045, respectively). Conclusions: Antibiotic resistance is pres-
ent in a significant proportion of S. pneumoniae isolates obtained
from military healthcare beneficiaries. Furthermore, data indicate
a significant penicillin resistance in serotype 9V and significant
multi-drug resistance in serotypes 19F and 23F. Those serotypes
found to be resistant are included in the 23-valent pneumococcal
vaccine; this may have important public health ramifications.
Continued surveillance of these trends is critical to assure success
in future treatment of the diseases caused by this pathogen.
Board 20. Penicillin-Resistant Streptococcus Pneumoniae in
New York State: Population Variability 
S. M. Zansky1, B. J. Anderson1, N. Spina1, G. Smith2, A. Jameson1,
N. Dumas3
1New York State Department of Health, Emerging Infections Program,
Albany, NY, 2New York State Department of Health, Emerging
Infections Program, Rochester, NY, 3New York State Department of
Health, Wadsworth Center, Albany, NY
Background: Streptococcus pneumoniae (SPN) is the
leading bacterial cause of a number of diseases including pneumo-
nia, meningitis, otitis media, and bacteremia resulting in high mor-
bidity and mortality in the U. S. The prevalence of drug resistant
SPN strains has increased since resistance was first reported in the
early 1990s. Drug resistant, invasive SPN disease became
reportable in New York State in July 1995. In 1999, all invasive
pneumococcal infections became reportable in the 15 Albany and
Rochester counties that comprise the Active Bacterial Core (ABC)
component of the NYS Emerging Infections Program (EIP). The
purpose of this report is to characterize populations at risk for inva-
sive disease and, more specifically, those at risk for penicillin-resist-
ant SPN. Methods: Confidential case reports were completed for
all culture-confirmed invasive cases among residents of the NYS
EIP during the period 1999-2000. Isolates were tested locally for
penicillin resistance and results were coded according to NCCLS
guidelines. In this analysis, intermediate and fully resistant cases
were collapsed into a single ’resistant’ category. Patient information
included demographic characteristics, length of hospitalization,
outcome, and underlying medical conditions. Results: During the
two-year period 1999-2000, 831 invasive SPN cases were reported
in the NYS EIP for an annual incidence rate of 19.9/100,000. Eight
cases with ’unknown’ susceptibility results were excluded from the
















(15.8/100,000 per year), and 165 resistant (4.0/100,000). Females
had slightly higher rates of infection compared to males (21.1 vs.
18.7/100,000 per year) and a higher percent resistant (22.3% vs.
17.3%), but these differences were not significant. The difference
in overall incidence rates between blacks and whites was highly
significant (44.5 vs. 17.9/100,000; OR=2.48, p<.00001) but there
was no difference in the percent resistant between the two groups
(20% resistant within each race). Younger (< 5 years; 69.1/100,000)
and older (> 65 years; 58.2/100,000) individuals were at signifi-
cantly greater risk for infection (OR=4.25, p<.00001 and OR=4.27,
p<.00001 respectively) compared to all other age categories but
there were no significant differences in the percent resistant by
age. Conclusions: Although both age and race were shown to be
independent risk factors for invasive pneumococcal disease, this
analysis did not identify any significant risk factors for infection
with penicillin-resistant strains. Identification of risk factors associ-
ated with drug-resistant SPN infection will continue to gain impor-
tance as the prevalence of these strains rises.
Board 21. Prevalence of Antimicrobial Resistance of
Salmonella in Chickens and Pigs in Thailand: Reflection of the
0veruse of Antimicrobial Drugs 
T. Chalermchaikit, M. Lertworapreecha, J. Sasipreeyajan, S.
Lueangyoslurchakul, P. Assawacheep, S. Wattanapunsuk, T.
Kienkaew, K. Poonsiri
Chulalongkorn University, Bangkok, THAILAND
Background: The estimated prevalence of human
Salmonellosis in Thailand is 76-1,053 cases per 100,000 population.
Likely sources of infection include food of animal origin such as
chicken and pork, which are a favorite protein diet of the Thai pop-
ulation. Methods: Fecal samples from 563 native-chickens, 1,645
farm-broilers, 114 native-pigs, and 722 farm-pigs were tested. All
Salmonella isolates were tested for antimicrobial susceptibility
using an agar dilution technique. Results: Salmonella was found in
8.9 % (50 isolates) of the native-chicken samples, 5.3 % (87 iso-
lates) of the farm-broiler samples, 6.1 % (7 isolates) of the native-
pig samples, and 3.1 % (24 isolates) of the farm-pig samples. The
results showed that Salmonella isolates from native-chickens and
native-pigs had a lower percentage of antimicrobial resistance than
Salmonella isolates from farm-broilers and farm-pigs (Table 1).
Table 1 Percentage of antimicrobial resistance of Salmonella iso-
lates from feces of native-chickens, farm-broilers, native-pigs and
farm-pigs in Thailand. 
| % Resistance of Salmonella Isolates from Feces
Antimicrobial Native- Farm- Native- Farm-
Testing Chickens Broilers Pigs Pigs
Ampicillan 0.96 24 0 75
Chloramphenicol 0 13.3 14.3 16.7
Kanamycin 0 13.3 14.3 25
Nitrofurantoin 0 11.7 0 4.2
Tetracycline 10.2 29.4 0 95.8
Nalidixic acid 33.3 59.2 28.6 45.8
Ciprofloxacin 0 0 14.3 20.8
Furazolidone 4.8 49.7 28.6 4.2
Sulfamethoxazole 9.3 16.2 0 70.8
Sulfamethoxazole + Trimethoprim 9.3 12.8 0 6.7
Conclusion: Native-chickens and native-pigs are raised in
rural areas, consume natural feed, and are rarely given antimicro-
bials as growth promoters or for disease prevention; this could
explain the lower prevalence of antimicrobial resistance among
these samples. Farm-broilers and farm-pigs, however, are raised
intensively and usually given antimicrobials as growth promoters or
for disease prevention. Since 2001, Thailand has fully adopted
“Recommended International Code of Practice for Control of the
Use of Veterinary Drugs (CAC/RCP 38-1993)” and implemented
“Good Farm Practices” in all industrial food-animal farms.
Additionally, the Ministry of Public Health has established food-
safety plans, which address all major national food-safety problems.
Related governmental sectors understand that food safety requires
the integration of all stakeholders rather than any individual organ-
ization; therefore, co-operation among stakeholders is improving.
However, the insurance of “Safe from Farm to Table” is still a chal-
lenging task that requires hard work from all related agencies. To
help reduce the burden of foodborne diseases and implement pru-
dent use of antimicrobials in food-animals, a strong collaboration of
all stakeholders involved in the food chain, including both govern-
ment and private agencies (i.e. veterinarians, farmers, food micro-
biologists, epidemiologists, etc.), is essential.
Board 22. The Use of Pulsed Field Gel Electrophoresis and
Automated Ribotyping to Monitor the Increased Prevalence of
a Multidrug Resistant Salmonella serotype Newport in
Massachusetts Associated with Cows 
J. L. Fontana1, A. Stout1, M. A. Tyndall1, B. L. Bolstorff2, R. Timperi1
1Mass. State Laboratory Institute, Boston, MA, 2Massachusetts
Department of Public Health, Boston, MA
A strain of multidrug resistant Salmonella serotype
Newport (MDR S. Newport) has recently emerged in the United
States, first appearing in Massachusetts in April 1999. This strain is
characterized by resistance to at least ampicillin, cephalothin, chlo-
ramphenicol, clavulanic acid, streptomycin, sulfamethoxazole,
tetracycline and ceftriaxone. Between January 1999 and December
2001, 167 human and 17 bovine isolates were identified as S.
Newport at the Massachusetts State Laboratory Institute (SLI).
The rate of MDR among S. Newport isolates received at SLI rose
from 23% in 1999, to 49% in 2000 and to 54% in 2001. All 17
bovine isolates were MDR, whereas 66 of the human isolates were
MDR suggesting a possible bovine reservoir for this particular
strain of S. Newport. Automated ribotyping discriminated S.
Newport from other serotypes and correctly identified MDR S.
Newport as one of two dominant ribotypes. There were 71 pulsed
field gel electrophoresis (PFGE) patterns of XbaI digests of S.
Newport in both MDR S. Newport (n=8) and other S. Newport
(n=63). The dominant PFGE pattern in the MDR S. Newport iso-
lates was MA-JJP0034. Thirteen of 17 the bovine and 43 of the 66
human isolates displayed this pattern. Thus, both typing methods
were helpful in identifying the MDR strain of S. Newport; howev-
er, automated ribotyping was particularly useful in rapidly identify-
ing the serotype and PFGE in detecting associations that aided epi-
demiologic investigations.
Board 23. Comparison of Two Campylobacter Isolation
Methods and Their Effect on Antimicrobial Resistance Patterns 
P. J. Fedorka-Cray1, M. L. Headrick2, B. Rose3, M. D. Englen1, J.
Plumblee1, E. Adams1
1USDA-ARS, Athens, GA, 2FDA-CVM, Rockville, MD, 3USDA-FSIS,
Washington, DC
Introduction: Campylobacter spp. are fairly ubiquitous in
the environment but their fastidious nature make detection and
isolation in the laboratory difficult and time consuming. As part of
the National Antimicrobial Resistance Monitoring System
(NARMS), we routinely isolate Campylobacter from chicken car-
cass rinses. We developed a new Campylobacter isolation method
and compared it to our conventional isolation method routinely
used in our ARS laboratory. Methods: In the conventional method
(CM), Bolton enrichment broth (BB) was inoculated with a cotton-
tipped applicator soaked in the carcass rinse while in the new, or
spin, method (SM), 10 mL of the carcass rinse was pelleted, the
I C E I D  2 0 0 2  A B S T R A C T Spage 134
supernatant was decanted and the pellet was resuspended in BB.
For both methods, broths were incubated at 42°C for 48 h under
reduced atmosphere, streaked to Cefex agar, and incubated at
42°C for 48 h. Typical Campylobacter isolates were picked and
confirmed by PCR. Results: Using the SM, 92/331 (27.8%) rinses
were positive for Campylobacter while only 356/2564 (13.9%) rins-
es were positive using the CM. Isolates were tested for resistance
to azithromycin (Az), ciprofloxacin (Ci), chloramphenicol (Cl),
clindamycin (Cm), erythromycin (Em), gentamicin (Gm), nalidixic
acid (Na), and tetracycline (Tc). No isolates were resistant to either
Cl or Gm. The total percent C. jejuni isolated by the SM (n=48)
that were resistant to Az (4.2%), Ci (22.9%), and Na (22.9%) was
higher than total percent C. jejuni isolated by the CM (n=217):
2.8%, 17.5%, and 19.4%, respectively. Conversely, resistance to Tc
was 33.3% from the SM versus 49.3% from the CM. For C. coli,
the total percent resistant to Az (13.6%), Ci (18.2%), Em (13.6%),
and Na (18.2%) from the SM (n=44) was lower than those from the
CM (n=139): 22.3%, 25.2%, 22.3%, and 29.5%, respectively.
Resistance to tetracycline was also reversed with more (61.4%) iso-
lates resistant from the SM versus the CM (54.0%). Preliminary
analysis of the isolates recovered from the same sample by both
methods (21/331; 6.3%) does not indicate any resistance differ-
ences between methods. Conclusions: The increase in recovery
from the SM versus the CM suggests that total numbers of
Campylobacter are low within the sample and/or there may be a
tendency for more fit bacteria to survive and propagate in one
method over the other, most likely by concentration of numbers.
Additionally, we have observed more particulate material in the
pellet which may have a higher association with Campylobacter.
The difference between methods for both recovery and resistance
data when isolates are not recovered from the same sample clearly
demonstrates that outcome is affected by methodology and must
be considered when analyzing data from different studies.
Board 24. Comparison of Antibiotic Susceptibility Patterns of
Enteric Pathogens Between Local Populations and U.S.
Travelers to Thailand from 1995 through 2000 
M. D. Lewis1, D. Tribble2, S. Baqar2, J. Sanders2, A. Srijan1, C.
Pitarangsi1, L. Bodhidatta1
1Armed Forces Research Institute of Medical Sciences, Bangkok,
THAILAND, 2Naval Medical Research Center, Silver Spring, MD
Antibiotic resistance among enteric pathogens is of a criti-
cal concern and influences the effectiveness of treatment for
patients suffering from traveler’s diarrhea (TD). The Armed
Forced Research Institute of Medical Sciences (AFRIMS) rou-
tinely tests enteric pathogen isolates from patients for antibiotics
susceptibility (AS) patterns during the course of conducting
research on TD in South East Asia. We reviewed our databases for
the years 1995 through 2000 to compare the AS patterns of isolates
from U.S. adults traveling to Thailand to isolates collected from
studies done by AFRIMS in Thailand with local populations. We
compared the differences of resistance in bacterial isolates to
ampicillin (AMP), tetracycline (TCN), trimethoprim-sul-
phamethoxazole (SXT), ciprofloxacin (CIP), and azithromycin
(AZM). Percentage of antibiotic resistance among enteric
pathogens isolated from U.S. adults traveling to Thailand
compared to isolates from Thai local populations.
| Bacterial Pathogen [% Resistance (n=)]
Antibiotic Isolate Campylo- E.coli ETEC Salmonella Shigella Vibrio
source bacter (non-ETEC) non-typhi
AMP Thai 24(25) 47(900) 57(345) 27(996) 39(379)
US 40(210) 22(82) 51(73) 20(184) 13(16) 58(12)*
TCN Thai 41(27) 54(899) 41(345) 54(995) 91(379)
US 92(266) 85(82) 67(73) 80(184) 100(16) 0(12)
SXT Thai 85(26) 49(900) 48(345) 37(996) 92(379)
US 99(264) 38(82) 47(73) 23(184) 88(16) 17(12)
CIP Thai 78(876) 1(900) 1(344) 0(996) 0(379)
US 91(329) 4(82) 0(73) 0(184) 0(16) 0(12)
AZM Thai 6(839) 17(101) 14(58) 2(190) 0(76)
US 2(328) 4(82) 3(71) 8(143) 33(3)* 0(12)
Bolded numbers denote a statistical difference of
p<0.05 between the isolate sources. * While a statistical dif-
ference exists between sources, would disregard due to
small “n” for U.S. isolates. Overall, widespread resistance is
noted for enteric isolates to AMP, TCN, and SXT as well as for
Campylobacter to CIP. With the exception of SXT, Vibrio appears
to continue to be susceptible to these antibiotics. AZM has the least
percentage of resistance of these antibiotics. Differences in the AS
patterns between the two sources of isolates are noted especially to
TCN. Higher percentages of resistance from U.S. isolates may be
a result of the widespread prophylactic use of doxycycline by the
U.S. military against malaria when deployed to Thailand.
Interestingly, Thai isolates appear to have higher percentages of
resistance to AZM, though still a relatively small percentage. A
consistent difference is noted among pathogens only for
Campylobacter where U.S. isolates had a higher percentage of
resistance than Thai isolates. More research on Campylobacter is
needed to explore this phenomenon. Reporting of results from
research studies and surveillance systems throughout Asia will be
increasingly important for tracking changes in AS patterns and
making recommendations for the clinical treatment of TD.
Board 26. Comparison of Antimicrobial Resistance Patterns
in Campylobacter Species Isolated from Broiler Chickens in
1999 and 2000 
P. J. Cray1, M. L. Headrick2, N. Anandaraman3, M. D. Englen1, J.
Plumblee1, E. Adams1
1USDA-ARS, Athens, GA, 2FDA-CVM, Rockville, MD, 3USDA-FSIS,
Washington, DC
Introduction: Antimicrobial resistance has been increas-
ing in many bacteria. The National Antimicrobial Resistance
Monitoring System — Enteric Bacteria (NARMS) was established
to monitor for emerging resistance in food borne and commensal
bacteria of human and animal origin. Methods: The animal arm of
NARMS conducted antimicrobial susceptibility testing on
Campylobacter species isolated from broiler chicken carcass rinses
collected at federally inspected slaughter and processing plants in
1999 (C. jejuni n=77; C. coli n=19) and 2000 (C. jejuni n=90; C.
coli n=16). All isolates were tested for susceptibility to eight antimi-
crobials: azithromycin, ciprofloxacin, chloramphenicol, clin-
damycin, erythromycin, gentamicin, nalidixic acid, and tetracycline
using the E-test (AB Biodisk) as per manufacturer and NARMS
protocol. Data were analyzed by dividing the US into regions rep-
resenting the Northeast (Region 1; R1), Southeast (Region 2; R2),
Central North (Region 3; R3), Central South (Region 4; R4), and
West (Region 5; R5). More isolates of C. jejuni were available than
C. coli in R2 and R4 (representing regions with the highest broiler
production) for both years. For C. jejuni, total numbers by region
for 1999 and 2000, respectively, were R1 - 14 and 9, R2 - 32 and
39, R3 - 4 and 6, R4 - 25 and 29, and R5 - 2 and 7. For C. coli, total
















1, R2 - 9 and 10, R3 -3 and 0, R4 - 3 and 5, and R5 - 2 and 0,
respectively. Results: In both years, all isolates were susceptible
to chloramphenicol and gentamicin. Resistance to other antimi-
crobials varied by year and district; however, isolates were more
resistant to tetracycline than any other antimicrobial. For C. jeju-
ni, total numbers of isolates resistant to ciprofloxacin were 9 for
1999 and 10 for 2000. Multiple resistance (defined as resistance
to 2 or more antimicrobials) among C. jejuni varied between
regions for both years. Total number of C. coli resistant to
ciprofloxacin decreased from 1999 (5) to 2000 (1). For both years,
multiple resistance was highest in R2 for C. coli isolates.
Conclusions: Regional distribution indicates that a majority of
the isolates originated from the Southeast (R2) and Central South
(R4) which correlates with the major poultry production areas.
The relatively low numbers of isolates from R1, R3 and R5 con-
found analysis of the data. Collectively, there appears to be little
variation among resistance patterns throughout the regions with
the exception of multiple resistance in C. coli as multiple resist-
ance was observed in all 5 regions for 1999 and while only in R2
and R4 in 2000. Continued monitoring and increasing total num-
bers of isolates tested is warranted.
Board 27. Multiple Resistance Among Salmonella Isolates of
Animal Origin from The National Antimicrobial Resistance
Monitoring System -Enteric Bacteria 1997-2000 
P. J. Fedorka-Cray1, M. L. Headrick2, N. Anandaraman3, J. T. Gray1,
D. A. Dargatz4, J. Hermosillo1, T. Ball1
1USDA-ARS, Athens, GA, 2FDA-CVM, Rockville, MD, 3USDA-FSIS,
Washington, DC, 4USDA-APHIS, Fort Collins, CO
Introduction: Developing antimicrobial resistance to new
and older drugs is of global concern. However, the growing trend
of multiple resistance involving both new and older drugs will exac-
erbate the problem. The National Antimicrobial Resistance
Monitoring System — Enteric Bacteria (NARMS-EB) was estab-
lished to monitor emerging resistance in food borne and commen-
sal bacteria of human and animal origin. Methods: As part of the
animal arm of NARMS, Salmonella isolates were submitted from
raw product collected at slaughter and processing plants (designat-
ed SI) or from feces or tissue samples collected from diagnostic
submissions (designated DI) from chickens (CH), cattle (CL),
swine (SW) and turkeys (TK) for 1997 through 2000. Antimicrobial
susceptibility testing was conducted using the SensititreTM
System (Trek Diagnostics, Inc.) as per manufacturer’s directions.
Antimicrobials were selected and configured in a 96 well custom
made panel. Results were analyzed by year, type (SI or DI), source
(CH, CL, SW, TK), and serotype. Total percent pan-susceptible
and resistance to only 1 antimicrobial were combined for this
analysis. Multiple resistance was defined as resistance to ≥ 2
antimicrobials. Results: Overall, SI from CL, SW, and TK were
more susceptible than DI regardless of year. For CH isolates, how-
ever, multiple resistance was 34% in 1997 and 1998 and 33% in
1999 and 2000 among SI while multiple resistance among DI was
23%, 40%, 26%, and 26% for 1997-2000, respectively. Regardless
of type, turkey isolates had more multiple resistance than CH, CL,
or SW. The least multiple resistance was observed among CL sam-
ples collected from SI. The most common resistance pattern from
all sources was to Streptomycin, Sulfamethoxazole and
Tetracycline. Resistance to more antimicrobials was observed
among DI. Analysis within source by year was variable and no
trend among sources was detected. The top 5 serotypes also varied
widely between sources by year. Conclusions: These data indicate
that multiple resistance is less in CL, SW and TK SI when com-
pared to DI. This is not unexpected as diagnostic submissions are
often made after an animal is ill or dead, and depending upon
source, may have been treated for prior illness. The data observed
for CH isolates was not expected. It is possible that this reflects
submission of samples from earlier periods in production prior to
extended exposure or use of antimicrobials or variations in
serotype. The most common multiple resistance pattern for all iso-
lates is to older drugs. However, when multiple resistance includ-
ed newer drugs, resistance was also observed to the older drugs.
Molecular analysis of multiple resistant cassettes will assist in fur-
ther analysis of the data. While multiple resistance does not appear
to be significantly changing among SI, analysis by serotype and
region will provide the additional detail which is necessary to
determine if trends are emerging.




The development of multiple resistance of Staphylococcus
aureus towards clinically relevant antibiotics was the reason to ana-
lyze the effectiveness of patented antibiotics towards S. aureus
back to the year 1948. The number of patents covered by this
analysis exceeds 600 and the number of antibiotics 1100 (1).
The effectiveness of the respective antibiotics is expressed
as ‘Therapeutic Index’ (TI) according to the formula TI = LD50
/MIC, which calculates the toxicity of antibiotics towards microor-
ganisms in vitro (MIC = minimal inhibitory concentration in ppm)
and the toxicity towards animals in vivo (LD50 = that dose causing
death of 50% of test animals in mg/kg/body weight). The toxicity
data of antibiotics towards animals have been determined on sev-
eral administration routes, and therefore, it was distinguished
between oral, intraperitoneal (ip) and intravenous (iv) ‘TIs’. The
TIs (iv, ip) of vancomycin were used as reference and only such
antibiotics are listed among results which show higher TIs than the
reference compound itself.
To select antibiotics with anti-staphylococcal activity having
different chemical basic structures than antibiotics used in the
therapy of S. aureus infections, antibiotics belonging to the follow-
ing groups were excluded from this analysis: tetracyclines, beta-lac-
tams, macrolides, aminoglycosides, ansa-type antibiotics and
quinolones. In a second attempt the selected antibiotics were
checked for occurrence of microbial resistances and positive com-
pounds were also excluded.
The selected antibiotics on the basis of iv toxicity data 
are nosiheptide, platomycin B, diumycin A, moenomycin,
pholipomycin, thiostrepton, siomycin, platomycin A, and FR-
900451. On the basis of ip toxicity data danomycin, nosiheptide,
thermorubin, thiostrepton, siomycin, platomycin B, A-82846-A,
diumycin A, enduradicin, A-47934, and thiopeptin A1 are selected.
On the basis of oral toxicity data chlorobiocin, pactamycin, resisto-
mycin Bayer, actinomycin C complex, carriomycin, cervinomycin
A2 monoacetate, cervinomycin A1 triacetate, AM-5344-A2, macro-
momycin, aflastatin A, T-2636-C and amicetin showed promising
results. The data on the selected antibiotics indicate that a greater
number of compounds exist being more effective against S. aureus
than vancomycin. Their usefulness as clinical therapeutics depends
on further factors, such as the failure of cross-resistance to thera-
peutically relevant antibiotics, satisfactory bioavailability, and
absence of side effects.
References
1) AMICBASE-EssOil: Database on Natural
Antimicrobials, ReviewScience, Germany (1999-2002)
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Board 30. Surveillance for Patients with Acute Meningitis 
in Egypt 
M. A. Azab1, H. El Sakka1, F. G. Youssef1, T. Ismail1, S. El Oun2, H.
Mansour1, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Ministry
of Health and Population, Cairo, EGYPT, 3Centers for Disease Control
and Prevention, Atlanta, GA.
Background: Acute meningitis is an important cause of
morbidity and mortality in Egypt. Surveillance for patients with
meningitis is a high priority to determine the etiology and design
prevention strategies. In June 1998, a project to develop enhanced
surveillance for patients with meningitis and encephalitis was
implemented in diverse areas of Egypt. This report describes clin-
ical and epidemiological features of bacterial meningitis from this
network during the first 3 years. Methods: Clinical and laboratory
training was conducted to optimize recovery of bacterial pathogens
and standardize collection of clinical information. Results: Of the
6868 patients evaluated between June 1998 and August 2001, 691
(10.1%) had culture-confirmed bacterial meningitis. The etiology
of disease included 244 patients (35%) with S. pneumonia (SP),
129 (19%) with H. influenzae (HI), 125 (18%) with N. meningitides
(NM), 106 (15%) with Mycobacterium tuberculosis (MTB), and 87
(13%) with other bacterial causes of disease. The mean age of cul-
ture-positive patients was 13 years for patients with SP, 1.0 for
patients with HI, 15 for patients with meningococcal disease, and
24 years for patients with MTB. The overall case fatality ratio was
25.5% and was highest among patients with MTB (46.2%), fol-
lowed by HI (25.6%), SP (23%) and NM (16%). The mean inter-
val from the onset of illness to date of hospital admission was high-
est among patients with TB meningitis (13 days) and was higher
among patients who died (7 days) compared to patients who sur-
vived (4.6 days). Sensitivity to penicillin and ceftriaxone was
56%/94% (SP), 71%/90% (HI) and 14%/81% (NM-ampicillin
used). Conclusion: SP is the leading cause of bacterial meningitis
in Egypt followed by HI, NM and TB. The case fatality ratio for
patients with all forms of meningitis is higher than what is report-
ed in United States and European countries and could be due to
delayed presentation and the emergence of antibiotic resistance.
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Board 31. The Association of Enterotoxigenic Escherichia coli
with Hospitalized Diarrheic Patients in Denpasar, Indonesia
D. S. Subekti1, M. Lesmana1,2, P. J. Tjaniadi1, N. N. Safari1, C. H.
Simanjuntak1, S. Sukarma3, N. Sriwati4, W. K. Alexander1, A. L.
Corwin1, B. A. Oyofo1
1U.S. Naval Medical Research Unit No.2, Jakarta, INDONESIA,
2Medical Faculty Trisakti University, Jakarta, INDONESIA, 3Sanglah
Hospital, Denpasar, Bali, INDONESIA, 4Wangaya Hospital,
Denpasar, Bali, INDONESIA
Infection caused by enterotoxigenic Escherichia coli
(ETEC) poses a serious health problem among children and adults
in developing countries. Colonization of the small intestinal
mucosa by ETEC strains is mediated by antigenically specific fim-
brae. The relationship between ETEC and hospitalized patients
with acute diarrhea was examined in two hospitals in Denpasar,
Indonesia. A total of 489 hospitalized patients with acute diarrhea
were enrolled in this study and their stools were screened for
enteric bacterial pathogens. Toxins, colonization factor antigens
(CFAs), in vitro antimicrobial susceptibility and seasonal distribu-
tion patterns associated with ETEC were ascertained. The diagno-
sis of ETEC infection and CFA association were performed with
GM-1 ELISA and Dot blot immunoassays. ETEC was isolated
from the stools of 14.9% of the patients. The distribution of toxins
among the ETEC strains was ST- 51 at 69.9% and LT and ST/LT
with 28.8% and 1.3%, respectively. A high isolation rate of ETEC
was found among children between 1 and 5 years. CFAs were iden-
tified in 28.8 % of the ETEC strains. A high prevalence of CFAs
was found among the stools of patients with ST isolates. A high
resistance to ampicillin, trimethoprim/sulfamethoxazole, chloram-
phenicol, tetracycline and cephalothin was observed among ETEC
strains. All ETEC strains were susceptible to norfloxacin,
ciprofloxacin and nalidixic acid. The results of this study document
the association of ETEC bacteria among hospitalized patients with
acute diarrhea in Denpasar, Indonesia. These data may help cur-
rent research efforts on the development of CFA-based vaccines
for humans against ETEC and provide additional information for
future ETEC vaccine trials in Indonesia.
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Board 32. Hepatitis C Virus: Tainted Blood in Latin America 
G. A. Schmunis1, J. R. Cruz1, F. Zicker2
1Pan American Health Organization, Washington, DC, 2World Health
Organization, Geneva, SWITZERLAND
The number of cases of transfusion-transmitted infectious
diseases can be estimated from the number of blood donors, per-
centage of donors screened, and the prevalence rate of serologic
markers in the donor population(1,2).We report here such infor-
mation for 9 Latin American countries in 1993 (Chile, Colombia,
Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Peru, and
Venezuela, with 1,125,579 screened donors for all these countries);
for 9 countries in 1994 (Colombia, Ecuador, El Salvador,
Honduras, Nicaragua, Panama, Peru, Uruguay and Venezuela,
with 976,670 screened donors); for 12 in 1995 (the same countries
as in 1994 plus Argentina, Costa Rica, and Paraguay, with
1,929,124 screened donors); and for 13 in 1997 (the same countries
as in 1995 plus Chile, with 2,326,685 screened donors for all these
countries). Estimates were based on official national reports of the
number of blood donors, percentage of donors screened, and
prevalence of HCV by EIA in the donor population (1-3). The
prevalence of HCV in the different countries varied from 0.5 to
9.4/1,000 donors during the study period. To calculate the poten-
tial number of tainted units of blood the following assumptions
were made (1,2): 1) Reagents and blood bank procedures were of
good quality and appropriate, 2) fractionation indices used were
those published elsewhere (3); when data were not available, it was
assumed that each blood donation was used for a single transfusion
to one recipient; 3) The prevalence of HCV for the non-screened
population was considered to be equivalent to that reported among
the screened donors. We estimated that there were 6,675 tainted
units of blood in 1993; 2,231 in 1994; 3,540 in 1995, and 797 in
1997. No country screened 100% of donors, and the percentage of
















were available in 1993. Donors were not screened in Bolivia and
Costa Rica in 1993, or in Paraguay in 1994. On the other hand, 4
and 6 countries, respectively, screened 100% of donors in 1995 and
1997. In those that did not, screening coverage varied from 25 to
99%. The number of tainted units per 10,000 blood donors
decreased from 59 in 1993, to 23 in 1994, 18 in 1995 and 3 in 1997.
Continuous collection of this type of information is essential for
obtaining the support needed to expand blood donor screening.
References: Schmunis GA, Zicker F, Pinheiro F, Brandling-
Bennett D, 1998. Risk of transfusion transmitted infectious dis-
eases in Central and South America. Emerg Infect Dis 4: 5-11.
Schmunis G, Zicker F, del Pozo A, Segura E, 2000. Blood trans-
mitted infectious diseases: Argentina 1995 through 1997.
Transfusion 40: 1048-1053. 3. Pan American Health Organization.
Third Meeting of the Task Force on Surveillance for Emerging and
Re-Emerging Infectious Diseases, 1998. November 16-17. Mexico
City, Mexico, PAHO/HCP/HCT/141/99.
Board 33. Detection of Viable Chlamydia pneumoniae in
Peripheral Blood Mononuclear Cells Obtained from Healthy
Blood Donors 
Y. Yamamoto1, H. Ikejima1, H. Yamaguchi1, H. Friedman1, G. F.
Leparc2
1University of South Florida College of Medicine, Tampa, FL, 2Florida
Blood Services, St. Petersburg, FL
C. pneumoniae (Cpn) is an obligate intracellular bacterium
associated with respiratory tract infections. Current studies suggest
a possible involvement of Cpn in some chronic diseases, such as
asthma, arthritis, and atherosclerosis. In particular, atherosclerosis
is recognized as a chronic inflammatory disease and the involve-
ment of Cpn in this disease has been strongly indicated. In this
regard, current studies showed that Cpn antigens can be detected
by PCR not only in atherosclerotic plaques but also in peripheral
blood mononuclear cells (PBMCs) obtained from patients with
coronary artery disease. However, the viability of these bacteria in
the specimens is not known due to the difficulty of Cpn culture.
Therefore, it is not clear whether the bacteria detected in speci-
mens, particularly in PBMCs, can be a potential risk factor for the
diseases associated with Cpn infection. In the present study, we
examined the prevalence of Cpn in PBMCs from healthy blood
donors by PCR assay specific for Cpn as well as by Cpn antigen
detection with FITC-conjugated anti-Cpn antibody. Furthermore,
the cultivation of PBMCs for detection of viable bacteria using RT-
PCR and determining increased numbers of Cpn was also per-
formed. The PBMCs of healthy blood donors were found positive
for Cpn in a significant number (8.9 %; 21 positive/237 tested) as
determined by both PCR and staining for Cpn. When a highly sen-
sitive PCR protocol, established in our laboratory, was utilized for
detection of Cpn in blood specimens, the prevalence of Cpn in the
blood obtained from healthy donors increased significantly.
Culture in vitro of PBMCs obtained from health donors resulted in
an increase of Cpn numbers as well as message levels of Cpn genes
determined by staining with specific antibody and RT-PCR,
respectively. These results clearly indicate that Cpn detected in the
PBMCs are viable and can proliferate. The demonstration of the
presence of viable Cpn with growth potential in blood of healthy
donors reveals a potential risk factor carried by a significant num-
ber of healthy people, as well as the possibility of transmission of
this pathogen through blood transfusions.
Board 34. Comparaison by PFGE of S. marcescens Strains
Isolated from Post Transfusional Infections
H. Tali-Maamar1, P. Pina2, F. Sahli3, P. Allouch2, K. Rahal1
1Pasteur Institute, Algiers, ALGERIA, 2Centre hospitalier André
Mignot, Versailles, FRANCE, 3Centre Hospitalo-Universitaire de Sétif,
Sétif, ALGERIA
We are reporting the analysis by PFGE of 32 strains of
S.marcescens isolated to investigate of nosocomial infections (gyne-
cology and surgery wards) . The strains prove from blood culture of
patients have presented a post transfusion hypothermia, from sur-
face groups and pockets of blood, some of which were adminis-
tered to some of these patients. All these cases happened in the
same period (on one month). A study of antibiotic sensitivity shows
a same profile of all, and identical at there of the wild strain
(cephalosporinase low level). The pulsed field gel electrophoresis,
after restriction with XbaI, reveal 3 different groups according (A,
B and C) to migration profil. Nevertheless the pulsotype A repre-
sent the majority (30/32=93.73%). For one patient we had: the
same strains isolated from blood culture and pocket blood that was
transfused for this patient. This presume that this patient was con-
taminated by the transfusion, and for all specimens the same
source of contamination was determined. If infection is a rare com-
plication of blood transfusion, this is often fatal. Bacterial control at
different steps of blood construction would have to be made.
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Board 35. Group I Intron as Therapeutic Target : Screening
of Chemotherapeutic Agents Lodging Amino Groups Against
Candida albicans 
R. Malathi
Department of Genetics, Dr.ALM PG IBMS, University of Madras,
Taramani Campus, Chennai, INDIA.
Earlier in vitro studies have shown that certain antimicro-
bial antibiotics act as potential inhibitors of group I intron self
splicing mechanism. Some of these agents act as competitive
inhibitors, while some lodging amino groups bind strongly to
unique regions of the RNA. Moreover the presence of the catalyt-
ic RNA in the essential genes of the pathogens, and their absence
in humans suggest that group I introns can be a potential target site
for such agents, especially if they are properly oriented and deliv-
ered to their target site.
The above reports were an initiative to take up the in vitro
screening of certain aminoglycoside antibiotics such as strepto-
mycin, amikacin, tobramycin, gentamycin, kanamycin; antimicro-
bial antibiotic - tetracycline; antitumour agents like mitoxantrone
and mitomycin C, against ATCC 10261 and three clinical strains of
Candida albicans. This pathogenic fungus is a normal commensal
organism causing mild, superficial infections in an immuno com-
petent host but capable of causing life threatening systemic, dis-
seminated disease in a compromised patient, for which self splic-
ing group I introns have been identified in the 25S rRNA gene,
denoted as Ca.LSU. Disc diffusion, growth curve analysis, broth
macro dilution, RNA isolation and fluorescent microscopic studies
were carried, and the results indicated that tetracycline, amikacin,
streptomycin, mitoxantrone and mitomycin C had inhibited
remarkably the multiplication of Candida albicans. Mobility shifts
were observed in the band corresponding to 25S rRNA isolated
from aminoglycosides and tetracycline treated candida and degra-
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dation in antitumor agents treated ones, suggesting the interactios
of drugs with RNA. Marked changes in the morphology of the
ovoid cells and hyphae were observed in the drug treated cells
stained with EtBr viewed under Nikon fluorescent microscope at
100X magnification.
These interpretations may suggest that detailed molecular
analysis as well as drug delivery system of the above drugs through
liposomes/epitopes would further aid in reacting with respective
target sites of RNA of Candida albicans.
REFERENCE:
1. Von Ahsen, U. and Schroeder, R. (1991). Streptomycin
inhibits splicing of group I introns by competetion with guanosine
substrate. Nucl. Acids. Res. 19 : 2261-2265.
2. Milletti, K.E., Leibowitz, M.J.,(2000). Pentamidine inhi-
bition of group I intron splicing in Candida albicans correlates with
Growth inhibition. Antimicrobial Agents and Chemotherapy. 2000,
44, No.4: 958-966.
Board 36. Natural Infection by SIV in Indian Primates
J. S. Nandi
National Institute of Virology, Pune, INDIA
It is generally believed that the Asian primates, unlike the
African primates are not naturally infected by SIVs. However sero-
logical and PCR based experimental evidence suggets that the wild
Indian rhesus monkeys (Macaca mulatta) are naturally infected by
putative SIV. Phylogenetically it is likely to be related to but dis-
tinct from the known African SIVs. The relevant data are present-
ed and discussed.
Board 37. Stealth-Adapted Viruses and Viteria: Insights into
Virus Construction, Replication and Potential Therapies Based
on DNA Sequence Analysis of an African Green Monkey
Simian Cytomegalovirus-Derived Stealth Virus
J. Martin
Center for Complex Infectious Diseases, Rosemead, CA
Stealth-adaptation is a mechanism that allows cytopathic
viruses to evade immune elimination through the deletion of genes
coding the major antigens targeted by the cellular immune system.
A prototype stealth-adapted virus, repeatedly cultured from a
patient with chronic fatigue syndrome (CFS), was cloned and par-
tially sequenced. The virus has a fragmented, genetically unstable,
genome. It has retained numerous viral sequences that can be
aligned to various regions of the genome of human
cytomegalovirus (HCMV). Where the comparison can be made,
the sequences match much more closely to those of African green
monkey simian cytomegalovirus (SCMV), indicating an unequivo-
cal origin from SCMV. Kidney cells from cytomegalovirus seropos-
itive African green monkeys were, until recently, routinely used to
produce live poliovirus vaccine. The SCMV-derived stealth-adapt-
ed virus has five adjacent, but divergent, open reading frames that
potentially code for molecules related to the US28 CC chemokine
receptor protein of HCMV. In addition, the virus has acquired cel-
lular sequences from infected cells, including a set of three diver-
gent genes that potentially code for proteins related to the putative
oncogenic CXC chemokine known as melanoma growth stimulato-
ry activity (MGSA/Gro-alpha). The amplification of chemokine and
chemokine receptor related genes in the prototype SCMV-derived
stealth-adapted virus, supports current experimental therapeutic
approaches based on chemokine suppression. Interestingly, the
MGSA-related genes generally lack introns and were, therefore,
presumably assimilated into viral DNA from cellular RNA through
reverse transcription. The virus has also acquired genetic
sequences from various bacteria. This finding has led to the sec-
ondary designation of this type of novel microorganism as viteria.
Molecularly heterogeneous viruses, inducing similar cytopathic
effects in culture (and when examined; non-inflammatory vacuo-
lating cellular damage in brain and tissue biopsies), have been cul-
tured from numerous patients with severe neurological, psychi-
atric, immunological and neoplastic diseases. In controlled, blind-
ed, studies, cytopathic effects were recorded in 9% of healthy indi-
viduals donating blood for transfusion; in contrast to the positive
results recorded in virtually all blood samples from patients with
various illnesses. The differing clinical manifestations in infected
patients may reflect the assimilation of different cellular and other
sequences in various stealth-adapted viruses. Stealth-adapted
viruses (and viteria) pose a major threat to Public Health. Further
information is available on the internet at www.ccid.org
Board 38. New Rickettsiae and Ehrlichiae Detected in Ticks
from Thailand and Vietnam 
P. Parola1,2,3, J. P. Cornet4, J. P. Gonzalez4, H. V. Thien5, D. Raoult3,
R. S. Miller2, S. R. Telford, III1, C. Wongsrichanalai2
1Harvard School of Public Health, Boston, MA, 2Armed Forces
Institute of Medical Sciences (AFRIMS), Bangkok, THAILAND, 3Unite
des Rickettsies, Marseille, FRANCE, 4Institut de Recherche pour le
Developpement, Mahidol University, Bangkok, THAILAND, 5Bao Loc
General Hospital, Bao Loc, Lam Dong Province, VIETNAM
Background: To date, 2 spotted fever group (SFG) rick-
ettsia have been identified in ticks in Thailand including (i) the
Thai tick typhus Rickettsia (TT-118, suggested to be a strain of
Rickettsia honei, which is an emerging pathogen prevalent on
Flinders Island, Australia) and (ii) a new rickettsia of unknown
pathogenicity (“R. thailandii sp. nov.’ Kollars et al. 2001). Their
role as agents of human disease is not known. Ehrlichioses of vet-
erinary importance are well-known to occur in Thailand, mainly
canine ehrlichiosis due to E. canis and transmitted by the brown
dog tick Rhipicephalus sanguineus. Although human ehrlichioses
have been suspected to occur in Thailand based upon on sero-
logical data, ehrlichiae that are recognised as human pathogens
have not yet been identified from patients or in human-biting
ticks. Accordingly, we analysed ticks collected from peridomestic
or other common animals for evidence of rickettsial and
ehrlichial infection.
Methods: Between September and December 2001,
around 500 ticks were collected in the central part of the Thai-
Myanmar border (Sangkhlaburi District, Kanchanaburi Province,
Thailand) by flagging vegetation, and from animals or people. Ticks
included 8 species from 5 different genera. Thirty specimens col-
lected in Vietnam were also included in this study. The DNA of
each tick was extracted and rickettsial DNA was detected by PCR
using RpCS.877p-RpCS.1273r which amplify an informative frag-
ment of the citrate synthase gene. Ehrlichial DNA was detected
with EHR16SR-EHR16SD primers which amplify a fragment of
the 16S rRNA gene of ehrlichiae; larger portions of the 16S rRNA
gene were subsequently amplified from tick DNA samples that
were found to be positive, using the universal primers fD1 and rp2.
All amplicons were sequenced and analysed by routine phyloge-
netic procedures.
Results: Five new ehrlichial genotypes were identified
from ticks infesting peridomestic animals, including (i) Bm52 and
Bm218 from Boophilus microplus collected on cattle in Thailand,
















wild pigs in Vietnam, and (iii) Aj360 from Amblyomma javanense
collected on pangolins in Thailand. Bm52, Bm218, Hh317 and
Hh324 were assigned to the Ehrlichia canis genogroup and Aj360
to the E. phagocytophila genogroup. Two new SFG rickettsial
genotypes were also detected from A. testudinarium and from a
pool of Dermacentor larvae; other genes are now being studied to
better characterize these new rickettsiae. We conclude that rick-
ettsiae and ehrlichiae are common infections of peridomestic ani-
mals in Thailand and Vietnam; their role as agents of human infec-
tion, however, remains to be described.
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Board 39. Spectrum of Gut Immunologic Reactions to New
Vibrio cholerae and its Toxin 
K. Walia1, H. Vohra2, N. K. Ganguly1
1Indian Council of Medical Research, New Delhi, INDIA,
2Postgraduate Institute of Medical Education and Research,
Chandigarh, INDIA
Vibrio cholerae is a normal inhabitant of aquatic environ-
ments. However, contaminated supplies in some areas of the world
have enabled some clones of the species to become pathogenic for
humans. We chose to work on an epidemic isolate of V.cholerae
WO7 which was devoid of ctx, zot and ace genes, but elaborated an
extracellular factor that evoked fluid accumulation in rabbit ileal
loop and elongated Chinese Hamster Ovary cells in culture. The
characterization and sequencing of purified toxin revealed that this
toxin was distinct from the known cholera toxins. The analysis of
the nature of immune responses evoked by this V.cholerae WO7 in
the gut of mice revealed striking differences as compared to those
elicited by V. cholerae569B. Oral infection with both V.cholerae
WO7 and 569B resulted in an increased number of CD4+ cells in
spleen, peyer’s patches and mesentric lymphnode compartments.
Significant differences were seen in the expression of CD45RO on
cells in different compartments with V.cholerae WO7 as compared
to V cholerae 569B.Infection with V.cholerae WO7 resulted in
enhanced expression of IL-2R on the peyer’s patches and splenic
lymphoid cells. Oral infection with V cholerae 569B yielded a
Th2type of response at peyer’s patch as well as splenic level with
traces of Il-12 and IFN-γ. However V.cholerae WO7 infection
resulted in release of Th1 type of cytokines at gut as well as at sys-
temic level during early stages which subsequently transformed to
Th2 type during later stages. Infection with both V.cholerae WO7
and 569B induced toxin specific IgA secreting cells at gut as well as
splenic level which was potentiated by the release of cytokines like
IL6 and IL-10 at the gut as well as splenic level. The abundant IgM
responses seen during initial stages decline gradually followed by
IgG1 during later stages. Although there was appearance of other
IgG isotypes but the net outcome in both the groups aws persist-
ing IgG1 at gut as well as splenic level along with IgA. This under-
standing of toxin specific T cells and their activation will provide
further basis for development of strategies for prevention and con-
trol of cholera infections.
Board 40. Haemophilus Influenzae Type B (Hib): Alternative
and Fractional-Dose Regimens of Hib Vaccines for the Prevention
of Hib Meningitis and Pneumonia in Resource-Poor Countries
D. Seyoum1, K. W. Johnson2, N. L. Blum3
1The United States Pharmacopeial Convention, Inc., Rockville, MD,
2Management Sciences for Health (MSH) [formerly with the USP],
Arlington, VA, 3The United States Pharmacopeia (USP), Rockville, MD
Background: Invasive disease caused by Haemophilus
influenzae type b (Hib), including meningitis, pneumonia, sepsis
and epiglottitis, is associated with high mortality and serious neu-
rological sequelae in children under 5 years of age. Hib conjugate
vaccines provide substantial protection against nonbacteremic
pneumonia, particularly those cases with alveolar consolidation,
pleural effusion or other signs of likely bacterial infection. Hib
meningitis is near elimination from many developed countries fol-
lowing the introduction of Hib conjugate vaccines into childhood
immunization schedules; however, Hib remains a major cause of
meningitis and pneumonia in many developing countries. Although
Hib conjugate vaccines have been successful, nearly eradicating
Hib disease in countries where used routinely, they are relatively
expensive, compared with the vaccines routinely used in the
Expanded Program for Immunization (EPI).
Methods: Although Hib vaccination would be considered a
cost-effective public health intervention, it may be cost-prohibitive
to implement in resource-poor countries. Members of the USP
Drug Information Expert Committees reviewed the published
clinical trials on alternative and fractional-dose regimens for vacci-
nation against Hib presented to them in the form of evidence
tables. The evidence tables were based on evidence ratings. The
main outcome of the study was safety, effectiveness, and cost of
Hib vaccines can be within reach of developing countries that cur-
rently cannot afford these vaccines.
Results: Published clinical trials of alternative and frac-
tional-dose regimens of Hib conjugate vaccines were analyzed
based on their evidence ratings. The immunogenicity of fractional-
dose and two-dose regimens of Hib conjugate vaccines was com-
pared to the standard three-dose series to identify more economi-
cal vaccination schedules. This analysis included the following reg-
imens: three full doses, three fractional doses consisting of one half
or one third of the full dose, and a regimen of two full doses (at age
4 and 6 months).
Conclusions: Alternative and fractional-dose regimens of
Hib vaccines are safe and effective and these alternative and frac-
tional-dose regimens could bring the cost of Hib vaccines within
the reach of countries that currently cannot afford them.
Therefore, the members of USP Drug Information Expert
Committees recommend that fractional doses of Hib conjugate
vaccines may be used in countries that currently cannot afford the
standard 3 dose-series.
Board 41. Human T Cell Proliferative Responses Induced
by ChimeriVaxTM-JE, an Experimental Live-Attenuated
Vaccine, and the Licensed Inactivated Japanese Encephalitis
Virus Vaccine 
S. Green1, A. L. Rothman1, J. Cruz1, F. Guirakhoo2, T. P. Monath2, F.
A. Ennis1
1University of Massachusetts Medical School, Worcester, MA,
2Acambis Inc., Cambridge, MA
Japanese encephalitis (JE) virus is a significant cause of
neurologic morbidity and mortality in Asia. Although an effective
vaccine is available, it is relatively expensive, requires multiple
doses and is reactogenic. ChimeriVaxTM-JE is a candidate second-
generation live-attenuated vaccine based on the safe and effica-
cious Yellow Fever (YF) 17D vaccine in which the prM and E
genes have been replaced with those of JE virus. We examined T
cell proliferative responses in 36 subjects enrolled in a Phase I clin-
ical trial of ChimeriVaxTM-JE. Subjects were stratified by immune
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status to YF and each stratum divided into three groups:
ChimeriVaxTM-JE 5 logs, ChimeriVaxTM-JE 4 logs, or YF-Vax® ,
the currently licensed YF vaccine. Blood specimens were collected
pre-vaccination and on day 31 post-vaccination, and peripheral
mononuclear cells were separated and cryopreserved. T cell prolif-
eration assays were performed using inactivated antigens prepared
as crude lysates of Vero cells infected with YF, JE Nakayama strain,
JE SA14-14-2 or the ChimeriVaxTM-JE virus.
Neutralizing antibody responses to JE viruses were detect-
ed in all subjects who received either dose of ChimeriVaxTM-JE.
Proliferation responses to inactivated JE antigens were detectable
in a minority of subjects, all of whom were in the YF-immune
group. In addition, less than half of the YF-na&#239;ve subjects
who received either ChimeriVaxTM-JE or YF-Vax® developed T
cell proliferative responses directed against YF or ChimeriVaxTM-
JE inactivated antigens by day 31. In contrast, T cell proliferative
responses directed against YF or ChimeriVaxTM-JE were detected
in the majority of YF-immune subjects on day 0; responses to YF
antigen declined in some of these subjects by day 31.
We also studied two subjects who received 3 doses of the
licensed inactivated JE vaccine as a control. PBMC from these
donors responded to JE antigens 3 and 30 days following the third
immunization. Serial samples from one donor demonstrated per-
sistent T cell proliferative responses as long as 235 days following
the third immunization.
We conclude that T cell proliferative responses to JE virus-
es can be induced by immunization with ChimeriVaxTMJE or by
the licensed inactivated JE vaccines. Studies of CD4+ and CD8+
T cell responses to JE following ChimeriVaxTM-JE are ongoing.
Board 42. The Use of Surface Antigens from Gram-negative
Bacteria for Vaccines
V. N. Parkhomenko1, E. D. Moroz1, M. T. Parkhomenko2
1Institute of Epidemiology and Infectious Diseases, Kiev, UKRAINE,
2Institute of Biochemistry, Kiev, UKRAINE
The aim of investigations was to develop the vaccines and
immune serum that are effective under hospital infections caused
by bacteria Escherichia, Proteus, Salmonella and Pseudomonas,
especially in consequence of immunodeficiency. Antigens were
obtained by J.E.Scott, W.Nimmich, investigated biochemical, on
cell cultures Vero, HeLa and neurons, on white mousses using pro-
bit analysis of lethality curves, in IHA. Samples were grouped in
four complex surface antigens (CSA) according to genera. Contents
of CSA: polysaccharide from 6-9 kDa to 300 kDa with small impu-
rities of nucleic acid. LD50 of CSA were from 2.21 to 3.26 mg. We
tested by factor analysis the method of serum obtaining with titers
of antibodies: Salmonella 1:2560, Escherichia 1:2560,Pseudomonas
1:1280, Proteus 1:2560. Rise of im-munity were after vaccination of
rabbit: increase of IgM, IgG and of bacteri-cidal, opsonic and cyto-
toxic neutralizing activity of serum, higher phagocytosis of bacteria
by polymorphonuclear and macrophage cells, enlargement of T-
helper and B lymphocytes. Protective action of serum was investi-
gated on nor-mal and compromised white mice. For reduction of
immunity the mice were X-rayed. LD50 for normal and LD*50 for
X-rayed animals were determined for all strains. Immune serum
(1:960) against Escherichia defended the normal mice from death
under injection 4 LD50 and compromised mice under injection of
3 LD*50 E.coli K1. Immune serum (1:960) against spp. Proteus
defended the normal mice from death under injection of 4 LD50
and X-rayed mice under in-jection 3 LD*50 P.mirabilis. Immune
serum (1:1920) against P.aeruginosa de-fended the mice from death
under injection 4 LD50 and x-rayed mice under in-jection of 4
LD*50 P.aerugiosa O2. Immune serum (1:1260) against Salmonella
defended the normal mice from death under injection 5 LD50 and
x-rayed mice under injection of 3 LD*50 S.typhimurium. LD50 and
LD*50 differed in 3,7 - 5,2 times. Thus antibodies against surface
antigens of Escherichia, Proteus, Salmo-nella, Pseudomonas can
significantly increase efficiency of macroorganisms re-sistance.
Board 43. Randomized, Placebo-Controlled Field Trial of an
Autoclaved Leishmania amazonensis Vaccine Plus BCG
Adjuvant Against New World Cutaneous Leishmaniasis 
R. X. Armijos1,2, M. Weigel3,2, A. Hidalgo1, W. Cevallos1, J. Correa1
1Universidad Central del Ecuador, Quito, ECUADOR, 2Fundacion
Internacional "Biociencias", Quito, ECUADOR, 3Virginia Tech,
Blacksburg, VA
The randomized, placebo-controlled study evaluated the
safety, immunogenecity, and efficacy of an autoclaved-killed, whole
cell L. amazonensis vaccine (Leishvaccin) against cutaneous leish-
maniasis (CL) in an endemic tropical Ecuadorian population.
Vaccine group subjects (n=1009) received two intradermal doses of
vaccine plus a BCG adjuvant administered two months apart.
Control group subjects (n=986) received two doses of an inert
placebo administered in the identical manner. No serious adverse
effects were recorded in either vaccination group. Significantly
more vaccine than control group subjects converted to a positive
leishmanin skin test (LST) two months after the second vaccina-
tion dose (74.4% vs. 14.7%; X2= 438; P= 0.000001). The inci-
dence of parasitologically confirmed CL at follow-up months 0-
26 was not significantly different. Likewise, the cumulative inci-
dence of CL was similar in the vaccine and control groups (2.0%
vs. 1.3%; X2= 1.1; p > 0.05). PCR analysis identified L. Viannia
as the subgenus responsible for infecting 91% of the vaccine and
100% of control group subjects. It also confirmed the presence
of L. Viannia and L. Leishmania DNA within the same lesion of
the remaining vaccine group subject. The lack of vaccine effica-
cy observed for the vaccine differs from that reported for anoth-
er candidate based on L. (V) brazilensis, L. (V) guayanensis, and
L. (L) amazonensis and tested in an adjacent population (J Infect
Disease 177:1352-7). It is possible that a L. amazonensis-based
vaccine may not adequately protect against infection caused by
species belonging to the L. Vivannia subgenus. Supported by
Special Programme for Research and Training in Tropical
Diseases (UNDP/WB/WHO/TDR) #TDR 970191.
Board 44. Field Trial of a Vaccine Against New World
Cutaneous Leishmaniasis in an At-
Risk Ecuadorian Child Population: Protection During Months 13-60 of
Follow-Up
R. X. Armijos1,2, M. Weigel3,2, L. Romero1, M. de la Cruz1
1Universidad Central del Ecuador, Quito, ECUADOR, 2Fundacion
Internacional "Biociencias", Quito, ECUADOR, 3Virginia Tech,
Blacksburg, VA
In a previous work (J Infect Disease 177:1352-7), we
reported on the results of a randomized, double-blinded, con-
trolled Phase III study which evaluated the effectiveness of a
phenol-killed whole parasite vaccine based on three Leishmania
species plus BCG adjuvant in an at-risk child population living
in an area of Ecuador endemic for cutaneous leishmaniasis
(CL). Briefly, the results of the first study indicated that leish-
manin skin test (LST) conversion was greater in vaccine com-
pared to control group subjects (who received BCG only) one
month after the second vaccination dose (85.8% vs.19.9 %; X2=
282; p= 0.000001). CL incidence was significantly reduced in
the vaccine compared to control group during the first 12-
months of follow-up (2.1% vs. 7.6%; X2= 8.95, P=0.0028). At the
end of 12 months, the study was re-blinded to permit the addi-
tional 48-months of follow-up. The results revealed that CL
incidence was significantly reduced in the vaccine compared to
control group between months 13-18 (5.9% vs. 13.8%; X2=8.8,
p=0.003). In addition, at follow-up month 18, 67% of vaccine
group subjects had a positive LST compared to only 36% in the
control group (X2=34.8, P= 0.001). However, by follow-up
months 24, 30, 36, 42, 48, 54 and 60, the incidence of CL in the
















Likewise, at month 60 of the follow-up, the proportion of sub-
jects in the vaccine versus control groups with a positive LST
was not significantly different (40.8% vs. 32.5%, X2=1.9, P >
0.05). The results suggest that the periodic administration of
boosters may be necessary to maintain protection against New
World CL in killed, whole-parasite vaccines. Supported by
USAID-Ecuador #518-0058EXT.
Board 45. Adverse Event Reports Associated with a Mass
Meningococcal Vaccine Campaign 
A. Huang, J. Iskander, R. K. Pless
CDC, Atlanta, GA
Background: Mass vaccination campaigns are one strate-
gy to control invasive meningococcal disease. Decisions to con-
duct a campaign are taken by public health authorities based on
the epidemiology of disease. During early 1998 approximately
152,000 residents of Rhode Island were immunized with
quadravalent meningococcal polysaccharide vaccine. Published
reviews of the safety of this vaccine have found that serious
adverse events were rare.
Methods: Reports to the Vaccine Adverse Event Reporting
System (VAERS) temporally and geographically associated with
the campaign were identified and analyzed in comparison to
meningococcal vaccine associated VAERS reports overall. Biologic
Surveillance data was used to calculate event reporting rates.
Results: A total of 47 reports were received. Only 5
(10.6%) were considered serious and there were no deaths. The
reporting rate of 30.9/100,000 (3.3/100,000 serious reports) con-
trasts with the 7.0/100,000 overall reporting rate for meningococ-
cal vaccine (rate ratio 4.4) in the VAERS database. Further, it was
similar to the reporting rate seen in other mass campaigns with
meningococcal vaccines.
Conclusions: Meningococcal and other mass vaccine cam-
paigns may stimulate adverse event reporting above baseline levels.
Planning for expected increases in adverse event reports during
mass campaigns conducted over short periods of time will help
alleviate undue concerns for the vaccine while highlighting the
need for swift investigation.
Board 46. Implementation of a Large, Double-Blind,
Placebo-Controlled Trial of the 23-Valent Pneumococcal
Vaccine in Healthy Young Adults 
K. L. Russell, C. Baker, M. K. Ryan, P. Vaccine Study Team
Naval Health Research Center, San Diego, CA
Background: Streptococcus pneumoniae infections are
a significant cause of morbidity among U.S. military popula-
tions, especially trainees. With increasing antibiotic resistance,
efforts to prevent pneumococcal infection must be pursued. A
23-valent pneumococcal vaccine has been available for nearly
20 years, but its value has not been well studied in healthy
young adults. The US military was charged with performing a
rigorous vaccine trial, although implementation of such a study
was anticipated to be complex.
Methods: A sample size of 191,808 subjects was calculat-
ed using estimates of vaccine efficacy, percent coverage, and
attrition. Collaboration with public health, academic, and other
military institutions, as well as a vaccine manufacturer, Wyeth-
Ayerst Pharmaceuticals, was essential for the design and initiation
of the study.
Military site investigators were identified to help secure
support from four U.S. Army, Navy, and Marine basic training sites.
Research assistants (RAs) dedicated to the study were hired for
daily maintenance; local investigators provide direct supervision.
Trainees are enrolled during medical in-processing in basic train-
ing. The RAs brief the trainees as a group. Those choosing to par-
ticipate complete consent forms and a brief information card.
Vaccine or placebo injections are then administered.
RAs identify participants with radiographically confirmed
pneumonia during basic training and collect laboratory specimens.
Diagnostic tests include evaluation for S. pneumoniae, M. pneu-
moniae, C. pneumoniae and viral studies. All participants also pro-
vide survey information of respiratory symptoms at the completion
of basic training. Cases of pneumonia and respiratory illness after
basic training are captured with comprehensive medical informa-
tion systems in the military.
Advanced software is used to design, scan, store, and inter-
pret all written data.
Results: As of December 2001, the study is in its 14th
month of enrollment and over 70,000 subjects have enrolled.
Average participation rate is 70%. Radiographically confirmed
pneumonia has been identified in 391 participants to date.
Laboratory testing is ongoing.
The study has been well-received at all participating
sites, and no adverse events related to study participation have
been reported.
Conclusion: The US military provides a unique setting for
the successful completion of a study of this magnitude. The large
number of healthy young adults living and working in controlled
environments, and the comprehensive medical databases available
to the military, are attributes unique to the Department of
Defense. Careful planning and coordination have resulted in suc-
cessful implementation of this complex study. As one of the largest
vaccine trials ever undertaken in military history, this work will bet-
ter define the value of vaccinating healthy young adults against
pneumococcal disease.
Board 47. Long Lasting Protection Against Canine Kala-azar
Using The Fml-quila Saponin Vaccine In An Endemic Area Of
Brazil(são Gonçalo Do Amarante, Rn) 
C. B. Palatnik de Sousa, Sr., G. P. Borja Cabrera, N. N. Correia
Pontes, V. O. da Silva, E. Palatnik de Sousa, W. R. Santos, E. M.
Gomes, K. G. Luz, M. Palatnik, C. P. Palatnik de Sousa
Federal Univ. Rio de Janeiro, Rio de Janeiro, RJ, CA
Human kala-azar is an emergent zoonotic canid disease.
The development of vaccines that could protect dogs form infec-
tion would reflect in the reduction of both canine and human cases
of the disease. Naturally exposed dogs of an endemic area were
vaccinated with the fucose mannose ligand (FML) antigen of
Leishmania donovani in formulation with QuilA saponin. 100% of
vaccinees were seropositive to FML and showed intradermal reac-
tion to L. donovani lysate, 2 months after vaccination. The
absorbency values and size of intradermal reaction were both sig-
nificantly higher in vaccinees than in controls during a 3.5-year
period (ANOVA, p<0.0001). Twenty five percent of the control ani-
mals (2 dogs on the first year and 6 dogs on the fourth year, respec-
tively) and 5% of the vaccinees (1 dog during the fourth year)
developed clinical and fatal disease by the end of experiment. This
difference was significant (c2= 3.93, p<0.05). This means that 95%
protection against kala-azar was achieved in vaccinees, after FML-
QuilA vaccination (vaccine efficacy 80%). Leishmania infection
was also confirmed, 3.5 years after vaccination, in saline controls
that showed positive PCR for Leishmania DNA and FML-serolo-
gy with no intradermal reaction. Higher seropositivities and intra-
dermal reactions with no Leishmanial DNA were detected in vac-
cinees. The FML-QuilA vaccine induced a significant, long-lasting
and strong protective effect against canine kala-azar in the field.
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Board 48. Severe, Concurrent Lyme Disease, Babesiosis and
Ehrlichiosis in a Healthy 23 Year-Old Connecticut Resident. 
M. Villanueva1, B. Behjatnia1, J. I. Meek2
1Waterbury Hospital, Waterbury, CT, 2Connecticut Emerging
Infections Program, New Haven, CT
Background: Lyme disease (LD), babesiosis, and human
granulocytic ehrlichiosis (HGE) are emergent zoonotic diseases
affecting residents in the Northeastern and Midwestern United
States. The etiologic agents of each disease are perpetuated in a
natural cycle between vertebrate reservoir hosts and the tick
vector, Ixodes scapularis. The geographical and ecological over-
lap between HGE, LD and babesiosis suggests the potential for
co-transmission, co-infection and co-morbidity. We describe the
case of a Connecticut resident simultaneously infected with all
three agents.
Case Report: A previously healthy, 23 year-old male pre-
sented to an emergency department (ED) after five days of
headache, fever, sweats, myalgia, and fatigue. He recalled a tick
bite about one week earlier. He was given the diagnosis of LD and
treated with clarithromycin. Approximately two weeks later, the
symptoms returned and he presented to our ED. Laboratory eval-
uation revealed leukopenia, thrombocytopenia, and a hematocrit of
41%. Liver function tests, and erythrocyte sedimentation rate were
normal. LD serologies were sent. On evaluation, he was found to
have tonsillar, cervical, and inguinal lymphadenopathy and
splenomegaly that was confirmed by abdominal CT scan.
Five days later, the patient returned to the ED with acute
left upper quadrant pain, and persistent fevers. Hematocrit was
29%. Repeat abdominal CT scan demonstrated increased
splenomegaly and new left flank and pelvic fluid. The patient was
admitted to the surgical intensive care unit with the presumed
diagnosis of splenic rupture. Laboratory data were significant for
leukopenia, thrombocytopenia, elevated LDH and AST, and
decreased haptoglobin. The hospital course was remarkable for
persistent high-grade fevers to 104.6° F. Lymph node biopsy
showed follicular lymphoid hyperplasia and no evidence for malig-
nancy. A peripheral smear showed intraerythrocytic ring forms
consistent with Babesia. The patient was treated with clindamycin
and quinine with rapid defervescence. 
LD serologies from the previous ED visit were positive on
both ELISA and Western Blot. After completing a course of clin-
damycin and quinine, the patient was started on a course of doxy-
cycline. Serum samples were sent for HGE and Babesia microti
serology. Indirect fluorescent antibody staining methods revealed
an HGE titer of 1:4096 and a B. microti titer of 1:640. HGE-spe-
cific ELISA was confirmatory. Nine months later, repeat testing
demonstrated a ≥ 4-fold decrease in antibody titer to both HGE
and B. microti.
Conclusion: This patient had concurrent infection with
three I. scapularis-borne diseases. The unexpected severity of ill-
ness in this otherwise healthy host can in part be attributed to the
delay in diagnosis resulting from an atypical presentation and the
possible immunosuppressive effects resulting from the interplay of
the three diseases.
Board 49. Assessment of the Competence Of Field-Collected
Culex tarsalis Mosquitoes to Transmit West Nile Virus Under
Laboratory Conditions 
R. Lindsay1, M. Drebot1, A. Dibernardo1, H. Artsob1, R. Gadawski2,
H. Weingartl3, J. Copps3
1Health Canada, Winnipeg, MB, CANADA, 2City of Winnipeg,
Insect Control Branch, Winnipeg, MB, CANADA, 3Canadian Food
Inspection Agency, Winnipeg, MB, CANADA
Based on testing of field-collected mosquitoes in the
United States, ornithophilic mosquito species such as Culex pipi-
ens are the primary enzootic vectors of West Nile virus (WNV). In
Canada, Cx. pipiens has a discontinuous distribution. It is abundant
in parts of British Columbia and from Ontario eastward but is
absent from the prairie provinces (i.e., Manitoba, Saskatchewan
and Alberta). The niche typically occupied by Cx. pipiens is filled
on the prairies by the closely related species, Cx. tarsalis. Currently
in Canada, the ranges of WNV and Cx. tarsalis do not overlap.
However, since 1999 the range of WNV in North America has
expanded dramatically. If WNV is introduced into the prairie
provinces or western states it is anticipated that Cx. tarsalis, a
proven vector of other related arboviruses (e.g., St. Louis
encephalitis virus), might be an important vector. To assess the vec-
tor competence of Cx. tarsalis, females were collected at a site near
Winnipeg, Manitoba, using CDC light traps, and allowed to feed
upon groups of 3 or 4 white leghorn chicks (4-8 day old) that were
syringe-inoculated subcutaneously 2, 4 and 6 days earlier with 0.1
ml of NY99 strain of WNV (titre-105 PFU/ml). To confirm chicks
were infected, blood samples were collected immediately after
mosquito feeding and tested for viral genome using standard RT-
PCR. Female mosquitoes that fed on syringe-infected chickens
were held for up to 22 days at 23.5 C (16 h Light: 8 h Dark), then
re-fed on uninfected chicks. Sera were collected from mosquito-
infected chickens 3 weeks post-feeding and tested for IgG and IgM
antibodies against WNV using an in-house ELISA. Viral RNA was
extracted from the bodies (non-disseminated infection) and legs
(disseminated infection) of selected females that fed on syringe- or
mosquito-infected chickens. WNV genome was then amplified
using a real time RT-PCR assay. WNV RNA was detected in all but
one syringe-inoculated chick and the amount of viral genome
detected decreased with days p.i. In total, 38.9% (28 of 72) of Cx.
tarsalis that fed showed evidence of infection (non- or disseminat-
ed infection) and WNV RNA was detected only in mosquitoes fed
on the 2 day p.i. group of birds. In these mosquitoes, the infection
(bodies only) and dissemination rates (bodies and legs) were 90.3
(range, 81.2-100%) and 77.4% (range, 68.8-87.5%), respectively.
However, only 1 of 3 uninfected birds exposed to these mosquitoes
developed WNV antibodies (titre, 1:32,000). The failure of all birds
in this group to acquire WNV may be due to differences in virus
titre in feeding Cx. tarsalis or because most mosquitoes did not
feed to repletion when exposed to the uninfected chicks. Overall
these results provide evidence that Cx. tarsalis is a competent lab-
oratory vector of WNV and it may be capable of contributing to the
enzootic amplification of virus should WNV be introduced into
areas where this mosquito species is abundant.
Board 50. Comparison of the Effectiveness of Two Topical
Paromomycin Treatments with Meglumine Antimoniate for
New World Cutaneous Leishmaniasis 
M. M. Weigel1,2, R. X. Armijos3,2, M. Calvopina3, M. Mancheno4
1Virginia Tech, Blacksburg, VA, 2Fundacion Internacional
"Biociencias", Quito, ECUADOR, 3Universidad Central del Ecuador,
Quito, ECUADOR, 4Fundacion, Quito, ECUADOR
The randomized, controlled study compared the therapeutic
efficacy and safety of two topical paromomycin preparations with
Glucantime (meglumine antimoniate) and with each other in 120
Ecuadorian patients. The two paromomycin treatment comparisons
















plus 12% methylbenzonium chloride (PMBC) dissolved in a soft
white paraffin base, applied twice daily for 30 days. Group 2 (n=40)
was also treated for 30 days with 15% paromomycin plus 10% urea
(PRU) dissolved in the same paraffin base. Group 3 (n=40) received
20mg/kg/day of IM Glucantime (GLU) for 10 days as per MPH con-
vention. Post-treatment lesion redness, inflammation, and soreness
were significantly more frequent in the two paromomycin groups
compared to GLU group (P < 0.05); lesion burning was more fre-
quent in the PRU than GLU group (P < 0.05). However, the fre-
quency of treatment-associated side effects was not significantly dif-
ferent between the paromomycin groups. The 10-day treatment was
completed by 90% of the GLU group while 72.5% and 75% of the
PMBC and PRU groups completed their 20-day treatment regimes
(P > 0.05). Six weeks after beginning treatment, 80.6% of the GLU
(80.6%) were clinically cured compared to 48.3% and 40% of the
PMBC and PRU groups (X2=12.6, P=0.002). At 12 weeks, the pro-
portion of clinically cured subjects in the GLU (91.7%), PMBC
(79.3%) and PRU (70%) groups was similar (X2=5.1, P >0.05). GLU-
treated subjects clinically cured by 12 weeks had a faster mean heal-
ing time than the PMBC- and PRU-treated groups (29.5 ± 12.2 days
vs. 43.1 ± 14.4 days vs. 43.5 ± 17 days; F=8.9; P= 0.0001). During the
12-month post-treatment follow-up period, infection reactivation
was observed in 15.2% (GLU), 17.4% (PMBC), and 10.5% (PRU) of
those subjects diagnosed as clinically cured by 12 weeks (X2= 0.6, P
>0.05). The results suggest that although healing time is longer, top-
ical paromomycin may be an acceptable therapeutic alternative in
cases where Glucantime is not available or is medically contraindi-
cated. Supported by: Pan American Health Organization-
Washington (#HDP/HDR/RG/ECU/1218).
Board 51. RNA isolated from Mosquito Pools Inhibits 
West Nile Virus Real Time RT-PCR: A Case Study Using 
the Smart Cycler 
S. Sakallah, D. Bolton, S. MacRae
NH Department of Health & Human Services, Concord, NH
In the period between August and November 2000, we
tested 440 birds and 200 mosquito pools for West Nile Virus. The
virus was detected in 7 birds, but none of the mosquito pools test-
ed positive for the virus. Since these pools were collected in the
areas where positive birds were identified, the possibility exists that
some positive mosquito pools may have been missed due to inhibi-
tion of the RT-PCR reaction. Preliminary experiments were
launched in the spring of 2001 to answer this question. Mosquito
pools were spiked with a known amount of RNA that tested posi-
tive for WNV. The Ct values reported for these reactions were
compared with that from the positive RNA. Real Time RT-PCR
reactions (25 ul) were carried out using the TaqMan One Step RT-
PCR kit (Roche) and a FAM-tagged probe. Thermal cycling was
performed in the Smart Cycler (Cepheid) starting with 30 minutes
at 50°C followed by 45 cycles of 15 seconds at 95°C and 1 minute
at 60°C with fluorescence detection.
Our preliminary data show that the majority of mosquito
pools tested (57 out of 66) exhibited some level of inhibition.
Inhibition patterns could be grouped into 3 categories: minor
(where Ct values increased by up to 3 cycles), significant (Ct
increased by 3-5 cycles), and total (Ct = 0, i.e. signal disappeared
completely). Thirty-seven pools exhibited minor inhibition, 18
showed significant inhibition and 2 pools were totally inhibited.
The majority of these pools (42 out of 57) contained 1-4 mosqui-
toes each, 12 pools had 6-25 mosquitoes each, while 3 pools had
26-50 mosquitoes each. There was no apparent correlation
between the number of mosquitoes in the pools tested and the
level of inhibition observed. Furthermore, we found no clear link
between mosquito genus or species and inhibition.
The cause of RT-PCR inhibition was not the focus of this
study. One possible explanation however could be the presence of
inhibitors in the blood mosquitoes feed on. Our results demon-
strate the importance of internal controls in these tests to ensure
the validity of the negative results. We are currently in the process
of developing controls for WNV and related viruses.
Board 52. RNA Isolated from Mosquito Pools Inhibits West Nile
Virus Real Time RT-PCR: A Case Study Using the Smart Cycler 
S. Sakallah, D. Bolton, S. MacRae
NH Department of Health & Human Services, Concord, NH
In the period between August and November 2000, we
tested 440 birds and 200 mosquito pools for West Nile Virus. The
virus was detected in 7 birds, but none of the mosquito pools test-
ed positive for the virus. Since these pools were collected in the
areas where positive birds were identified, the possibility exists that
some positive mosquito pools may have been missed due to inhibi-
tion of the RT-PCR reaction. Preliminary experiments were
launched in the spring of 2001 to answer this question. Mosquito
pools were spiked with a known amount of RNA that tested posi-
tive for WNV. The Ct values reported for these reactions were
compared with that from the positive RNA. Real Time RT-PCR
reactions (25 ul) were carried out using the TaqMan One Step RT-
PCR kit (Roche) and a FAM-tagged probe. Thermal cycling was
performed in the Smart Cycler (Cepheid) starting with 30 minutes
at 50 oC followed by 45 cycles of 15 seconds at 95 oC and 1 minute
at 60 oC with fluorescence detection.
Our preliminary data show that the majority of mosquito
pools tested (57 out of 66) exhibited some level of inhibition.
Inhibition patterns could be grouped into 3 categories: minor
(where Ct values increased by up to 3 cycles), significant (Ct
increased by 3-5 cycles), and total (Ct = 0, i.e. signal disappeared
completely). Thirty-seven pools exhibited minor inhibition, 18
showed significant inhibition and 2 pools were totally inhibited.
The majority of these pools (42 out of 57) contained 1-4 mosqui-
toes each, 12 pools had 6-25 mosquitoes each, while 3 pools had
26-50 mosquitoes each. There was no apparent correlation
between the number of mosquitoes in the pools tested and the
level of inhibition observed. Furthermore, we found no clear link
between mosquito genus or species and inhibition.
The cause of RT-PCR inhibition was not the focus of this
study. One possible explanation however could be the presence of
inhibitors in the blood mosquitoes feed on. Our results demon-
strate the importance of internal controls in these tests to ensure
the validity of the negative results. We are currently in the process
of developing controls for WNV and related viruses.
Board 53. Selection and Characterization of Antigenic
Variants of West Nile Virus Using Monoclonal Antibodies and
Membrane Receptor Preparations Which Recognize the
Putative Envelope Protein Receptor-Binding Domain III 
D. W. Beasley, A. D. Barrett
Dept. of Pathology, Sealy Center for Vaccine Development, and
WHO Collaborating Center for Tropical Diseases, The University of
Texas Medical Branch, Galveston, TX
The flavivirus envelope (E) protein is the major outer mem-
brane protein and plays important roles in attachment to and
fusion with target cell membranes. In particular, domain III of this
protein has been proposed to function as the likely receptor-bind-
ing domain and is an important target for virus neutralizing anti-
bodies. Five monoclonal antibodies were prepared against a North
American isolate of West Nile (WN) virus. Four of these antibod-
ies were found to specifically bind to purified recombinant WN
virus E protein domain III (derived from strain 385-99, an isolate
from the 1999 outbreak in New York) in ELISA and Western Blot
assays. The same four antibodies were also able to neutralize WN
viruses representing both genetic lineages I (which includes the
virus currently circulating in North America) and II, confirming
the importance of E domain III in WN virus infectivity. However,
neutralization of lineage II WN strains was significantly less effec-
tive than for lineage I viruses, suggesting differences in the pres-
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entation of domain III epitopes between WN lineages. The fifth
antibody did not neutralize any WN virus tested. In addition, a
polyclonal rabbit serum prepared against the purified recombinant
domain III was also able to neutralize WN strains of both lineages,
albeit with better efficiency against lineage I strains. We are cur-
rently evaluating potential neutralization escape variants that were
plaque purified in the presence of neutralizing antibodies to iden-
tify residues in domain III critical to neutralization of WN virus.
We have also investigated binding of WN virus strains to mouse
brain tissue membrane receptor preparations (MRPs). Several
strains in both lineage I and II were identified that bound strongly
to mouse brain MRPs and binding escape variants have been
selected. One variant, derived from lineage II strain H-442, con-
tained a single nucleotide substitution in the E gene encoding a
Lys-Thr mutation at E332, a residue which lies on the upper, out-
side face of domain III in structural models of the WN virus E pro-
tein. Additional MRP binding variants are being characterized.
The virulence of these antigenic variants for mice is being studied
to assess the role of E protein domain III in the virulence pheno-
type of WN virus.
Board 54. Epidemic Chikungunya Virus Transmission in
Western Indonesia Occurs Over a Foci of Endemic
Transmission 
J. L. McArdle1, W. Suharyono2, M. Juffrie3, R. Tan1, C. Beckett1, A.
Corwin1, K. Porter4
1NAMRU-2, Jakarta, INDONESIA, 2Ministry of Health, Jakarta,
INDONESIA, 3Gadjah Mada University, Yogyakarta, INDONESIA,
4NMRC, Forest Glen, MD
We present data confirming six recent episodes of epidem-
ic Chikungunya virus (CHIK) transmission in Indonesia and sug-
gesting one foci of endemic CHIK transmission. In April 2000, a
countrywide CHIK surveillance program was initiated with the
assistance of the Indonesian Ministry of Health to investigate anec-
dotal reports of CHIK transmission in Java and Sumatra. Forty-
eight representative acute samples from five geographic regions
were analyzed, 61% were CHIK IgM positive (+) and 42% were
CHIK RT-PCR (+). Two isolates were recovered and a portion of
the E2 gene was sequenced to confirm CHIK etiology. Ten percent
of the samples were dengue IgM (+) and 14% were dengue RT-
PCR (+). CHIK transmission has been confirmed by PCR and
serology in a 6th region of Indonesia in December 2001, suggest-
ing that CHIK transmission is far more widespread across
Indonesia than previously thought. Evidence also suggests that
Yogyakarta represents the first recognized foci of endemic CHIK
transmission. CHIK transmission was documented in Yogyakarta
during 1983, and again during 1998/1999. However, physicians
there report that they regularly treat patients with CHIK-like ill-
ness. A case-control study was initiated in Yogyakarta in December
2000, to verify ongoing CHIK transmission. Of cases examined,
34% (85/248) were CHIK RT-PCR (+) and 30% were CHIK IgM
(+). Three percent were RT-PCR (+) for dengue. Three cases were
dually infected with CHIK and dengue viruses (two with dengue 2
and one with dengue 4). Of controls, 7% (5/75) were CHIK IgM
(+). Dengue serology is pending. A longitudinal study was then ini-
tiated in Yogyakarta in June 2001 to estimate yearly CHIK attack
rates. Preliminary serological testing established that 19%
(156/800) of the volunteers were IgG seropositive for CHIK at
enrollment. Fifty-two of the 156 seropositive volunteers were born
after the 1983 CHIK outbreak. These 52 individuals did not report
CHIK-like illness in the past five years and were not living in the
area where CHIK transmission occurred in 1998/1999. For the
population born after 1983, (age 17 and under) this equates to
0.8% of the cohort seroconverting on average per year. Based on
these data, we hypothesize that endemic CHIK transmission
occurs in Yogyakarta and elsewhere in Indonesia.
Board 55. Sentinel Chickens Appear to be Useful Monitors of
West Nile Virus in Florida 
L. M. Stark1, C. Blackmore2, R. L. Oliveri3, L. A. Conti3, 
S. T. Wiersma3
1Florida Department of Health, Tampa, FL, 2Florida Department of
Health, Jacksonville, FL, 3Florida Department of Health, Tallahassee, FL
Flocks of sentinel chickens have been used in Florida
since 1978 for monitoring activity of St. Louis Encephalitis
(SLE) virus and Eastern Equine Encephalomyelitis (EEE) virus.
Historically, seroconversions to SLE virus in sentinel chickens
predates human cases in Florida. During 2001, flocks of 6 chick-
ens each were placed in 31 counties; the number of flocks per
county varied from 2 to 21.
Blood was collected weekly or biweekly from the chickens
and sent to the Department of Health Laboratory in Tampa where
sera were assayed by the Hemagglutination Inhibition test for total
antibody to flavivirus and to alphavirus. SLE virus strain TBH-28
sucrose acetone processed suckling mouse brain was used for fla-
vivirus antigen. We have previously determined this antigen cross-
reacts with antibody to other flaviviruses (Dengue 1-4) in the HAI
test. Sera positive for flavivirus antibody in the HAI assay were
assayed for IgM antibody to West Nile (WN) virus. Sera with low
P/N ratios in the Elisa and a sample of HAI negative sera were
assayed by serum neutralization plaque reduction assay (SNPR)
against WN and SLE viruses to confirm the etiology of infection.
Mosquitoes are active throughout the year in Florida, and
transmission of SLE and EEE viruses has been detected during
winter months. Testing is performed every week of the year,
although many counties only maintain their flocks from May
through December. This year approximately 23,000 sentinel sera
were submitted for testing. The first detections of WN virus in
birds, horses and chickens occurred within 2 weeks of one another,
in late June early July, 2001. Over the following 5 months, 177 sen-
tinels from 20 counties demonstrated antibody development to
WN virus. Seroconversions to SLE virus were minimal. Sentinel
seroconversions predated detection of virus in dead birds and/ or
horses in 7 counties. In counties where chickens were not the first
indicator of WN virus activity, seroconversions started on average
7.1 weeks after the first WN positive bird or horse was detected.
Human cases were reported from 2 counties with sentinel chicken
surveillance programs. In both counties, chicken seroconversions
to WN virus predated the human cases.
Board 56. Northern Expansion of Human Babesiosis
Infection in New York State 
G. S. Johnson1, R. Westphal1, J. Keithly1, J. Ennis1, A. Teal1, S.
Wong1, A. Huang2, A. S. Evans, Jr.3, M. C. Caldwell3, M. Fabiano4,
D. J. White1, B. J. Wallace1
1New York State Department of Health, Albany, NY, 2Westchester
County Department of Health, New Rochelle, NY, 3Dutchess County
Health Department, Poughkeepsie, NY, 4Columbia County Health
Department, Hudson, NY
Babesiosis is a protozoan tick-borne infection endemic in
focal geographic locations throughout the United States. It is pri-
marily transmitted by Ixodes scapularis, but occasional infections
occur through blood transfusion or organ transplantation. In north-
eastern United States, human Babesia microti infections are
endemic in areas of Massachusetts, Connecticut, Rhode Island and
New York State (NYS). In NYS, locally acquired infections have
been limited to Long Island, primarily the eastern portion. In 2001,
four cases of babesiosis were reported in NYS residents who had
not lived in, nor traveled to previously recognized babesia-endem-
ic areas. None had a history of blood transfusion or organ trans-
plantation. One patient resided in Westchester County, two resided
in Dutchess County, and one in Columbia County. Three (75%)
patients had significant exposure to tick habitat in their county of
















ease. The fourth patient had a travel history outside of NYS, but it
was to an area where locally acquired babesiosis has never been
documented and she had reported a recent tick bite acquired in
her county of residence. The mean age of the cases was 52 years
with a range of 42-77. Three (75%) patients reported an acute
febrile illness with onset during the summer months. One (25%)
patient, an afebrile 77 year-old female presenting with increasing
dyspnea, was hospitalized. Based upon the laboratory finding of
hemolytic anemia in this patient, peripheral blood smears were
reviewed and intraerythrocytic ring-forms/parasites were noted.
Three weeks prior to her admission, the patient had been placed
on a tapering dose of steroids, an antihistamine and asthma inhaler
for coughing, wheezing and shortness of breath. In addition, severe
aortic stenosis was identified. No other immunosuppressive condi-
tions were noted. None of the other patients had any history of
immunosuppressive conditions. All patients had intact spleens.
Each patient had at least one laboratory specimen confirmed by
NYS Department of Health Wadsworth Center. Peripheral blood
smears were available on 3 patients; B. microti was identified on all
smears. Indirect fluorescent assay (IFA) was conducted on speci-
mens from 3 patients; all had titers ≥ 128. Two patient specimens
were tested by PCR; one was positive. This is the first documenta-
tion of human babesiosis acquired in NYS outside of Long Island.
However, all 3 counties where the patients reside have high inci-
dence rates for Lyme disease and human granulocytic ehrlichiosis,
both of which are also transmitted by Ixodes scapularis. The pres-
ence of I. scapularis and the occurrence of non-travel associated
babesiosis in 3 counties north of New York City and east of the
Hudson River suggests a northern expansion of B. microti and a
corresponding risk of human babesiosis infection.
Board 57. Chagas Disease in a Domestic Transmission Cycle
in Southern Texas, USA 
C. B. Beard1, G. Pye2, F. J. Steurer1, Y. Salinas3, R. Campman2, A. T.
Peterson4, J. M. Ramsey5, R. A. Wirtz1, L. E. Robinson2
1Centers for Disease Control and Prevention, Chamblee, GA, 2Texas
Department of Health Zoonosis Control Division, Harlingen, TX,
3Cameron County Health Department, Harlingen, TX, 4Natural History
Museum, The University of Kansas, Lawrence, KS, 5Instituto Nacional
de Salud Pública, Cuernavaca, Morelos, MEXICO
Chagas disease is caused by the protozoan Trypanosoma
cruzi and is transmitted by insects in the Reduviidae subfamily
Triatominae. In the United States, the disease exists almost exclu-
sively as a zoonosis, with only five cases reported in humans. On
January 6, 1998, the Texas Department of Health Zoonosis Control
Division office in Harlingen, TX was contacted following the diag-
nosis of Chagas disease in a canine pet that died of acute car-
diomyopathy, following the death of a previous pet canine, in
September of 1997, with a similar diagnosis. Both animals were
purchased as puppies and owned for four or five months before
becoming ill. On April 8, 1999, following the death of a third dog
at the same location, personnel from CDC, TDH and the Cameron
County Health Department conducted an investigation of the
premises that included inspection of the home, garage, and
grounds. Blood was drawn from three additional canine pets and
tested for antibodies to T. cruzi. Because the homeowner recalled
finding bugs inside the house on at least one occasion, two adults
living in the home were also tested. The same veterinarian who
diagnosed the initial cases reported an additional dog, from a ken-
nel approximately two miles from the first site, to have Chagas dis-
ease-like symptoms. This second site was also inspected and blood
drawn from the symptomatic dog and three additional dogs from
the same kennel. A total of three dogs from the first site and one
dog from the second site tested positive. No humans tested posi-
tive. A follow-up serological study was completed through the
Cameron County Animal Control. A total of 28 of 347 stray dogs
(7.5%) tested positive for antibodies against T. cruzi, with titers
ranging from 1:32 to 1:512. During inspection of the first site, a
total of 31 adult and immature Triatoma gerstaeckeri were collect-
ed underneath concrete slabs of a patio and inside an adjacent
garage. Upon dissection, 24 or 31 were positive for hindgut try-
panosomes. Cultures were established and confirmed as T. cruzi.
No bugs could be found at the second site. Triatoma gerstaeckeri
is considered a sylvatic species, most frequently associated with
pack rat burrows. While it occasionally invades domestic dwellings,
it is not known to colonize these habitats. In this instance, colo-
nization appears to have occurred, the evidence being the observa-
tion of large numbers of bugs, including immature stages. At the
first site, six dogs either died or tested positive for T. cruzi, and 24
of 31 bugs contained hindgut trypanosomes. These observations
demonstrate the existence of a domestic transmission cycle. To
evaluate the potential for the occurrence of this problem in other
locations besides Cameron County, we used a niche analysis model
to predict the areas where T. gerstaeckeri is likely to be found. A
broad distribution was predicted, extending from central Mexico
north along the Texas-Mexico border, into the Texas panhandle and
New Mexico.
Board 58. Diagnosis and Treatment of Southern Tick
Associated Rash Illness: An Emerging Infections Network
Survey 
A. V. Bode, E. B. Hayes
Centers for Disease Control and Prevention, Ft Collins, CO
Lyme Disease (Ld) is endemic in areas of the Northeast
and upper Midwest. For more than a decade, the Centers for
Disease Control and Prevention (CDC) has received reports of
patients with an erythema migrans (EM)-like rash, often following
tick bites, from non-Lyme disease endemic areas in the South and
southern Midwest. Studies in these areas have found no evidence
ofBorrelia burgdorferi in the majority of these patients; rather,
there is evidence that a newly described Borrelia species might be
associated with this condition . The Emerging Infections Network
(EIN) recently surveyed their members about the diagnosis and
treatment of this “Southern Tick-Associated Rash Illness (STARI).”
Of the 278 physicians queried in the South and Missouri, 188
responded. Of these physicians, thirty nine (21%) had seen 96
patients for an EM-like rash during the summer of 2000. Thirty
two (82%) of these 39 physicians said they usually ordered Ld
serology on such patients, and 12 (31%) said they always (1) or
sometimes (11) obtained skin biopsies from these patients. Twenty-
seven (69%) of the 39 said they always treated the patients with
antibiotics; ten (26%) of the 39 said they sometimes treated with
antibiotics. Several antibiotics were used to treat these patients.
Doxycycline was prescribed by 33 physicians, amoxicillin by 15
physicians, ceftriaxone by 3 physicians and cefuroxime by 2 physi-
cians. Optimal management of STARI will depend on further def-
inition of its etiology and natural history.
Board 59. The Relevance of Geometric Morphometry in
Distinguishing Cryptic Species of the "Prolixus Complex"
J. P. Dujardin, Sr.1, A. Matias2, J. Villegas3, D. Feliciangeli4, F.
Monteiro5, C. B. Beard5
1IRD, Chamblee, GA, 2Ministerio de Salud, La Paz, BOLIVIA, 3EMSO,
Maracay, VENEZUELA, 4Universidad de Carabobo, Maracay,
VENEZUELA, 5CDC NCID, Chamblee, GA
Rhodnius prolixus is a vector of Chagas disease to humans,
R. robustus is not, however they have long been two problematic
taxa as to their species identities and distribution. Using both tra-
ditional and geometric morphometrics, we compared wing size and
shape in both sexes of 64 R. robustus and 38 R. prolixus reared in
the same laboratory during one generation. R. robustus specimens
were collected from palm trees in the state of Mérida (Venezuela),
and R. prolixus were collected from houses in the state of Cojedes
(Venezuela). Even after one generation of living in the same labo-
ratory conditions, the two lines showed distinct sizes, divergent
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allometric trends, and significant allometry-free differences in
shape. Due to the epidemiological importance of this question, a
further comparison was performed using other samples from other
geographic areas of Venezuela, on specimens already verified as
distinct species after mtDNA sequencing. Thus, 15 wings of R.
robustus collected in Venezuela were compared to 45 wings of R.
prolixus also from Venezuela. The wings were described by 9 land-
marks: the 6 landmarks already used by us before, and 3 landmarks
located at the junction between corium and membrane. The same
significant differences were observed, again poorly related to size
variation, while other differences were revealed at the corium-
membrane limit. Since the species compared were genetically the
most related pair within the so-called "prolixus complex", one could
expect that morphometrics would be an efficient tool for accurate
species diagnostic. As an example, using a discriminant analysis on
wing shape variation, we were able to assign to R. robustus one sin-
gle, unknown specimen of Rhodnius which was collected in
Bolivia. In that study, 7 landmarks were used for comparing the
questioned specimen to 64 confirmed R. robustus, 20 R. prolixus,
52 R. stali and 36 R. pictipes. Thus, it appears that geometric mor-
phometry provides a highly discriminating tool for morphological
diagnosis of cryptic species in Triatominae.
Board 60. The Genetic Characterization of Snowshoe Hare
Virus Strains from Across Canada 
M. A. Drebot, Jr., E. Burbidge, H. Artsob
Health Canada, Winnipeg, MB, CANADA
Snowshoe Hare (SSH) virus is a mosquito-transmitted bun-
yavirus belonging to the California serogroup. SSH virus has been
documented across Canada and has been associated with cases of
meningitis and encephalitis in Quebec, Ontario, New Brunswick,
and Nova Scotia. As part of a study to determine the genetic diver-
sity of SSH virus in Canada, 69 different viral isolates collected
from five provinces and two territories during the 1960s, 70s, and
80s were characterized by reverse transcriptase (RT)- PCR ampli-
fication and amplicon sequencing. Sequencing of amplified por-
tions of the M and S genomic segments indicated that the isolates
could be grouped into six distinct genogroups. G2 glycoprotein
encoding regions exhibited nucleotide sequence divergence as
high as 23 %; however, all but one isolate displayed 100 % amino
acid sequence similarity within the G2 portion analysed.
Nucleotide sequencing of amplicons generated from the nucleo-
capsid encoding region revealed less sequence variation compared
to the M segment genomic portions analysed in this study. All iso-
lates from Ontario displayed high RNA sequence homology (> 98
%) despite being collected over a 15 year time period. In contrast,
phylogenetic characterization of SSH strains from the Yukon and
Quebec revealed the existence of at least two distinct co-circulat-
ing genotypes within each province. A SSH “variant” isolated from
a larval mosquito in Saskatchewan displayed significant divergence
with respect to both nucleotide and amino acid sequence composi-
tion when compared to Canadian and American isolates. Despite
the M and S segment amino acid sequence changes displayed by
this isolate this virus did not appear to display any features consis-
tent with being a serotypic variant. Phenotypic and genetic prop-
erties that may distinguish this strain from other SSH isolates will
be the subject of future studies. This genetic variant provides fur-
ther evidence for the extensive evolution that these RNA viruses
may undergo during their transmission and amplification cycles
and the high degree of genetic diversity that may exist among
strains within the same serotype.
Board 61. Mosquito, Rodent and Tick Surveillance and
Vector-Borne Disease Threats at Selected US Forces Korea
Installations and Training Sites, Republic of Korea, 2000-2001 
T. A. Klein1, H. C. Lee1, J. W. Song2, J. S. Chae3
1Preventive Services Directorate, 18th Medical Command, Unit
15281, Seoul, REPUBLIC OF KOREA, 2Department of Microbiology,
College of Medicine, Korea University, Seoul, REPUBLIC OF KOREA,
3College of Veterinary Medicine, Chonbuk National University,
Chonju, REPUBLIC OF KOREA
Introduction: Vector-borne diseases are potential public
health threat to US Forces Korea (USFK). Malaria, transmitted by
Anopheles mosquitoes, is only one of several diseases that may
impact on military readiness and operations. Other vector-borne
diseases of primary interest include Japanese encephalitis, han-
taviruses, scrub typhus, murine typhus, leptospirosis, ehrlichiosis
and other potential tick-borne parasites. Surveillance systems pro-
vide USFK the capability to collect and assess data for of potential
exposures and to rapidly deploy and implement appropriate coun-
termeasures. While data collection in a combat situation may be
difficult and hazardous, during armistice there are many opportu-
nities for data collection analysis and prediction that are required
to obtain health threat information critical to the protection of the
fighting strength. Methods: 1. Mosquito surveillance is currently
conducted at selected US military installations. Because the taxon-
omy of anophelines is not well understood, mosquitoes were
reared for morphological and DNA studies for species determina-
tion. 2. Rodents were collected at selected installations and train-
ing sites and assayed for hantaviruses, scrub typhus, murine typhus
and leptospirosis. 3. Ticks were collected by cloth tick drags at
selected US installations and training sites and assayed by PCR or
Ehrlichia/Anaplasma, Ehrlichia chaffeensis, and human granulo-
cytic ehrlichiosis parasites. Results: 1. During 1999 and 2000,
>26,000 mosquitoes were assayed for malaria sporozoite antigen.
Positive mosquitoes were identified from CP Gary Owen and CP
Bonifas, near the DMZ. Of ?4,300 Cx. tritaeniorhynchus, 12 isola-
tions of Japanese encephalitis were made. Examination of progeny
broods of anophelines showed that An. sinensis could not be dif-
ferentiated from An. lesteri, based on current keys. It is also sus-
pect that there are at least two types of An. yatsushiroensis. 2.
Rodent surveillance indicated a very high prevalence of han-
taviruses at selected training sites near the DMZ (range 0-61% for
different trapping periods. Scrub typhus was also prevalent
throughout the same area, extending south. Murine typhus was
identified from house mice at Yongsan Garrison in Seoul.
Leptospirosis was infrequently isolated. 3. More than 95% of all
ticks collected were Haemaphysalis longicornis, the bush tick. PCR
results showed a high incidence of Ehrlichia/Anaplasma positive
ticks. In addition, tissues from rodents showed that >75% of all
rodents examined were positive for Ehrlichia/Anaplasma by PCR.
Conclusion: Surveillance of arthropods and rodents provides
information that can be used for threat analysis and provide data
for developing disease reduction strategies.
Board 62. Inferential Modeling of Factors Determining
Anopheles Distribution and Predictions of Potential Ranges 
R. S. Levine1, T. A. Peterson2, M. Q. Benedict3
1CDC/APHL, Chamblee, GA, 2Natural History Museum, Univ. of
Kansas, Lawrence, KS, 3CDC/NCID/Entomology, Chamblee, GA
The distribution of malaria vectors has been reported based
on mosquito collections, and factors influencing their distribution
have been identified by various methods. These methods often
employ statistical analyses to correlate the collections with a single,
or combination of, environmental variable(s) such as temperature
and rainfall. We have applied a powerful new technique known as
ecosystem niche analysis to model the distribution of the six mem-
ber species of the Anopheles gambiae complex throughout the
















high resolution base data and distribution information is available,
we analyzed the North American A. quadrimaculatus complex.
Niche analysis utilizes a genetic algorithm to produce a set of
expert rules describing the entire ecological nice occupied by an
organism. Since our maps elucidate the presence of areas where
suitable niches for A. gambiae (s.l.) exist, we describe regions
where collections could be made to validate these predictions. In
addition, because our predictions are based on the occurrence of
known ecological niches, we have created distribution maps that
predict the species’ prospective worldwide ranges based on the
occurrence of the explicit niches. Using these worldwide maps, we
depict the effect of various scenarios of global climate change on
the distribution of these human malaria vectors and its implications
for broadening of the vector habitat and subsequent control of the
disease. Finally, we transform the world distribution maps into
world risk-maps, which illustrate the areas of potential vector
establishment either through accidental or hostile release of a
species. We draw upon past incidents — the establishment of A.
gambiae s.l. in Brazil and Egypt — to show that establishment of
malaria-infected A. gambiae (s.l.) among non-immune human pop-
ulations has dire public health consequences, due to its superiority
as a vector of human malaria, and should not be ignored as an
emerging threat to global health.
Board 63. Dead Bird Clustering: An Early Warning System
for West Nile Virus Activity 
F. Mostashari1,2, M. Kulldorff3, J. Miller1, and the West Nile Virus
Surveillance Working Group1,4
1New York City Department of Health, New York, NY,
2OutbreakDetect, Inc, New York, NY, 3Division of Biostatistics,
Department of Community Medicine and Health Care University of
Connecticut School of Medicine, Farmington, CT, 4New York State
Department of Health, Albany, NY
Introduction: Since the 1999 West Nile (WN) virus out-
break in New York City (NYC), health officials have been search-
ing for an early warning system that could signal increased risk of
human WN infection, and provide a basis for targeted public edu-
cation and increased larval and/or adult mosquito control. Birds
and mosquitoes with laboratory evidence of WN virus preceded
most human infections in 2000, but sample collection and labora-
tory testing are time-consuming and costly. We describe a method-
ology for detecting small area clustering of dead bird reports, pres-
ent the results of its application to data from 2000, and review its
utility in providing an early warning of West Nile virus activity in
NYC in 2001.
Methods: All unique non-pigeon dead bird reports were
geocoded, and categorized as “cases” if occurring in the prior 7
days, “controls” if occurring during a historic baseline, or censored.
The most likely cluster area was determined using the spatial scan
statistic, and evaluated using Monte Carlo hypothesis testing.
Analyses were performed in a prospective simulation for 2000 and
in real time during 2001.
Results: For the 2000 data, dead bird clustering was found
in Staten Island on June 14, 2000, over 4 weeks prior to laboratory
evidence of WN virus in birds and mosquitoes from this area.
Clustering also occurred in other areas of the City prior to the
detection of bird, mosquito, and human infections. The imple-
mentation of this system in 2001 led to intensified larval control on
June 27, 2001 in eastern Queens, over three weeks prior to labora-
tory confirmation of bird, mosquito, and human infections from
this cluster area. Dead bird clusters were identified around the res-
idence of five of seven human infections, from 0-40 days (median
12) prior to the onset of illness, and 12-45 days (median 17) prior
to human diagnosis.
Conclusions: Prospective geographical cluster analysis
of dead bird reports may provide early warning of increasing
viral activity among birds and mosquitoes, and of subsequent
human infections.
Board 64. Risk Factors for Dengue Infection, East Maui
Dengue-1 Outbreak – Hawaii, 2001 
J. M. Hayes1, J. G. Rigau-Pérez2, P. Reiter2, P. Effler3, L. Pang4, V.
Vorndam2, S. Hinten5, K. Mark6, M. Myers6, K. Street7, L. Bergau8, C.
Meyer9, M. Amador2, M. Napier10, G. G. Clark2, D. J. Gubler11
1Dengue Branch (DB), Division of Vector-Borne Infectious Diseases
(DVBID), National Center for Infectious Diseases (NCID), Centers for
Disease Control and Prevention (CDC), San Juan, PR, 2DB, DVBID,
NCID, CDC, San Juan, PR, 3State of Hawaii Department of Health,
Honolulu, HI, 4Maui District Health Office (MDHO), Wailuku, HI,
5Epidemiology Program Office (EPO), CDC, Atlanta, GA, 6EPO,
CDC, Atlanta, GA, 7Hana Public Health Nurse Station (HDHS),
MDHO, Hana, HI, 8HPHNS, MDHO, Hana, HI, 9HPNS, MDHO,
Hana, HI, 10Pacific Disaster Center, Kihei, HI, 11DVBID, NCID, CDC,
Fort Collins, CO
Background: In September 2001, the Hawaii Department
of Health reported a dengue outbreak in East Maui, the first
recorded transmission of dengue in Hawaii since 1945.
Entomologic surveys revealed Aedes albopictus as the only poten-
tial vector. A survey was undertaken to identify risk factors for ill-
ness at the individual, household, and community level.
Methods: We surveyed communities A and B in the affect-
ed area, with high (19.3%) and low (0.4%) incidence respectively,
as determined by surveillance. A seroepidemiologic survey was
conducted, inquiring about travel history, symptoms, and potential
exposures to areas with observed high populations of mosquitoes.
Recent infection was defined as the detection of anti-dengue IgM
antibodies in persons without recent foreign travel, or IgG anti-
bodies in persons under age 56 without history of foreign travel or
immunization against Japanese encephalitis or yellow fever.
Results: Community A had 60 households and 135 resi-
dents, of which 39 (65%) and 90 (67%), respectively, participated,
compared to 44 of 49 (90%) households and 207 of 229 (90%) res-
idents in B. In A, 72 (80%) participants contributed serum sam-
ples, compared to 131 (63%) in B. Median household and lot size
in A and B were 2 persons and 2.8 acres, and 4 and 0.8, respec-
tively. There were 27 (38%) recent infections detected in commu-
nity A and 5 (4%) in B. Univariate analysis indicated a significant
association between recent dengue infection and living in a prop-
erty large enough that the neighboring house is not visible (19
[79%] of 24 cases vs. 27 [16%] of 164 non-cases, Odds Ratio
(OR)=19.28, 95% Confidence Interval [CI]=6.14-70.25), living in a
house without window screens (10 [34%] of 29 cases vs. 6 [4%] of
160 non-cases, OR=13.51, 95% CI=3.93-48.05), living in a proper-
ty with taller bushes (mean estimated height for case properties, 11
ft. vs. 6 ft. for non-cases, p < 0.0001), greater vegetation cover near
the house (67% vs. 33%, p < 0.0001), living in a property with mos-
quito positive containers (23 [79%] of 29 cases vs. 73 [43%] of 171
non-cases, OR=5.11, 95% CI=2.04-14.37), and the use of pay
phones (6 [19%] of 31 cases vs. 8 [5%] of 165 non-cases, OR=4.71,
95% CI=1.30-16.88). These conditions are also associated with
infection within each community (except the payphone, only for
A), but significance is lost with the reduction in sample size.
Multivariate analysis is currently underway.
Conclusions: Our survey indicates a 2 to 10-fold greater
incidence of dengue infection than detected by surveillance, and
risk factors consistent with a mosquito vector (Ae. albopictus) that
breeds in natural and artificial containers. Our findings suggest that
community A’s pay phone area was a focus for dengue transmission,
and that interventions such as using repellent when outdoors,
installing window screens, trimming vegetation, and eliminating
potential breeding sites may reduce the risk of dengue infection.
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Board 65. Detection of West Nile Virus Activity in the
Commonwealth of Virginia’s Avian Populations 
S. S. Walker, J. M. Hall, W. A. Holzrefe, S. T. Kelly, D. A. Pettit
Division of Consolidated Laboratory Services, Richmond, VA
To identify the presence of West Nile virus (WNV) in the
Commonwealth of Virginia, the Division of Consolidated
Laboratory Services has implemented a real-time reverse tran-
scription polymerase chain reaction (RT-PCR) assay to detect
WNV in tissues of recently dead birds. Over 1,253 dead wild birds,
were submitted by the Virginia Department of Health in 2001.
These birds were primarily crows (75%), blue jays (16%), and rap-
tors (6%) and were necropsied to remove kidney, brain, liver, and
heart tissues. Qiagen QIAamp Viral RNA kits were utilized to
extract RNA from kidney tissues. RNA extracts were analyzed with
a one-step RT-PCR assay using the LightCycler System with FAM-
and TAMRA-labeled probes and primers that have been previous-
ly reported (Lanciotti et al. J Clin Micro 38:11 and Briese et al.
Lancet 355:9215). The LightCycler assay amplified WNV c-DNA
and identified 212 positive tissue samples obtained from birds col-
lected from 19 counties. Of those tissue samples that yielded posi-
tive results, approximately 98% were derived from crows and 2%
were derived from blue jays. WNV positive dead birds were the
first indicator of WNV activity in 19 of the 20 counties in Virginia
with WNV activity. In one county a WNV positive horse was the
first indicator of WNV activity and in that instance, only one
recently dead bird had been submitted for testing prior to the sero-
conversion of the horse. These data suggest that real time RT-PCR
using the LightCycler System is a sensitive, specific, and cost effec-
tive method for the detection of WNV activity in the environment.
Board 67. Surveillance for West Nile Virus Infection in
Mosquitoes, Birds and Mammals in New York City, 1999-2001 
V. Kulasekera1, C. Glaser1, A. Fine1, B. Edwin1, L. Kramer2, I.
Poshni1, J. Gibson1, J. Miller1
1New York City Dept. of Health, New York, NY, 2Wadsworth Center,
Albany, NY
Local transmission of West Nile virus (WNV) was first
detected in New York City (NYC) in 1999. Infected mosquitoes,
birds, and mammals were detected in Queens, Brooklyn and the
Bronx, with the largest number of human infections in Queens. In
order to prevent a recurrence of WNV in 2000, a comprehensive
surveillance and control plan was implemented by the New York
City Department of Health. A network of adult mosquito traps and
dead bird sightings were monitored citywide to detect the pres-
ence of the virus. In 2000, West Nile virus transmission was most
intense on Staten Island, with positive mosquitoes and birds first
detected during the first week in July. Of the 4800 mosquito pools
tested 205 were positive. The virus was detected in 8 species, Culex
pipiens, Cx. salinarius, Cx. restuans, Aedes vexans, Ochlerotatus
cantator, Oc. triseriatus, Psorophora ferox and Anopheles punc-
tipennis. Overall, 14,849 dead bird reports were received from the
public of which 1083 birds were submitted for laboratory testing.
Corvus brachyrhynchos was the most prevalent species, accounting
for 133 out of 185 WNV positive dead birds. The 2000 outbreak
resulted in 14 laboratory-confirmed human cases. Ten cases were
from Staten Island, 2 from Brooklyn, 1 from Queens and 1 from
Manhattan. The number of fatalities associated with NYC was
reduced from 5 in 1999 to 1 in 2000. Other mammals infected with
the virus were 3 horses, and 1 squirrel. In 2001, the preliminary
results of surveillance activities resulted in 208 WNV positive mos-
quito pools out of 6226 submitted for testing. The species that test-
ed positive were Cx. pipiens, Cx. restuans, Cx. salinarius and Ae.
vexans. The public reported 5212 dead bird sightings, with 667
birds submitted for laboratory testing. Out of the 165 that tested
positive for WNV, 121 were Corvus brachyrhynchos. Active and
enhanced passive human surveillance resulted in 7 laboratory con-
firmed cases and no fatalities. Staten Island, Brooklyn and Queens
had two cases each, and 1 case was from Manhattan. There was no
evidence of other mammals being infected with WNV. The utility
of mosquito and bird surveillance data from 2000-2001 as early
predictors of human illness will be discussed.
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Board 68. Climate, Weather, and the Outbreak and Spread
of Infectious Diseases: A Strategy 
L. J. Pietrafesa1, E. Buckley2
1North Carolina State University, Raleigh, NC, 2NOAA Coastal
Services Center, Charleston, SC
Complex interactions and feedbacks across biological and
physical systems and/or simple structural threshold like responses
that cascade throughout are characteristic of the manner in which
ecological systems function. Yet, historically most efforts have been
focused on attempting to describe such complex nonlinear
responses as more readily tractable linear and even stationary
processes. Albeit, to anticipate and avoid surprises, particularly in
the area of human health, a more comprehensive understanding of
the inner relationships between human health, the outbreak and
spread of infectious diseases and their relationships to the weather
and climate of the coupled land, atmosphere, oceanic and hydro-
logic systems must be established. This paper describes a method-
ology which will result in a predictive capability for the outbreak
and spread of infectious diseases which are related to environmen-
tal factors and pose the greatest risk to US coastal populations,
including the Great Lakes. The intrinsic and ultimate objectives of
the proposed approach will be to: identify processes and biophysi-
cal gradients likely to generate non-linear responses and therefore
unexpected behavior under future environmental conditions; com-
prehend when nonlinear responses are important to scaling issues
temporally and spatially; quantify transform functions between
forcings and responses for verifying and parameterizing predictive
process models; develop new tools to study nonlinear responses
and thresholds; formulate new hypotheses derived from mathe-
matical treatment of model systems, such as spatial scale depend-
ence of perturbations that can be tested using data dependent
reconstructive methods; and employ this knowledge of the nonlin-
ear system responses to better guide human health policy develop-
ment for adaptive and mitigation strategies to future environmen-
tal weather events and climate variability. Data compiled from
meteorological, oceanographic, hydrological, epidemiological,
environmental, and ecological monitoring would be utilized by a
multidisciplinary team in the analysis of the complex connections,
likely non-linear and non-stationary, between weather events and
climate conditions and the outbreak and/or spread of infectious


















Tuesday, March 26, 8:30 a.m.
Grand Hall East
Board 70. Disparities in Foodborne Disease Education
Among Physician Specialties that Treat At-Risk Populations 
S. M. Thomas, K. G. McCombs, S. Lance-Parker
Georgia Division of Public Health, Atlanta, GA
Background: Foodborne disease is a significant problem
in the United States with an estimated 70 million cases each year.
Immunocompromised and pregnant individuals are at higher risk
of acquiring a foodborne disease and of having a more severe ill-
ness if infected. Research has shown that consumers are not well
educated about food safety, but are concerned about infectious dis-
ease. Because of the higher risk of illness in immunocompromised
and pregnant individuals and the inherent lack of food safety edu-
cation, physicians whose specialties are intimately involved in the
treatment or management of at-risk individuals are essential in the
education of these populations about foodborne disease.
Methods: In 2000, Georgia, as a member of the Emerging
Infections Program, conducted a survey targeting four physician
specialties that treat immunocompromised or pregnant individuals.
The specialties included obstetricians, oncologists and hematolo-
gists, infectious disease (ID) physicians, and nephrologists. The
survey focused on physician’s beliefs, knowledge, and practices
concerning education of their patients about foodborne disease
risk and prevention.
Results: Three hundred nine surveys were distributed to
these four specialties; 87 of the 134 questionnaires returned were
used in the analysis. No difference was found in the proportion of
physicians surveyed that treat at-risk individuals among the four
specialties, with 98% of physicians reporting that they treated at
least some at-risk patients. The proportion of patients that request-
ed information regarding foodborne disease also did not differ
among the four specialties, with 80% of physicians reporting that
their patients request information on food safety and foodborne dis-
ease prevention. Thirty-eight percent of physicians reported that
their practice provides information about foodborne disease to
patients. ID physicians’ practices were more likely to provide infor-
mation than both nephrology (p=0.001) and obstetric (p=0.004)
practices, while oncology/hematology practices were more likely to
provide information than nephrology practices (p=0.043).
Conclusions: There is a disparity in foodborne disease
education of patients among the four different physician special-
ties. ID physicians and oncologists/hematologists are more likely to
ensure that their patients receive education on foodborne disease
risk and prevention. Physician specialty appears to have the great-
est impact on whether a physician’s practice educates patients
about foodborne disease. This study highlights two physician spe-
cialties in Georgia that should be targeted for increased education
about foodborne disease and its impact on at-risk individuals.
Board 71. Multi-agency Coordination: The Key for West Nile
Virus Surveillance and Health Communication in Florida,
January- December 2001 
R. L. Oliveri, L. Conti, C. Blackmore, S. Wiersma
Florida Department of Health, Tallahassee, FL
A history of endemic eastern equine encephalitis and peri-
odic outbreaks of St. Louis encephalitis in Florida resulted in inter-
agency cooperation among local, state and federal government
agencies, state university research centers and local mosquito con-
trol agencies. The identification of West Nile (WN) virus in the
United States presented an opportunity to expand arbovirus sur-
veillance and expand partnerships in Florida leading to the early
detection of WN virus and subsequent public health response. The
collaboration and commitment of the interagency partnership
brought together a network of arbovirus expertise and experience
resulting in an inclusive and comprehensive response.
A Florida West Nile Virus Interagency Workgroup devel-
oped and provided consultation on a state West Nile virus
Surveillance and Response plan. This provided guidance to the
Florida Department of Health in its efforts to detect WN virus and
coordinate response. This group met weekly to discuss program
data and initiatives and provide input into public health communi-
cations, which included 1) press releases with health alerts, weekly
statewide public conference calls to disseminate and clarify
arbovirus surveillance information; and 2) establishment of a
statewide hotline and internet-based reporting site for dead-bird
reporting and regular internet summaries and GIS maps of sur-
veillance data on each agency website with links to other member
sites, as well as national arbovirus information sites.
Novel approaches to data access included development of
an internet-based web-board by the Department of Health to pro-
vide automatic and immediate notification of dead bird reports and
test results and the use of the Department’s weekly Epi Update.
Health alerts and data summaries were published through the
Bureau of Epidemiology’s Epi Update, a weekly electronic newslet-
ter targeting a broad public health audience. Through direct partic-
ipation and communication, complex surveillance strategies were
successfully implemented across several agencies to meet public
health objectives. Direct accomplishments achieved through multi-
agency coordination included early virus detection, continuing data
collaboration, consistent interagency public health messages,
decreased interagency program competition, shared resources, and
increased public participation in dead bird reporting and apparent
behavior modification to reduce risk of mosquito bites.
Board 72. Marketing Strategy in the Development of a
Sentinel Surveillance System. 
J. C. Hagen, B. Parota
DuPage County Health Department, Wheaton, IL
The critical need for, and role of, local public health sur-
veillance has become even more apparent in recent months. This
surveillance must reside at the local level, where both obstacles
and opportunities are clearly understood. This is true not only with
currently publicized bioagents, but to emerging diseases, and to
the health effects of environmental agents. Carefully chosen sen-
tinel events or conditions become foundation stones to this system.
The weakest link is the relationship between the heath care com-
munity and population-based public health. Soliciting and solidify-
ing a mutually beneficial interaction is a complex mix of education,
health promotion, and the innovative use of marketing. DuPage
County Health Department has undertaken a process to design
and implement an innovative marketing concept to enhance col-
lection of necessary surveillance data from several sectors.
Extensive input has been gained from staff and targeted profes-
sionals concerning methods for achieving marketing outcomes.
Five specific marketing elements are: clear, precise sentinel condi-
tions or events to be reported, provision of emerging disease work-
shops and training, rapid email/messaging or broadcast fax mecha-
nisms, dedicated interactive website for surveillance system part-
ners, and constant reporting back to those involved. Early results
indicate an increasing interest and level of support for this sentinel
surveillance system. The key has been to attract and involve the
health care professionals so critical to success of the system. Recent
events have identified gaps that exist in our system We must take
advantage of this opportunity to better protect the health and lives
of our residents.
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Board 73. The Pedagogy of Emerging Disease: Teaching
Medical Microbiology Using a Multifaceted Approach 
R. D. Siegel
Stanford, Stanford, CA
The control of emerging infectious disease demands a cadre
of physicians and allied health professionals well versed in the con-
cepts of microbiology and infectious disease. Medical students and
others often have difficulty in mastering this information. Several
factors contribute to this difficulty: 1) the large number of organ-
isms, 2) the variable clinical manifestations of infection even for a
single organism, 3) the complexity of interactions between
pathogen and host, 4) the rapid rate at which new genomic and vir-
ulence information is being acquired, and 5) the complexities and
protean nature of epidemiology and treatment. In addition, stu-
dents vary widely in the ways in which they learn most effectively.
In light of these considerations, we have developed a mul-
tifaceted approach to the instruction of microbiology and infec-
tious disease. This course is aimed at clinical medical students but
is also taken by graduate students and could be adapted to other
pedagogic settings.
Students can choose from a wide variety of instructional
modalities that best suit their learning needs. These modalities
include: 1) live daily lectures, 2) clinicopathological case discus-
sions, 3) demonstration laboratories, 4) video streamed web based
lectures, 5) teaching assistant led discussions and reviews, 6)
detailed course reader, 7) printouts and online versions of
PowerPoint presentations, 8) recommended textbooks, 9) optional
weekly problem sets, 10) online mastery quizzes of microbial tax-
onomy, 11) numerous practice tests in both final exam format and
arranged by organ system, 12) Microbe — a multimedia microbi-
ology teaching tool available on the web or on CD, 13) the
Interactive Simulated Patient, 14) an email distribution list, 15) a
course specific web site containing many of the above resources
and well as links to numerous other microbiology related websites,
16) PDA resources in conjunction with the Stanford Palm Project,
17) a resource bank of slides and video tapes, and 18) numerous
opportunities to interact with the infectious disease consult service
on working rounds and grand rounds.
Overall, the course is organized into nine sections: an initial
section on host-pathogen interactions and an intro to
structure/function relationships of the major pathogenic groups.
This is followed by seven sections organized by organ systems and
taught using a syndromic approach. The sections are: respiratory,
GI, skin, genitourinary, liver, CNS, and systemic. The final section
of the course deals with special topics including: use of antibiotics
and antibiotic resistance, nosocomial infection and hospital epi-
demiology, surgical infections, zoonoses, travel medicine, emerging
infections, and biological weapons.
This presentation will elaborate on the more innovative and
less obvious aspects of these teaching modalities. We will present a
detailed description of the website and how it is utilized.
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Board 74. Scenario Analysis of Expected Number of
Hospitalizations and Deaths Due to Pandemic Influenza in The
Netherlands 
M. L. Genugten, van, M. L. Heijnen, J. C. Jager
National Institute of Public Health and the Environment (RIVM),
Bilthoven, NETHERLANDS
Introduction: Another influenza pandemic, following the
1918, 1957 and the 1968 pandemics, is likely if not inevitable. In a
‘regular’ influenza epidemic 5%-20% of the population is to
become clinically ill; during a pandemic this percentage can mount
to 30% or even 50%. A pandemic could cause substantial social dis-
ruption, insofar it would involve a large proportion of the popula-
tion contracting a serious or less serious form of the illness. In
order to minimize the effects of such a potential pandemic the
Dutch Ministry of Health has drawn up an influenza pandemic
preparedness plan. Within the scope of this plan, the Ministry
asked us to calculate the expected number of hospitalizations and
mortality during an influenza pandemic.
Method: As many uncertainties are involved in this type of
studies, we have developed alternative scenarios and consulted
experts to give their opinion on these scenarios and on the under-
lying model and assumptions. Various interventions are compared
with the ‘do nothing’ scenario on their effect in terms of avoided
hospitalization and mortality. Possible interventions are influenza
vaccination, pneumococcal vaccination or therapeutic use of neu-
raminidase inhibitors.
Results: Age-specific attack rates and complication rates
appeared to be crucial to the outcomes in terms of number of hos-
pitalizations and deaths. In case of a pandemic with an overall
attack rate of 30%, age-specific attack and complication rates, and
health care as in a ‘regular’ epidemic, we estimated that influenza
vaccination of risk groups and health care workers could prevent
around 60% of hospitalizations and deaths, therapeutic use of neu-
raminidase inhibitors for each person with an influenza-like illness
about 50%, and pneumococcal vaccination of risk groups for
influenza about 26% of hospitalizations and 3% of deaths.
However, it is unlikely that an influenza vaccine will be available in
time. Treatment with neuraminidase inhibitors should start within
48 hours after first symptoms, which would be a logistic challenge,
whereas pneumococcal vaccination can be given before a pandem-
ic threat.
Conclusions: Our analysis makes assumptions explicit and
shows gaps in knowledge and data. Describing and comparing the
alternatives gives insight into the impact of the pandemic in terms
of number of hospitalizations and deaths, the impact of the various
possible interventions in terms of avoided influenza-related hospi-
talizations and deaths and in the crucial model parameters.
Scenario-analysis will be helpful in policy making and planning of
control measures on national and regional level. When there is an
acute pandemic threat, the availability of the underlying decision
support model provides the opportunity to update estimates of
hospitalizations and mortality based on surveillance data from the
pandemic source region. The model can also be used for other
















Board 75. Assessment of Antiviral Drugs for Influenza A
Prevention in Critical Occupational Groups 
J. L. Kingsbury1, J. C. Gaydos2
1Walter Reed Army Institute of Research, Silver Spring, MD, 2DoD-
Global Emerging Infections Surveillance & Response System, Silver
Spring, MD
Statement of Purpose: This review identified and evaluated
important variables related to the use of antiviral drugs to protect
large critical occupational groups when vaccination cannot be accom-
plished and influenza A outbreaks occur.
Statement of Methods Used: Four FDA approved drugs
for influenza A (amantadine, rimantadine, oseltamivir, and zanamivir)
were reviewed. Each drug’s mechanism of action, prophylaxis effica-
cy, dosing, side effects, effect on humoral response to infection and
vaccination, frequency of drug resistance, cost, shelf life, storage
requirements, production capacity, and availability were reviewed.
Information was obtained through literature search, search of select-
ed websites, and interviews. Efficacy data were obtained from stud-
ies on healthy adults with laboratory proven influenza illness.
Summary of Results: All 4 drugs have 70-90% prevention
efficacy. Major distinguishing features are: side effects, cost, and fre-
quency of drug resistance. The lowest cost drug is amantadine
($1.00/5 days, Federal price). Its limitations are 30% drug resistance
emergence and 10% occurrence of central nervous system (CNS)
symptoms. Jobs that require high levels of CNS functioning may
make this drug undesirable. Rimantadine is similar to amantadine but
only 2% experience CNS symptoms. The cost is higher ($6.80/5 days)
and drug resistance emergence is 30%. The neuraminidase inhibitor
oseltamivir costs $32.30/5 days; 10% of patients experience nausea
and vomiting but only 1.5% show drug resistance emergence.
Zanamivir is not approved for prophylaxis but studies show it is effi-
cacious and may have a low rate of drug resistance. It has cost limita-
tions ($26.76/5 days) and occasionally has caused bronchospasm and
airflow reduction in chronic respiratory disease patients.
Statement of Conclusions Reached: All 4 antiviral drugs
have similar prevention efficacies. Only 3 are approved for pro-
phylaxis. Shelf life, storage requirements, production capacity and
availability are under study. Decisions for use will have to balance




Ukrainian Anti-Plague Institute, Odessa, UKRAINE
In this research we investigated the influence of molecular
structure of macrocyclic pyridinophanes and their analogs on their
anti-influenza and antiherpetic activity. This task was solved by
means of elaborated 4D-QSAR approaches on basis of simplex rep-
resentation of molecular structure. Such representation for biolog-
ically active substances allows to unify the description of spatial
structure of compounds with saving of the complete stereochemi-
cal information. It enables easily to determine common fragments
of spatial structure either promoting or interfering the concrete
biological activity for researched molecules. On base of such
approaches it is easily to realize molecular design of compounds
with the given level of activity with the help of generation of the
allowed combinations of such types simplexes, which determine
researched property. Statistic characteristics for QSAR of PLS
(Partial Least Squares) models are satisfactory (R=0,92-0,97;
CVR=0,76-0,86). The molecular fragments that increase and
decrease antiviral activity were defined and will be demonstrated.
This information is useful for design and directed synthesis of
novel antiviral agents. Several compounds with predicted high anti-
influenza and antiherpetic activities were already synthesized. And
their activities were confirmed experimentally.
This work was partially supported by INTAS foundation
(grant INTAS 97-31528).
Board 77. Early Detection of Pneumonia and Influenza
Excess Mortality in 13 Big Cities in Japan 
Y. Ohkusa1, N. Shindo2, N. Okabe2
1Institute of Social and Economic Research, Osaka University, Osaka,
JAPAN, 2National Institute of Infectious Diseases, Tokyo, JAPAN
Background: There is a well-developed infectious disease
surveillance system in Japan that enables timely information about
the size of influenza epidemics. To know the real impact and sever-
ity of the circulating virus, mortality related to influenza is
required. In this project, we tried to find early warning signs in
influenza mortality. Formerly, influenza related mortality (if
‘influenza’ was listed in any row of the death certificate) reporting
was requested from all Public Health Centers in the country.
However, the number reported was about half of the primary cause
influenza deaths reported to the vital statistics office. In this proj-
ect, we chose 13 big cities covering one eighth of the total popula-
tion throughout Japan.
Methods: We produced mortality curves for each city
using pneumonia and influenza (P&I) mortality data (1987-1999).
Predicted mortality curves were produced by stochastic frontier
estimation. P&I mortality was reported from Public Health
Centers weekly by electronic files. The result was compared with
morbidity and viral surveillance data. Death cases are reported by
the date of death, sex, age, cause of death (pneumonia or influen-
za) and place of death.
Results: Within the cities with completed mortality reports
(Sapporo, Chiba, Kobe, Hiroshima and Kita-kyushu) no significant
excess deaths were found during the 2000/2001 season. Reporting
delays were different in each city. Sendai, Tokyo and three other
cities seemed to have some missing data, and the rest had difficul-
ty in complete reporting.
Conclusion: Low mortality observed during the season
was explained by the low morbidity especially among elderly and
because influenza B and A/H1N1 mainly circulated in Japan. In
Japan, large excess mortality is found when drifted A/H3N2
appears and co-circulates with influenza B.
In Japan, death certificates are brought to ward offices, and
then the records are transferred to the Public Health Center,
which is responsible for electronic data entry. This process of trans-
fer is not electronic; the main cause of delay exists here and some
infrastructure changes should be made. Preliminary reports of
death used in United States’ 122 cities are not available in our
country for legal and other reasons. Prompt reporting is essential if
this system is desired for early warning purposes.
Board 78. An Empirical Research for Demand of Influenza
Vaccination in the Elderly in Japan 
Y. Ohkusa
Osaka University, Ibaragi, JAPAN
Purpose: This paper examine to analyze what determines the
demand for vaccination in elderly as high risk group. Then, by using the
estimation results, this paper evaluate how the law recommendation
and/or subsidy affect their demand. Methods: Original data were
obtained from two survey to the elders living with decendants and the
elders living without decendants , conducted by the author. The survey
contain the information about the elders, the household, experience of
influenza during the last season, immunization during and hypothetical
questionare about immunization for Conjoint Analysis. The three esti-
mations are performed for actual behavior, Conjoint Analysis and Joint
Estimation which are combine the first two estimation. Results:
Among estimation results, cost, number of immunization, immuniza-
tion in night or weekend, and law recommendation heavily affect their
demand. Experience of influenza and immuzation in the last season,
are one of the most important determinant. Moreover, the superior of
the Joint Estimation is confirmed. Conclusions: The estimation results
implies that about 8.9 million elderlys will demand for vaccination if no
cost and with law recommendation. Conversely, it will reduce to be 3.2
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million if cost is 6000 yen (about 50 dollars) and without law recom-
mendation. The change from no cost to just 500 yen (about 4 dollars)
depress the demand by 1.6 million elders. Law recommendation alone
can push up 2.0 million elderlys.
Board 79. Forecasting the Geographical Spread of Influenza
Epidemics by the Method of Analogies
C. Viboud1, P. Boelle1,2, F. Carrat1,2, A. Valleron1,2, A. Flahault1,2
1INSERM U444, Paris cedex 12, FRANCE, 2Centre Hospitalo-
Universitaire Saint-Antoine, Paris cedex 12, FRANCE
This work presents a method for prediction of the time and
geographical spread of influenza epidemics, using a non parametric
forecasting technique, the “method of analogies,” previously pro-
posed for forecasting weather by Lorenz (1). No statistical or model-
ling approach is currently considered a benchmark for forecasting the
spread of an epidemic disease. Geographical mechanistic models
have been proposed, but require extensive data on transportation
flows (2). Statistical models for time series analysis demand assump-
tions that are rarely met, because the time series is neither stationary
nor exactly periodic. The method of analogies does not require exoge-
nous information for prediction, but uses retrospective data and a
suitably chosen measure of proximity between contemporary obser-
vations and historical observations to approximate the dynamics of
the epidemic. Incidence forecasts are based on the average evolution
of past patterns, so-called ‘neighbours’, that most closely resemble
contemporary observations.
We applied the method of analogies to forecast influenza-like
illness (ILI) incidences in France and in the 21 administrative regions
of France from a series of 807 consecutive weeks of ILI surveillance
(16 epidemics) spanning 1984-2000 and recorded by the French
Sentinel Network (3). Forecasts were made up to 10 weeks in
advance. Parameters estimation was done by minimization of a cross-
validation criterion based on the root mean square error of the pre-
dictions. The accuracy of the prediction was assessed by direct com-
parison of the distribution of observed and predicted incidences, and
by estimating the Pearson correlation coefficient between observed
and predicted incidences. The accuracy of the method of analogies
was in turn compared with that of a linear auto-regressive models fit-
ted to each series.
For the method of analogies, the correlation between
observed and predicted regional incidences (see Figure) was above
0.62 (10-week ahead forecasts) and up to 0.81 (1-week ahead fore-
casts). Similar results were obtained for national incidences. This
method yielded forecasts more accurate than those of linear AR mod-
els (P<0.001). However, the predicted incidences were slightly closer
to the mean of the series than observed incidences.
The method of analogies is probably suitable for prediction of
other communicable diseases, e.g. acute diarrhoea, as long as the dis-
ease displays recurring cycles. As any other prediction method, it also
requires real-time collection of data to make prediction worthwhile.
Finally, the method of analogies is a self-learning process, allowing its
accuracy to improve with the length of the time series.
Board 80. Is Flu-Like Syndrome or Flu the Main Event of the
Seasonal Illnesses in Patients Suffering From C Virus-Related
Chronic Hepatitis (CCH), During IFN Treatment? 
G. Tarantino1, P. Conca1, A. Perrella1, P. Sorrentino1, P. Ragucci1, E.
D' Avanzo1, O. Perrella2
1Dpt of Clinical and Experimental Medicine Federico II University
Medical School, Naples, ITALY, 2VII Division Infectious Disease,
Hospital D. Cotugno, Naples, ITALY
Among side-effects of IFN therapy the so-called flu-like
syndrome (FLS) is one of the most frequent and fearful experience
that limits, in some ways, the patients (pts) quality of life (QOL)
and the high dose-regimens, during their six- or twelve-month
treatment period. On the other hand, influenza and other viral res-
piratory diseases (VRD) with their impact on general well-being
sense casts shadows whether it should previously be managed with
prophylaxis or eventually treated. Both circumstances overlap and
sometimes it is difficult to distinguish between them, mainly facing
illness mild expressions. Trying to clarify the VRD incidence in our
setting we studied 246 (130 females) pts affected from chronic C
hepatitis of which 124 (68 females) had undergone IFN therapy
administered obviously in any year span (but at least started from
4 weeks). Were excluded pts with cardiovascular or pulmonary dis-
eases, decompensated diabetics, sustained smokers, those older
than 65 years and the vaccinated ones. On the base of clinical evi-
dence coupled with specific serology there were discovered 48
cases of VRD including influenza, para-influenza and adenovirus
infections in no treated pts, mostly evidenced during seasonal out-
breaks. Four pts suffered from complications (1 secondary bacter-
ial pneumonia, 1 marked muscle tenderness, 2 prolonged acute
diarrheal illness); in the opposite cohort, only 16 pts showed fever,
chills, headache, myalgias and sore throat associated or not with
rhinitis whose serology proved 5 viral episodes (chi-square = 13.2;
p < .0003), without serious sequelae; the remainder episodes were
judged to be ascribed very likely to FLS, at times tardily emerging.
The different hosts were characterized by a major frequency of
sore throat and rhinitis, typical of true VRDs (34/48 cases com-
pared with 2/5 ones; 71% versus 40%). Clinical manifestations
were strictly treated by the means of analgesic-antipyretics and
anti-inflammatory (overall paracetamol). In the following year the
same pts were monitored to detect the need of administering flu
vaccines and surprisingly the IFN-treated cohort had a significant-
ly minor incidence of VRD episodes also after having stopped
antiviral treatment (2 versus 39). Which conclusions could be
drawn from these epidemiological observations? The main feature
of IFN treatment-period seems to be the well-known FLS. QOL in
pts with CCH is sometimes impaired but, globally considering the
entire phase of IFN therapy, the decreased frequency of seasonal
viral respiratory illnesses improves such feature, cuts-back the
therapeutic costs and, what’s more, lessens hospitalisation periods.
Finally, in our opinion, the IFN immune-modulating and
antiviral actions play a pivotal role in inducing a marked reduction
of C virus activity and probably other intercurrent viral affections.
Board 81. The Method of Extrapolation of Influenza Virus
ID50 from One Mammals Species to Another. Perspectives of
Its Application when Controlling and Preventing Infectious
Diseases 
V. Zhukov1, L. Shishkina1, A. Sergeev1, A. Safatov1, O. Piankova1, V.
Petrishenko1, O. Piankov1, E. Ryabchikova2, E. Malkova2, S. Morse3
1Research Institute of Aerobiology, SRC VB "Vector", Koltsovo, RUSS-
IAN FEDERATION, 2Institute of Molecular Biology, SRC VB "Vector",
Koltsovo, RUSSIAN FEDERATION, 3Columbia University, New York, NY
The scheme of extrapolation is based on a mathematical
model of the formation of the infectious process in an organism.
The model connects a parameter of an organism susceptibility to a
















susceptible cells of the host, the probability of virus productive
adsorption on a susceptible cell and the average virus yield in a cell.
The method was tested when extrapolating the value of influenza
virus A/Aichi/2/68 ID50 from outbred mice to outbred rats. The
primary cells of lungs of both animals were used to measure
parameters of virus-cell interaction. The ratio of the numbers of
the main types of epithelial lung cells susceptible to influenza such
as ciliated cells and pneumo-cytes of the 1st and 2nd types was sim-
ilar to the ratio of the cells in lungs. The extrapolated and experi-
mentally measured values of the virus ID50 were statistically equal.
It indicates the validity of the method of extrapolation. Some
approaches how to use the method in the system of diseases con-
trol will be discussed. In particular, the method can be applied to
the solution of the following problems:
• assessment of an infectivity for human of emerging viruses
of non human origin;
• epidemiological investigation of human sub-population
with respect to their susceptibility to viruses.
[Supported by ISTC/DARPA Agreement #450p.]
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Board 82. Prevalence of Sexually Transmitted Diseases
Among Injection Drug Users in St Petersburg, Russian
Federation
N. Abdala1, J. M. Carney2, A. J. Durante1, A. M. Somlai3, A.
Shaboltas4, D. Ostrovski5, R. Heimer1
1Yale University School of Public Health, New Haven, CT, 2Urban
Health Study, UCSF, San Francisco, CA, 3Department of Psychiatry and
Behavioral Medicine of the Medical College of Wisconsin, Milwaukee,
WI, 4Department of Psychology, St. Petersburg State University, St.
Petersburg, RUSSIAN FEDERATION, 5St. Petersburg "Vozvrastcheniye"
Return Foundation, St. Petersburg, RUSSIAN FEDERATION
Background: Epidemics of HIV and syphilis have
appeared within the last half dozen years. Injecting drug users
(IDUs) are the nexus for these emerging epidemics. Infectious dis-
ease prevalence among IDUs can be estimated by testing the small
amounts of blood left inside syringes in a simple, non-invasive way.
We have collected used syringes to conduct a point prevalence
study and have investigated the associated risk behaviors among
the IDUs visiting a needle exchange program in St. Petersburg,
Russia. Method: IDUs returning syringes to the St. Petersburg
“Vozvrastcheniye"” syringe exchange program (SEP) from June to
July 2000 were invited to anonymously complete a 64 item ques-
tionnaire requesting demographic, knowledge, and behavioral
information, and to provide their used syringes to be tested for
antibodies indicating previous infection to HIV, Hepatitis C
(HCV), Hepatitis B (HBV) and syphilis. Results: A sample of 101
subjects was interviewed, and 136 syringes were collected for test-
ing. The median age of IDUs was 23 years (IQR: 19-26) and medi-
an number of drug injections in the previous month was 40 (IQR:
18-70). Syringe prevalences were 10.9% for HIV, 78.2% for HCV,
15.8% for HBV, and 6.9% for syphilis. All respondents recognized
that the sharing of syringes or the use of unsterile syringes is a sig-
nificant risk factor for getting AIDS and all were aware that clean-
ing used syringes with water alone is insufficient to kill residual
HIV. Only 65.3% of subjects recognized condoms as an effective
means of STD prevention. 49% thought oil based products were
good lubricants for condoms or were not sure. Although several
items on the questionnaire were significant predictors for return-
ing contaminated syringes to the SEP, none was an item which
identified an important behavioral risk or a gap in risk knowledge.
Conclusion: The IDU population studied was young and although
it possessed a high level of knowledge about injection drug use risk
behavior it requires additional interventions to encourage safer
sexual behaviors. HCV prevalence is approaching saturation and
syphilis infections appear to be much higher among IDUs than in
the general population. The SEP might serve as a useful vehicle to
institute a STD prevention intervention. Such an intervention
might have the synergistic effect of reducing syphilis infections
while keeping the sexual transmission of HIV and HBV low.
Board 83. Surveillance of Viral Gastroenteritis Outbreaks in
Europe: 1995 to 2000 
B. A. Lopman1, M. Reacher1, D. Brown1, G. Hernández2, 
M. Koopmans3
1Public Health Laboratory Service, London, UNITED KINGDOM,
2Instituto de Salud Carlos III, Madrid, SPAIN, 3Research Laboratory
for Infectious Diseases, National Institute for Public Health and the
Environment (RIVM), Bilthoven, NETHERLANDS
Viral agents are the most common cause of acute gastroen-
teritis, but estimates of the importance of foodborne transmission
vary widely among different countries. To gain understanding of
surveillance and epidemiology of viral gastroenteritis outbreaks,
data were compiled from ten surveillance systems associated with
the “Foodborne Viruses in Europe” network. Most surveillance
systems found Norwalk-like viruses to be responsible for at least
85% of all viral outbreaks. However, the absolute number and pop-
ulation-based rates of viral gastroenteritis outbreaks differed
markedly among European surveillance systems. A wide range of
estimates of the importance of foodborne transmission was also
found: from nearly 100% in Denmark and France to 7% in
England and Wales. These differences must be seen within the
context of the sources of information, clinical definitions and struc-
tures of the outbreak surveillance systems.
Board 84. International Trade and Emerging Infections:
What Can Trade Data Tell Us? 
A. Kimball, T. A. Harrison, N. Pautler
University of Washington, Seattle, WA
Background: Emergent infections (Nipah virus, Avian
Influenza, Bovine Spongiform Encephalopathy, etc.) have cost bil-
lions of dollars in lost trade and travel worldwide over the past
decade. Control of emerging infections is a new priority within the
Asia Pacific Economic Cooperation (APEC), according to the
Leaders Declaration (Shanghai, 2001). Beyond humanitarian con-
cern, the cost to global trade of emergent diseases is unacceptable
because: 1) it is not predictable or manageable, 2) it can profound-
ly affect corporate and national trade revenues through the disrup-
tion of trade, and 3) it can lead to long-term unpredictable changes
in global market position for trading nations. The action of APEC
follows similar actions by the European Union and ASEAN trading
communities. The World Trade Organization (WTO) collects and
disseminates data on trade. However, WTO information has not
previously been analyzed for the impact of infections on global
trade. Objectives: 1) To create an analyzable data set of independ-
ent variables from the collected urgent measures notifications of
the World Trade Organization, 2) Use this dataset to describe the
experience with emergent infections and trade restriction as
reported to the WTO. Methods: 394 urgent measures reports
were received by WTO, Geneva between April 1996 and August
2001. A database to accommodate these forms was designed con-
sisting of 16 independent variables. Data was entered using
STATA, and simple frequency analysis has been carried out. Data
linkage and comparison using other trade data sources is underway
and should be completed by early spring 2002. Results: Of the 394
forms analyzed to date, the distribution of reporting economies
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among regions was uneven, with reporting frequency higher for
countries in Europe and Australasia. The two most common caus-
es of urgent import restriction were concern for animal health
(54%) and food safety (24%). Two infections, bovine spongiform
encephalopathy and foot and mouth disease, were the major caus-
es of trade disruption reported in this system. Discussion: If vol-
ume of trade quantifies exposure to risk for urgent disruption of
trade, we would have expected that high volume countries prefer-
entially reported through the system. Our data do not support this.
Concern for animal health is the leading cause of trade disruption,
however, categories used for reporting are not mutually exclusive.
For this reason, data may suffer from misclassification. There is
tremendous potential value in using this information system to
describe the impact of emerging infections on trade. This value will
require additional data gathering and refinement to be realized,
given current information collection.
Board 85. International Circumpolar Surveillance: Invasive
Bacterial Disease Surveillance in the Arctic. 
A. J. Parkinson1, A. Bell1, J. Spika2, F. Steinz3
1CDC, Arctic Investigations Program, Anchorage, AK, 2LCDC, Bureau
of Infectious Diseases, Ottawa, ON, CANADA, 3Institute of the Chief
Medical Officer, Nuuk, GREENLAND
Background: The International Circumpolar Surveillance
(ICS) project was established in 1999 and aims to create an infec-
tious disease surveillance network of hospital and public health lab-
oratories and authorities throughout the Arctic States: USA
(Alaska) northern Canada, Greenland, Iceland, Norway, Finland,
Sweden and northern regions and Oblasts of the Russian
Federation. ICS will allow for the collection, comparison and shar-
ing of uniform laboratory and epidemiological data on infectious
diseases of concern, and assists in the formulation of prevention
and control strategies. Methods: In 2000 isolates of Streptococcus
pneumoniae (Sp), Haemophilus influenzae (Hi), Neisseia meningi-
tidis (Nm), Groups A (GAS) and B (GBS) streptococcus recovered
from normally sterile sites at 23 and 14 clinical laboratories in
Alaska (AK), and northern Canada (NC), respectively, were for-
warded to one of three reference laboratories for characterization.
Greenland (GL) submitted only Sp isolates from 17 clinical labora-
tories to a reference laboratory in Denmark. Identified cases were
reported to local public health personnel who review and provide
clinical, demographic, and immunization history. Case and culture
information was forwarded to the ICS coordinator at the Arctic
Investigations Program, for analysis, report generation and dissem-
ination. Results: A total of 159 Sp isolates were submitted from
AK (111), NC (45) and GL (3) in 2000. Estimated annual rates of
invasive Sp disease per 100,000 population were 18, 34, and 5 for
AK, NC, and GL respectively. Rates among children < 2 were sim-
ilar in NC and AK (189 vs 193/100,000), with 82% of Sp isolates
from NC and 74% from AK being serotypes contained in the 7-
valent vaccine. Among isolates from those > 2 years of age 100%,
89% and 100% from NC, AK and GL respectively were serotypes
contained in the 23 valent polysaccharide vaccine. The predomi-
nant Sp serotype in NC was serotype 1 (31%), and in AK was
serotype 14 (17%). In AK 23% of Sp were non susceptible to peni-
cillin. In NC 14% were fully resistant and all were serotype 9V. The
estimated rates for Hi and GAS were 2 times higher in NC than
AK. While no cases of Hi serotype b were detected in Canada in
2000, 9 occurred in AK. Rates of Nm and GBS were similar in NC
and AK. Conclusions: Collaborative standardized international
surveillance for invasive bacterial diseases is feasible and allows for
direct comparisons of disease rates, pathogen characteristics, and
intervention effectiveness between participating countries.
Board 86. Shortage of Vaccines During a Yellow Fever
Outbreak in Guinea 
N. Nathan
EPICENTRE, Paris, FRANCE
Yellow fever (YF) is a viral hemorrhagic fever transmitted
by mosquito bites that can be prevented by the 17D YF vaccine
which protects for at least 10 years. YF is endemic in rural areas in
the vicinity of tropical forests. Large epidemics usually occur when
a specific vector (Aedes aegypti) transmits the virus in urban set-
tings. The largest outbreaks were reported in the sixties in Ethiopia
and in Nigeria (100,000 cases each). Re-emergence of the disease
is observed in West Africa. A YF epidemic erupted in Guinea in
September 2000. From September 4th 2000 to January 7th 2001,
688 clinical cases (of which 88% from rural districts) and 225
deaths were reported. The peak of the epidemic occurred between
November 20th and November 26th. The outbreak spread to 16 of
the 33 districts of the country. Entomological investigations identi-
fied Aedes aegypti in the investigated towns (Labé, Coya,
Conakry), but at low density. A mass vaccination campaign was
organised by the Guinean Ministry of Health with the support of
international NGOs. Initial target population was all individuals
aged more than 9 months living in the affected areas (352,278
inhabitants). An appeal for vaccines was made on November 1st.
First vaccines (630,000 doses) were available 10 days later.
Because of the rapid extension of the outbreak, the target
population was re-estimated at 1,679,648 persons and a second
appeal for vaccines was made on November 13th. However,
300,000 doses only were brought 5 weeks after. Vaccination strate-
gies had to be revised and target populations were restricted to
affected urban areas and to the most affected rural areas. The ini-
tiation of the mass vaccination campaign was delayed until 4 weeks
after the peak of the epidemic in the region of Labé. At the end of
the intervention, 856,031 persons had been vaccinated in 2 regions
where the vaccine coverage was estimated at 56%. The Guinean
episode demonstrated that the international stocks of YF vaccines
were not sufficient to provide an adequate and quick response to
large outbreaks, in spite of a WHO recommendation made in 1998
that an emergency stockpile of 1 million doses be held in Africa
and America for outbreak response. Since the outbreak in Guinea,
the International Coordinating Group on Vaccine Provision for
Epidemic Meningitis Control decided that 2 million doses being
stored as part of a UNICEF stockpile to be used for response to
outbreaks only. This stock shall limit shortages of vaccines during
future epidemics. However, the problem of the prevention of the
occurrence of YF epidemics will remain. This can only be
addressed by the organisation of pre-emptive mass vaccination
campaigns or by the successful introduction of YF vaccination in
the EPI of countries at risk.
Board 87. External Quality Assurance System (EQAS)
Demonstrates Continued Need for Improvement in Salmonella
Serotyping and Susceptibility Testing: WHO Global Salm-Surv,
2000 and 2001 
A. Petersen1, F. M. Aarestrup1, A. B. Jensen1, D. Lo Fo Wong1, M. C.
Evans1, F. J. Angulo2, B. C. Imhoff2, H. C. Wegener1, WHO Global
Salm-Surv3
1Danish Veterinary Institute, Copenhagen, DENMARK, 2Centers for
Disease Control and Prevention, Atlanta, GA, 3World Health
Organization, Geneva, SWITZERLAND
Background: WHO Global Salm-Surv is an international
network of individuals and institutions involved in Salmonella sur-
veillance. WHO Global Salm-Surv strives to enhance Salmonella
serotyping and antimicrobial susceptibility capacity among mem-
ber institutions, and thereby improve surveillance data, through
training courses and an External Quality Assurance System
(EQAS). Materials and Methods: Laboratories participating in
















blinded Salmonella strains and one E. coli reference strain.
Laboratories serotyped and susceptibility tested the isolates fol-
lowing their routine laboratory protocols and reported the number
of specimens and Salmonella isolates tested yearly. Further analy-
sis is underway to compare performance before and after training
courses. Results: Between 2000 and 2001, the proportion of cor-
rect serotyping results increased from 73% to 78% and correct
antimicrobial susceptibility results of the reference strain increased
from 78% to 83%. Correct serotyping results from national refer-
ence laboratories were 14% higher than other laboratories, and
antimicrobial susceptibility test results of the Salmonella strains
and the E. coli reference strain were 5% and 11% higher, respec-
tively. Thirty-nine of the participants in EQAS 2001 had attended
a WHO Global Salm-Surv training course. Trained laboratories
had a higher percentage of correct results (84% versus 79%) than
untrained laboratories for susceptibility testing of the reference
strain, but a lower percentage of correct results in serotyping (70%
versus 81%). Conclusion: Although progress has been made in
improving the quality of serotyping and susceptibility results, fur-
ther improvement is needed. Such performances can be enhanced
by WHO Global Salm-Surv activities such as training courses and
EQAS. It is anticipated that these activities will improve surveil-
lance data worldwide.
Board 88. WHO Global Salm-Surv: Strengthening
Laboratory-Based Surveillance to Reduce the Global Burden of
Foodborne Diseases 
P. Braam1, B. C. Imhoff2, H. C. Wegener3, M. C. Evans3, A.
Petersen3, M. Jouan4, F. J. Angulo2, WHO Global Salm-Surv5
1World Health Organization, Geneva, SWITZERLAND, 2Centers for
Disease Control and Prevention, Atlanta, GA, 3Danish Veterinary
Institute, Copenhagen, DENMARK, 4Institut Pasteur, Paris, FRANCE,
5World Heatlh Organization, Geneva, SWITZERLAND
Background: World Health Organization (WHO) Global
Salm-Surv is a global network of national and regional public
health, veterinary, and food reference laboratories and individuals
involved in Salmonella surveillance. WHO Global Salm-Surv
strives to enhance the capacity and quality of Salmonella isolation,
identification, serotyping, and antimicrobial resistance testing
throughout the world and support local interventions that reduce
the human health burden of Salmonella and other foodborne dis-
eases. Initiated in January 2000, WHO Global Salm-Surv is coordi-
nated by a Steering Committee including WHO Headquarters
(Geneva, Switzerland), the Centers for Disease Control and
Prevention (Atlanta, Georgia, U.S.), Institut Pasteur (Paris,
France), and the Danish Veterinary Institute (Copenhagen,
Denmark). Methods: WHO Global Salm-Surv program elements
include: regional training courses, a moderated electronic discus-
sion group, an external quality assurance system (EQAS), a coun-
try databank of annual Salmonella surveillance summaries, a web
site, and reference testing services. Results: WHO Global Salm-
Surv currently has 404 members and 110 participating member
institutions from 106 countries. Of the member institutions, 66%
test non-human specimens and 58% test human specimens (some
laboratories test both human and non-human specimens). The
WHO Global Salm-Surv members live in the following regions:
Africa (5%), the Eastern Mediterranean (9%), Europe (32%), the
Americas (31%), South-East Asia (10%), the Western Pacific
(13%). WHO Global Salm-Surv Regional Centers have been estab-
lished in Asia (Thailand) and South America (Argentina). In 1999-
2001, we conducted 8 regional training courses (one in China,
Greece, and Mexico, two in Argentina, and three in Thailand),
resulting in training more than 160 microbiologists on Salmonella
isolation, identification, serotyping and antimicrobial susceptibility
testing methods. WHO Global Salm-Surv sent 80 electronic dis-
cussion group messages in 2000 and 2001. Thus far, we have con-
ducted 2 cycles of EQAS (2000 and 2001) with 113 laboratories
from 67 countries. A web-based country databank for Salmonella
surveillance summaries has been created; this and other informa-
tion, including the WHO Global Salm-Surv Strategic Plan, is avail-
able on the WHO Global Salm-Surv website at www.who.int/salm-
surv. Conclusion: Future WHO Global Salm-Surv activities
include regional training courses in Poland, Russia, the Caribbean,
and Africa, and continuing training courses in Thailand, Argentina,
Mexico, and the Eastern Mediterranean. Through these and other
activities, WHO Global Salm-Surv continues to strengthen the
capacity of local, national and regional laboratories, with the ulti-
mate goal of reducing the global burden of Salmonella and other
foodborne diseases.
Board 89. WHO Global Salm-Surv: Asian Regional Center 
T. Chalermchaikit1, A. Chongthaleoung1, S. Kanarat1, WHO Global
Salm-Surv2
1Center for Antimicrobial Resistance Monitoring of Foodborne
Pathogens, Bangkok, THAILAND, 2World Health Organization,
Geneva, SWITZERLAND
Background: Foodborne diseases and antimicrobial resist-
ance of foodborne pathogens are major global public health con-
cerns. In addition to contributing to a public health burden, food-
borne diseases may also result in economic loss. The impact of
these problems may be more serious in developing countries and
food exporting countries; however, laboratory-based surveillance of
foodborne diseases, including antimicrobial resistance of food-
borne pathogens, is limited in many of these countries. To address
these needs, the World Health Organization (WHO) established
The Center for Antimicrobial Resistance Monitoring in Foodborne
Pathogens in Thailand in 1999. The Center’s goals were to estab-
lish a laboratory for antimicrobial resistance monitoring of food-
borne pathogens, support standardization of antimicrobial suscep-
tibility testing in important foodborne pathogens isolated from
food-animals and food of animal origin in Asian countries, and
assist in the development of sustainable national policy for prudent
use of antimicrobials in food-animals. Methods: In 2000, WHO
Global Salm-Surv, a project created to improve laboratory capacity
and decrease the burden of foodborne illness worldwide, estab-
lished the WHO Global Salm-Surv Asian Regional Center in
Bangkok, Thailand. Results: Regional Center activities thus far
include hosting 3 regional training courses with participants from
Cambodia, China, India, Indonesia, Korea, Laos, Myanmar,
Malaysia, Nepal, Papua New Guinea, Philippines, Sri Lanka,
Vietnam, and Thailand and developing a plan to provide antisera to
WHO Global Salm-Surv member institutions. Additionally, during
the regional training course in 2001, participants noted that
Salmonella serotype Weltevreden was the second most common
serotype in Asia; this serotype is apparently rare elsewhere in the
world. In partnership with the Danish Veterinary Institute, the
WHO Global Salm-Surv Asian Regional Center launched a special
study to understand the epidemiology of Salmonella Weltevreden
in Southeast Asia. The Regional Center is also conducting a
National Program for Antimicrobial Resistance Monitoring in
Foodborne Pathogens and a National Program for Promoting
Prudent use of Antimicrobial Drugs in Food-Animals, which are
supported by governmental agencies’ research funds. Conclusion:
Future goals for the WHO Global Salm-Surv Regional Center
include hosting a regional training course for microbiologists and
epidemiologists in 2002, providing antisera to regional WHO
Global Salm-Surv members, and providing leadership in the
Southeast Asian Region.
I C E I D  2 0 0 2  A B S T R A C T Spage 156
61 Molecular 
Epidemiology II
Tuesday, March 26, 8:30 a.m.
Grand Hall East
Board 90. An Outbreak of Swine Streptococcus suis Illnesses
Occurred in China 
F. C. Zhu, H. Wang, X. S. Hu, H. F. Yang
Jiangsu Province Center for Disease Prevention and Control, Nanjing,
CHINA
Streptococcus suis (S. suis) is responsible for a wide variety
of infections in pigs. Illness will happen if human is involved, char-
acteristic of meningitis, arthritis, septicaemia, endocarditis, poly-
serositis, bronchopneumonia and abortions. Outbreak of illnesses
caused by S. suis through contacting infected swines or its carcass-
es occurred in Jiangsu , eastern China in 1998. The objectives of
this study were to elucidate the epidemiological characterization
and scales of the disease through case-control study, and genotype
the isolates of S. suis isolated from cases and infected swines by
RAPD with 10 primers. The underlying hypothesis is that if the
epidemiological characterization of the diseases caused by S. suis is
clear, there will be preventive methods made to control it. All 12
isolates isolated from the cases and infected swine were confirmed
using a battery of methods including API biochemical test, serum
coagulate test and thalli fatty acid profile analysis. In 1998, 25 cases
were found in 4 counties of Jiangsu province in the consecutive
month of July and August, among whom 16 cases progressed into
Streptococcal toxic syndrome, and 9 meningitis. Fourteen of 25
cases died of Streptococcal toxic shock syndrome or meningitis. All
the cases had histories of contacting infected swine or its carcasses
4 days before they got illnesses. The isolates were S. suis serotype
2. The results of the homologous regions (products of OPB3,
OPB8, OPB10, OPB10, OPB12, OPB13, OPB14, REP1, REP2,
ERIC1 and ERIC2 as primers ) found in the 12 isolates isolated
from the cases and the swine indicated that the outbreak was
caused by contacting swine infected by S. suis. The predominate
clinic symptoms of the outbreak are Streptococcal toxic shock syn-
drome and meningitis. This is the first report that an emerging
infectious of S. suis occurred in China. The results suggest that
human can get illness through intimately contacting with livestocks
infected by S. suis. Health promotion that help people know the
epidemiological knowledges on the disease , and surveillance for S.
suis in livestock need be carried out.
Board 91. A Study of the Emerging Sequence Types of
Multiple Drug Resistant Streptococcus Pneumoniae in
Queensland 
S. Byrne, D. Davis, D. Murphy, J. Bates, J. Savill
Queensland Health Scientific Services, Brisbane, AUSTRALIA
A molecular-based surveillance study was carried out in
Queensland for the presence of the sixteen recently described
international multi-drug resistant Streptococcus pneumoniae
clones. A representative set of twenty-three invasive cases of mul-
tiple drug-resistant pneumococcal infection in Queensland chil-
dren and adults were selected from all 1600 isolates referred in
1998 and 1999.A study of global genetic relatedness was undertak-
en. The isolates were examined by BOX -PCR fingerprinting and
DNA multi-locus sequencing to determine clonality and sequence
type (ST). The sequence type was determined by sequence com-
parison with an international database. BOX-PCR fingerprinting
discriminated between serotypes and identified clones within sev-
eral serotypes. Multi locus sequence typing identified an isolate of
serotype 6A to be a new clone. Isolates representing serotype 6B
were found to be the multi-drug resistant Spanish serotype 6B ST
90. Several 19F isolates were found to be a new single locus vari-
ant of the Danish ST 77 clone and another 19F to be a new single
locus variant of the Taiwanese ST 236 clone. Four isolates were
found to be that of the Spanish serotype 23F clone sequence type
81. New variants and four recently described multi drug resistant
Streptococcus pneumoniae clones were identified for the first time
in Queensland isolates. BOX-PCR fingerprinting was demonstrat-
ed to be an excellent screening tool for determining clonality. Multi
locus sequence typing was found useful to systematically provide
an internationally derived nomenclature to these clones. This
sequence type data on clones will serve a useful baseline for mon-
itoring emerging multi-drug resistance Streptococcus pneumoniae
infections in the future.
Board 92. Meningococcal Disease in a Christian Pilgrim –
Use of Molecular Approaches to Differentiate Sporadic from
Outbreak-Associated W135 Neisseria meningitidis Strains 
A. Boras1, B. Kaic2, S. Schmink1, C. Sacchi1, I. Ivic3, T. Popovic1
1Centers for Disease Control and Prevention, Atlanta, GA, 2Croatian
National Institute of Public Health, Zagreb, CROATIA, 3University
Hospital, Split, CROATIA
Background: Over 400 laboratory confirmed cases of
meningococcal disease caused by N. meningitidis serogroup W135
(NMSW135) have been reported in Saudi Arabia and subsequent-
ly worldwide among Hajj 2000 and 2001 pilgrims to Saudi Arabia
and their close contacts. Recently, extensive molecular characteri-
zation of these isolates demonstrated that they were of porA type
P1.5,2, had identical 16S rRNA gene sequences, indistinguishable
PFGE (NheI) profiles, and by multilocus-enzyme electrophoresis
(MEE) and multilocus sequence typing (MLST) belonged to the
ET-37 complex. Here we present the utility of molecular subtyping
of NMSW135 strains in an epidemiological investigation of a case
of meningococcal disease in a Croatian Christian pilgrim following
a religious event in a neighboring, predominantly Muslim country.
Results: On April 26, 2000, a previously healthy forty-one year old
housewife presented to the emergency room with signs of sep-
ticemia and meningitis. Two days earlier she returned from a
Catholic pilgrimage in Bosnia and Herzegovina where hundreds of
people from throughout the world were in attendance. No other
cases were reported associated with this event. From the patient’s
blood, cerebrospinal fluid and a throat swab NMSW135 was isolat-
ed. Molecular characterization of the isolate was carried out by
PFGE (NheI) and sequencing of the 16S ribosomal RNA gene.
Both PFGE pattern and 16S sequence type were clearly different
from those identified in all NMSW135 strains associated with the
Hajj pilgrimage to S. Arabia in 2000 and 2001. Conclusion: The
utility of molecular subtyping for rapid and precise identification of
N. meningitidis isolates associated with epidemic situations was
clearly demonstrated by the ability of molecular subtyping to rap-
idly differentiate NMSW135 isolate from a Christian pilgrim in
Croatia from those NMSW135 strains associated with the 2000 and
2001 outbreaks of meningococcal disease following the Hajj in S.
Arabia. Recognition of this case as a sporadic one, rather than
being the first sign of potential transmission of the outbreak-asso-
ciated NMSW135 strains to a not yet affected country, was helpful
to the public health officials.
Board 93. Prevalence and Virulence Profiles of Escherichia coli
O157:H7 in Livestocks in Jiangsu, China in 1999 and 2000 
Z. Y. Shi, H. Wang, L. Gu, X. L. Guo, L. Zhuang
Jiangsu Province Center for Disease Prevention and Control, Nanjing,
CHINA
Verotoxigenic Escherichia coli O157:H7 has emerged as an
important foodborne pathogen, causing bloody diarrhea and
hemolytic-uremic syndrome (HUS) in most of countries of all the
















O157. In China, there are some reports about sporadic isolates in
cattles and pigs, and cases caused by E.coli O157. Jiangsu province
is an important region in agriculture products in eastern China.
The objective of this study is to elucidate the prevalence of
Escherichia coli O157:H7 in livestocks in Jiangsu province through
epidemiological investigation. The underlying hypothesis is that if
the prevalence of E.coli O157 in livestocks in Jiangsu province,
preventive strategies can be made to control probably its outbreak.
In the summer of 1999 and 2000, 1733 (in 1999) and 1427 fecal
samples ( in 2000) were detected for E.coli O157:H7 using a bat-
tery of methods including Immunomagnetic separation (IMS), CT-
SMAC agar, Chromagar®O157, and biochemical test, anti-serum
agglutination test. One hundred and sixty seven (167) of total 252
isolates were detected for virulence genes ( SLTs, eaeA, hlyA) by
multiplex PCR. In 1999, the prevalence of E.coli O157 was 19.05%
in cattles, 12.01% in sheep, 7.75% in chicken and 7.54% in pigs,
compared to 9.34% in cattles, 7.47% in sheep, 3.65% in chicken
and 4.04% in pigs in 2000. Almost half of detected isolates (
82/167) carried at least one virulence gene. The results of virulence
gene pattern suggest that SLT2+eaeA+hylA pattern (52/82) is pre-
dominate, next is SLT1+SLT2+eaeA+hlyA pattern (15/82). These
results indicate that the prevalence of E.coli O157:H7 is signifi-
cantly higher in livestock in Jiangsu province than that in other
reports , and livestock are potential infectious source for E.coli
O157:H7 outbreak in population. Effective strategies and manage-
ment practices for control E.coli O157:H7 transmission need be
carried out in Jiangsu province to prevent outbreaks.
Board 94. Use of an AFLP-PCR Technique To Fingerprint and
Differentiate Isolates of Salmonella enterica Serotype
Typhimurium DT104
S. C. Rankin, J. P. Holt, S. R. Young, J. Cassidy, D. S. Munro, C. E.
Benson
University of Pennsylvania, New Bolton Center, Kennett Square, PA
Background: A wide range of methods exist for typing
foodborne pathogens, though none appear to be universally appli-
cable or acceptable for Salmonella. This is largely due to the high-
ly clonal nature of this pathogen. Sporadic isolates of Salmonella
enterica serotype Typhimurium phage type 104 (DT104) have
been shown to be virtually indistinguishable and patterns or pro-
files derived by a variety of molecular techniques indicate the
spread of an epidemic clone, rather than a diverse group of organ-
isms. The potential value of highly discriminating and reproducible
typing data cannot be underestimated when supplying information
on outbreak sources and routes of infection. Methods: All
Typhimurium isolates obtained at the University of Pennsylvania
Salmonella Reference Center from 1997 to 1999 were phage
typed. We used a single enzyme AFLP assay and evaluated two
restriction endonucleases (HindIII and EcoRI) and two selective
primers for each enzyme to determine the usefulness of this tech-
nique for discrimination of Typhimurium DT104. SRC also has an
extensive collection of isolates of DT104 from outwith the United
States and 36 of these were included for comparison with DT104
strains that originated in the United States. Antibiotic susceptibili-
ty testing was performed on all isolates. Results: AFLP-PCR with
the EcoRI-A, EcoRI-C, HindIII-A and HindIII-C primers suggest-
ed that discrimination within Salmonella Typhimurium DT104 is
possible with this technique. When results from all four primers
were combined nineteen different profiles could be discerned.
Eighty-seven isolates (62%) were classified as the predominant
type and a further 26% of the isolates comprised only four differ-
ent combined types. This combined typing is highly discriminating
given that DT104 has been shown to be highly clonal. However,
the application of four primers would be a costly and time-con-
suming process. Therefore, we examined the level of discrimina-
tion achieved using a combination of two primers. The most suc-
cessful of all the available combinations in this case, EcoRI-C and
HindIII-A showed a total of 16 combined profiles rather than the
nineteen observed with all four primers. The two-primer combina-
tion had little effect on the distribution of the strains. Eighty-nine
isolates (63%) were now classified in the predominant type. As
before a further 26% of the isolates comprise only four additional
combined types. Conclusions: This level of discrimination among
such a highly clonal group of organisms clearly indicates the advan-
tage of using a sequenced-based method. Minor mutations to the
genome sequence are more readily observed and this leads to
greater discrimination between unrelated strains. The ability to
discriminate different “types” within Typhimurium DT104 repre-
sents a major asset to the surveillance and subsequent control of
this pathogen in livestock.
Board 95. Molecular Characterisation of an Outbreak Strain
of Multiresistant Salmonella enterica Serotype Typhimurium
DT104 in the United Kingdom 
A. J. Lawson1, M. Desai1, R. H. Davies2, S. J. O' Brien3, E. J.
Threlfall1
1Central Public Health Laboratory, London, UNITED KINGDOM,
2Veterinary Laboratories Agency, New Haw, UNITED KINGDOM,
3Communicable Disease Surveillance Centre, London, UNITED KINGDOM
In summer 2000 a significant increase in confirmed cases of
multiresistant Salmonella enterica serotype Typhimurium, defini-
tive phage type 104 (MR DT104) was observed in England and
Wales — from 150 cases in August 1999 to 372 cases in August
2000. The majority of these isolates were from cases in the West
Midlands of England and included one fatality. Outbreak associat-
ed isolates were Pulsed-Field Gel Electrophoresis (PFGE) profile
xtm 1 and were resistant to ampicillin, chloramphenicol, strepto-
mycin, sulphonamides and tetracyclines (R-type ACSSuT). These
common profiles occur in 90% and 70% (respectively) of MR
DT104. However, Plasmid Profiling (PP) demonstrated that in
addition to the 60 MDa serotype-specific plasmid (found alone in
79% of MR DT104), a 2 MDa plasmid was present in isolates from
the outbreak cases. This profile (PP 60, 2) usually occurs in only
5% of MR DT104. In 2000 the frequency of PP 60, 2 among
human isolates of MR DT104 rose from 6% in June/July, to 64% in
August/September, and fell to 9% in October/November. Statistical
analysis of case-control studies from the outbreak implicated let-
tuce and other salad items used as garnish in fast-food establish-
ments as the most likely vehicle for infection. MR DT104 is a
zoonotic pathogen principally associated with infection in cattle.
Further investigation of animal isolates collected in 1999/2000
detected the ’R-type ACSSuT, PFGE xtm 1, PP 60, 2’ profile
among 13% of MR DT 104 isolates from pigs, 12% from poultry
and 3% from cattle. Strains from animals and humans were further
characterised by Fluorescent Amplified Fragment Length
Polymorphism (FAFLP). Using the restriction enzymes HindI and
HhaI FAFLP analysis demonstrated that the MR DT104 isolates
from the summer 2000 outbreak were identical to the predominant
FAFLP genotype found in the UK (shared by the first UK human
isolates of MR DT104 from 1984). Non-outbreak human and ani-
mal isolates were a mixture of FAFLP genotypes - despite all being
of the same, PP, R-type and PFGE profile. This investigation
demonstrates the importance of a hierarchical molecular approach
for the investigation of outbreaks of S. enterica.
Board 96. Pulsed-Field Gel Electrophoresis (PFGE)
Comparison of Pharyngeal and Sterile Site Group A
Streptococcal Isolates 
J. Rainbow, D. Boxrud, S. Johnson, T. Naimi, R. Danila, R. Lynfield
Minnesota Department of Health, Minneapolis, MN
Background: The Minnesota Department of Health
(MDH) does PFGE subtyping of all group A streptococcal (GAS)
isolates from invasive sites in MN. PFGE subtypes from invasive
GAS isolates were compared with throat culture isolates collected
during a 5-month period. An earlier MN study found that during a
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community-wide outbreak of invasive GAS disease, the PFGE sub-
type of the outbreak strain matched the predominant strain found
in pharyngeal isolates. Methods: Cases of invasive GAS disease
are reported to MDH through active surveillance and isolates are
submitted to the MDH laboratory. Five clinics representing dif-
ferent regions of the state sent up to 30 consecutive pharyngeal
isolates collected each month for the first 5 months of 1999.
PFGE on all invasive isolates obtained during the study period
were compared to a representative sample of throat isolates.
Results: Isolates were available for 96 of 108 (89%) of invasive
GAS cases during the study period. The most common PFGE
subtypes were: GA3 (12, 13%); GA131, GA34 and GA86 (7, 7%
each); GA1 and GA5 (6, 6% each); and GA2 (5, 5%). Thirty-five
other PFGE subtypes were identified, including 8 that were
unique. Two hundred forty-three (45%) pharyngeal isolates were
subtyped. The most common were: GA131 (71, 29%); GA3 (25,
10%); GA5 (6, 2%); GA1 (5, 2%); and GA2 and GA9 (4, 1% each).
Sixty-two other subtypes were identified, including 11 that were
unique. Geographic variation was noted for the distribution of the
pharyngeal GA131 subtype, which accounted for 0-52% of isolates
at each clinic. The GA3 subtype was the most evenly distributed
with a range of 7-18%. Of 19 invasive cases from facilities in the
same regions, 13 (68%) had a PFGE subtype that was found in
throat cultures in that region. Conclusions: The most common
PFGE subtypes for invasive GAS disease were also the most com-
mon for GAS pharyngitis. Although regional variability of certain
PFGE subtypes was noted for both pharyngeal and invasive iso-
lates, a similar distribution of PFGE subtypes was found among
pharyngeal and invasive isolates from the same region. This con-
cordance between invasive and pharyngeal GAS PFGE subtypes
at a statewide level in a non-outbreak setting is consistent with
findings from a previous regional study during an outbreak of
invasive GAS disease. Monitoring pharyngeal isolates may be use-
ful for detecting the presence of strains that have potential to
cause an increased incidence or severity of invasive disease, and
may be useful in guiding development of a GAS vaccine.
Board 97. Evaluation of Potential Behavioral and Household
Risk Factors for Pneumocystis carinii Pneumonia 
K. A. McCullough1,2, M. R. Fox1, G. Groner1, T. R. Unnasch3, H. K.
Dillon4, C. B. Beard1
1Centers for Disease Control and Prevention, Chamblee, GA,
2Association of Public Health Laboratories, Washington, DC,
3University of Alabama School of Medicine, Birmingham, AL,
4University of Alabama School of Public Health, Birmingham, AL
Pneumocystis carinii pneumonia (PCP) is the leading life-
threatening opportunistic infection in patients with AIDS in the
United States, where it is responsible for an estimated 3,000 deaths
per year. Despite recognition of the disease as an important cause
of pneumonia in immunocompromised individuals, its exact mode
of transmission remains unclear. This study investigates the poten-
tial behavioral and household risk factors for P. carinii exposure in
immunocompromised and healthy individuals. Non-hospitalized
patients with HIV/AIDS in the greater Atlanta area were recruited
through local AIDS relief organizations. Non-immunocompro-
mised individuals were recruited at the Centers for Disease
Control and Prevention — Chamblee campus. Volunteers were
interviewed using standardized questionnaires that collect data
about demographics, medical history, potential exposures, and
household information. Oral washes and environmental dust and
dirt samples were collected and analyzed for the presence of P.
carinii. DNA extracted from the samples was amplified by PCR to
examine regions of the mitochondrial large subunit ribosomal RNA
(mtlsurRNA) gene and the dihydropteroate synthase (DHPS)
gene. Genotypes from environmental samples were compared with
those from oral washes. To date, 65% of the 23 oral washes ana-
lyzed from AIDS patients were positive by PCR at one or both
gene loci, while there were no positive samples found in 20 oral
washes from the non-immunocompromised group (p<0.001). Of
the environmental samples taken from the homes of AIDS patients
and non-immunocompromised participants, 36% and 4% were
positive, respectively N=36, N=27 (OR=14.70, p=0.0024). The
genotypes observed were qualitatively and quantitatively similar to
those observed in clinical studies. No statistically significant associ-
ation (p > 0.05) was observed between a positive P. carinii oral
wash and a variety of clinical and environmental or behavioral fac-
tors, including CD4 lymphocyte count, PCP prophylaxis, the use of
central air, presence of house plants, outdoor activity, and exposure
to cigarette smoke. The significant difference in the number of P.
carinii positives in the HIV/AIDS versus non-immunocompro-
mised groups suggests the possibility of human colonization and
carriage of P. carinii.
Board 98. Heterogeneity in the Genetic Structure of
Toxoplasma gondii 
D. H. Graham1, C. R. Blackston2, J. P. Dubey3, S. M. Gennari4, D. S.
Azeredo5, P. Thulliez6, T. Lehmann1
1Centers for Disease Control and Prevention, DPD, Entomology
Branch, Chamblee, GA, 2Fred Hutchinson Cancer Research Center,
Seattle, WA, 3United States Department of Agriculture, Agricultural
Research Service, Animal and Natural Resources Institute, Parasite
Biology, Beltsville, MD, 4Departamento de Medicina Veterinaria
Preventiva e Saude Aminal, Faculdade de Medicina Veterinaria e
Zootecnia, Universidade de Sao Paulo, Sao Paulo, BRAZIL, 5UENF,
Rio de Janeiro, BRAZIL, 6Labortoire de la Toxoplasmose, Institute de
Puericulture, Paris, FRANCE
Previous studies on the genetic structure of Toxoplasma
gondii found little difference in strain composition between animal
hosts or geographic locations. We genotyped 120 T. gondii isolates
from various hosts including humans, bears, cats, chickens and pigs
at 6 microsatellite loci. Homogeneity of allele distribution between
isolates from different hosts was rejected (P<0.05, Fisher Exact
Test) in 5 of the loci, indicating different strain composition
between hosts. The most extreme differences in allele composition
were associated with isolates from chickens. However, nearly all
our chicken isolates originated from Brazil whereas most of the
other isolates were from North America and Europe. Thus, either
host or geographic effects may explain these results. Differences
were also found in genetic diversity between host groups.
Interestingly, diversity measured by the number of alleles (adjust-
ed to sample size) was highest in human isolates (P<0.05). The
same trend was observed based on expected heterozygosity, but the
difference was not significant. Our results suggest a substantially
greater genetic structure for T. gondii than previous studies have
shown. A comprehensive analysis of these data is under way and
will be presented.
Board 99. Genotyping and Characterization of
Mycobacterium avium paratuberculosis Using Amplified
Fragment Length Polymorphism
A. R. Ficht1, B. O'Shea2, S. Khare2, L. G. Adams2, T. A. Ficht2
1Texas A&M Health Science Center, College Station, TX, 2Texas A&M
University, College Station, TX
AFLP (amplified fragment polymorphism) has been
employed to compare Mycobacterium avium subsp. avium (M.
avium) and Mycobacterium avium subsp paratuberculosis
(MparaTb) for genetic differences that may be used as diagnostic
probes that vary between or within subspecies. The AFLP tech-
nology is not simply a fingerprinting technology, but an enabling
technology for genome research. It detects not only the primer
sequence, but allows the detection of restriction fragment poly-
morphism (RFLP) and can be used to bridge genetic and physical
maps. AFLP markers can be used to construct high-density genet-
ic maps and is an effective method to construct DNA marker maps.
















relative to MparaTb and exploit these in the identification of
knockout mutants and the study of host response. Ninety-six
primer sets have been employed to characterize 23 MparaTb nat-
urally occurring isolates and two M. avium isolates. Specifically, 16
MseI primers bearing selective dinucleotides at the 3’end were
used in combination with PstI primers also bearing 3’ selective
nucleotides. Using specific primer sets, diagnostic patterns have
been established for the identification of M. paratuberculosis iso-
lates when compared with the ATCC strain of M. avium or with a
field isolate of M. avium. One AFLP fragment unique to the
MparaTb genome has been cloned, sequenced and identified.
Primers generated within this region produce an appropriate PCR
product in 12 of 19 clinical MparaTb isolates as well as the ATCC
MparaTb isolate. The M. avium isolates and 7 of 20 MparaTb iso-
lates fail to act as template for this primer set. This work reveals the
presence of at least one polymorphism in the genome of MparaTb.
The nature and extent of this polymorphism is under investigation.
Additional MparaTb-specific bands, have been cloned and are
being tested for their diagnostic and epidemiological value.
Board 100. Changing Patterns of Infection with Vero
Cytotoxin-Producing Escherichia coli in Britain and Continental
Europe 
H. R. Smith1, A. Caprioli2, T. Cheasty1, J. E. Coia3, I. S. T. Fisher4, S.
J. O'Brien4, W. J. Reilly5, H. Tschäpe6, G. A. Willshaw1
1PHLS Laboratory of Enteric Pathogens Central Public Health
Laboratory, London, UNITED KINGDOM, 2Istituto Superiore di Sanità,
Rome, ITALY, 3Scottish E.coli O157 Reference Laboratory, Edinburgh,
UNITED KINGDOM, 4PHLS Communicable Diseases Surveillance
Centre, London, UNITED KINGDOM, 5Scottish Centre for Infection
and Environmental Health, Glasgow, UNITED KINGDOM, 6Robert-
Koch Institut, Wernigerode, GERMANY
During the 1980s Vero cytotoxin-producing Escherichia
coli (VTEC), and particularly those belonging to serogroup O157,
emerged as a cause of severe human disease including haemolytic
uraemic syndrome. Increased incidence of infection is due partly
to improved detection and reporting and also the ability to identi-
fy VTEC of all serogroups. Surveillance of VTEC infections has
been increased both nationally and internationally through
Enternet. Enternet is the surveillance network for VTEC and sal-
monella infections, funded by the European Commission and the
participants include all 15 European Union members plus
Australia, Canada, Japan Norway, South Africa and Switzerland.
Laboratory based methods for strain characterisation are applied
in combination with epidemiology and use serotyping, phage typ-
ing, VT gene typing as well as DNA-based methods such as pulsed
field gel electrophoresis (PFGE). The rates of infection from 1995
to 2001 with VTEC O157 varied considerably from less than 0.2/
100,000 in several continental European countries to 1 to 2/
100,000 in England and Wales. Rates in Scotland are consistently
the highest in Britain and peaked at 9.25 / 100,000 in 1996, the
year of the very large central Scotland outbreak. Phage typing of
VTEC O157 isolates from up to 12 countries has allowed the types
to be followed over time. These data show a significant change in
Britain with the emergence of PT21/28 as the currently predomi-
nant type and the decline of certain other types such as PT49.
PFGE has been the key method for examination of heterogeneity
within the common PTs. Surveillance of non O157 VTEC is limit-
ed but outbreaks caused by VTEC O26 have occurred in Europe
recently. Detailed strain typing combined with increased surveil-
lance and case-control studies have provided the evidence for
demonstrating the importance of transmission of infection direct-
ly or indirectly from animals and their faeces in addition to food-
borne and person to person routes. Rapid information exchange
has been applied to both national and international outbreaks of
VTEC O157 infection in Europe.
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Board 101. The First one-block Revese Transcriptase
Polymerase Chain Reaction (one-block-RT-PCR) for
Diagnostic of Lassa-, Marburg-, Ebola- (Zaire, Sudan &
Reston), Rift-Valley- and crimean-congo hemorrhagic Fever
Virus in Clinical Specimen 
A. Vahhabzadeh
Virology, Marburg, GERMANY
The term viral hemorrhagic fever (VHF) refers to a group
of illnesses, which belong to four viral families (Arenaviridae,
Bunyaviridae, Filoviridae and Flaviviridae). Most of these are
endemic, but the deadly viral hemorrhagic fever could be spread to
areas which are previously free from outbreaks. The diseases are
characterized by an acute onset and, in some cases, a high mortal-
ity rate. Typical for these severe diseases is bleeding as a complica-
tion. We present some aspects of VHF: epidemiology, anomaly of
blood values, pathogenic mechanism and membrane proteins, risks
and prevention of nosocomial transmission, treatment, and future
studies. The molecular biology of these agents has provided
nucleotide sequence data that are the basis for the development of
VHF-specific reverse transcriptase-polymerase chain reaction (RT-
PCR) assay. Therefore, we developed the first one-block-RT-PCR,
that allows simultaneous amplification for the rapid detection,
diagnosis, surveillance and identification of viral RNA in specimen.
Board 102. Expression of Hepatitis E Virus Capsid Protein 
S. Lin1, J. Drobeniuc1, E. Barsov2, L. Lu1, M. Favorov1, C. Humphrey1,
B. Robertson1
1CDC, Atlanta, GA, 2National Cancer Institute, Frederick, MD
Hepatitis E virus (HEV) is a single-stranded positive-sense
RNA virus and the etiological agent of acute hepatitis transmitted
by the fecal-oral route. The capsid protein of HEV is encoded by
open reading frame 2 (ORF2), containing 1,980 nucleotides, locat-
ed at the 3’ end of the HEV genome. By using recombinant DNA
technologies, we expressed the full-length ORF2 in two insect cell-
based expression systems: recombinant baculovirus (Bac-to-Bac,
Gibco-BRL) and InsectSelect (Invitrogen). We took advantage of
the ability of insect cells to posttranslationally process recombinant
proteins in a way that closely resembles posttranslational modifica-
tion of proteins in mammalian cells. The HEV capsid protein was
expressed in Hi-5 cells and purified by sucrose density gradient
centrifugation. Fractions were tested by immunoblotting with
pooled sera obtained from HEV-convalescent patients. We
observed three protein bands, which reacted with antibodies from
patients’ serum: a 75 kDa protein, which corresponded to the pre-
dicted molecular weight of the ORF2 gene product, a 150 kDa
protein, which could represent a multimer of the ORF2 protein,
and a 30 kDa product that may have been generated by proteolyt-
ic processing of the full-length ORF2 polypeptide. Analysis of the
protein preparations by electron microscopy revealed the presence
of self assembled virus-like particles (VLPs). The diameter of the
VLPs was approximately 27-30 nm, which corresponds to the
diameter of the native HEV virions. Both expression systems
allowed the expression of full-length capsid protein, which assem-
bled into VLPs. The time required to produce the recombinant
protein in both systems was similar. The InsectSelect cloning pro-
cedure offered the convenience of being able to modify the length
of the cloned fragment without the need for construction and
amplification of recombinant baculovirus. In addition, InsectSelect
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provided the continuous production of the recombinant protein by
continuous culture.
Board 103. Improvement of Methods of Getting Erythrocytes
Preparations for Plague Diagnostic 
O. Y. Aimanova, T. I. Tugambaev, T. N. Kunitsa, G. I. Denisov, E. A.
Ryabushko, A. G. Zhansarina
Kazakh Scientific Center for Quarantine and Zoonotic Diseases,
Almaty, KAZAKHSTAN
Serological reactions using for plague diagnostic are bases
on reveal of capsular antigen or antibodies to them. Conventional
method of F1 getting (Baker at al., 1947) has defects, the very
importance is decay of capsular antigens molecular on fragments,
during acetone action. That is why we used for cells inactivation
the warmed microbe mass 30 minutes on 70 C degrees with fol-
lowing bacteriological control. Immunology activity of getting
plague erythrocytes antigen diagnostics, with using our capsular
antigen was 2-4 higher in compare with commercial preparations,
investigated different series of plague agglutinating serums. We
have got experimental series of erythrocytes preparations, based on
plague F2 and LPS. Diagnosticums prepared by using poly-
ethilenglycol (PEG). Principle of this polymers action is displace-
ment of sensitine to sorbent from solution, in water medium con-
taining protein or LPS molecular, that promoting to raped sensibi-
lization of formalized erythrocytes and getting possibility of prepa-
rations prepare in one stage. Sensitivity of antitoxic plague antigen
diagnosticum in different series plague agglutinating serums were
1:32950, in serums of immunized laboratory animals - 1:2500.
Diagnosticum didn’t give positive result in RDGA with tularensis,
brusselosis, salmonellesis ABCDE and enteroyerseniosis aggluti-
nating serums, but revealed antibodies with pseudotuberculosis
agglutinating serum in titer 1:1280. Specific activity of plague ery-
throcytes diagnosticum based on LPS with different series of
plague agglutinating serums were 1:2560, with serums of immu-
nized animals - 1:8240. Diagnosticum didn’t reveal antibodies in
RDGA with different agglutinating serums, and pseudotuberculo-
sis too. Our results permission us to recommend these preparations
for serological plague diagnostic.
Board 104. Evaluation of Two Biphasic Media for the
Primary Culturing and Transport of Pathogenic Agents
Associated with Meningitis and Acute Febrile Illness 
M. Wasfy1, T. Ismail1, M. A. Maksoud1, H. Mansour1, F. Mahoney1,2
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Centers
for Disease Control and Prevention, Atlanta, GA
Background: Bacterial meningitis and undifferentiated
fever (or acute febrile illness) are serious priority diseases in Egypt.
As part of a collaborative surveillance activity between the
Egyptian Ministry of Health and Population and NAMRU-3, clin-
ical samples (CSF and blood, respectively) from both syndromes
were collected from suspected patients presenting to 12 fever hos-
pitals in diverse regions of the country. In this setting, blood is inoc-
ulated into Biphasic Blood Culture Bottles (BBC, PML
Microbiologicals, Wilsonville, Oregon) and CSF is centrifuged and
the sediment is Gram-stained, plated on suitable agars (if available)
and Biphasic Trans-isolate medium (TI, Ajello et al., 1984), which
has been designed as a growth and transport medium. Blood cul-
tures are incubated for up to 2-3 weeks, while CSF cultures are
incubated on TI for 1-2 days. Cultures are then kept at room tem-
perature and transported every 3-4 weeks to NAMRU-3 for
pathogen identification and QC of hospital results. Objectives: To
evaluate the use of BBC and TI, as growth and transport media for
a number of specific blood and CSF pathogens. Methods: Pure
triplicate cultures of S. typhi, Brucella melitensis, S. aureus,
Neisseria meningitidis, H. influenzae, and S. pneumoniae (clinical
and ATCC strains) were suspended in sterile saline to 0.5
MacFarland, serially diluted ten-fold and inoculated into BBC and
TI bottles (1ml inoculum /70 ml BBC and 0.5 ml/15 ml TI). Seven
ml of fresh human blood were inoculated into each BBC. 100 ul of
each bacterial dilution was also spread on blood and chocolate
plates for CFU determination. All biphasic bottles were incubated
at 37°C without venting. Identity and viability of growth was
checked on a weekly basis. When no growth was observed within 2
weeks, the experiment was repeated. Results: Both types of cul-
ture media supported the viability of H. influenzae for 3-4 weeks
and 9 weeks for S. aureus and S. typhi when 10-8 - 10-10 bacte-
ria/ml (>5 CFU/ml) were inoculated. TI was superior for B.
melitensis (>47 vs. 29 days in BBC). BBC seemed better than TI
for N. meningitides and S. pneumoniae (32 and 30 days vs. 24 and
25 days, respectively), presumably because of the presence of
blood. Conclusion: TI and BBC can support growth and transport
of blood and CSF pathogens for 3-9 weeks depending on the
species and inoculum concentration. Venting was not performed in
this study to minimize the possible contamination of cultures, a
modification which can be of value under field conditions.
Board 105. Use of PCR to Evaluate Patients with Meningitis
in Egypt 
T. Graham1, M. Wasfy1, F. Mahoney1,2
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Centers
for Disease Control and Prevention, Atlanta, GA
Objective: Bacterial meningitis is an important public
health problem in Egypt and its epidemiology is complex due to
the wide range of pathogens. The objective of this study was to
evaluate polymerase chain reaction (PCR) as a method to enhance
the diagnosis of the most important causes of bacterial meningitis
in Egypt and evaluate its role as part of a meningitis surveillance
project. Methods: Bacterial cultures and latex agglutination (at
some institutions) were used to evaluate patients with a clinical
diagnosis of meningitis admitted to infectious disease hospitals in
diverse areas of Egypt. Excess cerebrospinal fluid (CSF) samples
were stored in liquid nitrogen and sent to NAMRU-3 for further
evaluation. When possible, bacterial isolates were collected and
cultures were confirmed at NAMRU-3. PCR assays were carried
out on specimens classified by laboratory personnel as “purulent”
using primers specific for the ply gene (pneumolysin) of S. pneu-
moniae (SP), the bexA gene (capsule synthesis) of H. influenzae
(HI) and the ctrA gene (capsular transport) of N. meningitides
(NM). Results: Of the 105 CSF samples from patients with cul-
ture confirmed disease, 101 (96%) were PCR positive for the
appropriate bacterial target sequence. The sensitivity of the assay
for CSF from patients with culture confirmed SP was 97%(56/58),
HI was 96%(25/26), and from patients with NM 95%(20/21). Of
the 73 samples that were not culture confirmed at NAMRU-3, 40
(55%) were PCR positive for one of the three major agents. Most
discordant results occurred in institutions with limited experience
in microbiology or institutions that used latex to diagnose patients.
Among the 1,135 culture-negative samples tested by PCR, S. pneu-
moniae was detected in 74 samples (6.5%), H. influenzae in 31
samples (2.8%) and N. meningitidis in 34 samples (3.2%).
Conclusions: PCR is highly sensitive in the evaluation of patients
with the most common causes of bacterial meningitis and can be
used to confirm a bacterial etiology in culture-negative patients.
PCR can also be used as a quality control measure to evaluate the
performance of clinical laboratories developing microbiologic
capability. The finding that < 15% of patients with unexplained
purulent meningitis have evidence of infection with SP, HI, and
















Board 106. Function of Enterohaemolysin Reaction in Marks
Shiga-like Toxin (Verotoxin) Production Escherichia coli 
W. J. Yang
Henan Provincial Health & Anti-Epidemic, Zhengzhou, CHINA
Function of enterohaemolysin reaction in marks Shiga-like
toxin (Verotoxin) production Escherichia coli Vero (Shiga-like)
toxin-producing E.coli(VTEC) infection is an emerging infection in
China. In the last two years, the morbidity of the infection has been
increasing. Antibiotics are widely used to treat diarrheic patients at
all levels and that leads to acute renal failure and HUS in some
patients. In order to control VETC infection, we carried out an
investigation in 2000. We studied the patients, the surrounding
environment and the cattle in the near farms. During the normal
pathogens culturing and identification, we employed washed sheep
blood agar plates which could easily screen out positive-entero-
haemolysin-reaction strains. 65 strains 0157:H7 E.coli were isolat-
ed from the environment and the health sheep. 89.29% strains
showed positive enterohaemolysin reaction and harbored one or
more SLT genes by multiplex PCR assay. In some serious bloody
diarrhea fecal samples, we didn’t find 0157:H7 E.coli. It may imply
that sporadic cases infection are mainly caused by no-0157:H7 in
the region. For the 98 strains E.coli isolated from diarrheic chil-
dren, 5 strains showed clear enterohemilysin reaction. Only one
strain occured agglutination with 0157:H7 serotype. In addition,
lysis zones are seen in 11 strains which showed week positive
enterohemilysin reaction, but not as clear as standard 0157 lysis
zone(not determined Stx gene at present). There are 9 strains
0157:H7 E.coli from diarrhea patients that did not carry SLT genes
also exhibited haemolysis reaction. Although we found that 69 no-
E.coli showed enterohemilysin phenomenon in washed sheep
blood agar plates, this enterohemilysin reaction still has important
significance. At present, many clinical laboratories report the isola-
tion of E.coli from 40-60% samples that are not further character-
ized. Washed sheep blood agar plate is a simple tool for rapid iso-
lation and identification of major VETC. It is especially fit for
developing countries, for they lack funding, techniques and equip-
ment. As the method induces some question, further studies are
still needed.
Board 107. A Statistical Method to Improve Limit-Of-
Detection for Microbead-Based Immunoassays 
F. Y. Chuang, D. O. Nelson
Lawrence Livermore National Laboratory, Livermore, CA
The use of microbead-based immunoassays to perform flow
cytometric, multi-analyte determinations from single biological
samples has grown increasingly popular for a number of clinical
applications. We propose that this method may be well-suited for
rapid screening of respiratory pathogens (such as influenza or
inhalational anthrax) in nasopharyngeal swab samples. In order to
be a useful screening tool for early or presymptomatic stages of
infection, the proposed assay method may be required to detect
microbial levels that are comparable to (or possibly less than) the
concentration of microbeads used to capture the pathogens.
Conventional flow cytometric measures of mean or median
reporter fluorescence inherently require larger numbers of cap-
tured particles to meet the criteria for a “positive” test. We per-
formed a series of titrations using fluorescent microbeads to cap-
ture either influenza Type A virus, or Bacillus globigii (a laborato-
ry surrogate for B. anthracis) to characterize the progression of dis-
crete changes that occur in the distribution of individual
microbead reporter fluorescence intensities as the microbial con-
centration rises from normal baseline (i.e., zero antigen) to levels
that approach the conventional limit-of-detection by FACS analy-
sis. These observed concentration-dependent changes in intensity
distribution were converted into a mathematical model describing
the distribution of fluorescence intensity as a function of microbial
concentration. We then evaluated a statistical detection approach
based on the likelihood ratio test. In this approach, the observed
distribution of fluorescence intensities in a new sample is used to
estimate the underlying microbial concentration and test whether
or not sufficient evidence exists to conclude that the pathogen is
present. The test is considered positive when a quantity called the
likelihood ratio exceeds a threshold parameter, K (which can be
correlated to a false-positive rate that is deemed acceptable for the
given screening application). Receiver-Operating Characteristic
(ROC) curves were then used to estimate test sensitivity and speci-
ficity as a function of K. After comparing the limits-of-detection
using this method versus conventional FACS analysis, we will dis-
cuss strategies to better utilize microbead-based immunoassays for
direct microbial analysis of clinical samples.
Board 108. Rapid One Step RT-PCR for Diagnosis of
Oropouche Virus Infection in Human Serum Samples 
M. R. Nunes1, A. T. Rosa2, S. G. Rodrigues1, G. B. Araújo1, R. B.
Tesh2, R. E. Shope2, P. F. Vasconcelos1
1Instituto Evandro Chagas, Belém, BRAZIL, 2University of Texas
Medical Branch, Galveston, TX.
Objective: The present study reports the development of a
rapid one step RT-PCR protocol for diagnosis of Oropouche virus
(OROV) infection in human samples. Materials and Methods:
RNA extraction of 34 human serum samples (stored at -20°C) with
confirmed OROV isolations was performed using the TRIZOL LS
technique. Subsequently, a rapid RT-PCR protocol using specific
primers for the OROV SRNA segment was used for viral RNA
detection and amplification. The RT-PCR products were then
viewed in a 1.2% agarose gel. Later, the results obtained were com-
pared with previous results of serology, standard RT-PCR and virus
isolation for determination of the sensitivity and specificity of the
one step RT-PCR. Results: From a total of 34 samples tested, 11
(32,35%) were positive for OROV genome detection by this modi-
fied technique. Electrophoretic analysis in agarose gel revealed
products with approximately 600 bp according with the molecular
weight marker position. This procedure showed more sensitivity
and less time consuming in comparison with standard RT-PCR.
Conclusion: The development of this technique will allow early
detection of OROV in future outbreaks, facilitating a rapid diagno-
sis and the improvement of control measures during outbreaks.
Board 109. Kinetic Analysis of a Peptide Nucleic Acid
Synthesized to Bind the Crystal Protein Gene of Bacillus
thuringiensis: Applications as a Simulant for Bacillus anthracis
in Diagnostic Assays 
C. Kolanko1, S. C. Francesconi2, A. Churilla1
1Naval Research Laboratory, Washington, DC, 2Nova Research, Inc.,
Alexandria, VA
PNA is a synthetic molecule in which the standard nucle-
obases are attached to a polyamide backbone as opposed to the
phosphodiester backbone of DNA. It is capable of forming highly
stable duplexes with complimentary sequences, therefore making
them more conducive as a probe used in diagnostic assays for envi-
ronmental sampling. A custom peptide nucleic acid (PNA) com-
prised of the sequence AAG-TAA-CCC-TGA-AGT-Lys was syn-
thesized matching a highly conserved region of the crystal protein
gene (CryIA(c) gene) from the organism Bacillus thuringiensis
subsp Kurstaki. This organism is being used as a simulant for
Bacillus anthracis to develop a capture/detection diagnostic assay
system. B. thuringiensis’s genome is nearly identical to that of B.
anthracis except for the presence of extrachromosomal cry
sequences in B. thuringiensis and in the case of B. anthracis,
sequences encoding lethal/edema factors. Employing surface plas-
mon resonance (SPR), using a BIAcore 3000 biosensor, the PNA
probe was immobilized on a carboxyl-methyl dextran (CM5) sur-
face via amine-coupling through the lysine residue located on the
C-terminus of the probe. Direct detection of a 24-bp sequence tar-
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get DNA was achieved over a detection range of 10-100 nM. After
each detection of the target DNA, regeneration of the immobilized
probe was carried out by exposing the surface to a wash of 50 mM
NaOH. Additional binding studies were conducted determining
binding kinetics, varying target DNA size and binding under dif-
ferent sampling conditions (salt, pH).
Board 110. Detection of Bacillus anthracis in Veterinary
Clinical Samples Using Field Deployable Real-Time TaqMan
PCR Technology 
L. A. Cooper1, T. L. Hadfield2, W. Barnes1, K. L. Lohman1
1Molecular Epidemiology Branch, Brooks Air Force Base, San
Antonio, TX, 2Armed Forces Institute of Pathology, Division of
Microbiology, Washington, DC
Anthrax is a disease of both animals and humans. Its
causative agent, the spore forming bacterium Bacillus anthracis, is
endemic to the state of Texas in which periodic animal outbreaks
occur. In early July of 2001, the Texas Animal Health Commission
reported that suspected anthrax cases from the counties of
Edwards, Uvalde, and Val Verde had been confirmed by the Texas
Veterinary Medical Diagnostic Laboratory in College Station,
Texas. Subsequently, numerous reports of downed animals with
antemortem and/or postmortem pathology consistent with anthrax
infection were reported from ranches throughout this region. Field
observations also indicated that an unusually large anthrax out-
break was underway. In late July 2001, we initiated studies in which
fluorescent real-time PCR was used to detect anthrax DNA in vet-
erinary clinical samples. Specifically, we used five sets of B.
anthracis-specific PCR primers and TaqMan probes to detect
anthrax in cultured material, blood, tissue, nasal swabs, and envi-
ronmental samples collected from suspect cases. The PCR targets
were the genes encoding for B. anthracis capsular antigen (CAP),
lethal factor (LF), edema factor (EF), and protective antigen (PA).
The genetic regions encoding LF, EF, and PA are located on the
PX01 plasmid and the CAP gene resides on the PX02 plasmid. The
fifth primer set amplified a B. anthracis genomic region encoding
small acid soluble proteins (SASP). Each reagent set was user-
ready and supplied as pre-packaged ampules containing a dried
down formulation of the primers, probe, and all required PCR
reagents. Control organisms included Bacillus cereus, as well as the
Pasteur and Sterne strains of B. anthracis. Thermocycling was per-
formed with a mobile, capillary-based real-time PCR instrument
known as the Ruggedized Advanced Pathogen Identification
Device (RAPID; Idaho Technologies). Our main objective was to
test our B. anthracis molecular reagents and protocols using real-
world clinical material. Secondarily, the work establishes a proof of
principle for the veterinary applications of rapid, field ready molec-
ular tests and demonstrates the future applications of this technol-
ogy during anthrax outbreaks.
Board 111. A Real-Time PCR Assay for the Universal
Detection of Influenza A Viruses 
L. T. Daum, L. A. Cooper, L. C. Canas, K. L. Lohman
Molecular Epidemiology Branch, AFIERA/SDE, Brooks Air Force
Base, San Antonio, TX
Influenza A viruses infect numerous avian and mammalian
species and can undergo genetic reassortment in a process known
as antigenic shift. Aquatic birds are the reservoir for fifteen hemag-
glutinin subtypes (H1-H15), several of which have crossed the
species barrier to infect humans and other animals. PCR methods
for the rapid identification and subtyping of influenza A viruses in
humans have been described but are limited to the detection of
currently circulating H1N1 and H3N2 viruses. These assays specif-
ically target the hemagglutinin (HA) and neuraminidase genes
(NA) of human influenza viruses but would not be able to distin-
guish novel influenza A reassortants. To universally detect influen-
za A viruses from humans and other animals, a 5’-nuclease TaqMan
PCR assay targeting the highly conserved matrix (M) gene was
developed. This assay was shown to be extremely sensitive, capable
of detecting all 15 influenza subtypes (H1-H15) within three hours,
and showed no cross reactivity to a reference panel of respiratory
viruses and bacteria. From a public health perspective, this assay
could be valuable for detecting antigenic shift variants that would
otherwise go undetected using conventional PCR methods which
are based on amplification of currently circulating HA and NA
genes. Furthermore, state and federal laboratories could employ
this rapid PCR assay to differentially diagnose influenza A from
other upper respiratory infections and bioterrorism agents that
exhibit flu-like symptoms.
Board 112. Development of a High Throughput Flow
Analysis for the Detection of Bacillus globigii Spores 
P. Estacio, N. Cahanding, S. Hadley, F. Milanovich, K.
Venkateswaran
Lawrence Livermore National Laboratory, Livermore, CA
Unlike a single, short-lived high-explosion event, the use of
biological warfare agents has the potential to produce a devastat-
ing number of casualty days and possibly months beyond the ini-
tial exposure incident. While there is no evidence of infection
transmission between individuals by direct contact, Bacillus
anthracis is capable of maintaining infection capability in a dor-
mant spore form, allowing a sustained presence that provides the
potential for delayed exposures. Recent acts of bioterrorism
involving Bacillus anthracis-containing mail sent through the US
Postal Service have left many trace elements of pathogenic spores
on letters and packages, sorting machinery, and workspaces,
endangering postal employees and the general public. Inherent in
the timely response to an imminent threat to public health and
safety comes the need to quickly identify anthrax infection-pro-
ducing spores contained in a large number of individual samples
with sensitivity and specificity comparable to current standard
protocols. We demonstrate the development and usefulness of a
multiplex immuno assay suited for the detection of bacterial
spores with Bacillus globigii as a model system. This system is
rapid and amenable for high-throughput analysis for differentiat-
ing the presence or absence of the bacterial antigen in the sample.
Fluorescent-encoded microspheres are used in a liquid suspen-
sion array format in this multiplex assay. Measurement of intensi-
ty of the fluorescent-reporter antibody bound to each set of dis-
tinct microsphere population enables the detection of the bacter-
ial antigen in the sample. In our initial investigations, up to one
hundred samples were rapidly analyzed simultaneously for the
presence of antigen. Twenty-five random samples contained the
anthrax surrogate Bacillus globigii at 1x107cfu/ml. The twenty-five
samples containing Bacillus globigii were correctly identified. The
results display promise in a laboratory method that detects the
presence of bacterial agents without sacrificing the integrity of an
individual sample when analyzed in a multiplex format. This rapid
and cost effective detection method will be used to evaluate envi-
ronmental samples for the Bacillus anthracis presence in parallel
with standard culture methods for comparison analysis.
Board 113. Signature Screening for Assay Development 
E. A. Vitalis, J. R. Avila, L. E. Danganan, N. K. Montgomery, L.
Radnedge, C. L. Strout, L. L. Ott, T. A. Kuczmarski, T. R. Slezak, P. M.
McCready
Lawrence Livermore National Laboratory, Livermore, CA
Early detection and accurate identification of biological
agents are critical for successful handling of bioterrorist attacks or
outbreaks of infectious diseases. The speed and reliability provid-
ed by DNA-based diagnostics allow for rapid, unambiguous detec-
tion of pathogens. We are developing signature-based real-time
PCR assays to be provided to a community of users including
















Demonstration and Application Programs), USDA, public health
agencies, and others. Accurate, reliable DNA-based pathogen
detection requires the identification of genetic signatures that are
regions of DNA both unique to that pathogen and conserved
amongst its strains. We have developed a computational process
that uses available DNA sequence information to generate a large
number of potential DNA signatures. To ensure extremely high
selectivity and sensitivity, we have established a screening protocol
that rigorously screens DNA signatures. First, the candidate signa-
tures are in silicoscreened against an immense DNA sequence
database. This database contains sequence from over 600 microbes
and viruses and has been compiled from multiple research centers
around the world. Surviving candidate signature primer pairs then
proceed to wet chemistry screening utilizing standard PCR with
agarose gel electrophoresis. This step ensures that the primers will
react across strains representative of the diversity of the pathogen
(avoid false negative), but will not react with the DNAs of other
organisms that could be present in a sample (avoid false positives).
The collection of over 100 purified DNA templates used in this
screening process include: 1) Strain panels—representative of the
diversity of the target organism in nature; 2) Near neighbors—
organisms that are closely related at the genetic level and therefore
have the greatest likelihood of cross-reaction; 3) Soil samples from
around the country—complex mixtures of organisms from diverse
environmental collections; 4) Organisms causing similar clinical
symptoms—organisms causing nonspecific clinical symptoms com-
mon to many infections agents; 5) Microbial diversity based on 16S
analysis—organisms representative of microbial diversity; and 6)
Eukaryotic DNA—DNA that may carry over from sample collec-
tion procedures. As a result of this screening process, more than
300 DNA signatures have been found to be highly specific for six
top-priority threat bacteria and several high-impact viruses.
Signatures are further tested for suitability for real-time TaqMan®
fluorogenic PCR detection protocols. Assay performance is vali-
dated for a broad range of users in accordance with the FDA
approval process. This work was performed under the auspices of
the U. S. Department of Energy by the University of California,
Lawrence Livermore National Laboratory under Contract No. W-
7405-Eng-48.
Board 114. A Study of Virus-Cell Interaction by the Method
of Dielectrophoresis 
V. M. Generalov, T. S. Bakirov, A. G. Durymanov, A. A. Medvedev,
V. D. Poryvaev, V. S. Toporkov, G. I. Tunnikov, A. N. Sergeev, V. A.
Petrischenko, L. N. Shishkina, O. V. Fefelov
Research Institute of Aerobiology at State Research Center of Virology
& Biotechnology "Vector", Koltsovo, RUSSIAN FEDERATION
An attempt to study theoretically and experimentally the
changes in the cell membrane characteristics initiated by a virus
even at the adsorption stage was undertaken in this work. The cell
dielectrophoresis in the inhomogeneous alternate electric field
(IAEF) was used as a basic method for determination of electro-
physical characteristics of cells. The experimental data obtained
by us show that adsorption of the viruses of enteritis and grippe in
the cell membrane of erythrocytes of monkey and mouse leads to
considerable decrease of the membrane capacity and increase of
the cell equilibrium frequency as early as at the first minutes of
interaction. The cell equilibrium frequency measurements can be
used as a basis of the method for identification of cells infected by
a virus and the method for measurement of the virus concentra-
tion in cell suspension.
Board 115. A Study of Cell Membrane Properties During
Virus-Cell Interaction by the Method of Dielectrophoresis 
A. G. Durymanov, V. M. Generalov, L. F. Bakulina, L. N. Shishkina,
B. N. Zaitsev, T. S. Bakirov, O. V. Fefelov, E. P. Goncharova, L. E.
Bulychev, V. S. Toporkov, A. A. Chepurnov
State Research Center of Virology & Biotechnology "Vector",
Koltsovo, RUSSIAN FEDERATION
With the help of the of dielectrophoresis method it was
shown that at the first stage of adsorption of virus by cell, for
example: monkey erythrocyte — parvovirus, chicken erythrocyte
— grippe virus, goose erythrocyte — rubella virus, occurs impor-
tant changing of the cell membrane electrical capacity. Electron
microscopy also confirmed that one minute after mixing of cell
and virus suspensions on the membrane take place considerable
morphological alternations, probably connected with large redis-
tribution of the electrical charge on the cell surface. All study of
virus-cell interactions were made in the special isotonic solution
with low ionic force. Experimentally chosen components of the
solution provide the possibility of dielectrophoresis (due to small
conductance) and simultaneously very effective virus-cell interac-
tion. It was offered a new approach for study the degree of exter-
nal physical influences and chemical factors acting on biological
activity of the cell.
63 Prions and Public 
Health
Tuesday, March 26, 8:30 a.m.
Grand Hall East
Board 117. Modeling the Age Distribution of vCJD and
Predictive Epidemiology of the Disease
A. J. Valleron1, P. Y. Boelle2, R. Will3, J. Y. Cesbron4
1Inserm U444, Paris, FRANCE, 2INSERM U444, University Hospital
Saint-Antoine, FRANCE, 3National Creutzfeldt Jakob Surveillance
Unit, Western General Hospital (Edinburgh), UNITED KINGDOM,
4Immunité anti infectieuse (JE2236), Université Joseph Fourier
(Grenoble), FRANCE
The age distribution of the vCJD cases presently notified in
the UK (as of May 2001) is strikingly young, with a mean age of 28
yrs, and only 7% of the subjects are more than 50 yrs. This young
age distribution is not yet explained, as there are no published epi-
demiological, nor experimental work which explain this fact.
We have therefore devised a new epidemiological model of
the vCJD, which focuses on this age characteristic of the vCJD: we
have hypothesized that the risk of infection during the 1980 - 1989
period —where roughly 500,000 BSE infected cows are supposed
to have entered the chain food- — was strongly dependent on the
age: this risk was asumed to follow a plateau function of age before
age 15, then to decrease exponentially after (Valleron et al.,
Science, 2001; 294: 1726-8). From this asumption, analysing the
available information, we have derived an estimation of the incu-
bation time (mean: 16.7 yrs) and of the future number of cases (less
than 403 cases).
We shall present the results obtained with alternative mod-
els of the age-risk function. We shall present the sensitivity analy-
sis of the results when possible contaminations that may have
occured after 1989 are considered (1989 is the date of the UK
bovine specified risk materials ban).
The results will be updated using the latest surveillance
data available at the time of the conference.
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Emerging Rickettsioses of the Thai-Myanmar Border 
P. Parola1,2,3, R. S. Miller2, P. McDaniel4, P. E. Fournier3, D. Raoult3, S.
R. Telford, III1, C. Wongsrichanalai2
1Harvard School of Public Health, Boston, MA, 2Armed Forces
Institute of Medical Sciences (AFRIMS), Bangkok, THAILAND, 3Unite
des Rickettsies, Marseille, FRANCE, 4Kwai River Christian Hospital,
Sangkhlaburi, THAILAND
Background: Human rickettsioses known to occur in
Thailand include mainly murine typhus (caused by Rickettsia
typhi) and scrub typhus (caused by Orientia tsutsugamushi).
Spotted fever group (SFG) rickettsioses have been occasionally
noted but to date cases there have only been confirmed by gener-
al SFG serology. The etiologic agent(s) of SFG rickettiosis patients
in Thailand have never been specifically identified by isolation or
molecular characterisation, or by the use of specific serological
assays using panels of SFG antigens. Methods: Fourteen patients
clinically suspected (fever and/or rash and/or eschar and/or arthro-
pod bites) or with sera positive for rickettsioses using a dot-ELISA
test (PanBio-InDx multi-test Dip-S-Ticks) or microimmunofluo-
rescence were selected from volunteers enrolled in a fever surveil-
lance study conducted at the AFRIMS/Kwai River Christian
Hospital Clinical Center in 2000-2001. This study site is located on
the central part of the Thai-Myanmar border (Sangkhlaburi
District, Kanchanaburi Province, Thailand), where rickettsioses
have never been described. There, local Karen, Mon, Burmese and
Thai populations are commonly exposed to flea- and tick- bites.
Diagnostic tools for rickettsioses included serology by immunoflu-
orescence using a panel of 13 rickettsial antigens of acute and con-
valescent (Day 21) samples. Results: Rickettsioses were serologi-
cally documented in all of the 14 patients by evidence of serocon-
version and/or IgM. Three were murine typhus cases, three cases
were scrub typhus and eight were SFG rickettsioses. All of these
eight SFG rickettsioses cases demonstrated the highest titres to (i)
R. conorii strain Indian, known as an agent of SFG rickettsiosis in
India, and (ii) R. helvetica, an emerging pathogen known to be
prevalent in Europe and in Japan. However, an unknown Rickettsia
sp. cross-reactive with R. conorii and R. helvetica could also be
implicated in our cases. These results provide for the first time a
more precise documentation of SFG rickettsioses as well as murine
typhus and scrub typhus in Kanchanaburi Province. Attempts at
molecular detection or isolation are being undertaken to specifi-
cally identify the SFG agent(s) infecting residents of this area, with
















Clinical Management and Outcomes of Lyme Disease in
Wisconsin 
D. R. O'Leary1, E. Belongia2, K. Orloski1, P. Chyou P2, C. Gale2, M.
Finkel3, E. B. Hayes1
1United States Centers for Disease Control and Prevention, Division of
Vector-Borne Infectious Diseases, Fort Collins, CO, 2Marshfield
Medical Research Foundation, Marshfield, WI, 3Mayo-Midelfort
Clinic, Eau Claire, WI
Background: Lyme disease (LD) is a rapidly emerging
public health problem, but little is known regarding diagnostic and
treatment practices. We reviewed medical records of patients diag-
nosed with LD between 1992 and 1998 at two integrated health
care networks in Wisconsin to assess clinical management and out-
comes. Methods: We searched a health care database for encoun-
ters with ICD-9 codes consistent with LD (088.81, 695.9, 066.9)
and reviewed the corresponding medical charts. We classified
patients as having erythema migrans (EM), late (disseminated)
LD, or not LD. We classified LD as ‘probable’ if the manifestations
met the national surveillance case definition for LD, and ‘possible’
if there was 1) a clinically diagnosed EM with diameter < 5cm or
unspecified, or 2) a positive serologic test with recurrent arthralgias
or neurologic manifestations in a patient who did not otherwise
meet the national case definition criteria. We classified illness
episodes not meeting the criteria for probable or possible LD as
‘not LD’. We assessed patient outcomes by reviewing all clinic vis-
its up to three years after the initial visit. We classified patients as
having ’complete resolution’ if there was no mention of LD mani-
festations at the last clinic visit, as ‘persistent LD’ if manifestations
persisted at the last visit, and ’insufficient information’ if there was
no follow-up visit documented in their medical record. Results:
We identified 1,287 patients who were suspected to have LD by
their healthcare providers. Six hundred forty-five (50%) of these
patients had probable or possible LD: 304 (47%) had probable
EM; 107 (17%) had possible EM; 72 (11%) had probable late LD;
and 162 (25%) had possible late LD. The median age of all LD
patients was 37 years, and 56% were male. Serologic LD testing
was performed for 240 (79%) of probable EM patients, 71 (99%)
of probable late LD patients, and 559 (87%) of 642 patients deter-
mined not to have LD. Of the 559 patients without LD who had
serologic testing performed, 192 (34%) had three or more tests.
Antimicrobials were given to 97% of patients with probable late
LD and 92% of those without LD. Two or more courses of antimi-
crobials were given to 16% of patients with probable EM, 57% of
patients with probable late LD, and 29% of patients without LD.
Sixty-nine percent of patients with probable late LD had complete
resolution of symptoms based on the medical record; 20% had per-
sistent LD, and 11% had insufficient information. Conclusions:
In this LD-endemic area, many symptomatic patients without LD
have repeated serologic tests or multiple courses of antimicrobials.
The majority of patients with disseminated LD appear to have
complete resolution of symptoms.
A Neighborhood Outbreak of Q Fever Linked to a Goat Ranch
in California 
M. T. Jay1, J. Douglas2, K. Carter1, J. D. Miller3, J. McQuiston3, G.
Rishwain4, E. Schneider4, H. Thompson3, D. Kelaita2
1California Department of Health Services, Sacramento, CA,
2Calaveras Public Health Department, San Andreas, CA, 3Centers for
Disease Control and Prevention, Atlanta, GA, 4Stockton Medical
Groups, Stockton, CA
Q fever, a rickettsial zoonoses caused by Coxiella burnetii,
may manifest in humans as an acute nonspecific febrile illness or
an insidious chronic disease often characterized by endocarditis. In
the past decade, 1-8 sporadic cases of Q fever have been reported
annually in California; two notable outbreaks in urban areas
occurred during that time period and were associated with goats at
a humane society and sheep at a petting farm, respectively. We
describe the investigation of a recent goat-associated outbreak of Q
fever among neighbors in a rural area of the Sierra Nevada foothills
in California. The index case was a 56-year-old woman who was
hospitalized in May 2001 with a febrile illness, adenopathy, inter-
stitial lung infiltrates, and progressive weakness. A presumptive
diagnosis of gall bladder disease led to surgery, but her signs and
symptoms did not resolve. The patient developed hepatitis and was
diagnosed with Q fever by serology approximately 6 weeks after ill-
ness onset. Interviews with the patient revealed that her husband
had concurrently experienced a nonspecific febrile illness and sub-
sequent serologic evaluation indicated a recent Q fever infection.
The local public health nurse canvassed their neighborhood and
discovered a 76-year-old man who had complained of intermittent
fever and headache since April. Serologic testing of this patient was
also consistent with a recent Q fever infection. All three patients
were treated with doxycycline and recovered; however, we contin-
ue to monitor them for chronic manifestations. The patients lived
at the end of a dusty dirt road approximately one-quarter mile past
a goat herd pastured adjacent to the road. The goats were moved
to this neighborhood during the previous year and had kidded in
March-April. The ranch owner reported no history of reproductive
problems in the herd, but a serosurvey revealed that 38/40 females
(95%) and 4/6 (67%) males demonstrated antibodies to C. burnetii.
The patients denied direct contact with the goats, therefore inhala-
tion of aerosolized contaminated dust particles spread downwind
or while driving past the goats was the suspected source of trans-
mission. Recommendations were given to the ranch owner to min-
imize environmental contamination during the birthing season. In
California, Q fever is emerging in rural and urban settings where
susceptible individuals may have direct or indirect contact with
infected small ruminants. This outbreak illustrates the potential for
patients infected with Q fever to present without a history of direct
contact with animal reservoirs and it underscores the importance
of a thorough public health investigation to identify additional
cases and implement control measures.
Q fever in the United States: Experience of Infectious 
Diseaes Consultants and Comparison to National Reporting
During 2000 
J. H. McQuiston1, L. J. Strausbaugh2, D. B. Jernigan1, L. A. Liedtke2,
J. E. Childs1, H. A. Thompson1
1CDC, Atlanta, GA, 2VA Medical Center, Portland, OR
Q fever, caused by Coxiella burnetii, is a zoonotic disease
that is considered a potential agent of bioterrorism. Adequate sur-
veillance and reporting of Q fever is important to understand dis-
ease patterns, and to help distinguish natural outbreaks from inten-
tional release. Although Q fever was made nationally notifiable in
1999, little is known about the current prevalence or geographic
endemnicity of this disease in the United States. In order to assess
current diagnostic and reporting practices for Q fever, we sent a
questionnaire to 784 infectious disease consultants that were mem-
bers of the IDSA Emerging Infections Network (EIN). We
queried EIN members regarding diagnoses of Q fever made dur-
ing 2000, and whether they sought a diagnosis of Q fever for cases
with compatible clinical presentations, including pneumonia or
hepatitis of unknown etiology, and cases of culture-negative endo-
carditis. We also assessed members’ knowledge about the types of
laboratory tests that were available to them at different diagnostic
laboratories. Responses were received from 419 (53%) EIN mem-
bers. Twenty-four cases of Q fever were reported by 16 members
from 12 states during 2000, including 16 cases of acute Q fever and
8 cases of chronic Q fever. Members also reported encountering
over 3000 cases of pneumonia and over 1000 cases of hepatitis of
unknown etiology; most members (75%) tested less than 5% of
these cases for Q fever. EIN members also encountered 437 cases
of culture-negative endocarditis, of which 64% were tested for Q
fever. Serology was the most common laboratory test available to
members, and most (>50%) used commercial laboratories rather
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than state health department or hospital laboratories. Only 21 cases
of Q fever were reported to CDC through the National Electronic
Telecommunications System for Surveillance (NETSS) in 2000. At
least 18 of the cases identified through the EIN survey were not
reported to NETSS based on differences in reporting states. This
survey indicates that Q fever is under-reported in the United
States. Most EIN members surveyed did not routinely test cases of
pneumonia or hepatitis of unknown etiology for Q fever, even
though C. burnetii is sometimes associated with these syndromes.
Although C. burnetii is a proven cause of culture-negative endo-
carditis, one third of cases encountered during were not tested for
this agent. Furthermore, this survey indicates that at least 75% of
diagnosed cases go unreported to national authorities. Improved
recognition and reporting of Q fever by physicians will be impor-
tant to assist with national bioterrorism preparedness goals.
Emerging Zoonoses: A Novel Epizootic of Skunks Infected with
a Bat Variant of Rabies 
M. J. Leslie1, C. Hanlon2, J. Smith2, R. Rohde3, R. Cheshier1, C.
Rupprecht2
1Arizona Department of Health Services, Phoenix, AZ, 2Centers for
Disease Control and Prevention, Atlanta, GA, 3Texas Department of
Health, Austin, TX
In January 2001, a striped skunk (Mephitis mephitis), sub-
mitted from a residential area in Flagstaff, Arizona was confirmed
to be rabid. Historically, Flagstaff and the surrounding areas were
considered to have enzootic rabies virus activity in bats, but not ter-
restrial mammals. Due to the unusual location of this rabid animal,
tissues were sent to a regional reference laboratory at the Texas
Department of Health for antigenic variant identification.
Monoclonal antibody typing and genetic sequence analysis demon-
strated that the skunk was infected with a variant of rabies virus
associated with insectivorous bats. In the following six months, 18
additional skunks from Flagstaff were confirmed as infected with
the same rabies virus variant. Further analysis at the Centers for
Disease Control showed that rabies virus associated with bats was
present in the salivary glands of some of these skunks. A multi-
phased campaign was initiated in response to this novel outbreak
including active case surveillance, public awareness and education,
low cost pet vaccination clinics, and a trap, vaccinate and release
(TVR) program to attempt to control the epizootic. As of
December 1, 2001, more than 210 skunks trapped in Flagstaff
were parenterally vaccinated, eartagged and released. Surveillance
efforts continue to assess the extent of the epizootic as well as the
effectiveness of the TVR program. This epizootic represents the
first documented sustained transmission of a rabies virus variant
associated with insectivorous bats among terrestrial mammals. The
importance of exploring unusual disease events and the need to
develop new techniques to control rabies in wildlife are highlight-
ed along with the critical roles of public health laboratories, com-
munity rabies prevention programs, and collaboration among local,
state, federal and private entities.
Epidemiology of Raccoon and Skunk Rabies in the Eastern
United States 
M. A. Guerra, A. T. Curns, W. Ivy, III, C. A. Hanlon, C. E.
Rupprecht, J. W. Krebs, J. E. Childs
Viral and Rickettsial Zoonoses Branch, Division of Viral and
Rickettsial Diseases, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta, GA
Since 1981, an epizootic of raccoon rabies that began near
the Virginia/West Virginia border has spread through the eastern
US. Because of the close association of this species with the human
population, there is the possibility of an increased risk of rabies. In
several eastern states cases of rabies among skunks now outnumber
rabies cases in raccoons, which has raised concerns about the
emergence of an independent maintenance cycle of rabies virus in
skunks which would affect intervention strategies and control pro-
grams. The objectives of this study were to determine the tempo-
ral and spatial characteristics of rabies epizootics in raccoons and
skunks. These data were then used to investigate the evidence for
independent rabies virus cycling in skunk populations versus the
sporadic spillover of rabies infection from raccoons. Surveillance
data from 1981 through 2000 was obtained from the database
compiled yearly by CDC from health departments of Connecticut,
Delaware, Massachusetts, Maryland, North Carolina, New Jersey,
New York, Pennsylvania, Rhode Island, Virginia, and West
Virginia. The number of rabid raccoons and skunks submitted to
county health departments per month was used to construct coun-
ty-specific epizootic curves for time series analysis and to define
intervals of epizootic versus enzootic rabies in both species. The
first raccoon epizootic was significantly larger (median=40; range
4-785, p<0.05) than subsequent epizootics in raccoons, and also
significantly greater than the first skunk epizootic (median=10;
range 4-85, p<0.05). The size of subsequent epizootics among rac-
coons showed damped oscillations consistent with theoretical
models, while skunk epizootics appeared uniform. There was a
high degree of spatial correlation between epizootics in raccoons
and skunks in regions where the raccoon-associated variant of
rabies virus was enzootic. In several counties in Massachusetts and
Rhode Island, cases of skunk rabies outnumbered cases in raccoons
following the initial raccoon epizootic. However, in these counties
there was a significant cross-correlation between the numbers of
rabid raccoons and skunks. From our analysis we conclude that
skunk rabies is temporally and spatially correlated with raccoon
rabies in the eastern United States. The temporal patterning of
skunk rabies is different from raccoons, and also from the patterns
expected from theoretical models of rabies dynamics in raccoon
and fox populations. There is currently insufficient epidemiologic
and virologic data to conclude independent maintenance of rabies
virus among skunks in areas where the raccoon-associated variant
of rabies virus is enzootic. Future investigations need to assess
environmental factors, such as differences in habitat suitability and
population densities, and evidence of genetic changes in regional
rabies virus variants associated with adaptation to a new host.
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Three Outbreaks of E. coli O157 Infections Due to Retail
Ground Beef in Minnesota, 2000: Detection, Investigation, and
Characteristics 
K. Smith, E. Swanson, E. Wagstrom, F. Leano, D. Boxrud, J. Adams,
J. Besser, R. Danila, H. F. Hull
Minnesota Department of Health, Minneapolis, MN
Background: E. coli O157 (O157) is the primary cause of
hemolytic uremic syndrome (HUS) in the United States. Ground
beef is a major source of O157. This report summarizes three O157
outbreaks due to retail ground beef that occurred in Minnesota
during 2000. Methods: In Minnesota, clinical O157 isolates must
be submitted to the Minnesota Department of Health (MDH).
Isolates are subtyped by pulsed-field gel electrophoresis (PFGE)
in real time, and cases are interviewed about potential exposures,
including ground beef sources. If a temporal cluster of ≥5 cases
with an indistinguishable PFGE subtype is observed, a community
case-control study may be initiated if a common source is not
















the case’s telephone number are matched to each case by age.
Results: Outbreak 1 - Ten O157 isolates with the same PFGE sub-
type were submitted to MDH from 5 counties from December
1999 to February 2000. The median age of cases was 18 years
(range, 4 to 62 years). A case-control study implicated consumption
of ground beef from one chain of grocery stores (matched odds
ratio [MOR], 11.8; 95% confidence interval [CI], 1.5-93).
Outbreak 2 - In September 2000, MDH identified 3 O157 isolates
with the same PFGE subtype; all 3 cases had consumed the same
brand of ground beef patties; cultures of leftover patties from one
case household yielded the outbreak PFGE subtype of O157.
Outbreak 3 - During November 27-29, 2000 MDH identified 10
isolates of O157 with the same PFGE subtype. A case-control
study implicated consumption of ground beef from one chain of
grocery stores (MOR, 10.0; 95% CI, 1.0-434). Forty-two laborato-
ry-confirmed outbreak cases were ultimately identified from 14
counties. The median age of cases was 20 years (range, 1 to 87
years); 24 cases were hospitalized, 3 had HUS, and 2 had colec-
tomies. Twenty grocery stores were identified as sources of ground
beef for cases. Ground beef exposures for most cases were com-
prised of non-hamburger items (e.g., casseroles, spaghetti sauce).
O157 was isolated from ground beef from 3 case households, and
from 18 of 43 intact packages from 3 grocery stores. Positive
ground beef packages varied widely in weight and fat content.
Store grinding records implicated a single supplier, resulting in a
nationwide recall of 1.1 million pounds of ground beef.
Conclusions: Retail ground beef outbreaks are difficult to identi-
fy because cases may not be tightly clustered in time and space.
Strategies to enhance outbreak detection include real-time PFGE
subtyping of all O157 isolates, rapid interviewing of cases with
detailed questions about ground beef sources, community case-
control studies, and aggressive culturing of ground beef from case
households and retail sources. Contaminated ground beef from a
common source may be sold in numerous grocery stores, in pack-
ages of variable weight and fat content.
Epidemiology of Shiga Toxin-Producing Escherichia coli
(STEC) Infections in Connecticut, February 1, 2000 - 
January 31, 2001 
Q. Phan1, T. McCarthy2, P. Mshar1, C. Welles3, R. Howard3, T.
Rabatsky-Ehr4, J. L. Hadler1
1Connecticut Department of Public Health, Epidemiology Section,
Hartford, CT, 2Centers for Disease Control and Prevention, Atlanta,
GA, 3Connecticut Department of Public Health, Laboratory Division,
Hartford, CT, 4Connecticut Emerging Infections Program, Yale
University, New Haven, CT
Background: Infections with Shiga toxin-producing
Escherichia coli (STEC) are an important public health problem.
E. coli O157 is the most common STEC in the United States (US).
However, standard culture methods for E. coli O157 do not detect
non-O157 STEC. Studies in other countries suggest that disease
caused by non-O157 STEC is as prevalent as O157 STEC.
Recognizing that standard cultures do not detect non-O157 STEC,
some clinical laboratories in Connecticut have begun using tests to
detect Shiga-toxin directly rather than culture for E. coli O157. We
took advantage of the change in laboratory methods to character-
ize the prevalence and epidemiology of non-O157 STEC infection.
Methods: To determine the relative frequency of non-O157
STEC, we conducted statewide laboratory-based surveillance for
STEC at each of the 40 clinical microbiology laboratories in CT. As
part of reporting requirements, clinical laboratories submit O157
isolates or shiga-toxin positive broths depending on which test they
use to the State Laboratory for confirmation and further testing.
Laboratory audits were performed to ensure that all cases of STEC
were reported. To determine the spectrum of illness and risk fac-
tors for O157 and non-O157 STEC infections in Connecticut, we
interviewed patients with STEC from February 1, 2000 through
January 31, 2001. Differences between case-patients with non-
O157 and patients with O157 STEC were assessed. Results: From
February 1, 2000 through January 31, 2001, a total of 90 STEC
infections were reported: 61 were detected by laboratories that
culture for O157 and 29 were detected by laboratories that test
directly for Shiga toxin. Among STEC infections identified by
Shiga toxin testing only, 17 (59%) were found on subsequent test-
ing by the state laboratory to be O157 and 12 (41%) were non-
O157 STEC, comprising nine different serotypes. Overall, 78
O157 STEC and 12 non-O157 STEC were identified. Compared
with patients who had O157 infection, patients with non-O157
were less likely to have diarrhea (p=0.017) or bloody stool
(p=0.001), and were less likely to be hospitalized (p=0.005). No
differences in demographics, food, or other exposures were identi-
fied between patients with non-O157 and O157 STEC infection.
Conclusions: Based on results of Shiga toxin testing in
Connecticut, non-O157 STEC was detected nearly as often as
O157 STEC. Severity of illness caused by non-O157 STEC infec-
tion appears to be milder. Differences in risk factors between non-
O157 STEC and O157 were not identified. Clinicians evaluating
patients with diarrhea should consider infection with non-O157
STEC. Ongoing surveillance for both O157 and non-O157 STEC
is needed to better define the incidence and epidemiology of
STEC infections in Connecticut.
Microbiologic Testing to Identify Shiga Toxin-producing E. coli
in HUS Patients: FoodNet 1997-2001 
C. R. Braden1, J. C. Lay1, E. Boothe2, D. J. Vugia3, N. Dumas4, B.
Shiferaw5, E. Wagstrom6, S. Tong7, S. Burnite8, S. M. Thomas9, S.
Hurd10, and the EIP FoodNet Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA, 2Tennessee
Department of Health, Nashville, TN, 3California Department of
Health Services, Berkeley, CA, 4New York State Department of
Health, Albany, NY, 5Oregon Department of Human Services,
Portland, OR, 6Minnesota Department of Health, Minneapolis, MN,
7Maryland Department of Health and Mental Hygiene, Baltimore,
MD, 8Colorado Department of Public Health and Environment,
Denver, CO, 9Georgia Division of Public Health, Baltimore, MD,
10Connecticut Emerging Infections Program, Yale University, New
Haven, CT
Background: Hemolytic uremic syndrome (HUS) is a life
threatening illness characterized by hemolytic anemia, thrombocy-
topenia, and acute renal failure. In developed countries, nearly all
cases of HUS in children are caused by infection with Shiga toxin-
producing E. coli (STEC), of which the most well known serotype
is O157:H7. E. coli O157:H7 may be identified by the characteris-
tic color of its colonies on Sorbitol-McConkey agar (SMAC). Other
serotypes may be responsible for a portion of HUS cases, but their
isolation from stool specimens is difficult since they do not share
this distinguishing characteristic. With the advent EIA and PCR
tests for Shiga toxin, and the potential for human serology to iden-
tify antibodies to STEC in HUS cases, the etiology of STEC in
HUS may be better understood. Methods: Since 1997, HUS sur-
veillance has been part of CDC’s Foodborne Diseases Active
Surveillance Network (FoodNet) at all sites (California, Colorado,
Connecticut, Georgia, Maryland, Minnesota, New York,
Tennessee, Oregon). Pediatric nephrologists in catchment areas for
sites were contacted at least monthly for surveillance. Adult cases
are reported in a passive system, as are cases outside of catchment
areas. Case information is collected using standard medical and
microbiologic record abstraction forms. Results: From 1997
through October, 2001, 322 cases of HUS were reported. The aver-
age incidence among sites was 0.2 per 100,000 population, with a
range from 0.04 to 0.5. There were a total of 25 deaths (8%). Of
288 cases for which information was available, microbiologic test-
ing identified STEC for 169 cases (59%). The proportion of cases
with an STEC isolate identified increased from 38% in 1997 to
64% in 2000. All but 2 STEC identified were serotype O157:H7.
Among all cases, 97% had stool cultured on SMAC and 38% had
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stool tested for Shiga-toxin. Among cases without STEC identified,
only 24% had Shiga toxin testing done. This proportion increased
from 5% in 1997 to 47% in 2000. A total of 21 cases had STEC
serology done to identify anti- O157, O111 or O126 antibody; 10
cases (48%) had detectable antibody to O157. No antibody against
non-O157 STEC serotypes was detected among these cases.
Conclusion: E. coli O157 causes the majority of pediatric HUS
cases: the proportion caused by other STEC is uncertain. To
determine the etiology of HUS in the United States, a complete
microbiologic assessment should be conducted. Although SMAC
culture is done for high proportion of cases, serotype indiscrimi-
nate tests for Shiga-toxin was conducted for only a minority of
cases. Increased efforts by clinicians and clinical laboratories to
conduct complete STEC testing will aid the specific diagnosis.
Serologic testing for antibodies against the major STEC serotypes
may be helpful if microbiologic tests are not done or negative.
Risk Factors for Sporadic Escherichia coli O157 Infections in
the United States: a Case-control Study in FoodNet Sites,
1999-2000 
M. H. Kennedy1, T. Rabatsky-Ehr2, S. M. Thomas3, S. Lance-Parker3,
J. Mohle-Boetani4, K. Smith5, W. Keene6, P. Sparling7, F. P. Hardnett1,
P. S. Mead1, and the EIP FoodNet Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA,
2Connecticut Emerging Infections Program, Yale University, New
Haven, CT, 3Georgia Division of Public Health, Atlanta, GA,
4California Department of Health Services, San Francisco, CA,
5Minnesota Department of Health, Minneapolis, MN, 6Oregon
Department of Human Services, Portland, OR, 7USDA, Food Safety
and Inspection Service, Washington, DC
Background: Escherichia coli O157 (E. coli O157) infec-
tions can cause severe gastrointestinal illness, characterized by
abdominal cramps and profuse, often bloody, diarrhea. In the
United States, E. coli O157 infections cause an estimated 62,000
foodborne illnesses, 1,800 hospitalizations and 50 deaths each year.
To identify new risk factors for illness and collect more information
on previously identified risk factors, we conducted a matched case-
control study of sporadic E. coli O157 infections in 1999-2000.
Methods: Culture-confirmed E. coli O157 cases were
identified through active laboratory surveillance in 7 sites
(California, Connecticut, Georgia, Minnesota, Maryland, New
York, Oregon) as part of the CDC’s Foodborne Diseases Active
Surveillance Network (FoodNet). Age-matched controls were
interviewed for each case within 7 days of the matched-case inter-
view. Interviews were conducted by telephone using sequential
digit dialing and a standardized questionnaire. Information was
collected on demographics, clinical illness, and exposures (e.g.,
food, water, animal contact) in the 7 days before the case’s onset.
Results: Between February 1999 and April 2000, 326 cases and
591 matched controls were enrolled. In preliminary univariate
analysis, infection was associated with eating pink hamburgers in
the home (mOR=2.2, 95% CI= 1.2-4.3), thawing ground beef in
microwave (mOR=1.5, 95% CI= 1.0-2.2), swimming in a pond,
lake, river, or stream with cattle nearby (mOR=15.8, 95% CI=1.9-
127.7), drinking pond, lake, river or stream water (mOR=3.5, 95%
CI= 1.6-7.6), drinking from water fountains or pool water
(mOR=3.5, 95% CI= 1.5-8.2), living on a farm (mOR=1.9, 95%
CI= 1.1-3.4), and visiting a farm <12 times a year (mOR=3.0, 95%
CI= 1.1-8.5). Consumption of ground turkey, pork chops or roast
pork, organic produce, bottled water, or any of 12 produce items
(romaine lettuce, red leaf lettuce, raw cabbage, onions, broccoli,
carrots, cantaloupe, honeydew, strawberries, watermelon, apples,
parsley, cilantro) had odds ratios of less than one. Conclusions:
Preliminary analysis indicates undercooked ground beef, surface
waters, and farms continue to be sources of sporadic E. coli O157
infections in the United States. However, unlike previous case-con-
trol studies, infections were not associated with restaurant con-
sumption of undercooked ground beef, possibly reflecting
improvements in restaurant handling of ground beef or changes in
eating habits. Consumption of several produce items was negative-
ly associated with E. coli O157 infections. Final interpretation
awaits multivariate analysis.
Re-Estimating the Global Burden of Typhoid Fever 
J. A. Crump, S. P. Luby, E. D. Mintz
Centers for Disease Control and Prevention, Atlanta, GA
Background: Reliable disease burden information is nec-
essary to guide health policy decisions. Typhoid fever is common in
the developing world, where surveillance data are extremely limit-
ed because the nonspecific clinical presentation of typhoid fever
limits the value of syndrome-based surveillance and modern labo-
ratory methods including blood culture are frequently not available
to confirm infection. In 1986, a global estimate was 16 million ill-
nesses and 600,000 deaths annually. We developed a method for
refining this estimate. Methods: We reviewed the literature for
population-based studies of typhoid fever incidence, complica-
tions, and mortality. Because studies of typhoid fever incidence
frequently used age cohorts, we developed and used age-specific
incidence curves for typhoid fever at various levels of endemicity
to extrapolate incidence rates from age cohorts to other age
groups within populations. Where countries lacked reliable
typhoid fever incidence data, we extrapolated from neighboring
countries within the regions that experience similar socioeconom-
ic conditions. The regional, age-stratified, year 2000 population
estimates of the United Nations Sex and Age Distribution of the
World Populations were used to derive total annual cases from
incidence data. Morbidity and mortality estimates were made
from published series. Results: We found 22 population-based
typhoid incidence studies from which extrapolations within
regions could be made to develop a new estimate of the global
typhoid fever burden. These were predominantly vaccine studies,
or population-based studies designed specifically to measure
typhoid incidence. We found that high typhoid fever incidence
(>100/100,000/year) regions include south-central Asia and south-
east Asia. Medium incidence (10-100/100,000/year) regions
include the rest of Asia, Africa, Latin America and the Caribbean,
and Oceania except for Australia and New Zealand. Europe,
North America, and the rest of the developed world enjoy low
typhoid fever incidence (<10/100,000/year). Overall, our model
yields an estimate of the global typhoid fever disease burden of 11
million illnesses and 110,000 deaths. Conclusions: New data and
improved understanding of typhoid fever epidemiology allowed us
to further refine the global typhoid burden estimate. Using these,
we find that typhoid fever remains a major global health burden.
More detailed incidence studies in selected countries and regions
are needed to further improve the estimate.
Yersinia enterocolitica Surveillance in Minnesota 
J. Scheftel1, J. Bender2, F. Leano1, D. Boxrud1, K. Smith1
1Minnesota Department of Health, Minneapolis, MN, 2University of
Minnesota College of Veterinary Medicine, Saint Paul, MN
Background: Yersinia enterocolitica is an important cause
of acute febrile enteritis, accounting for an estimated 96,000 cases
annually in the U.S. Y. enterocolitica is ubiquitous; human patho-
genic strains have been associated with defined bioserogroups.
Methods: To improve our understanding of yersiniosis in
Minnesota, we reviewed the clinical histories of Y. enterocolitica
cases reported to the Minnesota Department of Health (MDH)
from 1995 to 2000. We characterized Y. enterocolitica isolates by
biotype and pulsed-field gel electrophoresis (PFGE). From the
FoodNet Survey of Clinical Laboratory Practices 2000, we evaluat-
ed laboratory practices for enteric culture that might affect sur-
veillance for Yersinia in Minnesota. Results: There were 151 cases
of Y. enterocolitica reported to MDH from 1995 to 2000. The
















59% of cases resided outside the Minneapolis-St. Paul (Twin
Cities) metropolitan area. Thirty (22%) of 136 patients with known
status were hospitalized for a mean of 8.2 days (range, 1-33 days).
Of 126 Y. enterocolitica isolates submitted to MDH, 52 (41%) were
classified as pathogenic biotypes, and 74 (59%) were classified as
non-pathogenic biotypes based on pre-existing literature. Reported
symptoms and length of hospitalization were similar for cases
whether isolates were characterized as pathogenic or non-patho-
genic. Thirty-eight (75%) of 51 pathogenic isolates subtyped were
represented by one of five closely related PFGE patterns. All 74 of
the non-pathogenic isolates were biotype 1A, and all 74 had differ-
ent PFGE patterns. Of 61 Minnesota laboratories responding to
the Yersinia section of the laboratory survey, 33 (54%) routinely
test for Yersinia as part of their enteric screen. Only two of 28 Twin
Cities metropolitan area laboratories that handle enteric samples
test for Yersinia; 31 of 33 laboratories that test for Yersinia are
located outside the Twin Cities metropolitan area in small city or
county hospitals. Overall, the number of stool samples tested for
Yersinia, both as part of enteric screens and specific physician
requests, was 15,229 (21%) of 71,735 stool samples submitted for
culture. Conclusion: Case-patients with yersiniosis in Minnesota
had similar clinical illness regardless of whether their Y. enterocol-
itica isolates were classified as pathogenic or non-pathogenic based
on biotype; isolates classified as non-pathogenic accounted for 59%
of all isolates submitted during 1995-2000. Therefore, the clinical
significance of putative non-pathogenic strains of Y. enterocolitica
warrants further investigation. Survey of laboratory testing prac-
tices in Minnesota indicated that a minority of stool samples sub-
mitted for enteric culture were tested for Yersinia; thus, yersiniosis
may be substantially under-diagnosed in Minnesota.
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Randomized Trial of Day Care Staff Education to Improve
Parent Knowledge and Attitudes Regarding Appropriate
Antibiotic Use. 
D. R. Croft1, E. Belongia2, M. Knobloch2, P. Chyou2, R. Besser3, J. P.
Davis4
1Wisconsin Division of Public Health and the Centers for Disease
Control and Prevention, Madison, WI, 2Marshfield Medical Research
Foundation, Marshfield, WI, 3Centers for Disease Control and
Prevention, Atlanta, GA, 4Wisconsin Division of Public Health,
Madison, WI
Background: Antimicrobial resistance is an emerging pub-
lic health problem and has focused attention on the importance of
appropriate antibiotic use. Approximately 45% of children with a
common cold who present to healthcare providers receive antibi-
otics inappropriately. Children in day care have frequent viral res-
piratory illnesses and parent education might reduce demand for
antibiotics. We conducted a group-randomized trial to determine if
presentations and materials for day care staff promote improved
knowledge and attitudes among parents. Methods: Day care cen-
ters with capacity of 50 to 70 children were randomly selected from
a database of all licensed facilities in Wisconsin. They were
assigned to the intervention or control group and recruited sequen-
tially until 300 households were represented per group based on
information from the day care centers. Workers in intervention
centers received a presentation about appropriate antibiotic use
along with parent education materials. All centers subsequently
distributed a self-administered survey to parents of children <5
years old. The survey asked questions about knowledge and atti-
tudes of antibiotic use, resistance, and demand. One parent or
guardian per household was requested to complete the survey. The
data were analyzed using univariate, stratified, and multivariate
analyses to control for confounding. Results: Six intervention cen-
ters and nine control centers participated and distributed the sur-
vey. Surveys were returned by 150 (50%) of 298 of parents at inter-
vention centers and 150 (42%) of 361 parents at control centers.
The mean age was 32 years in each group; intervention center par-
ents were significantly more likely to be non-Hispanic white, col-
lege graduates, and insured. Analysis stratified by education level
revealed that the college-educated intervention group parents cor-
rectly answered the nine knowledge questions more often than col-
lege-educated control group parents (> median) was significantly
associated with white race (p=0.02) and being a college graduate
(p=0.02) after adjusting for the design effect of day care clusters.
There was a borderline association between a high knowledge
score and the intervention group after adjusting for the design
effect (p=0.06). There were no significant differences in attitudes
of appropriate antibiotic use between the intervention and control
groups. Conclusions: Presentations and distribution of education-
al materials to day care staff promote improved knowledge among
parents of children <5 years old, particularly among more highly
educated parents. Changing attitudes and beliefs might require
more sustained or multifaceted interventions.
Quinupristin/Dalfopristin-Resistant Enterococcus faecium
Isolated from Human Stools, Retail Chicken, and Retail Pork:
EIP Enterococci Project 
K. Gay, K. Joyce, J. E. Stevenson, F. J. Angulo, T. Barrett, and the
NARMS Working Group
Centers for Disease Control and Prevention, Atlanta, GA
Background: With the emergence of vancomycin-resistant
Enterococcus faecium, quinupristin/dalfopristin (Q/D) has become
an important therapeutic for life-threatening enterococcal infec-
tions. Q/D was approved for human use in 1999. However, virgini-
amycin, a Q/D analogue, has been used in food animals since 1974.
Methods: Between July 1998 and June 1999, laboratories in
Georgia, Maryland, Minnesota, and Oregon used gram-positive
selective media (CNA agar) to culture human stools from outpa-
tients submitted to public health laboratories for other diagnostic
reasons (n=334) and from chickens purchased from grocery stores
(n=407). From July 1999 until June 2000 Michigan was added to
the study and culture of pork samples (n=585) replaced chicken.
Enterococcus isolates were forwarded to CDC for antimicrobial
susceptibility testing by broth microdilution and Q/D-resistant iso-
lates (MIC ≥ 4 µg/ml) were speciated by biochemical testing.
Results: We examined enterococci isolates isolated from outpa-
tients (n=286), retail chicken (n=984) and retail pork (n=897). Of
119 Q/D-resistant enterococci isolates isolated from humans, 3
(2%) were determined to be E. faecium. All 3 of the Q/D-resistant
human E. faecium isolates had MICs for gentamicin < 250 µg/ml.
Of 740 Q/D-resistant enterococci isolates isolated from retail
chicken, 299 (40%) were E. faecium. Among the 299 Q/D-resistant
E. faecium isolates from chicken, 80 (27%) had MICs for gentam-
icin ≥ 1000 µg/ml. Q/D resistance was found in 348 of the entero-
cocci isolates isolated from pork. Of the 348 Q/D-resistant pork
isolates, 7 (2%) were E. faecium. One of the Q/D-resistant pork E.
faecium isolates had a MIC for gentamicin ≥ 1000 µg/ml; the other
6 had MICs < 64 µg/ml. Conclusion: Q/D-resistant E. faecium are
more common in retail chicken than pork and human populations.
Isolates from retail chickens are more likely than Q/D-resistant E.
faecium from pork or human stools to also express high-level gen-
tamicin resistance. Q/D-resistant E. faecium from retail chicken
could potentially colonize humans, posing a serious threat to pub-
lic health. The possibility that genetic determinants for Q/D resist-
ance could be transferred from retail chicken and pork to human
enterococcal isolates will be explored further.
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Antimicrobial Resistance in Salmonella Serotype Typhimurium,
R-Type ACSSuT, is Associated with Bacteremia: NARMS
1996-2000 
K. Molbak1, J. K. Varma2, S. Rossiter2, J. C. Lay2, K. Joyce2, K.
Stamey2, F. J. Angulo2, and the NARMS Working Group2
1Statens Serum Institut, Copenhagen, DENMARK, 2Centers for
Disease Control and Prevention, Atlanta, GA
Background: Antimicrobial resistance in Salmonella
increased during the 1990s, particularly amongst the most common
serotype, S. Typhimurium. Multidrug-resistant S. Typhimurium
phage type DT104, which usually is resistant to five drugs: ampi-
cillin, chloramphenicol, streptomycin, sulfonamides, and tetracy-
cline (R-type ACSSuT) is the most prevalent strain among S.
Typhimurium. Methods: After serotyping, public health laborato-
ries at 17 sites forward every 10th non-typhoidal Salmonella isolate
to the National Antimicrobial Resistance Monitoring System
(NARMS) for Enteric Bacteria. NARMS performs susceptibility
testing for 14 antimicrobials, using broth microdilution according
to NCCLS standards. Results: In 1996-2000, 1,513 (23%) of 6,670
isolates were serotype Typhimurium; of which 95% were from
stool and 5% from blood. The median age of patients with S.
Typhimurium from stool was 9 years (interquartile range 3-33
years) and from blood 42 years (interquartile range 32-63 years).
Of the 1,513 isolates, 818 (54%) were resistant to ≥ 1 agent; 6%
(53) of resistant isolates were from blood compared with 3% (21)
of pan-susceptible isolates (OR 2.2; 95% CI 1.3 to 3.7). 462 (31%)
isolates were R-type ACSSuT; 7% (33) were from blood compared
with 3% of pan-susceptible (OR 2.5; 95% CI 1.5 to 4.5). Adjusting
for age in a multivariable logistic regression model, R-type
ACSSuT was 2.5 times (95% CI 1.3 to 4.6) more likely to be from
blood, and resistant isolates other than R-type ACSSuT isolates
were 1.7 times (95% CI 0.9 to 3.5) more likely to be from blood
than pan-susceptible strains. Conclusions: Antimicrobial resist-
ance in S. Typhimurium, particularly R-type ACSSuT, is associated
with an increased risk of bacteremia. Further studies are needed to
confirm this increased invasiveness and determine the potential
biological mechanisms.
Antimicrobial Resistance in Salmonella is Associated with
Increased Hospitalization:NARMS 1996-2000 
J. K. Varma1, K. Mølbak2, S. Rossiter1, M. A. Hawkins3, T. F. Jones4,
S. H. Mauvais5, T. Rabatsky-Ehr6, S. Stenzel7, D. J. Vugia8, M. Park9,
K. Joyce1, K. Stamey1, H. Chang10, F. J. Angulo1, and the EIP
FoodNet Working Group1
1Centers for Disease Control and Prevention, Atlanta, GA, 2Staten
Serum Institut, Copenhagen, DENMARK, 3University of Maryland
School of Medicine, Baltimore, MD, 4Tennessee Department of
Health, Nashville, TN, 5Oregon Department of Human Services,
Portland, OR, 6Connecticut Emerging Infections Program, Yale
University, New Haven, CT, 7Minnesota Department of Health,
Minneapolis, MN, 8California Department of Health Services,
Berkeley, CA, 9Georgia Division of Public Health, Atlanta, GA,
10New York State Department of Health, Albany, NY
Background: Non-Typhoidal Salmonella is a leading cause
of foodborne illness, and the prevalence of antimicrobial resistance
has increased. Few studies have explored the human health conse-
quences, other than treatment failures, associated with increasing
resistance among Salmonella. Methods: The Foodborne Diseases
Active Surveillance Network (FoodNet) has conducted laboratory-
based surveillance for Salmonella since 1996. In 2000, nine sites,
representing 11% of the U.S. population, completed case reports
on all Salmonella infections confirmed at one of the >400 labora-
tories in surveillance. Case reports included hospitalization status
at the time of culture collection or up to seven days later. Clinical
laboratories send isolates for serotyping to public health laborato-
ries, which forward every 10th non-Typhoidal Salmonella to the
National Antimicrobial Resistance Monitoring System (NARMS).
NARMS performs susceptibility testing via broth microdilution
using NCCLS standards for 14 antimicrobials. We linked suscepti-
bility results from NARMS to FoodNet case reports. Results:
From 1996-2000, 15,653 cases of non-Typhoidal Salmonella were
reported in FoodNet sites, and 1020 (7%) of these reports had
both data on hospitalization and NARMS susceptibility results. Of
these, 557 (55%) patients were female, and 163 (16%) were non-
white. The median age was 25 years (inter-quartile range 5 to 42).
The most common serotypes were Typhimurium (29%) and
Enteritidis (19%). Isolates came from blood in 68 (7%), and hospi-
talization occurred in 238 (23%). Resistance to antimicrobials com-
monly used to treat Salmonella (cephalosporins, quinolones, or
aminoglycosides) was found in 63 patients, 22 (35%) of whom were
hospitalized. Patients with isolates resistant to one of these agents
had a higher risk of hospitalization compared to patients with iso-
lates susceptible to these agents (OR 1.8, 95% CI 1.1-3.2). Other
risk factors for hospitalization included age, race, surveillance site,
serotype, and bloodstream infection. After controlling for these
factors in multivariate analysis, the association between resistance
to one of these agents and hospitalization persisted (OR 2.0, 95%
CI 1.1-3.7). Hospitalization also occurred more frequently in
patients with isolates resistant to any antimicrobial, compared to
those with pan-susceptible isolates (OR 1.5, 95% CI 1.0-2.2).
Conclusions: Antimicrobial-resistant Salmonella infections were
associated with an increased risk of hospitalization, particularly
when isolates were resistant to commonly used agents. Given the
limited number of patients studied, further research should
explore factors that may have contributed to increased hospitaliza-
tion, including failure of empiric antimicrobial therapy, increased
co-morbidity among patients infected with resistant bacteria, and
increased virulence of resistant Salmonella.
Emerging Fluoroquinolone Resistance among Non-Typhoidal
Salmonella in the United States: NARMS 1996-2000 
S. Rossiter, J. McClellan, T. Barrett, K. Joyce, A. D. Anderson, and
the NARMS Working Group
Centers for Disease Control and Prevention, Atlanta, GA
Background: Fluoroquinolones (e.g., ciprofloxacin) com-
monly are used for treating Salmonella infections in adults; fluoro-
quinolones (e.g. enrofloxacin) also are used in cattle, chickens, and
turkeys in the United States. Among Salmonella, cross-resistance
occurs for all fluoroquinolones and usually arises from accumula-
tion of two mutations in the gyrA gene. A single mutation of the
gyrA gene confers decreased susceptibility to fluoroquinolones and
has been associated with treatment failures. Methods: The
National Antimicrobial Resistance Monitoring System (NARMS)
for Enteric Bacteria was established in 1996 to monitor antimicro-
bial resistance in Salmonella and other enteric bacteria. After
serotyping, public health laboratories in the 17 NARMS participat-
ing sites forwarded every tenth non-typhoidal Salmonella isolate to
CDC for susceptibility testing to ciprofloxacin and 16 other antimi-
crobial agents using broth microdilution (Sensititre®) according to
NCCLS standards. Patients with isolates exhibiting decreased sus-
ceptibility (MIC ≥ 0.25 µ?g/ml) to ciprofloxacin, including
ciprofloxacin resistance (MIC ≥ 4 µg/ml), were interviewed.
Results: From 1996-2000, 57 (0.8%) of 6970 non-typhoidal
Salmonella isolates tested demonstrated decreased susceptibility to
ciprofloxacin. The percent of isolates that demonstrate decreased
susceptibility to fluoroquinolones was 0.4% (5/1326) in 1996 and
1.4% (20/1378) in 2000. Seven (0.1%) of these isolates were
ciprofloxacin-resistant (MIC ≥ 4 µg/ml) and included serotype
Senftenberg (n = 3), Schwarzengrund (n = 3), and Indiana (n = 1).
All 7 infections were associated with international travel. Of the 50
isolates with ciprofloxacin MICs ≥ 0.25 µg/ml and < 4 µg/ml, the
most common serotypes were Enteritidis (n = 14), Berta (n = 7),
Typhimurium (n = 6), and Virchow (n = 5). Twenty-eight (56%) of
these 50 patients were interviewed; 20 (71%) of the 28 patients
















onset. Conclusion: Emerging fluoroquinolone resistance in non-
typhoidal Salmonella is evident. Resistant isolates were associated
with international travel, whereas other isolates with decreased
susceptibility were from infections acquired domestically. The
sources of infection were not investigated, but many presumably
were acquired through eating contaminated food. Mitigation
efforts in partnership with the agricultural and veterinary commu-
nities are needed to limit use of fluoroquinolones and to preserve
the efficacy of this commonly used antimicrobial agent.
Prevalence of Salmonella spp. and Campylobacter spp.
Following the Discontinued Use of Antimicrobial Growth
Promoters in Broilers and Swine in Denmark 
M. C. Evans, H. C. Wegener
Danish Zoonosis Centre, Danish Veterinary Institute, Copenhagen V,
DENMARK
Introduction: Previous studies have suggested that the use of
antibiotics in food-producing animals may affect pathogen shed-
ding, causing either an increase or decrease in pathogen load. In
1998, the food animal industries in Denmark decided to stop the
use of antibiotics for growth promotion in food animals by the end
of 1999. We examined the effect of discontinued use on pathogen
load by comparing the mean prevalence of Salmonella and
Campylobacter in broiler flocks and swine herds before and after
the withdrawal of antimicrobial growth promoters in Danish food
animal production.
Methods: Broiler flocks were examined for Salmonella 3
weeks prior to slaughter by sock samples and after slaughter by
neck-skin samples. Campylobacter in broilers was measured by
cloacal swab samples of ten birds per flock at slaughter. Salmonella
in swineherds was monitored by serological testing of meat juice
samples. Herds were then classified into levels 1, 2 or 3 with level
1 herds having no or few sero-reactors and level 3 herds having a
high level of sero-reactors. Salmonella in pork was measured by
monthly slaughterhouse samples. A t-test for comparisons of
means was performed using SAS Version 8.0. Equal time periods
were used for comparisons, however periods varied between
pathogen and animal species. 
Results: Salmonella in broilers: The mean percent of flocks
testing positive during period 1 (before withdrawal) was 14.4
(range: 3.7-33.6) for ante-mortem examination and 17 (range: 8.1-
38.8) for post-mortem. Period 2 samples averaged 2.4 (range: 0.2-
5.8) and 4.9 (range: 0.7-24.9) respectively. A comparisons of means
showed that period 2 (after withdrawal) was significantly lower for
both ante-mortem (p<0.0001) and post-mortem samples
(p<0.0001).   Campylobacter in broilers: The percentage of posi-
tive flocks during period 1 was 35.3 (11.4-64.8) and period 2 was
40.8 (18-77). There was no difference in the means (p=0.2470).
Salmonella in pigs: The percentage of herds classified as level 2 or
3 during period 1 was 5 (4.2-6.2) and 3.3 (2.5-4.4) for period 2. A
comparisons of means showed that period 2 was significantly lower
(p<0.0001).  Salmonella in pork: The percentage of positive sam-
ples at slaughter was 1.1 (0.5-1.8) for period 1 compared with 0.8
(0.4-1.5) for period 2. A comparisons of means showed that period
2 was significantly lower (p=0.0290). 
Conclusion: Contrary to producer concerns that the discon-
tinued use of antibiotics would lead to an increase in pathogen
shedding, our study showed that there was a significant decrease in
the levels of Salmonella in broilers and swine, and no change in the
prevalence of Campylobacter in broilers or Salmonella in fresh
pork. Although it is likely that the decreases are mainly due to suc-
cessful control programs and better sampling methods, we cannot
discount the effect that the removal of growth promoters may play.
Additional research and more in-depth analysis are needed to fully
explain the observed effects.
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A Greenhouse Study to Model Potential Field Use of
Genetically Modified Bacterial Symbionts for Chagas Disease
Control 
P. Sen1,2, E. M. Dotson1, A. Betz1, J. Anderson1, G. Groner1, O.
Kruglov3, R. V. Durvasula3, C. B. Beard1
1Centers for Disease Control and Prevention, Atlanta, GA,
2Association of Public Health Laboratories, Washington, DC, 3Yale
University School of Medicine, New Haven, CT
Chagas disease, a parasitic disease caused by the protozoan
Trypanosoma cruzi and transmitted by triatomine bugs, affects 16-
18 million people annually in Central and South America. While
Chagas disease control strategies have primarily focused on the
elimination of vector populations through insecticide spraying,
drawbacks to this control method include the development of
insecticide resistance, environmental hazards, as well as general
issues concerning the sustainability and practicality of continual
spraying. In exploring alternate possibilities for control measures,
we have looked to genetic modification of the bacterial symbionts
found in the gut of the triatomine bugs. These symbionts, which
are transferred between bugs by coprophagy, are essential for
growth and reproduction of the insects. In the vector-symbiont
intervention (VSI) project, we genetically modified Rhodococcus
rhodnii, a bacterial symbiont of the Chagas disease vector
Rhodnius prolixus, to express genes whose products render the tri-
atomine bug incapable of transmitting the disease. We also have
developed a formulation of these genetically modified (GM) bac-
teria (CRUZIGUARD) that would enable introduction and spread
of the GM bacteria into natural insect populations, thereby serving
as a novel and potentially effective way to prevent disease trans-
mission. In previous laboratory studies, we have shown that the
bugs can easily acquire the GM symbionts and that these sym-
bionts are stable within the bug, allow for normal development of
the bug, and can reduce or eliminate the T. cruzi from the gut of
the bug. In the current study, we have designed and executed a
simulated field study inside a reed hut (dimensions 6 feet x 6 feet
x 6 feet), enclosed within a double-containment tent system inside
a greenhouse. Thirty-six R. prolixus females containing native bac-
teria were released in the hut and allowed to lay eggs. After the
eggs hatched, CRUZIGUARD prepared with Rhodococcus rhodnii
genetically modified to contain only the marker gene LacZ, was
applied to the hut. Bugs were removed from the hut on four dif-
ferent occasions, at approximately one-month intervals, and the
midguts were assayed at various instars for bacteria. Of the 67 bugs
assayed to date, 38 (56.7%) contained transformed R. rhodnii, and
24 (35.8%) contained the native form of these symbiont bacteria.
Three bugs harbored Gordona, another native bacterial symbiont
of R. prolixus, and no bacterial isolates were obtained from two
early instars. In addition to the midgut assays, we concurrently
assayed the CRUZIGUARD each week in order to determine its
viability as a function of time. Over a 5-month period, approxi-
mately one log reduction of the bacteria was noted. Observations
were made on various ways of improving efficiency of preferential
uptake of the GM symbionts. These initial results, however, are
considered to be very positive.
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Ecological Niche Modeling and Differentiation of Populations
of Triatoma brasiliensis Neiva, 1911, the Most Important
Chagas Disease Vector in Northeastern Brazil (Hemiptera,
Reduviidae, Triatominae) 
J. Costa1, A. Townsend Peterson2, C. Ben Beard1
1Centers for Disease Control and Prevention, Atlanta, GA, 2The
University of Kansas, Lawrence, KS
Ecological niche modeling has allowed numerous advances
in understanding the geographic ecology of species, including dis-
tributional predictions, distributional change and invasion, and
assessment of ecological differences. We used this tool to charac-
terize ecological differentiation of Triatoma brasiliensis popula-
tions, the most important Chagas disease vector in northeastern
Brazil. The species’ ecological niche was modeled based on data
from the Fundação Nacional de Saúde of Brazil (1997-1999) with
the Genetic Algorithm for Rule Set Prediction (GARP). This
method involves a machine-learning approach to detecting associ-
ations between occurrence points and ecological characteristics of
regions. Four independent ’ecological niche models’ were devel-
oped and used to test for ecological differences among T. brasilien-
sis populations (brasiliensis, macromelasoma, juazeiro and melani-
ca). These four populations can be distinguished on the basis of
patterns of coloration. These differences are also reflected in mor-
phological, ecological, and genetic variation. These models con-
firmed four ecologically distinct and differentiated populations,
and allowed characterization of dimensions of niche differentia-
tion. Patterns of ecological similarity matched patterns of molecu-
lar genetic distances, suggesting that “T. brasiliensis” is a complex
of distinct populations at various points in the process of speciation.
The brasiliensis population was best able to predict the distribu-
tions of the other populations. Interestingly, ecological similarity
was not symmetric — brasiliensis predicts macromelasoma and
juazeiro very well (0.87), yet the converse was not true (0.44 and
0.51). The distribution of melanica was poorly predicted by other
populations (0.38, 0,10 and 0.21), and melanica was little able to
predict other populations. Because of the remarkably widest niche
model observed for brasiliensis population it is possible that this
population also presents the highest potential to invade new areas.
Application of GARP modeling technology in understanding
species’ distributions in geographic and ecological space is rela-
tively new, and yet increasingly supported by rigorous empirical
tests. This paper represents a first application in the field of epi-
demiology and disease transmission. Future analyses will approach
the challenges of predicting dispersal potential for this species,
changes to be expected as a part of climate change, and transitions
between sylvatic and domestic distributional situations for Chagas
disease vectors.
In vivo Sensitivity of Plasmodium falciparum to Chloroquine
and Sulfadoxine/Pyrimethamine During an Outbreak of
Malaria in Burundi, 2001 
F. Dantoine
EPICENTRE, Paris, FRANCE
Introduction: A major outbreak of Plasmodium falci-
parum (Pf) malaria erupted in Burundi in September 2000.
Immediately, suspicions were raised about the clinical efficacy of
the antimalarial drugs of reference used in the country, namely
chloroquine (CQ, first-line drug) and sulfadoxine/pyrimethamine
(SP, second-line drug). This malaria epidemic led to thousands of
deaths between September 2000 and May 2001. In this context,
the objective of the in vivo sensitivity studies was to estimate the
efficacy of CQ and SP and of the combination CQ+SP in the treat-
ment of uncomplicated Pf malaria in the provinces of Kayanza and
Karuzi.
Methods: The protocol was adapted from the World
Health Organization protocol for areas of intense transmission.
Children 6 to 59 months old were recruited in health centres, and
classified as therapeutic failures or adequate responders according
to both clinical and parasitological criteria. Follow-up was of 14
days in Kayanza and of 28 days in Karuzi.
Results: The studies were conducted between January and
April 2001. Overall, 465 children were included. Age, mean para-
sitaemia and temperature on inclusion were similar among the
groups. The CQ parasitological failure rates (PFR) at day 14 were
100% and 97·8% [86·8 - 99·9] in Kayanza and Karuzi respectively.
With SP, PFR at day 14 were 73·7% [64·7 - 81·2] and 89·7% [80·8
- 94·9] in Kayanza and Karuzi respectively. The PFR of patients
treated with SP rose to 96·1% [90·4 - 98·9] when followed until day
28. Finally, among 119 patients treated with CQ+SP, PFR at day 14
was 54·8 % [44·8 - 64·5].
Discussion: The high levels of resistance to CQ and SP
observed in Burundi raise questions about the use of these drugs
during the malaria epidemic in this country. Efforts were made
during and after the outbreak to resort to more effective com-
pounds, like combinations of antimalarials including an artemisinin
derivatives. Future policies for treatment of malaria in Africa will
necessarily rely on more expensive therapies. Their deployment
should be foreseen along with improvements in the diagnostic
capacities throughout health systems.
Risk Factors for Lyme Borreliosis: A German Case-Control Study 
J. Fitzner1, A. Ammon1, I. Baumann2, T. Talaska3, A. Schönberg4, K.
Stoebel5, V. Fingerle6, B. Wilske6, L. R. Petersen7
1Robert Koch Institute, Berlin, GERMANY, 2Gesundheitsamt Oder-
Spree, Beeskow, GERMANY, 3Beratergruppe Lyme Borreliose Oder-
Spree, Lindow, GERMANY, 4Federal Institute for Health Protection of
Consumers and Veterinary Medicine, Berlin, GERMANY, 5Federal
Institute for Health Protection of Consumers and Veterinary Medicine,
Berlin, GERMANY, 6Max v. Pettenkofer Institute, Ludwigs-Maximilians-
Universität, Munich, GERMANY, 7CDC, Fort Collins, CO
Introduction: Although Lyme borreliosis is a public health
problem throughout much of the world, most risk factor studies
have been carried out in the USA, where only one of the 3 defined
human pathogenic Borrelia burgdorferi s.l. species is found and
whose tick vector species differ from those in Europe. We studied
the risk factors for erythema migrans (EM), a characteristic early
sign, in a German district, Landkreis Oder-Spree (LOS), where the
reported disease incidence (48 cases/100,000 inhabitants) is high
compared to other districts.
Methods: A case-control study was conducted. Cases were
patients with EM 35 cm, living in the district, reported between 1.
May and 31. December 1999. Controls were selected using ran-
dom digit dialling, and included if they lived in LOS and had no
EM-like lesion during 1999. Standard telephone interviews were
conducted. A 3:1 case-control ratio was attempted. Questions on
exposures related to the 4-week interval before the lesion (cases)
occurred, or before the interview (controls). In four areas, which
were selected after mapping the residence and exposure location
of cases and controls, ticks (Ixodes ricinus) were collected and test-
ed for B. burgdorferi s.l. by immunofluorescence assay (IFA) and
polymerase chain reaction (PCR).
Results: Analysis included 48 cases and 118 controls.
Cases were on average 12 years older than controls (p=0.02).
Cases spent twice as much time in gardens (p=0.04) and were 2.2
times more likely to have been in a garden within 200 metres of
woods (CI 95% 1.1 - 4.6). Cases were more likely to have had skin
contact with garden bushes (p=0.02) and countryside bushes
(p=0.04). Cases were no more likely than controls to work or pur-
sue recreational activities in the countryside. There was no differ-
ence in frequency of pet ownership, but pets of cases were more
likely to have ticks (OR: 2.6; CI 95% 1.1 - 5.7). In a logistic regres-
sion model, age, having pets with ticks, visiting a garden within
200m of woods, and skin contact with bushes in the countryside
were independent risk factors for EM. Sixty-five percent of cases
















after potential exposures. Twenty-two percent (100/455) of ticks
from 3 areas were positive for B. burgdorferi s.l by IFA, with no
difference in prevalence among areas. In contrast 12% (62/514) of
ticks were positive by PCR, with a prevalence varying from 2-23%
among the four areas.
Conclusion: Peridomestic exposures, particularly in gar-
dens, were important risk factors for EM. Having pets with ticks
may signal higher risk. Similar to US findings, these results indicate
that tick exposure prevention in the peridomestic setting will like-
ly have the greatest impact on disease incidence. The varying
results of Borrelia testing of ticks using IFA and PCR indicate a
need to further standardize test methods.
Dengue Fever Outbreak in Hawaii – 2001 
P. Effler1, L. Pang2, P. Kitsutani3, M. Nakata1, K. Mills2, V. Vorndam4,
K. Street2, J. Elm1, T. Tom1, P. Reiter4, J. Rigau4, J. M. Hayes4, D.
Sasaki1, M. Napier5, G. Clark4, D. Gubler6
1State of Hawaii Department of Health, Honolulu, HI, 2Maui District
Health Office, Wailuku, HI, 3Centers for Disease Control and
Prevention, Atlanta, GA, 4Centers for Disease Control and Prevention,
San Juan, PR, 5Pacific Disaster Center, Kihei, HI, 6Centers for Disease
Control and Prevention, Fort Collins, CO
Background: Autochthonous dengue infections have not
been reported in Hawaii since 1945. On September 12, 2001 a
physician in Hana, Maui called the Hawaii Department of Health
(HDOH) to report an unusual febrile illness in a local resident with
no travel history. Dengue was confirmed at the Centers for Disease
Control and Prevention and an investigation ensued to determine
the extent of the outbreak and assess factors that contributed to the
emergence of dengue in Hawaii.
Methods: Active surveillance for febrile illness was initiat-
ed at 50 clinics and hospitals statewide. HDOH staff interviewed
suspected case-patients, queried location-proximal contacts, and
obtained blood samples for dengue diagnostic testing at CDC and
HDOH. Ad-hoc mosquito surveys were performed on 4 islands.
Results: As of December 1, 2001, 1380 persons have been
evaluated for dengue and 89 locally-acquired infections have been
confirmed; dengue virus, serotype 1, was isolated from 13 of those
patients. Laboratory positive autochthonous dengue cases were
identified with onset in June (4 cases), July (7 cases), August (9
cases), September (49 cases), October (17 cases) and November (3
cases), 2001. The island of residence was Maui, Oahu, and Kauai
for 65, 20, and 4 of the cases, respectively. Fifty-five (85%) of the
Maui cases had exposure in the Hana area; only 2 of 24 Oahu and
Kauai cases had exposure in Maui. Patient ages ranged from 1 to
77 years (mean - 39 years); 62% were male. The most frequently
reported symptoms for 86 patients with complete histories were
fever (92%), body pain (88%), headache (84%), chills (80%), joint
pain (69%), rash (62%), and eye pain (52%). Hemorrhagic mani-
festations included petechiae (17%), bleeding gums (9%), epistaxis
(7%), melena (5%) and menorrhagia (5%). Although 3 patients
were hospitalized, most illnesses were mild; there was no dengue
hemorrhagic fever. To date, there have been no confirmed dengue
infections among visitors staying in guest accommodations. All
mosquitoes captured in the Hana area in September 2001 were
identified as Aedes albopictus; Ae. aegypti was not found on any
island. Preceding this outbreak 24 cases of dengue infection were
imported to the islands of Oahu (15 cases), Hawaii (4 cases), Maui
(3 cases) and Kauai (2 cases) in 2001. This compares to a mean of
2 imported cases per year for the period 1992-2000 (range 0-8). In
3 instances (1 each on the affected islands) one or more autochtho-
nous cases were linked to persons with illness after recent travel to
other Pacific Islands with epidemic dengue.
Conclusions: This is the first known transmission of
dengue fever in Hawaii in 56 years. Available data implicate Ae.
albopictus as the mosquito vector. In response to the outbreak,
extensive mosquito control measures were initiated on all
islands, including spraying with residual adulticides, house-to-
house source reduction campaigns, and public education to res-
idents and visitors.
Re-Introduction of Dengue 3 in Aragua, Venezuela: Clinical,
Epidemiological and Laboratory Features of a New Outbreak 
G. Comach1, M. Jimenez1,2, M. De Quintana1,2, D. Camacho1,2, M.
Salcedo1, A. Chiarello1,2, M. Bracho1, M. Alvarez1, M. Soler1, G.
Sierra1, E. Sanchez1, I. Villalobos3, J. Duarte3, E. Rojas2, F. Herrera1,
L. Urdaneta1, R. Barrios1, N. Zoghbi1, Y. Rubio4, N. Uzcategui5, R.
Cuello De Uzcategui6, E. C. Holmes7, E. A. Gould5, F. Liprandi8, A. P.
Goncalvez8
1LARDIDEV-BIOMED, Universidad de Carabobo, Maracay,
VENEZUELA, 2Corposalud Aragua, Maracay, VENEZUELA, 3Hospital
Central de Maracay, Maracay, VENEZUELA, 4IAESP-MSDS,
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A new outbreak of dengue occurred in Aragua, Venezuela,
caused by a Den-3 virus reintroduced after 36 years of its last
detection. In this study we analyzed clinical, epidemiological and
laboratory-based surveillance data from 2,604 suspected dengue
patients reported by sentinel health centers between September
2000 and November 2001. Clinical diagnosis was made following
WHO guidelines for dengue case definition. Laboratory diagnosis
were made by virus isolation in C6/36 cells followed by typing with
monoclonal antibodies (VI), reverse transcriptase-polymerase
chain reaction (RT-PCR), IgM- and IgG-capture ELISAs. We also
performed phylogenetic analysis of 10 dengue 3 isolates from
dengue fever (DF) patients, as well as RT-PCR dengue virus detec-
tion and typing on Aedes aegypti captured in some houses with
confirmed dengue patients. Of 1,227 confirmed dengue cases, 979
(79.8%) were infected by Den-3, 126 by Den 2 (10.3%), 104 by
Den 4 (8,5%) and 18 by Den 1 (1.5%). Also, Den-3 and Den-1
infected A. aegypti were detected in neighboring dwellings hous-
ing DF patients. Phylogenetic analysis revealed that Den-3 isolates
belonged to subtype III, which includes viruses from Sri Lanka,
India, Samoa, and probably the one introduced in Nicaragua in
1994. Den-3 virus transmission occurred uninterrupted through-
out the studied period (61weeks), and circulated together with at
least another serotype almost continuously during the 53 weeks
and alone the remaining weeks. Den-3 virus was detected in all 17
municipalities of Aragua State and hyperendemicity of two or more
serotypes was the rule in 16 (94,1%) of them. As expected, 95.1%
of the Den-3 infected cases were <40 years old people. Infections
were prevalent in males of all age groups but 5 - 9 and ≥ 40 years
old ones. Undifferentiated febrile and DF were the predominant
clinical forms in Den-3 infected patients (99.5%), and the very few
cases that met all four WHO clinical criteria for DHF were grades
I (0.1%), II (0,2%) and IV (0,2%). GAC-ELISA analysis of 46
paired sera of Den-3 infected patients revealed that 73.9% were
secondary infections. This new Den-3 outbreak in Aragua,
Venezuela, is the worst ever recorded in terms of morbidity and
geographic extension; yet, severe clinical forms (DHF) were
almost absent in spite of the intense hyperendemicity and the high
rates of secondary infections.
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An Evaluation of an Educational Videotape to Prevent Botulism
Among Alaska Natives 
C. Dentinger1, A. Horn2, L. Chiou3, D. Dahlberg2, T. Hennessy4, J.
Butler4
1CDC, Anchorage, AK, 2Bristol Bay Area Health Corporation,
Dillingham, AK, 3University of Washington, School of Medicine,
Seattle, WA, 4CDC/NCID/AIP, Anchorage, AK
Background: Rates of foodborne botulism in Alaska are
the highest in the U.S. Since 1980, the incidence of foodborne bot-
ulism has doubled in Alaska, and all cases have been associated
with eating traditional Alaska Native foods. We conducted a survey
among southwestern Alaska Natives regarding traditional food
preparation and consumption practices and used the results to
guide prevention messages that were incorporated into an educa-
tional video. In April 2000, the video was distributed to all rural
schools and medical facilities in Alaska. We repeated the survey to
evaluate the specific impact of the video on food preparation and
consumption practices.
Methods: In-person interviews of a population-based, 16%
random sample of persons > 18 years old in 9 villages of south-
western Alaska were conducted during August 2001. Data collect-
ed included information about video viewing; frequency of con-
sumption of traditional Native foods; knowledge about the cause,
symptoms, and treatment of botulism; and methods of fermented
food preparation.
Results: We interviewed 254 adults (40% male, 92% Alaska
Native) and 97 (38%) reported they saw the video. Of these, 78%
learned about the video on public televison; and most saw it either
at home or in a medical facility (78% and 18%, respectively). In
total, 220 (93%) individuals knew that botulism was a foodborne ill-
ness, 169 (77%) of whom knew it was associated with eating fer-
mented foods. Compared with the pre-video survey, overall con-
sumption (pre-video survey: 77%, post-video survey: 81%) and
preparation (pre: 27%, post: 20%) of traditional Native fermented
foods did not change. Among those who prepare fermented foods,
the proportion who use plastic or metal buckets rather than tradi-
tional methods as encouraged in the video, did not differ signifi-
cantly between pre and post video surveys (34% versus 33%,
respectively); or between those who saw the video and those who
did not (28% versus 37%, respectively). Overall, willingness to
decrease the risk of botulism from fermented foods did not change
for behaviors such as boiling foods to destroy toxin (pre: 45%, ver-
sus post: 43%), or avoiding foods fermented in plastic containers
(pre: 65%, versus post: 68%). The prevalence of misconceptions
about botulism did not appear to change, including the belief that
some people were protected from becoming ill from botulism (pre:
23%, versus post: 17%), or that antibiotics could cure botulism did
not change (pre: 3%, versus post: 7%).
Conclusion: While the botulism prevention video has been
well received in Alaska and in the health care community, a year
after distributing it to rural Alaskan schools and clinics, few
changes that might reduce the risk of botulism from fermented
foods were noted. This finding might be reflective of the limited
number of adults saw the video. Methods to market the use of the
video, reinforce prevention messages, and support behavior
change are being explored.
Active Laboratory Surveillance in Massachusetts 
B. Bolstorff, G. Conidi, J. Daniel, L. Glenn, G. Hamilton, D. Heisey,
T. LaPorte, J. Nsubuga, B. Matyas
Massachusetts Dept. of Public Health, Jamaica Plain, MA
Introduction: Timely identification and reporting of
infectious diseases to health departments is necessary to effec-
tively implement appropriate control measures and prevent ill-
ness. In September 2001, the Massachusetts Department of
Public Health (MDPH) began a statewide, laboratory-based,
active surveillance project to monitor selected organisms and
antimicrobial susceptibility patterns (if applicable). Organisms of
interest include Bacillus anthracis, Brucella species,
Cryptosporidium species, E. coli O157:H7, Francisella tularen-
sis, Giardia lamblia, Streptococcus pyogenes (groups A and B),
Haemophilus influenzae, Listeria monocytogenes, methicillin-
resistant Staphylococcus aureus (MRSA), Neisseria meningi-
tidis, Salmonella species, Shigella species, Streptococcus pneu-
moniae, vancomycin-resistant enterococci and Yersinia pestis.
The goals of this surveillance project are to enhance timely iden-
tification of foodborne and waterborne outbreaks and unusual
events, such as a bioterrorism incident, and to monitor antimi-
crobial resistance across the state.
Methods: Laboratories have been asked to submit retro-
spective data from January 2000 forward. Prospective data are sub-
mitted either electronically or in paper format, weekly or monthly,
depending on laboratory size and capability. Data are entered or
imported into an ACCESS database using National Electronic
Data Surveillance System (NEDSS) guidelines.
Results: As of 10 December 2001, MDPH epidemiologists
visited 40 of 85 hospital laboratories and received electronic data
from 8 laboratories and data in paper format from 7 laboratories.
In comparison to active surveillance reports received from the first
4 reporting hospitals, the existing passive reporting system had
received 100% of the Shigella and Listeria cases, 93% of shiga
toxin-positive E. coli cases, 89% of Cryptosporidium cases and 67%
of Giardia cases from the same laboratories. Two invasive cases
each of Neisseria meningitidis and Haemophilus influenzae
occurred, none of which were reported.
Discussion: Through this active surveillance initiative,
MDPH expects to increase notification of reportable conditions to
allow for appropriate public health control measures, as well as ini-
tiate reporting and awareness around emerging pathogens.
Additionally, MDPH will obtain antimicrobial resistance data to
monitor resistance trends and facilitate appropriate public health
action if an unusual or significant resistance pattern is identified.
The Emergence of Serogroup Y Disease and the Epidemiology
of Invasive Meningococcal Disease in Colorado, 1997 - 2001 
L. M. Hammond, K. A. Gershman
Colorado Department of Public Health and Environment, Denver, CO
Background: National surveillance data suggest that the
recent increase in serogroup Y disease (SYD) is associated with a
different clinical and epidemiologic picture of invasive meningo-
coccal disease (IMD). We sought to describe the change in
serogroup distribution in Colorado over the past decade and to
characterize the subsequent effect of SYD on the clinical epidemi-
ology of IMD.
Methods: A case of IMD was defined as the isolation of N.
meningitidis from a sterile source. Eligible cases were identified
through both active (Jul 2000-Jun 2001, ABCs project in the
Denver Metro area) and passive (Jan 1997-Jun 2001, statewide)
surveillance from 1997 through June of 2001 (N=171, serogroup
available 77%). Information on type of infection was only available
from January 1999 through June of 2001 (N=94, serogroup avail-
able 86%). For the purpose of assessing changes in serogroup dis-
tribution over time, serogroup data for IMD cases from 1991
















Results: The overall serogroup distribution in Colorado has
notably shifted in the past ten years with Y replacing C as the most
prevalent serogroup. Serogroup Y comprised 7% of IMD cases
from 1991-1994 and increased to 40% of IMD cases from 1998
through mid 2001. Persons with SYD were more likely than per-
sons with IMD due to other serogroups to be ≥ 35 years (RR=2.5;
95%CI 1.5, 4.2). When stratified by gender, this association was
limited to females (RR=4.3; 95%CI 2.0, 9.4). Female cases of SYD
were significantly older than male cases (median age, 51 vs. 16
years; Wilcoxon Rank Sum, P=0.03). All cases of IMD with pneu-
monia for which serogroup information was available occurred in
persons ≥ 35 years. Persons with SYD were much more likely to
have pneumonia than were persons with IMD due to all other
serogroups among all ages (RR=18.9; 95%CI 2.6, 137.7) and
among persons ≥ 35 years (RR=5.5; 95%CI 0.9, 35.1). In persons
with available outcome data (98%), serogroup C had the highest
overall case-fatality ratio (22.7%). SYD had a higher case-fatality in
persons ≥ 35 years (16.7%) compared to persons < 35 years (4.3%);
whereas serogroup C had similarly high case fatality among both
younger (23.5%) and older (20%) ages. When compared to cases
with other serogroups and non-groupable disease, persons with
SYD had similar distributions of race and ethnicity, metro vs. non-
metro residence, and gender.
Conclusions: The emergence of SYD in Colorado has
resulted in a changed epidemiology of invasive meningococcal dis-
ease. Compared with persons with IMD due to other serogroups,
persons with SYD are more likely to have pneumonia and be ≥ 35
years. Among those with SYD, females are significantly older than
males and persons ≥ 35 years have a much higher case fatality ratio
than those < 35. Ongoing enhanced surveillance will continue to
monitor the shift in serogroup distribution and characterize the
resulting epidemiology of IMD in Colorado.
Transmission of the Main Viral Pathogens Causing
Gastroenteritis, NLV, SLV and Rotavirus 
M. A. de Wit, M. P. Koopmans, Y. T. van Duynhoven
National Institute of Public Health and the Environment, Bilthoven,
NETHERLANDS
Viral pathogens are the most common causes of gastroen-
teritis in the community. To identify modes of transmission and
thereby opportunities for prevention, a case-control study was
conducted in the Netherlands in 1999, nested in a cohort study.
Risk factors for Nowalk-like virus gastroenteritis, Sapporo-like
virus gastroenteritis and rotavirus-gastroenteritis were studied,
by comparing cases with gastroenteritis that tested positive for
the virus and their matched controls without gastroenteritis, by
using conditional logistic regression analysis. A food handling
hygiene score was calculated based on several variables address-
ing hygiene at different steps in foodhandling. For NLV-gas-
troenteritis, having a household member with gastroenteritis,
contact with a person with gastroenteritis outside the household,
and poor food handling hygiene were associated with illness, with
population attributable risk fractions (PARs) of respectively 17%,
56% and 47%. In a sub-analysis, excluding all cases with contact
with symptomatic persons (with the aim to exclude cases due to
contamination of food in the home), we found a PAR for food-
handling hygiene of 12-16%. For SLV-gastroenteritis, only con-
tact with a person with gastroenteritis outside the household was
associated with a higher risk and with a population attributable
risk fraction of 60%. For rotavirus-gastroenteritis, contact with a
person with gastroenteritis outside the household and food han-
dling hygiene were associated with a higher risk, with PARs of
86% and 46%. Transmission of these viral pathogens occurs pri-
marily from person-to-person. However, for NLV-gastroenteritis
foodborne transmission seems to play an important role, with an
estimated 12-16% of infections being attributable to contaminat-
ed food entering the household. Strict hygiene measures when
being in contact with a person with gastroenteritis, and good food
handling hygiene may prevent an estimated 80% of all NLV-gas-
troenteritis cases, 60% of SLV-gastroenteritis cases, and 92% of
rotavirus-gastroenteritis cases.
Improving Influenza and Pneumococcal Vaccination Rates for
People 65+ in Rhode Island through Coalition Building Efforts 
T. E. Bertrand
Rhode Island Department of Health, Providence, RI
Background: Vaccines are among the greatest public
health achievements of the 20th Century. In recognition of the
public health benefits of vaccines, the Ocean State (Rhode Island)
Adult Immunization Coalition (OSAIC) was formed in 1997 in
order to reduce the mortality and morbidity associated with
influenza and pneumococcal disease among Rhode Island’s elderly
population (people aged 65+). In its first two years, the Coalition
witnessed dramatic increases in both influenza and pneumococcal
disease vaccination rates.
Coalition Activities: The OSAIC is composed of thirty-
five agencies that are committed to increaseing influenza and
pneumococcal immunization rates for people 65+. The members
include hospitals, long-term care facilities, vaccine manufacturers,
medical societies, managed care, Visiting Nurse Associates, RI
Department of Health, RI Quality Partners, and community-based
organizations. Strategies to improve immunization rates include:
1. Providing resources, materials, and training to medical
providers;
2. Developng and conducting public clinics and education
campaigns; parrticularly for under-served populations;
3. Facilitating partnerships among communicty groups,
health care providers, and private organizations to make vaccines
readily accessible and free to all seniors;
4. Improving adult immunization tracking and reporting
systems; and
5. Monitoring national trends in adult immunization activi-
ties and promoting national adult immunization recommendations.
Trends In Immunization Rates: The immunization rates
for Rhode Island’s seniors jumped significantly after the OSAIC
was formed in 1997. According to the CDC Behavioral Risk Factor
Surveillance System, from 1997 to 1999, Rhode Island’s influenza
rates increased from 67% to 76%, and for pneumococcal from 43%
to 57%. On a national level, these increases propelled Rhode
Island from a ranking of #20 to #1 for influenza, and from #36 to
#14 for pneumococcal disease.
Conclusion: Through the collaboration of organizations,
significant progress can be made in improving immunization rates
in just two years. Importantly, despite the substantial progress
made by the OSAIC, the Healthy Poeple 2010 Objective is to reach
of level of 90% coverage for influenza and pneumococcal.
Reaching this objective will require broadening and intensifying
OSAIC’s efforts in coming years.
Evidence of Effectiveness of Egg Quality Assurance Programs,
Mandatory Refrigeration, and Traceback Investigations To
Mitigate Egg-Associated Salmonella enteritidis Infections in the
United States 
G. A. Mumma, P. M. Griffin, M. I. Meltzer, C. R. Braden, R. V. Tauxe
Centers for Disease Control and Prevention, Atlanta, GA
Background: In the past 30 years, the reported rate of
Salmonella Enteritidis (SE) infections in the United States has
increased from a low of 0.55/100,000 in 1976 to a high of
3.88/100,000 in 1995. Shell eggs have been identified to be a major
cause of SE, and so there is a need for interventions that reduce
exposure to SE-tainted eggs. We examined correlations between
SE incidence and introduction of programs to reduce SE contam-
ination of eggs. The programs examined included egg quality assur-
ance programs (EQAPs), state refrigeration requirements for eggs,
and egg traceback investigations by USDA and FDA.
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Methods: Regression models were used to determine pro-
grams associated with changes in national and state SE incidence.
SE isolations from humans were reported to CDC by state public
health department laboratories. Information concerning imple-
mentation of EQAPs and refrigeration requirements was obtained
through interviews with state agricultural and public health offi-
cials, U.S. Census Bureau, USDA, and FDA records.
Results: The average 0 to 7-year post-EQAP SE incidence
increased by 122% for the 5 states that had industry-sponsored
programs but decreased by 22% for the 10 states with state-spon-
sored EQAPs. The average 7-year post-refrigeration requirement
SE incidence for the 17 states requiring egg refrigeration from
farm to table decreased by 13% and that for the 13 states requiring
refrigeration at retail only decreased by 16%. The average 3-year
post-USDA traceback SE incidence for 7 states decreased by 14%,
and 3-year post-FDA traceback SE incidence for 3 public health
regions decreased by 30%. SE outbreaks and SE outbreaks traced
to eggs decreased by 18 percent and 37 percent, respectively.
The state-level regression model of the impact of EQAP
found the following: A 1% increase in the population at high risk
for SE (defined here as children 65 years) was associated with a
10% increase in SE incidence (p<0.01); a 1% increase in eggs pro-
duced under EQAP was associated with a 0.47% decrease in SE
incidence (p<0.04); and having a state-sponsored instead of indus-
try-sponsored EQAP was associated with a 72% reduction in SE
incidence (p<0.002). The model for national-level data found that
a 1% increase in the population at high risk for SE was associated
with a 51% increase in SE incidence (p<0.000), a 1% increase in
eggs produced under an EQAP was associated with a 2.2%
decrease in SE incidence [p<0.05], and an additional FDA trace-
back investigation was associated with a 1.2% decrease in the fol-
lowing year’s SE incidence (p<0.06).
Conclusions: These data indicate that state-sponsored
EQAPs, egg refrigeration from farm to table, and egg trace back
investigations probably played a major role in reducing SE illness
in the U.S. and should be continued and expanded. Incidence of
egg-related SE may be reduced through risk-reduction programs
focused on populations at high risk for SE infections.
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Detection of La Crosse Virus in Cerebrospinal Fluid and Tissues
by Reverse Transcription-Polymerase Chain Reaction 
B. Slater1, K. Bloch2, T. F. Jones3, G. Woodlief4, T. McPherson4, C.
Huang1
1New York State Department of Health, Slingerlands, NY, 2Vanderbilt
University Medical Center, Nashville, TN, 3Tennessee Department of
Health, Nashville, TN, 4North Carolina State Lab of Public Health,
Raleigh, NC
La Crosse encephalitis is one of the most common causes of
reported arboviral illness in the United States. The causative agent
is La Crosse virus, which has been historically distributed in the
upper Midwestern States — Illinois, Indiana, Iowa, Minnesota,
Ohio, and Wisconsin. In recent years, human cases of La Crosse
encephalitis have increased in Southeastern States — West
Virginia, Tennessee, and North Carolina. Our interest continues to
be the determination of the appropriate role of nucleic acid ampli-
fication methods, particularly RT-PCR, in the diagnosis of such
infections. Toward this end, a reverse transcription-polymerase
chain reaction (RT-PCR) method was used to retrospectively
detect La Crosse virus genome in patients with central nervous sys-
tem infections. The RT-PCR method was evaluated directly on
cerebrospinal fluid (CSF) and autopsied tissues of patients with La
Crosse encephalitis. Since La Crosse virus is a member of
California (CAL) serogroup viruses, universal primers for CAL
serogroup viruses and specific primers for La Crosse virus were
evaluated to determine their effectiveness with clinical specimens.
Ten CSF samples from 8 patients were examined with group-spe-
cific primers and PCR bands with the expected size were obtained
in 3 samples. In all 9 samples with enough CSF available for addi-
tional testing, La Crosse was detected by RT-PCR with virus-spe-
cific primers. La Crosse virus RNA was also detected in both
frontal lobe and spinal cord of autopsied tissues. The results indi-
cate that PCR may be a useful technique for identification of La
Crosse sequence, particularly when La Crosse-specific primers are
used. PCR offers the advantage of providing a rapid diagnosis at
the time of clinical presentation. Based on the results, we suggest
that PCR be considered as a complementary test for laboratory
diagnosis of suspected cases of La Crosse encephalitis.
Real-time Fluorescence PCR Assays for the Detection and
Characterization of Heat-labile and Heat-stable Enterotoxin
Genes from Enterotoxigenic Escherichia coli 
M. YOUSSEF1, N. STROCKBINE1, N. LEHN2, U. REISCHL2
1Centers for Disease Control and Prevention, Atlanta, GA, 2Institute of
Medical Microbiology and Hygiene, University of Regensburg,
Regensburg, GERMANY
Enterotoxigenic Escherichia coli (ETEC) is a major cause
of watery diarrhea among children in developing countries and
travelers from the industrialized world to endemic areas. In addi-
tion to sporadic infections caused by these organisms, ETEC
strains also cause waterborne and foodborne outbreaks.
Convenient methods for the detection ETEC are needed for out-
break investigations and for diagnostic efforts to estimate the bur-
den of diarrheal disease attributable to these organisms. ETEC
strains cause disease through the elaboration of one or more
enterotoxins, designated heat-labile toxin (LT) and heat-stable
toxin (ST), and are most reliably detected by assays that target the
toxins they produce or the genes encoding these toxins.
Conventional block cycler PCR assays for ETEC have proved use-
ful for detecting ETEC; however, recent advances in PCR tech-
nology have facilitated the development of real-time fluorescence
PCR assays with greatly reduced amplification times and more reli-
able methods for the detection of amplified target sequences. To
improve our ability to diagnose ETEC infections, we developed
and evaluated real-time fluorescence PCR assays for the
LightCycler? against the enterotoxin genes present in these organ-
isms. Separate LC-PCR assays for LT and ST were designed using
the hybridization probe format to have identical cycling conditions
so they could be run together on the same thermal cycler. Findings
from the testing of 160 E. coli isolates of human origin (138 ETEC
and 22 non-ETEC) with the LightCycler? PCR (LC-PCR) assays
were compared with those obtained by block cycler PCR analysis.
The sensitivities and specificities of the LC-PCR assays were each
100 % for the LT and ST genes. Findings from the melting curve
analyses of the amplified LT and ST genes revealed sequence vari-
ation within each gene that was confirmed by DNA sequence
analysis of the amplicons. In the case of the ST gene, variation
observed in the melting point temperatures correlated with the
presence of toxin variants ST Ia (STp) and ST Ib (STh). The rapid-
ity and specificity of the LC-PCR assays make them attractive
alternatives to block cycler PCR assays or other genetic and phe-

















Development and Evaluation of PCR-based Diagnostics for
Identification of Salmonella O antigens based on the rfb Locus 
R. Sherwood, C. Fitzgerald, L. Gheesling, P. I. Fields
CDC, Atlanta, GA
The Kauffman-White serotyping scheme includes about 50
different Salmonella O antigen groups, which together with the
detection of H antigens, forms the basis for serotype identification.
We have been characterizing the genes required for O and H anti-
gen biosynthesis with the goal of developing a DNA-based system
for serotype determination in Salmonella. We report PCR-based
diagnostics for the identification of 15 Salmonella O serogroups;
eight developed from our de novo sequence data, three developed
from sequence data reported from other laboratories, and four
evaluated from a previously described assay. We recently complet-
ed sequencing the rfb gene clusters from S. Sundsvall (O:6,7), S.
Gaminara (O:16), S. Jangwani (O:17), S. Cerro (O:18), S. Marina
(O:48), S. Ealing (0:35), S. Roan (0:38), and S. Ipswich (0:41) and
used this information to design serogroup-specific primers to tar-
get defined regions of the putative wzy and wzx genes for these O
serogroups. Preliminary evaluation indicated that each primer pair
is specific for the appropriate O serogroup. We also developed
PCR assays for identification of serogroups C1, E, and O:54 based
on wzy (polymerase), wzx (flippase) and wbbF (transferase) O-
antigen synthesis genes, respectively, using previously described
sequence data. All 59 strains belonging to serogroups C1, E and
O:54 were accurately identified to yield amplicons of 628 bp, 920
bp, and 538 bp, respectively. The 289 strains from the 46 other
serogroups were negative in the PCR assays. In addition, a PCR-
based assay for identification of Salmonella serogroups A, B, C2
and D had been reported previously, and is based on the selective
amplification of abequose and paratose synthase genes. We are
currently evaluating the sensitivity and specificity of these assays
with the aim of including them in our panel of serogroup-specific
assays. These PCR-based assays will be a rapid and sensitive tech-
nique amenable to high throughput O serogroup identification of
Salmonella in the routine public health laboratory environment.
PulseNet Experience: Software Changes and Improvements to
Online E. coli National Database 
S. B. Hunter, K. A. Kubota, E. M. Ribot, B. Swaminathan
Centers for Disease Control and Prevention, Atlanta, GA
PulseNet is the national molecular subtyping network of
public health laboratories that performs pulsed-field gel elec-
trophoresis (PFGE) on foodborne pathogens. E. coli O157:H7
PFGE patterns are electronically shared via the Internet among
laboratories and the national database maintained at the Centers
for Disease Control and Prevention (CDC). Use of the current
PulseNet online database allows for rapid communication of
PFGE subtyping data needed for the identification of clusters and
outbreaks. The online E. coli database was begun in 1998 using
Molecular Analyst Fingerprint Plus with Data Sharing (Bio-Rad,
Hercules, CA) Tools as the analysis software, and an SQL server
software was used to store isolate-related information. The local
interface program facilitated uploading of data from a local
Molecular Analyst Fingerprinting Plus database and isolate data
from a local Microsoft Access database. Molecular Analyst itself
contained minimal isolate information fields, making it necessary
to maintain these data in a separate Access database. Also, security
concerns also made it difficult to add participants to this system
and hard for participating public health laboratories to connect to
this system. In April 2001, we began migrating to a new system
using a PulseNet customized version of BioNumerics (Applied
Maths, Sint-Martens-Latem, Belgium). A major advantage of the
new on-line BioNumerics database is the customized entry
screens, which allow for the input of isolate-associated information
such as date of isolation, serotype, geographic information, toxin
type, phage type, and food vehicle-associated information. Security
is maintained using a SecurID (Security Dynamics Bedford, MA)
to authenticate to the CDC firewall and passwords to gain access
to the specific server and database. Currently 28 U.S. public
health laboratories have direct access to the database.
Laboratories are given access after successfully PFGE typing a set
of certification strains, obtaining the expected PFGE patterns,
and correctly analyzing the resulting tiff image files. Currently,
over 8,600 entries have been uploaded to the online server. There
are 7875 XbaI patterns and 1383 BlnI patterns associated with
these entries. Improvements in the setup of the PulseNet
National online database for E. coli have allowed for more rapidly
adding additional online participants, increased security of data,
improved viewing and searches of isolate related data, inclusion of
antimicrobial susceptibility data, and increased possibilities for
analyzing data online.
Molecular Characterisation of a Multiresistant Strain of
Salmonella enterica Serotype Typhimurium DT204b
Responsible for an International Outbreak of Salmonellosis 
E. J. Threlfall1, E. A. Lindsay1, A. J. Lawson1, R. A. Walker1, L. R.
Ward1, H. R. Smith1, F. W. Scott1, S. J. O'Brien2, I. S. T. Fisher2, P. D.
Crook2, D. Wilson3, D. J. Brown4, H. Hardardottir5, W. J. B.
Wannet6, H. Tschäpe7
1Central Public Health Laboratory, London, UNITED KINGDOM,
2PHLS Communicable Diseases Surveillance Centre, London, UNITED
KINGDOM, 3County Durham and Darlington Health Authority,
Durham, UNITED KINGDOM, 4North Glasgow Univeristy Hospitals
NHS Trust, Glasgow, UNITED KINGDOM, 5Landspitali University
Hosptial, ReyKjavik, ICELAND, 6National Institute of Public Health
and the Environment, Bilthoven, NETHERLANDS, 7Robert-Koch Institut,
Werningerode/Harz, GERMANY
From July - October 2000 patients in five European coun-
tries (England, Scotland, Germany, The Netherlands, Iceland)
were infected with a strain of Salmonella enterica serotype
Typhimurium definitive phage type (DT) 204b (= DT204b) resist-
ant to ampicillin, chloramphenicol, gentamicin, kanamycin, strep-
tomycin, sulphonamides, tetracyclines, trimethoprim and nalidixic
acid, and with decreased susceptibility to ciprofloxacin (R-type
ACGKSSuTTmNxCpL). Over 350 laboratory-confirmed cases
were recognised. As a result of epidemiological investigations
shredded lettuce was implicated as the vehicle of infection. Isolates
from patients in Iceland, The Netherlands and Scotland were char-
acterised in the PHLS Laboratory of Enteric Pathogens and com-
pared with those from patients infected in England and from
patients returning to England and Wales after visiting other coun-
tries in Europe. Methods included phage typing, antibiogram
analysis, plasmid profile typing, pulsed-field gel electrophoresis
(PFGE), fluorescent amplified fragment length polymorphism fin-
gerprinting (FAFLP) and integron typing; specific resistance genes
were characterised by PCR; the mutation conferring decreased
susceptibility to ciprofloxacin was identified by a LightCycler gyrA
mutation assay (GAMA). Isolates from Germany and Scotland
were typed independently using the same phenotypic methods and
also by plasmid profile and PFGE. All isolates possessed five plas-
mids ranging from 120 MDa to 2.0 MDa. With the exception of
resistance to nalidixic acid/decreased susceptibility to
ciprofloxacin, the complete resistance spectrum was transferable to
E. coli K12 as an intact linkage group. When PCR amplification
was performed on DNA extracted from transconjugants, positive
results for aadA2, blaTEM, sul1 and tetA (class A) were obtained
whilst blacarb-2, tetA (class G) and tetA (class B) were negative.
When studied by integron PCR, one discrete band of 1.6 kilobases
(kb) was generated and one faint amplicon of about 4 kb was also
consistently produced. When studied by GAMA the gyrA mutation
was that of aspartate to glycine (GAC-GGC) at codon 87. PFGE
profiles of all isolates were indistinguishable. To facilitate epidemi-
ological investigations PFGE TIFs of these isolates and those from
Scotland and Germany were exchanged electronically. In all cases
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the resultant PFGE profiles were indistinguishable. Finally, The
FAFLP profiles of all isolates were identical. These results con-
firmed that the strains of DT204b of R-type ACGKSSuTTmNxCpL
responsible for outbreaks in five European countries in the sum-
mer of 2000 represented a single clone. A key aspect of this inves-
tigation was the use of harmonised techniques of phage typing and
antibiogram analysis coupled with the rapid exchange of molecular
fingerprints between laboratories. It would be of major benefit for
the global control of salmonellosis if compatible networks were
now developed for the international exchange of real-time molec-
ular data for S. enterica.
Determination of Allelic Diversity in the mec Operon of
Methicillin-Resistant Staphylococcus aureus in Wisconsin 
S. K. Shukla1, M. E. Stemper1, J. M. Conradt1, R. A. Reich2, S. V.
Ramaswamy2, E. A. Graviss2, K. D. Reed1
1Marshfield Medical Research Foundation, Marshfield, WI, 2Baylor
College of Medicine, Houston, TX
Background: Methicillin resistance in staphylococci is
dictated by the presence of the mecA encoded penicillin binding
protein 2a (PBP2a) which has low affinity for beta-lactam antibi-
otics. PBP2a is made in the absence of transcriptional repression
due to mutated mecI, the repressor gene. It has been proposed
that mecI receives a transducing signal from the membrane bound
sensory protein, MecR1 after interacting with beta-lactam drugs.
The extent of allelic diversity present in these genes affecting
methicillin resistance is not well studied. We investigated the
diversity of sequence variations in the mec operon and its correla-
tion with oxacillin minimum inhibitory concentration (MIC),
antibiogram, and pulsed-field gel electrophoresis (PFGE) profiles
from a select group of MRSA strains isolated in Wisconsin.
Methods: The isolates in the study were collected from 1989-
1999 at Marshfield Laboratories in Wisconsin. We typed 316
MRSA strains by PFGE after SmaI restriction digestion.
Antibiograms for seven drugs (ciprofloxacin, clindamycin, eryth-
romycin, tetracycline, trimethoprim-sulfamethaxazole, gentam-
icin, and rifampin) were obtained by using the Vitek system. In
addition, oxacillin MICs for 216 were determined by the E-test.
We sequenced mecA, mecI and mecR genes from 316 MRSA.
Colony PCR was used to amplify the mecA complex followed by
direct sequencing of the PCR products. The generated sequences
were assembled using the DNASTAR program and compared
with S. aureus N315, a pre-MRSA strain that has an intact mecA
complex. Results: Of the 316 MRSA isolates studied, 77 PFGE
profiles were identified, of which 55 isolates (17.4%) had unique
fingerprints. Sixteen different susceptibility patterns were identi-
fied; the largest group with 124 isolates had resistance to three
drugs in addition to beta-lactam antibiotics. Mutations were
detected in all three genes of the mec operon. Thirty-one percent
of the isolates had a nucleotide substitution, G->T at position 7
upstream of the start site of mecA; and 64% of these isolates
(n=88) had an oxacillin MIC ≥ 96 µg/ml. Interestingly, 70% of
these strains were also resistant to erythromycin. Ninety-six per-
cent of the isolates had a Glu->Gly change at codon 246 of mecA.
About thirty isolates (9.5%) had a Asn->Lys change at codon 121
of mecI. In addition, mutations resulting in truncation of mecI
were also identified in four isolates. About 8% percent of the iso-
lates had synonymous changes in mecR at codon 583 (GAA->
GAG). Polymorphisms identified in mecR correlated well with
PFGE profiles indicating clustering. Conclusion: Multiple muta-
tions were identified in various combinations in the mec operon
suggesting differential regulation of methicillin resistance. Based
on the MICs and sequencing analysis, it seems very likely that
additional genes may be involved in the mecA regulation.
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Analysis of a Health Indicator Surveillance System: Its Ability
to Detect Annual Influenza Activity for the 1999-2000 and
2000-2001 Seasons Compared to Traditional Surveillance
Systems 
J. Lee, J. Pavlin, Y. Elbert, P. Kelley
Department of Defense Global Emerging Infections System, Silver
Spring, MD
Introduction: We analyzed the ability of an automated
data collection system using outpatient visits in a military benefici-
ary population to detect annual influenza epidemics in the
Washington D.C. metropolitan area. The system is called the
Electronic Surveillance System for the Early Notification of
Community-based Epidemics (ESSENCE) developed by the
Department of Defense Global Emerging Infections System. We
analyzed illnesses that are coded at clinic visits by ICD9 codes dur-
ing annual winter respiratory outbreaks for the 1999-2000 and
2000-2001 seasons and compared these to codes used at other
nonepidemic times. Currently, ESSENCE has complete surveil-
lance data for the Washington, DC area within three days of
patient visit. Although we realize the need for improved timeliness
in this system, we propose that its ability to rapidly detect an out-
break exceeds that of most traditional surveillance systems.
However, its sensitivity may not be equal to traditional, active sur-
veillance systems. Methods: To test this hypothesis, we compared
the percentage of visits for combinations of specific respiratory and
febrile conditions at primary care clinics and emergency rooms
during the influenza seasons in ESSENCE with what is reported
by the Centers for Disease Control and Prevention’s (CDC) sen-
tinel physician surveillance system. We determined the best com-
bination of ICD9 codes that most closely approximated the epi-
demic curve observed by the CDC system during these two
influenza epidemic periods. Results and Discussion: ESSENCE
influenza data are as accurate and valid as CDC sentinel physician
data in detecting an influenza outbreak by showing similar out-
break curves and peaks. Specifically, ESSENCE’s measurements of
the start date and the end date of the influenza outbreak season did
not exceed seven days from similar dates reported by CDC sentinel
physicians. Among the types of illnesses that are coded during win-
ter respiratory outbreaks, particular ICD9 codes such as fever,
upper respiratory infection, viral syndrome and cough, are the best
indicators of respiratory outbreaks.
Lessons Learned from Implementing Electronic Laboratory
Reporting, New York State
P. F. Smith, M. Davisson, J. M. Fuhrman, H. Chang, I. J. Gotham, G.
Birkhead, D. L. Morse
New York State Department of Health, Albany, NY
Background: One of the main goals of developing the
National Electronic Disease Surveillance System (NEDSS) is to
promote the transmission of public health data by establishing uni-
form national standards for information exchange. New York State
(NYS) has developed the Electronic Clinical Laboratory Reporting
System (ECLRS) as one application of this approach.
Implementation of ECLRS required developing solutions to sev-
eral unanticipated challenges. Methods: ECLRS is an automated,
internet-based, secure system that permits laboratories to transmit
test results electronically to NYS counties to meet public health
















the past paper-based system with electronic reports, to increase the
speed of reporting, to simplify the work of laboratories and to pro-
vide an automated alert system for diseases of urgent importance.
The system was designed and implemented via a collaborative
effort among epidemiologists, information technologists, lab spe-
cialists and administrators. Results: The initial expectation of inte-
grated, standardized reporting capabilities of laboratories was
unrealistic. The system ultimately had to accommodate the wide
range of laboratory reporting capabilities. Because most laborato-
ries do not use either the Logical Observation Identifier Names
and Codes (LOINC) or the Systemized Nomenclature for
Medicine (SNOMED) coding, or the Health Level 7 (HL7) file
format, ELCRS allows laboratories to transmit results via any one
of three specified file formats, and does not require
LOINC/SNOMED codes. There are 27 laboratories currently
using and 22 preparing to use ECLRS. Of the 27 using ECLRS, 3
report by ASCII file format, 22 by web page data entry, and 2 by
HL7. Four laboratories report with LOINC/SNOMED codes.
Quality, completeness and timing of reporting were also chal-
lenges. Not all test reports have complete information for patient
address, which is critical to the correct routing of reports to coun-
ties. ECLRS has a hierarchical method of assigning each report to
a county; nevertheless, there are still many reports that require
manual assignment to counties. Many laboratories find it chal-
lenging to simply provide electronically what has been sent by
paper in the past, and providing automatic alerts was more com-
plicated than expected because of the problem of false alerts and
messages being sent off-hours. Conclusions: The successes of
ECLRS have shown the critical importance of involving all actual
and potential system users throughout the planning and execution
process. The challenges encountered indicate the need for evolu-
tionary changes in existing commercial laboratory information sys-
tems. The successful outcome of this process can be effected only
through close partnerships among commercial laboratories, CDC
and state and local health.
Outbreak Surveillance: An Important Tool for Controlling
Communicable Diseases 
M. G. Baker, C. N. Thornley
ESR, Wellington, NEW ZEALAND
Background: The identification, control and prevention of
communicable disease outbreaks are important and enduring
objective of public health services. Despite the importance of these
objectives, many outbreaks are not identified or investigated and
much of the information that could be used for preventing future
outbreaks is lost because findings are often not reported in a sys-
tematic manner. Method: New Zealand introduced a national out-
break surveillance system in July 1996. This system provides a
standardised way of reporting outbreaks, including details of the
causal agent, characteristics of cases, mode of transmission, con-
tributing factors, and outbreak management. The system is fully
electronic and integrated with other components of the national
infectious disease surveillance system. Results: The number of
recognised outbreaks has increased from 45 in 1996 (6 months) to
289 in 2000. In 2000, outbreaks involved a total of 2296 cases, of
which 150 required hospitalisation and 5 died. There were 200
common source outbreaks reported, of which 164 arose from com-
mon events. The most common pathogens or toxins implicated
were Norwalk like virus (34 outbreaks), Campylobacter (37) and
Salmonella (30). The most common non-enteric pathogen or toxin
was Bordetella pertussis (11 outbreaks). Commercial food opera-
tions (mainly restaurants or cafés) were implicated in 147 out-
breaks. Foodborne transmission accounted for 190 outbreaks in
2000. Person to person and waterborne transmission accounted for
114 and 23 outbreaks respectively. Abuse of temperature was the
most common factor contributing to foodborne outbreaks. The
most commonly implicated food type was poultry (43 outbreaks)
though the quality of evidence establishing the link was relatively
weak in most instances. Conclusions: These surveillance data are
beginning to define the burden of disease caused by outbreaks in
New Zealand. More importantly, they provide information that
should be useful for policy makers, particularly those concerned
with improving food safety. The outbreak surveillance system was
significantly upgraded in 2000 with an ‘active’ process of integrat-
ing epidemiological data with that from communicable disease and
food laboratories to improve the sensitivity and timeliness of out-
break reporting.
Lyme Disease Incidence in Wisconsin: A Comparison of State
Reported Rates with Rates from a Population-Based Cohort 
A. Naleway1, E. Belongia1, J. Kazmierczak2, R. Greenlee1, J. Davis2
1Marshfield Medical Research Foundation, Marshfield, WI,
2Wisconsin Division of Health, Madison, WI
Background: In endemic areas, Lyme disease (LD) is now
frequently regarded by physicians as a routine medical condition
and is often managed in urgent care centers or other high-volume
outpatient settings. As a result, many cases of Lyme disease may
not be reported to state health departments. Few studies in the
past decade have assessed the accuracy and completeness of state-
based passive LD surveillance systems, nor have any recent studies
examined LD incidence using alternative data sources. Methods:
Potential LD cases (1992-1998) were identified from chart review
and laboratory results at two large multispecialty clinic networks in
Wisconsin. Cases were confirmed if they met the CDC case defi-
nition, and they were then compared with cases reported to the
Wisconsin Division of Public Health (DPH) that also met the CDC
case definition. Using clinic data, incidence rates were calculated
for residents of the Marshfield Epidemiologic Study Area (MESA),
a dynamic population-based cohort of nearly 90,000 residents in
north-central Wisconsin. The Marshfield Clinic is the main
provider of health care in the 24 zip codes that comprise MESA,
and capture of health events for MESA residents is nearly com-
plete. Incidence rates were also calculated using DPH data for an
eight county region that surrounds and includes MESA, and for the
entire state of Wisconsin. Results: Four hundred definite cases of
Lyme disease were identified through review of clinic records. The
average incidence of definite Lyme disease (1992-1998) was 17.6
per 100,000 in MESA. Based on DPH case reports, the LD inci-
dence was 17.7 per 100,000 in the eight county region surrounding
MESA, and 9.5 statewide. Temporal trends in statewide incidence
generally were comparable to those observed in MESA. LD inci-
dence rose sharply from 1996 to 1998 in both MESA and the sur-
rounding eight county region. Sixty-eight percent of definite Lyme
disease cases meeting the CDC case definition were not reported
to the Wisconsin DPH. Conclusion: These findings suggest that
the state passive surveillance system accurately monitors trends in
LD incidence, but is less useful for estimating the true burden of
Lyme disease due to substantial underreporting of definite cases.
Surveillance for Patients with Acute Febrile Illness in Egypt 
S. Afifi1, M. A. Azab1, F. G. Youssef1, H. El Sakka1, K. Earhart1, S. El
Oun2, F. Mahoney1,3
1U.S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Ministry
of Health and Population, Cairo, EGYPT, 3Centers for Disease Control
and Prevention, Atlanta, GA
Introduction: Acute fever of undetermined etiology (AFI)
is a common clinical syndrome that is not well characterized in
Egypt. In 1999, training on a standard clinical and laboratory eval-
uation of patients with AFI was provided to a network of providers
in 13 infectious disease hospitals throughout Egypt. The results for
the first 29 months are reported, demonstrating typhoid and bru-
cellosis as the primary etiologies. Methods: Standard case defini-
tions were used to identify patients. Case investigations forms
included clinical, demographic, and risk factor information.
Patients were classified as having confirmed S. typhi infection or
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brucellosis based on positive blood cultures. Patients with Brucella
tube agglutination titers > 1:160 were classified as having con-
firmed brucellosis. Patients with Widal titers > = 1:160 were clas-
sified as having probable typhoid fever. Nested analysis was per-
formed to calculate age-adjusted prevalence ratios (PR) to identify
risk factors for patients with brucellosis. Results: Of the 4906
patients evaluated between March 1999 and August 2001, 278
patients (6%) had positive blood cultures for S. typhi and 516
(10.5%) patients were classified with probable disease. Patients
with typhoid fever were identified in all participating institutions
with a peak in the number of cases during the fall (Sept-Nov). The
mean age of patients with S. typhi infection was 19 (range 3 - 79);
50% were male. Brucellosis was identified in 533 patients (10.9%),
including 114 persons with culture confirmed disease. Patients
with brucellosis were diagnosed in all participating hospitals, both
rural and urban, and in all months of the year, with a peak during
the months of September to October. The mean age of patients
with brucellosis was 32 yrs +/- 14.8; 64.8% of patients were male.
Exposures significantly associated with brucellosis, as compared to
other patients with AFI, included increasing age (p<0.001), contact
with an animal abortus (PR 3.1), handling raw meat (OR 2.3),
slaughtering animals (PR 2.2), daily contact with domestic animals
(PRs of sheep 2.4, cattle 2.0, camel 4.9, buffalo 2.1), consumption
of non-pasteurized milk (PR 1.6) and soft cheese (PR 1.2).
Conclusion: The surveillance network has identified typhoid fever
and brucellosis as the most commonly recognized causes of com-
munity-acquired bloodstream infections in Egypt. Improving labo-
ratory capacity can lead to greater success in diagnosing causes of
AFI to help tailor therapy and define burden of disease.
Foodborne Viruses in Europe: Web-Based Technologies for
Investigation of Transnational Outbreaks of Viral
Gastroenteritis 
M. Koopmans1, B. A. Lopman2, H. Vennema1, M. Reacher2, J.
Carrique-Mas3, Y. van Duynhoven4, F. Hanon5, D. W. Brown2
1Research Laboratory for Infectious Diseases, National Institute for
Public Health and the Environment (RIVM), Bilthoven, NETHERLANDS,
2Public Health Laboratory Service, London, UNITED KINGDOM,
3Swedish Institute for Infectious Disease Control, Solna, SWEDEN,
42Research Laboratory for Infectious Diseases, National Institute for
Public Health and the Environment (RIVM), Bilthoven, NETHERLANDS,
5Statens Serum Institute, Copenhagen, DENMARK
Viral agents have been estimated to cause more human dis-
ease than any other foodborne pathogen. Transnational outbreaks
of Norwalk-like virus (NLV) due to international food distribution
have been documented recently as advances in molecular charac-
terization have allowed for an improved capability to trace virus
through the population. A network of surveillance systems of nine
European countries has been initiated in order to allow more rapid
and internationally standardized assessment of foodborne viruses.
We have harmonized the collection of clinical information from
outbreaks and virological characterization data. A standard ques-
tionnaire and minimum dataset for use in outbreak investigations
has been agreed as well as molecular techniques and sequencing
protocols for the characterization of NLV. The web-based data
communication instruments (Active Server Pages (ASP) for clinical
data and Bionumerics software for characterization data) will be
described. The two databases are relational, accessible to all par-
ticipants and data can be viewed over the Internet immediately fol-
lowing an outbreak report. Thus, the system functions both as an
early alert tool for investigators and a comprehensive database of
previously investigated outbreaks. Results from the winter
2001/2002 will be presented.
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PER.C6: A Human Designer Cell Line Providing a Pandemic
Proof Platform for the Manufacturing of Safe Influenza
Vaccines 
M. Pau, C. Ophorst, M. Oerlemans, A. Vooys, J. Pasma, R. Lonsdale,
G. Marzio, C. Tuijn, F. G. UytdeHaag
Crucell Holland BV, Leiden, NETHERLANDS
Influenza virus is killing thousands of people per year and
causes widespread morbidity with an enormous social and eco-
nomic impact. Influenza virus continuously evolves by antigenic
drift causing yearly epidemics. In addition, new strains against
which no immunity exists in the population can suddenly appear,
giving rise to pandemics with catastrophic results as demonstrated
by the Spanish Flu pandemic killing between 20 to 40 million peo-
ple. The recent emergence of new strains — H5N1 in 1997 in
Hong Kong that killed 6 out of 18 infected humans and H9N2 in
1999 isolated from children in Hong Kong and China — indeed
show that influenza is ‘standing at the gate’. Are we prepared to
combat a new pandemic?
Vaccination is the cornerstone of influenza management
and its benefits are firmly established.Influenza vaccines are
presently produced on embryonated hen’s eggs.
This production system is not flexible and an undercapacity
to produce vaccine for future inter-pandemic periods is anticipat-
ed. In case of a pandemic threat it is unlikely that such a manufac-
turing system will be able to meet the global demand for a pan-
demic vaccine.
The human designer suspension cell line PER.C6TM,
derived from human primary retina cells by transformation with an
E1 minigene of adenovirus type 5, provides a safe cell substrate for
the manufacturing of influenza vaccines. All strains tested replicate
with fast kinetics (3-4-days) to high titres (1E+07-1E+09 PFU/ml)
resulting in excellent yields of hemagglutinin in crude bulk as meas-
ured in the SRID (up to>65ug/ml). Furthermore, PER.C6 TM can
be grown in large capacity bioreactors (>1000L) in high cell densi-
ties (>6E+06 vc/ml) in an animal component free medium.
Altogether, these properties make PER.C6 TM a powerful
pandemic proof vaccine manufacturing platform .
Acute Respiratory Virus Surveillance in Cairo and Alexandria,
Egypt, July 2000 to June 2001 
D. E. Salman1, S. Lewis1, E. Aoun2, C. Fayez1, H. M. Esmat2, B.
Botros1, A. K. Soliman1, G. D. Chapman1, R. R. Graham1
1U. S. Naval Medical Research Unit No. 3, Cairo, EGYPT, 2Ministry
of Health and Population, Cairo, EGYPT
In collaboration with the Egyptian Ministry of Health and
Population, the U.S. Naval Medical Research Unit No.3
(NAMRU-3) conducts influenza and respiratory virus surveillance
as part of a region-wide surveillance program to characterize
influenza viruses circulating within the WHO Eastern
Mediterranean Region (EMR). In this report, we describe the
results of this surveillance activity from July 2000 to June 2001 in
two major cities in Egypt, Alexandria and Cairo. A total of 1923 and
375 throat swab samples were collected from Alexandria Fever
Hospital (AFH) and Shoubra General Hospital (SGH) Cairo,
respectively. These samples were processed for virus isolation(s) in
four different cell cultures i.e. H292, LLCMK2, MRC5 and
MDCK. Viral isolates were identified using immunofluorescent
techniques (IFA) with commercial respiratory and enteroviruses
















Subtyping of influenza isolates was done by heamagglutination
inhibition (HI) using WHO influenza subtyping kits provided by
the CDC Influenza Branch, Atlanta, GA. A total of 251 influenza
viruses were isolated during the surveillance period with a 12%
(229/1923) isolation rate from AFH and 6% (22/375) from SGH.
Influenza viruses isolated included 241(96%) type B and 10 (4%)
type A. Only influenza A (H1N1) and influenza B
(B/Sichuan/379/99-like) were isolated. In addition, 2 parainfluenza,
27 adeno and 27 entero viruses were isolated. Representative sam-
ples from the influenza A and B isolates were submitted to the
WHO Collaborating Center on Influenza at CDC for strain analy-
sis. The H1N1 isolates were identified as A/New Caledonia/20/99-
like and B isolates as B/Sichuan/379/99-like. The previous year sur-
veillance showed a predominance of influenza A (H3N2) similar to
that observed worldwide.
Influenza Surveillance in New York State, 1998-2001
M. Kacica, V. Randle
New York State Department of Health, Albany, NY
Background: New York State Department of Health
influenza surveillance consists of laboratory surveillance, nosoco-
mial outbreak reporting, sentinel physician surveillance, and the
State Epidemiologist’s weekly assessment of influenza activity. This
report examines the corroboration of data and possible redundan-
cy of collected information over a three-year period.
Methods: Ten laboratories in New York State participate in
World Health Organization and Centers for Disease Control col-
laborating laboratory surveillance systems. Throughout influenza
season (October-May), these laboratories report the number of
respiratory specimens tested and the number positive for influen-
za each week. The state’s hospitals and long-term care facilities
report outbreaks of nosocomial influenza, as required by state pub-
lic health law. Sentinel physicians report on the number of patients
seen weekly, and the number with Influenza-like Illness (ILI).
Based on population, laboratory and outbreak reporting, the State
Epidemiologist categorizes the level of influenza activity (as none,
sporadic, regional or widespread) each week. Results: Surveillance
data were reviewed for the period 1998-2001. Peak periods of
influenza activity each season were characterized by ≥ 10% of res-
piratory specimens testing positive for influenza. Periods of
increased virus isolation ranged from 11 to 14 weeks. Peak periods
were also characterized by receipt of ≥ 5 outbreak reports/week the
first two seasons and ≥ 2 reports/week in the third. Periods of ele-
vated outbreak activity ranged from 8 to 10 weeks. When ≥ 15% of
specimens tested positive for influenza, nosocomial outbreaks
increased. During all three seasons, outbreaks at least doubled
coincident with high circulating virus. Increases in ILI appeared
earlier, and showed more fluctuation, than increases in viral iso-
lates or outbreaks in all seasons. Conclusion: Nosocomial out-
breaks increased sharply at the same time laboratories reported ≥
15% of specimens testing positive for influenza. Peak periods of
outbreak activity in healthcare facilities were of shorter duration
than peak periods of virus isolation from the community, which
may be attributed to aggressive infection control and public health
oversight. Sentinel surveillance is a sensitive system for early sea-
son ILI detection; early fluctuations may be due to reporting arti-
fact and other circulating viruses. Three of the surveillance systems
were complementary in defining influenza activity. The State
Epidemiologist’s Report was a summary of these surveillance sys-
tems for national comparison.
Geographical Coherence of Influenza Epidemics in the US,
France and Australia: 1978-98
C. Viboud1, A. Flahault1,2
1INSERM U444, Paris cedex 12, FRANCE, 2Centre-Hospitalier Saint-
Antoine, Paris cedex 12, FRANCE
There is a substantial inter-annual variability in the circu-
lating strains, impact, and time of onset of influenza epidemics
occurring in temperate areas of the world. It is assumed that the
disease results from human to human transmission of influenza
viruses, and that the global circulation of these viruses stems from
rapid transportation fluxes (1,2). To what extent influenza epi-
demics display similarities, or coherence, in geographically dis-
tant areas has not been determined. Here we examine the coher-
ence of influenza epidemics in the US, France and Australia over
20 epidemic seasons.
Weekly number of deaths from pneumonia and influenza
(P&I) and demographic data were provided by national agencies
for vital statistics from Jan 1st, 1978, to Dec 31st, 1998, in the US,
France and Australia. We used codes 480-487 from the
International Classification of Diseases, 9th revision. Mortality
time series dating back to 1968-77 are currently analysed.
From the national weekly P&I mortality time series, we
defined epidemic weeks and baseline mortality by a linear season-
al regression model (3). For each winter season, we measured the
overall and age-specific excess mortality (< or ≥ 65 years old), i.e.
the difference of the reported mortality to the expected baseline
mortality (4).
We estimated an average of 6,000 P&I excess deaths in the
US over the study period (range 0-14,700), 2,100 in France (range
0-8,600) and 300 in Australia (range 0-1,000). Two of 20 influenza
seasons did not result in substantial P&I excess mortality in the
US, 3 in France and 1 in Australia. The duration of the epidemic
periods was similar in the 3 countries : on average 12.3 weeks in
the US (range [4-18]),12.3 in France (range [8-18]), and 10.2 in
Australia (range [2-19]) (P=0.80). The maximum incidence of P&I
excess mortality in elderly (persons over 65 years old) was
40/100,000 in the US, 60/100,000 in France and 42/100,000 in
Australia. The proportion of P&I excess mortality in elderly
ranged from 46% to 96% in the US, 87% to 100% in France and
40% to 100% in Australia. The correlation coefficient between the
numbers of P&I excess deaths in the US and France in contem-
poraneous winter seasons was 0.70 (P=0.001). The number of P&I
excess deaths in Australia was not correlated with that in France
or the US in the preceding or following influenza season. In the
influenza seasons resulting in substantial P&I excess mortality
both in France and the US, the median time lag between the epi-
demic onsets was 1 week (range 0 - 11 weeks).
There is a fairly good coherence in the overall impact of
influenza epidemics on P&I mortality in France and the US, con-
trary to Australia. Whether the lack of coherence is associated with
differences in the circulating strains, vaccination coverage, or
demographic factors, will be explored.
A DoD Global Influenza Surveillance Program 
L. C. Canas, J. S. Neville, A. R. Krull, M. J. Rodriguez, L. T. Daum
Brooks Air Force Base, San Antonio, TX
Military global influenza surveillance began in 1976 as a
United States Air Force public health program. In 1997 the
Department of Defense (DoD) Global Emerging Infections
Surveillance and Response System (GEIS) expanded the program
to include all US military services, as well as local residents in areas
where DoD overseas research activities operated. This worldwide
DoD surveillance infrastructure provides valuable information
designed to provide rapid responses to outbreaks that are poten-
tially a significant threat to military readiness. Although this was
first recognized during the 1918 influenza pandemic that took the
lives of 43,000 US military personnel, it has been underscored by
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more recent outbreaks that have impacted training and operational
missions. The influenza surveillance initiative combines viral isola-
tion, antigenic characterization, and molecular sequencing with
clinical and public health information. This information, as well as
selected isolates sent for further antigenic characterization, is
shared with the Centers for Disease Control and Prevention
(CDC) and the World Health Organization (WHO) and has con-
tributed to important decisions in influenza vaccine composition.
From October 1999-October 2001, nearly 12,000 specimens were
submitted to the Brooks Air Force Base virology laboratory in San
Antonio, TX. These samples came primarily from 24 sentinel sites
around the world and were processed according to standard virol-
ogy protocols for the presence of any respiratory virus. A retro-
spective look at this data demonstrates the unpredictability from
season to season of the type of virus that will circulate or the impact
the virus will exert and the importance of continuing and even
expanding the surveillance network. Since there are several respi-
ratory viruses that cause “flu-like symptoms,” any isolate is tracked,
but influenza is the focus of the program. During the 1999-2000
season, 89% of the influenza isolates (337/377) were influenza A.
Of those that were antigentically subtyped by hemagglutination-
inhibition, 80% were H3N2. In contrast, during the 2000-2001 sea-
son, 43% of the influenza isolates (222/521) were influenza A and
only 42% of those subtyped were H3N2. While the prevailing per-
ception is that change originates in the Far East, the H3N2
(A/Panama) and the H1N1 (New Caledonia) components of the
2000-2001 and 2001-2002 seasons have emerged from Central
America and the Southern Hemisphere respectively. Before that,
Influenza A/Sydney/05/97(H3N2), also from the Southern
Hemisphere, had predominated for three years (1997-2000). The
DoD sponsors a unified program that is global in scope and is actu-
ally a microcosm of the larger international programs that pull from
many geographically distinct surveillance programs.
Using CUSUM Techniques To Identify Influenza Outbreaks
V. Foster1, J. Matheson1, M. Stoto2
1George Washington University School of Public Health & Health
Services, Washington, DC, 2The RAND Corporation, Arlington, VA
The objective of this research is to develop statistical meth-
ods for determining the beginning of an influenza epidemic. Each
year influenza infections are responsible for large numbers of
excess deaths, hospitalizations and physician visits in the United
States, all of which are intensified during epidemic years. Influenza
is a largely preventable illness because effective vaccines can be
prepared and administered in advance of the typical November to
March season. However, the timing of annual outbreaks can vary
within this broad range, therefore timely identification of changes
in the epidemiology of influenza can improve implementation of
control and prevention programs. Additionally, influenza outbreaks
occurring outside the typical season may elude detection until
large numbers of cases have accumulated.
In the United States the Centers for Disease Control and
Prevention’s Influenza Branch coordinates surveillance for influen-
za using weekly mortality reports, laboratory data, disease reports,
and sentinel physician reports. Because influenza is not a
reportable disease, however, most cases are not reported to health
officials. Surveillance is further complicated because many illness-
es have “flu-like” symptoms, therefore laboratory confirmation is
necessary for an accurate diagnosis. Reliance on laboratory confir-
mation or diagnoses that include influenza or influenza-like illness
may miss the earliest cases in an epidemic because they appear as
non-specific respiratory illnesses.
Emergency room visits at the George Washington
University Hospital from Jan. 1, 1998 through May 15, 2001 were
categorized according to five ICD-9 code groups: Flu (influenza),
ILI (influenza-like illness), URI (upper respiratory infection), Viral
NOS (not otherwise specified), and pneumonia. Exponential
smoothing produced the equivalent of a non-symmetric running
average. CUSUM methods with constant background and with
exponential smoothing background level were compared to stan-
dard outbreak detection models (Z-scores) to detect the start of
epidemics in 1999 and 2000.
For ILI and Viral NOS, CUSUM methods are preferable to
standard Z-score methods because they have fewer false positives
and no delay in recognizing outbreaks. Neither exponential
smoothing nor constant (Poisson) CUSUM methods are clearly
preferable to the other for identification of influenza epidemics.
Because most agents of bioterrorism first appear with flu-like
symptoms, the same data and methods described here can be used
for early detection of bioterrorism attacks.
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Tuberculosis Status Among Iranian and Afghan patients
Admitted to the National Research Institute of Tuberculosis and
Lung Disease (1998-2000) 
M. Yazdanpanah, M. R. Masjedi, H. Masjedi, M. Hosseini, A.
Velayati
National Research Institute of Tuberculosis and Lung Disease, Tehran,
IRAN (ISLAMIC REPUBLIC OF)
Objectives: Surveys carried out world wide revealed that
over 50% of refugees develop TB. Tuberculosis is of high preva-
lence in Afghanistan. No systematic study has been conducted on
the evaluation of TB and the related treatment status among
Afghan refugees in Iran yet. On the other hand, National Research
Institute of Tuberculosis and Lung Disease (NRITLD), as a refer-
ral center, receives a high number of Afghans suffering TB from
different parts of the country. Accordingly, during the past two
years, a study was performed on the TB status among Afghan
refugees in order to access preventive measures and anti-TB pro-
grams. Method: A cohort study was conducted on all adult TB
cases (>15 years) referring to NRITLD from the beginning of 1998
to the end of 2000. A questionnaire containing personal data (age,
gender, nationality and occupation) and TB status was distributed
among the cases. The result of sputum smear before the treatment
initiation and at the end of attack phase of treatment was recorded
in the questionnaire as well. Result:A total of 1028 TB cases, 68.3%
Iranian and 31.7% Afghan (326 cases) were studied. The mean age
was 32.76 and 48.98 among Afghans and Iranians respectively
(P<0.0001). Out of 712 patients with positive smear, grade of spu-
tum smear of 686 cases were recorded. The minimum and the
maximum of smear grade were +1(43.5%) and +3(37.4%) among
Iranians, whereas, they were 32.4% and 44.1% among Afghans
respectively (Table 2) (P<0.0001). Sputum smear was negative
among 77.4% of Iranians (260 cases) and 63.3% (93 cases) of
Afghans at the end of the second month, (X2=10.36 and df=1 and P<0.001).
Sputum smear of 70.6% (89 cases) of Iranians with smear grade of
3+ turned to negative at the end of the second month, however,
this was 55.6%(32 cases) amongst Afghan cases (P=0.04, df=1 and
X2=4.23). Treatment after default was seen among 49.2% of
Afghan with smear positive pulmonary TB and 32.4% of Iranians
(X2=40.2, df=1 and P<0.001). Discussion: The recent study sug-
gested that Afghan TB patients were younger than Iranians and
Afghans developed more severe forms of the disease compared to
Iranians.Afghan refugees play an important role in transmission of
Tuberculosis in Iran; therefore, controlling Afghan refugees for
















being treated, should be taken into special consideration. As a
consequence we will be able to prevent the dissemination of the
disease, and also take an essential step in control of TB through-
out the country.
Modeling Tuberculosis Dissemination in Harris County, Texas,
1995-1998, with Spatial Analysis and Geographic Information
Systems (GIS) 
M. L. Stone1, E. A. Graviss2, L. Teeter2
1University of Texas-Houston, School of Public Health, Houston, TX,
2Baylor College of Medicine, Houston, TX
Modeling Tuberculosis Dissemination in Harris County,
Texas, 1995-1998, with Spatial Analysis and Geographic
Information Systems (GIS) The main focus of this study was to
examine the spatial distribution of tuberculosis (TB) cases by area
in Harris County, Texas over a three-year period, October, 1995 to
September, 1998, using geographical information systems (GIS)
software and spatial analytical techniques. A major objective of this
study was to show how epidemiologic data could be merged with
GIS in order to formulate study questions, generate and test
hypotheses and critically evaluate topographic density maps that
were prepared by merging systematic spatial analytical techniques
with the database management and imaging qualities of a GIS. In-
depth spatial analysis was conducted on a subset of 1480 incident
TB cases gathered by the Houston Tuberculosis Initiative (HTI)
during a 36-month period. Analytical methods included describing
spatial point pattern distributions through the use of exploratory
and analytical techniques in order to observe whether overall TB
cases or subsets of TB cases exhibited any systematic patterns as
opposed to being randomly distributed (according to theoretical
Complete Spatial Randomness) throughout Harris County during
the three year period. These methods included spatial point pat-
tern techniques such as kernelling estimation, nearest neighbor
analysis, (h) function methods, spatial filtering methods and a spa-
tial scan statistical method. Analysis, after adjusting for underlying
U.S. Census 2000 population, found that much of the intensity of
TB cases in Harris County centered on a 5 mile radius from down-
town Houston, inside the Highway 610 Loop. There was evidence
of clustering of overall TB cases with larger clusters over smaller
geographical areas (6-10 miles) and the 3-year incidence estimates
climbed toward more than 300 cases/100,000 population. Black TB
cases were found to be more concentrated in larger clusters over a
smaller geographic area than other ethnic groups. Results of the
spatial filtering process calculated the mean incidence for Black
TB cases equal to 182 cases/100,000 population over 3 years. A spa-
tial scan statistical method found significant (P < 0.05) clusters of
four different molecularly characterized, clonally related groups.
Further analysis of one specific cluster (Print 4) showed the indi-
vidual risk of having TB for this Print type was 9 times higher than
expected (P < 0.01). In addition, out of 7 individuals who rode pub-
lic transportation in this cluster, 6 had a shared bus route.
Mapping of West Nile Virus Risk in the Northeast United
States Using Multi-Temporal Meteorological Satellite Data 
P. Backenson1, D. J. White1, M. Eidson1, P. F. Smith1, L. D. Kramer1,
D. L. Morse1, C. J. Tucker2, M. F. Myers3, S. I. Hay4, S. E. Randolph4,
D. J. Rogers4
1New York State Department of Health, Albany, NY, 2NASA, Greenbelt,
MD, 3International Research Partnership for Infectious Diseases,
Greenbelt, MD, 4Oxford University, Oxford, UNITED KINGDOM
West Nile Virus (WNV) was first discovered in the United
States in September of 1999, after a cluster of cases of human neu-
rological illness in the borough of Queens in New York City.
Eventually, that outbreak led to 62 human cases of WNV, including
7 deaths. Multiple researchers identified and isolated the virus in
several bird and mosquito species in New York. In 2000, an elabo-
rate surveillance system was developed to detect the presence of
WNV before human cases occur. This system was largely success-
ful, as the number of WNV detections in birds and mosquitoes
increased tremendously, while the number of human cases
dropped to 14. In 2001, this surveillance system, and those like it
in other states, detected the spread of WNV to over 20 states, with
over 40 human cases. Detecting WNV in both birds and mosqui-
toes, however, is a time and labor intensive task, requiring dedicat-
ed staff and resources. In New York it has required hundreds of
staff, and millions of dollars. It often takes at least 10 days from the
time of specimen collection to the time when results are available.
To improve efficiency and cost-effectiveness, proxies are sought
to estimate the risk of WNV infection in a given area, preferrably
on a real time basis. The project discussed here utilizes remotely
sensed meteorological data to accomplish that goal. Data from
the Advanced Very High Resolution Radiometer (AVHRR) on
the NOAA series of meterological satellites provided the
Normalized Difference Vegetation Index (NDVI) and land sur-
face temperature proxies, as well as elevation, and were temporal
Fourier processed. Bird and mosquito data (both infected and
uninfected) were added to these images to suggest conditions
favoring disease transmission. AVHRR data were also used to
analyze changes over time that might be associated with the
arrival of WNV in the United States, and with its potential spread
over time. Maximum likelihood methods applied to these satellite
data allowed production of a series of risk maps that measured
the similarity of satellite conditions in a given area to the bird and
mosquito data collected on the ground. Both bird and mosquito
risk maps showed high kappa indices of agreement. As surveil-
lance teams collect more field data on the ground, these risk
maps should become more accurate. These risk maps can then be
used by state and local authorities to better direct public health
staff and resources, and hopefully prevent large-scale outbreaks
of West Nile Virus in the future.
Investigation of Q Fever in Bosnia-Herzegovina, 2000: An
Example of International Cooperation 
J. H. McQuiston1, W. L. Nicholson1, R. Velic2, R. V. Gibbons1, L.
Castrodale1, S. H. Wainwright3, T. J. Vannieuwenhoven3, E. W.
Morgan4, L. Arapovic2, A. Delilic2, P. Puvacic5, T. Bajrovic2
1CDC, Atlanta, GA, 2Veterinary Faculty, Sarajevo, BOSNIA AND
HERZEGOVINA, 3USDA-APHIS, Riverdale, MD, 4US Army - SFOR,
Sarajevo, BOSNIA AND HERZEGOVINA, 5Ministry of Health,
Sarajevo, BOSNIA AND HERZEGOVINA
In July 2000, CDC and USDA investigators traveled to
Bosnia-Herzegovina (BiH) to assist authorities with the investiga-
tion of reported outbreaks of Q fever in humans and animals. Local
investigations of the disease had been hampered by limited diag-
nostic testing capability for Coxiella burnetii, the causative agent of
Q fever. The CDC-USDA investigators worked with local health
officials to establish a laboratory team to test human and animal
specimens by immunofluorescence antibody assays (IFA). The
team tested specimens from 415 persons, and detected antibodies
in 177 (42.7%) from all over the country. The team also tested over
2000 animal specimens, and detected antibodies in 10% of cattle
and 4% of sheep. Case control studies were conducted in two
towns (Kakanj and Mostar) to further define risk factors for infec-
tion. Cases were defined as a patient with a clinically compatible
illness that was also seropositive. Twenty-five cases and 23 controls
were examined from Kakanj; most cases had illness onset in early
March and early June consistent with two point-source outbreaks.
Seventeen of 25 (68%) cases were male; mean age = 37 years,
median age = 36 years. Unexpectedly, cases were less likely to have
handled sheep (p=0.07) or cattle (p=0.02) than controls.
Consuming milk purchased from a neighbor appeared to be a risk
factor (OR 4.1 p=0.04), while consuming milk collected at home
appeared protective (OR 0.23 p=0.05). Although not significant,
cases engaged in general outdoor activities more often than con-
trols (OR 2.8, p=0.12). In Mostar, 13 cases were examined with ill-
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ness onset throughout January-June, consistent with sporadic
exposures. Seven (54%) were male; mean age = 46, median age =
43. Eight cases were compared to matched controls in Mostar;
cases appeared similar to controls with respect to livestock contact,
but numbers examined were too small to determine significance.
The serologic findings suggest widespread exposure in both
humans and animals in BiH, which contradicts the perception that
Q fever was a recent introduction to the country through animal
importation. Q fever is probably endemic to the region, and the
emergence of clinical disease and outbreaks may be associated with
undefined changes in farming practices. The outbreak in Kakanj
occurred in mainly persons with limited animal contact, indicating
possible exposure by wind or dairy products. During their visit,
CDC and USDA personnel worked to foster cooperation between
the veterinary and medical communities in the Federation of BiH,
and facilitated a meeting between veterinary officials from the
Federation of BiH and the Republic of Srpska for the first time
since the civil war. The team worked closely with these national
representatives to make recommendations regarding the diagnosis,
control, and prevention of zoonotic diseases such as Q fever.
A WHO Global Salm-Surv Retrospective Study Examining
Salmonella Serotypes in South America, 2000: Dominance of
Salmonella Serotype Enteritidis 
WHO Global Salm-Surv South America Working Group1,WHO
Global Salm-Surv2
1Instituto INEI-ANLIS "Carlos G Malbran", Buenos Aires, ARGENTI-
NA, 2World Health Organization, Geneva, SWITZERLAND
Background: Salmonella is a leading cause of foodborne
illness around the world. Laboratory-based surveillance data are
needed to understand the epidemiology of Salmonella and other
foodborne pathogens, influence public health action, and ultimate-
ly facilitate a decrease in the global burden of foodborne disease.
In response to a need to strengthen national and regional laborato-
ry capacity and foster collaboration between microbiologists and
epidemiologists involved in human and animal health and food-
related disciplines, World Health Organization (WHO) Global
Salm-Surv was created. This is a collaborative project of WHO, the
Danish Veterinary Institute, the Centers for Disease Control and
Prevention, and Institut Pasteur. Key components of the program
include an external quality assurance system and regional training
courses. The first South American (SA) regional training course
was conducted in Argentina in July 2000. During the second
regional training course in September 2001, the WHO Global
Salm-Surv SA Working Group, which involves microbiologists
from national public health, veterinary, and food reference labora-
tories from SA countries, was established to exchange information
and communicate Salmonella surveillance data. Methods: As an
initial step in the surveillance of Salmonella in the SA Region, we
conducted a retrospective study examining the distribution and
rank of Salmonella serotypes during 2000. The SA Working Group
member laboratories received Salmonella isolates for confirmation
and serotyping using the Kaufman-White scheme with the O and
H antisera available in each country. The SA WHO Global Salm-
Surv members reported Salmonella surveillance data using country
report forms. Results: In 2000, the SA Working Group member
laboratories received 9,468 specimens, of which 9402 (99.1%) were
serotyped. The specimen sources were human (n=2476, 26.3%),
animal (n=2297,24.4%), food (n=1577, 16.7%), feed
(n=2007,21.3%), and environmental (n=1045, 11.1%). Looking at
all sources, the most frequent serotype in SA in 2000 was S.
Enteritidis (n=4197, 44.6%). In humans, 1148 (46.3%) of the
serotyped strains were S. Enteritidis, followed by S. typhimurium
(12.7%) and S. typhi (9.8%). In food, S. Enteritidis accounted for
60% of the serotyped strains, S. typhimurium was found in only
5.2% and Agona in 3.4%. Salmonella Enteritidis was identified in
49.5% of the animal isolates, S. Heidelberg in 12.3%, and S.
typhimurium in 5.4%. Conclusion: Salmonella Enteritidis was the
most frequently isolated serotype from human and non-human
sources in the SA Region in 2000. These data provide baseline
information for a surveillance program that will monitor, over time,
the prevalence of Salmonella serotypes in SA. Regional differences
in isolation rates have been observed and reasons for these differ-
ences will be explored by the SA Working Group.
Recurrent Histoplasmosis Outbreaks in Acapulco, Mexico
Y. A. Roldán, L. E. Soto-Ramírez, G. Rosales, G. R. Pena, J. Sifuentes-
Osornio, L. Taylor, G. M. Ruiz-Palacios
Natl Inst Med Sc and Nutrition, Mexico City, MEXICO
Although Histoplasmosis has a worldwide distribution it is
often overlooked in the differential diagnosis of acute respiratory
illness. Recently, 2 outbreaks of acute pulmonary histoplasmosis
occurred in tourists in Acapulco. In a cohort study by CDC of the
outbreak in American students, the only significant risk factor was
staying at a beach hotel. In September a new outbreak occurred in
convention attendees in the same hotel. We describe clinical and
epidemiological characteristics of this outbreak and identification
of the source. Methods: 291 persons, all guests in a hotel in
Acapulco in September 13-21, 2001 were studied. Diagnosis was
made by clinical and X-ray findings and serology and urine antigen.
Controls were matched by date of stay; cases and controls
answered a questionnaire on risk factors. Environmental sources
were searched for by direct culture, and by peritoneal inoculation
of samples and direct exposure of sentinel BALB/C mice. Results:
Of 291, 227(78%) were ill (cases). Of these, 152 (67%) were male;
median age was 38 yr, range 20-64. The most frequent symptoms
were headache (89%), fatigue (82%), fever (81.5%; median
39.2°C), night sweats (78%), chills (71%), cough (63%), chest pain
(55%), anorexia (52%), weight loss (43%; mean 3.7 Kg) and diar-
rhea (14%). Histoplasma Ag was found in 7/27 (26%) urine sam-
ples taken after 10 days of illness. Specific Abs were found in 41%
and 89% of acute and convalescent sera, respectively, from 104 ill
pts. Of the environmental samples, H.capsulatum was isolated only
from soil of plants from the beach restaurant. The hotel was closed
for study and remodeled following our recommendations. There
have been no further cases after the last outbreak. Results of the
case-control study of risk factors will be presented. Conclusions:
A third outbreak of acute pulmonary histoplasmosis occurred in
Acapulco, affecting 227 convention attendees (attack rate of illness
78%). Recurrence of outbreaks stresses the importance of source
detection and elimination. Contaminated plant soil prepared from
compost was the source of the outbreaks. Interestingly, plants and
soil were changed by the same nursery before each outbreak.
Histoplasmosis should be considered in the differential diagnosis
in travelers with respiratory symptoms who visit endemic areas.
Detection of H. capsulatum antigen in urine is low in acute pul-
monary histoplasmosis. Acute/convalescent serology is recom-
mended, since over 50% of acute sera were negative.
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An Effective Proteoliposome-Based Vaccine Against B&C
Meningococcal Disease 
G. Sierra
Finlay Institute, Habana, CUBA
A purifed vaccine VAMENGOC-BC consisting of purified
OMP(s) from N. meningitidis B and purified C polysaccharide
from N. meningitidis C presented as a protein-polysaccharide com-
plex based on a Proteoliposome model has been developed and
carefully tested.
In a well controlled, randomized, stratified, prospective,
double blinded placebo-vaccine trial this vaccine has shown an effi-
cacy of 83%;95% Cl (42%-95%). After ten years (1987-97) of mas-
sive application in Cuba and many other countries of more than 40
millions of VA-MENGOC-BC doses under epidemic and endemic
situations an effectivity ranging from 75 to 98% have been proved
under different trial conditions (cohort studies, case-control stud-
ies, etc.)
A satisfactory low reactogenic and safe profile has been
demostrated for this vaccine in vaccinees ranging from 3 monthes
to adult age.
This Finlay’s vaccine is the first in the world with proven
clinical efficacy against group B meningococcus coused disease.
The protective capacity of this vaccine has been tested against
many different patogenic Men B-Sero-Subtypes.
Laboratory as well as clinical data based on more than 18
years of experience will be discussed during the presentation.
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Developing Countries 
S. Sirinavin
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Appropriate antimicrobial drug use is defined as use that
maximizes therapeutic benefit while minimizing development of
resistance, adverse reaction, and cost. Antimicrobial drug use is a
major cause of antimicrobial-resistance problems. Although
methodology to maintain the useful life of antimicrobial drugs is
available, but all are still far from adequacy. “Drugs” and “users”
are the two key components.
Antimicrobial drugs are not adequately available in the
poorest countries, while overloading with too many items and
preparations of drugs is the problem in the others. Competitive
business promotion of many new drugs usually results in overuse
and rapid resistance. Too many drugs also give confusion to users
and appropriate use is more difficult. Locally manufactured drugs
are sometime of substandard which can cause inadequate therapy
and also contribute to antimicrobial-resistance problems.
Antimicrobial drugs in developing countries are usually
available “over-the-counter”. Effects of antimicrobials on creating
resistant microbes are difficult to be perceived while the drugs
seems to be harmless and useful. Antimicrobials are therefore fre-
quently used for several illnesses, especially for those with any
inflammatory reaction. Rational antimicrobial prescription needs
good diagnostic approach, including microbiologic diagnosis.
Quality of curriculum for professional trainees, etiologic epidemi-
ology information and laboratory supports are necessary. These are
frequently insufficient in developing countries. Infectious disease
specialists who are competent in guiding rational antimicrobial use
are also scanty. In addition, antimicrobial drugs are widely used in
animal husbandry without adequate guide or controlled.
In Thailand, inappropriate use of antimicrobial drugs and
antimicrobial resistance problems have been concerned. The
National Committee on Revising Essential Drug List tried to min-
imize the antimicrobial items in a National Drug List 2000.
National guideline for antimicrobial therapy has been developed
since 1994 and revised in 1996. National Antimicrobial Resistant
Surveillance Center for monitoring resistance problems in human
beings and Center for Antimicrobial Resistance Monitoring in
Food-Producing Animals were developed recently. Activities to get
people who concern about antimicrobial resistance problems in
animals and in human to work and to think together have been
organized through the National Committee on Controlling Non-
Typhoidal Salmonellosis. Several strategies to improve prevention
and treatment of infectious diseases, have been implemented in
hospitals and community. Drug utilization reviews in hospital set-
ting are performed for all restricted antibiotics. So far, inappropri-
ate use of antimicrobial drugs and resistance problems in Thailand
are still increasing. A strong national policy commitment and sup-
port on solving this problem is necessary.
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CHERRY, BRYAN .......................Slide.................45
CHESHIER, RON ......................Slide.................74





CHONGTHALEOUNG, A ........Poster ..............60...............89
CHRISTIANSEN, LASSE E.......Poster ..............8.................65
CHU, MAY C.................................Poster ..............23...............46
CHU, PATRICIA .........................Poster ..............4.................22
CHUANG, FRANK Y...................Poster ..............62...............107
CHUANG, ILIN ..........................Poster ..............20...............24
CHURCH, T ................................Poster ..............28...............77
CHURILLA, ALBERT ...............Poster ..............62...............109
CHYOU, PO .................................Slide.................76
CHYOU P, PO ..............................Slide.................74
CICCARESE, PAOLO ................Poster ..............1.................5
CIESLAK, P .................................Poster ..............28...............82
CIESLAK, PAUL R ......................Poster ..............20...............24
CIESLAK, PAUL .........................Poster ..............28...............101
CIESLAK, PAUL R ......................Poster ..............28...............102
CIESLAK, PAUL .........................Poster ..............50...............15
CLAIN, ALISABET .....................Poster ..............27...............74
CLARK, GARY G..........................Poster ..............56...............64
CLARK, GARY .............................Slide.................77
CLEMENS, JOHN ......................Poster ..............50...............6
CODRINGTON, G .....................Poster ..............27...............71
COIA, J E.......................................Poster ..............61...............100
COKER, PAMALA ......................Poster ..............50...............18
COLFORD, JOHN M..................Poster ..............5.................29
COLFORD, JOHN M..................Poster ..............9.................83
COLFORD, JOHN M..................Slide.................33
COLLINS, EMILY ......................Poster ..............22...............28
COMACH, GUILLERMO .........Slide.................77
COMMISSIONG, E ....................Poster ..............28...............93
COMMISSIONG, E ....................Slide.................47
COMO-SABETTI, KATHRYN ...Poster ..............20...............16
COMO-SABETTI, KATHRYN ...Poster ..............50...............15
CONCA, PAOLO .........................Poster ..............3.................19
CONCA, PAOLO .........................Poster ..............59...............80
CONIDI, GIUSEPPE .................Slide.................78
CONRADT, JENNIFER M.........Slide.................79
CONTI, LISA ...............................Poster ..............10...............85
CONTI, LISA A ............................Slide.................34
CONTI, LISA A ............................Poster ..............56...............55
CONTI, LISA ...............................Poster ..............58...............71
COOPER, DUNCAN ..................Poster ..............22...............28
COOPER, LYNN A ......................Poster ..............62...............110
COOPER, LYNN A ......................Poster ..............62...............111
COPPS, JOHN .............................Poster ..............56...............49
CORBET, SYLVIE .......................Slide.................47
CORNET, J P ................................Poster ..............54...............38
CORREA, JOSUE .......................Poster ..............55...............43
CORREA, MARIA T ....................Poster ..............27...............61
CORREIA PONTES, N N...........Poster ..............55...............47
CORWIN, A .................................Poster ..............56...............54
CORWIN, ANDREW L...............Poster ..............13...............107
CORWIN, ANDREW L...............Poster ..............20...............17
CORWIN, ANDREW L...............Poster ..............52...............31
COSTA, JANE ..............................Slide.................77
COULL, JAMES ..........................Poster ..............1.................11
COULL, JAMES ..........................Poster ..............50...............14
COUNTS, JON M.........................Slide.................33
COURTNEY, A K .........................Poster ..............28...............97
CRAIG, ALLEN S ........................Poster ..............4.................22
CRAIG, ALLEN S ........................Poster ..............6.................35
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CRAIG, ALLEN S ........................Poster ..............20...............6
CRAIG, ALLEN  S .......................Poster ..............20...............24
CRANFIELD, MICHAEL R ......Poster ..............6.................49
CRAY, PAULA J.............................Poster ..............50...............26




CROWE, COLLEEN A...............Poster ..............8.................70
CRUCETTI, JAMES ...................Poster ..............1.................7
CRUMP, JOHN A .........................Slide.................44
CRUMP, JOHN A .........................Slide.................75
CRUZ, JOHN ...............................Poster ..............55...............41
CRUZ, JOSE R..............................Poster ..............53...............32
CUELLO DE UZCATEGUI, R ....Slide.................77
CUMMING, MELISSA ..............Poster ..............27...............74
CUMMINGS, KATE ...................Poster ..............8.................75
CUMMINS, JAMES E.................Poster ..............6.................53
CUNNINGHAM-MYRIE, C ......Poster ..............27...............71
CURNS, AARON T ......................Slide.................74
CURRIER, MARY .......................Slide.................44
D’ AVANZO, ERNESTO ............Poster ..............3.................19
D’ AVANZO, ERNESTO ............Poster ..............59...............80
DA SILVA, V O..............................Poster ..............55...............47
DAHLBERG, DEBORAH .........Slide.................78
DALTON, R M..............................Poster ..............30...............110
DALTON, R M..............................Slide.................35
DAMBAUGH, TIMOTHY .........Poster ..............2.................16
DANGANAN, LINDA E .............Poster ..............62...............113
DANIEL, JAMES ........................Slide.................78
DANILA, RICHARD ..................Poster ..............1.................8
DANILA, RICHARD ..................Poster ..............20...............16
DANILA, RICHARD ..................Poster ..............25...............50
DANILA, RICHARD ..................Poster ..............61...............96
DANILA, RICHARD ..................Slide.................75
DANKO, LINDA H .....................Poster ..............13...............104
DANTOINE, FRANÇOIS ..........Slide.................77
DARGATZ, DAVID A ..................Poster ..............50...............27
DAS, DEBJANI ...........................Poster ..............22...............33
DAS, DEBJANI ...........................Slide.................45
DAS, SUMAN R ...........................Poster ..............26...............56
DAS NEVES, CESAR .................Poster ..............13...............112
DASILVA, ALEXANDRE J .........Poster ..............6.................49
DASZAK, PETER ........................Invited Panel...39
DAUM, LUKE T ..........................Poster ..............62...............111
DAUM, LUKE T ..........................Slide.................81
DAVIES, CLIVE R .......................Poster ..............9.................84
DAVIES, R H ................................Poster ..............61...............95
DAVIS, DEIRDRE ......................Poster ..............61...............91
DAVIS, JEFFREY P .....................Slide.................76
DAVIS, JEFFREY ........................Slide.................80
DAVIS, STEPHEN ......................Slide.................45
DAVISSON, MICHAEL .............Poster ..............13...............105
DAVISSON, MICHAEL .............Slide.................80
DAWOOD, MAGDY R ................Poster ..............30...............111
DE AMORIM, GIOVANA V .......Slide.................45
DE GROOTE, MARY A ..............Poster ..............20...............10
DE JAGER, CAROLIEN M........Slide.................44
DE LA CRUZ, MARCO .............Poster ..............55...............44
DE QUINTANA, MARITZA ......Slide.................77
DE WIT, MATTY A ......................Slide.................47
DE WIT, MATTY A ......................Slide.................78
DELGADO, BERNARDO .........Poster ..............26...............59
DELILIC, AZRA .........................Slide.................82
DELIRA, STEVE ........................Poster ..............20...............14
DELONG, S M .............................Poster ..............28...............92
DELONG, S M .............................Poster ..............28...............97
DELONG, S M .............................Poster ..............28...............99
DENISOV, GEORGY I ................Poster ..............62...............103
DENNIS, DAVID T .....................Poster ..............1.................6
DENTINGER, CATHERINE ...Slide.................78
DERESINSKI, STANLEY ..........Poster ..............5.................27
DESAI, MEETA ..........................Poster ..............61...............95
DEVINCENT, STEPHEN J........Poster ..............50...............3
DIBERNARDO, ANTONIA ......Poster ..............56...............49
DICK, J .........................................Poster ..............1.................9
DILLON, H K...............................Poster ..............61...............97
DOMEN, HARRY Y.....................Poster ..............31...............121
DOMINGUE, GIL ......................Poster ..............20...............5
DONLAN, RODNEY ..................Poster ..............20...............11
DOTSON, ELLEN M..................Slide.................77
DOUGLAS, JEANIE ...................Slide.................74
DRAYTON, JOYCE R ..................Poster ..............3.................17
DREBOT, MICHAEL A..............Poster ..............27...............72
DREBOT, MICHAEL .................Poster ..............56...............49
DREBOT, MICHAEL A..............Poster ..............56...............60
DROBENIUC, JAN ....................Poster ..............62...............102
DRONOVA, IRINA Y...................Poster ..............50...............10
DUARTE, JOHNNY ...................Slide.................77
DUBEY, J P ...................................Poster ..............61...............98
DUCK, WILLIAM M...................Poster ..............20...............21
DUJARDIN, JEAN-PIERRE P ..Poster ..............56...............59
DUMAS, N ...................................Slide.................75
DUMAS, NELLIE B....................Poster ..............4.................23
DUMAS, NELLIE ......................Slide.................45
DUMAS, NELLIE ......................Poster ..............50...............20
DUPNIK, KATHRYN .................Poster ..............2.................16
DUPREY, ZANDRA ....................Slide.................44
DUPUIS, MICHELLE ...............Poster ..............6.................51
DUPUIS, MICHELLE ...............Slide.................35
DURANTE, AMANDA J .............Poster ..............60...............82
DURVASULA, RAVI V.................Slide.................77
DURYMANOV, A G .....................Poster ..............62...............114
DURYMANOV, 
ALEXANDER G...........................Poster ..............62...............115
DYER, K S .....................................Poster ..............1.................1
EARHART, KENNETH .............Poster ..............2.................15
EARHART, KENNETH .............Poster ..............4.................21
EARHART, KENNETH C ..........Poster ..............27...............62
EARHART, KENNETH .............Slide.................80
EBEL, ERIC D.............................Poster ..............8.................68
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EBERHARD, MARK L ...............Poster ..............27...............71
EDWIN, BARBARA ....................Poster ..............56...............67
EEROLA, ERKKI .......................Slide.................46
EFFLER, PAUL V........................Poster ..............31...............121
EFFLER, PAUL ..........................Poster ..............31...............122
EFFLER, PAUL V........................Slide.................48








































EL KHOLY, A ..............................Slide.................34
EL OUN, SAID ............................Poster ..............2.................15
EL OUN, SAID ............................Poster ..............51...............30
EL OUN, SAID ............................Slide.................80
EL SAKKA, HAMMAM .............Poster ..............2.................15
EL SAKKA, HAMMAM .............Slide.................34
EL SAKKA, HAMMAM .............Poster ..............51...............30
EL SAKKA, HAMMAM .............Slide.................80
ELBERT, YEVGENIY ................Poster ..............1.................2
ELBERT, YEVGENIY ................Poster ..............13...............117
ELBERT, YEVGENIY ................Slide.................80
ELGENDY, ATEF .......................Poster ..............50...............6
ELGH, FREDRIK ......................Poster ..............27...............76
ELLIS, JOSEPH H.......................Poster ..............1.................3
ELLIS, STEPHANIE ..................Slide.................34
ELM, JOE .....................................Slide.................77
ENDLEY, SEEMA ......................Poster ..............8.................64
ENGEL, GREGORY A................Poster ..............6.................34
ENGLEN, MARK D....................Poster ..............50...............26
ENGLEN, MARK D....................Poster ..............50...............23
ENNIS, FRANCIS A....................Poster ..............55...............41
ENNIS, JILL ................................Poster ..............56...............56
EOC INTERNATIONAL 
TEAM  ...........................................Poster ..............22...............26
ERDMANN, CHRISTINE ........Poster ..............9.................83
ESCOFFERY, C ...........................Poster ..............27...............71
ESMAT, HALA M.........................Slide.................81
ESTACIO, PETE .........................Poster ..............62...............112
ESTRADA, LIBRADA ................Poster ..............9.................82
ETTINGER, MATTHEW R........Slide.................45
EVANS, ANDREW S ...................Poster ..............56...............56
EVANS, KATHRYN G..................Poster ..............30...............114
EVANS, MARY C..........................Poster ..............8.................65
EVANS, MARY C..........................Poster ..............60...............87
EVANS, MARY C..........................Poster ..............60...............88
EVANS, MARY C..........................Slide.................76
FABIANO, MARCIA ...................Poster ..............56...............56
FACKLAM, RICHARD ..............Poster ..............50...............13
FACKLAM, RICHARD ..............Poster ..............50...............15
FARBER, JEFFREY ...................Poster ..............30...............116
FARLEY, M M ..............................Poster ..............28...............88
FARLEY, M M ..............................Poster ..............20...............22
FARLEY, M M ..............................Poster ..............50...............13
FARLEY, M M ..............................Poster ..............50...............15
FAVOROV, MICHAEL ...............Poster ..............62...............102
FAYEZ, CAROLINE ...................Slide.................81
FEDCHUK, ALLA S....................Poster ..............31...............123
FEDCHUK, ALLA S....................Poster ..............50...............10
FEDCHUK, ANDREW O ..........Poster ..............31...............123
FEDCHUK, OLEKSANDR P ....Poster ..............31...............123
FEDCHUK, PAVLO O ................Poster ..............31...............123
FEDORKA-CRAY, PAULA J.......Poster ..............20...............18
FEDORKA-CRAY, PAULA J.......Poster ..............50...............27
FEDORKA-CRAY, PAULA J.......Poster ..............50...............17
FEDORKA-CRAY, PAULA J.......Poster ..............50...............23
FEFELOV, O V.............................Poster ..............62...............114
FEFELOV, O V.............................Poster ..............62...............115
FEIG, JILL C................................Poster ..............12...............96
FEIKIN, DANIEL R....................Poster ..............20...............24
FEIKIN, DANNY ........................Poster ..............22...............31
FEIN, S B ......................................Poster ..............28...............92
FELDMAN, KATHERINE A.....Poster ..............1.................6
FELDMANN, HEINZ ................Poster ..............27...............76
FELICIANGELI, DORA ...........Poster ..............56...............59
FERNÁNDEZ, JORGE ..............Poster ..............6.................48
FERRERA, ROCCO ...................Poster ..............6.................51
FERRERA, ROCCO ...................Slide.................35
FERRIERI, PATRICIA ...............Poster ..............50...............15
FEY, PAUL D................................Poster ..............20...............8
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FIANDACA, MARK ....................Poster ..............50...............14
FICHT, ALLISON R....................Poster ..............61...............99
FICHT, THOMAS A ....................Poster ..............61...............99
FIELDS, PATRICIA I..................Slide.................79
FIFADARA, NIMITA H ..............Poster ..............20...............4
FILATOV, FELIX P......................Poster ..............6.................45
FINE, ANNIE ..............................Poster ..............22...............30
FINE, ANNIE ..............................Poster ..............22...............31
FINE, ANNIE ..............................Poster ..............22...............33
FINE, ANNIE ..............................Slide.................45
FINE, ANNIE ..............................Poster ..............56...............67
FINGERLE, VOLKER ...............Slide.................77
FINKE, M P ..................................Poster ..............28...............94
FINKEL, MICHAEL ..................Slide.................74
FINNEGAN, C ............................Poster ..............28...............82
FIORE, ANTHONY E .................Slide.................44
FISCHER, MARC .......................Poster ..............22...............31
FISHER, IAN S ............................Slide.................33
FITZGERALD, COLLETTE ....Slide.................79
FITZNER, JULIA ........................Slide.................77
FLAHAULT, ANTOINE .............Poster ..............13...............114
FLAHAULT, ANTOINE .............Poster ..............22...............32
FLAHAULT, ANTOINE .............Poster ..............59...............79
FLAHAULT, ANTOINE .............Slide.................81
FLETEMIER, HEIDI ................Slide.................44
FLICK, RAMON .........................Poster ..............27...............76
FOLKS, THOMAS M ..................Poster ..............6.................53
FONSECA PACHECO, 
ANTONIO G.................................Poster ..............30...............115
FONTANA, JOHN L....................Poster ..............50...............22
FORDE, KENT J..........................Poster ..............12...............96
FORRESTER, LESLIE A ...........Poster ..............30...............111




FOUT, G S .....................................Slide.................47
FOX, MELISSA R ........................Poster ..............61...............97
FRANCESCONI, STEPHEN C...Poster ..............62...............109
FRASER, ZACK ...........................Poster ..............50...............12
FREEMAN, REBECCA .............Poster ..............1.................3
FRENCK, ROBERT ...................Poster ..............50...............6
FRIDKIN, SCOTT ......................Poster ..............20...............16
FRIDKIN, SCOTT K ...................Poster ..............20...............22
FRIEDMAN, HERMAN ............Poster ..............27...............70
FRIEDMAN, HERMAN ............Poster ..............53...............33
FROST, JENNIFER A .................Poster ..............8.................66
FROST, JENNIFER A .................Poster ..............20...............5
FROST, JENNIFER A .................Slide.................33
FROST, JENNIFER A .................Slide.................48
FUENTES, AGUSTIN ...............Poster ..............6.................34
FUHRMAN, JOHN M.................Slide.................80
FULLER, JULIE M .....................Poster ..............25...............53
FULLER, JULIE M .....................Poster ..............50...............19
FURUNO, JON P .........................Poster ..............27...............75
FUSCHINO, MEGHAN E .........Poster ..............28...............77
FYFE, MURRAY ..........................Slide.................46
GADAWSKI, RANDY .................Poster ..............56...............49
GAFFNEY, KRISTIN .................Slide.................34
GAGE, KENNETH L..................Poster ..............23...............46
GAHR, PAMELA .........................Slide.................48
GALE, CRAIG .............................Slide.................74
GALENO, HECTOR ..................Poster ..............6.................48
GANDACU, D .............................Poster ..............27...............68
GANGULY, NIRMAL K ..............Poster ..............55...............39
GARCIA, MARIANNE ...............Poster ..............8.................64
GARMAN, R L..............................Poster ..............28...............89
GARMAN, R L..............................Poster ..............28...............95
GAVRILOV, ALEKSANDR ........Poster ..............26...............55
GAY, KATHRYN ..........................Slide.................76
GAY, VALERIO ............................Poster ..............27...............67
GAYDOS, CHARLOTTE A.........Poster ..............11...............93
GAYDOS, JOEL C........................Poster ..............1.................4
GAYDOS, JOEL C........................Poster ..............12...............97
GAYDOS, JOEL C........................Poster ..............12...............98
GAYDOS, JOEL C........................Poster ..............13...............100
GAYDOS, JOEL C........................Poster ..............26...............57
GAYDOS, JOEL C........................Poster ..............29...............106
GAYDOS, JOEL C........................Poster ..............59...............75
GAYNOR, EUGENE ..................Slide.................45
GDALEVICH, MICHAEL .........Poster ..............6.................52
GDALEVICH, MICHAEL .........Poster ..............28...............103
GENERALOV, V M......................Poster ..............62...............115
GENERALOV, V M......................Poster ..............62...............114
GENNARI, S M............................Poster ..............61...............98
GENUGTEN, MARIANNE L....Poster ..............59...............74
GERBER, D E..............................Poster ..............28...............81
GERBER, D E..............................Poster ..............28...............94
GERNER-SMIDT, PETER ........Poster ..............8.................65
GERNER-SMIDT, PETER ........Poster ..............28...............78
GERSHMAN, KEN ....................Poster ..............13...............111
GERSHMAN, KEN ....................Poster ..............20...............24
GERSHMAN, KEN A..................Slide.................78
GETTNER, S S .............................Poster ..............28...............89
GHEESLING, LINDA ...............Slide.................79
GIBBONS, ROBERT V ...............Slide.................82
GIBBS, DONNA ..........................Poster ..............6.................35
GIBSON, JAMES ........................Poster ..............56...............67
GIESECKE, JOHAN ..................Poster ..............27...............69
GILL, NOEL ................................Slide.................33
GILLESPIE, IAIN A....................Poster ..............8.................60
GILLESPIE, IAIN A....................Poster ..............8.................73
GILLESPIE, IAIN A....................Slide.................33
GILLESPIE, IAIN A....................Slide.................48
GILMAN, ROBERT H ................Slide.................35
GIULIVI, ANTONIO ..................Poster ..............30...............111
GLASER, AMY ............................Poster ..............13...............102
GLASER, AMY L..........................Slide.................34
GLASER, CARLA .......................Poster ..............56...............67
GLASS, GREGORY E..................Poster ..............1.................3
GLENN, LYNDA .........................Slide.................78
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GLENNEN, ANITA ....................Slide.................48
GODDARD, JEROME ...............Poster ..............23...............45
GOGUET, YVES ..........................Slide.................46
GOLD, BEN D.............................Poster ..............20...............21
GOLDEN, N ................................Poster ..............28...............98
GOLDENBAUM, MARY B.........Poster ..............1.................4
GOMES, E M................................Poster ..............55...............47
GONCALVEZ, ANA P .................Slide.................77
GONCHAROVA, E P...................Poster ..............62...............115
GONZALEZ, J P ...........................Poster ..............54...............38
GOPALAN, SARLA .....................Poster ..............26...............56
GOTHAM, IVAN .........................Poster ..............1.................7
GOTHAM, IVAN J........................Slide.................80
GOULD, ERNEST A...................Slide.................77
GOVE, JAMES .............................Poster ..............11...............91
GOVORUKHINA, MARINA V...Poster ..............23...............47
GRACZYK, THADDEUS K........Poster ..............6.................49
GRAHAM, DOUGLAS H ...........Poster ..............61...............98
GRAHAM, R R .............................Slide.................81
GRAHAM, ROBERT ..................Slide.................34
GRAHAM, TAE WHA ................Poster ..............62...............105
GRAMICCIA, MARINA .............Slide.................44
GRAVISS, EDWARD A ...............Slide.................79
GRAVISS, EDWARD A ...............Slide.................82
GRAY, JEFF T...............................Poster ..............50...............27
GRAY, JEFF T...............................Poster ..............50...............17
GREEN, SHARONE ..................Poster ..............55...............41
GREENKO, JANE A....................Poster ..............22...............30
GREENLEE, ROBERT .............Slide.................80
GREGOR, SIMON ......................Poster ..............22...............28
GRENDON, JOHN .....................Slide.................44
GRIFFIN, P M..............................Poster ..............28...............81
GRIFFIN, P M..............................Poster ..............28...............96
GRIFFIN, PATRICIA M .............Poster ..............8.................80
GRIFFIN, PATRICIA M .............Slide.................78
GRIFFITH, CHRIS J...................Poster ..............8.................72
GRIGGS, DEBORAH J ...............Poster ..............20...............5
GRIMONT, FRANCINE ............Poster ..............8.................58
GRIMONT, FRANCINE ............Poster ..............8.................71
GRIMONT, FRANCINE ............Slide.................48
GRONER, GENA ........................Poster ..............61...............97
GRONER, GENA ........................Slide.................77
GU, LING .....................................Poster ..............61...............93
GUBLER, DUANE .....................Poster ..............13...............102
GUBLER, DUANE J ...................Poster ..............56...............64
GUBLER, DUANE .....................Slide.................77
GUERIN, PHILIPPE J................Poster ..............28...............100
GUERIN, PHILIPPE J................Slide.................47
GUERIN, PHILIPPE J................Slide.................48
GUERRA, MARTA A ...................Slide.................74
GUHARAT, SURIYA ...................Poster ..............13...............113
GUHARAT, SURIYA ...................Poster ..............28...............79
GUIRAKHOO, FARSHAD ........Poster ..............55...............41
GUMS, JOHN G...........................Poster ..............20...............12
GUNN, JULIA E ..........................Poster ..............1.................1
GUO, XI L .....................................Poster ..............61...............93
HAAS, CRYSTAL M.....................Poster ..............20...............15
HAASE, GERHARD ...................Poster ..............1.................11
HACKBARTH, ALLISON ..........Poster ..............10...............87
HADDAD, MENASHE ..............Slide.................46
HADFIELD, TED L ...................Poster ..............62...............110
HADIDI, MANSOUR .................Poster ..............1.................8
HADLER, J L................................Poster ..............8.................74
HADLER, J L................................Poster ..............28...............84
HADLER, J L................................Poster ..............28...............88
HADLER, J L................................Slide.................75
HADLER, J L................................Poster ..............50...............11
HADLER, J L................................Poster ..............50...............12
HADLEY, SCOTT .......................Poster ..............62...............112
HAGEMAN, JEFFREY C ...........Poster ..............20...............22
HAGEN, JAMES C ......................Poster ..............58...............72
HAHN, J .......................................Poster ..............8.................74
HAJJEH, RANA A ........................Poster ..............4.................24
HALE, JUDITH A........................Slide.................48
HALL, JEFFERY M.....................Poster ..............56...............65
HALPIN, KIM .............................Poster ..............27...............63
HALSE, TANYA ...........................Slide.................45
HAMIDOU, TAMBOURA .........Poster ..............3.................18
HAMILTON, GILLIAN .............Slide.................78
HAMLIN, CINDY .......................Poster ..............20...............11
HAMLIN, CINDY E....................Poster ..............50...............1
HAMMOND, LUCINDA M.......Slide.................78
HAMPTON, ROBIN W...............Poster ..............6.................46
HAND, SHERYL .........................Slide.................44





HANSEN, CHRISTIAN J............Poster ..............11...............92
HANSEN, JOEL ..........................Poster ..............2.................16
HANSLIK, THOMAS .................Poster ..............22...............32
HARCOURT, BRIAN ..................Poster ..............27...............63
HARCOURT, BRIAN ..................Poster ..............27...............64
HARDARDOTTIR, H ................Slide.................79
HARDNETT, F P .........................Poster ..............28...............87
HARDNETT, F P .........................Poster ..............28...............86
HARDNETT, F P .........................Slide.................75
HARRISON, LEE H....................Poster ..............20...............24
HARRISON, LEE H....................Poster ..............30...............115
HARRISON, LEE H....................Poster ..............30...............119
HARRISON, LEE .......................Poster ..............50...............13
HARRISON, TABITHA A ...........Poster ..............60...............84
HARRUS, SHIMON ...................Poster ..............23...............41
HASEEB, MUHAMMAD A........Slide.................35
HASSAN, ZAITON ......................Poster ..............20...............4
HAUGARREAU, LARISSA ........Poster ..............8.................61
HAWKINS, M A............................Poster ..............8.................78
HAWKINS, M A............................Poster ..............28...............96
HAWKINS, M A............................Poster ..............28...............81
HAWKINS, M A............................Poster ..............28...............88
HAWKINS, M A............................Poster ..............28...............95
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HAWKINS, M A............................Poster ..............28...............97
HAWKINS, M A............................Poster ..............28...............98
HAWKINS, M A............................Slide.................76
HAWKSWORTH, ANTHONY W..Poster ..............50...............19
HAY, SIMON I ..............................Slide.................82
HAYES, EDWARD B...................Poster ..............1.................6
HAYES, EDWARD B...................Poster ..............56...............58
HAYES, EDWARD B...................Slide.................74
HAYES, JOHN M .........................Poster ..............56...............64
HAYES, JOHN M .........................Slide.................77
HE, J ..............................................Poster ..............31...............124
HEADRICK, MARCIA L............Poster ..............50...............26
HEADRICK, MARCIA L............Poster ..............50...............27
HEADRICK, MARCIA ...............Poster ..............50...............17
HEADRICK, MARCIA L............Poster ..............50...............23
HECHEMY, KARIM ..................Slide.................45
HEDBERG, CRAIG W ...............Poster ..............8.................63
HEFFERNAN, RICHARD ........Poster ..............22...............33
HEIJNEN, MARIE-LOUISE L ....Poster ..............59...............74
HEIMER, ROBERT ...................Poster ..............60...............82
HEISEY, DAWN ..........................Slide.................78
HELMS, MORTEN ....................Poster ..............28...............78
HENEINE, WALID ....................Poster ..............6.................53
HENKEL, RICHARD ................Poster ..............6.................34
HENNESSY, THOMAS ..............Poster ..............20...............11
HENNESSY, THOMAS W..........Poster ..............50...............1
HENNESSY, THOMAS ..............Slide.................78
HENNIGAN, SCOTT .................Poster ..............27...............74
HERMOSILLO, JOVITA ...........Poster ..............50...............27
HERNÁNDEZ, GLORIA ...........Poster ..............60...............83
HERRERA, FLOR ......................Slide.................77
HERYFORD, ANNETTE G .......Slide.................47
HEUVELINK, ANNET E...........Slide.................44
HIBBS, JONATHAN R ................Poster ..............20...............24
HIBBS, JONATHAN ...................Slide.................45
HIDALGO, ANGEL ...................Poster ..............55...............43
HIGA, HENRY Y..........................Poster ..............31...............121
HIGHTOWER, A W ....................Poster ..............28...............91
HINDIYEH, MUSA ....................Poster ..............27...............68
HINTEN, STEVE ........................Poster ..............56...............64
HOEKSTRA, R M ........................Poster ..............28...............87
HOFFMAN, DANIELLE ..........Poster ..............27...............74
HOFFMAN, KENNETH J..........Poster ..............13...............100
HOFFMAN, RICHARD E..........Invited Panel...42
HOLLAND, BEN ........................Slide.................44
HOLM, MAX JENS .....................Poster ..............24...............49
HOLMES, EDWARD C..............Slide.................77...............
HOLT, JEFF P ..............................Poster ..............20...............23
HOLT, JEFF P ..............................Poster ..............61...............94
HOLZREFE, WILLIAM A .........Poster ..............56...............65
HOOVER, PAUL J .......................Slide.................35
HORN, ANDREA .......................Slide.................78
HOSPEDALES, J ........................Poster ..............28...............93
HOSPEDALES, J ........................Slide.................47
HOSSEINI, MOSTAFA ..............Poster ..............2.................13
HOSSEINI, MOSTAFA ..............Slide.................82
HOWARD, MICHAEL ...............Poster ..............6.................36
HOWARD, R ................................Poster ..............28...............84
HOWARD, R ................................Slide.................75
HU, XIAO S...................................Poster ..............61...............90
HUANG, ADA .............................Poster ..............56...............56
HUANG, ANNE ..........................Poster ..............55...............45
HUANG, CINNIA .......................Poster ..............6.................51
HUANG, CINNIA .......................Slide.................35
HUANG, CINNIA .......................Slide.................79
HUDDLE, MICHELLE E .........Poster ..............8.................77
HUDSON, CHARLENE R.........Poster ..............20...............18
HUDSON, CHARLENE R.........Poster ..............50...............17
HUGH-JONES, MARTIN ..........Poster ..............50...............18
HUIE, SHARON M .....................Poster ..............4.................24
HULL, HARRY F .........................Slide.................75
HULL, RENE ..............................Poster ..............6.................51
HULL, RENE ..............................Slide.................35
HUME, MICHAEL ....................Poster ..............8.................64
HUMPHREY, CHARLES ..........Poster ..............62...............102
HUMPHREY, TOM ....................Poster ..............20...............5
HUNTER, FIONA ......................Poster ..............27...............72
HUNTER, SUSAN B ...................Poster ..............30...............117
HUNTER, SUSAN B ...................Slide.................79
HURD, S .......................................Poster ..............28...............96
HURD, S .......................................Slide.................75
HURLBURT, DEBBY A..............Poster ..............50...............1
HUTWAGNER, LORI ................Slide.................45
HYLDIG-NIELSEN, JENS J......Poster ..............1.................11
IBRAHIM, M ...............................Slide.................34
IEONG, MAN-CHENG .............Poster ..............31...............122
IKEJIMA, HIDEAKI ..................Poster ..............53...............33
ILYUKHIN, V. I ............................Poster ..............22...............29
IM, THERESA .............................Poster ..............4.................24
IMHOFF, B C ...............................Poster ..............28...............91
IMHOFF, B C ...............................Poster ..............28...............97
IMHOFF, BETH C ......................Poster ..............1.................12
IMHOFF, BETH C ......................Poster ..............60...............87
IMHOFF, BETH C ......................Poster ..............60...............88
INDAR, LISA ...............................Poster ..............28...............93
INDAR, LISA ...............................Slide.................47
INGRAM, M ................................Poster ..............28...............93
INGRAM, M ................................Slide.................47
INNOCENT, RWEGO B.............Poster ..............6.................49
IRIZARRY-DE LA CRUZ, M .....Poster ..............22...............26
ISAAC-RENTON, JUDITH .......Slide.................46
ISKANDER, JOHN .....................Poster ..............55...............45
ISMAIL, THARWAT ...................Poster ..............4.................21
ISMAIL, THARWAT ...................Poster ..............5.................33
ISMAIL, THARWAT ...................Poster ..............27...............62
ISMAIL, THARWAT ...................Poster ..............51...............30
ISMAIL, THARWAT ...................Poster ..............62...............104
IVERSON, CHRISTOPHER J....Slide.................48
IVIC, IVO ......................................Poster ..............61...............92
IVY, WADE ...................................Slide.................74
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JAGER, JOHANNES C................Poster ..............59...............74
JALAVA, JARI ...............................Slide.................46
JAMEEL, SHAHID .....................Poster ..............26...............56
JAMESON, ANGUS ....................Poster ..............50...............20
JANAKIRAMAN, VANITHA ......Slide.................44
JAY, MICHELE ...........................Poster ..............5.................27
JAY, MICHELE T.........................Poster ..............8.................75
JAY, MICHELE T.........................Slide.................74
JENSEN, A B ................................Poster ..............60...............87
JERNIGAN, DAN B.....................Poster ..............20...............10
JERNIGAN, DAN B.....................Slide.................74
JERNIGAN, JOHN A...................Poster ..............20...............22
JIMENEZ, MATILDE ................Slide.................77
JOHNSON, GERALDINE S ......Poster ..............56...............56
JOHNSON, KEITH W.................Poster ..............55...............40
JOHNSON, MAGGIE .................Poster ..............20...............5
JOHNSON, S ................................Poster ..............28...............96
JOHNSON, SUSAN ....................Poster ..............20...............24
JOHNSON, SUSAN ....................Poster ..............50...............15
JOHNSON, SUSAN ....................Poster ..............61...............96
JONES, RON ...............................Poster ..............50...............7
JONES, RON ...............................Poster ..............50...............8
JONES, T ......................................Poster ..............28...............86
JONES, T F ...................................Poster ..............28...............89
JONES, T F ...................................Poster ..............28...............88
JONES, T F ...................................Poster ..............28...............90
JONES, T F ...................................Poster ..............28...............95
JONES, T F ...................................Poster ..............28...............96
JONES, T F ...................................Poster ..............28...............97
JONES, T F ...................................Poster ..............28...............99
JONES, T F ...................................Slide.................76
JONES, T F ...................................Poster ..............4.................22
JONES, T F ...................................Poster ..............7.................54
JONES, T F ...................................Poster ..............8.................57
JONES, T F ...................................Slide.................79
JONES-ENGEL, LISA ...............Poster ..............6.................34
JORDAN, NIKKI N......................Poster ..............12...............97
JORGENSEN, JAMES ................Poster ..............20...............24
JORGENSEN, JAMES ................Poster ..............50...............12
JOUAN, MARC ............................Poster ..............1.................12
JOUAN, MARC ............................Poster ..............60...............88
JOYCE, K ......................................Slide.................76
JOYCE, KEVIN ............................Poster ..............20...............7





JUFFRIE, M ................................Poster ..............56...............54
JUNI, BILLIE ..............................Poster ..............25...............50
JUNI, BILLIE ..............................Poster ..............50...............13
KACICA, MARILYN ...................Slide.................46
KACICA, MARILYN ...................Slide.................81
KAIC, BERNARD .......................Poster ..............61...............92
KAITA, K D ...................................Poster ..............30...............111
KANARAT, S .................................Poster ..............60...............89
KANE-AIDARA, AWA ................Poster ..............8.................71
KANTARDJIEFF, KATHERINE ...Poster ..............20...............14
KARAN, LUDMILA S .................Poster ..............23...............47
KARAN, LUDMILA S .................Slide.................34
KARPATI, ADAM ........................Poster ..............22...............33
KARPATI, ADAM ........................Slide.................45
KASE, JULIE A ............................Poster ..............27...............61
KASSENBORG, HEIDI .............Poster ..............1.................8
KATZ, ALAN R .............................Poster ..............31...............121
KATZ, DOLORES J......................Poster ..............28...............85
KATZ, LOIUS M...........................Poster ..............5.................29
KAZAKOV, ARKADI ...................Slide.................46
KAZMIERCZAK, JAMES ..........Slide.................80
KEENE, W ...................................Poster ..............28...............99
KEENE, W ...................................Slide.................75
KEITHLY, JAN ............................Poster ..............56...............56
KELAITA, DEAN ........................Slide.................74
KELLEY, KATI ............................Slide.................45
KELLEY, PATRICK W ................Poster ..............1.................2
KELLEY, PATRICK ....................Poster ..............13...............117
KELLEY, PATRICK ....................Slide.................80
KELLY, MOLLY ..........................Slide.................45
KELLY, SEAN T ...........................Poster ..............56...............65
KENNEDY, M .............................Poster ..............28...............82
KENNEDY, M H..........................Poster ..............28...............87
KENNEDY, M H..........................Poster ..............28...............94
KENNEDY, M H..........................Poster ..............28...............96
KENNEDY, M H..........................Slide.................75
KHALAKDINA, ASHEENA ......Poster ..............9.................83
KHALAKDINA, ASHEENA ......Slide.................33
KHAMZIN, TLEPBERGEN .....Poster ..............27...............66
KHAN, SHABANA I ....................Poster ..............29...............109
KHARE, SANGEETA .................Poster ..............61...............99
KHAVALEVSKY, ELINA ............Poster ..............6.................52
KHAVALEVSKY, ELINA ............Poster ..............28...............103
KIBSEY, PAMELA ......................Slide.................46
KIENKAEW, T ............................Poster ..............50...............21
KILLENBECK, BRADLEY J .....Poster ..............29...............106
KIMBALL, ANN MARIE ...........Poster ..............60...............84
KING, RAYMOND J ....................Poster ..............9.................84
KINGSBURY, JEFFREY L .........Poster ..............59...............75
KINNEY, ARISTEA ....................Slide.................45
KIRCHHOFF, LOUIS ................Poster ..............28...............95
KIRSCHKE, DAVID L ................Poster ..............4.................22
KIRSCHKE, DAVID L ................Poster ..............7.................54
KISHORE, KAMAL ....................Slide.................45
KISTEMANN, THOMAS ...........Poster ..............27...............69
KITSUTANI, PAUL .....................Slide.................77
KLATKA, L A ................................Poster ..............8.................78
KLEABONAS, M P ......................Poster ..............28...............77
KLEIN, TERRY ...........................Poster ..............29...............106
KLEIN, TERRY A ........................Poster ..............56...............61
KLEIN, THOMAS W...................Poster ..............27...............70
KLENK, KACI .............................Poster ..............6.................38
KLODA, PIOTR ..........................Poster ..............3.................17
KNAPP, JOAN S............................Slide.................48
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KNIGHT, R ..................................Poster ..............28...............93
KNIGHT, R ..................................Slide.................47
KNOBLOCH, MARY JO ............Slide.................76
KNOWLES, TAMECE T.............Poster ..............23...............41
KOEHLER, K M ..........................Poster ..............28...............92
KOLANKO, CHRISTOPHER ...Poster ..............62...............109
KOLANO, JOHN A......................Poster ..............30...............119
KONDRACKI, STAN F...............Poster ..............4.................23
KONDRACKI, STAN ..................Poster ..............4.................26
KONECKI, JOANNE .................Poster ..............22...............27
KONOMI, RAIMOND ...............Poster ..............27...............74
KOOPMANS, MARION .............Poster ..............8.................61
KOOPMANS, MARION .............Slide.................47
KOOPMANS, MARION .............Poster ..............60...............83
KOOPMANS, MARION P ..........Slide.................78
KOOPMANS, MARION .............Slide.................80
KOPELOWITZ, JUNE ...............Poster ..............6.................52
KOPELOWITZ, JUNE ...............Poster ..............28...............103
KORLAGUNTA, SAYI PRASAD K ..Poster ..............10...............88
KOSOY, MICHAEL Y..................Poster ..............23...............46
KRALOVIC, STEPHEN M.........Poster ..............13...............104
KRAMER, JOHN ........................Poster ..............22...............28
KRAMER, LAURA ......................Poster ..............27...............72
KRAMER, LAURA ......................Poster ..............56...............67
KRAMER, LAURA D ..................Slide.................82
KRASNOVA, ELENA M..............Poster ..............23...............47
KRASNOVA, ELENA M..............Slide.................34




KSIAZEK, THOMAS G ...............Poster ..............27...............64
KUBERSKI, TIM ........................Poster ..............6.................50
KUBOTA, KRISTY A....................Poster ..............30...............117
KUBOTA, KRISTY A....................Slide.................79
KUCZMARSKI, THOMAS A......Poster ..............62...............113
KUHLENSCHMIDT, MARK S..Poster ..............8.................76
KULASEKERA, VARUNI ..........Poster ..............56...............67
KULLDORFF, MARTIN ...........Poster ..............56...............63
KUMAR, ANAND .......................Poster ..............1.................5
KUNITSA, TATIYNA N...............Poster ..............6.................44
KUNITSA, TATYANA N ..............Poster ..............30...............112
KUNITSA, TATYANA N ..............Poster ..............62...............103
KUUSI, MARKKU ......................Poster ..............28...............100
KUUSISTO, PASI ........................Poster ..............6.................40
LADELY, SCOTT R .....................Poster ..............20...............18
LAI, JAMES E...............................Poster ..............22...............26
LAINE, MARIA ...........................Poster ..............6.................40
LAL, SUNIL K..............................Poster ..............29...............105
LALL, BHAVNA R .......................Poster ..............12...............95
LAMPLEY, DEARL ....................Poster ..............6.................35
LANCE-PARKER, S ...................Slide.................75
LANCE-PARKER, SUSAN ........Poster ..............8.................79
LANCE-PARKER, SUSAN ........Poster ..............28...............104
LANCE-PARKER, SUSAN ........Poster ..............58...............70
LANCIOTTI, ROBERT ..............Poster ..............27...............72
LANE, K M ...................................Poster ..............28...............99
LANE, KIMBERLY M.................Poster ..............8.................79
LAPORTE, TRACY .....................Slide.................78
LARASATI, RIA P.........................Poster ..............13...............107
LASKY, T ......................................Poster ..............28...............92
LASSEN, JORGEN .....................Poster ..............28...............100
LAWSON, A J................................Slide.................79
LAWSON, ANDREW J................Poster ..............61...............95
LAY, J C..........................................Poster ..............28...............88
LAY, J C..........................................Slide.................75
LAY, JENNY C ..............................Poster ..............28...............86
LAY, JENNY C ..............................Slide.................44
LAY, JENNY C ..............................Slide.................76
LAYTON, MARCELLE ..............Poster ..............10...............86
LAYTON, MARCELLE ..............Poster ..............22...............31
LAYTON, MARCELLE ..............Poster ..............22...............33
LAYTON, MARCELLE ..............Slide.................45
LAYTON, MARCI .......................Poster ..............22...............30
LAZORENKO, VITALII V ..........Poster ..............23...............47
LAZORENKO, VITALY V ...........Slide.................34
LE, CHARLES ............................Poster ..............25...............53
LE, LINH H..................................Poster ..............1.................7
LE GUYADER, SOIZICK ..........Poster ..............8.................61
LEANO, FE .................................Slide.................44
LEANO, FE .................................Poster ..............50...............5
LEANO, FE .................................Slide.................75
LEANO, FE .................................Slide.................75
LECHEVALLIER, MARK W .....Poster ..............5.................29
LEDELL, KATHLEEEN ...........Poster ..............20...............16
LEE, HEE C.................................Poster ..............29...............106
LEE, HEE C.................................Poster ..............56...............61
LEE, JIEUN .................................Slide.................80
LEE, KAREN E............................Poster ..............28...............104
LEE, LORE E...............................Poster ..............28...............102
LEE, MARIE V.............................Slide.................48
LEE, ROBIN ................................Poster ..............8.................63
LEE, S H........................................Poster ..............28...............91
LEE, SHERLINE .......................Poster ..............5.................29
LEE, TERRENCE ......................Poster ..............12...............97
LEGROS, DOMINIQUE ...........Slide.................48
LEHMANN, T .............................Poster ..............61...............98
LEHN, NORBERT .....................Slide.................79
LEMAN, RICHARD ...................Poster ..............20...............11
LENG, JENNIFER .....................Poster ..............22...............33
LEPARC, GERMAN F ................Poster ..............53...............33
LERTWORAPREECHA, M ......Poster ..............50...............21
LESLIE, MIRA J ..........................Slide.................74
LESMANA, MURAD ..................Poster ..............20...............17
LESMANA, MURAD ..................Poster ..............52...............31
LEVETT, PAUL N........................Poster ..............28...............93
LEVETT, PAUL N........................Slide.................47
LEVIN, DAVID B.........................Slide.................45
LEVINE, PRISCILLA ................Poster ..............8.................68
LEVINE, REBECCA S................Poster ..............56...............62
LEVY, D A .....................................Poster ..............28...............91
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LEVY, STUART ...........................Poster ..............50...............7
LEVY, STUART ...........................Poster ..............50...............8
LEWIS, MICHAEL D .................Poster ..............50...............24
LEWIS, MICHAEL ....................Poster ..............50...............9
LEWIS, SAM ................................Slide.................34
LEWIS, SAMUEL .......................Slide.................81
LEWIS, SHELLAE .....................Poster ..............50...............15
LEWIS, TOBY C...........................Poster ..............11...............91
LI, ELENA E................................Poster ..............27...............60
LI, ELENA E................................Poster ..............27...............60
LI, ELENA E................................Poster ..............27...............66
LI, YUANZHANG .......................Poster ..............1.................4
LI, YUE .........................................Poster ..............8.................56
LIEDTKE, LAURA A ..................Poster ..............20...............10
LIEDTKE, LAURA A ..................Slide.................74
LIGHTFOOT, NIGEL ................Poster ..............22...............28
LIKOS, ANNA M..........................Poster ..............12...............98
LIMBERGER, RON ...................Slide.................45
LIN, SEH-CHING ......................Poster ..............62...............102
LINDBÄCK, JOHAN ..................Poster ..............27...............69
LINDEMAN, CINDY .................Poster ..............50...............5
LINDO, JOHN F..........................Poster ..............27...............71
LINDQUIST, ALAN H................Poster ..............6.................49
LINDQUIST, JOHN ...................Poster ..............25...............50
LINDSAY, E A ..............................Slide.................79
LINDSAY, ROBBIN ....................Poster ..............27...............72
LINDSAY, ROBBIN ....................Poster ..............56...............49
LIPANI, FILIPPO .......................Poster ..............27...............67
LIPRANDI, FERDINANDO ....Slide.................77
LITTLE, CHRISTINE L.............Poster ..............8.................60
LITTLE, CHRISTINE L.............Poster ..............8.................72
LO FO WONG, D .......................Poster ..............60...............87
LOBO, MONICA B......................Poster ..............20...............19
LOGAN, JULIE M .......................Poster ..............8.................66
LOHMAN, KENTON L ..............Poster ..............62...............110
LOHMAN, KENTON L ..............Poster ..............62...............111
LOMBARDO, JOSEPH ..............Poster ..............13...............117




LOPEZ, WILFREDO .................Invited Panel...42
LOPMAN, BEN A ........................Poster ..............60...............83
LOPMAN, BENJAMIN A ...........Poster ..............4.................20
LOPMAN, BENJAMIN A ...........Slide.................80
LOWELL, JENNIFER L ............Poster ..............23...............46
LOZITSKY, VICTOR P................Poster ..............50...............10
LOZITSKY, VIKTOR P................Poster ..............59...............76
LU, LING .....................................Poster ..............62...............102
LU, LINGENG ............................Poster ..............8.................64
LUBY, STEPHEN P.....................Slide.................75
LUDWIG, SHARON L................Poster ..............26...............57
LUEANGYOSLURCHAKUL, S ...Poster ..............50...............21
LUKHNOVA, LARISSA Y ...........Poster ..............6.................43
LUKHNOVA, LARISSA Y ...........Poster ..............6.................44
LUKHNOVA, LARISSA Y ...........Poster ..............30...............112
LUNA, CARLOS ..........................Poster ..............27...............61
LUTE, SCOTT .............................Poster ..............30...............116
LUUKKAINEN, REIJO .............Poster ..............6.................40
LUUKKAINEN, REIJO .............Slide.................46
LUZ, K G .......................................Poster ..............55...............47
LYNFIELD, RUTH .....................Poster ..............20...............16
LYNFIELD, RUTH .....................Slide.................48
LYNFIELD, RUTH .....................Poster ..............50...............13
LYNFIELD, RUTH .....................Poster ..............50...............15
LYNFIELD, RUTH .....................Poster ..............61...............96
MAAS, H M...................................Slide.................44
MACDOUGALL, LAURA ..........Slide.................46
MACINTOSH, VICTOR H .........Poster ..............26...............57
MACK, JAMES ............................Poster ..............28...............102
MACKENZIE, WILLIAM R.......Poster ..............28...............104
MACRAE, SUEANN ...................Poster ..............56...............51
MACRAE, SUEANN ...................Poster ..............56...............52
MACY, JONATHAN T..................Poster ..............22...............26
MAHONEY, FRANK ..................Poster ..............2.................15
MAHONEY, FRANK ..................Poster ..............4.................21
MAHONEY, FRANK ..................Poster ..............5.................33
MAHONEY, FRANK ..................Poster ..............27...............62
MAHONEY, FRANK ..................Slide.................34
MAHONEY, FRANK ..................Poster ..............51...............30
MAHONEY, FRANK ..................Poster ..............62...............104
MAHONEY, FRANK ..................Poster ..............62...............105
MAHONEY, FRANK ..................Slide.................80
MAINZER, HUGH M .................Slide.................47
MAJIDUDDIN, FAHD K ...........Poster ..............20...............1
MAK, SUNNY ..............................Slide.................46
MAKSOUD, MOHAMED A.......Poster ..............4.................21
MAKSOUD, MOHAMED A.......Poster ..............5.................33
MAKSOUD, MOHAMED A.......Poster ..............62...............104
MALAKOOTI, MARK ................Poster ..............26...............57
MALATHI, RAGHUNAT HAN ....Poster ..............20...............3
MALATHI, RAGHUNATHAN .....Poster ..............54...............35
MALEEV, VICTOR V ..................Poster ..............23...............47
MALKOVA, E ...............................Poster ..............59...............81
MANCHENO, MANUEL ..........Poster ..............56...............50
MANKOVSKAYA, 
NADEZHDA N ............................Poster ..............50...............10
MANNINEN, RAIJA ...................Slide.................46
MANSOUR, HODA ....................Poster ..............5.................33
MANSOUR, HODA ....................Poster ..............51...............30
MANSOUR, HODA ....................Poster ..............62...............104
MARCIANO, DAVID C...............Poster ..............23...............41
MARCUS, R .................................Poster ..............28...............86
MARCUS, R .................................Poster ..............28...............88
MARCUS, R .................................Poster ..............28...............95
MARCUS, R .................................Poster ..............28...............94
MARCUS, R .................................Poster ..............28...............97
MARDINI, LÚCIA ......................Poster ..............23...............40
MARGOLIS, HAROLD S ...........Slide.................44
MARK, KAREN ...........................Poster ..............56...............64
MARSHALL, K ............................Poster ..............8.................74
MARSHALL, MARILYN M ........Poster ..............5.................30
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MARSHALL, STACIE L .............Poster ..............1.................6
MARTIN, JOHN ..........................Poster ..............54...............37
MARTINEZ, PATRICIA .............Poster ..............11...............91
MARTINEZ, PATRICIA .............Poster ..............20...............11
MARZIO, GIUSEPPE ................Slide.................81
MASCI, JOSEPH .........................Slide.................35
MASJEDI, HEYDAR ..................Poster ..............2.................13
MASJEDI, HEYDAR ..................Slide.................82
MASJEDI, MOHAMMAD R ......Poster ..............2.................13
MASJEDI, MOHAMMAD R ......Slide.................82
MATHESON, JANICE ...............Slide.................81
MATHEW, SEEMAN .................Slide.................45
MATIAS, ABRAHAN ..................Poster ..............56...............59
MATYAS, BELA ...........................Slide.................78
MAUNULA, LEENA ..................Poster ..............8.................61
MAUPIN, PEGGY .......................Slide.................45
MAUVAIS, S H..............................Slide.................76
MAUVAIS, STEVEN ...................Poster ..............28...............101
MAYERNICK, G ..........................Poster ..............4.................22
MAYNARD, NANCY G ...............Poster ..............9.................81
MAYO, DONALD R.....................Slide.................45
MCALLISTER, SIGRID ............Poster ..............20...............11
MCARDLE, JAMES L.................Poster ..............56...............54
MCAULIFFE, JAY ......................Poster ..............22...............26
MCCAIG, LINDA F ....................Poster ..............50...............2
MCCARTHY, T ............................Poster ..............8.................74
MCCARTHY, T ............................Poster ..............28...............84
MCCARTHY, T ............................Slide.................75
MCCLELLAN, JENNIFER ......Poster ..............20...............8
MCCLELLAN, JENNIFER ......Slide.................48
MCCLELLAN, JENNIFER ......Slide.................76
MCCOMB, ADAM T ...................Poster ..............26...............59
MCCOMBS, K G..........................Poster ..............28...............97
MCCOMBS, K G..........................Poster ..............28...............104
MCCOMBS, K G..........................Poster ..............58...............70
MCCOMBS, K .............................Poster ..............8.................79
MCCOMBS, K ..............................Poster ..............20...............24
MCCREADY, PAULA M.............Poster ..............62...............113




MCEWEN, SCOTT .....................Poster ..............20...............13
MCGAVERN, M ..........................Poster ..............28...............92
MCGAVERN, M ..........................Poster ..............28...............99
MCGIVERN, T ............................Poster ..............28...............94
MCGIVERN, TERESA E............Poster ..............28...............101
MCGRIFF, WILSON W..............Poster ..............12...............96
MCKEE, KELLY T ......................Poster ..............26...............57
MCKENNA, VERNA ..................Poster ..............1.................1
MCMAHON, BRIAN J ................Poster ..............50...............1
MCNAMARA, TRACEY .............Poster ..............13...............102
MCNAMARA, TRACY S .............Slide.................34






MEAD, P S ....................................Poster ..............28...............89
MEAD, PAUL S............................Poster ..............8.................62
MEAD, PAUL S............................Poster ..............8.................69
MEAD, PAUL S............................Poster ..............8.................70
MEAD, PAUL S............................Slide.................44
MEAD, PAUL S............................Slide.................75
MEDUS, C ...................................Poster ..............28...............86
MEDUS, C ...................................Poster ..............28...............88
MEDUS, C ...................................Poster ..............28...............97
MEDUS, CARLOTA ...................Slide.................44
MEDUS, CARLOTA ...................Slide.................48
MEDVEDEV, A A ........................Poster ..............62...............114
MEEK, JAMES I ..........................Poster ..............56...............48
MEITES, ELISSA .......................Poster ..............5.................27
MEKA-MECHENKO, TATIYNA V .Poster ..............6.................44
MELE, LISA ................................Poster ..............9.................82
MELTZER, MARTIN I................Poster ..............8.................80
MELTZER, MARTIN I................Poster ..............50...............4
MELTZER, MARTIN I................Slide.................78
MENDELSON, ELLA ...............Poster ..............27...............68
MENDELSON, ELLA ...............Poster ..............30...............108
MERINO, LUIS A........................Poster ..............30...............113
MERRILL, DEANE W ...............Poster ..............9.................83
MEYER, CHAD ..........................Poster ..............56...............64
MEYER, DANIEL ......................Poster ..............13...............105
MEYERS, R A ...............................Poster ..............28...............89
MIC, DANIEL .............................Slide.................48
MICHEL, ANITA ........................Poster ..............6.................41
MIDDENDORF, REBECCA ....Slide.................44
M’IKANATHA, NKUCHIA M....Poster ..............13...............116
MILANOVICH, FRED ..............Poster ..............62...............112
MILLER, BENJAMIN ...............Poster ..............1.................8
MILLER, JAMES ........................Poster ..............56...............67
MILLER, JAMES ........................Poster ..............56...............63
MILLER, JEFFREY D................Slide.................74
MILLER, LINDA ........................Poster ..............50...............7
MILLER, LINDA ........................Poster ..............50...............8
MILLER, NANCY S.....................Slide.................35
MILLER, R S ................................Poster ..............54...............38
MILLER, R S ................................Slide.................74
MILLS, KRISTIN ........................Slide.................77
MINTZ, ERIC D ..........................Poster ..............1.................12
MINTZ, ERIC D ..........................Poster ..............22...............26
MINTZ, ERIC D ..........................Slide.................75
MIRONOV, KONSTANTIN O....Slide.................34
MITCHELL, ROBERT T............Poster ..............8.................60
MITCHELL, ROBERT T............Poster ..............8.................72
MITCHELL, ROBERT T............Poster ..............8.................67
MOHANTY, SUJIT K...................Poster ..............5.................32
MOHAREB, E .............................Slide.................34
MOHLE-BOETANI, J ................Poster ..............28...............88
MOHLE-BOETANI, J ................Slide.................75
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MOHRAN, ZAYNAB ...................Poster ..............50...............6




MØLBAK, KÅRE ........................Poster ..............8.................77
MØLBAK, KÅRE ........................Poster ..............28...............78
MØLBAK, KÅRE ........................Slide.................47
MONATH, THOMAS P...............Poster ..............55...............41
MONROE, STEVE S ...................Slide.................47
MONTEIRO, FERNANDO ......Poster ..............56...............59
MONTEIRO, HAMILTON O.....Poster ..............23...............40
MONTENIERI, JOHN A............Poster ..............23...............46
MONTGOMERY, NANCY K......Poster ..............62...............113
MONZÓN, MARIA C ..................Poster ..............30...............113
MORA, JUDITH ..........................Poster ..............6.................48
MORGAN, EARL W....................Slide.................82
MORIN, CRAIG ..........................Slide.................48
MORIN, CRAIG ..........................Poster ..............50...............11
MOROZ, EUGEN D....................Poster ..............55...............42
MORRAY, BARBARA .................Poster ..............11...............91
MORRIS, J G.................................Poster ..............8.................78
MORRIS, J G.................................Poster ..............28...............98
MORRIS, JULIE M......................Poster ..............50...............1
MORSE, D ...................................Poster ..............28...............77
MORSE, D L.................................Poster ..............28...............97
MORSE, DALE L ........................Poster ..............13...............105
MORSE, DALE ...........................Slide.................45
MORSE, DALE L ........................Slide.................80
MORSE, DALE L ........................Slide.................82
MORSE, DLAE L ........................Slide.................46
MORSE, S ....................................Poster ..............59...............81
MOSTAFAEE, ALI ......................Poster ..............31...............120
MOSTASHARI, FARZAD ..........Poster ..............13...............117
MOSTASHARI, FARZAD ..........Poster ..............22...............30
MOSTASHARI, FARZAD ..........Poster ..............22...............33
MOSTASHARI, FARZAD ..........Poster ..............22...............34
MOSTASHARI, FARZAD ..........Slide.................45
MOSTASHARI, FARZAD ..........Poster ..............56...............63
MÖTTÖNEN, TIMO ..................Slide.................46...............
MOURA, ALEXANDRE ............Poster ..............10...............86
MSHAR, P ....................................Poster ..............28...............84
MSHAR, P ....................................Slide.................75
MSHAR, P .....................................Poster ..............50...............12
MSHAR, R ....................................Poster ..............28...............84
MUMMA, GERALD A ................Poster ..............8.................80
MUMMA, GERALD A ................Slide.................78
MUNRO, DONALD S.................Poster ..............20...............23
MUNRO, DONALD S.................Poster ..............61...............94
MUNSON, ROBERT ..................Poster ..............20...............23
MURASHKO, ELENA V.............Poster ..............5.................31
MURPHY, DENISE ....................Poster ..............61...............91
MUSGRAVE, KARL J ..................Slide.................47
MUSSAGALIEVA, RAYKHAN S...Poster ..............27...............66
MUSSER, KIMBERLEE ...........Slide.................45
MYERS, CAROL A.......................Poster ..............8.................75
MYERS, MELANIE ....................Poster ..............56...............64
MYERS, MONICA F....................Slide.................82
N. V. RESPONSE TEAM, W .....Poster ..............27...............74
NADLE, JOELLE .......................Slide.................33
NAIMI, TIMOTHY .....................Poster ..............20...............16
NAIMI, TIMOTHY .....................Poster ..............25...............50
NAIMI, TIMOTHY .....................Poster ..............61...............96
NAKATA, MICHELE .................Poster ..............31...............122
NAKATA, MICHELLE ...............Slide.................77
NALEWAY, ALLISON ................Slide.................80
NANDI, JAYASHREE S ..............Poster ..............54...............36
NANG, ROBERTO N ..................Poster ..............12...............97
NAPIER, MICHAEL ..................Slide.................77
NAPIER, MIKE ...........................Poster ..............56...............64
NARMS WORKING GROUP ...Poster ..............20...............6
NARMS WORKING GROUP.....Poster ..............20...............8





NATAS, OLAV ..............................Poster ..............24...............49
NATHAN, NICOLAS ..................Poster ..............60...............86
NAVARRO, VICTOR ...................Slide.................46
NAVONE, FABRIZIA .................Poster ..............27...............67
NEGREDO, N .............................Poster ..............30...............110
NEGREDO, N .............................Slide.................35
NELSON, DAVID O....................Poster ..............62...............107
NELSON, KENRAD E................Poster ..............11...............93
NELSON, WM M.........................Slide.................34
NEUHAUSER, KATERINA M ..Poster ..............12...............96
NEVILLE, JAMES S....................Poster ..............12...............96
NEVILLE, JAMES ......................Poster ..............12...............98
NEVILLE, JAMES S....................Slide.................81
NEWTON, CATHERINE ..........Poster ..............27...............70
NGUYEN, TRANG Q ..................Poster ..............1.................7
NICHOLSON, WILLIAM .........Poster ..............23...............45
NICHOLSON, WILLIAM L.......Slide.................82
NICOLL, ANGUS .......................Poster ..............22...............28
NIDR, IBRAHIMA .....................Poster ..............26...............58
NIGHTINGALE, KENDRA ......Poster ..............30...............114
NINASHVILI, NANULI Z ..........Poster ..............12...............94
NIUTTA, DANIELA ...................Poster ..............8.................63
NIVIN, BETH ..............................Poster ..............22...............31
NOONAN-TOLY, CANDACE ...Poster ..............13...............105
NORDIN, JAMES .......................Poster ..............1.................8
NSUBUGA, JOHNSON ..............Slide.................78
NUNES, MÁRCIO R ...................Poster ..............62...............108
NYGARD, KARIN .......................Poster ..............28...............100
NYGÅRD, KARIN .......................Poster ..............27...............69
O’ BRIEN, S J ...............................Poster ..............61...............95
O’BRIEN, THOMAS ...................Poster ..............50...............7
O’BRIEN, S J.................................Poster ..............61...............100
O’BRIEN, S J.................................Slide.................79
O’BRIEN, SARAH J .....................Poster ..............8.................73
O’BRIEN, SARAH J .....................Poster ..............28...............83
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O’BRIEN, SARAH J .....................Slide.................33
O’BRIEN, SARAH J .....................Slide.................47
O’BRIEN, SARAH J .....................Slide.................48
O’BRIEN, THOMAS ...................Poster ..............50...............8
OBUKHOV, IGOR L....................Poster ..............23...............47
OBUKHOV, IGOR L....................Slide.................34
O’CONNOR, ANNETTE ...........Poster ..............20...............13
O’CONNOR, NORMAN ............Slide.................48
OERLEMANS, MARCO ............Slide.................81
OGUNBANWO, JAMIU A..........Poster ..............29...............109
OHKUSA, YASUSHI ...................Poster ..............59...............77
OHKUSA, YASUSHI ...................Poster ..............59...............78
OHYE, ROY G ..............................Slide.................48
OKABE, NOBUHIKO ................Poster ..............59...............77
OKSI, JARMO ..............................Poster ..............6.................40
O’LEARY, DANIEL R .................Slide.................74
OLIVEIRA, KENNETH .............Poster ..............1.................11
OLIVERI, ROBIN .......................Poster ..............10...............85
OLIVERI, ROBIN L ....................Slide.................34
OLIVERI, ROBIN L ....................Poster ..............56...............55
OLIVERI, ROBIN L ....................Poster ..............58...............71
OLSEN, SONJA J .........................Poster ..............8.................62
OLSEN, SONJA J .........................Poster ..............8.................69
OLSEN, SONJA J .........................Poster ..............8.................70
OLSEN, SONJA O........................Poster ..............8.................77
OLSON, BETTY H.......................Poster ..............25...............52
OPHORST, CARLA .....................Slide.................81
ORLOSKI, KATHLEEN ............Slide.................74
ORLOSKI, KATHY A...................Poster ..............8.................68
ORSHAN, LAOR .........................Poster ..............27...............68
O’SHEA, BRIAN .........................Poster ..............61...............99
OSTERHOUT, GERARD ..........Poster ..............1.................9
OSTERHOUT, GERARD ..........Poster ..............13...............110
OSTROVSKI, DIMITRI .............Poster ..............60...............82
OTREMBA, CAROL ...................Poster ..............26...............59
OTT, LINDA L .............................Poster ..............62...............113
OYOFO, BUHARI A ....................Poster ..............20...............17
OYOFO, BUHARI A ....................Poster ..............52...............31
PABLOS-MENDEZ, ARIEL .....Poster ..............10...............86
PADDOCK, CHRIS ....................Poster ..............23...............45
PAGOTTO, FRANCO .................Poster ..............30...............116
PAINTER, JOHN A......................Poster ..............8.................70
PALAN, VANDANA A .................Poster ..............26...............54
PALATNIK, M ..............................Poster ..............55...............47
PALATNIK DE SOUSA, C P ......Poster ..............55...............47
PALATNIK DE SOUSA, 
CLARISA B ...................................Poster ..............55...............47
PALATNIK DE SOUSA, E .........Poster ..............55...............47
PALMER, CAROL J.....................Slide.................35
PALZKILL, TIMOTHY G ...........Poster ..............20...............1
PANDA, SUBRAT K.....................Poster ..............5.................32
PANG, LAUREN .........................Poster ..............56...............64
PANG, LORRIN ..........................Slide.................77
PANT, GILBERT .........................Poster ..............13...............100
PARASHAR, U D..........................Poster ..............28...............89
PARK, M .......................................Slide.................76
PARK, MAHIN M.........................Poster ..............20...............6
PARKHOMENKO, LARYSA V...Poster ..............5.................31
PARKHOMENKO, MYKOLA T Poster ..............55...............42
PARKHOMENKO, 
VICTORIA N.................................Poster ..............55...............42
PARKINSON, ALAN J.................Poster ..............50...............1
PARKINSON, ALAN J.................Poster ..............60...............85
PARKS, DEBRA J.........................Poster ..............50...............1
PAROLA, P ...................................Poster ..............54...............38
PAROLA, P ...................................Slide.................74
PAROTA, BEVERLY ...................Poster ..............58...............72
PASCUCILLA, MICHAEL A .....Poster ..............20...............6
PASINI, WALTER .......................Poster ..............24...............48
PASMA, JUTTA ............................Slide.................81
PASS, M A......................................Poster ..............8.................78
PASS, PEGGY ..............................Poster ..............30...............119
PATEL, PAYESH .........................Poster ..............4.................22
PATRICK, DAVID .......................Slide.................46
PAU, MARIA GRAZIA ................Slide.................81
PAULI, ALEXANDER ................Poster ..............50...............29
PAUTLER, NEDRA ....................Poster ..............60...............84
PAVLIN, BORIS ..........................Poster ..............8.................57
PAVLIN, JULIE A.........................Poster ..............1.................2
PAVLIN, JULIE ...........................Poster ..............13...............117
PAVLIN, JULIE ...........................Poster ..............29...............106
PAVLIN, JULIE ...........................Slide.................80
PEARCE, MARTY .......................Slide.................46
PEARSE, LISA A..........................Poster ..............13...............109
PEARSON, JAMES L ..................Slide.................45
PENER, HEDVA .........................Poster ..............27...............68
PERGE, ANNETTE ...................Slide.................47
PERRELLA, ALESSANDRO ....Poster ..............3.................19
PERRELLA, ALESSANDRO ....Poster ..............59...............80
PERRELLA, ORESTE ...............Poster ..............59...............80
PERRY-O’KEEFE, HEATHER ...Poster ..............50...............14
PERUSKI, LEONARD ...............Poster ..............50...............18
PETERS, HELEN .......................Poster ..............11...............91
PETERSEN, ANNE ....................Poster ..............60...............87
PETERSEN, ANNE ....................Poster ..............60...............88
PETERSEN, LYLE R...................Slide.................77
PETERSON, A T ..........................Poster ..............56...............57
PETERSON, TOWNSEND A ....Poster ..............56...............62
PETRI, MICHELLE ..................Poster ..............20...............14
PETRISCHENKO, V A ...............Poster ..............62...............114
PETRISHENKO, V .....................Poster ..............59...............81
PETTIT, DENISE A ....................Slide.................45
PETTIT, DENISE A ....................Poster ..............56...............65
PHAN, Q .......................................Poster ..............8.................74
PHAN, Q .......................................Poster ..............28...............84
PHAN, Q .......................................Poster ..............28...............99
PHAN, Q .......................................Slide.................75
PHILLIPS, JEFF .........................Poster ..............6.................36
PHILLIPS, MICHAEL ...............Poster ..............22...............31
PIANKOV, O ................................Poster ..............59...............81
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PICHEL, MARIANA G ...............Poster ..............30...............113
PIDDOCK, LAURA J ..................Poster ..............20...............5
PIENIAZEK, NORMAN J...........Poster ..............6.................49
PIESMAN, JOE ...........................Poster ..............23...............45
PIETRAFESA, LEONARD J......Poster ..............57...............68
PILATE, THRESIA .....................Poster ..............8.................57
PILLAI, SURESH D....................Poster ..............8.................64
PILLAI, SURESH D....................Poster ..............20...............9
PILLAI, SURESH D....................Poster ..............20...............15
PINA, PATRICK ..........................Poster ..............53...............34
PISHARODY, RAMDAS ............Poster ..............6.................37
PITARANG, C ..............................Poster ..............50...............9
PITARANGSI, C ..........................Poster ..............50...............24
PITLIK, SILVIO ..........................Slide.................46
PLATONOV, ALEXANDER E ...Poster ..............23...............47
PLATONOV, ALEXANDER E ...Slide.................34
PLESS, ROBERT K .....................Poster ..............55...............45
PLUMBLEE, JODIE ..................Poster ..............50...............26
PLUMBLEE, JODIE ..................Poster ..............50...............23
PODDAR, SAIBAL .....................Poster ..............25...............53
POLYAK, CHRISTINA S.............Poster ..............1.................2
POLYAK, CHRISTINA S.............Poster ..............22...............26
POMMEPUY, MONIQUE .........Poster ..............8.................61
POONSIRI, K ...............................Poster ..............50...............21
POPOVIC, TANJA .......................Poster ..............22...............26
POPOVIC, TANJA .......................Poster ..............61...............92
POPPE, CORNELIUS ................Poster ..............20...............13
POROPATICH, RON K...............Poster ..............1.................4
PORTER, K ..................................Poster ..............56...............54
PORYVAEV, V D...........................Poster ..............62...............114
POSHNI, IQBAL .........................Poster ..............56...............67
POTTER, ROBERT N.................Poster ..............13...............109
PRABHAKAR, P ..........................Poster ..............28...............93
PRABHAKAR, P ..........................Slide.................47
PRIKHOD’KO, GRIGORI G......Poster ..............31...............124
PRUCKLER, JANET M ..............Poster ..............20...............21
PUSHKINA, VALENTINA A......Poster ..............50...............10
PUTNAM, SHANNON D ...........Poster ..............50...............6
PUTRA, ARTA .............................Poster ..............6.................34
PUVACIC, P .................................Slide.................82
PYE, GREG ..................................Poster ..............56...............57
QUAGLINI, SILVANA ................Poster ..............1.................5
RABATSKY-EHR, T ....................Poster ..............8.................74
RABATSKY-EHR, T ....................Poster ..............28...............81
RABATSKY-EHR, T ....................Poster ..............28...............88




RADNEDGE, LYNDSAY ...........Poster ..............62...............113
RADU, SON .................................Poster ..............20...............4
RAGUCCI, PAOLA .....................Poster ..............3.................19
RAGUCCI, PAOLA .....................Poster ..............59...............80
RAHAL, KHEIRA .......................Poster ..............53...............34
RAINBOW, JEAN ........................Poster ..............61...............96
RAKHA, MAGDA ........................Poster ..............27...............62
RALSTON, A ................................Poster ..............31...............124
RAMASWAMY, SRINIVAS V ......Slide.................79
RAMSEY, JANINE M ..................Poster ..............56...............57
RANDLE, VICKI ........................Slide.................81
RANDOLPH, SARAH E .............Slide.................82
RANKIN, JAMES ........................Poster ..............13...............116
RANKIN, SHELLEY C ...............Poster ..............20...............23
RANKIN, SHELLEY C ...............Poster ..............61...............94
RAO, MALLA ..............................Poster ..............50...............6
RAOULT, D ..................................Poster ..............54...............38
RAOULT, D ..................................Slide.................74
RAVANSHAD, MEHRDAD ......Poster ..............31...............120
RAY, S M ........................................Poster ..............28...............92
REACHER, MARK .....................Poster ..............4.................20
REACHER, MARK .....................Poster ..............60...............83
REACHER, MARK .....................Slide.................80
REASONOVER, ALISA .............Poster ..............20...............11
REASONOVER, ALISA L...........Poster ..............50...............1
REDDING, GREGORY J............Poster ..............11...............91
REDUS, S .....................................Poster ..............1.................9
REED, CARRIE ..........................Slide.................35
REED, KURT D...........................Slide.................79
REGO, VIRGINIA H ...................Poster ..............20...............22
REICH, ROBERT A ....................Slide.................79
REILLY, BILL ..............................Slide.................33
REILLY, W J..................................Poster ..............61...............100
REINGOLD, ARTHUR .............Poster ..............20...............24
REINGOLD, ARTHUR .............Poster ..............50...............13
REISCHL, UDO ..........................Slide.................79
REITER, PAUL ...........................Poster ..............56...............64
REITER, PAUL ...........................Slide.................77
RENZULLO, PHILLIP O...........Poster ..............26...............57
RESTO-RUIZ, SANDRA I ..........Poster ..............27...............70
REYES, H .....................................Poster ..............31...............124
RIBOT, EFRAIN M .....................Poster ..............30...............117
RIBOT, EFRAIN M .....................Slide.................79
RICHARDSON, JUDITH F .......Poster ..............8.................66
RIDDLE, MARK .........................Poster ..............50...............6
RIDLEY, MICHAEL ..................Slide.................45
RIGAU, JOSE ..............................Slide.................77
RIGAU-PÉREZ, JOSÉ G.............Poster ..............56...............64
RISHWAIN, GEORGE ...............Slide.................74
ROBERTSON, BETTY H............Slide.................44
ROBERTSON, BETTY ...............Poster ..............62...............102
ROBINSON, L .............................Poster ..............6.................50
ROBINSON, LAURA E...............Poster ..............56...............57
RODRIGUES, SUELI G.............Poster ..............23...............40
RODRIGUES, SUELI G.............Poster ..............62...............108
RODRIGUEZ, MELANIE J .......Poster ..............12...............96
RODRIGUEZ, MELANIE J .......Slide.................81
ROE, MATTHEW T.....................Poster ..............20...............9
ROE, MATTHEW T.....................Poster ..............20...............15
ROGERS, DAVID J......................Slide.................82
ROGIER, CHRISTOPHE ..........Poster ..............8.................58
ROGIER, CHRISTOPHE ..........Poster ..............8.................71
ROHDE, RODNEY ....................Slide.................74
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ROHN, D D ..................................Poster ..............8.................78
ROHN, DALE .............................Poster ..............13...............116
ROJAS, EDNA .............................Slide.................77
ROLLIN, PIERRE E ...................Poster ..............27...............64
ROMAGNOLI, M ........................Poster ..............1.................9
ROMAN, E ...................................Poster ..............30...............110
ROMAN, E ...................................Slide.................35





ROOT, T ........................................Poster ..............28...............81
ROSA, AMÉLIA T........................Poster ..............62...............108
ROSE, BONNIE ..........................Poster ..............50...............23
ROSELLE, GARY A.....................Poster ..............13...............104
ROSEMBLATT, MARIO ............Poster ..............6.................48
ROSEN, BLAIR ...........................Poster ..............6.................51
ROSEN, BLAIR I .........................Slide.................35
ROSENBERG, JON ....................Poster ..............8.................75
ROSENBERG, SHOSHANA .....Slide.................46
ROSSITER, S ...............................Slide.................76




ROTA, PAUL A .............................Poster ..............27...............63
ROTA, PAUL A .............................Poster ..............27...............64
ROTHMAN, ALAN L ..................Poster ..............55...............41
ROWTON, EDWARD ................Slide.................44
ROY, KAKOLI ..............................Poster ..............50...............4





RUPPRECHT, CHARLES E ......Slide.................74
RUSAKOVA, NADEZHDA V .....Poster ..............23...............47
RUSAKOVA, NADEZHDA V .....Slide.................34
RUSH-WILSON, K .....................Poster ..............28...............77
RUSSELL, KEVIN L ...................Poster ..............11...............92
RUSSELL, KEVIN L ...................Poster ..............25...............53
RUSSELL, KEVIN L ...................Poster ..............50...............19
RUSSELL, KEVIN L ...................Poster ..............55...............46
RUSSELL, RICHARD C.............Poster ..............23...............44
RUSUL, GULAM R .....................Poster ..............20...............4
RYABCHIKOVA, ELENA ..........Poster ..............59...............81
RYABUSHKO, ELENA A............Poster ..............62...............103
RYAN, MARGARET ...................Poster ..............11...............92
RYAN, MARGARET A. K............Poster ..............25...............53
RYAN, MARGARET A. K............Poster ..............50...............19
RYAN, MARGARET A. K............Poster ..............55...............46
RYAN, MIKE ................................Slide.................48
SAADBYE, PETER .....................Slide.................47
SABAHI, FARZANEH ................Poster ..............31...............120
SACCHI, CLAUDIO ...................Poster ..............61...............92
SACCO, FRANK D ......................Poster ..............50...............1
SAFARI, NUNUNG N.................Poster ..............52...............31
SAFATOV, A .................................Poster ..............59...............81
SAFRAN, ELIZABETH S ...........Poster ..............3.................17
SAGOO, SATNAM K....................Poster ..............8.................72
SAHAR, GIDEON .......................Slide.................46
SAHLI, FADILA ..........................Poster ..............53...............34
SAHM, DAN ................................Poster ..............50...............7
SAHM, DAN ................................Poster ..............50...............8
SAKALLAH, SAMEER ..............Poster ..............56...............51
SAKALLAH, SAMEER ..............Poster ..............56...............52
SALCEDO, MARIA ....................Slide.................77
SALEK, SALEK ...........................Poster ..............2.................13
SALINAS, YVETTE ....................Poster ..............56...............57
SALMA, D ....................................Slide.................34
SALMAN, DIAA E .......................Slide.................81
SAMMONS, JULIE C..................Poster ..............25...............53
SAMMONS, JULIE C..................Poster ..............50...............19
SAMRA, ZMIRA ..........................Slide.................46
SAMUEL, M ................................Poster ..............28...............86
SAMUEL, M ................................Poster ..............28...............99
SANCHEZ, ERLINDA ...............Slide.................77





SANDERS, J .................................Poster ..............50...............24
SANDERS, J .................................Poster ..............50...............9
SANDERS, JUDY ........................Poster ..............6.................35
SANDHU, SUKHMINDER K....Poster ..............5.................29
SANTOS, JORGE M ....................Poster ..............20...............19
SANTOS, W R...............................Poster ..............55...............47
SARISKY, JOHN P........................Slide.................47
SARNO, RENE ............................Poster ..............20...............14
SASAKI, DAVID M ......................Poster ..............31...............121
SASAKI, DAVID ..........................Slide.................77
SASIPREEYAJAN, J ....................Poster ..............50...............21
SASSER, M ...................................Poster ..............1.................9
SASSER, M ...................................Poster ..............13...............110
SAUDERS, BRIAN D..................Poster ..............30...............114
SAVARINO, STEPHEN ..............Poster ..............50...............6
SAVILL, JOHN ............................Poster ..............61...............91
SCHAFFNER, WILLIAM .........Poster ..............4.................22
SCHAFFNER, WILLIAM .........Poster ..............6.................35
SCHAFFNER, WILLIAM .........Poster ..............7.................54
SCHAFFNER, WILLIAM .........Poster ..............8.................57
SCHANTZ, PETER M.................Slide.................44
SCHARF, SHIMON ....................Poster ..............6.................52
SCHARF, SIMON .......................Poster ..............28...............103
SCHEFTEL, JONI ......................Slide.................75
SCHILLACI, MICHAEL A.........Poster ..............6.................34
SCHLEZINGER, SARA .............Poster ..............27...............68
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SCHMINK, SUSANNA ..............Poster ..............61...............92
SCHMUNIS, GABRIEL A..........Poster ..............53...............32
SCHNEIDER, EDWARD ..........Slide.................74






SCHURGIN, A .............................Poster ..............6.................50
SCOTT, F W..................................Slide.................79
SEGLER, S D ...............................Poster ..............28...............95
SEGLER, S D ...............................Poster ..............28...............94
SEGLER, SUZANNE D..............Poster ..............28...............104
SEHGAL, SHOBHA ...................Poster ..............26...............56
SELMAN, C .................................Poster ..............28...............90
SELMAN, CAROL A ...................Poster ..............8.................63
SELVIN, STEVE ..........................Poster ..............9.................83
SEN, PRITHA ..............................Slide.................77
SERGEEV, A ................................Poster ..............59...............81
SERGEEV, A N.............................Poster ..............62...............114
SEYOUM, DANIEL ....................Poster ..............55...............40
SEYS, SCOTT A............................Slide.................47
SHABOLTAS, ALLA ...................Poster ..............60...............82
SHAH, KAJARI V .........................Poster ..............12...............95
SHAHDAD, SABA ......................Poster ..............2.................14
SHALLOW, S ...............................Poster ..............28...............81
SHALLOW, S ...............................Poster ..............28...............97
SHALOM, URI ............................Poster ..............27...............68
SHANMUGAM, VEDAPURI ....Poster ..............6.................53
SHAW, SUSAN E..........................Poster ..............5.................29
SHCHERBA, YURY ....................Poster ..............32...............125
SHEALEY, LASHONDRA .........Poster ..............50...............13
SHEN, JOHN ...............................Poster ..............23...............45
SHERWOOD, RACHEL ............Slide.................79
SHI, ZHI Y.....................................Poster ..............61...............93
SHIFERAW, B .............................Poster ..............28...............82
SHIFERAW, B .............................Poster ..............28...............88
SHIFERAW, B .............................Poster ..............28...............92






SHILLAM, P J...............................Poster ..............28...............81
SHILLAM, P J...............................Poster ..............28...............94
SHINDO, NAHOKO ..................Poster ..............59...............77
SHIPULIN, GERMAN A ............Poster ..............23...............47
SHIPULIN, GERMAN A ............Slide.................34
SHISHKINA, L ............................Poster ..............59...............81
SHISHKINA, L N.........................Poster ..............62...............114
SHISHKINA, L N.........................Poster ..............62...............115
SHITIKOVA, LARYSA I ..............Poster ..............50...............10
SHOHAT, T ..................................Poster ..............30...............108
SHOPE, ROBERT E....................Poster ..............62...............108
SHORTRIDGE, KEN F ..............Invited Panel...39
SHRIVASTAVA, JAYA ..................Poster ..............29...............105
SHUKLA, SANJAY K ...................Slide.................79
SHULMAN, L ..............................Poster ..............27...............68
SHULMAN, L ..............................Poster ..............30...............108
SHVAGER, MIKHAIL M............Poster ..............23...............47
SICCARDI, MARCO ..................Poster ..............20...............5
SIEGEL, ROBERT D..................Poster ..............58...............73
SIERRA, GLORIA .......................Slide.................77
SIERRA, GUSTAVO ....................Invited Panel...90...............
SIITONEN, ANJA .......................Poster ..............28...............100
SILBERSTEIN, I .........................Poster ..............30...............108
SIMANJUNTAK, CYRUS H........Poster ..............13...............107
SIMANJUNTAK, CYRUS H........Poster ..............20...............17
SIMANJUNTAK, CYRUS H........Poster ..............52...............31
SIMBARTL, LORETTA A...........Poster ..............13...............104
SINGH, SHALINI .......................Slide.................45
SINGLETON, ROSALYN J.........Poster ..............11...............91
SIRIANNI, NICKY ......................Poster ..............50...............18
SIRINAVIN, SAYOMPORN .......Invited Panel...91...............
SITZ, JOSH ...................................Poster ..............20...............22
SIVANESAN, MEERA A.............Poster ..............8.................73
SLATER, BRETT ........................Poster ..............6.................51
SLATER, BRETT ........................Slide.................35
SLATER, BRETT ........................Slide.................79
SLEZAK, THOMAS R .................Poster ..............62...............113
SMART, G .....................................Poster ..............30...............111
SMITH, BESA .............................Poster ..............50...............19
SMITH, D. SCOTT .....................Poster ..............5.................27
SMITH, DARVIN S......................Poster ..............4.................25
SMITH, GLENDA ......................Poster ..............50...............20









SMITH, KIRK ..............................Poster ..............50...............5
SMITH, KIRK ..............................Slide.................75
SMITH, KIRK ..............................Slide.................75
SMITH, MATT .............................Poster ..............9.................82
SMITH, P ......................................Poster ..............28...............96
SMITH, PERRY F ........................Poster ..............13...............105
SMITH, PERRY F ........................Slide.................46
SMITH, PERRY F ........................Slide.................80
SMITH, PERRY F ........................Slide.................82
SMITH, RONALD D...................Poster ..............8.................76
SMOLE, SANDRA C...................Poster ..............30...............116
SMOLENSKI, SUSAN ................Poster ..............50...............11
SOBEL, JEREMY ........................Poster ..............20...............21
SOBSEY, MARK D.......................Poster ..............20...............20
SOBSEY, MARK D.......................Poster ..............27...............61
SOBSEY, MARK D.......................Slide.................44
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SOCKETT, PAUL ........................Poster ..............27...............72
SOFAIR, ANDRE N.....................Poster ..............4.................24
SOFAIR, ANDRE ........................Slide.................46
SOFER, D ....................................Poster ..............30...............108
SOKOLOFF, ABBY .....................Poster ..............8.................75
SOLER, MARITZA .....................Slide.................77
SOLIMAN, ATEF K.....................Slide.................81
SOMECH, E ................................Poster ..............30...............108
SOMLAI, ANTON M...................Poster ..............60...............82
SONG, JIN W................................Poster ..............56...............61
SONG, QUNSHSENG ...............Poster ..............20...............21
SORENSON, HEATHER L........Poster ..............23...............41
SORRENTINO, PAOLO ............Poster ..............3.................19
SORRENTINO, PAOLO ............Poster ..............59...............80
SOUDER, BARBARA .................Poster ..............50...............7
SOUDER, BARBARA .................Poster ..............50...............8
SOUZA, MARIA R........................Poster ..............23...............40
SPARKS, RACHEL .....................Poster ..............20...............11
SPARLING, P ...............................Slide.................75
SPERB, ALETHÉA .....................Poster ..............23...............40
SPIKA, JOHN ...............................Poster ..............60...............85
SPINA, NANCY L ........................Poster ..............4.................23
SPINA, NANCY ...........................Poster ..............50...............20
SPIRA, THOMAS ........................Poster ..............6.................53
SRIJAN, A .....................................Poster ..............50...............24
SRIJAN, A .....................................Poster ..............50...............9
SRIKANTIAH, PADMINI ..........Slide.................44
SRINIVAS, G ................................Poster ..............29...............107
SRIWATI, NI LUH ......................Poster ..............52...............31




STANDRIDGE, JON H...............Poster ..............25...............52
STARK, LILLIAN ........................Poster ..............10...............85
STARK, LILLIAN M....................Slide.................34
STARK, LILLIAN M....................Poster ..............56...............55
STARR, MIKE .............................Slide.................46
STAVNES, TRINE-LISE ............Slide.................47
STEFANELLI, MARIO ..............Poster ..............1.................5
STEFONEK, KAREN .................Poster ..............50...............13
STEIN, LOUISE .........................Slide.................46
STEINGRABER, K .....................Poster ..............28...............82
STEINZ, FLEMMING ...............Poster ..............60...............85
STELLING, JOHN .....................Poster ..............50...............7
STELLING, JOHN .....................Poster ..............50...............8
STEMPER, MARY E ...................Slide.................79
STENDER, HENRIK .................Poster ..............1.................11
STENDER, HENRIK .................Poster ..............50...............14




STERLING, CHARLES R ..........Slide.................35
STETSON, CAROLYN ...............Poster ..............1.................7
STEURER, FRANK ....................Slide.................44
STEURER, FRANK J ..................Poster ..............56...............57
STEVENSON, HEATHER L......Poster ..............23...............46
STEVENSON, JENNIFER E.....Poster ..............20...............6
STEVENSON, JENNIFER E.....Poster ..............20...............7
STEVENSON, JENNIFER E.....Slide.................76
STOEBEL, KATRIN ...................Slide.................77
STONE, MATTHEW L ...............Slide.................82
STOTO, MICHAEL ....................Poster ..............9.................82
STOTO, MICHAEL ....................Slide.................81
STOUT, ALISON .........................Poster ..............50...............22
STRAUSBAUGH, LARRY J ........Poster ..............20...............10
STRAUSBAUGH, LARRY J ........Slide.................74
STREET, KATHLEEN ...............Poster ..............56...............64
STREET, KATHLEEN ...............Slide.................77
STROCKBINE, NANCY ............Slide.................79
STROUT, CHERYL L..................Poster ..............62...............113
STURBAUM, GREG D ...............Slide.................35
SUARYANA, KOMANG .............Poster ..............6.................34
SUBEKTI, DECY S......................Poster ..............20...............17
SUBEKTI, DECY S......................Poster ..............52...............31
SUHARYONO, W ........................Poster ..............56...............54
SUKARMA, S ...............................Poster ..............52...............31
SULEIMENOV, 
BAKHTIYAR M ............................Poster ..............27...............60
SULEIMENOV, 
BAKHTIYAR M ............................Poster ..............27...............65
SULEIMENOV, 
BAKHTIYAR M ............................Poster ..............27...............66
SULKA, ALANA C .......................Poster ..............8.................62
SULKA, ALANA ..........................Poster ..............20...............21
SUMNER, JOHN ........................Poster ..............23...............45
SUN, BENJAMIN .......................Poster ..............8.................75
SUNDBERG, LARRY .................Poster ..............25...............50
SUPARMANTO, SRI ASTUTI S....Poster ..............13...............107
SURVEILLANCE TASK 
FORCE, . ......................................Poster ..............1.................1
SVENSSON, ÅKE .......................Poster ..............27...............69
SWAMINATHAN, BALA ............Slide.................79
SWAMINATHAN, BALASUBR .Poster ..............20...............21
SWANSON, E ..............................Poster ..............28...............81
SWANSON, E ..............................Poster ..............28...............92
SWANSON, ELLEN ...................Slide.................75
SWEGER, DEBRA .....................Poster ..............27...............70
SWITZER, WILLIAM M ............Poster ..............6.................53
T. FISHER, I S..............................Poster ..............61...............100
T. FISHER, I S..............................Slide.................79
TAGHIZADEH, RAHIM ............Poster ..............2.................13
TALASKA, THOMAS ..................Slide.................77
TALI-MAAMAR, HASSIBA .......Poster ..............53...............34
TALL, ADAMA ............................Poster ..............8.................58
TALL, ADAMA ............................Poster ..............8.................71
TAMIN, AZAIBI ..........................Poster ..............27...............64
TAN, R ..........................................Poster ..............56...............54
TANKSON, JEANETTA D..........Poster ..............50...............17
TAORMINA, PETER J ................Poster ..............8.................55
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TARANTINO, GIOVANNI .........Poster ..............59...............80
TAUXE, ROBERT V ....................Poster ..............8.................80
TAUXE, ROBERT V ....................Slide.................78
TAYLOR, CHARLOTTE ............Slide.................48
TEAL, ALLEN .............................Poster ..............56...............56
TEATES, KATHRYN S ................Poster ..............13...............108
TEETER, LARRY ........................Slide.................82
TEKWANI, BABU L ....................Poster ..............29...............109
TELFORD, S R ............................Poster ..............54...............38
TELFORD, S R ............................Slide.................74
TEMIRALIYEVA, GULNARA A...Poster ..............6.................43
TEMIRALIYEVA, GULNARA A...Poster ..............6.................44
TEMIRALIYEVA, GULNARA A...Poster ..............30...............112
TENGELSEN, LESLIE .............Slide.................44
TESH, ROBERT B.......................Poster ..............62...............108
TESKA, J .......................................Poster ..............1.................9
THIEN, H V..................................Poster ..............54...............38
THOMAS, JENNIFER L ............Poster ..............8.................75
THOMAS, PAULINE .................Poster ..............22...............31
THOMAS, PAULINE .................Poster ..............22...............33
THOMAS, S M..............................Poster ..............28...............81
THOMAS, S M..............................Slide.................75
THOMAS, S M..............................Slide.................75
THOMAS, STEPHANIE M ........Poster ..............28...............104
THOMAS, STEPHANIE M ........Poster ..............58...............70





THRELFALL, E J ........................Poster ..............61...............95
THRELFALL, E J ........................Slide.................79
THRELFALL, JOHN ..................Slide.................33
THULLIEZ, P ..............................Poster ..............61...............98
THWAITES, RICHARD T..........Poster ..............8.................66
TIMPERI, RALPH ......................Poster ..............50...............22
TISCHLER, NICOLE ................Poster ..............6.................48
TJANIADI, PERISKA J ...............Poster ..............20...............17
TJANIADI, PERISKA J ...............Poster ..............52...............31
TKACHENKO, EUGENE A ......Poster ..............6.................45
TOIVANEN, AULI ......................Poster ..............6.................40
TOIVANEN, PAAVO ...................Slide.................46
TOLMASKY, MARCELO ...........Poster ..............20...............14
TOM, TAMMY .............................Poster ..............31...............122
TOM, TAMMY .............................Slide.................77
TONEY, DENISE ........................Poster ..............2.................16
TONG, S F.....................................Poster ..............28...............86
TONG, S F.....................................Poster ..............28...............89
TONG, S .......................................Slide.................75
TOPORKOV, V S...........................Poster ..............62...............114
TOPORKOV, V S...........................Poster ..............62...............115
TORPEY, D ..................................Poster ..............28...............98
TORPEY, DAVID J.......................Poster ..............20...............6
TORRES, MARIA AMÉLIA N...Poster ..............23...............40
TOTH, THOMAS E .....................Poster ..............6.................36
TOWNSEND PETERSON, A ...Slide.................77
TRAVERS, KARIN U...................Poster ..............50...............7
TRAVERS, KARIN U...................Poster ..............50...............8
TRAVIS, DOMINIC ....................Poster ..............13...............102
TREADWELL, TRACEE ..........Slide.................45
TRIBBLE, D ................................Poster ..............50...............24
TRIBBLE, D ................................Poster ..............50...............9
TRIPATHI, ABHAI K...................Poster ..............29...............109





TUCKER, NICOLE A .................Poster ..............8.................69
TUGAMBAEV, TLEULY I ..........Poster ..............62...............103
TUIJN, CEES ...............................Slide.................81
TULISOV, ANDREI ....................Poster ..............26...............55
TUNNIKOV, G I ...........................Poster ..............62...............114
TURELL, MICHAEL .................Slide.................34
TURNBULL, PETER .................Poster ..............50...............18
TURNER, SHERRI ....................Poster ..............6.................36
TYAGI, SHWETA ........................Poster ..............29...............105
TYNDALL, MARK A ...................Poster ..............50...............22
UNNASCH, THOMAS R ............Poster ..............61...............97
UNNIKRISHNAN, DILIP .........Poster ..............6.................37
URDANETA, LUDMEL ............Slide.................77
UTEPOVA, IRINA B....................Poster ..............27...............66
UYTDEHAAG, FONS G .............Slide.................81
UZCATEGUI, NATHALIE ........Slide.................77
VAHHABZADEH, AMIR REZA ..Poster ..............62...............101
VAINIONPÄÄ, RAIJA .................Poster ..............6.................40
VALENZUELA, PABLO .............Poster ..............6.................48







VAN BENEDEN, CHRIS ..........Poster ..............13...............111
VAN BENEDEN, CHRIS ..........Poster ..............22...............31
VAN BENEDEN, CHRIS A........Poster ..............50...............13
VAN DER ZWALUW, W K .........Slide.................44
VAN DUYNE, SUSAN ................Slide.................44
VAN DUYNHOVEN, Y ...............Slide.................80
VAN DUYNHOVEN, Y T ............Slide.................44
VAN DUYNHOVEN, Y T ............Slide.................78
VAN PELT, WILFRID ................Slide.................44
VANNIEUWENHOVEN, TY J ...Slide.................82




VASCONCELOS, HELENA B...Poster ..............23...............40
VASCONCELOS, PEDRO F ......Poster ..............23...............40
VASCONCELOS, PEDRO F ......Poster ..............62...............108
VASILYEVA, I ...............................Poster ..............31...............124
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VASTRUP, PERNILLE ...............Poster ..............28...............78
VEGA, EVERARDO ...................Poster ..............20...............9
VELAYATI, ALI AKBAR .............Poster ..............2.................13







VIBOUD, CECILE .....................Poster ..............59...............79
VIBOUD, CECILE .....................Slide.................81
VIBOUD, CÉCILE .....................Poster ..............22...............32
VICENTE, GILBERTO A...........Poster ..............9.................81
VIJAYALEKSHMI, N ..................Poster ..............6.................37
VILLAGRA, ELIECER ..............Poster ..............6.................48
VILLALOBOS, IRIS ...................Slide.................77
VILLANUEVA, MERCEDITAS ...Poster ..............56...............48
VILLEGAS, JUDITH ..................Poster ..............56...............59
VIRGIN, FRANK W.....................Poster ..............30...............117
VITALIS, ELIZABETH A ...........Poster ..............62...............113
VOETSCH, A C ............................Poster ..............28...............81
VOHRA, HARPREET .................Poster ..............55...............39
VOJDANI, ARISTO .....................Slide.................46




VORNDAM, VANCE ..................Poster ..............56...............64
VORNDAM, VANCE ..................Slide.................77
VUGIA, D J....................................Poster ..............28...............90
VUGIA, D J....................................Poster ..............28...............92
VUGIA, D J....................................Poster ..............28...............95
VUGIA, D J....................................Poster ..............28...............94
VUGIA, D J....................................Poster ..............28...............96
VUGIA, D J....................................Slide.................75
VUGIA, D J....................................Slide.................76
VUGIA, D J....................................Poster ..............8.................59
VUGIA, D J....................................Slide.................33
WADDA, HADDY A ....................Poster ..............20...............5
WADE, DAVID ............................Poster ..............20...............2




WALIA, KAMINI .........................Poster ..............55...............39
WALKER, H K..............................Poster ..............6.................46
WALKER, LARRY A ....................Poster ..............29...............109
WALKER, R A...............................Slide.................79
WALKER, SABRINA S................Slide.................45
WALKER, SABRINA S................Poster ..............56...............65
WALLACE, B ...............................Poster ..............4.................26
WALLACE, BARBARA J.............Poster ..............56...............56
WANAMAKER, BOYCE ............Poster ..............6.................35
WANG, HUA ................................Poster ..............61...............90
WANG, HUA ................................Poster ..............61...............93
WANG, SUSAN A.........................Slide.................48
WANG, X ......................................Poster ..............28...............94
WANNET, WIM J .........................Slide.................44
WANNET, W J B...........................Slide.................79
WARD, DON ...............................Poster ..............13...............108




WASFY, MOMTAZ ......................Poster ..............4.................21
WASFY, MOMTAZ ......................Poster ..............5.................33
WASFY, MOMTAZ ......................Poster ..............27...............62
WASFY, MOMTAZ ......................Poster ..............62...............104
WASFY, MOMTAZ ......................Poster ..............62...............105
WATTANAPUNSUK, S ...............Poster ..............50...............21
WATTS, BEVERLY L...................Poster ..............1.................4
WEBER, JONATHAN T..............Poster ..............50...............4
WEDDERKOP, ALICE ..............Poster ..............8.................65
WEGENER, HENRIK C ............Poster ..............1.................12
WEGENER, HENRIK C ............Poster ..............8.................65
WEGENER, HENRIK C ............Poster ..............60...............87
WEGENER, HENRIK C ............Poster ..............60...............88
WEGENER, HENRIK C ............Slide.................76
WEIGEL, MARY-MARGARET ...Poster ..............55...............43
WEIGEL, MARY-MARGARET ...Poster ..............55...............44
WEIGEL, MARY-MARGARET ...Poster ..............56...............50
WEINGARTL, HANA ................Poster ..............27...............72
WEINGARTL, HANA ................Poster ..............56...............49
WEINSTOCK, HILLARD S.......Slide.................48
WEISS, DON ...............................Poster ..............10...............86
WEISS, DON ...............................Poster ..............22...............31
WEISS, DON ...............................Poster ..............22...............33
WEISS, DON ...............................Slide.................45
WEISS, LEAH .............................Poster ..............27...............68
WELLES, C .................................Slide.................75
WELLIVER, DAVID ..................Poster ..............13...............116
WELLS, J G...................................Poster ..............28...............81
WERNER, BARBARA G.............Poster ..............27...............74
WERNER, S B ..............................Poster ..............8.................59
WERNER, S B ..............................Poster ..............8.................75
WESTPHAL, ROBERT G...........Poster ..............1.................7
WESTPHAL, ROBERT ..............Poster ..............56...............56
WHICHARD, JEAN M................Poster ..............20...............8
WHITE, DAVID G.......................Poster ..............20...............6
WHITE, DENNIS J .....................Poster ..............56...............56
WHITE, DENNIS J .....................Slide.................82
WHITNEY, CYNTHIA G ............Poster ..............20...............24
WHITNEY, CYNTHIA ...............Poster ..............50...............13
WHITNEY, CYNTHIA ...............Poster ..............50...............15
WHO GLOBAL SALM-SURV ...Poster ..............1.................12
WHO GLOBAL SALM-SURV ...Poster ..............60...............87
WHO GLOBAL SALM-SURV ...Poster ..............60...............88
WHO GLOBAL SALM-SURV ...Poster ..............60...............89
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WIEDMANN, MARTIN ............Poster ..............30...............114
WIERSMA, STEVEN .................Poster ..............10...............85
WIERSMA, STEVEN .................Poster ..............13...............108
WIERSMA, STEVEN T...............Slide.................34
WIERSMA, STEVEN T...............Poster ..............56...............55
WIERSMA, STEVEN .................Poster ..............58...............71
WIERZBA, THOMAS .................Poster ..............50...............6
WILCKE, BURTON ...................Poster ..............12...............95
WILHELMI, I .............................Poster ..............30...............110
WILHELMI, I .............................Slide.................35
WILL, ROBERT ..........................Poster ..............63...............117
WILLIAMS, KAREN ..................Poster ..............8.................64
WILLSHAW, G A..........................Poster ..............61...............100
WILSKE, BETTINA ...................Slide.................77
WILSON, D .................................Slide.................79
WILSON, RITA ...........................Poster ..............4.................25
WIRTZ, ROBERT A.....................Poster ..............56...............57
WISEDCHAISRI, GORAGOT ..Poster ..............20...............14
WNV SURV WORKING GRP ...Poster ..............56...............63
WOLF, LESLIE ...........................Poster ..............50...............16
WONG, SUSAN ...........................Poster ..............56...............56
WONGSRICHANALAI, C .........Poster ..............54...............38
WONGSRICHANALAI, C .........Slide.................74
WOODLIEF, GINA ....................Slide.................79
WORON, R F................................Poster ..............28...............99
WRIGHT, CATHERINE C .........Poster ..............5.................29
WRIGHT, JENNIFER G.............Slide.................44
XUE, H ..........................................Poster ..............31...............124
YAMAGUCHI, HIROYUKI .......Poster ..............53...............33
YAMAMOTO, YOSHIMASA ......Poster ..............53...............33
YANG, HUA F...............................Poster ..............61...............90
YANG, WANG J ............................Poster ..............62...............106
YAZDANPANAH, MOJGAN ......Poster ..............2.................13
YAZDANPANAH, MOJGAN ......Slide.................82
YAZYSHINA, SVETLANA B.......Poster ..............23...............47
YAZYSHINA, SVETLANA B.......Slide.................34
YING, BAI ....................................Poster ..............23...............46
YISHAI, RUTH ............................Poster ..............6.................52
YISHAI, RUTH ............................Poster ..............28...............103
YOAKUM, GEORGE H ..............Poster ..............1.................10
YORK, THOMAS L......................Slide.................45
YOUNG, SHERI R.......................Poster ..............61...............94
YOUNG, SHERYL ......................Poster ..............22...............33
YOUSSEF, FOUAD G .................Poster ..............2.................15
YOUSSEF, FOUAD G .................Poster ..............5.................33
YOUSSEF, FOUAD G .................Poster ..............27...............62
YOUSSEF, FOUAD G .................Poster ..............51...............30
YOUSSEF, FOUAD G .................Slide.................80
YOUSSEF, MOHAMMAD .........Slide.................79
YURDANOVA, ALLA N ..............Poster ..............50...............10
ZAITSEV, B N ...............................Poster ..............62...............115
ZAMBONI, CHRISTINA ...........Poster ..............6.................36
ZAMIR, DORON .........................Poster ..............6.................52
ZAMIR, DORON .........................Poster ..............28...............103
ZANSKY, S ....................................Poster ..............4.................26
ZANSKY, S M................................Poster ..............28...............88
ZANSKY, S M................................Poster ..............28...............94
ZANSKY, SHELLEY M ...............Poster ..............4.................23
ZANSKY, SHELLEY M ...............Poster ..............50...............20
ZARCONE, PATINA ...................Poster ..............27...............74
ZELL, ELIZABETH ...................Poster ..............13...............111
ZHANSARINA, AIGUL G ..........Poster ..............62...............103
ZHU, FENG C..............................Poster ..............61...............90
ZHUANG, LING .........................Poster ..............61...............93
ZHUKOV, ALEXANDER N........Slide.................34
ZHUKOV, VLADIMIR ...............Poster ..............59...............81
ZICKER, FABIO .........................Poster ..............53...............32
ZIEBELL, KIM ...........................Poster ..............20...............13
ZOGHBI, NORMIG ....................Slide.................77
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